Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.9132002186477342,1.875462849779282,0.0,0.1486441040692164,0.19,4/11,5.82%,PRIMPOL;ATR;THOC1;FAM111A
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.8474238960880398,1.8412585294179704,0.0,0.12161790332935887,0.3,1/13,0.03%,CREB5
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8106527181408894,1.7493740099830961,0.0,0.39413209412292227,0.73,6/13,14.21%,PRIMPOL;ATR;THOC1;FAM111A;MSH3;MCM9
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.7349841395128827,1.6977456139495937,0.0,0.6705876058577149,0.95,3/20,5.82%,RSAD2;EIF2AK2;FAM111A
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.8089080436248042,1.6700171023443475,0.0,0.8364609128985906,0.99,2/10,1.65%,BMP6;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.8540615448352499,1.6553638619633955,0.0,0.8670906070704292,1.0,3/10,3.72%,RSAD2;HOMER1;IL15
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.8147502436137929,-1.6464245840098952,0.0,1.0,0.6,6/39,7.01%,PIK3R3;SERPINE1;JUN;CDKN1B;PIK3R1;PRKCE
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.7999088368636299,-1.6397085061329397,0.0,0.9737412757284545,0.71,12/41,7.81%,PIK3R3;SERPINE1;LDHA;PGK1;GAPDH;CDKN1B;PIK3R1;IFNGR1;FLT1;IFNGR2;HIF1A;SLC2A1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.8679518637832909,1.6387592256872967,0.0625,0.9478474688050035,1.0,2/7,5.26%,ARID5B;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.7681889291153027,1.6315641370701712,0.0,0.9172016876089149,1.0,4/22,5.82%,UBP1;RSAD2;EIF2AK2;FAM111A
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.7699229266817494,-1.6289086759132847,0.0,0.8405319682588586,0.78,9/45,6.88%,PIK3R3;PSMC6;MAP3K5;ITPR1;GRIN2B;GRIA2;PIK3R1;PSMA1;RB1CC1
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.7551573593203056,-1.6211190507351383,0.0,0.7682987522366129,0.85,13/69,9.83%,PIK3R3;MAP3K5;ITPR1;ERO1A;PPARG;JUN;FOS;HSPA5;NFE2L2;PIK3R1;VAV3;RAP1A;SOD2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.8588646814246437,-1.615658435226496,0.0136986301369863,0.709198848218412,0.87,1/13,0.37%,DDIT4
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.8440219231270656,-1.6111299191532642,0.012345679012345678,0.6735512870645763,0.91,6/21,7.81%,PIK3R3;PKM;LDHA;PIK3R1;HIF1A;SLC2A1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7404733148378146,-1.6105170087919822,0.0,0.5805459959338927,0.91,26/67,15.14%,RPS18;RPS12;RPL23;PPA1;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;PPA2;RPL37A;LARS1;RPL24;RPL7A;RPLP1
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.7779846936048309,-1.6038395623758246,0.012048192771084338,0.5938133213257338,0.93,9/49,7.92%,PIK3R3;MAP3K5;JUN;FOS;NFE2L2;DUSP1;PIK3R1;KLF2;PECAM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.8328989648577227,1.6034857028461371,0.03225806451612903,1.0,1.0,1/7,4.52%,OTUD4
prerank,KEGG_2021_Human__Autophagy,-0.7530413046789587,-1.5919714045674893,0.0,0.6641703499188302,0.97,8/52,7.49%,PIK3R3;DDIT4;ITPR1;ATG12;PIK3R1;RB1CC1;LAMP2;HIF1A
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.8591636038609861,1.591241199384083,0.02857142857142857,1.0,1.0,1/8,1.99%,UIMC1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.7910006350541101,-1.5890568842572392,0.0,0.6461589505989975,0.97,7/41,7.78%,PIK3R3;DOCK3;LBR;ARHGAP21;PIK3R1;GIT2;VAV3
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7541382899630102,-1.5848565840144666,0.0,0.6559833502279971,0.97,25/60,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;DMD;RPS27A;RPL37;EEF1A1;RRBP1;GGT5;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.7815498623785129,-1.5807844727290803,0.0,0.6716750996354273,0.99,3/47,1.62%,PIK3R3;PCK1;PRKAG2
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,-0.7460819040808259,-1.578002040277894,0.0,0.6710978111956889,0.99,20/43,19.26%,LDHA;PGK1;RPL34;SRGN;SCARB2;GAPDH;ATP2B1;TSC22D3;RPS27A;GGT5;TMEM132C;RPS11;RPS27;RPL8;NFKBIA;PTMA;ARHGAP29;RPS28;RPL31;IFITM3
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.8841425108520429,1.5765671754849002,0.0,1.0,1.0,4/7,8.26%,SLCO1A2;HSD17B4;OSBPL9;NCOA2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.7682891041429183,-1.5743466103529549,0.0,0.6665825908991649,0.99,4/49,2.47%,PIK3R3;PKM;PCK1;PPARG
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.8533272085670718,-1.5718608050768785,0.015625,0.6551646502589139,0.99,7/15,8.13%,SERPINE1;VSIR;SPOCK1;PSMB9;GAPDH;TIMP3;SERPINB6
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.8139932379156137,1.5716506640530437,0.06666666666666667,1.0,1.0,6/10,17.82%,CHD9;TBL1X;NCOA2;TBL1XR1;CPT1A;NCOA6
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.8584902836331394,-1.569804074525127,0.0,0.6529132253439347,0.99,3/20,6.27%,PIK3R3;FES;PIK3R1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.8183218776467747,-1.5686249576917892,0.013157894736842105,0.6231149544103881,0.99,7/32,6.27%,PIK3R3;MAP3K5;PRKAG2;PPARG;JUN;FOS;PIK3R1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.8519440613979103,-1.567506716137745,0.0,0.5978783940888904,0.99,9/16,9.19%,MAFF;SERPINE1;BHLHE40;NFKBIZ;LGALS3;TINAGL1;FOSL2;CD55;KLF4
prerank,KEGG_2021_Human__Chagas disease,-0.8252450485388786,-1.5669943228111964,0.011627906976744186,0.5717434323565309,0.99,8/33,8.74%,PIK3R3;SERPINE1;JUN;FOS;PIK3R1;IFNGR1;IFNGR2;PPP2R2B
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.7547323404358949,-1.5664780986056033,0.011111111111111112,0.5499105354836417,0.99,3/49,1.86%,PIK3R3;DDIT4;WNT2B
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.8652667883470138,-1.5660248516680355,0.012658227848101266,0.5296209085712705,0.99,2/17,1.86%,DIXDC1;WNT2B
prerank,KEGG_2021_Human__Ribosome,-0.7644519886645623,-1.565609730387009,0.0,0.5086173557930025,0.99,25/52,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;MRPL33;RPL31;RPS19
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.80849671665043,-1.5632746023597046,0.0,0.5065706058702942,0.99,1/25,0.05%,PIK3R3
prerank,KEGG_2021_Human__Coronavirus disease,-0.7374867327368884,-1.5624455314783672,0.0,0.49437538758082417,0.99,29/87,15.14%,PIK3R3;RPS18;RPS12;RPL23;RPL34;JUN;FOS;RPS9;RPS27A;RPL37;JAK1;PIK3R1;RPS11;RPL10;VWF;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;PLCG2;RPL15;NFKBIA;RPL37A;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.8245665817702518,-1.5616136868691486,0.0,0.4804540768565369,0.99,3/18,3.56%,MAP3K5;BCAP31;GRIN2B
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.7491939988202398,-1.5599941146998872,0.012048192771084338,0.47842779443305566,0.99,9/36,15.51%,PIK3R3;PIK3R1;IFNGR1;IFNGR2;VAV3;SHC2;PLCG2;TNFRSF10B;PPP3CC
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.7683474704489778,-1.559252065975206,0.011235955056179775,0.46612834350863286,0.99,8/39,10.81%,PIK3R3;ITPR1;MGLL;GRK5;PIK3R1;PRKCE;ANXA1;DGKG
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.7241698037314047,-1.5575375505083524,0.011363636363636364,0.46114006740732344,0.99,16/71,8.47%,TBX3;DDIT4;NRCAM;GRIK1;PBX3;SPOCK1;GRIN2B;NES;BTD;SEMA6B;ELP3;SMARCA1;MBP;SLC2A1;PRKN;NPAS2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7121028819747712,1.5565274513452132,0.041666666666666664,1.0,1.0,4/19,3.35%,PLA2G4A;IL1R1;OCLN;NKD1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.9102144345545422,-1.5563633886171002,0.014285714285714285,0.4564958103474836,0.99,1/9,0.16%,TBX3
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.8399753261280232,-1.5554550734801018,0.012195121951219513,0.44953450802415734,0.99,4/25,6.27%,PIK3R3;JUN;FOS;PIK3R1
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.8251896703664227,-1.5514636957185692,0.0,0.4658997041803495,0.99,3/21,6.27%,PIK3R3;JAK1;PIK3R1
prerank,KEGG_2021_Human__GnRH secretion,-0.8492653786017799,-1.5504212383152807,0.0375,0.4608385372847816,0.99,4/19,6.27%,PIK3R3;ITPR1;ESR2;PIK3R1
prerank,KEGG_2021_Human__Focal adhesion,-0.6918003896887356,-1.5500898576930822,0.0,0.44823823307310884,0.99,18/84,14.37%,PIK3R3;LAMC1;JUN;ACTN1;PIK3R1;LAMA5;FLT1;VAV3;RAP1A;ITGA10;VWF;ITGB5;MYL12A;SHC2;PAK2;PARVB;BCAR1;VEGFC
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7469682180336821,-1.5498578222533634,0.0,0.43637912322682865,0.99,23/51,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.7459282047939129,-1.5492060803849748,0.011363636363636364,0.43034379089171665,0.99,23/49,19.84%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;TRAM1;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19;SPCS3
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.753919357852776,-1.5480079204607835,0.0,0.4168178558812631,0.99,22/48,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.753919357852776,-1.5480079204607835,0.0,0.4168178558812631,0.99,22/48,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.9002989165670864,-1.5477891307786296,0.0,0.4085151260205472,0.99,3/13,2.31%,MAP2;NRCAM;RTN4
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9178156336990406,-1.547098427370069,0.0,0.4038132635968898,0.99,2/11,2.82%,TBX3;HES1
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.7776302551850629,-1.546143770904826,0.0125,0.401316491095022,0.99,5/31,6.27%,PIK3R3;NRG3;ESR2;ERBB4;PIK3R1
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.8578794152448967,-1.545756142941368,0.02631578947368421,0.3950976161774273,0.99,4/15,7.01%,PIK3R3;PKM;PIK3R1;PRKCE
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.9578478415957563,-1.543258813046441,0.0,0.39661729606899,1.0,1/8,0.16%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.9578478415957563,-1.543258813046441,0.0,0.39661729606899,1.0,1/8,0.16%,TBX3
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.8162528720357785,-1.5425031637609483,0.0,0.3937435163810014,1.0,4/27,6.27%,PIK3R3;FOS;ESR2;PIK3R1
prerank,KEGG_2021_Human__Alcoholism,0.5949308562730834,1.5419121156670261,0.0,1.0,1.0,4/31,6.93%,CREB5;H2AC6;GNB4;HDAC9
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.8369668178738696,1.5415958211490768,0.034482758620689655,1.0,1.0,1/7,6.08%,SMYD3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6738845317389391,1.5413113408317307,0.029411764705882353,1.0,1.0,6/17,14.21%,PSMD14;INO80;RAD51B;SEM1;SPIDR;MCM9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.7352478381754087,1.5407284774278565,0.06451612903225806,1.0,1.0,4/12,14.56%,PRIMPOL;ERCC6;CIRBP;CLOCK
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.8892856541317851,-1.5406886699553806,0.0273972602739726,0.3992526849229578,1.0,1/11,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.7816566011191581,-1.537696987556096,0.0,0.41259808767986283,1.0,1/33,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8513610669769436,1.53763224490901,0.02631578947368421,1.0,1.0,2/6,3.27%,PACS2;ATP2A2
prerank,KEGG_2021_Human__Amoebiasis,-0.8011174446300837,-1.5363969556675132,0.012048192771084338,0.41627409598230325,1.0,6/31,8.13%,PIK3R3;LAMC1;ACTN1;PIK3R1;LAMA5;SERPINB6
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.7477656241579211,-1.5357798451300704,0.011363636363636364,0.412292187555545,1.0,22/48,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;PBRM1;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,KEGG_2021_Human__Apoptosis,-0.7819925666638261,-1.5336535598823753,0.011904761904761904,0.4190407188695767,1.0,6/42,6.27%,PIK3R3;MAP3K5;ITPR1;JUN;FOS;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7936016486463868,1.5330216416170523,0.043478260869565216,1.0,1.0,3/13,3.24%,BMP6;PRKD1;IL6R
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,-0.7793579146795739,-1.532624391215543,0.0,0.41831474920311407,1.0,11/28,9.19%,ERO1A;NFKBIZ;LGALS3;S100A6;NFE2L2;EMP1;FOSL2;AHNAK;CD55;ANXA1;KLF4
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,0.8921231247513264,1.5315191705187823,0.0,1.0,1.0,1/6,2.39%,CASP10
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.7720500464011284,-1.5305577268130925,0.012658227848101266,0.42931582937591384,1.0,4/36,6.27%,PIK3R3;ITPR1;JUN;PIK3R1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.7572412000596381,-1.5299950319086129,0.0,0.42582238536190975,1.0,22/48,19.10%,ATF3;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.8208287222299481,1.5286829506364896,0.0,1.0,1.0,2/8,4.94%,PLA2G4A;GNB4
prerank,KEGG_2021_Human__Cellular senescence,-0.736151101952225,-1.527998954927167,0.011235955056179775,0.4369038726520734,1.0,3/58,1.04%,PIK3R3;SERPINE1;ITPR1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7779682438263396,-1.526742467616673,0.025,0.4388193931510162,1.0,6/27,12.22%,CEP57;NR4A1;HYAL2;KIF16B;FGFR1;ZFP36
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.738390961585773,-1.5262121388923207,0.0,0.4369811084982134,1.0,8/48,11.87%,PIK3R3;PPP2R3A;MAP3K5;PIK3R1;PRKCE;PPP2R2B;S1PR1;GNA13
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.8305426882549302,1.5251511155145079,0.0,1.0,1.0,2/10,2.79%,GULP1;ARHGAP12
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.8648715689306089,-1.5247379866910917,0.0,0.43983193874769994,1.0,2/17,0.40%,PIK3R3;DOK5
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.837360614027884,-1.5239511573742066,0.012658227848101266,0.4384353781801377,1.0,3/17,4.70%,MAP2;KDM1A;GPC5
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.7337188343567466,-1.5238024246122717,0.011111111111111112,0.43184658929555736,1.0,21/50,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,-0.7428603865119993,-1.523793803989928,0.027777777777777776,0.4245271555786835,1.0,3/34,1.20%,SERPINE1;LAMC1;PLS3
prerank,KEGG_2021_Human__Alzheimer disease,-0.7013134758751141,-1.5224061365035217,0.010638297872340425,0.42702025887436657,1.0,11/82,6.88%,PIK3R3;PSMC6;MAP3K5;ITPR1;WNT2B;RTN4;GRIN2B;GAPDH;PIK3R1;PSMA1;RB1CC1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.7542955438500405,-1.5218204477232802,0.013157894736842105,0.4251871314845749,1.0,10/28,12.75%,ENPP2;GLUL;GRIA2;GAS7;TMEM132C;SLC8A1;TNS1;VWF;PLXDC2;PLP1
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.750885463227433,-1.5214527890530911,0.0,0.4221421715585785,1.0,21/47,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.9247896147483392,1.5202599013534879,0.05555555555555555,1.0,1.0,2/6,0.98%,GBP2;GBP4
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.8520756602056845,-1.5196333902790886,0.0,0.43080837063607735,1.0,1/20,0.05%,PIK3R3
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.7089614882331515,-1.5191966691596035,0.010869565217391304,0.42741894870306074,1.0,20/73,16.49%,PIK3R3;ITPR1;JUN;FOS;RPS27A;JAK1;PIK3R1;IFNGR1;HIF1A;UBC;CLEC2B;GABARAPL1;ZFP36;PLCG2;NFKBIA;CDKN1A;CDK6;PPP3CC;PIK3C3;TBK1
prerank,KEGG_2021_Human__Homologous recombination,0.8671160722518605,1.5188266046657495,0.09090909090909091,1.0,1.0,5/7,12.88%,UIMC1;ATM;RAD51B;SEM1;BABAM2
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.6743976298757199,-1.5170568033158482,0.011111111111111112,0.4388546718890002,1.0,15/78,14.00%,PIK3R3;ITPR1;WNT2B;TIMP3;ERBB4;PIK3R1;HIF1A;ANK2;VAV3;ITGB5;RPS6;FGFR1;PLCG2;CDKN1A;MSN
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.8700392844788633,-1.5161295686738276,0.0,0.43936898340803976,1.0,1/15,0.05%,PIK3R3
prerank,KEGG_2021_Human__Breast cancer,-0.7500310183540018,-1.5155668704498064,0.0,0.43566752272692305,1.0,10/46,11.02%,PIK3R3;WNT2B;HES1;JUN;FOS;ESR2;PIK3R1;JAG2;SHC2;FGFR1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.7430889262944282,-1.5146005421370137,0.011627906976744186,0.43720685297498274,1.0,21/48,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.7091473356200486,-1.5133550793329311,0.010638297872340425,0.44033303228467763,1.0,23/61,19.10%,ATF3;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;MTOR;RPS19
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.9729269842240502,-1.5118766645151618,0.030303030303030304,0.4454605010351476,1.0,1/5,0.19%,CCDC3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.7749988342783746,1.5107679287342006,0.0625,1.0,1.0,2/8,13.84%,YEATS2;KAT6B
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.7300449490496678,-1.5106901185453578,0.012195121951219513,0.4526632487510767,1.0,8/50,13.07%,PIK3R3;MAP3K5;JUN;PIK3R1;RAP1A;SHC2;PLCG2;NFKBIA
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.8571793065351593,-1.50880078541802,0.02631578947368421,0.46326194604743265,1.0,1/13,0.05%,PIK3R3
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.7782661743743244,-1.5086316500000365,0.0,0.45799534229369065,1.0,7/35,6.27%,PIK3R3;NR4A1;NRG3;ESR2;CDKN1B;ERBB4;PIK3R1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.8071747484328591,-1.507306538689344,0.013333333333333334,0.46245484740110937,1.0,1/22,0.11%,CEP57
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.8519483570953704,-1.507185688980956,0.014285714285714285,0.4571893527350863,1.0,2/14,3.88%,SERPINE1;LGALS3
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.8106397636739289,-1.5070152245284594,0.0,0.45221054377836495,1.0,8/35,7.49%,PIK3R3;JUN;FOS;JAK1;PIK3R1;IFNGR1;IFNGR2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.7040036750435396,-1.5069777689453783,0.0,0.44648387599650174,1.0,9/65,7.92%,PIK3R3;SUN2;NEDD9;VSIR;HSPA5;SEMA6B;ELP3;FLT1;PECAM1
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.7217635484556452,-1.5067546792651427,0.0379746835443038,0.4427802332792201,1.0,10/34,14.16%,PIK3R3;ASAP2;PIK3R1;PRKCE;VAV3;CFL1;ARPC2;PLCG2;INPP5D;PLPP1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.8373742710164711,-1.5059794327453424,0.0410958904109589,0.4438726968455602,1.0,4/12,7.60%,CLIC2;CX3CL1;DMD;ANK2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.8169849328473278,-1.5047254259095015,0.025974025974025976,0.4483149861952104,1.0,1/17,0.05%,PIK3R3
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.7223605846038478,-1.5038693375194825,0.0,0.45084089038223163,1.0,10/63,6.27%,PIK3R3;JUN;FOS;KDM1A;RAD21;ESR2;CDKN1B;JUND;ERBB4;PIK3R1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7369042005445825,-1.5035218054236188,0.0,0.44904944493271887,1.0,24/51,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.690801795185338,-1.50315316173596,0.011363636363636364,0.44635177079495003,1.0,22/82,19.42%,PIK3R3;SSH1;ACTN1;PIK3R1;VAV3;ITGA10;TMSB4X;CFL1;ITGB5;MYL12A;FGFR1;ARPC2;GNA13;PAK2;BCAR1;MSN;MYH10;PIP5K1C;PIKFYVE;ITGB1;MYL12B;EGFR
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.8217647486454157,-1.5028053596503756,0.013888888888888888,0.4429142466670165,1.0,2/18,5.37%,TBX3;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.6691351700227726,-1.502660778120435,0.010638297872340425,0.4386305481418077,1.0,15/90,9.83%,PIK3R3;SUN2;NEDD9;VSIR;RTN4;ENPP2;HSPA5;SEMA6B;ELP3;PRKCE;FLT1;HIF1A;PECAM1;RREB1;SOD2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.8957190598149103,-1.5016822238921037,0.01639344262295082,0.4359224447450884,1.0,1/9,0.29%,LAMC1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8957190598149103,-1.5016822238921037,0.01639344262295082,0.4359224447450884,1.0,1/9,0.29%,LAMC1
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.7494560729690753,-1.4996202647032495,0.011764705882352941,0.4475986237222625,1.0,11/44,7.97%,PIK3R3;PPARG;JUN;JUNB;FOS;JUND;JAK1;PIK3R1;IFNGR1;IFNGR2;FOSL2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7317926232875996,-1.4986170383026973,0.0,0.4500320139042464,1.0,22/54,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;TRAM1;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.8844036309326345,-1.4975720836266433,0.0136986301369863,0.4527865662346828,1.0,1/11,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.9458750932265803,-1.496578860049779,0.0,0.4548620556251702,1.0,1/6,1.62%,PRKAG2
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.8170632810327025,-1.495964672155825,0.04054054054054054,0.45468994478599356,1.0,3/16,6.27%,PIK3R3;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.9405697841168081,-1.495876865734784,0.015873015873015872,0.45064811604662025,1.0,2/6,3.61%,GRIN2B;PSMB9
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.7177278420856515,-1.4949299972166166,0.03333333333333333,0.45244060259526514,1.0,21/54,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.8444168426260446,1.4936013838186062,0.05263157894736842,1.0,1.0,5/6,14.56%,ATR;ERCC6;ATM;STK33;CLOCK
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.7647547351084207,-1.492439901933435,0.012658227848101266,0.46628194949698426,1.0,5/34,6.27%,PIK3R3;NRG3;ESR2;ERBB4;PIK3R1
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.8073355368279169,-1.4921850541417172,0.013157894736842105,0.4630665098568963,1.0,5/22,6.27%,PIK3R3;NRG3;ESR2;ERBB4;PIK3R1
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.7286806083263038,-1.491955708817034,0.0,0.46131000190937443,1.0,23/53,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;LARS1;RPL7A;RPLP1;TXNRD1;RPS28;RPL31;RPS19
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,-0.8043127560133937,-1.491653006353824,0.013333333333333334,0.4586703921179331,1.0,15/24,15.86%,MAP2;MAP1B;GRIA2;GPM6B;NPAS3;ERBB4;CNTN1;STOX2;CTNND2;DCLK1;ATRNL1;ADGRL3;SYT1;LRP1B;CADM2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.9083552496433587,-1.489200891408578,0.0,0.47223069050041117,1.0,4/10,6.53%,ADAMTS9;HES1;SMAD7;FOXF1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.9851079770626494,-1.4885123367014033,0.0,0.4744878008318423,1.0,1/5,0.11%,CEP57
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.9839929597221411,-1.4880729476671264,0.0,0.4733565155404047,1.0,1/5,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8631204883421055,-1.4872392036346274,0.0273972602739726,0.4741235997426544,1.0,2/15,2.47%,CCDC3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.8622386735272395,-1.4872232827879504,0.03125,0.46952045799758013,1.0,5/11,8.13%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.9531264966332116,-1.4869980073163152,0.0,0.4671706698581602,1.0,3/6,4.01%,PCK1;PGK1;GAPDH
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.8263945101938992,-1.4861173968120407,0.02564102564102564,0.46958291083849496,1.0,5/25,6.27%,PIK3R3;FOS;ESR2;CDKN1B;PIK3R1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.8016901401377844,-1.4849754831992934,0.014084507042253521,0.4748170186260137,1.0,6/22,6.24%,MTHFD1L;LDHA;PPARG;SCP2;BTD;GGT5
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.8841207622861706,-1.4846197628342572,0.028985507246376812,0.47269402537388,1.0,1/7,0.16%,TBX3
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,-0.682456611334566,-1.4843527552195503,0.01098901098901099,0.47040188154169504,1.0,11/76,6.27%,PIK3R3;PCK1;JUN;FOS;KDM1A;RAD21;ESR2;CDKN1B;JUND;ERBB4;PIK3R1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.8126162103408838,-1.483642433656619,0.0136986301369863,0.4716631920508938,1.0,3/14,4.59%,ST18;SLC4A10;GRIA2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.9276987558795273,-1.4832556383800677,0.016129032258064516,0.46952443226927476,1.0,1/6,2.34%,SLC6A6
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.7105936115230566,-1.4824495939357218,0.022222222222222223,0.47198790785192174,1.0,21/53,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.8844794550824292,1.4816019041181205,0.08108108108108109,1.0,1.0,5/7,11.05%,ACAT1;HIBCH;HADHB;HIBADH;AUH
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.6253492812658159,1.4808897334511804,0.04,1.0,1.0,3/25,5.82%,RSAD2;EIF2AK2;FAM111A
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.724269110524769,-1.480548036358027,0.011494252873563218,0.48214666594440503,1.0,26/55,19.84%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19;CHMP4B;SPCS3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.8739241714949736,1.4805122194771256,0.07317073170731707,1.0,1.0,1/6,1.54%,ATG10
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.7219425587425614,-1.479342748411202,0.024691358024691357,0.4860487681496884,1.0,11/40,14.50%,PIK3R3;JUN;NRG3;CDKN1B;ERBB4;PIK3R1;SHC2;PLCG2;PAK2;CDKN1A;NCK1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.7104611600336922,-1.479237684713691,0.022222222222222223,0.48257515611854346,1.0,21/55,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.7090319450695624,-1.4789410656243047,0.010638297872340425,0.4803366112087988,1.0,18/57,20.35%,PIK3R3;WNT2B;PHF10;NFE2L2;PIK3R1;PBRM1;SHC2;PLCG2;CDKN1A;SMAD3;CDK6;SMARCC1;TXNRD1;MTOR;GRB2;EGFR;GADD45B;PIK3CB
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.938602382705573,-1.4787423788476852,0.0,0.4783307502556859,1.0,3/7,4.01%,PCK1;PGK1;GAPDH
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.7103954328588409,-1.4773857140570752,0.0,0.48617308099954354,1.0,24/62,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;PBRM1;RPS11;RPS27;RPS6;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;NUP54;RPL31;RPS19
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.7297022640930805,-1.4771498360988027,0.011764705882352941,0.48386555799889497,1.0,21/48,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.7131578190483182,-1.4771011768079436,0.03614457831325301,0.48027244930037044,1.0,15/50,14.00%,PIK3R3;CD99L2;ACTN1;PIK3R1;RAPGEF3;VAV3;PECAM1;RAP1A;AFDN;MYL12A;PLCG2;CLDN5;CTNNA3;BCAR1;MSN
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.7752299502906513,-1.4770077325252002,0.05263157894736842,0.4765516070039064,1.0,4/17,9.61%,ADAMTS9;DENND3;PRKN;NGLY1
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.7421504121038328,-1.4754004256197328,0.0,0.48424242489529506,1.0,5/44,6.27%,PIK3R3;TBX3;WNT2B;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.9560542205860282,-1.4739140704636795,0.014925373134328358,0.49272987893394743,1.0,1/6,0.37%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.8173340840110426,-1.4729417886802578,0.012658227848101266,0.4965032586894934,1.0,8/22,11.00%,DDIT4;MAP3K5;SLC6A6;GRIN2B;FOS;CDKN1B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.8430582200391239,1.4727797658314945,0.02631578947368421,1.0,1.0,4/5,14.56%,ATR;ERCC6;ATM;CLOCK
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.7774093232883538,1.4722351577885096,0.027777777777777776,1.0,1.0,2/11,1.81%,CREB5;UBE3D
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6797185281742838,-1.4720466282245204,0.0,0.5005789105320435,1.0,18/76,15.59%,TBX3;NR4A1;RPL23;JUN;GRK5;JUNB;CDKN1B;JUND;DUSP1;MAGI2;RASSF1;CRLF3;CDKN1A;SDCBP;CYLD;SMAD3;CDK6;RACK1
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.7191292315339913,-1.471881570369806,0.0,0.4980151911933737,1.0,14/40,12.56%,CCDC3;MAP2;DOK5;ADM;MAP1B;NES;NFASC;PTPRD;ANK2;SHC2;STOX2;GJA1;DCLK1;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.8931721876757887,-1.4717094220826794,0.03225806451612903,0.4954921658124606,1.0,5/9,7.49%,ATF3;HSPA5;NFE2L2;KLF2;HIF1A
prerank,KEGG_2021_Human__Small cell lung cancer,-0.7617011467160241,-1.4712053192501187,0.0,0.4961112302810213,1.0,5/35,6.43%,PIK3R3;LAMC1;CDKN1B;PIK3R1;LAMA5
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.8729673588852765,-1.4706781850898887,0.02857142857142857,0.4954014275811402,1.0,3/11,6.27%,PIK3R3;JAK1;PIK3R1
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,-0.7473925983774025,-1.4700559252878846,0.05194805194805195,0.4966224492692239,1.0,9/30,11.93%,CCDC3;ADAMTS9;NES;FOXF1;PTPRD;FLT1;ADAMTS1;SHC2;GJA1
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,-0.7544139099417833,-1.4695789126511334,0.02531645569620253,0.49661238028480975,1.0,7/24,8.07%,SUN2;ZEB2;GLUL;MBP;SLC2A1;AHNAK;RASSF1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.7451784814174924,-1.4687713726497995,0.025974025974025976,0.4994382292312383,1.0,14/40,19.07%,PIK3R3;JUN;FOS;PIK3R1;VAV3;PAK2;NFKBIA;TEC;NCK1;PPP3CC;MALT1;LCP2;DLG1;GRB2
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.7281361685597334,-1.468620821076373,0.06172839506172839,0.49701910623098905,1.0,1/31,0.05%,PIK3R3
prerank,KEGG_2021_Human__Melanoma,-0.7772639740487324,-1.4671586554949674,0.02631578947368421,0.5058088455607148,1.0,1/22,0.05%,PIK3R3
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.7186192800969963,-1.467056868268738,0.036585365853658534,0.5027902282145458,1.0,6/40,7.49%,PIK3R3;JUN;CHPT1;FOS;PIK3R1;HIF1A
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,0.6851123826651204,1.466641509671183,0.0,1.0,1.0,4/19,1.86%,RSAD2;SAMD9L;GBP2;GBP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.8655805151480557,1.4661866081845123,0.02564102564102564,1.0,1.0,3/7,6.85%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.7257025881824171,-1.4651603791805008,0.024390243902439025,0.5136584250470803,1.0,14/32,18.83%,MAP2;RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;SMAD3;BTG1;RACK1;ADAM15;ACVRL1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.763322180792041,-1.4647683495506223,0.02564102564102564,0.5134407627799731,1.0,5/18,7.81%,MTHFD1L;SLC2A3;BTD;SLC52A3;SLC2A1
prerank,Reactome_2022__Translation R-HSA-72766,-0.6804013764452415,-1.4647311551796864,0.03260869565217391,0.509939526363511,1.0,28/73,19.84%,RPS12;RPL23;PPA1;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RPS11;TRAM1;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;PPA2;RPL37A;LARS1;RPL7A;RPLP1;RPS28;MRPL33;RPL31;RPS19;SPCS3
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.9016750721633178,-1.46453088169068,0.0,0.5073863395351418,1.0,3/8,4.01%,PCK1;PGK1;GAPDH
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.9131227382840348,-1.4639294969071444,0.0,0.5083523090404216,1.0,3/8,6.27%,PIK3R3;JAK1;PIK3R1
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.6891869818825636,-1.4635036919825528,0.0,0.5073746861970725,1.0,11/53,11.66%,PIK3R3;PCK1;PRKAG2;ATG12;CDKN1B;PIK3R1;KLF2;BCL6;SOD2;S1PR1;GABARAPL1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.948054050120574,-1.4634314039325116,0.015151515151515152,0.5041754729820186,1.0,1/5,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.917783112235113,-1.4633503220901634,0.017543859649122806,0.5014969722590737,1.0,2/7,2.47%,PRKAG2;PPARG
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.937132558757795,-1.4629532978142945,0.0,0.5006665195547897,1.0,3/6,3.19%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.7187201017771864,-1.462047282169508,0.03571428571428571,0.5055543376795051,1.0,7/30,9.54%,SERPINE1;ADAMTS9;PGK1;PPARG;KLF2;KLF4;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.9056483266915627,-1.4614998851571885,0.014285714285714285,0.5052508050580651,1.0,2/8,3.88%,SERPINE1;LGALS3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.8048622323879794,-1.461331682571627,0.041666666666666664,0.503409358558166,1.0,4/16,4.59%,MAP2;RTN4;GRIN2B;GRIA2
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.8402242572736364,-1.461291256319961,0.04285714285714286,0.5005974377285131,1.0,3/13,7.78%,PIK3R3;PIK3R1;VAV3
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.7539043555003041,-1.461238739960299,0.0375,0.497519269218858,1.0,1/32,0.05%,PIK3R3
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.6861656194211331,-1.4602649286998661,0.024390243902439025,0.5007531656537375,1.0,12/56,10.49%,SERPINE1;LAMC1;ADAMTS9;DMD;ACTN1;LAMA5;COL18A1;PECAM1;PLOD2;ITGA10;ADAMTS1;ITGB5
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.8686109777721179,-1.460048815939083,0.02857142857142857,0.4995161411366931,1.0,1/11,0.32%,MAP2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.9092450215434277,-1.4598203738967759,0.0,0.4974008951238562,1.0,1/7,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6855482626218988,-1.459491787855981,0.012658227848101266,0.49635032171677074,1.0,12/56,10.49%,SERPINE1;LAMC1;ADAMTS9;GPM6B;LAMA5;COL18A1;PECAM1;PLOD2;ITGA10;VWF;ADAMTS1;ITGB5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6978748407221268,-1.459340250715242,0.0,0.49420984163119336,1.0,21/60,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.8484850400705611,1.4589511124845171,0.14705882352941177,1.0,1.0,4/5,10.84%,PLA2G4A;PLAAT3;OSBPL8;PLA1A
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.7282754738873581,1.45866117045777,0.0,1.0,1.0,5/15,17.88%,TNRC6C;ANAPC16;CDC16;TCF7L2;TNRC6A
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.9644221658146839,-1.4586337435129793,0.015873015873015872,0.49553277592997474,1.0,3/6,3.19%,RIMKLB;GLUD1;GLUL
prerank,KEGG_2021_Human__Glioma,-0.7361182383857791,-1.4585757691770422,0.012195121951219513,0.4924810434991348,1.0,11/31,20.35%,PIK3R3;PIK3R1;SHC2;PLCG2;CDKN1A;CDK6;MTOR;GRB2;EGFR;GADD45B;PIK3CB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.6482117282588195,-1.4584769018694477,0.0,0.4904786906125911,1.0,21/140,9.99%,PIK3R3;SERPINE1;SUN2;NEDD9;VSIR;CX3CL1;ENPP2;HSPA5;SMAD7;SEMA6B;ELP3;ERBB4;MAGI2;FLT1;PECAM1;TPM1;ANXA1;DLC1;TMSB4X;SOD2;AFDN
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.8326026295908446,-1.4582408694735634,0.05555555555555555,0.48900375541902436,1.0,4/12,10.15%,MAP2;FOS;NES;PRNP
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.6392175428938874,-1.4569837499324882,0.0,0.4950997384237235,1.0,23/142,14.50%,PIK3R3;CEP57;DDIT4;NEDD9;GRIN2B;FES;ERBB4;PIK3R1;FLT1;VAV3;SULF2;ANKS1B;KIF16B;SHC2;EFNB2;FGFR1;ARPC2;PAK2;CASS4;BCAR1;SDCBP;VEGFC;NCK1
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.8673609504633251,-1.4555775978528442,0.013513513513513514,0.5016146390763151,1.0,5/15,8.84%,RFC3;NPLOC4;RPS27A;WDR48;UBC
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.7722590962533349,-1.455343844169905,0.03896103896103896,0.5001681162683225,1.0,11/30,15.83%,PIK3R3;JUN;FOS;PIK3R1;VAV3;CD81;PLCG2;INPP5D;NFKBIA;PPP3CC;MALT1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.7509194523773062,-1.4549320843879179,0.012048192771084338,0.5003477233413148,1.0,6/28,8.29%,CCDC3;PCK1;PRKAG2;PPARG;LSS;SIN3B
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.9367930839103579,-1.4544813297396442,0.04838709677419355,0.5006640898896392,1.0,2/5,2.31%,NRCAM;RTN4
prerank,KEGG_2021_Human__Colorectal cancer,-0.7369972424461819,-1.4539397227275046,0.0,0.502357816918953,1.0,4/39,6.27%,PIK3R3;JUN;FOS;PIK3R1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.7108029493929529,-1.4539140766970429,0.03614457831325301,0.49936330050222094,1.0,7/27,9.40%,RFC3;RPS27A;POLA1;HMGN1;COMMD1;UBC;CCNH
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.6997190063951673,-1.4538746289814501,0.03529411764705882,0.4965415312490238,1.0,15/50,20.48%,TBX3;PPARG;HES1;ABCA5;SMAD7;ZFPM2;NFKBIA;TRIB2;SMAD3;WWTR1;CDK6;NOTCH4;GATA2;EGFR;SPRED1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,-0.7269679264887148,-1.4531794186559523,0.03614457831325301,0.49343729386624957,1.0,12/21,17.03%,GRIA2;GPM6B;NPAS3;TMEM132C;LSAMP;CTNND2;ADGRL3;PLP1;LRRC4C;CACNA1C;CADM2;TRIM9
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,-0.7269679264887148,-1.4531794186559523,0.03614457831325301,0.49343729386624957,1.0,12/21,17.03%,GRIA2;GPM6B;NPAS3;TMEM132C;LSAMP;CTNND2;ADGRL3;PLP1;LRRC4C;CACNA1C;CADM2;TRIM9
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,-0.7269679264887148,-1.4531794186559523,0.03614457831325301,0.49343729386624957,1.0,12/21,17.03%,GRIA2;GPM6B;NPAS3;TMEM132C;LSAMP;CTNND2;ADGRL3;PLP1;LRRC4C;CACNA1C;CADM2;TRIM9
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,-0.7126040531012401,-1.4525264973896526,0.060240963855421686,0.4953134812953988,1.0,11/43,10.94%,SERPINE1;ANGPTL4;MGLL;TINAGL1;EMP1;TNS1;NPAS2;DLC1;TGM2;EPAS1;CFH
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.6393535425045912,-1.452124107918379,0.0,0.4952472629155465,1.0,22/106,9.03%,TBX3;RAPGEF5;NRCAM;GRIK1;ZEB2;HES1;SPOCK1;NES;NFASC;BTD;SEMA6B;SPG7;ELP3;GPM6B;FEZ2;ERBB4;PRX;MBP;SLC2A1;PRKN;NPAS2;LSAMP
prerank,KEGG_2021_Human__Endometrial cancer,-0.748647818604398,-1.4518564487037262,0.03571428571428571,0.49399685853810116,1.0,1/29,0.05%,PIK3R3
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.8643035218412386,1.450267419249179,0.12903225806451613,1.0,1.0,3/6,8.26%,HSD17B4;OSBPL9;NCOA2
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.6606770058744919,-1.4502043428976448,0.010752688172043012,0.5023164599553628,1.0,18/109,9.43%,PIK3R3;PSMC6;ITPR1;NR4A1;PPARG;JUN;NRG3;PSMB9;KDM1A;ESR2;RPS27A;CDKN1B;ERBB4;PIK3R1;PSMA1;PRKCE;UBC;CNOT6L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.8458283465019534,-1.4500571737360137,0.043478260869565216,0.5012348589619623,1.0,3/10,7.30%,PIK3R3;PIK3R1;FLT1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.7527796897857988,-1.4471457860512982,0.036585365853658534,0.521191928594009,1.0,1/26,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.9541547506446242,-1.4462657831016144,0.031746031746031744,0.5250322901731228,1.0,1/5,0.50%,B3GNT2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,-0.7014934443809664,-1.4461456515613973,0.06578947368421052,0.5230725271221295,1.0,8/43,10.92%,SERPINE1;LAMC1;RRBP1;EMP1;COL18A1;TGM2;ITGB5;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.874168929356177,1.4459239028322493,0.02702702702702703,1.0,1.0,1/5,0.16%,BMP6
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.9020258577080977,-1.4457621974734705,0.0,0.5232972937979636,1.0,2/6,1.91%,PGK1;VSIR
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.8367278755460116,1.4451330393029114,0.11428571428571428,1.0,1.0,1/5,2.28%,RC3H1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.8661965946836426,-1.4448120040015966,0.015384615384615385,0.5271875868333049,1.0,1/11,0.24%,SERPINE1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,-0.8088156968080902,-1.4448034048344314,0.02666666666666667,0.5156010464633423,1.0,2/14,4.06%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,-0.8088156968080902,-1.4448034048344314,0.02666666666666667,0.5156010464633423,1.0,2/14,4.06%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,-0.8088156968080902,-1.4448034048344314,0.02666666666666667,0.5156010464633423,1.0,2/14,4.06%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,-0.8088156968080902,-1.4448034048344314,0.02666666666666667,0.5156010464633423,1.0,2/14,4.06%,CCDC3;NES
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.7703289514730852,-1.4443682040889738,0.05128205128205128,0.5158592715031314,1.0,5/16,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.6882758355838287,1.4403699698672394,0.03125,1.0,1.0,2/14,3.19%,FAXDC2;TNRC6C
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5892139802129663,1.4400879524143497,0.05263157894736842,1.0,1.0,3/16,3.24%,SAMD9L;GBP2;IL6R
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.9582729313512073,-1.439726283948001,0.0,0.5442575011862485,1.0,5/6,4.01%,PKM;LDHA;PCK1;PGK1;GAPDH
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.7971991342147471,-1.4396231175593688,0.013513513513513514,0.5427151031540125,1.0,3/22,1.81%,PKM;PCK1;PGK1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,-0.7204365509379493,-1.439622690613347,0.0125,0.5397972800187759,1.0,20/50,13.81%,DOK5;BTG2;ATF3;DTNA;JUN;SPOCK1;GLUL;JUNB;FOS;JUND;TIMP3;HIF1A;GRAMD2B;TNS1;DGKG;EPAS1;ZFP36;NFKBIA;CST3;PON2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.73091900192334,1.4390545117116478,0.037037037037037035,1.0,1.0,4/12,4.52%,PSMD14;UIMC1;USP25;OTUD4
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.845789781214985,1.438754394661909,0.034482758620689655,1.0,1.0,3/9,8.26%,ARNT2;MIA3;NCOA2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.9181508438839998,-1.4383245386722427,0.0,0.5466628249445207,1.0,3/6,7.60%,SMAD7;DMD;ANK2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.8704789654114604,-1.4383020710099577,0.03389830508474576,0.5440544355718078,1.0,3/7,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.7409937006394922,-1.4381538563517335,0.023529411764705882,0.5421288247655989,1.0,19/48,15.46%,DDIT4;BHLHE40;NRCAM;WNT2B;CX3CL1;HES1;SPOCK1;MAP1B;ELP3;PTPRD;SMARCA1;IL1RAPL1;GPM6A;FGFR1;ADGRL3;NAV1;MYEF2;PAFAH1B1;CDK6
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.640762506138191,-1.4368825958895095,0.0,0.5472147503880745,1.0,35/125,15.14%,LAMC1;RPS18;DENND3;ERO1A;RPS12;RPL23;RPL34;RPS9;SPG7;RPS27A;RPL37;EEF1A1;RRBP1;MGAT4A;RPS11;SHISA5;PRKN;MSRB3;PLOD2;RPL10;RPS27;RPS6;MSRA;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;CST3;RPL37A;STK38;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.8404607683219519,1.4362490449846046,0.08823529411764706,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.8404607683219519,1.4362490449846046,0.08823529411764706,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,KEGG_2021_Human__Measles,-0.7465530952189612,-1.4352998186274744,0.036585365853658534,0.5559015653948359,1.0,6/41,6.27%,PIK3R3;JUN;FOS;CDKN1B;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.8834830842196976,-1.4352460024628657,0.0136986301369863,0.5532407681703815,1.0,2/10,1.75%,PIK3R3;NR4A1
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.8625052670803453,-1.4351792619605923,0.013333333333333334,0.5507825251851686,1.0,4/12,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,-0.7790296222942671,-1.4342938394097668,0.05333333333333334,0.5539781871985909,1.0,6/19,9.19%,CD9;LGALS3;S100A6;EMP1;ANXA1;KLF4
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.9408026572577564,-1.4338747045319857,0.014084507042253521,0.5543700886806194,1.0,1/6,0.85%,BHLHE40
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.9577972199811304,-1.433329614658287,0.01639344262295082,0.5556769401128228,1.0,1/6,0.53%,PSMC6
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,-0.764277302606178,-1.4333153097968716,0.02631578947368421,0.5529705305140256,1.0,10/21,12.56%,MAP2;GRIN2B;MAP1B;GRIA2;GPM6B;NPAS3;CNTN1;IL1RAPL1;DCLK1;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.8256196220744374,-1.433235714603143,0.09210526315789473,0.5506325833730414,1.0,4/9,8.50%,PCK1;VSIR;BCL6;PNP
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.8203451100852622,-1.4332094231912582,0.04054054054054054,0.5478655854666443,1.0,3/16,6.27%,PIK3R3;MGLL;PIK3R1
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.7301175683214554,-1.4330931462085987,0.03896103896103896,0.5463645412425496,1.0,9/33,13.17%,PIK3R3;JUN;PIK3R1;HIF1A;SLC2A1;RAP1A;EPAS1;PAK2;CDKN1A
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.6743322104617834,-1.433009565419056,0.045454545454545456,0.5442063656430789,1.0,7/59,6.27%,PIK3R3;PSMC6;HES1;JUN;CDKN1B;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8338442974965707,1.4328847356457306,0.0625,1.0,1.0,3/6,12.93%,ABL1;MTERF1;TOP2B
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,-0.6677471396539609,-1.432111902097217,0.010752688172043012,0.548255403801095,1.0,34/75,19.60%,PCDH9;RPS18;RPS12;RPL23;PDE5A;RPL34;TSC22D3;RPS27A;EEF1A1;TIMP3;TPM1;LSAMP;RPL10;ADAMTS1;DLC1;TMSB4X;PLIN2;RPS6;CFH;RPL8;PPFIA2;RPS7;RPL13A;RIMS2;RPL15;NPM1;SYT1;RPL24;CALD1;CHSY1;RPL31;TFPI;RPS19;EMP2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.7008874914674299,-1.4318472539150935,0.025974025974025976,0.5440391724700686,1.0,10/43,10.49%,SERPINE1;LAMC1;ADAMTS9;LAMA5;COL18A1;PECAM1;ITGA10;VWF;ADAMTS1;ITGB5
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.7008874914674299,-1.4318472539150935,0.025974025974025976,0.5440391724700686,1.0,10/43,10.49%,SERPINE1;LAMC1;ADAMTS9;LAMA5;COL18A1;PECAM1;ITGA10;VWF;ADAMTS1;ITGB5
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.6608035782176517,-1.4317218355451913,0.010638297872340425,0.542373753298742,1.0,14/93,6.48%,PIK3R3;PSMC6;NR4A1;PPARG;JUN;NRG3;PSMB9;KDM1A;ESR2;RPS27A;CDKN1B;ERBB4;PIK3R1;PSMA1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.6900012659690176,-1.4316440530652872,0.034482758620689655,0.5402326871233796,1.0,17/43,22.50%,LAMC1;NRCAM;NFASC;CNTN1;ANK2;ITGA10;FGFR1;MSN;SDCBP;ANK3;DLG1;ITGB1;EGFR;SCN2A;CHL1;CLTA;DNM2
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.8252303430840138,-1.4305517071080482,0.0684931506849315,0.5455082928056814,1.0,2/14,1.75%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.9495711529413178,-1.4305314861056764,0.01639344262295082,0.5429397775738025,1.0,2/6,2.31%,MAP2;RTN4
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,-0.7349668194310007,-1.4302896563488088,0.0641025641025641,0.5423348676776175,1.0,11/29,11.93%,PSMC6;LDHA;GLUD1;RPL23;AKAP12;RPL34;RPS27A;PSMA1;KLF4;ATP1B3;GJA1
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.7469182214526098,-1.428760785539926,0.041666666666666664,0.5506878131328606,1.0,1/25,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.9572159289043713,-1.4285801491640477,0.0,0.5493583495151574,1.0,4/5,4.01%,PKM;LDHA;PGK1;GAPDH
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.8728159818958445,-1.4284818156539822,0.0,0.547191833699516,1.0,1/11,0.16%,TBX3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.9476351135502636,-1.4273593902584227,0.0,0.5529732132729148,1.0,4/6,4.01%,PKM;LDHA;PGK1;GAPDH
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.7294981194062167,-1.4263948102722006,0.06666666666666667,0.5565964258269557,1.0,3/26,7.78%,PIK3R3;PIK3R1;VAV3
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6970376283496406,-1.4263209876831566,0.022988505747126436,0.5543741162743849,1.0,22/53,19.10%,RPL23;RPL34;GLUL;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;NPM1;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.8645342205748143,-1.425388709863698,0.06349206349206349,0.5573840154097528,1.0,3/9,2.82%,BHLHE40;CX3CL1;HES1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.8488316235979978,-1.4253124811584437,0.043478260869565216,0.5553860631282509,1.0,3/9,9.06%,RTN4;SCARB2;CD81
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.8289802958993184,-1.424657239831411,0.04,0.5580022392491742,1.0,1/14,0.16%,TBX3
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.7772441605686515,-1.4246231176017528,0.06666666666666667,0.5505803598644556,1.0,5/15,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.7772441605686515,-1.4246231176017528,0.06666666666666667,0.5505803598644556,1.0,5/15,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.7772441605686515,-1.4246231176017528,0.06666666666666667,0.5505803598644556,1.0,5/15,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.7081289168369554,-1.424289198427593,0.04938271604938271,0.5503821177293466,1.0,6/42,8.90%,TBX3;LAMC1;PLS3;NES;SMARCA1;PLOD2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.8464092338237097,-1.4241859929273761,0.10294117647058823,0.5485702814142988,1.0,3/12,2.82%,BHLHE40;CX3CL1;HES1
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.6700048867662749,-1.4235399396393162,0.045454545454545456,0.5505940037614031,1.0,17/45,21.62%,SERPINE1;ITPR1;PRKAG2;KLF2;PRKCE;SLC8A1;RPS6;GABARAPL1;GNA13;MEF2A;SMAD3;PIK3C3;MTOR;PLAT;GNAI3;RYR3;ADCY2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6594471547624973,-1.4223616886424306,0.0,0.555751732346393,1.0,29/89,16.18%,RPS18;RFC3;RPS12;RPL23;RPL34;RPS9;RPS27A;POLA1;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;GOLPH3;RPS7;RPLP2;RPL13A;MEF2A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;PTMA;THRB
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.6927590050562715,-1.421897882130808,0.05747126436781609,0.5563310813141904,1.0,12/42,11.13%,SERPINE1;UFL1;MGLL;NFKBIZ;PPARG;CX3CL1;BCL6;ANXA1;KLF4;TMSB4X;HYAL2;SNX6
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.8813295890730132,-1.4216026649958777,0.0,0.5552688275995775,1.0,5/10,4.01%,PKM;LDHA;PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8766398232877255,-1.4213417839932803,0.0,0.5545121320203972,1.0,4/8,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.8997250287011347,-1.4211290868626916,0.04285714285714286,0.5537620451362314,1.0,1/7,0.85%,BHLHE40
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,-0.6733513220114478,-1.4207976563232882,0.08045977011494253,0.5423059885633665,1.0,9/45,7.60%,CCDC3;RAPGEF5;ADAMTS9;KIAA1217;NES;KHDRBS3;PTPRD;SMARCA1;ANK2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.890459533009375,-1.420793446539238,0.029411764705882353,0.5378245635508055,1.0,2/8,2.52%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.890459533009375,-1.420793446539238,0.029411764705882353,0.5378245635508055,1.0,2/8,2.52%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.8264563168286323,-1.4204709026539257,0.06329113924050633,0.5374094513443775,1.0,4/11,11.93%,PLS3;SULF2;TGM2;GJA1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.7872850829653204,-1.4204416467785457,0.0410958904109589,0.5355847846909452,1.0,4/16,10.17%,MAFF;JUNB;CD81;CREM
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.6850200222707774,-1.4191956329235207,0.034482758620689655,0.5422181670241297,1.0,21/55,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.7661432768872847,-1.4177532108621025,0.039473684210526314,0.5501510922950968,1.0,4/17,11.16%,TBX3;HIF1A;FGFR1;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.6227734463230157,-1.417571950096453,0.0,0.5489011156353969,1.0,28/101,15.46%,TBX3;LAMC1;UFL1;RPL23;CX3CL1;HES1;GRK5;NES;RPS9;KDM1A;S100A6;ERBB4;FLT1;CD81;CNOT6L;ZFPM2;RPS6;EFNB2;FGFR1;GJA1;CLDN5;NPM1;CDKN1A;CNBP;SDCBP;VEGFC;WWTR1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.8803800419245155,-1.4164280440894217,0.0821917808219178,0.5548882228728289,1.0,3/8,4.46%,CX3CL1;NES;KDM1A
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.8486792451228404,1.4156987556014349,0.1,1.0,1.0,2/6,2.23%,CTBP2;TLE4
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.6810419459075678,-1.4152633837007453,0.0,0.5614260202946822,1.0,9/64,8.15%,PIK3R3;DDIT4;ZEB2;CDKN1B;TIMP3;PIK3R1;PRKCE;RASSF1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.8354704848408472,1.4148418096673094,0.1111111111111111,1.0,1.0,2/5,13.94%,DDX60;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8354704848408472,1.4148418096673094,0.1111111111111111,1.0,1.0,2/5,13.94%,DDX60;ANKRD17
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,-0.7991758704198719,-1.4147499905691971,0.10606060606060606,0.562718386403038,1.0,8/14,12.75%,GPM6B;PTPRD;ANK2;STOX2;CTNND2;DCLK1;ADGRL3;PLP1
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.8930446326887639,-1.4135345001833206,0.07352941176470588,0.5689423977222554,1.0,1/9,0.05%,PIK3R3
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.6357361795637235,-1.4134212693139796,0.0,0.5674593444616314,1.0,15/102,12.54%,PIK3R3;ADM;ITPR1;MGLL;CX3CL1;GRK5;GRM7;PIK3R1;PRKCE;PDE7A;VAV3;ANXA1;DGKG;GNA13;FGD4
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8281452241563798,-1.4132513024699642,0.09836065573770492,0.5665783425155029,1.0,5/10,8.13%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,-0.6981584642531797,-1.4130310201458038,0.0379746835443038,0.5658852542327955,1.0,2/35,0.19%,TBX3;CCDC3
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.8958148201123664,-1.4123534427030027,0.04225352112676056,0.5687999905203162,1.0,2/8,3.80%,MAP2;MAP1B
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.7371626499984262,-1.4122054964155968,0.07407407407407407,0.5676102335453249,1.0,9/20,19.02%,BHLHE40;NDRG1;MGLL;KLF4;CDKN1A;SLC20A1;KLF12;MYO1E;TBC1D9
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.86736403759563,-1.4121210913882856,0.06451612903225806,0.5658491944055569,1.0,1/8,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6842596652094705,-1.4118132054238437,0.011494252873563218,0.5657483753746853,1.0,20/49,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7484006976764569,-1.4115797279891982,0.06756756756756757,0.5653824338659094,1.0,6/18,13.23%,SERPINE1;ANXA1;KLF4;TMSB4X;HYAL2;RAB1A
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,-0.7678728881637723,-1.410670592180585,0.05714285714285714,0.5700961049419591,1.0,5/21,6.19%,PRKAG2;GRIN2B;GRIA2;LRRC7;ERBB4
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.6238163617491069,-1.410635794087859,0.010101010101010102,0.5680450596035123,1.0,58/208,19.10%,PIK3R3;LAMC1;DOK5;PSMC6;NRCAM;RPS12;RPL23;RPL34;GRIN2B;PSMB9;MYO9B;NFASC;RPS9;RPS27A;FES;RPL37;PIK3R1;PSMA1;CNTN1;ANK2;RPS11;VAV3;UBC;ITGA10;PRNP;RPS27;RPS6;MYL12A;EFNB2;FGFR1;ARPC2;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;MSN;SH3KBP1;SDCBP;RPL37A;NCK1;CACNA1C;RPL7A;RPLP1;MYL6;ROBO2;MYH10;PIP5K1C;RPS28;DAG1;ANK3;RPL31;DLG1;ITGB1;MYL12B;GRB2;RPS19
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.8376157336747875,-1.4102471208701,0.0759493670886076,0.5682876818470556,1.0,1/11,0.05%,PIK3R3
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.6243055568650865,-1.4095851637500232,0.010101010101010102,0.5707100365877217,1.0,61/217,19.10%,PIK3R3;LAMC1;DOK5;PSMC6;NRCAM;RPS12;RPL23;RPL34;GRIN2B;PSMB9;MYO9B;NFASC;RPS9;RPS27A;FES;RPL37;PIK3R1;PSMA1;PRX;CNTN1;ANK2;RPS11;VAV3;UBC;ITGA10;PRNP;RPS27;RPS6;MYL12A;EFNB2;FGFR1;ARPC2;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;MSN;SH3KBP1;SDCBP;RPL37A;NCK1;CACNA1C;RPL7A;RPLP1;WWTR1;SREBF2;MYL6;ROBO2;MYH10;PIP5K1C;RPS28;DAG1;ANK3;RPL31;DLG1;ITGB1;MYL12B;GRB2;RPS19
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.8153110477999025,1.409197210793923,0.18518518518518517,1.0,1.0,5/9,10.84%,PLA2G4A;PLAAT3;MBOAT2;OSBPL8;PLA1A
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6850413992642164,-1.4087530226313991,0.011363636363636364,0.5742002809225617,1.0,21/52,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RIOK3;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.8818687212642571,-1.4078618460725185,0.03076923076923077,0.5787893896815464,1.0,2/8,3.19%,SLC6A6;GLUL
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,-0.6862949382314348,-1.407269739271768,0.05,0.5805829651443193,1.0,12/33,12.14%,CX3CL1;CD9;HSPA5;NES;ABCA5;FLT1;PECAM1;CD55;KLF4;EPAS1;GJA1;DCLK1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.8014948484732756,-1.4071949447019096,0.07142857142857142,0.5787966608718179,1.0,2/14,2.47%,ADAMTS9;PPARG
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.9069270170278455,-1.4055655306531512,0.08620689655172414,0.5875534184014811,1.0,1/7,0.13%,MAFF
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.7952344682380966,-1.4051579115780712,0.07894736842105263,0.5884406027786246,1.0,5/14,12.30%,ITPR1;ERO1A;GRIN2B;SLC8A1;PLCG2
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.6817616939670699,-1.4047506160288044,0.08536585365853659,0.5888113348400963,1.0,7/42,13.89%,PIK3R3;PIK3R1;SEPTIN11;SHC2;ARPC2;CTNNA3;BCAR1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.7402601245975502,-1.40361473966651,0.025,0.5954003219706908,1.0,7/22,18.33%,UFL1;COMMD1;KLF4;TMSB4X;NFKBIA;CYLD;ERBIN
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.94872146724863,-1.4035079010414881,0.0,0.5937606194316565,1.0,4/6,4.75%,RIMKLB;GLUD1;GLUL;ADSS2
prerank,KEGG_2021_Human__Pancreatic cancer,-0.736169307754966,-1.4032236081354015,0.027777777777777776,0.593435283560159,1.0,3/32,6.27%,PIK3R3;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.7785835599352836,1.4025345591644705,0.14285714285714285,1.0,1.0,1/6,3.61%,TTN
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.6891491950372136,-1.4024927252606014,0.036585365853658534,0.5961254259084958,1.0,13/38,13.78%,TBX3;ANGPTL4;EPS8;TIMP3;LAMA5;COL18A1;TNS1;CD55;ITGB5;SHC2;EPAS1;CST3;PLSCR4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.9060212463879859,-1.4012041040732583,0.08571428571428572,0.6022978578108865,1.0,2/8,2.47%,PRKAG2;PPARG
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.8651990478535045,-1.4003404027269808,0.029411764705882353,0.6064308548667836,1.0,1/7,1.04%,ITPR1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.6184291624092368,-1.4003242352757033,0.0,0.604408262102106,1.0,28/174,14.50%,PIK3R3;LAMC1;ITPR1;DOCK3;NRG3;GRIN2B;FOS;RPS27A;FES;JUND;CDC37;ERBB4;PIK3R1;LAMA5;PRKCE;FLT1;HIF1A;VAV3;RAP1A;UBC;SHC2;FGFR1;MEF2A;TEC;BCAR1;SH3KBP1;VEGFC;NCK1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.7396809671769308,-1.4003049607035956,0.05128205128205128,0.6022767822011816,1.0,5/30,6.27%,PKM;PCK1;NR4A1;PPARG;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.902911350749552,-1.4000483155413106,0.04411764705882353,0.6019685739830941,1.0,1/7,0.80%,MAP3K5
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.8285991784838986,1.3996144281288885,0.03125,1.0,1.0,2/5,7.52%,TEAD4;KIAA1549
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.9370103893324435,-1.3993690332750983,0.015625,0.6047736671618366,1.0,2/5,1.81%,PCK1;PGK1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.7343502927573751,-1.399353105982544,0.047058823529411764,0.6027456049558139,1.0,4/27,7.01%,PIK3R3;ITPR1;PIK3R1;PRKCE
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.7681757525028359,-1.399293437537404,0.02666666666666667,0.6011385801871956,1.0,6/23,9.11%,MAP3K5;JUN;FOS;NFE2L2;TPM1;ANXA1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.8579298795083625,-1.3987000271165728,0.0,0.6037949084038335,1.0,3/10,3.13%,MAP2;MDGA2;SPOCK1
prerank,KEGG_2021_Human__Influenza A,-0.6570298513389764,-1.3983609616388726,0.06593406593406594,0.6039306116022751,1.0,6/46,8.31%,PIK3R3;JAK1;PIK3R1;IFNGR1;IFNGR2;CALCOCO2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7427908327866829,-1.3982614475346369,0.05405405405405406,0.6024571848385999,1.0,5/29,6.06%,TBX3;LAMC1;PLS3;PPARG;TIMP3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.7284648565197529,-1.398104755402926,0.0641025641025641,0.6013147326305351,1.0,3/19,8.34%,DENND3;BNIP3L;PRKN
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.8877492438771231,-1.3967386965418147,0.08450704225352113,0.6088028613181921,1.0,2/8,1.62%,PCK1;PRKAG2
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.8241879125937356,-1.3961402157965672,0.11475409836065574,0.6105100635176502,1.0,2/10,5.26%,RFC3;POLA1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.811840728429313,-1.3959663247509155,0.04,0.6099458906989114,1.0,4/11,13.89%,DDIT4;MAGI2;RAP1A;BCAR1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.8971944964733839,-1.3951910843404836,0.01694915254237288,0.6144810070584146,1.0,2/6,6.88%,ATG12;RB1CC1
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.6212545902363981,-1.3939328899109906,0.031578947368421054,0.6214641255700136,1.0,21/105,11.02%,PIK3R3;LAMC1;DDIT4;PPP2R3A;PCK1;NR4A1;PKN3;CDKN1B;CDC37;JAK1;ERBB4;PIK3R1;LAMA5;MAGI2;FLT1;PPP2R2B;ITGA10;VWF;ITGB5;RPS6;FGFR1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.9266478176455608,-1.3938781146975299,0.016129032258064516,0.6197694265084414,1.0,1/6,0.40%,DOK5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.8082931440854701,-1.3936780677099885,0.02857142857142857,0.6188682409524976,1.0,2/11,5.29%,SERPINE1;NFE2L2
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.6148212418102241,-1.3936404989601232,0.021052631578947368,0.6169605402829366,1.0,18/109,12.54%,PIK3R3;ADM;ITPR1;MGLL;WNT2B;CX3CL1;GRK5;GRM7;PIK3R1;PRKCE;PDE7A;VAV3;CD55;ANXA1;S1PR1;DGKG;GNA13;FGD4
prerank,KEGG_2021_Human__Mitophagy,-0.731833533131544,-1.3933693306578936,0.0625,0.6166575206785819,1.0,11/30,16.65%,BNIP3L;JUN;RPS27A;HIF1A;CALCOCO2;PRKN;TBC1D15;UBC;GABARAPL1;TBK1;PINK1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.7560823384652098,-1.3930240999288699,0.02531645569620253,0.6167434264520887,1.0,5/20,9.61%,ADAMTS9;DENND3;LAMP2;PRKN;NGLY1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.7115513413929602,-1.3924143771070696,0.07228915662650602,0.6191032998227591,1.0,7/28,9.11%,ADM;MGLL;CX3CL1;FOS;GGT5;REL;ANXA1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6596912632696275,1.392378389346413,0.10714285714285714,1.0,1.0,6/17,12.96%,EFNA5;CLASP1;BICD1;PHLDB2;ROCK1;MARK2
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,-0.6848430031396397,-1.391816172702889,0.03571428571428571,0.6217928468263058,1.0,14/43,18.22%,MAP2;ZEB2;RTN4;GRIA2;MBP;TMSB4X;RAB2A;RPL13A;TMEFF2;PLP1;NPM1;RACK1;ARL4A;RPL31
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.8479136450197546,-1.3914046754203446,0.07462686567164178,0.6230473846350286,1.0,3/6,14.26%,TSG101;PRKN;SDCBP
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6131556578579965,-1.3913306059648607,0.010526315789473684,0.6213169570455841,1.0,34/123,18.22%,RPS18;YTHDC1;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;TPR;GOLPH3;RPS7;RPLP2;RPL13A;MEF2A;HNRNPH3;RPL15;RPL37A;RPL24;RPL7A;RPLP1;PTMA;THRB;SRRM1;RPS28;NUP54;RPL31
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.8519557512494362,-1.391287636198477,0.09859154929577464,0.61967428318698,1.0,3/9,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.886133206784306,1.391239749953892,0.0,1.0,1.0,3/5,9.69%,GBP1;EFNA5;KANK1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.886133206784306,1.391239749953892,0.0,1.0,1.0,3/5,9.69%,GBP1;EFNA5;KANK1
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.6810168071790011,-1.3912117868601455,0.011764705882352941,0.6160064779960394,1.0,22/55,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RIOK3;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.6810168071790011,-1.3912117868601455,0.011764705882352941,0.6160064779960394,1.0,22/55,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RIOK3;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.770065705112241,-1.3911693771889937,0.09876543209876543,0.6143603973683732,1.0,1/18,0.19%,CCDC3
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.8127824640787278,-1.3902061050332923,0.0958904109589041,0.6182788054018399,1.0,1/12,0.32%,MAP2
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.7425702443439455,-1.389348154773334,0.041666666666666664,0.622395572011328,1.0,5/26,6.19%,PRKAG2;GRIN2B;GRIA2;LRRC7;ERBB4
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.8855478904824651,1.3877383673194368,0.14285714285714285,1.0,1.0,4/5,11.05%,ACAT1;HIBCH;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.8855478904824651,1.3877383673194368,0.14285714285714285,1.0,1.0,4/5,11.05%,ACAT1;HIBCH;HIBADH;AUH
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.7530191174612726,-1.3876446305724843,0.06666666666666667,0.6320018118124238,1.0,6/19,13.89%,HES1;KIAA1217;SHC2;EPAS1;EFNB2;BCAR1
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,-0.6720234742083055,-1.3875791126437353,0.05405405405405406,0.6303989761941439,1.0,11/32,13.31%,CX3CL1;ENPP2;NFASC;GAS7;PTPRD;TMEM132C;SLC8A1;NCALD;LSAMP;ADGRL3;LRRC4C
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.8596670684983638,-1.3872598977843391,0.046153846153846156,0.6302878861489969,1.0,2/7,4.86%,CLIC2;DMD
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.6978558497802012,1.3863392715019176,0.0967741935483871,1.0,1.0,1/8,2.84%,RHBDD1
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.7616653639026935,-1.3855411608281165,0.028169014084507043,0.6397368533005326,1.0,5/19,9.54%,LAMC1;ADAMTS9;LAMA5;COL18A1;ADAMTS1
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.680871837381507,-1.3851834071583635,0.011627906976744186,0.6397431253510832,1.0,22/56,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RIOK3;RPL37A;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.6844145994960457,-1.3848752499833699,0.08641975308641975,0.639859361016043,1.0,6/41,6.06%,LAMC1;PLS3;KIAA1217;NES;DMD;TIMP3
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5932598029734457,1.384821383172937,0.1111111111111111,1.0,1.0,4/13,10.81%,ALS2;EEA1;TMCC1;RAB27A
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.7006803241049195,-1.384764766887856,0.0625,0.6384397794619264,1.0,10/35,18.54%,PIK3R3;PIK3R1;MTMR12;SYNJ2;INPP5D;PIK3C3;RAB14;PIP5K1C;MTMR2;PIKFYVE
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.9211194208604797,-1.3835940908571949,0.04411764705882353,0.6454084756273377,1.0,2/5,1.75%,PIK3R3;NR4A1
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,-0.8227357072733105,-1.3834271943939214,0.06666666666666667,0.6448153583110261,1.0,1/9,1.04%,ITPR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,-0.6752110638535715,-1.3825550447145083,0.08108108108108109,0.648569640298959,1.0,15/36,13.31%,PCDH9;GRIA2;GPM6B;NPAS3;MAGI2;TMEM132C;VAV3;ANKS1B;PPP2R2B;LSAMP;GPM6A;PPFIA2;CTNND2;ADGRL3;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.8199782657146883,-1.3822890554607865,0.02666666666666667,0.6485114009909309,1.0,6/15,11.00%,DDIT4;MAP3K5;GRIN2B;FOS;PRNP;EFNB2
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.7668575907979617,-1.381423842710816,0.08860759493670886,0.6522298855135098,1.0,8/18,11.71%,RPS12;RPS9;RPS27A;RPS11;RPS27;RPS6;RPS15;RPS7
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.6425136799593336,-1.3805886468224466,0.03409090909090909,0.6553869246931953,1.0,30/90,18.22%,PSMC6;RIMKLB;RPS12;GLUD1;RPL23;RPL34;GLUL;PSMB9;RPS9;TINAGL1;RPS27A;RPL37;PSMA1;RPS11;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;LARS1;RPL7A;RPLP1;TXNRD1;RPS28;SERINC3;RPL31
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.7752480350261326,-1.380516938467736,0.05970149253731343,0.6537351741224192,1.0,3/12,8.92%,ADM;WNT2B;CD55
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,0.827314992657348,1.380082751762786,0.08571428571428572,1.0,1.0,1/5,0.50%,FAM193B
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.7455956009073784,-1.3800774642277172,0.0547945205479452,0.6555850112398751,1.0,3/18,8.84%,ANGPTL4;RPS27A;UBC
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.6798591986793883,-1.3795600854532377,0.08888888888888889,0.6571035745547791,1.0,8/36,15.46%,PIK3R3;CDKN1B;PIK3R1;SHC2;NFKBIA;CDKN1A;SMAD3;CDK6
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,-0.7021271549390705,-1.3793625817818982,0.075,0.6541483330559139,1.0,11/37,10.92%,SERPINE1;NDRG1;LGALS3;EPS8;S100A6;NFE2L2;EMP1;FOSL2;AHNAK;ANXA1;EPAS1
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,-0.7021271549390705,-1.3793625817818982,0.075,0.6541483330559139,1.0,11/37,10.92%,SERPINE1;NDRG1;LGALS3;EPS8;S100A6;NFE2L2;EMP1;FOSL2;AHNAK;ANXA1;EPAS1
prerank,KEGG_2021_Human__Axon guidance,-0.6387020219128907,-1.379252361896845,0.06896551724137931,0.6525262616866728,1.0,20/68,20.69%,PIK3R3;SSH1;SEMA6B;FES;PIK3R1;CFL1;MYL12A;EFNB2;PLCG2;PAK2;LRRC4C;NCK1;PPP3CC;ROBO2;ITGB1;MYL12B;BOC;GNAI3;PIK3CB;UNC5C
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.8139757323176825,-1.3792173051454095,0.046875,0.6507389520615562,1.0,5/10,14.61%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,-0.8327289411057962,-1.3788781485830885,0.06756756756756757,0.6513050646903783,1.0,3/10,13.89%,MAP1B;NES;BCAR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.8891737991379589,-1.3784448055144538,0.028985507246376812,0.6521813379876722,1.0,3/8,2.02%,MAP3K5;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.7286802951004792,-1.3779905296955697,0.0625,0.6532606674604439,1.0,7/26,15.70%,PKM;PCK1;PPARG;PIK3R1;OGT;LPIN2;RAB8B
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.7911035219853941,-1.3779705828943538,0.06329113924050633,0.6513545465566416,1.0,10/21,15.38%,DDIT4;NRCAM;SPOCK1;MAP1B;ELP3;GPM6A;FGFR1;ADGRL3;NAV1;PAFAH1B1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8009033169500496,1.37791591218671,0.0975609756097561,1.0,1.0,4/7,19.52%,INO80;TOP2B;SMC1A;LATS1
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,-0.9279353806979347,-1.3778279831185416,0.041666666666666664,0.650599644526395,1.0,1/5,1.70%,MGLL
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.7259766542407398,-1.3777588561828824,0.1095890410958904,0.6490575741133895,1.0,5/21,10.49%,LAMC1;LAMA5;ITGA10;VWF;ITGB5
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,-0.8019616223852658,-1.3774709814213355,0.04285714285714286,0.6487604446318544,1.0,4/13,4.59%,CNTN5;GRIN2B;GRM7;GRIA2
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,-0.8778909297669845,-1.3774202583864366,0.03125,0.6470964740438369,1.0,3/7,6.19%,PLS3;LDHA;ERBB4
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.75079475329563,1.3774189437309476,0.12121212121212122,1.0,1.0,2/5,18.86%,HDAC9;HDAC4
prerank,KEGG_2021_Human__Purine metabolism,-0.7126381314062866,-1.376763229112361,0.037037037037037035,0.6500477754521432,1.0,6/26,8.50%,PKM;PDE5A;ADSS2;GMPS;PDE7A;PNP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.688524843907591,-1.3761414551362896,0.05,0.6523350648672784,1.0,6/27,13.33%,PCK1;PPARG;PIK3R1;HIF1A;RPS6;FOXK1
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.5526491041741247,1.3754044905800182,0.041666666666666664,1.0,1.0,7/26,12.30%,BMP6;SMAD1;SMAD9;ID3;ID1;ACVR1;ROCK1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.8838396947744231,1.3750766212831071,0.058823529411764705,1.0,1.0,2/5,10.41%,PARD3;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.9163419727193751,-1.3750075037928788,0.0,0.6581349036106031,1.0,2/5,5.71%,SERPINE1;DUSP1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.7830757286827134,-1.3748281243443456,0.1,0.657510729674823,1.0,4/17,9.93%,BHLHE40;CX3CL1;HES1;TGM2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8563751112868601,1.3739890602284957,0.1875,1.0,1.0,5/6,10.84%,PLA2G4A;PLAAT3;MBOAT2;OSBPL8;PLA1A
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.7172116857820734,-1.373246866965511,0.08,0.6665970354559335,1.0,8/28,15.51%,JUN;FOS;JAK1;IFNGR1;IFNGR2;JAG2;NFKBIA;PPP3CC
prerank,KEGG_2021_Human__DNA replication,-0.9264874150609448,-1.37253770941836,0.04838709677419355,0.6701181440972078,1.0,2/5,5.26%,RFC3;POLA1
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.6611937739236964,-1.372358990959072,0.07142857142857142,0.6696984021654306,1.0,10/58,13.89%,PIK3R3;CX3CL1;GRK5;PIK3R1;VAV3;RAP1A;SHC2;PLCG2;NFKBIA;BCAR1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.9028815581215092,-1.3723465124557108,0.05714285714285714,0.667777974411675,1.0,1/6,0.16%,TBX3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.7156560533762681,-1.3723458754443143,0.10843373493975904,0.665802299931167,1.0,4/20,11.71%,UFL1;RPL23;COMMD1;RPS7
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.8335649569524276,-1.3720796218089468,0.06944444444444445,0.6654654173478005,1.0,2/8,8.34%,PSMC6;PRKN
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.614157121477709,-1.371553622188655,0.043010752688172046,0.6672495045819634,1.0,18/88,15.27%,LAMC1;ADM;PLS3;EHD4;KIAA1217;MAGI2;SMARCA1;TPM1;PLOD2;ITGB5;GJA1;MYO1B;NEBL;TRIB2;PLSCR4;BCAR1;NAV2;WWTR1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.7364779061996722,-1.371484503433565,0.06944444444444445,0.6655238458354599,1.0,6/21,8.84%,UFL1;RPS27A;RB1CC1;CALCOCO2;PRKN;UBC
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.6469262369575814,-1.3711632919693084,0.04597701149425287,0.6654540571071955,1.0,27/75,19.10%,RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;CANX;PBRM1;RPS11;RPS27;RPS6;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;KPNB1;RPS28;NUP54;RPL31;KPNA4;RPS19
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.7094166429706579,-1.3703126440114497,0.04819277108433735,0.6692902083260713,1.0,4/36,7.81%,PIK3R3;GAPDH;PIK3R1;SLC2A1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.7133543461664525,-1.3703064019941367,0.08333333333333333,0.6674100456540472,1.0,12/24,12.75%,CCDC3;CX3CL1;NFASC;GPM6B;CNTN1;PTPRD;TMEM132C;ANK2;SHC2;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.8202521079896179,-1.3701928985200211,0.08823529411764706,0.6662912574474337,1.0,5/8,14.61%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,-0.8063364591509385,-1.369930918317671,0.1044776119402985,0.6660573823620207,1.0,5/11,15.43%,JUN;CD9;JUNB;SMAD3;SMC3
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.8275679894572999,-1.3697263244287687,0.041666666666666664,0.6654031186042655,1.0,5/13,13.17%,BTG2;CDKN1B;CNOT6L;NPM1;CDKN1A
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,-0.6034321583613467,-1.369329342563317,0.0,0.6659171451114865,1.0,59/219,14.26%,PKM;ADM;BTG2;LBR;DENND3;PGK1;KLF6;NFKBIZ;ZEB2;BNIP3L;RTN4;SRGN;GLUL;SLC2A3;CHPT1;LGALS3;SPOPL;LRRFIP1;ATP2B1;ESYT2;S100A6;TSC22D3;JUND;DUSP1;JAK1;ACTN1;GAS7;IFNGR1;LAMP2;IFNGR2;HIF1A;SULF2;PECAM1;BCL6;AHNAK;SERPINB6;PNP;CD55;ANXA1;KLF4;SOD2;PLXDC2;WIPF1;LIMS1;ARPC2;ZFP36;TMBIM6;BRI3;FGD4;ACAP2;NFKBIA;CDKN1A;CCNL1;CST3;PELI1;MSN;SH3KBP1;TNFRSF10B;SDCBP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.8493442579406592,-1.3690776389212167,0.08695652173913043,0.6659766507102175,1.0,3/8,11.02%,PPARG;FLT1;FGFR1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.6552574760393614,-1.3679650404587231,0.03409090909090909,0.6716000521382612,1.0,27/67,19.10%,PSMC6;RPS12;RPL23;RPL34;PSMB9;RPS9;RPS27A;RPL37;PSMA1;RPS11;UBC;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL7A;RPLP1;ROBO2;RPS28;DAG1;RPL31;RPS19
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.8940248898436827,-1.3679555922423634,0.07692307692307693,0.669847019576256,1.0,1/6,0.24%,SERPINE1
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.7297909680850644,1.3678720684018941,0.1282051282051282,1.0,1.0,4/9,12.88%,UIMC1;HERC2;ATM;BABAM2
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.702280405655026,-1.3676428060210317,0.05263157894736842,0.6704705020246665,1.0,8/26,16.65%,PCK1;CDKN1B;BCL6;KLF4;CDKN1A;SMAD3;BTG1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.7911259523468868,-1.3673533166493141,0.07894736842105263,0.67051643431091,1.0,6/13,14.95%,BTG2;CDKN1B;BCL6;CHFR;SMAD3;BTG1
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,0.8818476448496222,1.367030106763945,0.02564102564102564,1.0,1.0,1/5,0.24%,SKAP2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.7180508921166375,-1.3669191794434332,0.15384615384615385,0.6711663030444714,1.0,1/14,1.12%,NDRG1
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.7016355535884996,-1.3663903519020437,0.0641025641025641,0.6731126291586063,1.0,6/25,15.27%,SERPINE1;SMAD7;RPS27A;UBC;SMAD3;WWTR1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.8606840702261841,-1.3654890368411527,0.15942028985507245,0.6772298792711667,1.0,2/6,11.08%,FGFR1;STOX2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.7395970361886299,-1.3652423545157903,0.08333333333333333,0.6776032212603021,1.0,1/14,0.32%,MAP2
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.8137658952026765,-1.3646082355788738,0.07142857142857142,0.6805843695503816,1.0,8/15,13.86%,ANGPTL4;PCK1;PPARG;SCP2;UBC;PLIN2;ACSL5;ACOX1
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.7374872419020205,-1.3645700791221256,0.05333333333333334,0.6788453758270504,1.0,6/23,10.92%,CD9;LGALS3;TINAGL1;MT1L;EMP1;EPAS1
prerank,KEGG_2021_Human__Shigellosis,-0.6394787387989,-1.3644472319452552,0.033707865168539325,0.6779915973135628,1.0,21/99,16.49%,PIK3R3;ITPR1;ATG12;JUN;RPS27A;ACTN1;PIK3R1;ARF1;PRKCE;CALCOCO2;UBC;SEPTIN11;MYL12A;ARPC2;GABARAPL1;PLCG2;NFKBIA;BCAR1;PIK3C3;MALT1;TBK1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.8228856209451334,-1.3638463876918823,0.04477611940298507,0.6801049500788623,1.0,2/9,5.29%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.7550925127157304,1.3633035523378658,0.18421052631578946,1.0,1.0,1/6,1.17%,MLLT3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5666614299966348,1.3632591086610926,0.125,1.0,1.0,2/23,0.72%,RSAD2;GBP2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5666614299966348,1.3632591086610926,0.125,1.0,1.0,2/23,0.72%,RSAD2;GBP2
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.6735900821000668,-1.3630435626302566,0.07317073170731707,0.6841346426732027,1.0,2/42,1.04%,PIK3R3;ITPR1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.6145942567948096,-1.3629429990306183,0.042105263157894736,0.682746156035531,1.0,15/89,9.83%,TBX3;ST18;BTG2;PPARG;HES1;PPM1D;CDKN1B;ERBB4;PBRM1;MAGI2;COL18A1;KLF4;ADAMTS1;DLC1;SOD2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,-0.6858207637614475,-1.3627157556209122,0.10256410256410256,0.6829116067660462,1.0,7/33,15.27%,SERPINE1;ANGPTL4;EMP1;MYO1B;BCAR1;NAV2;WWTR1
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,-0.8647043713192331,-1.3617767327910677,0.057971014492753624,0.6876098421843659,1.0,2/9,6.43%,LAMC1;LAMA5
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.7646511517681553,1.3617553242669738,0.16666666666666666,1.0,1.0,3/8,7.68%,DNMT3A;H2AC6;JARID2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.8210671381282992,-1.3616711687909775,0.07462686567164178,0.6862847558460154,1.0,2/6,11.93%,SLC6A6;GJA1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7882024613663031,1.3616116202963189,0.10810810810810811,1.0,1.0,1/7,0.05%,DSE
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.7911729580332014,-1.3615028274941157,0.07042253521126761,0.6853963177821208,1.0,3/13,4.57%,DDIT4;PRKAG2;SMAD7
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.7471124346226403,-1.3609653810635676,0.0379746835443038,0.6874493493794156,1.0,12/23,19.76%,DDIT4;MAP3K5;GRIN2B;FOS;PRKN;PRNP;EFNB2;PICALM;TBK1;CD34;CHMP4B;CLU
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.6724981644133449,-1.3607729131551383,0.08433734939759036,0.6870506844206502,1.0,19/43,21.25%,PIK3R3;PIK3R1;MTMR12;ARF1;SYNJ2;PLCG2;TTC7A;INPP5D;PIGN;EFR3B;PIK3C3;RAB14;PIP5K1C;MTMR2;PIKFYVE;PIGC;PIK3CB;SOCS3;MTMR6
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.6556581382465415,-1.360064199155429,0.0975609756097561,0.6903355583902088,1.0,4/49,7.81%,PIK3R3;PIK3R1;HIF1A;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.7202624549447082,1.3599702878269,0.16666666666666666,1.0,1.0,1/8,0.16%,BMP6
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.827567444558438,-1.3593347236994031,0.11428571428571428,0.6934813535289354,1.0,5/11,10.41%,RPS27A;EEF1A1;LAMP2;UBC;PLIN2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.8197676305550334,-1.3590755507664767,0.05084745762711865,0.6935841270338796,1.0,7/15,11.98%,PCK1;PGK1;PPARG;LGALS3;ERBB4;ANXA1;HNRNPH3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.7115601399338045,-1.359031241412819,0.125,0.69190573191435,1.0,2/19,5.10%,CCDC3;PLCL1
prerank,KEGG_2021_Human__Parkinson disease,-0.6399027169915033,-1.3587856731887382,0.053763440860215055,0.6913800841854223,1.0,11/54,10.46%,PSMC6;MAP3K5;ITPR1;HSPA5;RPS27A;NFE2L2;DUSP1;PSMA1;PRKN;UBC;NDUFA12
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,-0.8868614175873315,-1.358565241662502,0.0,0.6910073349053809,1.0,2/6,3.67%,JUN;FOS
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.8489722240019721,1.3583499129533765,0.1282051282051282,1.0,1.0,2/5,5.58%,OFD1;RFX3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.7969736327978314,-1.3574317391131159,0.0273972602739726,0.6968938530048958,1.0,3/12,4.17%,PLS3;NEDD9;EPS8
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.9118643914931825,-1.357320540678552,0.03508771929824561,0.6958216816148227,1.0,3/6,5.02%,MAP2;RTN4;SEMA6B
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.8450865748542995,-1.3572647857173232,0.05405405405405406,0.694278691043749,1.0,1/9,0.16%,TBX3
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,-0.6763509839266517,-1.3568013695006247,0.09302325581395349,0.6920915644156181,1.0,15/50,20.42%,LAMC1;PLS3;SCARB2;EPS8;HIF1A;PLOD2;MYO1B;TMEM30A;CTNNA1;RAPH1;MYO1E;TBC1D9;PSD3;EGFR;REEP3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,-0.6763509839266517,-1.3568013695006247,0.09302325581395349,0.6920915644156181,1.0,15/50,20.42%,LAMC1;PLS3;SCARB2;EPS8;HIF1A;PLOD2;MYO1B;TMEM30A;CTNNA1;RAPH1;MYO1E;TBC1D9;PSD3;EGFR;REEP3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,-0.6763509839266517,-1.3568013695006247,0.09302325581395349,0.6920915644156181,1.0,15/50,20.42%,LAMC1;PLS3;SCARB2;EPS8;HIF1A;PLOD2;MYO1B;TMEM30A;CTNNA1;RAPH1;MYO1E;TBC1D9;PSD3;EGFR;REEP3
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8197673400972865,-1.3565687883570545,0.0821917808219178,0.6916648452810747,1.0,4/8,12.59%,TSG101;PPARG;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.6525061143366211,-1.3565432733792757,0.06172839506172839,0.6900352836679371,1.0,25/50,24.67%,ADM;CD9;SCARB2;CANX;HIP1R;SCARF1;AP1G1;CD81;LRP1B;SGIP1;PICALM;HSPH1;PIP5K1C;PIKFYVE;SCARB1;ITGB1;GRB2;CAV2;SPARC;CLTA;DNM2;CALR;SNX9;NEDD4;HSP90AA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.8590651150402562,-1.35626246574603,0.07142857142857142,0.6887313489913293,1.0,3/7,8.84%,RFC3;RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.8590651150402562,-1.35626246574603,0.07142857142857142,0.6887313489913293,1.0,3/7,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6617324067232971,1.3553184329067745,0.1388888888888889,1.0,1.0,4/10,17.53%,IL15;PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.7922535478253954,-1.3546219918871296,0.04,0.6974459435456585,1.0,3/13,4.17%,PLS3;NEDD9;EPS8
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.7977255458821194,-1.3545405146294442,0.05970149253731343,0.6963127857205342,1.0,4/15,10.49%,SERPINE1;LAMC1;LAMA5;ITGB5
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.6209201455816036,-1.3543995724064954,0.03333333333333333,0.6952434953304617,1.0,22/91,12.30%,PIK3R3;SERPINE1;ITPR1;MGLL;SYTL4;SRGN;CD9;HSPA5;ACTN1;TIMP3;PIK3R1;PRKCE;LAMP2;RAPGEF3;VAV3;PECAM1;RAP1A;VWF;TMSB4X;DGKG;GNA13;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8961859469518314,-1.3540142587117432,0.06153846153846154,0.6962343448519513,1.0,3/5,7.01%,ADM;PPARG;PRKCE
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.9324623344841946,-1.353472065360783,0.03076923076923077,0.6982880967073594,1.0,2/5,4.44%,KCNMB4;RIMS1
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,-0.8138235269669319,-1.353230609239772,0.09333333333333334,0.6982008390429386,1.0,4/12,9.19%,TBX3;VSIR;ALPL;KLF4
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.5936020135081492,-1.3530945679224005,0.0,0.6973673805529607,1.0,42/187,14.37%,PIK3R3;MAFF;SERPINE1;ITPR1;MAFK;DOCK3;MGLL;SYTL4;PDE5A;SRGN;CD9;CD99L2;HSPA5;ATP2B1;KCNMB4;KDM1A;ACTN1;TIMP3;PIK3R1;PRKCE;LAMP2;RAPGEF3;SLC8A1;VAV3;PECAM1;SERPINB6;RAP1A;ITGA10;VWF;TMSB4X;ZFPM2;KIF16B;DGKG;ATP1B3;GNA13;PLCG2;CBX5;INPP5D;ZNF160;BCAR1;TNFRSF10B;VEGFC
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.7581312893850987,-1.3528752194271805,0.09210526315789473,0.6970537570739954,1.0,5/17,10.49%,LAMC1;DMD;ACTN1;LAMA5;ITGB5
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,-0.6957334933849436,-1.3528326393310486,0.08641975308641975,0.6955702989234244,1.0,8/34,14.37%,LAMC1;ADM;SCARB2;ACTN1;ITGB5;MYO1B;PTTG1IP;VEGFC
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.8765685083117696,-1.352630987173482,0.04285714285714286,0.6956617996789807,1.0,4/7,9.19%,ANGPTL4;TMEM45B;LGALS3;KLF4
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.7363774151998168,-1.3517346343540508,0.0641025641025641,0.6999884735662247,1.0,2/17,2.55%,ZEB2;PKN3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.8787209054870895,-1.3515121986821685,0.057971014492753624,0.6998415406372646,1.0,3/6,4.33%,ADM;ATP2B1;KCNMB4
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.702517137158068,-1.3513199949072872,0.08433734939759036,0.6991862298779271,1.0,5/23,8.84%,CLIC2;TSC22D3;RPS27A;ANO2;UBC
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.7145419620761331,-1.3509918679170203,0.11842105263157894,0.7001705778826562,1.0,4/21,12.30%,ADM;GGT5;CD81;PLCG2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.7895788176163141,-1.3508414626789964,0.04285714285714286,0.699292578592504,1.0,6/14,15.27%,SERPINE1;SMAD7;RPS27A;UBC;SMAD3;WWTR1
prerank,KEGG_2021_Human__Leishmaniasis,-0.8050000022621369,-1.3506838522444218,0.03896103896103896,0.698447030981043,1.0,7/15,13.07%,JUN;FOS;EEF1A1;JAK1;IFNGR1;IFNGR2;NFKBIA
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.8848909742970715,-1.350411824479949,0.03125,0.6983057600103664,1.0,4/7,8.84%,RFC3;RPS27A;WDR48;UBC
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.667107054087374,-1.35039355228969,0.04878048780487805,0.6966288579983054,1.0,14/35,18.94%,RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;SMAD3;BTG1;RACK1;ADAM15;ACVRL1;MT1M
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.8067204315499432,1.349906411760282,0.13043478260869565,1.0,1.0,2/5,10.41%,IL6R;TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.7483807513914036,-1.3497923249138308,0.06756756756756757,0.6992234754515491,1.0,4/18,4.04%,HES1;TMEM45B;LGALS3;KIAA1217
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.7905100105431189,-1.3491431139433576,0.10526315789473684,0.7021388244109467,1.0,2/12,7.65%,SLC4A10;COL18A1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7801461499786171,-1.3491063613522842,0.029850746268656716,0.7006589606098707,1.0,4/17,3.88%,PPP2R3A;PGK1;PPARG;LGALS3
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.8922180241212492,-1.349034167937818,0.09090909090909091,0.6996012506078746,1.0,2/5,5.26%,RFC3;POLA1
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,-0.8228879276108405,-1.3485232712334068,0.06451612903225806,0.6997858002853697,1.0,5/10,9.19%,LGALS3;S100A6;FOSL2;ANXA1;KLF4
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,-0.8228879276108405,-1.3485232712334068,0.06451612903225806,0.6997858002853697,1.0,5/10,9.19%,LGALS3;S100A6;FOSL2;ANXA1;KLF4
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.871630591067255,-1.3484723102252423,0.08064516129032258,0.6983810260659514,1.0,3/6,8.84%,RPS27A;WDR48;UBC
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,-0.8525700988453587,-1.3483493530052795,0.03389830508474576,0.6975034900834233,1.0,4/7,6.19%,GRIN2B;GRIA2;LRRC7;ERBB4
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7328773776406886,-1.3480216413611539,0.0684931506849315,0.6979417236435166,1.0,6/20,10.04%,JUN;FOS;HIF1A;TPM1;SOD2;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.6138701562155868,-1.3479715011026216,0.030612244897959183,0.6965788756320279,1.0,21/105,15.96%,TBX3;ANGPTL4;BNIP3L;CX3CL1;GRK5;HSPA5;RPS27A;PIK3R1;UBC;RPL10;ANXA1;CFL1;GOLPH3;TMBIM6;PAK2;NPM1;NFKBIA;NAA16;PTMA;MALT1;MCL1
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.6224209165483462,-1.3478717063595356,0.0449438202247191,0.6953313759160045,1.0,5/70,4.94%,CEP57;PRKAG2;GLUD1;RAB11FIP3;CEP70
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,-0.6818123601758299,-1.3476077264813444,0.024691358024691357,0.6955817963229962,1.0,13/39,19.63%,SERPINE1;PLS3;SPOCK1;EPS8;GJA1;MYO1B;PLSCR4;NAV2;VEGFC;WWTR1;CALD1;EGFR;PLAT
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.8928127455636672,-1.3475008529005277,0.0410958904109589,0.6944238722138617,1.0,2/6,1.54%,MTHFD1L;PCK1
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.5999402653141731,-1.3474532208701122,0.1111111111111111,0.6930015466717997,1.0,11/76,11.02%,PIK3R3;RAPGEF5;GRIN2B;PIK3R1;MAGI2;RAPGEF3;FLT1;VAV3;RAP1A;AFDN;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.8698044967258887,-1.346861625506994,0.10294117647058823,0.6955718026803807,1.0,3/6,4.09%,PPARG;SCP2;ABCA5
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.6997648667879639,-1.3468575550188375,0.07692307692307693,0.6939117267789955,1.0,2/28,4.94%,CEP57;CEP70
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.7504134716121706,1.3464033168666425,0.15625,1.0,1.0,2/6,15.83%,PPP2R5A;PPP2R5E
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.865767449426178,1.34526641129816,0.08571428571428572,1.0,1.0,2/5,7.65%,PLA2G4A;HADHB
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.6847872783623348,-1.345250521288621,0.08333333333333333,0.703650693963642,1.0,8/32,8.84%,PSMC6;MAFK;PSMB9;NPLOC4;RPS27A;NFE2L2;PSMA1;UBC
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.623276309620254,-1.3442503296546655,0.05555555555555555,0.7089314580859917,1.0,20/81,18.73%,PIK3R3;DOCK3;LBR;MYO9B;ARHGAP21;PIK3R1;GIT2;VAV3;DLC1;WIPF1;ARHGAP23;GNA13;VRK2;RASGRF2;FAM13A;ARHGAP29;ARHGAP15;ARHGAP17;ERBIN;ITGB1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.7065831249797739,-1.3440652714378531,0.0641025641025641,0.7090387943145035,1.0,5/26,7.81%,MTHFD1L;ENPP2;SLC2A3;SLC52A3;SLC2A1
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.7933802262404466,1.3440243814473343,0.17073170731707318,1.0,1.0,1/5,2.18%,GCH1
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.7324484643315758,-1.3438992496430335,0.08536585365853659,0.7085601461148717,1.0,5/19,16.49%,LRRFIP1;RPS27A;UBC;NFKBIA;TBK1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.8356958182584948,-1.343840132762904,0.13114754098360656,0.7074996596033334,1.0,2/8,2.82%,BHLHE40;HES1
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.5966120044634381,-1.3437588002784637,0.020833333333333332,0.7061792900971459,1.0,37/131,17.50%,BTG2;NR4A1;KLF6;PPA1;SRGN;JUN;GLUL;JUNB;TM6SF1;FOS;TSC22D3;FES;DUSP1;MGAT4A;KLF2;IFNGR1;LAMP2;SERPINB6;CD81;TACC1;HERPUD1;PLXDC2;GPM6A;MYL12A;LIMS1;MEF2A;ZFP36;BRI3;INPP5D;NFKBIA;MSN;SYT1;LPIN2;STOM;EGFL7;TSC22D1;PSAP
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.7092269503509419,-1.3433374142536625,0.07894736842105263,0.7079040146405484,1.0,9/17,19.04%,PDE5A;TPM1;ANXA1;ITGB5;MYL12A;DYSF;MYL6;CALD1;MYL12B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.8590978286649653,-1.342953095651153,0.109375,0.7089352153243862,1.0,3/6,8.84%,RFC3;RPS27A;UBC
prerank,KEGG_2021_Human__Yersinia infection,-0.6381668963064768,-1.3428581756088418,0.08045977011494253,0.7078311601859479,1.0,10/59,13.89%,PIK3R3;JUN;FOS;PIK3R1;GIT2;VAV3;WIPF1;ARPC2;NFKBIA;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.8832436066584728,-1.342610020570811,0.05454545454545454,0.7078081078863152,1.0,3/6,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.7403597695366958,-1.3425233652282342,0.15942028985507245,0.7069736026629092,1.0,2/12,3.85%,ERO1A;HSPA5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.7004685607432909,-1.3422853437259525,0.10526315789473684,0.7067698166976107,1.0,2/26,4.94%,CEP57;CEP70
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.813075818555206,-1.3422370203119236,0.1791044776119403,0.7054464733601135,1.0,3/10,4.59%,SLC2A3;GRIN2B;GRIA2
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.6179955114313922,-1.341549220950867,0.06451612903225806,0.7085229007843535,1.0,27/85,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;CNOT6L;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;ZFP36;RPL15;RPL37A;RPL24;RPL7A;RPLP1;DCP2;RPS28;RPL31;RPS19
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.857591766902889,-1.341437721547536,0.09230769230769231,0.7080835109909454,1.0,2/5,8.13%,SERPINE1;SERPINB6
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8922415270674409,-1.3413150654194423,0.07017543859649122,0.7071026939872245,1.0,2/5,6.19%,TBX3;ERBB4
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.7053568183588717,-1.3408596293962707,0.08571428571428572,0.7080886272167595,1.0,9/26,13.89%,NRG3;KHDRBS3;RPS27A;CDKN1B;ERBB4;HIF1A;UBC;EPAS1;BCAR1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.8827564306484764,-1.3407801115195332,0.10526315789473684,0.7069834873180892,1.0,2/6,5.26%,RFC3;POLA1
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.7221272296188382,1.340737781690035,0.10810810810810811,1.0,1.0,1/9,2.20%,RPP38
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.6361683578037584,-1.3403688898842285,0.09411764705882353,0.7083250074979862,1.0,13/40,20.35%,NEDD9;FES;ERBB4;PTPRD;FLT1;SHC2;FGFR1;CASS4;BCAR1;TIE1;LCP2;EGFR;PIK3CB
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.737269315631292,-1.3397783774760252,0.1125,0.7100450557604883,1.0,8/22,11.71%,RPS12;RPS9;RPS27A;RPS11;RPS27;RPS6;RPS15;RPS7
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,-0.630156022974832,-1.339077158709092,0.10843373493975904,0.7129853355754222,1.0,7/47,12.06%,SERPINE1;LAMC1;TPM1;PLOD2;TRAM1;ITGB5;MYO1B
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.7610576755932025,-1.338909640107822,0.1,0.7127725385596486,1.0,5/13,19.76%,HSPA5;RPL13A;RIOK3;PPM1A;CLU
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,-0.7550124624211233,-1.3389046712240635,0.11428571428571428,0.7111853996139818,1.0,7/18,17.26%,SLC4A10;DUSP1;IFNGR1;PNP;PRNP;NFKBIA;IL18R1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.7061406336615418,-1.3388835473712914,0.056338028169014086,0.709630837197584,1.0,6/23,13.41%,LAMC1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.8205348831148517,-1.3387000327762135,0.07042253521126761,0.709274909870945,1.0,1/10,0.80%,MAP3K5
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.7311029498615415,-1.3384028447544583,0.1038961038961039,0.7092747389458831,1.0,3/15,8.84%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7487488368163073,-1.337538534885266,0.11940298507462686,0.7137420823517777,1.0,2/16,2.82%,TBX3;HES1
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.7271441525517321,-1.3373396993662507,0.12162162162162163,0.7120885118927712,1.0,2/21,4.94%,CEP57;CEP70
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.7271441525517321,-1.3373396993662507,0.12162162162162163,0.7120885118927712,1.0,2/21,4.94%,CEP57;CEP70
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,-0.7138401962880763,-1.3367764672262799,0.05063291139240506,0.7140877998712061,1.0,8/24,13.28%,CCDC3;ADAMTS9;NES;PTPRD;ANK2;TPM1;GJA1;CTNNA3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.7045485432467096,-1.3366737051266875,0.10666666666666667,0.7133014447301516,1.0,6/20,12.88%,LAMC1;DMD;MBP;PECAM1;GJA1;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.8520244945135202,-1.3365827697515127,0.04838709677419355,0.71216913164283,1.0,3/6,11.87%,FLT1;FGFR1;GNA13
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.9174124413879119,-1.3365744759786902,0.028985507246376812,0.7106931567903007,1.0,1/5,0.61%,ANGPTL4
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,-0.7638410039715873,-1.336382025330994,0.1527777777777778,0.7103419557911387,1.0,5/13,19.44%,DMD;ERBB4;MAGI2;CTNNA3;MTUS2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.6737826391008197,-1.3359354352296224,0.11392405063291139,0.7121990950764787,1.0,7/30,8.26%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;SCARF1;RAP1A
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8857038543012055,-1.3357138670859596,0.078125,0.7118213871303656,1.0,2/5,8.26%,MAGI2;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.7199109115409366,-1.335473196302122,0.05194805194805195,0.7115687691815478,1.0,2/24,3.88%,SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.8234465729944811,-1.335334732153452,0.09090909090909091,0.7109477669160434,1.0,2/8,6.88%,UFL1;RB1CC1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.912483164291558,-1.335094458768771,0.07142857142857142,0.7093705254995105,1.0,2/5,6.37%,LBR;LSS
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.912483164291558,-1.335094458768771,0.07142857142857142,0.7093705254995105,1.0,2/5,6.37%,LBR;LSS
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.689793970874586,1.33480537367943,0.23529411764705882,1.0,1.0,3/7,19.07%,CPEB3;NLGN1;CAPRIN1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.870786791387864,-1.3346301702850514,0.11290322580645161,0.7110342489643188,1.0,3/5,8.84%,RFC3;RPS27A;UBC
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,0.7423291375909795,1.3341964192463842,0.16216216216216217,1.0,1.0,2/9,0.98%,MMRN1;GBP4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.6693751463443179,-1.334107345053563,0.10588235294117647,0.7125930788386081,1.0,10/36,15.83%,ST18;MAP3K5;PPARG;BCAP31;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1;MALT1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.7554803267084915,-1.3340945052553423,0.15942028985507245,0.7111724999295949,1.0,2/10,3.85%,ERO1A;HSPA5
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.8026759134462738,-1.333668761127928,0.06756756756756757,0.7120192077231373,1.0,3/9,1.54%,PKM;LDHA;PCK1
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.6383965852068165,-1.3336229957390238,0.0449438202247191,0.709247265958519,1.0,8/54,9.40%,CEP57;PSMC6;PSMB9;CEP70;RPS27A;PSMA1;UBC;CCNH
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.6383965852068165,-1.3336229957390238,0.0449438202247191,0.709247265958519,1.0,8/54,9.40%,CEP57;PSMC6;PSMB9;CEP70;RPS27A;PSMA1;UBC;CCNH
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.6641996187353228,-1.3336199509819562,0.07058823529411765,0.7077494330370948,1.0,5/41,7.46%,PIK3R3;JAK1;PIK3R1;IFNGR1;IFNGR2
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.8706271918469681,-1.3335936739202239,0.06060606060606061,0.7063544355849266,1.0,3/7,8.84%,RFC3;RPS27A;UBC
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,-0.582683576032512,-1.3335935324467327,0.010101010101010102,0.7048451312353862,1.0,78/302,19.15%,PIK3R3;LAMC1;DOK5;PSMC6;ANGPTL4;NRCAM;PCK1;RPS12;RPL23;PPARG;RPL34;JUN;KAZN;GRIN2B;PSMB9;MYO9B;NFASC;RPS9;RPS27A;FES;RPL37;PIK3R1;PSMA1;PRX;CNTN1;ANK2;RPS11;VAV3;UBC;KLF4;ITGA10;ZFPM2;PRNP;RPS27;RPS6;MYL12A;EPAS1;EFNB2;FGFR1;ARPC2;RPL8;RPS15;RPS7;RPLP2;RPL13A;MEF2A;PIAS2;RPL15;CDKN1A;MSN;SH3KBP1;SDCBP;RPL37A;NCK1;SMAD3;CACNA1C;RPL7A;RPLP1;WWTR1;SREBF2;MYL6;CTNNA1;ROBO2;TSC22D1;MYH10;PIP5K1C;RPS28;DAG1;ANK3;RPL31;GATA2;DLG1;KMT2A;ITGB1;MYL12B;GRB2;RPS19;BOC
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7886019303095544,1.3335214193723852,0.2857142857142857,1.0,1.0,4/7,18.51%,MFF;PLAAT3;PEX14;TMEM135
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.8033562475973314,-1.3329260635051623,0.0945945945945946,0.7055342948993503,1.0,2/9,2.02%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.8033562475973314,-1.3329260635051623,0.0945945945945946,0.7055342948993503,1.0,2/9,2.02%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.8379932821856014,-1.3324697961274448,0.06349206349206349,0.7070717057828161,1.0,1/10,0.32%,MAP2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.8819629241956641,-1.3316624590712276,0.10714285714285714,0.7113930335169085,1.0,1/5,0.29%,LAMC1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,-0.8539945446442261,-1.3314289548815708,0.1044776119402985,0.7116977870775325,1.0,2/5,7.92%,CD9;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8815300554358897,-1.3312126126103796,0.06060606060606061,0.7103127110710857,1.0,2/6,7.84%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8815300554358897,-1.3312126126103796,0.06060606060606061,0.7103127110710857,1.0,2/6,7.84%,HIF1A;SULF2
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,-0.834241950336718,-1.331172776105598,0.03508771929824561,0.7090096528474052,1.0,3/6,7.94%,NDRG1;BCL2L14;BCL6
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.8331876653543977,-1.3309060512588278,0.1111111111111111,0.709222448060288,1.0,2/7,3.80%,MAP2;MAP1B
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.8707538564537484,-1.3306380259146082,0.07462686567164178,0.7093872519769875,1.0,3/6,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.727947849076031,-1.3306208245846136,0.06666666666666667,0.7079767804148742,1.0,8/21,15.46%,BTG2;NR4A1;CDKN1B;DUSP1;IPO7;SMAD3;BTG1;CDK6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.7208097467753444,-1.3305546656988847,0.05063291139240506,0.7069005186177041,1.0,5/23,13.17%,BTG2;NDRG1;CDKN1B;CNOT6L;CDKN1A
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,-0.7122248329088907,-1.3303248001399086,0.136986301369863,0.7069755076059066,1.0,7/24,10.76%,ZEB2;GLUL;MBP;SLC2A1;AHNAK;RASSF1;WDR37
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.6377070663792854,-1.3302976780204092,0.07142857142857142,0.7055554635012258,1.0,16/53,18.54%,PIK3R3;CHPT1;PIK3R1;MTMR12;ARF1;DGKG;SYNJ2;PLCG2;INPP5D;LPIN2;PIK3C3;AGPAT4;RAB14;PIP5K1C;MTMR2;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.773910679248124,-1.3295950809475916,0.07142857142857142,0.7085462612865339,1.0,1/11,0.24%,SERPINE1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.7192695571423843,-1.3291875975493541,0.1095890410958904,0.709733794220938,1.0,6/21,15.27%,SERPINE1;SMAD7;RPS27A;UBC;SMAD3;WWTR1
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,-0.630700736265233,-1.3281898059794324,0.0875,0.7141659093710461,1.0,14/50,15.27%,SERPINE1;PLS3;KIAA1217;EPS8;TINAGL1;EMP1;NPAS2;PLOD2;ITGB5;EPAS1;PLSCR4;PON2;BCAR1;WWTR1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,-0.7637865809521446,-1.327943217612976,0.10606060606060606,0.7143641543505141,1.0,8/15,12.75%,PPP1R9A;GPM6B;ERBB4;PTPRD;STOX2;CTNND2;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.840095552828656,-1.3279276157117215,0.1864406779661017,0.7130359789770004,1.0,1/6,2.82%,HES1
prerank,CellMarker_Augmented_2021__Stem cell:Molar,-0.7291659945759371,-1.3276092449253614,0.09333333333333334,0.7139046953767699,1.0,3/17,7.17%,SERPINE1;TIMP3;EMP1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.7516254945814052,-1.3270210956927466,0.125,0.7164733908884875,1.0,5/15,11.50%,PRKAG2;SCARB2;HIF1A;TPR;OGT
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,-0.6617474251825939,-1.3262330992839004,0.12195121951219512,0.7187135258122644,1.0,9/40,14.13%,LAMC1;AKAP12;MAP1B;NES;SMARCA1;ANK2;GJA1;BCAR1;NAV2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,-0.6617474251825939,-1.3262330992839004,0.12195121951219512,0.7187135258122644,1.0,9/40,14.13%,LAMC1;AKAP12;MAP1B;NES;SMARCA1;ANK2;GJA1;BCAR1;NAV2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.6719518430850911,-1.3261583791695195,0.12941176470588237,0.7178476146600998,1.0,11/35,9.80%,MAP3K5;UFL1;ITPR1;ATF3;ERO1A;BCAP31;JUN;HSPA5;PIK3R1;PRKN;HERPUD1
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,-0.5900842048573692,-1.3259503571859677,0.04081632653061224,0.7176702340546923,1.0,48/173,16.55%,DDIT4;PKM;RPS18;LDHA;WNT2B;GLUD1;RPL23;SLC6A6;AKAP12;SYTL4;RPL34;CD9;SCP2;RAD21;DMD;ALPL;FES;RPL37;EEF1A1;ACTN1;HMGN1;MBP;SLC2A1;SHISA5;TPM1;PNP;CD81;KLF4;TMSB4X;RPS6;RPL8;OGT;GABARAPL1;RPS7;RPL13A;FGD4;RPL15;NPM1;TEC;RSU1;SDCBP;RPL24;RPL7A;UPP1;STOM;MCL1;MYL6;BLCAP
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.8153912011760771,1.3256706513440446,0.175,1.0,1.0,2/6,15.70%,ANAPC16;CDC16
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.7085431188742816,-1.3256215254216384,0.13157894736842105,0.7181999903380145,1.0,3/17,12.22%,SERPINE1;PRKCE;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.8011472132526525,-1.32561278768322,0.09230769230769231,0.7167945645982404,1.0,2/8,15.59%,DYSF;RACK1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.6850296185194925,-1.3253548328847837,0.075,0.7168473381009518,1.0,4/27,8.34%,SEC22B;VSIR;CDKN1B;PRKN
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.8204957603765062,-1.3252909386992788,0.0967741935483871,0.7158126920330385,1.0,2/8,9.48%,DPH6;ARSG
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.8483537362340874,-1.324822891563275,0.13513513513513514,0.7172687146305358,1.0,3/8,12.67%,POLA1;PURA;NOC3L
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.6869860848486986,-1.324724423910581,0.1111111111111111,0.7165080834133339,1.0,4/31,8.84%,CEP57;CEP70;RPS27A;UBC
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.7582362060116528,-1.3244095955882829,0.07142857142857142,0.7171463781682882,1.0,6/15,14.00%,RAPGEF3;PECAM1;RAP1A;AFDN;RAB1A;MSN
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.8327728322582544,-1.3243218399958392,0.12962962962962962,0.7164564355191928,1.0,4/8,9.46%,APOLD1;FLT1;PECAM1;VWF
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.7438875782071683,-1.3243153459830632,0.07692307692307693,0.7150516560153198,1.0,8/13,13.17%,PPARG;JUN;CDKN1B;TPM1;ADAMTS1;SOD2;GJA1;CDKN1A
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.759301145481341,-1.324194986036507,0.15714285714285714,0.7142791012571819,1.0,5/13,9.19%,CD9;NES;PECAM1;CD55;KLF4
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.6391612456403409,-1.3240926311679502,0.025,0.7134649410632631,1.0,21/48,21.91%,ITPR1;CLIC2;PDE5A;ATP2B1;KCNIP4;DMD;SLC8A1;TPM1;ANXA1;ITGB5;MYL12A;ATP1B3;DYSF;CACNA1C;WWTR1;MYL6;CALD1;MYL12B;SCN2A;RYR3;AHCYL1
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,-0.6873951887524805,-1.3238701193668447,0.12195121951219512,0.7136125327052026,1.0,5/29,4.59%,LBR;PPARG;SLC2A3;GRIN2B;GRIA2
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.6892075600339157,-1.3238500240467868,0.07894736842105263,0.7123579622295486,1.0,3/31,8.07%,PIK3R3;PIK3R1;RASSF1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.8437618992668883,-1.3236548497604272,0.07462686567164178,0.7125071550461425,1.0,2/7,4.46%,CX3CL1;KDM1A
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.7265673215245363,-1.323623442177707,0.1,0.7099729137589255,1.0,2/22,4.94%,CEP57;CEP70
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.7265673215245363,-1.323623442177707,0.1,0.7099729137589255,1.0,2/22,4.94%,CEP57;CEP70
prerank,KEGG_2021_Human__Platelet activation,-0.6571649636449131,-1.323612354823936,0.12195121951219512,0.7086691011795934,1.0,8/46,12.30%,PIK3R3;ITPR1;PIK3R1;RAP1A;VWF;MYL12A;GNA13;PLCG2
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.864443686846896,-1.323567257562436,0.0625,0.7048539931193295,1.0,2/6,5.87%,CANX;JAK1
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,-0.864443686846896,-1.323567257562436,0.0625,0.7048539931193295,1.0,2/6,5.87%,CANX;JAK1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.864443686846896,-1.323567257562436,0.0625,0.7048539931193295,1.0,2/6,5.87%,CANX;JAK1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,-0.7310420412023259,-1.3235431557373016,0.11940298507462686,0.7035483849103905,1.0,6/14,12.56%,GRIA2;GPM6B;TMEM132C;LSAMP;CTNND2;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.7646230240013144,-1.3234633942059726,0.10526315789473684,0.7025538659450755,1.0,4/15,13.71%,NEDD9;DOCK3;PRNP;CASS4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.7435764065118796,-1.3233565677382049,0.08450704225352113,0.7017377307676091,1.0,6/19,13.07%,SERPINE1;NFKBIZ;CX3CL1;CD81;HYAL2;NFKBIA
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,0.8092431114652096,1.322295071277979,0.15384615384615385,1.0,1.0,3/7,12.72%,IL1R1;IL6R;PROM1
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.6482257952099932,1.3219844667739336,0.1724137931034483,1.0,1.0,6/17,12.27%,MAN1A2;VPS45;COG3;COG6;CYTH3;COG5
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.8856333888728873,-1.3218102785665584,0.034482758620689655,0.7100915795676783,1.0,4/6,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5703642113767373,-1.3216986531121553,0.02040816326530612,0.7092640439205831,1.0,42/180,15.46%,TBX3;ST18;UFL1;BTG2;RPL23;CX3CL1;HES1;JUN;GRK5;JUNB;RPS9;PPM1D;CDKN1B;FES;JUND;ERBB4;PBRM1;MAGI2;FLT1;COL18A1;BCL6;JAG2;CD81;KLF4;CNOT6L;ADAMTS1;DLC1;SOD2;RPS6;EFNB2;FGFR1;LIMS1;CLDN5;NPM1;CDKN1A;CNBP;PLPP1;SDCBP;VEGFC;BTG1;WWTR1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.909898554977705,-1.3216608322175887,0.08064516129032258,0.7081794168985274,1.0,1/5,4.46%,KDM1A
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.8085111756358072,-1.3210670083783485,0.13636363636363635,0.7106925820562345,1.0,1/7,2.34%,SLC6A6
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,-0.7020431773527963,-1.3209923505607106,0.09210526315789473,0.7097390173438868,1.0,9/26,14.98%,GRIN2B;MAP1B;GRIA2;MAGI2;ANK2;IL1RAPL1;DCLK1;SYT1;EFR3B
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.6158494299642626,-1.3208536492062797,0.04395604395604396,0.709587024927891,1.0,27/61,23.53%,SERPINE1;ANGPTL4;PGK1;PPARG;GLUL;RAPGEF3;FLT1;HIF1A;KLF4;ADAMTS1;CLDN5;VEGFC;BTG1;TIE1;ATF2;GATA2;ITGB1;MECP2;CD34;EMP2;SPRED1;SASH1;PPP1R16B;SPARC;CDH5;AGO2;ANXA3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.7065884798256326,-1.319983965116214,0.09210526315789473,0.7143000691060797,1.0,6/25,12.56%,ADM;AKAP12;GRK5;S1PR1;GNA13;ADGRL3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.6456497706864954,-1.3194826236934774,0.10227272727272728,0.7165245724169602,1.0,3/34,2.02%,MAP3K5;ITPR1;ERO1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,-0.6334553655903012,-1.3192300932449148,0.12222222222222222,0.7168322507872933,1.0,15/54,14.79%,ADAMTS9;DTNA;PPP1R9A;MAP1B;DMD;ERBB4;PTPRD;SMARCA1;ANK2;STOX2;DCLK1;ADGRL3;CTNNA3;NAV2;LRP1B
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,-0.8207439130970815,-1.3191365550257546,0.11475409836065574,0.7161114931569884,1.0,2/6,14.61%,PRNP;CACNA1C
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.7049560593692367,-1.3185904351757056,0.11842105263157894,0.7181276491146288,1.0,4/17,8.84%,RPS27A;CDKN1B;PIK3R1;UBC
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.8827638074484014,-1.3185040271504382,0.10294117647058823,0.7158382109166489,1.0,3/6,8.84%,RFC3;RPS27A;UBC
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.8827638074484014,-1.3185040271504382,0.10294117647058823,0.7158382109166489,1.0,3/6,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.7875272145868049,-1.3184029299392461,0.14084507042253522,0.7152734475173178,1.0,3/11,9.11%,MAP3K5;NFE2L2;ANXA1
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,-0.6641856202147792,-1.3180779623368888,0.14285714285714285,0.7159192031906187,1.0,11/31,23.13%,SERPINE1;EMP1;ANXA1;ARHGAP23;VEGFC;WWTR1;ITGB1;PLAT;CAV2;ANXA5;TUBB6
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.6706271119749947,-1.3176630364358717,0.05952380952380952,0.7169010913486035,1.0,9/38,11.00%,UFL1;MGLL;CX3CL1;BCL6;CAMKMT;CD55;ANXA1;TMSB4X;EFNB2
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.6317616105157662,-1.3175942405676775,0.060240963855421686,0.7160840688777288,1.0,13/54,13.09%,PSMC6;ITPR1;JUN;PSMB9;FOS;RPS27A;PIK3R1;PSMA1;VAV3;UBC;PLCG2;NFKBIA;TEC
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.9170383531978774,-1.3174800878979167,0.043478260869565216,0.7156495600534644,1.0,1/6,5.26%,POLA1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.6560580657788799,-1.3174254872589526,0.08974358974358974,0.7146064762852309,1.0,13/39,18.54%,PIK3R3;PIK3R1;MTMR12;ARF1;LPGAT1;SYNJ2;PLCG2;INPP5D;PIK3C3;RAB14;PIP5K1C;MTMR2;PIKFYVE
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,-0.8748665056321946,-1.3173917179081325,0.06451612903225806,0.7133572636397352,1.0,3/5,6.27%,NRG3;ERBB4;PIK3R1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.7308135036372354,-1.3172720321590274,0.10810810810810811,0.7128883341126049,1.0,7/13,20.42%,SUN2;SUN1;TPR;NUP54;RPS19;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.8417992338880318,-1.3171177544541304,0.12903225806451613,0.7125048439114109,1.0,1/5,5.05%,SPG7
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6936992041518673,-1.316834878296531,0.18181818181818182,0.7128955292012624,1.0,3/20,12.30%,ADM;GGT5;PLCG2
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.6464805900298624,-1.3165055428440193,0.0759493670886076,0.7135349258324457,1.0,3/46,4.94%,CEP57;RAB11FIP3;CEP70
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.8442413693352255,-1.3164828969721105,0.015151515151515152,0.7123200472687525,1.0,3/7,8.02%,DMD;ANK2;AHNAK
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.7258107923124866,-1.3164278860463139,0.1506849315068493,0.7113588868822295,1.0,4/14,8.84%,RPS27A;CNTN1;JAG2;UBC
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.7917599162093737,-1.3162615196806349,0.07547169811320754,0.7109610132071156,1.0,3/9,7.36%,VSIR;GRIN2B;MBP
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6391436669879695,-1.316124731500856,0.11363636363636363,0.7103162833784199,1.0,12/49,9.19%,LAMC1;NR4A1;KLF6;ZEB2;TIMP3;FOXF1;KLF2;HIF1A;FOSL2;TNS1;CD55;KLF4
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.923049749122248,-1.314986955299447,0.01694915254237288,0.7154987069254635,1.0,1/7,0.32%,MAP2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7422957523691274,-1.3149287654344237,0.12857142857142856,0.7146624709516486,1.0,6/14,14.56%,CDC37;YBX3;OGT;PELI1;SDCBP;CYLD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7608625219222196,-1.3147578284923125,0.10126582278481013,0.7144261053336285,1.0,7/16,19.10%,GLUL;RPS6;RPS15;RPS7;NPM1;RPS28;RPS19
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.7587800145082412,-1.3145258883443989,0.12121212121212122,0.7147041573170834,1.0,10/16,15.86%,HES1;MAP1B;GRIA2;ANK2;STOX2;CTNND2;ADGRL3;LRRC4C;EFR3B;CADM2
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.7324296593253938,-1.314508166559175,0.07692307692307693,0.7135048521541643,1.0,5/18,4.59%,ADM;GRIK1;GRIN2B;GRM7;GRIA2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.7567346838176513,1.3140359647933173,0.09302325581395349,1.0,1.0,3/6,14.21%,ABL1;MSH3;MCM9
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8628290697108452,-1.3137622722226534,0.09230769230769231,0.7166899529355242,1.0,1/6,0.37%,DDIT4
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.8422691118063041,1.313652064192445,0.22857142857142856,1.0,1.0,2/5,1.54%,UGCG;ATG10
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7232368786720372,1.31322461296661,0.19444444444444445,1.0,1.0,2/7,8.07%,MOB3B;WWC3
prerank,KEGG_2021_Human__Tight junction,-0.6178246335825441,-1.3129907063096804,0.10112359550561797,0.7207011370308732,1.0,20/60,19.04%,MAP3K5;PRKAG2;JUN;ACTN1;YBX3;PRKCE;RAP1A;PPP2R2B;AFDN;MYL12A;ARPC2;CLDN5;MSN;RAB8B;MYL6;MYH10;ARHGAP17;DLG1;ITGB1;MYL12B
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.7288998458979843,-1.3129843439574254,0.11428571428571428,0.7193955190290057,1.0,8/12,24.67%,SCARF1;DLC1;HSPH1;SCARB1;SPARC;FTL;CALR;HSP90AA1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.6764109761400812,-1.312619986395201,0.125,0.7203338340094928,1.0,6/34,9.54%,LAMC1;PLS3;GAPDH;NES;SMARCA1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.6797285176478297,-1.3124839310776137,0.12658227848101267,0.7196431840153366,1.0,4/30,5.26%,NPLOC4;GAPDH;LRRFIP1;POLA1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.6285396935676504,1.311895836914961,0.19047619047619047,1.0,1.0,4/14,9.19%,CHD9;TBL1X;NCOA2;TBL1XR1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.7828592729837375,-1.311838045773235,0.1232876712328767,0.7224640004201806,1.0,7/11,16.65%,CX3CL1;HIF1A;PRKN;SOD2;SNX6;CPEB4;PINK1
prerank,KEGG_2021_Human__Toxoplasmosis,-0.6911011215247214,-1.311721119522144,0.13157894736842105,0.7222376759634348,1.0,5/31,7.46%,LAMC1;JAK1;LAMA5;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.755581146782418,-1.3116673921155186,0.057971014492753624,0.7212239633388119,1.0,7/20,13.68%,SERPINE1;NFKBIZ;CX3CL1;NPAS2;HYAL2;NFKBIA;RIOK3
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.6276412394084098,-1.3115814744569656,0.10227272727272728,0.7204963209100633,1.0,6/36,7.81%,MTHFD1L;ENPP2;SLC2A3;GPC5;SLC52A3;SLC2A1
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.7135691006635022,-1.3114644463595286,0.1375,0.7199525235726054,1.0,8/24,11.71%,RPS12;RPS9;RPS27A;RPS11;RPS27;RPS6;RPS15;RPS7
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.7623482059493494,-1.311432721768363,0.1746031746031746,0.7189282201724287,1.0,2/12,4.46%,UFL1;KDM1A
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.5971154712779316,1.3113706072527973,0.16,1.0,1.0,4/18,9.14%,CREB5;RASSF3;MYO10;SPOCK3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.8142310810565871,-1.311340533817148,0.14925373134328357,0.7182687596406093,1.0,2/6,4.57%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6616933933285385,1.3111215755020198,0.1724137931034483,1.0,1.0,6/15,12.96%,EFNA5;CLASP1;BICD1;PHLDB2;ROCK1;MARK2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.8247303657151077,-1.3106326451233654,0.0967741935483871,0.7214574963319991,1.0,3/6,7.60%,LGALS3;ATP2B1;ANK2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.6643675327729002,-1.310383110217636,0.15384615384615385,0.721635671461014,1.0,10/37,9.03%,SERPINE1;MAP2;AKAP12;MAP1B;NFASC;GRIA2;CNTN1;PTPRD;ANK2;LSAMP
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.7136511092838614,-1.3101927888378777,0.10666666666666667,0.721553742033767,1.0,7/16,21.91%,ITPR1;VAV3;PLCG2;TEC;LCP2;GRB2;AHCYL1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.925338387258942,-1.3097470099895487,0.04477611940298507,0.7228269423940377,1.0,2/5,6.27%,PIK3R3;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.7043333404392983,-1.309505772604772,0.10666666666666667,0.723061420353928,1.0,2/22,4.94%,CEP57;CEP70
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.8844622997475196,-1.3094590668588675,0.15492957746478872,0.7221236949525511,1.0,2/5,10.15%,BCAP31;PRNP
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.7214945320567937,-1.309409785787388,0.05263157894736842,0.7211298147572975,1.0,7/20,10.92%,PRKAG2;ATG12;RPS27A;PRKN;UBC;PLIN2;EPAS1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.8479455861248293,-1.3092035757023,0.12698412698412698,0.7211286305007703,1.0,2/6,8.82%,EEF1A1;CAMKMT
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6749430870344709,-1.3091911731905614,0.0945945945945946,0.7199424899179613,1.0,14/29,17.29%,MAP1B;NFASC;GRIA2;GPM6B;CNTN1;MAGI2;PTPRD;ANK2;LSAMP;DCLK1;ADGRL3;PLP1;EFR3B;ROBO2
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.7572060880381893,1.3090137615669646,0.21428571428571427,1.0,1.0,1/5,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.6331348993542637,-1.3089370754522265,0.04938271604938271,0.7202391104985195,1.0,20/57,19.42%,RTN4;SPOCK1;NRG3;CHPT1;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;BCAR1;SDCBP;SMAD3;BTG1;RACK1;MTOR;ADAM15;ACVRL1;EGFR
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7752644637746677,-1.308878269798349,0.10144927536231885,0.7193341963933615,1.0,5/14,7.46%,PPARG;CDC37;JAK1;IFNGR1;IFNGR2
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,-0.7202534991179216,-1.3086525559792275,0.11538461538461539,0.7194343838266501,1.0,6/19,9.72%,AKAP12;MYO9B;ARHGAP21;ACTN1;PIK3R1;SLC4A7
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6258732443987619,1.3080083689224404,0.13793103448275862,1.0,1.0,5/22,5.87%,BMP6;HIVEP1;SMAD1;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6258732443987619,1.3080083689224404,0.13793103448275862,1.0,1.0,5/22,5.87%,BMP6;HIVEP1;SMAD1;TGFBR3;SMAD9
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.758775292392413,-1.3077268548444163,0.12857142857142856,0.7233977300863986,1.0,2/18,1.81%,PKM;PGK1
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.7794354212203449,-1.307454453190747,0.11594202898550725,0.7237254333220161,1.0,4/9,8.84%,RPS27A;CNTN1;JAG2;UBC
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,-0.7822777969900934,-1.3074484666590045,0.1388888888888889,0.7225080527939393,1.0,3/12,7.65%,LAMC1;LAMA5;COL18A1
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,-0.6766071436752918,-1.3073567266691968,0.1282051282051282,0.7204364967992332,1.0,6/30,14.37%,SERPINE1;TIMP3;EMP1;EPAS1;PLSCR4;VEGFC
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,-0.6766071436752918,-1.3073567266691968,0.1282051282051282,0.7204364967992332,1.0,6/30,14.37%,SERPINE1;TIMP3;EMP1;EPAS1;PLSCR4;VEGFC
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.6332182746530322,-1.3073103685201724,0.10112359550561797,0.71948385495437,1.0,4/43,4.46%,MAFF;MAFK;DOCK3;KDM1A
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,-0.796992271075972,-1.3072992595626987,0.16129032258064516,0.7182821832202241,1.0,4/8,14.02%,SLC2A3;GAS7;PHTF2;SH3KBP1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.7401734761923466,-1.3072314146187514,0.16666666666666666,0.7173365286339991,1.0,2/12,12.30%,PPP1R9A;PLCG2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6855032031387374,-1.3069902757651752,0.0759493670886076,0.7179414947954784,1.0,3/24,9.19%,MAP3K5;BCAP31;KLF4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.6359300227344982,-1.3064009286288798,0.09195402298850575,0.7203594279856324,1.0,7/51,8.84%,CEP57;PSMC6;PSMB9;CEP70;RPS27A;PSMA1;UBC
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7138362350069192,1.3063209284989947,0.11627906976744186,1.0,1.0,2/6,9.64%,ATR;ATM
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.7381737231818465,-1.3062689782778827,0.0759493670886076,0.7198198681512328,1.0,5/16,15.59%,PCK1;PIK3R1;HIF1A;FOXK1;RACK1
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.6405824734600906,-1.3061847473723676,0.06976744186046512,0.7192051811738744,1.0,10/46,8.84%,PSMC6;MAFK;ERO1A;PSMB9;NPLOC4;RPS27A;NFE2L2;PSMA1;SIN3B;UBC
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.8721040339952211,-1.3060087744062718,0.13793103448275862,0.7188615336470339,1.0,2/6,12.03%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.8010360352369994,-1.3055655621138498,0.1111111111111111,0.7203792632561701,1.0,2/8,6.19%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.8577622034659189,-1.3055513655517932,0.13846153846153847,0.7192115627637696,1.0,2/5,7.84%,KIAA1217;SULF2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.8845763791581367,-1.3055030895063007,0.109375,0.7183153990201523,1.0,1/6,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.855073238358214,-1.304825812650057,0.08695652173913043,0.7212764072962233,1.0,1/7,2.05%,RFTN1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.7471339590575359,-1.304685391941589,0.18840579710144928,0.7207035914387788,1.0,3/9,11.39%,RTN4;AFDN;TPR
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.7326588838055362,-1.3045963279888233,0.14864864864864866,0.7200566491175087,1.0,5/15,9.19%,PPARG;JUN;FOS;HIF1A;KLF4
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8455268098976358,-1.3042818280989048,0.047619047619047616,0.7210254731933864,1.0,2/7,5.87%,CANX;JAK1
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.6995513441399446,1.3042066988611856,0.24242424242424243,1.0,1.0,2/13,3.82%,TLE4;H2AC6
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.8777508492427115,-1.3041617199207245,0.12280701754385964,0.7204559727933073,1.0,2/5,10.39%,PRKAG2;LPGAT1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8456275055377285,-1.3041401503945371,0.1267605633802817,0.7193964787156701,1.0,5/8,13.89%,RFTN1;VAV3;PLCG2;TEC;BCAR1
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,-0.8230305546703864,-1.3039589303191605,0.10294117647058823,0.7181178095650208,1.0,3/9,7.12%,CD9;TINAGL1;SLC52A3
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,-0.8230305546703864,-1.3039589303191605,0.10294117647058823,0.7181178095650208,1.0,3/9,7.12%,CD9;TINAGL1;SLC52A3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.6088366393909836,-1.303404204921233,0.1111111111111111,0.720248901939923,1.0,19/63,20.48%,DDIT4;ITPR1;DUSP1;PEBP1;MAGI2;TMSB4X;HERPUD1;HYAL2;DGKG;RIOK3;CYLD;RACK1;MCL1;PINK1;DAG1;PDE10A;PPM1A;PIK3CB;SPRED1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7530678050372971,-1.3034032523993069,0.12,0.7190464830719098,1.0,5/12,14.56%,CDC37;OGT;PELI1;SDCBP;CYLD
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.7521930994527232,-1.3033261869368136,0.05714285714285714,0.7182420716269112,1.0,7/15,22.60%,JUN;FOS;VAV3;PLCG2;LCP2;GRB2;MAPK8
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.7903480012477825,-1.3032814414813485,0.14285714285714285,0.7173466838092264,1.0,2/10,2.52%,NR4A1;CX3CL1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7140632679436564,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7140632679436564,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7140632679436564,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7948908099662901,-1.3028767162523605,0.13333333333333333,0.7150413889068701,1.0,5/8,18.73%,PPARG;CD9;CD81;SREBF2;ITGB1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.7278482403542196,-1.3027710002289976,0.18309859154929578,0.7144558882426617,1.0,5/15,12.75%,GLUD1;HSPA5;CCDC14;MBP;PLP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.7535601085847418,-1.302008587603052,0.14516129032258066,0.7183046936323719,1.0,3/13,12.22%,JUNB;CD55;ZFP36
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.8103179452632944,-1.3016382398004942,0.10606060606060606,0.7193821023568864,1.0,3/7,8.10%,SRGN;FES;SCARF1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.9016938801649033,-1.3016021543485874,0.031746031746031744,0.7182747893781388,1.0,1/5,0.32%,MAP2
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.6294990695836129,-1.3015352381396281,0.075,0.7175217386828018,1.0,18/46,13.07%,BHLHE40;NDRG1;KLF6;NFKBIZ;JUNB;LGALS3;S100A6;NFE2L2;DUSP1;FOSL2;AHNAK;CD55;ANXA1;HERPUD1;EPAS1;ZFP36;DUSP5;NFKBIA
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.736373074948569,-1.3009611368954102,0.060240963855421686,0.7198479775216681,1.0,1/13,0.37%,DDIT4
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.7590520129512995,-1.300561338013519,0.125,0.720787064692569,1.0,4/10,12.30%,ITPR1;PIK3R1;PRKCE;PLCG2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7568940323907615,-1.3001525625260515,0.08695652173913043,0.7223290995578087,1.0,5/13,14.00%,RAPGEF3;COL18A1;PECAM1;RAP1A;MSN
prerank,KEGG_2021_Human__Circadian rhythm,-0.7981204115470976,-1.299994927173128,0.1111111111111111,0.7222893807045281,1.0,3/14,8.47%,BHLHE40;PRKAG2;NPAS2
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.7002563540901301,-1.2999045910181666,0.12162162162162163,0.7217006629902063,1.0,2/22,4.20%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.8619826572724565,-1.2997712954614051,0.078125,0.7211138566970351,1.0,1/6,4.06%,NES
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.7578278909885394,-1.2997220054692318,0.07575757575757576,0.7203100133174578,1.0,4/13,8.84%,RPS27A;CNTN1;JAG2;UBC
prerank,KEGG_2021_Human__Mismatch repair,-0.8488446134227121,-1.2996007631958753,0.16393442622950818,0.7198366487875687,1.0,1/5,1.78%,RFC3
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.7695169935277949,-1.2993326079409067,0.1232876712328767,0.7195118268612193,1.0,4/9,8.84%,ATG12;RPS27A;PRKN;UBC
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.7695169935277949,-1.2993326079409067,0.1232876712328767,0.7195118268612193,1.0,4/9,8.84%,ATG12;RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6551168773754249,-1.2991243585869972,0.0963855421686747,0.7194952198102648,1.0,9/38,11.93%,TBX3;PLS3;KIAA1217;ALPL;SULF2;TGM2;HYAL2;FGFR1;GJA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.762917259353289,1.298836588962664,0.08108108108108109,1.0,1.0,1/5,5.79%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.651569211894112,-1.2986692867122305,0.07228915662650602,0.7209989209239294,1.0,5/39,6.48%,CEP57;PSMC6;PSMB9;CEP70;PSMA1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.846152997990478,-1.2981681428271283,0.1076923076923077,0.7228049715007495,1.0,2/6,5.29%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7233152105048223,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7233152105048223,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7233152105048223,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.8288723312338954,-1.2974956758365657,0.0847457627118644,0.7222513674623496,1.0,4/10,10.81%,ITPR1;MGLL;PRKCE;DGKG
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.8021839481589391,-1.2973816841829087,0.12121212121212122,0.7217824492559544,1.0,3/7,11.71%,RPS9;RPS6;RPS7
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7202497037890556,-1.2971626954848687,0.09722222222222222,0.7222456587352621,1.0,9/22,19.23%,ADM;CD9;CD81;KIF16B;PICALM;SNX25;ITGB1;GRB2;ARFGEF2
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.6861408999917528,-1.297143854125899,0.10256410256410256,0.721188579313261,1.0,7/25,8.84%,PSMC6;MAFK;PSMB9;RPS27A;NFE2L2;PSMA1;UBC
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.7485214448217281,-1.2968039090904215,0.11764705882352941,0.7218296631138572,1.0,1/16,0.24%,SERPINE1
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,-0.6595762567285359,-1.296748462165279,0.06329113924050633,0.7210615775963871,1.0,15/40,12.75%,CCDC3;MAP2;MAP1B;NES;NFASC;CNTN1;PTPRD;SMARCA1;ANK2;SHC2;STOX2;GJA1;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.8490615466486799,-1.2963406461629194,0.109375,0.7222343495034014,1.0,3/6,12.64%,MAGI2;RAP1A;ACAP2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.7406667238357335,1.2961758571922575,0.25,1.0,1.0,1/9,0.19%,UBP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.8485825000465965,-1.2961397589755594,0.125,0.7221960330588274,1.0,2/5,9.93%,BCAP31;TGM2
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.8202255591059197,-1.2960655565150634,0.13114754098360656,0.7214664548417625,1.0,3/5,15.46%,CDKN1B;CDKN1A;CDK6
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,-0.7211391410807746,-1.2959640940735144,0.09722222222222222,0.7207568707772275,1.0,9/17,13.07%,BHLHE40;NFKBIZ;JUNB;LGALS3;NFE2L2;FOSL2;ANXA1;ZFP36;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.8299993132726836,-1.2959104886371322,0.14925373134328357,0.7197667610846403,1.0,3/7,14.56%,HYAL2;PAK2;CYLD
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8634095235740806,-1.295740015364741,0.0958904109589041,0.7197854857496615,1.0,3/5,12.46%,LAMA5;REL;PLEC
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.864735052106522,-1.2953238422219309,0.11475409836065574,0.7207554581106363,1.0,3/7,8.34%,PPARG;HES1;PRKN
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.7176754826559939,-1.2952133599997748,0.18181818181818182,0.7202800802218247,1.0,5/11,16.10%,MGLL;DGKG;PLPP1;LPIN2;AGPAT4
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.7342783399377343,-1.2951412630840389,0.16455696202531644,0.7195778819528319,1.0,5/14,16.65%,SSH1;ARF1;PRKN;KIF16B;PINK1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.625783489205923,-1.2948516832266697,0.10752688172043011,0.7203332315596247,1.0,6/69,7.46%,PIK3R3;ZNF43;JAK1;PIK3R1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.8326067323008126,-1.2948478434461386,0.1076923076923077,0.7192129621481789,1.0,2/6,7.33%,CDKN1B;IPO7
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,-0.6260003424508577,-1.2946797845713751,0.16049382716049382,0.7189352121752702,1.0,13/50,19.63%,LAMC1;PLS3;MAP1B;SMARCA1;PLOD2;GJA1;MYO1B;BCAR1;NAV2;WWTR1;CALD1;EGFR;PLAT
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.6254023763468036,-1.2941136726779343,0.07058823529411765,0.721206447764967,1.0,4/49,6.64%,CEP57;RAD21;CEP70;SPC25
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.7236633553868204,-1.2938169815606928,0.16455696202531644,0.7219545992847021,1.0,4/14,13.07%,SSH1;RPL10;KLF4;NFKBIA
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.8043819158790211,-1.2936366659959233,0.12121212121212122,0.7218652882346775,1.0,5/9,14.95%,CDKN1B;KLF4;CDKN1A;SMAD3;BTG1
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.8149064455484569,-1.2936207566485627,0.125,0.7207686706981655,1.0,3/7,5.82%,GRIN2B;GRIA2;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7148601670860483,-1.293467796731318,0.07407407407407407,0.7204559727933074,1.0,3/14,11.00%,RTN4;SPOCK1;EFNB2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.645076820843318,-1.2933417913514496,0.13253012048192772,0.7199883691571193,1.0,8/27,19.76%,VSIR;CX3CL1;IFNGR1;ZFP36;PLCG2;CD34;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.8036897277070929,-1.2927560209003897,0.14705882352941177,0.7220641334468638,1.0,1/6,2.52%,CX3CL1
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.6255984193394534,-1.2924223569122284,0.10344827586206896,0.7229767399527165,1.0,10/72,13.07%,PIK3R3;ITPR1;JUN;FOS;PIK3R1;AP1G1;CFL1;PLCG2;PAK2;NFKBIA
prerank,KEGG_2021_Human__Gastric cancer,-0.6660021837105675,-1.2923445386916026,0.12987012987012986,0.7221109252576104,1.0,4/41,6.27%,PIK3R3;WNT2B;CDKN1B;PIK3R1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.6437494030924968,-1.2918561915771367,0.1282051282051282,0.7240362203645279,1.0,3/33,6.24%,ADM;ITPR1;GGT5
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6978225217475272,-1.2912436327820425,0.0945945945945946,0.7266087217976013,1.0,1/20,0.37%,DDIT4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6904493937562366,-1.2911717928342255,0.1,0.7258786120702387,1.0,9/30,13.07%,BHLHE40;EHD4;JUNB;LGALS3;NFE2L2;FOSL2;KLF4;ZFP36;NFKBIA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.8175015271947819,-1.290572005092088,0.15625,0.7279607225099043,1.0,3/8,9.40%,RPS27A;UBC;CCNH
prerank,KEGG_2021_Human__Ras signaling pathway,-0.5930950772221389,-1.2903940090055042,0.06666666666666667,0.7276413714581343,1.0,13/76,12.72%,PIK3R3;RAPGEF5;GRIN2B;PIK3R1;FLT1;REL;RASSF1;RAP1A;AFDN;SHC2;FGFR1;PLCG2;PAK2
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.8490175692005123,-1.2903398084998878,0.208955223880597,0.7268276077954865,1.0,2/6,7.81%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.8129572141804688,-1.2903343333879642,0.15,0.7224764823323911,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.8129572141804688,-1.2903343333879642,0.15,0.7224764823323911,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.8129572141804688,-1.2903343333879642,0.15,0.7224764823323911,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.8129572141804688,-1.2903343333879642,0.15,0.7224764823323911,1.0,1/6,0.50%,B3GNT2
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,-0.6903573615963245,-1.289858628821725,0.1625,0.7240670684777242,1.0,7/24,15.27%,SERPINE1;ANGPTL4;EPS8;PLOD2;MYO1B;VEGFC;WWTR1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.7287621826331832,-1.2897105939606026,0.15492957746478872,0.7236553660935408,1.0,1/9,1.62%,PRKAG2
prerank,KEGG_2021_Human__AMPK signaling pathway,-0.6402654626726677,-1.2893913920050426,0.10588235294117647,0.7250872823030992,1.0,5/42,2.47%,PIK3R3;PPP2R3A;PCK1;PRKAG2;PPARG
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,-0.6296325780701193,-1.289278155468346,0.10843373493975904,0.7247090393493397,1.0,13/40,19.18%,ZEB2;ENPP2;LRRC32;GGT5;FLT1;PECAM1;TNS1;VWF;CFH;NOTCH4;TIE1;ACVRL1;CD34
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.7004882665821284,-1.2882480028046648,0.12345679012345678,0.7284318727163274,1.0,8/24,11.71%,RPS12;RPS9;RPS27A;RPS11;RPS27;RPS6;RPS15;RPS7
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.7004882665821284,-1.2882480028046648,0.12345679012345678,0.7284318727163274,1.0,8/24,11.71%,RPS12;RPS9;RPS27A;RPS11;RPS27;RPS6;RPS15;RPS7
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.6761294167941073,-1.2882026941532478,0.14864864864864866,0.7275462811076445,1.0,3/19,10.52%,PCK1;PPARG;RPS6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.8164140523593004,-1.2875036002947995,0.11475409836065574,0.7306393924907165,1.0,5/8,15.56%,SMAD7;NFE2L2;KLF2;KLF4;SREBF2
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.7397112280135218,-1.2864829851174737,0.1917808219178082,0.7351471904304849,1.0,5/14,8.84%,NRG3;RPS27A;CDC37;ERBB4;UBC
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,-0.6455878622165131,-1.286368404425666,0.0875,0.7346737378581827,1.0,13/50,14.37%,SERPINE1;MGLL;TIMP3;EMP1;FOSL2;TNS1;KLF4;TGM2;ITGB5;EPAS1;CFH;CST3;VEGFC
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,-0.655752263402439,-1.2859075224855165,0.13414634146341464,0.7359052906446104,1.0,5/34,8.26%,ITPR1;PRKAG2;RAPGEF3;SLC2A1;RAP1A
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.9026701753795873,-1.2858836042167294,0.05,0.7350151872435055,1.0,1/5,2.76%,ATG12
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.8202815560599727,1.2858678732841515,0.22916666666666666,1.0,1.0,2/5,15.70%,ANAPC16;CDC16
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.8202815560599727,1.2858678732841515,0.22916666666666666,1.0,1.0,2/5,15.70%,ANAPC16;CDC16
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.7824811863539266,-1.2857985943963914,0.08064516129032258,0.7342942427958785,1.0,7/10,19.76%,SERPINE1;CD55;VWF;CFH;TFPI;PLAT;CLU
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.6090168157679774,-1.285492447110275,0.06382978723404255,0.7352215955739678,1.0,15/99,9.43%,DDIT4;BTG2;NDRG1;PRKAG2;RFC3;BNIP3L;JUN;FOS;RPS27A;CDKN1B;BCL2L14;BCL6;UBC;CCNH;CNOT6L
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,-0.660827355358513,-1.285445900178783,0.12195121951219512,0.7343364390832964,1.0,6/27,10.28%,NFKBIZ;TCP11L2;NFE2L2;LAMP2;SOD2;ALPK1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.8008941985405991,-1.285328485673563,0.1,0.7340341539815833,1.0,1/7,2.58%,SYTL4
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.7731046986910796,-1.285042065442478,0.15873015873015872,0.734411496347185,1.0,7/10,12.70%,HES1;KDM1A;DMD;SLC8A1;ANK2;DYSF;NEBL
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.8747032142368565,-1.2847410653123599,0.12903225806451613,0.735068745369236,1.0,1/5,3.56%,GRIN2B
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.5970990072772985,-1.2845943111531017,0.08602150537634409,0.7349317766821392,1.0,28/92,18.22%,PSMC6;RPS12;RPL23;RPL34;PSMB9;MYO9B;RPS9;RPS27A;RPL37;PSMA1;RPS11;UBC;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;NCK1;RPL7A;RPLP1;ROBO2;RPS28;DAG1;RPL31
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.6654910699839581,-1.2843892009187354,0.14285714285714285,0.7350589191671832,1.0,12/34,19.42%,PLS3;GAPDH;KIAA1217;PEBP1;SMARCA1;ADAMTS1;ITGB5;MYO1B;BCAR1;FKBP5;DAG1;EGFR
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.6628427008746699,-1.2842103124229107,0.14942528735632185,0.7349223653391159,1.0,4/30,16.60%,PPP2R3A;PPP2R2B;CSTF3;SRRM1
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.7892006167473596,-1.2841753326240406,0.0945945945945946,0.7319425001979678,1.0,3/8,14.48%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7892006167473596,-1.2841753326240406,0.0945945945945946,0.7319425001979678,1.0,3/8,14.48%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7892006167473596,-1.2841753326240406,0.0945945945945946,0.7319425001979678,1.0,3/8,14.48%,PPA1;PPA2;LARS1
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.6408352952466632,-1.2839443894954308,0.11392405063291139,0.7321221498600231,1.0,7/43,8.37%,PRKAG2;GRIK1;GRIN2B;GRIA2;LRRC7;ERBB4;NCALD
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.8135831862117322,-1.283715737406859,0.1875,0.7324646615633337,1.0,1/5,1.27%,ADAMTS9
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.7488721125019502,-1.2834741225143371,0.1625,0.7327409217859107,1.0,4/15,11.66%,TSG101;RPL23;LAMP2;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.8187616836802128,-1.2824179392527328,0.15,0.7372846409349383,1.0,1/7,2.39%,AKAP12
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.6083474775737416,-1.2823332072642732,0.04819277108433735,0.736642156249985,1.0,11/60,10.92%,PSMC6;PSMB9;NPLOC4;RPS27A;NFE2L2;PSMA1;FEM1C;HIF1A;COMMD1;UBC;EPAS1
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.81850836503895,-1.2822335480138536,0.1388888888888889,0.7361802102947486,1.0,3/9,12.99%,BTG2;CNOT6L;NPM1
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.6733729816883823,-1.2820571777572174,0.18292682926829268,0.736125111610813,1.0,9/24,20.66%,RPS27A;CDC37;UBC;OGT;PELI1;TNFRSF10B;SDCBP;CHMP4B;XIAP
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.6658990261997871,-1.2820139453573143,0.11538461538461539,0.7352441091053642,1.0,5/32,12.30%,DIXDC1;WNT2B;RPS27A;UBC;PLCG2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7641400346686801,-1.2819892598409637,0.15714285714285714,0.7343009420980637,1.0,3/9,12.22%,PCK1;ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.73570662610457,-1.2819574176255257,0.16216216216216217,0.7334735372228134,1.0,5/10,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.7014357185645423,-1.281908196541284,0.18309859154929578,0.7326646308208086,1.0,2/14,6.08%,SEC22B;FEZ2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.7506539262186016,1.2818956706348283,0.13513513513513514,1.0,1.0,2/5,11.50%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.8302100146696779,-1.2804946224308216,0.11475409836065574,0.7394594162816859,1.0,3/6,16.33%,UFL1;CHD1;MBD2
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.7779337754612917,-1.2803120814685938,0.15873015873015872,0.7396091661771652,1.0,5/10,14.53%,RPS27A;EDEM3;UBC;UGGT2;AMFR
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.7777083684241805,-1.2799863022056086,0.15625,0.7404490114462956,1.0,4/11,12.22%,PPARG;RREB1;AAMDC;ZFP36
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.8246375470834016,1.2796435204445489,0.2222222222222222,1.0,1.0,4/5,14.08%,ATM;RAD51B;SEM1;SPIDR
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.8246375470834016,1.2796435204445489,0.2222222222222222,1.0,1.0,4/5,14.08%,ATM;RAD51B;SEM1;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.7717292390526358,-1.27963651635887,0.11842105263157894,0.7408855692440435,1.0,3/11,7.73%,MAP2;SSH1;HIP1R
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.6801162402926414,-1.2795971732706657,0.14457831325301204,0.7399117428622946,1.0,9/25,18.41%,MAP2;UFL1;KDM1A;AFDN;TPR;RACK1;PICALM;RAB14;DLG1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.8326479408576324,-1.2794099616843757,0.14864864864864866,0.7398041556564089,1.0,1/7,1.51%,MTFR1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6763662545119699,1.2790830400736655,0.21621621621621623,1.0,1.0,5/8,29.93%,STAT2;OAS3;ISG15;PTPN2;YTHDF2
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.7562657814434023,-1.2785171195244738,0.12,0.7438644048880545,1.0,1/16,1.89%,YTHDC1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.679676482902402,-1.2781089366980447,0.2028985507246377,0.7449633389004098,1.0,5/17,8.34%,PPARG;HES1;JUN;KDM1A;PRKN
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,0.5600631559615217,1.2780296297203904,0.13333333333333333,1.0,1.0,2/26,0.98%,MMRN1;GBP4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.7458225707801226,-1.2780141460285919,0.15942028985507245,0.7444032363868613,1.0,3/12,13.23%,SERPINE1;HYAL2;RAB1A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6628580899146485,-1.2779489730444196,0.18666666666666668,0.7437811165099338,1.0,8/25,18.27%,PPARG;AAMDC;ZFPM2;ZFP36;TRIB2;SMAD3;WWTR1;GATA2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6456316822881296,-1.2774020085906326,0.10588235294117647,0.7457964111875711,1.0,11/39,14.56%,BHLHE40;UFL1;HES1;KDM1A;SMAD7;COMMD1;KLF4;TMSB4X;PRNP;NFKBIA;CYLD
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.5614724017512559,-1.2773751924336822,0.02,0.7449521100724812,1.0,24/177,11.39%,PIK3R3;PSMC6;NR4A1;NRG3;PSMB9;LRRFIP1;ESR2;RPS27A;CDKN1B;WDR48;RRBP1;CDC37;PEBP1;ERBB4;PIK3R1;PSMA1;JAG2;RAP1A;UBC;VWF;DUSP16;RPS6;FGFR1;TPR
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.6002360616049919,-1.277291140056506,0.10588235294117647,0.7444585056421702,1.0,17/76,11.02%,PSMC6;NRG3;GRIN2B;PSMB9;RPS27A;LRRC7;JAK1;PEBP1;ERBB4;PIK3R1;PSMA1;RAP1A;UBC;VWF;DUSP16;SHC2;FGFR1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7878403310267968,1.277197132944789,0.18604651162790697,1.0,1.0,3/5,17.53%,TTN;CDH2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.7381293917780077,-1.2770438488256963,0.10526315789473684,0.7448200584252089,1.0,4/14,11.00%,SPOCK1;GRIN2B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.7631475542197084,-1.2770412233834347,0.1267605633802817,0.7437912184057833,1.0,6/9,21.38%,PPM1D;DUSP1;DUSP16;DUSP5;PPM1A;DUSP6
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6876418618291804,-1.276847523674927,0.1375,0.7437743022698765,1.0,9/21,20.35%,SERPINE1;ARF1;HIP1R;RAB21;SGIP1;PICALM;LRPAP1;CLU;PIK3CB
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.7158555022422243,-1.2768380343982697,0.10666666666666667,0.741712442660987,1.0,7/19,14.26%,RPS27A;CDC37;UBC;OGT;PELI1;TNFRSF10B;SDCBP
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.7158555022422243,-1.2768380343982697,0.10666666666666667,0.741712442660987,1.0,7/19,14.26%,RPS27A;CDC37;UBC;OGT;PELI1;TNFRSF10B;SDCBP
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.611252981309639,-1.2765837396170718,0.13924050632911392,0.742106704716293,1.0,9/57,12.30%,PIK3R3;GRM7;PIK3R1;ARF1;RAPGEF3;DGKG;SHC2;GNA13;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.6771505993228949,-1.2765803723826201,0.1566265060240964,0.7411044868116043,1.0,7/26,15.59%,TSG101;CX3CL1;LGALS3;TPR;SDCBP;SMAD3;RACK1
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,-0.6540316727670639,-1.276366101258891,0.13333333333333333,0.7413889012448167,1.0,7/37,12.06%,LAMC1;PLS3;NES;SMARCA1;TPM1;GJA1;MYO1B
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.7729213896755041,1.2763361840430376,0.20454545454545456,1.0,1.0,2/6,15.70%,ANAPC16;CDC16
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.6103536788616916,-1.27615627203515,0.1125,0.7416725256379366,1.0,9/46,12.88%,SERPINE1;CX3CL1;SMAD7;MAGI2;TPM1;DLC1;AFDN;TMEFF2;CLDN5
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.5809210489603546,-1.2761560109370147,0.08602150537634409,0.7406438536190214,1.0,14/112,9.46%,PIK3R3;LAMC1;PPP2R3A;PKM;WNT2B;BCAP31;HES1;CDKN1B;JAK1;PIK3R1;LAMA5;PPP2R2B;ITGA10;VWF
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.584576455690101,-1.2760618236749801,0.020833333333333332,0.7401013702508812,1.0,27/129,16.65%,TBX3;ANGPTL4;BNIP3L;CX3CL1;GRK5;HSPA5;RPS27A;PIK3R1;PRKN;UBC;RPL10;ANXA1;KLF4;SOD2;CFL1;SNX6;GOLPH3;TMBIM6;PAK2;NPM1;NFKBIA;CPEB4;NAA16;PTMA;MALT1;MCL1;PINK1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.9049435743703154,-1.2759067198144185,0.06557377049180328,0.739902927971792,1.0,1/5,1.94%,ATF3
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,-0.8282987537916234,-1.2755565468243286,0.1111111111111111,0.7405291051499234,1.0,3/6,10.28%,RPS27A;UBC;ALPK1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.604331097907512,-1.2754022641119114,0.1111111111111111,0.7402995661818816,1.0,21/63,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;SMAD3;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.8428988798818924,-1.2752873248893637,0.12121212121212122,0.7398225686528725,1.0,2/5,10.15%,GGT5;PRNP
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.6288940885476626,-1.2752196165404361,0.14814814814814814,0.7392230085357739,1.0,9/38,19.12%,SERPINE1;SMAD7;RPS27A;UBC;ITGB5;SMAD3;WWTR1;ITGB1;PPM1A
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.7929726760291977,-1.2743682999627683,0.16176470588235295,0.7426300341125381,1.0,2/7,6.67%,KCNMB4;KLF2
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.574958422493406,1.2743275409043913,0.15151515151515152,1.0,1.0,6/19,14.45%,PSMD14;RALA;NDUFS4;PSMB1;NDUFAF2;PALD1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.6424213165288378,-1.2743266019095483,0.12658227848101267,0.7417966396828896,1.0,4/28,8.34%,MAP2;SSH1;HIP1R;PRKN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.8017710831847966,-1.2741540155206443,0.125,0.7419061923599917,1.0,1/8,2.82%,HES1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7778505959254014,-1.2739204410374418,0.19480519480519481,0.7421540419123603,1.0,3/10,17.66%,SUN2;MYO1B;MYO1E
prerank,CellMarker_Augmented_2021__Platelet:Blood,-0.7156279319185658,-1.273779437837495,0.16901408450704225,0.7416937993478573,1.0,9/15,25.55%,CD9;LRRC32;LAMP2;PECAM1;ITGB1;CD109;CD63;BSG;CD46
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.7155722624463815,-1.2735652632439116,0.16049382716049382,0.7420180504238028,1.0,2/14,0.85%,SERPINE1;BHLHE40
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.7080539516748596,1.2735286874489,0.25,1.0,1.0,3/7,9.40%,MIPOL1;WDPCP;MDM4
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7467240537077506,-1.2734598279694918,0.14705882352941177,0.7416052572466871,1.0,3/12,9.11%,ALPL;GGT5;ANXA1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.8150468919774736,-1.2733682815423786,0.14084507042253522,0.7411476398690676,1.0,3/8,12.59%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.8428466046819387,-1.2729615854222986,0.12307692307692308,0.7421137015950083,1.0,4/6,15.56%,PPARG;ABCA5;NFKBIA;SREBF2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6819258736329505,1.2727119029391971,0.125,1.0,1.0,2/10,2.79%,GULP1;ARHGAP12
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.7539786833272607,-1.2724241617409553,0.19047619047619047,0.744406001739625,1.0,4/6,22.66%,FES;RASSF1;GATA2;GUK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.7929623936984009,-1.2723480067779287,0.17142857142857143,0.7438396746541673,1.0,1/6,2.31%,RTN4
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.72889587185418,-1.272303257044857,0.15492957746478872,0.7430311536052085,1.0,3/15,9.11%,MAP3K5;NFE2L2;ANXA1
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.7048272415842259,-1.2717435256206218,0.125,0.7449630372394649,1.0,7/15,21.91%,ITPR1;PIK3R1;PLCG2;SH3KBP1;NCK1;GRB2;AHCYL1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.8007978516226748,-1.2715735143854636,0.10144927536231885,0.7449299642779991,1.0,3/9,12.70%,KDM1A;DMD;NEBL
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.8866718174121266,-1.2715557863417746,0.1076923076923077,0.7440625574813631,1.0,3/5,11.24%,PTPRD;IL1RAPL1;PPFIA2
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.5911743064951557,-1.2714293051672323,0.0963855421686747,0.7436823146147269,1.0,17/61,14.53%,MAP3K5;ERO1A;BCAP31;SEC24D;NPLOC4;HSPA5;NFE2L2;RRBP1;CANX;PRKN;EDEM3;TRAM1;NGLY1;HERPUD1;ERO1B;UGGT2;AMFR
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,-0.7758789656757795,-1.2711706169878185,0.1643835616438356,0.7440898821830745,1.0,5/9,19.18%,CD9;PECAM1;CD81;IL18R1;CD34
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.6688901009123873,-1.271123693404624,0.13157894736842105,0.7432724266296726,1.0,11/27,22.92%,BCAP31;SMIM3;SHISA5;MYL12A;RSU1;PTTG1IP;DHRSX;MYL6;IFITM3;CD63;ANXA5
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.8078301259826154,1.2708086459218844,0.18181818181818182,1.0,1.0,2/5,12.72%,OCLN;PROM1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6686779058322601,-1.2707736847984594,0.09876543209876543,0.7439661605784106,1.0,10/39,10.92%,PSMC6;NDRG1;PGK1;BNIP3L;PSMB9;RPS27A;PSMA1;HIF1A;UBC;EPAS1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.7927978757832777,-1.2706891628901955,0.14754098360655737,0.7434524548566145,1.0,1/8,3.05%,JUN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6058072043114537,-1.2706193614226888,0.12643678160919541,0.7418580360705452,1.0,17/45,22.60%,PSMC6;JUN;PSMB9;FOS;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;MALT1;LCP2;GRB2;PSMA7;PIK3CB;CUL1;MAPK8
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6058072043114537,-1.2706193614226888,0.12643678160919541,0.7418580360705452,1.0,17/45,22.60%,PSMC6;JUN;PSMB9;FOS;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;MALT1;LCP2;GRB2;PSMA7;PIK3CB;CUL1;MAPK8
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.7701958959957271,1.2701552776550122,0.13513513513513514,1.0,1.0,2/5,8.90%,CLASP1;ABL1
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.6994504380504608,-1.270089562232222,0.19230769230769232,0.7439008109079562,1.0,6/19,18.73%,SMAD7;RPS27A;UBC;ITGB5;SMAD3;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8833768339453696,-1.270040674778766,0.11594202898550725,0.7431650856174973,1.0,1/5,0.32%,MAP2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7723962801367827,-1.2695656621754294,0.10144927536231885,0.7449012978342704,1.0,5/11,18.41%,DUSP1;PRKN;CYLD;PINK1;DLG1
prerank,Reactome_2022__S Phase R-HSA-69242,-0.6441586663471142,-1.2694499891381448,0.14634146341463414,0.7445847896112107,1.0,13/42,15.43%,PSMC6;RFC3;PSMB9;RAD21;RPS27A;POLA1;CDKN1B;PSMA1;UBC;CCNH;CDKN1A;MAX;SMC3
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.6839070617149903,-1.2694483287343268,0.15584415584415584,0.7436122065010831,1.0,7/25,8.84%,PSMC6;RFC3;PSMB9;RPS27A;POLA1;PSMA1;UBC
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6470481820244273,-1.2694314039545753,0.13513513513513514,0.742686930066379,1.0,15/34,13.31%,MAP2;DOK5;MAP1B;NFASC;GRIA2;GPM6B;NPAS3;PTPRD;ANK2;PPFIA2;GJA1;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.7774613080825794,-1.2691750201049685,0.1935483870967742,0.7421820745157937,1.0,2/8,8.84%,RPS27A;UBC
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.7774613080825794,-1.2691750201049685,0.1935483870967742,0.7421820745157937,1.0,2/8,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.6328005418673976,-1.2691454822224741,0.08536585365853659,0.7414405598966416,1.0,8/35,9.19%,SERPINE1;ANGPTL4;PKM;JAK1;RAPGEF3;FLT1;HIF1A;KLF4
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.7699187400958822,-1.269082397725811,0.1643835616438356,0.7407899883297785,1.0,2/9,5.37%,FOS;CDKN1B
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6546218610553647,1.2683227110542572,0.25,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,KEGG_2021_Human__Insulin secretion,0.537084609534749,1.2680509649351892,0.22727272727272727,1.0,1.0,1/24,0.03%,CREB5
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.610166972859949,1.2680034162388578,0.16216216216216217,1.0,1.0,3/12,9.91%,ATR;ATM;NEK7
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.7495319080543633,1.2674509799633287,0.17073170731707318,1.0,1.0,2/5,20.80%,TRPM7;TRPC1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5807376828997135,-1.26725807608665,0.1368421052631579,0.7494875045917218,1.0,34/90,27.38%,SUN2;SCARB2;RIMS1;RPS27A;ANK2;HIP1R;SUN1;UBC;ARPC2;SYNJ2;DYSF;SH3KBP1;SYT1;SGIP1;PICALM;PIP5K1C;TOR1AIP2;ANK3;GRB2;USO1;CHMP4B;EGFR;REEP3;VAPB;CLTA;DNM2;CCDC88A;SNX9;TF;SERP1;SYNJ1;SPTBN1;FZD4;FCHO2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.7351693932503037,1.267049403250697,0.2647058823529412,1.0,1.0,1/6,0.58%,PGM5
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.8435273274975179,-1.2668551917619713,0.125,0.7506475513180926,1.0,2/7,2.63%,SEC22B;SEC24D
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,-0.7331915585226886,-1.2667521453861725,0.18421052631578946,0.7502976941073346,1.0,4/11,19.12%,PRKAG2;RPS6;MTOR;PPM1A
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.5761226512309203,-1.2667488938636124,0.043478260869565216,0.7493438494874689,1.0,26/138,14.58%,PIK3R3;PSMC6;JUN;PSMB9;FOS;RPS27A;CANX;JAK1;PIK3R1;LAMA5;PSMA1;HIF1A;BCL6;UBC;ANXA1;IL1RAPL1;S1PR1;ALPK1;MEF2A;INPP5D;NFKBIA;TEC;CDKN1A;PELI1;MSN;SMAD3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.6524322449233076,-1.266701917054357,0.1282051282051282,0.7486429875992955,1.0,8/32,16.23%,LAMC1;ACTN1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB;TBCD
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8112686887704339,-1.2661087635064114,0.078125,0.7509017123298547,1.0,1/5,11.53%,GOLPH3
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.5482647078680786,-1.2660401364656306,0.0,0.7503329104705428,1.0,105/430,18.25%,PIK3R3;MTHFD1L;B3GNT2;PSMC6;ANGPTL4;SPNS2;PKM;RIMKLB;ITPR1;LDHA;LBR;PCK1;PRKAG2;MGLL;PGK1;RPS12;GLUD1;RPL23;PPARG;SEC24D;PPA1;RPL34;ENPP2;GLUL;SLC2A3;CHPT1;PSMB9;RPS9;ESYT2;TINAGL1;GPC5;ADSS2;RPS27A;RPL37;DHRS7B;GMPS;GGT5;PIK3R1;MTMR12;PSMA1;SLC52A3;RAPGEF3;RPS11;SLC2A1;RAP1A;SIN3B;NPAS2;UBC;STARD4;ARSG;HYAL2;PRNP;SLC26A2;RPS27;LPGAT1;PLIN2;NDUFA12;RPS6;RPL8;ACSL5;RPS15;CHST11;TPR;SYNJ2;RPS7;RPLP2;RPL13A;PLCG2;RPL15;INPP5D;PPA2;NOSTRIN;MTHFD2L;PON2;ACOX1;HS6ST3;PLPP1;RPL37A;LARS1;CACNA1C;RPL7A;RPLP1;LPIN2;SULT1C4;UPP1;SREBF2;PIK3C3;AGPAT4;SH2D3C;EGFL7;ENTPD4;RAB14;TXNRD1;SAMD8;B4GALT1;KPNB1;PIP5K1C;RPS28;MTMR2;ZDHHC21;CHSY1;SERINC3;NUP54;RPL31;ADK
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.6273074665268721,-1.2657427884233263,0.1,0.750866353652738,1.0,19/60,21.62%,PRKAG2;GRIK1;SYN3;GLUL;GRIN2B;RIMS1;GRIA2;LRRC7;ERBB4;NCALD;PPFIA2;SYT1;SH2D3C;SLC38A2;RASGRF2;DLG1;GNAI3;PRKAR1A;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.7582207118333717,-1.2657294364002918,0.125,0.7499766093738274,1.0,1/11,0.37%,DDIT4
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.5865164863947742,-1.2656894090858586,0.1348314606741573,0.7492209270061416,1.0,15/64,17.56%,PIK3R3;MGLL;CHPT1;PIK3R1;MTMR12;LPGAT1;SYNJ2;INPP5D;LPIN2;PIK3C3;AGPAT4;SH2D3C;RAB14;PIP5K1C;MTMR2
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8033043926163216,-1.2656280454241609,0.234375,0.7484818270921055,1.0,2/6,9.00%,WNT2B;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.616538232731616,-1.2654122344607686,0.18055555555555555,0.7486644872922671,1.0,9/41,9.16%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;PTPRD;SCARF1;RAP1A;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.7321870880311734,-1.2651290301048137,0.16216216216216217,0.7491674731663244,1.0,6/12,18.43%,EPS8;VAV3;MSN;LARS1;PICALM;MTOR
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.8162901773038427,-1.2640643065189285,0.14516129032258066,0.7540089029622065,1.0,2/7,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7983178981978349,-1.2640026512748945,0.13846153846153847,0.7532819807591199,1.0,2/7,7.60%,CX3CL1;ANK2
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,-0.6436468473380602,-1.263596191491806,0.2125,0.7525467461953581,1.0,12/35,19.42%,PPARG;TIMP3;PLOD2;DLC1;ITGB5;EPAS1;MYO1B;PLSCR4;PON2;THRB;RAPH1;EGFR
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,-0.6436468473380602,-1.263596191491806,0.2125,0.7525467461953581,1.0,12/35,19.42%,PPARG;TIMP3;PLOD2;DLC1;ITGB5;EPAS1;MYO1B;PLSCR4;PON2;THRB;RAPH1;EGFR
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,-0.6436468473380602,-1.263596191491806,0.2125,0.7525467461953581,1.0,12/35,19.42%,PPARG;TIMP3;PLOD2;DLC1;ITGB5;EPAS1;MYO1B;PLSCR4;PON2;THRB;RAPH1;EGFR
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,-0.8743716341093498,-1.2633604836199601,0.14925373134328357,0.7529829857038021,1.0,1/5,1.75%,NR4A1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.7833999278227994,-1.2632493024252691,0.1694915254237288,0.7527100190720835,1.0,1/6,4.91%,ESR2
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6688397287217903,-1.2630166915978622,0.09876543209876543,0.7528707186846089,1.0,7/26,13.07%,PSMC6;ST18;PSMB9;PSMA1;TMSB4X;LIMS1;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.6831879494032116,-1.2629909144084412,0.14814814814814814,0.752079700472335,1.0,2/25,2.47%,SERPINE1;PPARG
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.738792960062497,-1.2627465485166975,0.17567567567567569,0.7527446306213003,1.0,6/15,9.19%,PKM;ADAMTS9;GLUL;JAK1;KLF2;KLF4
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.7314729539154704,-1.2623709741645412,0.1917808219178082,0.7535947622506942,1.0,4/15,14.58%,SMAD7;RPS27A;UBC;SMAD3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8438187153636901,-1.262309399610278,0.22388059701492538,0.7529781502960347,1.0,1/5,9.43%,CNOT6L
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5449622360949247,-1.2621225252672683,0.08247422680412371,0.7530944639174627,1.0,25/135,14.37%,TBX3;UFL1;RPL23;SLC6A6;CX3CL1;HES1;GRK5;RPS9;CDKN1B;ERBB4;FLT1;TPM1;CD81;CNOT6L;TGM2;RPS6;EFNB2;FGFR1;ZFP36;CLDN5;NPM1;SMC6;CNBP;SDCBP;VEGFC
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.5748686758131154,-1.2617372353424297,0.11363636363636363,0.7543848889738765,1.0,17/66,22.60%,ADM;ITPR1;JUN;MYO9B;GGT5;VAV3;WIPF1;ARPC2;PLCG2;NCK1;MYO1E;GRB2;GNAI3;PRKAR1A;ADCY2;AHCYL1;MAPK8
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.6221764607498775,-1.261699171859102,0.14864864864864866,0.7536838004775285,1.0,9/40,13.44%,NRCAM;VSIR;CD99L2;NFASC;CNTN1;PECAM1;CLDN5;LRRC4C;NCAM2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.7475748929395463,-1.2615986119949711,0.14285714285714285,0.7522441522012503,1.0,5/9,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.7475748929395463,-1.2615986119949711,0.14285714285714285,0.7522441522012503,1.0,5/9,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.6921559048413122,-1.2615665373053107,0.1780821917808219,0.7514344396614373,1.0,8/15,23.82%,PIK3R1;VAV3;PLCG2;LCP2;GRB2;PIK3CB;B2M;HLA-B
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.8044758694369674,-1.261562909299055,0.2,0.7495795185685102,1.0,3/6,4.33%,ITPR1;PDE5A;KCNMB4
prerank,Reactome_2022__cGMP Effects R-HSA-418457,-0.8044758694369674,-1.261562909299055,0.2,0.7495795185685102,1.0,3/6,4.33%,ITPR1;PDE5A;KCNMB4
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.7140220135778552,-1.2615479250483377,0.1780821917808219,0.7487052513608256,1.0,4/12,8.10%,LBR;ABCA5;LSS;SCARF1
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.807322265968854,-1.261462489589057,0.1044776119402985,0.7481167411127292,1.0,4/8,14.10%,SYN3;RIMS1;PPFIA2;SYT1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.5826879290556207,-1.2612726001875612,0.13333333333333333,0.7483368259857213,1.0,18/91,12.93%,PSMC6;MAP3K5;GRIN2B;PSMB9;RPS27A;LRRC7;JAK1;PEBP1;ERBB4;PIK3R1;PSMA1;MBP;UBC;SHC2;FGFR1;MEF2A;ZFP36;DUSP5
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6819659892037967,-1.2608728808600445,0.17647058823529413,0.7491361846499506,1.0,5/20,9.19%,PPARG;JUN;FOS;HIF1A;KLF4
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,-0.6702695180088265,-1.2593748181224056,0.15789473684210525,0.7557810274505388,1.0,6/23,9.11%,CD9;LGALS3;S100A6;EMP1;HIF1A;ANXA1
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.5717023037738784,-1.259238903826772,0.06315789473684211,0.755398200327162,1.0,26/132,15.46%,CEP57;PSMC6;LBR;RFC3;PSMB9;RAD21;CEP70;RPS27A;POLA1;CDKN1B;PSMA1;SPC25;UBC;CCNH;RPS27;ENSA;RAB2A;TPR;ARPP19;CDKN1A;RAB1A;MAX;LPIN2;PAFAH1B1;SMC3;CDK6
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.7494426208279197,-1.258643525731889,0.22727272727272727,0.75752417649362,1.0,5/14,19.65%,SCP2;LSS;ACSL5;AGPAT4;CBR4
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.584269255956114,-1.2586172871476375,0.15555555555555556,0.7567320567359078,1.0,16/47,25.29%,ITPR1;PIK3R1;FLT1;VAV3;SHC2;BCAR1;VEGFC;NCK1;CTNNA1;MTOR;PIK3CB;AHCYL1;CDH5;ABI1;HSP90AA1;MAPKAP1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.650261688916338,-1.258545555562935,0.15476190476190477,0.7560543455126708,1.0,4/22,9.80%,PSMC6;NPLOC4;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.7532502256469654,-1.2585327954733163,0.1724137931034483,0.7551677796183901,1.0,1/10,4.17%,EPS8
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,-0.7586947966198694,-1.2584875594517115,0.2753623188405797,0.7545357608899086,1.0,3/8,9.19%,NES;PECAM1;KLF4
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6734962785690177,-1.2583861686762234,0.16216216216216217,0.7539333171447687,1.0,4/19,11.50%,VSIR;SRGN;SPG7;OGT
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.6954590721433279,1.2581786654144782,0.25,1.0,1.0,4/7,27.30%,YWHAG;FOXO3;AKT3;FOXO1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.7072726530399854,1.2581028400675436,0.29411764705882354,1.0,1.0,1/5,4.94%,GNB4
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.7072726530399854,1.2581028400675436,0.29411764705882354,1.0,1.0,1/5,4.94%,GNB4
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.7867455012444895,-1.2578300377708123,0.11940298507462686,0.7565906434784375,1.0,4/10,14.10%,SYN3;RIMS1;PPFIA2;SYT1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5494079473005578,1.2577218631402738,0.21428571428571427,1.0,1.0,2/18,2.74%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7678979855429872,1.2575469220301443,0.2571428571428571,1.0,1.0,1/5,2.79%,ARHGAP12
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.6207618273424967,-1.2572912659381974,0.1625,0.7583335433232283,1.0,5/29,7.49%,SERPINE1;ANGPTL4;RAPGEF3;FLT1;HIF1A
prerank,KEGG_2021_Human__Long-term potentiation,-0.6532456697761471,-1.2572881489094465,0.19230769230769232,0.7574496461174991,1.0,7/30,15.51%,ITPR1;GRIN2B;GRIA2;RAPGEF3;RAP1A;CACNA1C;PPP3CC
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.8001954626629816,-1.2570152440143918,0.2153846153846154,0.7577800281598233,1.0,1/7,3.43%,PKIG
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.7773129528089927,-1.256952602512867,0.1791044776119403,0.7572607867619086,1.0,5/11,17.26%,JUN;IFNGR1;IFNGR2;SMAD3;IL18R1
prerank,KEGG_2021_Human__Pathways in cancer,-0.5637553622918817,-1.2566548193842078,0.0625,0.7576739723137641,1.0,30/164,14.69%,PIK3R3;LAMC1;WNT2B;PPARG;HES1;JUN;FOS;ESR2;NFE2L2;CDKN1B;JAK1;PIK3R1;LAMA5;IFNGR1;IFNGR2;HIF1A;SLC2A1;JAG2;RASSF1;EPAS1;FGFR1;TPR;GNA13;PLCG2;NFKBIA;CDKN1A;CTNNA3;VEGFC;SMAD3;MAX
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.754975052209315,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.754975052209315,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.754975052209315,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.7080349859713235,-1.2565931240971766,0.1891891891891892,0.7541581995611454,1.0,3/15,11.95%,MAP2;CTNND2;MEF2A
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.6165527209489081,-1.2563831847933533,0.10465116279069768,0.7543930955914889,1.0,6/40,9.69%,LBR;PKN3;MYO9B;ARHGAP21;PIK3R1;DLC1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.6862078435589345,-1.2563068298676225,0.22077922077922077,0.7537582996607062,1.0,2/26,1.62%,DDIT4;PRKAG2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.684183550693834,-1.2559422494062975,0.16883116883116883,0.7545166973332602,1.0,8/24,10.92%,PSMC6;PSMB9;RPS27A;NFE2L2;PSMA1;HIF1A;UBC;EPAS1
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.6484108312967469,-1.2556623173171118,0.16666666666666666,0.7550530524770324,1.0,7/24,10.25%,ADM;WNT2B;CX3CL1;GRM7;CD55;ANXA1;S1PR1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8272272440940406,-1.255522418372369,0.16901408450704225,0.7548183799205828,1.0,2/7,8.26%,RAPGEF3;RAP1A
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,-0.6713463145695312,-1.2553589901398015,0.12658227848101267,0.754886300151646,1.0,10/26,21.97%,SERPINE1;EMP1;VEGFC;ITGB1;ATP8B1;EGFR;CD109;CAV2;REEP3;ADAM9
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.7532530835320412,1.2552978877515824,0.17073170731707318,1.0,1.0,1/5,9.64%,ATM
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.6075433323506707,-1.254826159367127,0.18421052631578946,0.7566131439309436,1.0,7/30,16.65%,ZEB2;SCARB2;PRKN;GOLPH3;PAK2;MSN;PINK1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.6913365718385016,-1.2545323496374854,0.24242424242424243,0.7561833232059766,1.0,5/13,16.65%,ATG12;RB1CC1;PRKN;GABARAPL1;PINK1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.6913365718385016,-1.2545323496374854,0.24242424242424243,0.7561833232059766,1.0,5/13,16.65%,ATG12;RB1CC1;PRKN;GABARAPL1;PINK1
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6788241513533522,-1.2545299061499642,0.16,0.7552656249982024,1.0,6/18,8.84%,PSMC6;PSMB9;GPC5;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.8321348929390522,-1.2544404862481893,0.15625,0.7548277264953214,1.0,2/5,4.62%,KIAA1217;TINAGL1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.7424307699481215,1.254397567415151,0.3,1.0,1.0,2/5,22.15%,ROCK1;GAS6
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.7262280127012636,-1.254042686582156,0.17105263157894737,0.7561898476545371,1.0,6/14,14.26%,ADM;FOS;ALPL;SOD2;PELI1;SDCBP
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.7501663000900477,-1.2540153476870923,0.24615384615384617,0.7553707545763868,1.0,1/8,4.73%,RAD21
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.721518619448581,-1.2538402441607157,0.14285714285714285,0.7554237558931034,1.0,4/13,9.40%,RPS27A;HMGN1;UBC;CCNH
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,-0.8075192221954967,-1.2535570728507661,0.15,0.7560333749479828,1.0,1/5,1.54%,PCK1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.6713665538515904,-1.2534961327574066,0.16455696202531644,0.7554208729789463,1.0,7/27,9.16%,DDIT4;WNT2B;PBX3;SPOCK1;PTPRD;SMARCA1;IL1RAPL1
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.7616986883245965,-1.2531481034364456,0.16923076923076924,0.7562457719832877,1.0,5/9,19.42%,NRG3;ERBB4;PRKCE;GRB2;EGFR
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.7715401765788301,-1.2528125270313266,0.13043478260869565,0.7567574935077839,1.0,5/11,17.90%,LAMC1;PRX;WWTR1;SREBF2;DAG1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.8075836811239858,-1.2524118283548584,0.1935483870967742,0.7575788073758256,1.0,3/9,4.86%,DDIT4;SMAD7;DMD
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.7365449350117839,-1.2517546702529112,0.14516129032258066,0.759545460525798,1.0,4/13,11.63%,ENPP2;NFASC;GRIA2;CTNND2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.6162247253554182,-1.2509273483017849,0.1875,0.7634757147316202,1.0,11/39,11.24%,MAP2;PPP1R9A;NFASC;GRIA2;ERBB4;CNTN1;PTPRD;ANK2;SHC2;STOX2;PPFIA2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.700051024117671,-1.2509215710429549,0.15714285714285714,0.7625759317290405,1.0,4/18,12.56%,ADM;S1PR1;GNA13;ADGRL3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7266254465661935,-1.2507271203035701,0.19696969696969696,0.7626735522922281,1.0,3/13,6.19%,CCDC60;CX3CL1;ERBB4
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.7666462459943292,-1.2502413046407002,0.21875,0.7645575718140493,1.0,2/7,5.82%,GRIN2B;LRRC7
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.8091210065087518,-1.2501885789577347,0.1891891891891892,0.7638609763687384,1.0,4/7,18.09%,RIMS1;RIMS2;SYT1;ARHGAP17
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.7119994730015322,-1.2499350176227368,0.23880597014925373,0.7642515479251624,1.0,4/14,8.66%,PKN3;SEMA6B;ERBB4;PDXDC1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.5948719603535665,-1.2499091671583311,0.1111111111111111,0.7635703583530435,1.0,10/58,12.75%,MAP2;BTG2;PPP1R9A;GRM7;GPM6B;GAS7;GPM6A;CTNND2;DCLK1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7257123788044283,-1.249355916397707,0.21428571428571427,0.7656181661590993,1.0,4/12,9.11%,SERPINE1;PRKCE;RREB1;ANXA1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.6926287991185103,-1.249040071681844,0.19736842105263158,0.7660319706273738,1.0,4/17,12.56%,MAP1B;NES;ERBB4;ADGRL3
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,-0.6161314529898789,-1.2488749684479403,0.13636363636363635,0.7661113488831972,1.0,16/49,11.79%,DDIT4;WNT2B;RPL23;CD9;HSPA5;DMD;ALPL;EEF1A1;PEBP1;MBP;PNP;CD81;RPL10;TMSB4X;GABARAPL1;RPL13A
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.7046981342044366,-1.2488722710270688,0.24242424242424243,0.7652047082336313,1.0,4/16,6.48%,PSMC6;PRKAG2;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.7807167259235196,1.248861927956188,0.18421052631578946,1.0,1.0,1/5,3.61%,TTN
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,-0.5592974031640343,-1.2483805171924742,0.11956521739130435,0.7668683256505594,1.0,16/87,12.30%,MTHFD1L;PPP2R3A;ADM;PRKAG2;YTHDC1;CD9;SCARB2;KHDRBS3;CDKN1B;ANK2;TPM1;NCALD;TMSB4X;PLXDC2;GABARAPL1;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6450008190330889,-1.248179071653103,0.11494252873563218,0.7672122470016688,1.0,7/35,14.53%,CLIC2;PPARG;HES1;HIP1R;PRKN;CLDN5;AMFR
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.632536838450974,-1.2480022409578753,0.1282051282051282,0.767024360775304,1.0,8/29,15.27%,ITPR1;CLIC2;ATP2B1;KCNIP4;SLC8A1;ATP1B3;CACNA1C;WWTR1
prerank,KEGG_2021_Human__Prion disease,-0.5953091275761813,-1.247937073956801,0.1348314606741573,0.7665849909276551,1.0,8/60,6.48%,PIK3R3;LAMC1;PSMC6;ITPR1;GRIN2B;HSPA5;PIK3R1;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.6726506424119791,-1.2476665001191283,0.1728395061728395,0.7669942501535221,1.0,8/19,22.97%,LGALS3;PIK3R1;PRKCE;DPP10;DLG1;ITGB1;EGFR;PRKCH
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.7051832753047907,-1.2476545683822788,0.21052631578947367,0.7661855611075417,1.0,3/22,4.46%,PPARG;JUN;KDM1A
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.7002110497666201,-1.2475490203855304,0.08196721311475409,0.765722297668415,1.0,2/17,8.84%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,-0.6673006519053845,-1.2470582418783032,0.18055555555555555,0.7647874762301912,1.0,6/16,15.86%,GRIN2B;GRIA2;ANKS1B;GPM6A;PLP1;CADM2
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,-0.6673006519053845,-1.2470582418783032,0.18055555555555555,0.7647874762301912,1.0,6/16,15.86%,GRIN2B;GRIA2;ANKS1B;GPM6A;PLP1;CADM2
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,-0.6673006519053845,-1.2470582418783032,0.18055555555555555,0.7647874762301912,1.0,6/16,15.86%,GRIN2B;GRIA2;ANKS1B;GPM6A;PLP1;CADM2
prerank,CellMarker_Augmented_2021__Glial cell:Brain,-0.6673006519053845,-1.2470582418783032,0.18055555555555555,0.7647874762301912,1.0,6/16,15.86%,GRIN2B;GRIA2;ANKS1B;GPM6A;PLP1;CADM2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.7672876326257737,-1.246959358660005,0.2,0.764394224488786,1.0,2/8,7.73%,RTN4;HIP1R
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.6102567139181737,-1.2468954113929487,0.20238095238095238,0.7638706874999844,1.0,13/43,15.83%,PSMC6;ITPR1;PSMB9;RPS27A;PIK3R1;PSMA1;REL;UBC;PLCG2;NFKBIA;SH3KBP1;NCK1;MALT1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7380925456595638,-1.2465506850032066,0.2028985507246377,0.7647243858480184,1.0,2/9,7.07%,SCARB2;LAMP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.8216645250464805,-1.2465325904044446,0.22388059701492538,0.7639922476027284,1.0,2/5,9.80%,NPLOC4;HERPUD1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.6290782928931515,-1.2462791551288428,0.19480519480519481,0.7644515874210925,1.0,13/30,18.83%,LRRC32;HIF1A;SLC2A1;TNS1;VWF;ITGB5;EFNB2;DYSF;CST3;EGFL7;PSAP;ITGB1;ACVRL1
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.6947416662451443,-1.2460723940464855,0.22535211267605634,0.7643091332602434,1.0,4/16,7.78%,PCK1;GMPS;GGT5;VAV3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5965252753475819,-1.2460518096830833,0.14634146341463414,0.7635278445734982,1.0,7/42,12.75%,MAP2;BTG2;PPP1R9A;GPM6B;TPM1;GPM6A;PLP1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.5484880687875359,-1.2459877442780576,0.0625,0.7629307715365471,1.0,35/147,15.59%,ST18;BTG2;NR4A1;BNIP3L;RTN4;CD9;PPM1D;ESR2;CDKN1B;DUSP1;ACTN1;ERBB4;PBRM1;MAGI2;COL18A1;BCL6;PRKN;NPAS2;KLF4;ADAMTS1;DLC1;SOD2;HYAL2;CRLF3;GJA1;DYSF;TMBIM6;NPM1;CDKN1A;PLPP1;NCK1;SMAD3;BTG1;CDK6;RACK1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.556679255733722,-1.2455908578250507,0.02,0.7639358030877877,1.0,38/209,15.96%,TBX3;ANGPTL4;MAP3K5;NDRG1;BNIP3L;RTN4;CX3CL1;JUN;GRK5;HSPA5;RPS27A;ACTN1;PIK3R1;BCL2L14;HIP1R;VAV3;BCL6;PRKN;UBC;RPL10;ANXA1;TGM2;CFL1;RPS6;GOLPH3;GNA13;TMBIM6;FGD4;PAK2;NPM1;NFKBIA;BCAR1;TNFRSF10B;NAA16;RACK1;PTMA;MALT1;MCL1
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.5545936276391586,-1.2455273979732433,0.05154639175257732,0.7634436298015974,1.0,51/223,18.43%,PSMC6;MAP3K5;MAFK;ATF3;ERO1A;RPS12;RPL23;RPL34;JUN;PSMB9;FOS;NPLOC4;HSPA5;RPS9;RPS27A;NFE2L2;CDKN1B;RPL37;EEF1A1;PSMA1;HIF1A;RPS11;SIN3B;NPAS2;UBC;HERPUD1;RPS27;RPS6;EPAS1;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;RPL15;CDKN1A;RPL37A;RPL7A;CREB3L2;RPLP1;CRTC3;CDK6;HSPH1;TXNRD1;DCP2;RPS28;FKBP5;NUP54;RPL31;MTOR
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.7230441435214454,-1.2453911022450617,0.1232876712328767,0.7632901757605276,1.0,2/13,5.74%,SLC4A10;ANO2
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.6613919292788827,-1.2452654450736738,0.24358974358974358,0.7628776945496241,1.0,5/25,8.84%,NRG3;RPS27A;ERBB4;PIK3R1;UBC
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,-0.6090301271680563,-1.244870004471191,0.1951219512195122,0.7639299774807056,1.0,8/44,11.16%,PKM;SLC6A6;SRGN;GAPDH;RNF19A;PHTF2;CREM;LIMS1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.7116942186426134,-1.244586390274699,0.20833333333333334,0.7647469353448787,1.0,6/15,18.01%,PRKAG2;HIF1A;TPR;OGT;PINK1;NUP54
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.684045319638253,-1.244556757408281,0.2153846153846154,0.7639593956625358,1.0,5/10,21.81%,RPS6;NPM1;MECP2;CUL1;EML4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.5258749610862621,1.2444708871206507,0.09523809523809523,1.0,1.0,6/29,7.84%,PRIMPOL;ATR;RHBDD1;INO80;ERCC6;TAF1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.817662228638177,-1.2443401410312003,0.18518518518518517,0.7642838832655207,1.0,2/5,11.39%,RTN4;TPR
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.6825059517128444,-1.2442469835869703,0.1527777777777778,0.7638339419455962,1.0,2/17,7.01%,ITPR1;PRKCE
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7046832431989742,-1.2442396218507663,0.19736842105263158,0.7630115100878776,1.0,4/16,13.17%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.7918136315197489,-1.243591157472881,0.16071428571428573,0.7654201446667468,1.0,2/7,4.06%,CD9;NES
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,-0.8470947820315782,-1.2435190809687409,0.1694915254237288,0.7648933435467188,1.0,2/5,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.7903801938533456,-1.2429682200987537,0.20588235294117646,0.766678214063773,1.0,1/5,8.34%,PRKN
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,-0.6010484006066473,-1.2427269455456775,0.1956521739130435,0.767330742093783,1.0,17/51,15.86%,MAP2;NRCAM;MAP1B;NFASC;GRIA2;NPAS3;CNTN1;ANK2;STOX2;PPFIA2;CTNND2;TMEFF2;DCLK1;ATRNL1;SYT1;LRP1B;CADM2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8154374041168438,-1.2422703124755385,0.17857142857142858,0.7687501898262206,1.0,3/6,13.07%,PPARG;ABCA5;NFKBIA
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,-0.757670982700436,-1.24215948034934,0.2191780821917808,0.7682603756755622,1.0,1/12,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7846221038312606,-1.241983505266204,0.17391304347826086,0.7682444471521143,1.0,3/6,9.16%,PRKN;ANXA1;IL1RAPL1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.844368649271953,-1.2419707497071404,0.109375,0.7673989480614086,1.0,1/5,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6868586630474922,-1.2419478378697733,0.22666666666666666,0.7667720923636302,1.0,5/12,19.07%,PRKN;CDKN1A;PINK1;PIKFYVE;GRB2
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.7966647065318097,-1.2417254495361,0.09230769230769231,0.7667706357784824,1.0,3/8,7.60%,NRCAM;NFASC;ANK2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6682765979388834,1.2416022275977303,0.2558139534883721,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6745845976410458,-1.2413657672517684,0.1891891891891892,0.7679648544737981,1.0,10/27,10.92%,PSMC6;ATF3;PSMB9;RPS27A;NFE2L2;PSMA1;KLF2;HIF1A;UBC;EPAS1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.8136532514201341,-1.2413331432375327,0.2727272727272727,0.7673648937081087,1.0,3/5,13.89%,NEDD9;CASS4;BCAR1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.6538863465738227,-1.2412660682637704,0.1917808219178082,0.766817050664889,1.0,8/24,15.51%,PPP1R9A;BCAP31;SLC8A1;ANK2;PRNP;PLCG2;CACNA1C;PPP3CC
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.8289865008306996,-1.2412531036315584,0.1896551724137931,0.7660422565447983,1.0,2/6,6.53%,HES1;FOXF1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.7814224565047498,-1.2412049763348263,0.19402985074626866,0.7652692054935941,1.0,3/8,13.23%,RPL23;RPS7;RAB1A
prerank,PanglaoDB_Augmented_2021__Platelets,-0.6166415478168814,-1.2409364661761895,0.11842105263157894,0.7654212288199964,1.0,10/35,10.57%,SERPINE1;ERO1A;SRGN;SLC2A3;CD9;LRRC32;CAVIN2;PECAM1;VWF;WIPF1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6893760626813742,-1.2408165364878667,0.2,0.7651433461057711,1.0,6/20,16.57%,SYN3;GLUL;RIMS1;PPFIA2;SYT1;SLC38A2
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.6661856286307766,-1.2407671689182158,0.1780821917808219,0.764550584076586,1.0,5/19,11.85%,ITPR1;CLIC2;ATP2B1;SLC8A1;ATP1B3
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.6175108653617007,-1.2406507007262706,0.14772727272727273,0.7642490867610418,1.0,14/50,18.35%,DIXDC1;ADAMTS9;AKAP12;MAP1B;NES;NFASC;ANK2;TPM1;GJA1;NAV1;WWTR1;MYH10;CALD1;PDE10A
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.6542457017960146,-1.2405549725990137,0.16883116883116883,0.7638601209025518,1.0,7/25,11.85%,ITPR1;ATP2B1;SMAD7;SLC8A1;ANK2;TPM1;ATP1B3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.6994378507867547,-1.2405443510848173,0.17105263157894737,0.7631072682496988,1.0,5/19,17.66%,PPFIA2;MYO1B;RAB1A;PAFAH1B1;MYO1E
prerank,Reactome_2022__Innate Immune System R-HSA-168249,-0.5447509748639109,-1.240485699756307,0.020202020202020204,0.7624942973776824,1.0,69/267,22.79%,PSMC6;PKM;ITPR1;ATG12;JUN;SLC2A3;PSMB9;FOS;LGALS3;MYO9B;LRRFIP1;NFASC;TINAGL1;RPS27A;EEF1A1;LRRC7;PIK3R1;PSMA1;PRKCE;LAMP2;VAV3;PECAM1;SERPINB6;RAP1A;UBC;CD55;CD81;DLC1;ALPK1;WIPF1;CFH;ARPC2;MEF2A;PLCG2;NFKBIA;TEC;CST3;PELI1;SDCBP;NCK1;CYLD;STOM;PIK3C3;MALT1;TMEM30A;TBK1;EGFL7;RAB14;B4GALT1;KPNB1;LCP2;MYO1E;PIKFYVE;GRB2;CLU;PSMA7;PIK3CB;CAPZA2;DUSP6;CUL1;CD63;SCAMP1;AHCYL1;FTL;CYSTM1;B2M;DNM2;MAPK8;DNAJC5
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.7144151508084423,-1.2401768122247743,0.14705882352941177,0.7632631655747659,1.0,2/12,13.86%,PPARG;ACOX1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6844166541582022,1.240126656417044,0.27906976744186046,1.0,1.0,2/7,9.22%,ZNRF3;CHD7
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.7940038085001933,-1.240065432927616,0.18181818181818182,0.7629898521726172,1.0,2/7,9.11%,CX3CL1;ANXA1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6699094610954905,1.2399116767294913,0.3055555555555556,1.0,1.0,3/11,15.94%,TLE4;TCF7L1;TCF7L2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6770355355150905,-1.2396325253685168,0.21794871794871795,0.7640569825483529,1.0,6/15,14.61%,ITPR1;RAPGEF3;SLC2A1;RAP1A;ENSA;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6333305840188782,1.2395155569395548,0.16666666666666666,1.0,1.0,4/9,23.13%,PDGFC;PPP2R5A;PPP2R5E;PDGFB
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5655329698611664,-1.239052692755724,0.17777777777777778,0.7663850410588807,1.0,14/86,12.06%,LAMC1;PLS3;NEDD9;RTN4;HES1;EPS8;RIMS1;RAD21;SPG7;GPM6B;SLC2A1;WIPF1;LIMS1;MYO1B
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.6715144973068665,-1.2387072608322542,0.14705882352941177,0.7672586239115741,1.0,10/22,19.18%,LRRC32;GGT5;FLT1;SCARF1;VWF;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7428381370015069,-1.2386731176592742,0.17647058823529413,0.7665702469665208,1.0,7/10,24.75%,COMMD1;PRKN;PICALM;XIAP;FTL;B2M;TF
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7599596670105129,-1.238560382837895,0.23076923076923078,0.7660953228140074,1.0,1/8,2.52%,CX3CL1
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,-0.6622797829653605,-1.238342539486313,0.13253012048192772,0.7662316253788335,1.0,6/23,9.72%,LBR;AKAP12;ARHGAP21;ACTN1;PIK3R1;SLC4A7
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.8363340121045346,-1.238293714074072,0.2153846153846154,0.7647638163187787,1.0,2/6,9.91%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.8363340121045346,-1.238293714074072,0.2153846153846154,0.7647638163187787,1.0,2/6,9.91%,GRIN2B;INSYN2A
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.7288864909882754,-1.2382507299909984,0.2,0.7641316303225874,1.0,3/13,9.40%,JUN;FOS;CCNH
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7406084060955188,-1.2379917185018352,0.1643835616438356,0.7645050516640159,1.0,8/12,19.10%,RPS27;RPS6;RPS15;RPS7;NPM1;RIOK3;RPS28;RPS19
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6683018456379405,-1.2379171570658623,0.21621621621621623,0.763911693512018,1.0,6/17,8.84%,PSMC6;PSMB9;RPS27A;NFE2L2;PSMA1;UBC
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.637485139016441,-1.2378767912940307,0.19767441860465115,0.7632701575776075,1.0,6/27,8.84%,PSMC6;SEC22B;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.7560159202415934,-1.2378362681029302,0.1643835616438356,0.7626300300645676,1.0,2/8,17.21%,MGAT4A;B4GALT1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7036237200066078,1.237804115408418,0.3055555555555556,1.0,1.0,1/7,1.12%,HABP4
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.7820397965153812,-1.2377544202268176,0.12121212121212122,0.7623616064904236,1.0,3/7,14.26%,MYL12A;EFNB2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.714189130474534,-1.2377474721410324,0.14084507042253522,0.7615389290732105,1.0,5/9,23.05%,DMD;ANK2;ATP1B3;ANK3;STK39
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.7393359975213628,1.237625273685408,0.25,1.0,1.0,2/7,6.45%,H2AC6;ERCC6
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,0.5110413024843561,1.23754400324368,0.24,1.0,1.0,2/27,0.72%,RSAD2;GBP2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.832120481534639,-1.2374789415265512,0.12121212121212122,0.7622083276170443,1.0,2/5,13.17%,LBR;CDKN1A
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.64550356678263,-1.2374078429922841,0.17073170731707318,0.7617320962345906,1.0,7/30,13.47%,TSG101;CDKN1B;CDC37;SLC8A1;CCNH;CDKN1A;TRIB2
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.6508779914103474,-1.237336617214315,0.1927710843373494,0.7612077469094135,1.0,7/35,10.17%,SERPINE1;BHLHE40;RPS27A;HIF1A;NPAS2;UBC;CREM
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.5811621316905451,-1.2371796270302942,0.18181818181818182,0.7613228950504796,1.0,17/65,19.39%,CCDC3;NDFIP1;HIF1A;REL;PRKN;KLF4;CLDN5;SDCBP;RACK1;PICALM;PINK1;MTMR2;GATA2;ACVRL1;MECP2;CD34;LRPAP1
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.8048100627199948,-1.2371280079666567,0.1774193548387097,0.7606652445591919,1.0,2/8,8.84%,RPS27A;UBC
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,-0.5519967260156218,-1.2369698172039592,0.061855670103092786,0.7604867487571357,1.0,53/226,19.10%,PSMC6;MAP3K5;MAFK;ATF3;ERO1A;RPS12;RPL23;RPL34;JUN;PSMB9;FOS;NPLOC4;HSPA5;RPS9;RPS27A;NFE2L2;CDKN1B;RPL37;EEF1A1;PSMA1;HIF1A;RPS11;SIN3B;NPAS2;UBC;HERPUD1;RPS27;RPS6;EPAS1;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;RPL15;CDKN1A;RPL37A;RPL7A;CREB3L2;RPLP1;CRTC3;CDK6;HSPH1;TXNRD1;DCP2;RPS28;FKBP5;NUP54;RPL31;MTOR;MT1M;RPS19
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.7341308385999532,-1.2367885079262448,0.15942028985507245,0.7605044170689951,1.0,2/12,5.87%,ST18;JAK1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7667813096304483,-1.2364672851679563,0.18333333333333332,0.760974287631286,1.0,1/8,1.25%,NEDD9
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.5890292401040429,-1.2364383860199464,0.14444444444444443,0.760271030535969,1.0,18/73,19.10%,RPS12;SEC24D;RPS9;RPS27A;JAK1;RPS11;RPS27;RPS6;RPS15;TPR;RPS7;GJA1;CNBP;PIK3C3;TBK1;RPS28;NUP54;RPS19
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6872474986397105,-1.2363815583760682,0.1643835616438356,0.7596668671684847,1.0,8/18,24.14%,ADM;CD9;CD81;PICALM;ITGB1;GRB2;DNM2;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7984817105779501,-1.2363119950464692,0.18840579710144928,0.7591858418664595,1.0,4/8,12.59%,TSG101;HYAL2;SNX6;ZFYVE28
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,-0.7943940575010104,-1.2359903611862433,0.234375,0.7599350129240757,1.0,3/7,8.84%,RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.8508336044696445,-1.235936748074855,0.1875,0.7593331697593069,1.0,3/5,12.59%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.7128533901560947,-1.235851267685324,0.21621621621621623,0.7589633536207004,1.0,6/14,16.65%,PRKN;SOD2;PRNP;SNX6;CPEB4;PINK1
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.5789437978183308,-1.2358510733624932,0.15294117647058825,0.7581455051792988,1.0,17/79,11.02%,PSMC6;NRG3;GRIN2B;PSMB9;RPS27A;LRRC7;JAK1;PEBP1;ERBB4;PIK3R1;PSMA1;RAP1A;UBC;VWF;DUSP16;SHC2;FGFR1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.8348292208679631,-1.2358241441328872,0.11475409836065574,0.7575354143424785,1.0,2/5,5.26%,RFC3;POLA1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,-0.6357041559142883,-1.2357810639553513,0.2028985507246377,0.7569629488340434,1.0,9/20,13.31%,DOK5;GPM6B;PTPRD;TMEM132C;CTNND2;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.7897215966943139,-1.2355545727017414,0.23809523809523808,0.757238113455855,1.0,2/6,9.80%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.4704142645449956,1.234625720500204,0.10526315789473684,1.0,1.0,3/25,3.59%,HOMER1;ALS2;RNF213
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7832430755062677,-1.234140722937494,0.18032786885245902,0.7630687791240274,1.0,3/7,6.48%,PSMB9;NFE2L2;PSMA1
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,-0.7414713645326697,-1.2340847017035734,0.2033898305084746,0.7626370097856272,1.0,1/10,0.45%,MTHFD1L
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,-0.5781907486449561,-1.2339475063096446,0.12222222222222222,0.7624110591372163,1.0,21/87,14.10%,DOK5;MGLL;DTNA;GLUD1;HES1;JUN;GLUL;CD9;LGALS3;ALPL;GPM6B;TIMP3;SERPINB6;S1PR1;GJA1;PLEC;TRIB2;CST3;PON2;PTTG1IP;SYT1
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.706596148849106,-1.233935708290741,0.21428571428571427,0.7616438050614541,1.0,7/13,22.36%,PIK3R1;VAV3;PLCG2;LCP2;GRB2;PIK3CB;B2M
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6754173065984496,-1.2337985664581836,0.14666666666666667,0.7616238546521397,1.0,10/22,12.75%,MAP2;GRIA2;S100A6;GPM6B;NPAS3;STOX2;CTNND2;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.698950365363149,-1.233717039269385,0.1875,0.7610753305176632,1.0,5/16,16.49%,RPS27A;REL;UBC;NFKBIA;TBK1
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.7533878338656674,-1.2336587816840034,0.21212121212121213,0.7598738914325578,1.0,2/7,14.69%,MYO9B;MAX
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.7533878338656674,-1.2336587816840034,0.21212121212121213,0.7598738914325578,1.0,2/7,14.69%,MYO9B;MAX
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.664858994332504,-1.2335533395985527,0.208955223880597,0.7595325658655242,1.0,4/17,8.23%,SUN2;CD9;RAD21;SUN1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5814067849153681,1.2333288487897802,0.17142857142857143,1.0,1.0,3/14,9.91%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.6974230015658035,-1.2328770233210595,0.14102564102564102,0.7620511079122355,1.0,4/18,13.17%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.8391805459745758,-1.2327120807958512,0.23636363636363636,0.7619352502874284,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.6849705509149238,1.2326983023552602,0.18518518518518517,1.0,1.0,2/7,12.59%,HERC5;RNF216
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.797139312828492,-1.2325419409972656,0.27419354838709675,0.7621180775296648,1.0,1/5,8.31%,CALCOCO2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.7768115943075449,-1.2321530021108635,0.2923076923076923,0.7628371388305725,1.0,1/8,0.96%,SUN2
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.6295539625312232,-1.2321416972718322,0.1875,0.7620656406664393,1.0,7/29,8.84%,PSMC6;RFC3;PSMB9;RPS27A;POLA1;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6934516032213428,-1.2315764218125054,0.2537313432835821,0.7639851077774167,1.0,4/13,19.63%,SPOPL;OGT;CST3;PLAT
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6618523487736457,-1.23131209052846,0.21794871794871795,0.7645691610693759,1.0,8/27,15.46%,POLA1;CDKN1B;CCNH;CDK14;CRLF3;CDKN1A;MAX;CDK6
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.7067503558250839,-1.2309318366026505,0.2191780821917808,0.7655675933207627,1.0,6/14,19.42%,RPS27A;UBC;SH3KBP1;SH3GL1;GRB2;EGFR
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6379736686901789,-1.2308883860871174,0.23376623376623376,0.7649150907139691,1.0,7/27,12.30%,RTN4;ENPP2;GLUL;PRKCE;HIF1A;RREB1;PLCG2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.7943192725654644,-1.2308719431880053,0.2835820895522388,0.7642876610065055,1.0,2/6,7.94%,VSIR;BCL6
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.686152351696108,-1.2306672239832726,0.19736842105263158,0.7644072909285194,1.0,5/15,15.72%,PRKAG2;HSPA5;SIK2;CPEB4;PIK3C3
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.6782893578070238,-1.2306558109937529,0.22727272727272727,0.763651640936262,1.0,3/13,8.23%,SUN2;RAD21;SUN1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5926510875731659,1.2299250866121025,0.2222222222222222,1.0,1.0,2/9,4.52%,USP25;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8327636876680956,-1.2294494686031974,0.11940298507462686,0.7685792944282749,1.0,4/5,15.59%,UFL1;HSPA5;NCK1;RACK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6731107039125299,-1.2292699229952417,0.22857142857142856,0.7686940495880376,1.0,9/16,12.38%,PCK1;PPARG;TMEM45B;COL18A1;CD55;SLC26A2;PLIN2;ACSL5;TTC7A
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.616502487011676,-1.2292426255182292,0.12195121951219512,0.7680187975678655,1.0,5/40,5.63%,MAP2;BTG2;PPP1R9A;PBX3;GPM6B
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.7273816207917125,-1.2290847527356215,0.24,0.7679690456591055,1.0,2/8,9.40%,RFC3;CCNH
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.721323219057248,-1.2290235144803676,0.23943661971830985,0.7675076951544169,1.0,4/11,13.17%,CDKN1B;CDC37;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6993402067129506,-1.229021153715387,0.25,0.7667065388964268,1.0,3/12,9.11%,SERPINE1;PRKCE;ANXA1
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.6850600491761704,-1.2289927255782818,0.24675324675324675,0.7660009606458561,1.0,3/17,8.26%,LAMC1;LAMA5;RAP1A
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.8598700926482996,-1.228382095168725,0.13846153846153847,0.7680876811508336,1.0,1/5,7.49%,HIF1A
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.712978294084124,-1.2283290382620755,0.21212121212121213,0.7674641319182348,1.0,6/12,18.27%,PPARG;CD9;PECAM1;VWF;LCP2;GATA2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.7988967316773692,-1.2280828059261715,0.16129032258064516,0.767754618876184,1.0,1/6,2.05%,RFTN1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,-0.7467537654878247,-1.2279903652371358,0.15151515151515152,0.7673548137013868,1.0,3/9,8.84%,RPS27A;JAG2;UBC
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,-0.6892501220419169,-1.227953213644695,0.2222222222222222,0.7619564650405506,1.0,3/15,7.20%,PPP1R9A;CX3CL1;PTPRD
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.8123290606259816,-1.2273464417826572,0.19696969696969696,0.7633187485666489,1.0,1/6,3.05%,JUN
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.8123290606259816,-1.2273464417826572,0.19696969696969696,0.7633187485666489,1.0,1/6,3.05%,JUN
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.6150477340551912,-1.2272432554821442,0.25925925925925924,0.7632746963818869,1.0,8/34,13.07%,PSMC6;ITPR1;PSMB9;RPS27A;PSMA1;UBC;PLCG2;NFKBIA
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.758390589984498,-1.2270503297611919,0.22580645161290322,0.7632654075216571,1.0,4/9,14.53%,RPS27A;UBC;UGGT2;AMFR
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.7659307234548838,-1.2270441127600407,0.12280701754385964,0.7625056627438398,1.0,4/8,7.92%,CD9;LRRC32;LAMP2;PECAM1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.724701622115276,-1.2268506588929045,0.208955223880597,0.7626817238882789,1.0,2/10,8.34%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.7417663233096837,-1.226560501722463,0.19718309859154928,0.7630072123583932,1.0,1/12,0.24%,SERPINE1
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,0.3630491768507754,1.2265196456072829,0.0,1.0,1.0,37/238,11.18%,TSTD3;RSAD2;GBP4;BTBD9;ZNF875;PIGU;ALS2;TSHZ2;RC3H1;ATR;DCP1A;NEK3;YEATS2;OCLN;IL6R;NKD1;WDPCP;GNB4;STXBP4;ITSN1;MFHAS1;FAM111A;LEPR;TDRD3;MBOAT2;ZNF33B;SLC25A29;XAF1;TAF1;OPHN1;LENG8;MDM4;ATM;RAB27A;ATRN;SYNRG;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6485780218140864,-1.2265193677327173,0.1794871794871795,0.7625493312497414,1.0,5/21,9.93%,CX3CL1;KDM1A;PTPRD;IL1RAPL1;TGM2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.7826274838421998,-1.2260940943477174,0.2835820895522388,0.7640471467089647,1.0,1/6,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.7108207841537307,-1.2259307552641943,0.2638888888888889,0.7638303629920881,1.0,4/14,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.7388090687960625,-1.2258521006552752,0.2463768115942029,0.7633730430380667,1.0,3/9,7.57%,ITPR1;ATP2B1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6832020695840837,-1.2257327793691617,0.20833333333333334,0.7632720219656438,1.0,4/17,8.34%,MAP2;KDM1A;FES;PRKN
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.7010250212894338,-1.2256322884311073,0.2028985507246377,0.7629536221294588,1.0,3/13,6.27%,DOCK3;GRIN2B;PIK3R1
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.8220788216790846,-1.2254129579684154,0.1875,0.7608424754475167,1.0,2/5,8.84%,RPS27A;UBC
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,-0.8220788216790846,-1.2254129579684154,0.1875,0.7608424754475167,1.0,2/5,8.84%,RPS27A;UBC
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,-0.8220788216790846,-1.2254129579684154,0.1875,0.7608424754475167,1.0,2/5,8.84%,RPS27A;UBC
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",-0.8220788216790846,-1.2254129579684154,0.1875,0.7608424754475167,1.0,2/5,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7135245077807872,-1.2252846911225745,0.22580645161290322,0.7606420845095585,1.0,4/11,14.87%,RPL10;NPM1;RPL24;RPL7A
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.6722842074108517,-1.225261622462907,0.25396825396825395,0.7599298939517879,1.0,4/22,5.71%,SERPINE1;CX3CL1;SPOCK1;DUSP1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.6782892511269565,-1.2252587513164184,0.1,0.7591622879983013,1.0,8/21,18.43%,NDRG1;PGK1;BNIP3L;HIF1A;EPAS1;CPEB4;PINK1;MTOR
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.8263199968669936,-1.2250862400752676,0.18518518518518517,0.7591345895213789,1.0,2/5,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.6047638603239192,-1.2250832114506474,0.18292682926829268,0.7583806807865539,1.0,12/36,24.14%,PRKAG2;BNIP3L;GAPDH;RB1CC1;SNX6;TBK1;PINK1;MTOR;GNAI3;MAPK8;ATP6V1E1;NEDD4
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.6211016877560049,-1.2247951574056515,0.17567567567567569,0.7587732749717025,1.0,10/27,12.75%,LAMC1;NDRG1;NFASC;GRIA2;PRX;TMEM132C;ANK2;SHC2;DCLK1;PLP1
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.5883333472854004,-1.2246208819826485,0.21176470588235294,0.7587573765280119,1.0,14/51,22.60%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;PLCG2;NFKBIA;PELI1;TBK1;DUSP6;CUL1;DNM2;MAPK8
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.7130564431051998,-1.2245600927525981,0.23376623376623376,0.7582550212402678,1.0,7/15,18.27%,RFC3;KDM1A;ALPL;GMPS;NPM1;SMARCC1;GATA2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8087661744096972,-1.224347903035489,0.23943661971830985,0.7586578614109244,1.0,1/6,1.46%,TSG101
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.6316609396592625,-1.2241684369703414,0.22077922077922077,0.7586647085620597,1.0,4/26,6.96%,PSMC6;PSMB9;PSMA1;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7856437874757065,-1.2238088170500403,0.265625,0.7597318322820706,1.0,3/6,11.71%,RPL23;SMAD7;RPS7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.668232858333489,-1.2229729613292417,0.22388059701492538,0.7626448360649876,1.0,3/12,12.01%,TAF1D;CCNH;CSTF3
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.5730265456716543,-1.2228581091520798,0.19318181818181818,0.7625013330805418,1.0,14/43,25.29%,ITPR1;PIK3R1;VAV3;SHC2;BCAR1;NCK1;CTNNA1;MTOR;PIK3CB;AHCYL1;CDH5;ABI1;HSP90AA1;MAPKAP1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.6012148569588975,-1.2226451578022308,0.19767441860465115,0.7626842472975355,1.0,12/42,13.07%,PSMC6;ST18;CX3CL1;PSMB9;NFE2L2;YBX3;PSMA1;TMSB4X;HYAL2;LIMS1;ZFP36;NFKBIA
prerank,Reactome_2022__M Phase R-HSA-68886,-0.5613492125185121,-1.222552426770164,0.09782608695652174,0.7621814824451651,1.0,27/101,20.37%,CEP57;PSMC6;LBR;PSMB9;RAD21;CEP70;RPS27A;PSMA1;SPC25;UBC;RPS27;ENSA;RAB2A;TPR;ARPP19;RAB1A;LPIN2;PAFAH1B1;SMC3;VRK2;KPNB1;NUP54;USO1;CHMP4B;PSMA7;DYNC1I2;CSNK1D
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,-0.6013938035774052,-1.2222337754123926,0.2073170731707317,0.7626673840856121,1.0,13/32,25.05%,CD9;LGALS3;ASAP2;EMP1;KLF4;ITGB5;EPAS1;CTNNA1;MYO1E;CD63;ADAM9;DSTN;DSP
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.681359127338065,1.2219777932326845,0.2,1.0,1.0,2/7,15.83%,PPP2R5A;PPP2R5E
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.681359127338065,1.2219777932326845,0.2,1.0,1.0,2/7,15.83%,PPP2R5A;PPP2R5E
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7896404210055429,-1.2219343385483181,0.203125,0.7634662615077484,1.0,3/6,9.77%,ANXA1;KLF4;TMSB4X
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.6502607340434406,-1.2218796822921298,0.2125,0.7629978226793301,1.0,10/28,14.69%,PSMC6;PSMB9;RPS27A;POLA1;CDKN1B;PSMA1;UBC;CCNH;CDKN1A;MAX
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.7430874021862149,1.2216867710613253,0.2702702702702703,1.0,1.0,1/5,4.94%,GNB4
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.7430874021862149,1.2216867710613253,0.2702702702702703,1.0,1.0,1/5,4.94%,GNB4
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.6325016265683852,-1.2216504185278991,0.1917808219178082,0.7631010043588407,1.0,8/25,21.62%,ADM;GRK5;PDE7A;PDE10A;ITGB1;GNAI3;PRKAR1A;ADCY2
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.6437431215335155,-1.221641125710146,0.20481927710843373,0.7623543868019549,1.0,6/33,8.84%,LAMC1;RPS27A;PIK3R1;LAMA5;RAP1A;UBC
prerank,CellMarker_Augmented_2021__Macrophage:Eye,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Artery,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,0.5905790221593719,1.2213082713812862,0.23076923076923078,1.0,1.0,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,-0.619715177203974,-1.2210713286756552,0.21518987341772153,0.7641220016502925,1.0,19/30,24.99%,CD9;GPM6B;CNTN1;LSAMP;LRRC4C;TRIB2;CST3;PON2;SYT1;CADM2;ARL4A;PLAT;DUSP6;SPARC;CD63;B2M;ANXA5;LIMA1;PDE4B
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.7840017309338432,-1.2204024537613936,0.20967741935483872,0.766622455935941,1.0,1/5,0.45%,MTHFD1L
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.699329527301715,-1.2201354425238875,0.18055555555555555,0.7669334079193608,1.0,1/15,0.93%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8225666157918621,-1.219825556305851,0.2033898305084746,0.7674330337047651,1.0,2/5,9.06%,CD55;CD81
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.6390687873733548,-1.2193241511399595,0.21428571428571427,0.7693332508388513,1.0,9/22,19.42%,LGALS3;PIK3R1;PRKCE;DPP10;CNST;RACK1;DLG1;ITGB1;EGFR
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.5972160153672145,-1.2193232482133385,0.1686746987951807,0.7685737905714882,1.0,15/48,15.83%,PSMC6;RFTN1;NFKBIZ;PSMB9;PIK3R1;PSMA1;VAV3;PLCG2;BTNL9;PAK2;INPP5D;TEC;BCAR1;NCK1;MALT1
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,-0.5381023569784374,-1.2191275984185361,0.0625,0.7688149813221481,1.0,21/215,9.06%,PIK3R3;PSMC6;UFL1;ITPR1;SEC22B;SEC24D;PSMB9;HSPA5;RPS27A;CANX;RNF19A;PIK3R1;PSMA1;RAPGEF3;REL;RAP1A;PRKN;AP1G1;UBC;ARIH2;CD81
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7760926425487957,-1.2190692060173478,0.2222222222222222,0.7682682526380109,1.0,2/6,15.88%,JUN;CHD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.7014527898147176,-1.218764303775892,0.21428571428571427,0.7691408206103256,1.0,2/14,5.87%,ST18;JAK1
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,-0.5389716984786963,-1.2182221491923453,0.10309278350515463,0.7709636025231478,1.0,29/165,15.46%,CEP57;PSMC6;SUN2;LBR;RFC3;PSMB9;RAD21;CEP70;RPS27A;POLA1;CDKN1B;PSMA1;SPC25;SUN1;UBC;CCNH;RPS27;ENSA;RAB2A;TPR;NPM1;ARPP19;CDKN1A;RAB1A;MAX;LPIN2;PAFAH1B1;SMC3;CDK6
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.5436035456026631,-1.2178141316288222,0.1935483870967742,0.7722962478494073,1.0,18/102,11.02%,PSMC6;JUN;NRG3;GRIN2B;PSMB9;RPS27A;LRRC7;JAK1;PEBP1;ERBB4;PIK3R1;PSMA1;RAP1A;UBC;VWF;DUSP16;SHC2;FGFR1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.7190740798376701,-1.2176899822129539,0.18181818181818182,0.7721569963561244,1.0,4/10,14.56%,RPS27A;UBC;ALPK1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7262667794555349,1.2175776889646763,0.2826086956521739,1.0,1.0,3/5,5.31%,RSAD2;IL15;MIA3
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.7109769668955755,-1.2173684218786731,0.25675675675675674,0.7726250197202982,1.0,4/12,12.30%,RPS27A;UBC;ALPK1;PLCG2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7295125386376834,-1.2169686371700676,0.189873417721519,0.7738308406356862,1.0,2/10,5.71%,CX3CL1;DUSP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.6890905905019634,-1.2167420868430678,0.28378378378378377,0.7740760143105195,1.0,4/15,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.6007449212595419,-1.2166962524874394,0.20224719101123595,0.7735284183697694,1.0,12/44,11.66%,TSG101;PRKAG2;ATG12;RPS27A;EEF1A1;RB1CC1;LAMP2;PRKN;UBC;PLIN2;EPAS1;GABARAPL1
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.692437473483832,-1.2166430335506202,0.1917808219178082,0.7729928852380586,1.0,3/16,8.26%,ITPR1;RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.7349708013551153,-1.2166116275844214,0.1111111111111111,0.7724254493673611,1.0,5/10,21.62%,PCK1;GOLPH3;MSN;ADAM15;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.7907684715540733,-1.2162641858824461,0.18032786885245902,0.7731318549415265,1.0,3/7,13.17%,CDKN1B;IPO7;CDKN1A
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,-0.7258534068464187,-1.2161820913648822,0.20512820512820512,0.7727846122485662,1.0,4/11,17.00%,BTG2;NFKBIA;BTG1;PNRC1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.7554364018264355,1.216069163504136,0.3111111111111111,1.0,1.0,2/5,9.61%,CHN1;CDH2
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.8328128468088377,-1.2160584900710605,0.17647058823529413,0.772536599717629,1.0,3/6,8.84%,MAFK;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.7995855712940342,-1.2160430199874148,0.15942028985507245,0.7718405346283742,1.0,3/8,13.33%,SCARB2;PRKN;FOXK1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.6160857457597414,-1.2159321095190396,0.19230769230769232,0.7715611325139006,1.0,3/29,6.24%,ADM;LGALS3;GGT5
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.696267671453086,-1.2151431768557583,0.23529411764705882,0.7738590729832331,1.0,3/16,8.84%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.7300510121482007,-1.2150801329029197,0.323943661971831,0.7733382789358394,1.0,3/9,5.82%,GRIN2B;GRIA2;LRRC7
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,-0.5945913731680418,-1.2149166296489744,0.18181818181818182,0.7732325984624444,1.0,15/38,19.18%,CLEC1A;LRRC32;FES;GGT5;PECAM1;SCARF1;TNS1;VWF;CFH;DYSF;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,-0.7636473627334384,-1.2148841212314248,0.18309859154929578,0.7725718870486501,1.0,2/6,17.21%,MGAT4A;B4GALT1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.803233498537675,-1.2148579180413233,0.16129032258064516,0.7719668346162104,1.0,4/7,18.41%,KCNMB4;ANK2;NOS1AP;DLG1
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.6169342337268288,-1.214732602776577,0.2235294117647059,0.7717975882531344,1.0,11/34,15.46%,PSMC6;PSMB9;RPS27A;POLA1;CDKN1B;PSMA1;UBC;CCNH;CDKN1A;MAX;CDK6
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.6489302132363796,-1.2146612522995714,0.20833333333333334,0.7714658362238123,1.0,6/25,8.84%,PSMC6;PSMB9;SPOPL;RPS27A;PSMA1;UBC
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.774277870994269,-1.2145726515760797,0.25,0.7711021883662954,1.0,3/9,9.80%,ATF3;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7753245817462597,-1.2145641976348682,0.29508196721311475,0.7703708649170256,1.0,3/7,15.17%,CX3CL1;SCARF1;ANKS1A
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6979824953860825,-1.214541969770041,0.2857142857142857,0.7697600135997003,1.0,3/12,8.84%,RPS27A;JAK1;UBC
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.566600909299554,-1.214470393746616,0.2,0.7693341697947745,1.0,6/69,7.92%,PIK3R3;ERBB4;RB1CC1;FLT1;HIF1A;PECAM1
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.605859686884317,-1.2144700746193335,0.1875,0.7685958452556241,1.0,8/43,13.07%,PSMC6;ITPR1;PSMB9;RPS27A;PSMA1;UBC;PLCG2;NFKBIA
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,-0.6228122433091086,-1.2141587186411542,0.2375,0.7692512366505482,1.0,5/31,7.78%,DOCK3;LBR;ARHGAP21;PIK3R1;VAV3
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.5650247201273886,-1.2140958407311209,0.18181818181818182,0.7688271038689596,1.0,14/63,13.31%,CX3CL1;SPOCK1;SCARB2;FES;LRRC7;MAGI2;SCARF1;RAP1A;IL1RAPL1;CFL1;EFNB2;PPFIA2;PAK2;LRRC4C
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.7112699983012593,-1.214022642366037,0.22058823529411764,0.7685007341368801,1.0,3/11,18.73%,PRKCE;HYAL2;ITGB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,-0.5991489562582407,-1.2136364839490648,0.17857142857142858,0.7693803402096311,1.0,10/44,14.13%,PPP2R3A;PLS3;KIAA1217;DMD;TIMP3;ANK2;STOX2;GJA1;DCLK1;NAV2
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,-0.8045442144268542,-1.213556149880583,0.15625,0.7690110583522641,1.0,3/7,8.84%,RPS27A;ERBB4;UBC
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.5945647614854505,-1.2134928947492023,0.14102564102564102,0.7685350659204371,1.0,15/42,24.67%,ITPR1;MYO9B;PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;MYO1E;GRB2;PIK3CB;AHCYL1;ABI1;HSP90AA1
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.5967533452127232,-1.2134010472212524,0.25316455696202533,0.7681458313355717,1.0,3/33,2.47%,ANGPTL4;PCK1;PPARG
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6384460166024583,-1.213199780069421,0.21686746987951808,0.7685399763346463,1.0,9/33,8.84%,PSMC6;RFC3;PSMB9;RPS27A;POLA1;PSMA1;BAZ1A;PURA;UBC
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.7007120826157489,1.2131869331259082,0.23684210526315788,1.0,1.0,1/7,0.03%,CREB5
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7551633664514106,-1.2131190471457984,0.2,0.7681728995118223,1.0,1/6,6.53%,FOXF1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7962750067763433,-1.212858080305603,0.17333333333333334,0.768694677720711,1.0,1/6,2.52%,CX3CL1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.6156020325341205,-1.2128340121100858,0.23170731707317074,0.7658788968592444,1.0,8/39,13.76%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.6156020325341205,-1.2128340121100858,0.23170731707317074,0.7658788968592444,1.0,8/39,13.76%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.6156020325341205,-1.2128340121100858,0.23170731707317074,0.7658788968592444,1.0,8/39,13.76%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.6156020325341205,-1.2128340121100858,0.23170731707317074,0.7658788968592444,1.0,8/39,13.76%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.8002759811346107,-1.2123661656819789,0.2153846153846154,0.7674014837924928,1.0,1/7,3.88%,LGALS3
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.6471684983743266,-1.2122110165766868,0.28378378378378377,0.7673145518366338,1.0,7/17,14.53%,RPS27A;CANX;EDEM3;UBC;NGLY1;UGGT2;AMFR
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.6242927943296857,-1.211779934764762,0.21951219512195122,0.7684502291253685,1.0,5/28,8.84%,MAP3K5;JUN;FOS;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8030990437499121,-1.2116520147869965,0.23728813559322035,0.7683730917385226,1.0,2/5,11.93%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7365828086597321,-1.2116468364292923,0.208955223880597,0.7676701145070535,1.0,4/10,15.03%,WNT2B;SULF2;HYAL2;CREB3L2
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,-0.5661156151352833,-1.2116269043542804,0.16129032258064516,0.7670108608657563,1.0,11/59,19.42%,PLS3;CD9;TINAGL1;ASAP2;EMP1;NPAS2;MYO1B;ARHGAP29;CALD1;ITGB1;EGFR
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.7899248375592475,1.211609459566731,0.2564102564102564,1.0,1.0,3/5,15.59%,SLC44A1;SLC25A29;SLC25A26
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.6276629962865089,-1.2115018688681636,0.18292682926829268,0.7667023161786021,1.0,7/30,10.49%,PSMC6;SEC22B;PSMB9;RPS27A;PSMA1;UBC;ITGB5
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.8123865326995754,-1.2112132119534291,0.2153846153846154,0.7671243717593447,1.0,1/5,8.55%,AP1G1
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,-0.7511251318785227,-1.2111314556933095,0.2153846153846154,0.7669008604760216,1.0,2/10,2.52%,BHLHE40;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.734091457131322,-1.2110030169283434,0.25,0.766688328692831,1.0,1/7,3.03%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.5568550797655895,-1.2108021473665909,0.19047619047619047,0.7670459091782541,1.0,6/65,9.69%,PIK3R3;ERBB4;RB1CC1;RAPGEF3;PECAM1;DLC1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,-0.619396431489673,-1.210701644669435,0.1686746987951807,0.7666544531414035,1.0,12/37,14.13%,PPP1R9A;MAP1B;NES;PTPRD;SMARCA1;ANK2;STOX2;GJA1;DCLK1;ADGRL3;PLP1;NAV2
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.6879732393971875,-1.2105552632852712,0.22535211267605634,0.7665796450459191,1.0,6/17,16.57%,SYN3;RIMS1;PPFIA2;SYT1;SH2D3C;SLC38A2
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,-0.6006966094271765,-1.2105220644781174,0.27848101265822783,0.7659789429200106,1.0,4/35,8.15%,LAMC1;PLS3;TIMP3;TPM1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.7926236635990598,-1.210466420267037,0.18571428571428572,0.7657051990257302,1.0,1/6,1.89%,YTHDC1
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.5345432012171559,-1.210416533037391,0.16304347826086957,0.7651694396215766,1.0,24/83,21.57%,PSMC6;MAP3K5;NRG3;GRIN2B;HSPA5;GRIA2;ERBB4;PSMA1;RB1CC1;PRKN;NDUFA12;TPR;GABARAPL1;RAB1A;PPP3CC;PIK3C3;TBK1;PINK1;NUP54;MTOR;PSMA7;COX6C;KLC1;VAPB
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.7174330732449288,-1.2098796093315192,0.22535211267605634,0.7667958788951834,1.0,2/13,6.19%,NRG3;ERBB4
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.6580027295883478,-1.2094412885197179,0.2,0.7678742517289004,1.0,5/16,12.93%,RPS27A;PEBP1;UBC;DUSP16;DUSP5
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.7335190760484297,1.2094007464742267,0.2702702702702703,1.0,1.0,1/5,4.94%,GNB4
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,-0.7296111599792445,-1.2091818699183823,0.2191780821917808,0.7683537288915135,1.0,3/11,11.05%,TMEM184B;LSS;NUDCD3
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7688477243653075,-1.2090767248443612,0.24324324324324326,0.7681627460846857,1.0,3/8,10.73%,RPS27A;UBC;CHFR
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.589949030782763,-1.2087307302110297,0.1566265060240964,0.7691427752722887,1.0,14/44,15.83%,PSMC6;RFTN1;NFKBIZ;PSMB9;PIK3R1;PSMA1;PLCG2;BTNL9;PAK2;INPP5D;TEC;BCAR1;NCK1;MALT1
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,-0.7481398403074605,-1.2086131939184552,0.2857142857142857,0.7689514148395172,1.0,3/7,13.89%,RAP1A;VWF;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.6226836068509527,-1.2083686123031376,0.20512820512820512,0.7694072503701465,1.0,5/25,20.27%,BNIP3L;CALCOCO2;TBK1;PINK1;GNAI3
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.7653768849690986,-1.2083518607799404,0.2361111111111111,0.7687261060399191,1.0,6/8,19.76%,CX3CL1;IFNGR1;DYSF;PLCG2;CRTC3;CLU
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.6858849240639138,-1.2078650447981731,0.2625,0.7702018415206667,1.0,4/12,17.56%,ARF1;PRNP;CTNND2;MTMR2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7144809740915381,1.2078254199702738,0.30303030303030304,1.0,1.0,1/6,6.29%,EZH1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.8269170761704943,-1.2078201703646538,0.24242424242424243,0.7697188978045179,1.0,1/6,1.49%,LBR
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.7667714829274808,-1.2072706295235143,0.18461538461538463,0.7712949352086477,1.0,3/9,5.37%,MAP2;RTN4;CDKN1B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6996077810270089,1.2071538611243826,0.15151515151515152,1.0,1.0,1/9,0.16%,BMP6
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,-0.6807332075613182,-1.207071358897996,0.23529411764705882,0.7714453470209242,1.0,5/12,12.93%,SPNS2;ADM;GIT2;TGM2;DUSP5
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.6648254478027615,-1.2068686322660305,0.23684210526315788,0.7714709788161284,1.0,6/21,9.03%,ADM;PCK1;ENPP2;NFASC;PTPRD;LSAMP
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,-0.7672027842809671,-1.206757052896508,0.2857142857142857,0.7711544960859533,1.0,2/6,6.19%,NRG3;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6795075337291565,1.2067206821061949,0.2564102564102564,1.0,1.0,2/8,9.69%,EVL;KANK1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,-0.5970195727205426,-1.2066408444434586,0.1951219512195122,0.7710974991697918,1.0,14/41,19.18%,SERPINE1;LRRC32;EMP1;TNS1;MSRB3;VWF;TGM2;EPAS1;CFH;PLSCR4;TIE1;ITGB1;ACVRL1;CD34
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.7830082574737299,-1.2064667897946262,0.234375,0.7711233800021887,1.0,2/6,9.61%,ADAMTS9;NGLY1
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,-0.6551137973456083,-1.2063717122017914,0.2857142857142857,0.7702042013045655,1.0,3/21,4.89%,MAFF;RAPGEF5;ALPL
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,-0.6551137973456083,-1.2063717122017914,0.2857142857142857,0.7702042013045655,1.0,3/21,4.89%,MAFF;RAPGEF5;ALPL
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.7235086859778133,-1.205920535406649,0.2361111111111111,0.7712936013730596,1.0,4/10,17.10%,KCNMB4;ANK2;ATP1B3;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5643355724307683,-1.2058793498612073,0.2159090909090909,0.7707419193833621,1.0,16/70,17.26%,SERPINE1;RFTN1;GAPDH;LRRFIP1;MBP;HIF1A;SULF2;PNP;ANXA1;HYAL2;PLCG2;TMED10;RAB1A;MALT1;TBK1;IL18R1
prerank,KEGG_2021_Human__TNF signaling pathway,-0.607978044015961,-1.2058489380515374,0.22988505747126436,0.7701706482946983,1.0,6/44,3.67%,PIK3R3;MAP3K5;CX3CL1;JUN;JUNB;FOS
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.6926427354547933,1.2057220489033076,0.2857142857142857,1.0,1.0,2/7,8.26%,SLCO1A2;NCOA2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.7707654533617302,-1.2055197837130551,0.25,0.7710924536279147,1.0,3/7,14.61%,GRIN2B;SLC8A1;CACNA1C
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.7933462104424963,-1.2052722000145775,0.26153846153846155,0.7713340636802091,1.0,2/5,7.78%,GMPS;VAV3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.8049203056177989,-1.2046580155309805,0.234375,0.7728010889797629,1.0,2/6,8.84%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.8049203056177989,-1.2046580155309805,0.234375,0.7728010889797629,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7641528448052235,-1.2044910699993399,0.27419354838709675,0.7729789684191628,1.0,1/8,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.7405942890800618,-1.2041043108084488,0.23076923076923078,0.7738940245742258,1.0,1/11,1.89%,YTHDC1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,-0.7695902742408359,-1.2040304968136737,0.17647058823529413,0.7735896007868137,1.0,3/8,9.19%,CD9;PECAM1;KLF4
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.605576131733348,-1.2037665088521776,0.23170731707317074,0.7738889728191052,1.0,4/32,6.64%,CCDC60;ATF3;ANKRD37;SPC25
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.6833616465623594,-1.2036270157257885,0.24285714285714285,0.7739222069357781,1.0,6/15,15.86%,DTNA;PIAS2;BTNL9;CTNNA3;LRP1B;CADM2
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,-0.6756866466647014,-1.203545699251288,0.25,0.7736389974168614,1.0,6/16,15.46%,RPS27A;CDKN1B;UBC;CCNH;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.5253224659450616,-1.2034476897961537,0.12,0.773590824387311,1.0,51/264,15.56%,MAFF;TBX3;SERPINE1;ST18;NR4A1;ATF3;KLF6;ZEB2;PPARG;CX3CL1;PHF10;HES1;JUN;JUNB;FOS;KDM1A;SMAD7;RPS27A;NFE2L2;JUND;PIK3R1;FOXF1;KLF2;SMARCA1;HIF1A;REL;FOSL2;PRKN;NPAS2;UBC;RREB1;CD81;KLF4;CEBPZ;HYAL2;ZFPM2;CRLF3;EPAS1;OGT;MEF2A;NPM1;NFKBIA;CNBP;NCK1;SMAD3;MAX;TMF1;LPIN2;WWTR1;CRTC3;SREBF2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,-0.7872640742059116,-1.2033172911055459,0.2153846153846154,0.773624238093198,1.0,3/5,19.18%,NES;ITGB1;CD34
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.5630888457290025,-1.203260883670069,0.1702127659574468,0.7731385015452591,1.0,23/101,19.31%,RPS12;SEC24D;RPS9;GPC5;RPS27A;CANX;JAK1;MGAT4A;RPS11;UBC;RPS27;RPS6;RPS15;TPR;RPS7;GJA1;CNBP;PIK3C3;TBK1;RPS28;NUP54;RPS19;CHMP4B
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5808797252341286,-1.203225404689075,0.19230769230769232,0.7725722902696751,1.0,16/51,21.83%,LAMC1;PPARG;EPS8;ZC3H7A;TIMP3;EMP1;PRKN;EPAS1;NAV2;WWTR1;CALD1;EGFR;PLAT;HMCN1;SASH1;GLI3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.6786310763020921,-1.203074478119395,0.19480519480519481,0.7725963729001334,1.0,1/18,0.24%,SERPINE1
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.6878101805918444,-1.2029944383826314,0.27419354838709675,0.7714984124198376,1.0,3/12,9.46%,PEBP1;RAP1A;VWF
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.6878101805918444,-1.2029944383826314,0.27419354838709675,0.7714984124198376,1.0,3/12,9.46%,PEBP1;RAP1A;VWF
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.5702980778806573,1.2027582278136377,0.2727272727272727,1.0,1.0,4/14,15.94%,CTBP2;PPP2R5A;PPP2R5E;TCF7L2
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.6021645921748588,-1.2026335738542993,0.24705882352941178,0.7722731960840502,1.0,15/37,17.29%,NES;GRIA2;GPM6B;NPAS3;ANK2;LSAMP;PPFIA2;CTNND2;DCLK1;ATRNL1;ADGRL3;LRRC4C;EFR3B;CADM2;ROBO2
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.7716104114844977,-1.2025237639971647,0.22950819672131148,0.772125364727,1.0,2/6,5.82%,GRIN2B;LRRC7
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.699122922844444,-1.2022675873893158,0.30303030303030304,0.7724733956941943,1.0,2/13,2.82%,TBX3;HES1
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,-0.6254888171402048,-1.2022037320374033,0.24050632911392406,0.771330099011153,1.0,6/28,14.37%,SERPINE1;TIMP3;EMP1;EPAS1;PLSCR4;VEGFC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,-0.6254888171402048,-1.2022037320374033,0.24050632911392406,0.771330099011153,1.0,6/28,14.37%,SERPINE1;TIMP3;EMP1;EPAS1;PLSCR4;VEGFC
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.7615081278328754,-1.201852598223283,0.22535211267605634,0.7720713011532895,1.0,4/8,16.12%,RIMS1;PPFIA2;SYT1;SH2D3C
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.8077729611575504,-1.201468874526926,0.2,0.7729925801423941,1.0,4/5,17.56%,PRKN;RAB21;MSN;MTMR2
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.6986020548085575,-1.2013365842082155,0.22580645161290322,0.7722548418157706,1.0,5/12,19.07%,RAPGEF3;RAP1A;VWF;BCAR1;GRB2
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.6986020548085575,-1.2013365842082155,0.22580645161290322,0.7722548418157706,1.0,5/12,19.07%,RAPGEF3;RAP1A;VWF;BCAR1;GRB2
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.6608636066840656,-1.201020087440244,0.28,0.7728317550788253,1.0,7/19,10.92%,PSMC6;PSMB9;RPS27A;PSMA1;HIF1A;UBC;EPAS1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.8051018099171239,-1.2009462779242093,0.21621621621621623,0.7723833511847296,1.0,2/5,13.97%,SULF2;HS6ST3
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.6483724150799307,-1.200927591242331,0.2361111111111111,0.7717551510031472,1.0,6/16,8.84%,PSMC6;PSMB9;RPS27A;CDKN1B;PSMA1;UBC
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8043660618003665,-1.2006620235160492,0.25806451612903225,0.7721104366708106,1.0,2/5,6.67%,ADAMTS9;KLF2
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.6632347943620371,-1.2002083535622479,0.20833333333333334,0.7735166898731969,1.0,6/22,8.84%,PSMC6;PSMB9;ABCA5;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,-0.5768801747834021,-1.2001814311029988,0.2261904761904762,0.7729291828117533,1.0,10/42,22.28%,UFL1;RAD21;EDEM3;TRAM1;ATF2;ARFGEF2;CMPK1;CBFB;SCAMP1;DNAJB14
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6687012936701984,-1.200096979396049,0.2602739726027397,0.7725226733137829,1.0,6/17,20.19%,PIK3R1;HYAL2;TPR;SMAD3;WWTR1;ECT2
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.5399197687732674,-1.199590063604754,0.11224489795918367,0.7739647716821404,1.0,36/192,19.07%,PIK3R3;DOCK3;LBR;AKAP12;PKN3;BCAP31;PDE5A;MYO9B;ARHGAP21;CDC37;ACTN1;PIK3R1;GIT2;VAV3;DLC1;SLC4A7;WIPF1;ARHGAP23;GNA13;GJA1;FGD4;NCK1;STK38;TMEM59;STOM;PICALM;SRRM1;VRK2;RASGRF2;FAM13A;ARHGAP29;ARHGAP15;ARHGAP17;ERBIN;ITGB1;GRB2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.7037230693422698,-1.199169097847061,0.22857142857142856,0.7751548201293018,1.0,5/12,21.70%,PPARG;FLT1;CAV2;ATOH8;SPARC
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6225015318333044,-1.1991023695298086,0.21794871794871795,0.7746277689096995,1.0,5/20,17.37%,MYO9B;EPS8;CFL1;GNA13;ARHGAP29
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6755390140324836,1.1986885696447915,0.26666666666666666,1.0,1.0,2/5,16.68%,MCM9;PARN
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.6529247065721349,-1.1983795880295367,0.22058823529411764,0.7771799261822052,1.0,2/15,5.26%,RFC3;POLA1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7673920184050121,-1.1981890702479292,0.27586206896551724,0.7773487438544058,1.0,4/7,17.48%,SMAD7;PAK2;TBCD;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7155457081116672,1.1981761008578593,0.2647058823529412,1.0,1.0,2/6,11.18%,HSPD1;NFAT5
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,-0.5798571653469103,-1.1975414814199385,0.18518518518518517,0.7794166544227729,1.0,9/39,17.64%,PLS3;AKAP12;MAP1B;NES;SMARCA1;GJA1;BCAR1;MYH10;CALD1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.6996149335819349,-1.197485503139722,0.2028985507246377,0.7790069305336945,1.0,2/12,2.58%,TSG101;SYTL4
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.7819160309425528,-1.19738031237814,0.21875,0.7787071253554647,1.0,6/8,21.78%,KCNIP4;ANK2;DPP10;ANK3;DLG1;CD63
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.5676042668941634,-1.1968952182239299,0.20454545454545456,0.7800245104116527,1.0,12/58,11.39%,B3GNT2;PKM;PCK1;PGK1;GPC5;RPS27A;SLC2A1;UBC;HYAL2;SLC26A2;CHST11;TPR
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.5688903936145975,-1.1968777889748172,0.15730337078651685,0.7794171446424515,1.0,8/64,7.68%,PIK3R3;PKM;JUN;CDKN1B;JAK1;ACTN1;PIK3R1;REL
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.65661837521458,-1.196824722368742,0.2125,0.7790088617431152,1.0,4/14,18.19%,AFDN;GOLPH3;PREPL;ANK3
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.5651984482602036,-1.1965455091273831,0.19767441860465115,0.7796795271253801,1.0,4/78,4.94%,CEP57;EHD4;RAB11FIP3;CEP70
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.7448591117979314,-1.1964808862270269,0.22580645161290322,0.7793606808410481,1.0,5/7,16.65%,NFE2L2;HIF1A;PRKN;SOD2;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.8067932736504395,-1.1963555537988138,0.1875,0.7792497620204366,1.0,4/6,18.19%,KCNMB4;ANK2;NOS1AP;ANK3
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.6139821427618878,-1.1959160723827607,0.25882352941176473,0.7806386720981822,1.0,4/31,4.59%,ITPR1;MGLL;RIMS1;GRIA2
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.7070020831694487,-1.1956647339518587,0.2727272727272727,0.7810394120553978,1.0,1/8,3.61%,PSMB9
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.618296486559522,-1.1952437989577573,0.14634146341463414,0.7820106784740566,1.0,9/37,9.11%,KLF6;NFKBIZ;FOS;LGALS3;S100A6;NFE2L2;EMP1;FOSL2;ANXA1
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.6395753856464639,-1.1950883633913905,0.27692307692307694,0.7818683106184143,1.0,3/15,8.23%,SUN2;RAD21;SUN1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7467374945230058,1.1946993758479012,0.27906976744186046,1.0,1.0,5/6,25.26%,MBOAT2;TAPT1;SOX5;TRPS1;BMPR2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5339824949790526,1.1938296872965763,0.22727272727272727,1.0,1.0,3/23,3.24%,BMP6;PRKD1;IL6R
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.5944212032309291,-1.193391829173349,0.25316455696202533,0.7883133298377862,1.0,11/42,22.60%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;TBK1;DUSP6;CUL1;MAPK8
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.824406337309402,-1.193251872429251,0.23076923076923078,0.7881558877760118,1.0,1/5,4.59%,GRIA2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7287320219549108,-1.1932493058833336,0.25806451612903225,0.787468742276643,1.0,4/7,19.18%,LRRC32;HIF1A;SMAD3;CD34
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.8023250999939991,-1.1932484183233003,0.234375,0.7868024056101562,1.0,2/5,6.69%,CX3CL1;IFNGR1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.650203541316221,-1.1931567889951282,0.22666666666666666,0.7866368922914959,1.0,3/23,5.74%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.6950611829021636,1.1929351660648073,0.25806451612903225,1.0,1.0,2/6,8.26%,SLCO1A2;NCOA2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7131377060216142,-1.1929066995355155,0.2898550724637681,0.7870198398448629,1.0,3/11,17.45%,NR4A1;S1PR1;LCP2
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.6133687589485898,-1.1924731851540775,0.2375,0.7883312504212607,1.0,8/40,13.76%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.6531713283847224,-1.1922568977024903,0.20270270270270271,0.7884677670999672,1.0,5/17,19.31%,SEC22B;FEZ2;PINK1;PIKFYVE;CHMP4B
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.6095785046433776,-1.192229743471631,0.24358974358974358,0.7879108502329887,1.0,8/38,13.31%,NRCAM;CX3CL1;PTPRD;GPM6A;PPFIA2;CTNND2;ADGRL3;LRRC4C
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.701667369612917,-1.1921860082183415,0.2692307692307692,0.787423182677759,1.0,3/10,8.84%,RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.7892383023300714,-1.1917051448754155,0.1746031746031746,0.7885152809374587,1.0,2/6,17.34%,BLCAP;KPNB1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.5794999044071816,-1.191549422136147,0.2222222222222222,0.7884077161182383,1.0,14/72,15.46%,CEP57;NES;EPS8;CEP70;CDKN1B;CCNH;ENSA;CDK14;CRLF3;ARPP19;CDKN1A;MAX;PAFAH1B1;CDK6
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,-0.7071198920594918,-1.191480779572684,0.3,0.7872113047931407,1.0,3/10,11.21%,EHD4;SLC2A1;RPL8
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,-0.7071198920594918,-1.191480779572684,0.3,0.7872113047931407,1.0,3/10,11.21%,EHD4;SLC2A1;RPL8
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7622926784383217,-1.1914602674589354,0.15384615384615385,0.7866486423169591,1.0,2/7,6.08%,SEC22B;FEZ2
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.7755600966376521,-1.1913163168590584,0.34615384615384615,0.78655276199987,1.0,2/5,19.07%,FGFR1;GRB2
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,-0.7371223751414261,-1.1912546899515712,0.3389830508474576,0.786117684783998,1.0,3/7,19.07%,RAP1A;VWF;GRB2
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7139047009499473,1.191159048973997,0.2972972972972973,1.0,1.0,1/6,2.28%,RC3H1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6992684315254043,-1.1907670320654276,0.25,0.7873593310671696,1.0,3/14,5.82%,GRIN2B;GRIA2;LRRC7
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,-0.6215664832278716,-1.1906628344663015,0.24096385542168675,0.7871469343763078,1.0,8/26,14.10%,PCDH9;GRK5;FOXF1;ADAMTS1;DLC1;FGFR1;ADGRL3;SYT1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.8007275892541307,-1.190430129321917,0.24242424242424243,0.7875248378507813,1.0,2/6,15.19%,MGLL;LPIN2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7307057397974037,-1.1902838543675252,0.31746031746031744,0.7875349073846584,1.0,3/8,13.92%,KDM1A;PRKN;PTTG1IP
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,-0.6238481722610647,-1.190226829193726,0.22727272727272727,0.7870236176851632,1.0,8/25,12.56%,DOK5;NFASC;TIMP3;PTPRD;ANK2;GJA1;DCLK1;ADGRL3
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.5380339937453282,1.1898649157532923,0.14814814814814814,1.0,1.0,5/22,9.91%,INO80;OFD1;STARD9;CLASP1;NEK7
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.7341256583756686,-1.1896620523070542,0.2191780821917808,0.7887125396244642,1.0,4/9,14.61%,DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.7961898732322698,-1.1895101673494155,0.25,0.7887119284777333,1.0,1/5,3.85%,HSPA5
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6258295030407293,-1.1894096846572024,0.2112676056338028,0.7885861322179311,1.0,4/22,8.82%,MGLL;GRK5;GIT2;CAMKMT
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.7542336576780302,-1.189379681461621,0.25862068965517243,0.788075692034645,1.0,3/8,13.07%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.634616697158096,-1.1893593279913137,0.2564102564102564,0.7874603778206524,1.0,7/22,16.65%,KDM1A;SMAD7;NDFIP1;COMMD1;PTTG1IP;MALT1;PINK1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.563530685073405,-1.189205731983643,0.23076923076923078,0.7872495259450333,1.0,16/65,14.90%,RPL23;RTN4;GAPDH;SMAD7;CDC37;PIK3R1;LAMP2;ANK2;HIP1R;PRKN;CCNH;RAB21;RPS7;ATP1B3;CDKN1A;NAA16
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5738875020206946,-1.188909705535101,0.2235294117647059,0.7879027515762274,1.0,17/62,22.18%,MAP2;ATG12;GRIA2;OXR1;ARHGAP21;NCALD;LPGAT1;PPFIA2;CTNND2;SYT1;CADM2;TRIM9;GATA2;PSD3;HIVEP2;SCAMP1;NOL4
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.7772333106783083,-1.1888799570097783,0.3064516129032258,0.7873658665612974,1.0,3/5,15.33%,PPA1;PPA2;SULT1C4
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.6351753019788121,-1.1887020017116572,0.33766233766233766,0.7873951467548345,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.7531918110184118,-1.1886476431065394,0.203125,0.7869553302948368,1.0,4/10,18.83%,HES1;SMAD7;ROBO2;ACVRL1
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,-0.6266541951081283,-1.1886303082469376,0.24050632911392406,0.7850292836499806,1.0,7/28,10.94%,SERPINE1;MGLL;S100A6;EMP1;ANXA1;EPAS1;CFH
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,-0.6266541951081283,-1.1886303082469376,0.24050632911392406,0.7850292836499806,1.0,7/28,10.94%,SERPINE1;MGLL;S100A6;EMP1;ANXA1;EPAS1;CFH
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,-0.6266541951081283,-1.1886303082469376,0.24050632911392406,0.7850292836499806,1.0,7/28,10.94%,SERPINE1;MGLL;S100A6;EMP1;ANXA1;EPAS1;CFH
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6622341210446283,-1.1882922591541638,0.22972972972972974,0.7856423560308162,1.0,3/13,14.10%,RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6192181335871473,-1.1881823923505628,0.2876712328767123,0.7855204371017208,1.0,10/25,20.48%,SMAD7;RPS27A;UBC;SNX6;SMAD3;STRAP;SNX25;PPM1A;CD109;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8064581214943343,-1.1880127339448276,0.23636363636363636,0.7853511054949465,1.0,1/5,2.20%,GLUD1
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.6475834884130721,-1.1878863113684988,0.3150684931506849,0.7852201231371266,1.0,5/18,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.7070214439952877,1.1877906134541167,0.2692307692307692,1.0,1.0,1/11,0.16%,BMP6
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.6491894925083764,-1.1874971327763781,0.3055555555555556,0.7864489640723185,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.618954034333225,-1.186983123357542,0.2876712328767123,0.7879227227771953,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.7600711082894873,-1.1869778488598812,0.34375,0.7872963364159158,1.0,1/7,2.90%,PBX3
prerank,KEGG_2021_Human__Pertussis,-0.6440072991949066,-1.1868791732865172,0.29577464788732394,0.7872210587303451,1.0,6/16,22.60%,JUN;FOS;CFL1;ITGB1;GNAI3;MAPK8
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6592486330637509,-1.18674008812042,0.23076923076923078,0.787164859163058,1.0,3/18,5.66%,BCAP31;SEC24D;CANX
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.7625745799640724,-1.186359769851774,0.17647058823529413,0.7881123329381372,1.0,2/5,14.63%,ARPC2;SPIRE1
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,-0.6295751778983796,-1.1862766015041417,0.2537313432835821,0.78771492718617,1.0,4/23,6.43%,LAMC1;PLS3;KIAA1217;LAMA5
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5777243207515715,-1.186212115508158,0.22727272727272727,0.7873181887822328,1.0,9/54,7.36%,GRIK1;DTNA;SYN3;GRIN2B;GRM7;KCNMB4;RIMS1;GRIA2;MBP
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,-0.64482611465379,-1.1860491834469433,0.2702702702702703,0.787432086455353,1.0,10/21,27.94%,LDHA;CALCOCO2;ANXA1;ADK;UBE2J1;CALR;APLP2;NUCB2;GCNT1;VIM
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.6532606048330611,-1.185675058383226,0.3108108108108108,0.7870096005101578,1.0,5/16,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6532606048330611,-1.185675058383226,0.3108108108108108,0.7870096005101578,1.0,5/16,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6532606048330611,-1.185675058383226,0.3108108108108108,0.7870096005101578,1.0,5/16,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,-0.6089246054179096,-1.18547420083201,0.23809523809523808,0.7856871570995878,1.0,12/37,17.64%,AKAP12;SPOCK1;MAP1B;NES;KHDRBS3;PTPRD;SMARCA1;ANK2;GJA1;NAV2;MYH10;CALD1
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,-0.6089246054179096,-1.18547420083201,0.23809523809523808,0.7856871570995878,1.0,12/37,17.64%,AKAP12;SPOCK1;MAP1B;NES;KHDRBS3;PTPRD;SMARCA1;ANK2;GJA1;NAV2;MYH10;CALD1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,-0.6089246054179096,-1.18547420083201,0.23809523809523808,0.7856871570995878,1.0,12/37,17.64%,AKAP12;SPOCK1;MAP1B;NES;KHDRBS3;PTPRD;SMARCA1;ANK2;GJA1;NAV2;MYH10;CALD1
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.7355812779768255,-1.1854327254292123,0.3492063492063492,0.7851820919086777,1.0,2/8,7.49%,PIK3R1;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.799048503144258,-1.1853873426237485,0.23214285714285715,0.7847998206759805,1.0,1/6,2.20%,GLUD1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.7402740985169318,-1.1853535577995513,0.36363636363636365,0.784333827895649,1.0,1/8,1.54%,PCK1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7713804810766862,-1.185172301806664,0.2786885245901639,0.7843930688605378,1.0,3/5,15.19%,ENPP2;ACOX1;LPIN2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.5905070982033047,-1.184945397018225,0.2125,0.7848358706114956,1.0,11/38,22.60%,SERPINE1;FES;ZFP36;MSN;TFPI;ADAM15;EGFR;ADCY2;ADAM9;ATP1A1;MAPK8
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.6863570341194987,1.184860905526927,0.21875,1.0,1.0,1/6,6.96%,TRIM22
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.696327512611085,-1.184803092510688,0.2923076923076923,0.7847543496218422,1.0,5/12,19.39%,PRKN;SDCBP;PINK1;MTMR2;LRPAP1
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.7041087994736461,-1.1847834786704747,0.2903225806451613,0.7842338893682543,1.0,6/9,25.98%,MTMR12;PIK3C3;MTMR2;PIKFYVE;MTM1;INPP5F
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6755791455454767,-1.1846894572275932,0.27631578947368424,0.7839383146124316,1.0,4/15,22.50%,RIMS1;DYSF;USO1;DNM2
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,-0.5965475893234313,-1.1845257146387955,0.2682926829268293,0.783923025595431,1.0,7/41,7.30%,ADAMTS9;CX3CL1;KIAA1217;NES;TIMP3;PTPRD;FLT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7588361070645839,-1.184197159686788,0.288135593220339,0.7847091797005126,1.0,3/7,13.92%,KDM1A;PRKN;PTTG1IP
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8364169577654323,-1.1838024418774327,0.3220338983050847,0.7855592110295926,1.0,3/5,8.84%,PGK1;RPS27A;UBC
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.5306797518708357,-1.1837089398239529,0.16666666666666666,0.7852635180732426,1.0,21/108,16.65%,PSMC6;MAP3K5;ITPR1;WNT2B;GRIN2B;HSPA5;GRIA2;RPS27A;PSMA1;RB1CC1;PRKN;UBC;PRNP;NDUFA12;GABARAPL1;RAB1A;CACNA1C;PPP3CC;PIK3C3;TBK1;PINK1
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.5769176801548589,-1.183199455360193,0.25609756097560976,0.7867623886419689,1.0,14/39,27.30%,PKN3;MYO9B;ARHGAP21;PIK3R1;DLC1;STOM;ERBIN;ECT2;PCDH7;STK10;ARHGEF2;PREX1;MCF2L;RHOB
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,-0.8190126911408631,-1.1830591817127818,0.2459016393442623,0.7867169684346473,1.0,2/5,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.38869503347128953,1.1829619528853468,0.14285714285714285,1.0,1.0,18/101,10.92%,SCFD2;PACS2;STX8;PIGU;EVI5;HERC2;TBC1D5;OCLN;WLS;ITSN1;VPS45;COG3;BICD1;CEP68;ID1;RAB28;TBC1D4;SYNRG
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.5730472066989721,-1.1829575691776437,0.22784810126582278,0.7864396131292566,1.0,6/39,6.19%,JUN;FOS;KDM1A;RAD21;JUND;ERBB4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.7723254111987461,1.1829418027442165,0.35294117647058826,1.0,1.0,2/5,5.68%,DISP1;CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.7723254111987461,1.1829418027442165,0.35294117647058826,1.0,1.0,2/5,5.68%,DISP1;CLYBL
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.7229945096569157,-1.1828253903468626,0.2702702702702703,0.7862739878119299,1.0,3/9,19.12%,PRKAG2;MTOR;PPM1A
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.597690101520345,-1.1828181398706854,0.24691358024691357,0.7856639092197386,1.0,7/27,14.53%,PSMC6;NPLOC4;HSPA5;PRKN;HERPUD1;UGGT2;AMFR
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.6422769371538707,-1.1825432080990703,0.225,0.786073159460132,1.0,5/25,9.77%,UFL1;MGLL;BCL6;ANXA1;TMSB4X
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.598706973895436,-1.182493358285496,0.20512820512820512,0.7855752472446333,1.0,9/35,16.65%,DDIT4;SMAD7;DMD;RAPGEF3;NCK1;RACK1;SH2D3C;TBK1;PINK1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.7143998466720816,-1.1822623791049292,0.15714285714285714,0.7858914752483644,1.0,4/14,13.71%,NEDD9;HYAL2;PRNP;CASS4
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.5474297386372622,-1.1822057459622326,0.24444444444444444,0.7854407025993279,1.0,18/65,19.60%,RFTN1;EHD4;KCNIP4;LRRC7;MAGI2;ANK2;RAP1A;PACS1;CD81;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;NUP54;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7247092353575961,1.1822037680977209,0.25,1.0,1.0,2/5,18.70%,NLGN1;BTRC
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.7871798071632299,-1.182112576241285,0.2542372881355932,0.7850921675860472,1.0,4/5,21.09%,APOLD1;BTG1;NOTCH4;ATOH8
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.5489519209328394,-1.181981785554886,0.13829787234042554,0.784937814952864,1.0,35/137,19.31%,RPS12;SEC24D;RPS9;KDM1A;GPC5;RPS27A;NFE2L2;CANX;JAK1;MGAT4A;IFNGR1;IFNGR2;RPS11;UBC;S1PR1;RPS27;RPS6;RPS15;TPR;RPS7;ATP1B3;GJA1;PLCG2;SH3KBP1;CNBP;NCK1;PIK3C3;RCOR1;TBK1;RPS28;NUP54;ITGB1;GRB2;RPS19;CHMP4B
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.605103261062015,1.1819321301726158,0.20689655172413793,1.0,1.0,1/11,0.13%,THSD1
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,-0.756650715770683,-1.181488787524274,0.26865671641791045,0.7862392187747542,1.0,2/6,7.20%,GRIN2B;PTPRD
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.8183158726158826,-1.181472350185786,0.2545454545454545,0.7856975909346474,1.0,1/5,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.791367410973981,-1.1814369947940733,0.23529411764705882,0.7852396210821663,1.0,2/6,10.15%,ARF1;PRNP
prerank,KEGG_2021_Human__Vitamin digestion and absorption,-0.7383901982464376,-1.1813739624851516,0.26865671641791045,0.7848467253617091,1.0,2/6,7.12%,BTD;SLC52A3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.7029287138745178,1.181214467670009,0.3125,1.0,1.0,1/5,0.16%,BMP6
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.5864554004063777,-1.181061403177733,0.27848101265822783,0.7855654918476168,1.0,7/43,8.84%,PSMC6;PSMB9;SPOPL;GPC5;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.6621732063681655,-1.1810293412621644,0.32,0.7850445278114522,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7241066635767831,-1.1807923362410018,0.25,0.7855052854834198,1.0,3/8,10.15%,ARF1;COMMD1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.708461374306109,-1.180729466674409,0.3,0.785159250252267,1.0,6/9,27.04%,PNP;ANXA1;PLCG2;MALT1;PDE4B;SPTBN1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.6123553702455046,-1.180474388638186,0.28,0.7856008611868892,1.0,3/24,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7225987526285549,-1.1803940703997464,0.3,0.7852187317205287,1.0,4/11,7.46%,CDC37;JAK1;IFNGR1;IFNGR2
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,-0.7628568938186531,-1.180350165440702,0.29508196721311475,0.7847367125533636,1.0,5/6,23.27%,FLT1;PECAM1;VWF;CD34;CDH5
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.7281156121170145,-1.1800083796212413,0.2222222222222222,0.7854423578088027,1.0,5/11,19.31%,SEC22B;FEZ2;PINK1;MTOR;CHMP4B
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.6707120173039869,-1.179981523166198,0.2318840579710145,0.7849883060532833,1.0,5/19,11.53%,ADAMTS9;MGAT4A;HIF1A;NGLY1;GOLPH3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.7099562259542883,-1.17971997956418,0.2714285714285714,0.7854100373444853,1.0,1/9,1.54%,PCK1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7643225984918074,-1.179486382456583,0.24242424242424243,0.7851503128118454,1.0,3/6,14.10%,RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7643225984918074,-1.179486382456583,0.24242424242424243,0.7851503128118454,1.0,3/6,14.10%,RIMS1;RIMS2;SYT1
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,-0.679611611679671,-1.1794292463754297,0.2702702702702703,0.7846979640062607,1.0,3/17,5.26%,RFC3;KDM1A;POLA1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.7741265111656147,-1.1793319059142144,0.21311475409836064,0.7843917158389403,1.0,2/7,15.46%,PPARG;CDK6
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,-0.8047956651639914,-1.1792557857584343,0.23809523809523808,0.7840405699889262,1.0,1/5,2.47%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6958265550891231,-1.1791753842811552,0.3380281690140845,0.7836537060030546,1.0,1/15,0.24%,SERPINE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,-0.5771945094300425,-1.1789958037913855,0.17073170731707318,0.7837659688928602,1.0,22/62,24.41%,SYTL4;KIAA1217;TINAGL1;TIMP3;EMP1;NPAS2;VWF;DLC1;EPAS1;CFH;PLSCR4;WWTR1;ARHGAP29;ATP8B1;CD34;EGFR;PLAT;CAV2;CDH5;NFIB;RBMS2;TNS2
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,-0.6527564572554563,-1.1788495182029604,0.25,0.783887107566089,1.0,6/13,16.95%,HSPA5;GAPDH;HYAL2;NPM1;TNFRSF10B;TXNRD1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7280057734030319,-1.1788399504628215,0.19444444444444445,0.7833022189127999,1.0,3/8,18.91%,BCAP31;TGM2;MICU2
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,-0.613313850301746,-1.1787817107748264,0.26582278481012656,0.7828810234479884,1.0,9/22,19.76%,NFKBIZ;CD9;TIMP3;DLC1;NFKBIA;CST3;TSC22D1;GATA2;CLU
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.7819353224170065,-1.1785611200068773,0.23809523809523808,0.7831109960091179,1.0,1/5,1.78%,RFC3
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.7224913104496512,-1.1785609080739936,0.26865671641791045,0.7818560104385904,1.0,3/8,21.75%,ZEB2;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.7224913104496512,-1.1785609080739936,0.26865671641791045,0.7818560104385904,1.0,3/8,21.75%,ZEB2;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7193511997809692,-1.1784405881226028,0.30434782608695654,0.7816716574311694,1.0,4/9,11.93%,CX3CL1;JUN;ADAMTS1;GJA1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6871395065873237,1.1779845457741376,0.2903225806451613,1.0,1.0,4/7,13.17%,CLASP1;BICD1;PCM1;PEX14
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.44485619684222005,1.1778652663747515,0.13636363636363635,1.0,1.0,4/45,1.65%,DSE;MMRN1;BMP6;PLA2G4A
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.6924487726449876,-1.177804015772421,0.30666666666666664,0.7832797336208838,1.0,6/14,24.86%,JUN;FOS;MEF2A;DUSP6;MAPK8;RPS6KA2
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.6357888480407441,-1.1777491253079593,0.28,0.7823341927009994,1.0,9/23,14.69%,PSMC6;PSMB9;RPS27A;CDKN1B;PSMA1;UBC;CCNH;CDKN1A;MAX
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.6357888480407441,-1.1777491253079593,0.28,0.7823341927009994,1.0,9/23,14.69%,PSMC6;PSMB9;RPS27A;CDKN1B;PSMA1;UBC;CCNH;CDKN1A;MAX
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.7176666543771945,-1.1776653938153254,0.30303030303030304,0.7819883321017342,1.0,2/6,8.15%,DMD;TPM1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.7293648347685996,-1.1775038536758382,0.2153846153846154,0.7819482402080071,1.0,6/10,23.11%,MAGI2;HYAL2;RACK1;DAG1;PIK3CB;PHLPP1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5868092917736865,1.1773980389071494,0.2413793103448276,1.0,1.0,6/15,22.92%,THOC1;WRNIP1;PARG;WDR70;SUB1;MPHOSPH8
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.5945840515186738,-1.177356820274411,0.2777777777777778,0.7819979104095284,1.0,4/19,10.49%,COL18A1;PECAM1;ITGA10;ITGB5
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.7659927225100633,-1.1773548609294018,0.31666666666666665,0.781375300608247,1.0,4/6,18.41%,GRIN2B;LRRC7;RASGRF2;DLG1
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.5921343023439617,-1.1773299598014182,0.24675324675324675,0.7808342813724202,1.0,11/43,22.60%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;TBK1;DUSP6;CUL1;MAPK8
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,-0.6747963020339368,-1.1773111296365757,0.32857142857142857,0.7802314832545962,1.0,3/11,10.28%,NFE2L2;SOD2;ALPK1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.7970407694777182,-1.1772704226329858,0.2638888888888889,0.7797637625512751,1.0,2/6,10.54%,POLA1;CDK14
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7485210178803905,-1.1769396365401164,0.3387096774193548,0.779794677828462,1.0,2/5,9.40%,TAF1D;CCNH
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7485210178803905,-1.1769396365401164,0.3387096774193548,0.779794677828462,1.0,2/5,9.40%,TAF1D;CCNH
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,-0.7482334573854383,-1.1768795854530356,0.3508771929824561,0.7795157365099338,1.0,1/6,2.18%,ZEB2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.6562603345373496,-1.1763111697574289,0.22077922077922077,0.781412009980726,1.0,7/26,14.71%,PKIG;CDKN1B;DUSP1;IPO7;SLC8A1;HYAL2;STK38
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.5189265248928119,-1.1763018632467337,0.125,0.7808116161826003,1.0,38/175,17.56%,PIK3R3;ANGPTL4;SPNS2;LBR;PRKAG2;MGLL;PPARG;SEC24D;CHPT1;ESYT2;DHRS7B;GGT5;PIK3R1;MTMR12;SIN3B;NPAS2;STARD4;ARSG;LPGAT1;PLIN2;ACSL5;SYNJ2;INPP5D;PON2;ACOX1;PLPP1;LPIN2;SREBF2;PIK3C3;AGPAT4;SH2D3C;EGFL7;RAB14;TXNRD1;SAMD8;KPNB1;PIP5K1C;MTMR2
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.5872341716953889,-1.176185126083283,0.25,0.7806304205209301,1.0,14/36,20.08%,PRKAG2;ATG12;RPS27A;RB1CC1;PRKN;UBC;PLIN2;EPAS1;GABARAPL1;PIK3C3;PINK1;MTOR;CHMP4B;DYNC1I2
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.7503303271461277,-1.1761563620404696,0.3220338983050847,0.7800760519992108,1.0,8/10,24.91%,NRG3;CDC37;ERBB4;ERBIN;GRB2;EGFR;HSP90AA1;NRG2
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.7229814895397908,-1.1757985614331672,0.3188405797101449,0.780855288389313,1.0,3/10,13.33%,PRKN;OGT;FOXK1
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,-0.5738486024274454,-1.1755765034408683,0.22784810126582278,0.7811805249165602,1.0,16/47,20.19%,SERPINE1;MGLL;KHDRBS3;S100A6;SOD2;TGM2;CFH;RSU1;MCL1;SLC38A2;FKBP5;MRPL33;MT1M;IFITM3;EMP2;ECT2
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.7139655802760788,-1.1748939700515386,0.2638888888888889,0.7830753915278912,1.0,4/10,16.57%,RIMS1;PPFIA2;SYT1;SLC38A2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.6217106833343465,-1.1746702274177034,0.275,0.7833983677589236,1.0,5/18,11.85%,ITPR1;ATP2B1;SLC8A1;ANK2;ATP1B3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.6793983566849178,-1.1745244578685767,0.2571428571428571,0.7833222751006306,1.0,3/11,8.15%,SMAD7;FOXF1;TPM1
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.7444391359788,1.1744455792681867,0.3333333333333333,1.0,1.0,1/5,8.29%,YWHAG
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.7512015347631738,1.1741982796737171,0.25,1.0,1.0,3/7,8.74%,RHBDD1;TRIQK;FBXL7
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.7867896705879791,-1.1741888928736621,0.25,0.7842020956808636,1.0,1/5,5.63%,GPM6B
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.7605590470628385,-1.1741418079652757,0.2698412698412698,0.7837717716591762,1.0,1/10,0.90%,UFL1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5892131261449753,-1.1739680223371718,0.20454545454545456,0.7838369418480365,1.0,8/35,13.78%,ADM;PDE5A;ALPL;TIMP3;PECAM1;TNS1;MYO1B;PLSCR4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.7119511849712766,-1.1739075460160757,0.25396825396825395,0.7834075792395854,1.0,1/8,5.05%,SPG7
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5944084457178705,-1.1737037554708276,0.25609756097560976,0.783614087865154,1.0,10/26,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.743795678197776,-1.173670824974327,0.26865671641791045,0.7831238651996751,1.0,1/8,1.54%,PCK1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.6383716160915861,-1.173625052914734,0.2972972972972973,0.7828986614564009,1.0,5/18,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.7799460592528106,-1.1734896380576594,0.19642857142857142,0.7828410384593424,1.0,2/5,16.65%,PRKN;PINK1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.8063965744284284,-1.173163835402942,0.2631578947368421,0.7835926113270372,1.0,4/5,15.56%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6989938283202279,-1.1730430603450066,0.2923076923076923,0.7835257488073779,1.0,5/11,17.48%,SYN3;RIMS1;RIMS2;SYT1;PIP5K1C
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.6057320528795793,-1.1730027615519958,0.2631578947368421,0.783055068810803,1.0,5/29,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.7343171195113478,-1.1729248616122248,0.3076923076923077,0.7827781519480091,1.0,2/7,15.88%,JUN;CHD1
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.660334851477186,-1.1728019925329272,0.29577464788732394,0.7819890801972493,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.660334851477186,-1.1728019925329272,0.29577464788732394,0.7819890801972493,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7804068042933583,-1.1727709704660403,0.3076923076923077,0.781573580710819,1.0,1/6,0.96%,SUN2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5892568572104139,-1.172611931814748,0.2625,0.781482358309271,1.0,4/33,8.15%,TBX3;NES;TIMP3;TPM1
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.6317753332880656,-1.172242372415013,0.28378378378378377,0.7825187380156152,1.0,5/20,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6611988744706634,-1.1721580243963023,0.32,0.7822085933278966,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.8428544253400978,-1.172068528306147,0.1774193548387097,0.7819512882036082,1.0,1/5,0.93%,NRCAM
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.5643652145082176,-1.1719034196347562,0.25842696629213485,0.7819995709727124,1.0,9/52,9.43%,PSMC6;PPARG;JUN;PSMB9;KDM1A;RPS27A;PSMA1;UBC;CNOT6L
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6189450040774129,-1.1718871850827908,0.2125,0.7814465858151866,1.0,7/31,12.99%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;CCNH;NPM1
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,-0.7698224338142963,-1.1718591314719382,0.2903225806451613,0.7809031622159671,1.0,3/5,19.18%,NES;ITGB1;CD34
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.7066521764164501,-1.1717991422261167,0.34782608695652173,0.7805258686122045,1.0,4/11,19.07%,RPS27A;UBC;FGFR1;GRB2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6418584097778002,-1.1717728031285228,0.26865671641791045,0.7800448445777924,1.0,5/20,11.00%,ADM;HES1;SMAD7;FLT1;EFNB2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.6470217596543416,-1.1717343367273807,0.2972972972972973,0.7796427373406356,1.0,7/22,14.56%,LGALS3;BCL2L14;HYAL2;FGFR1;PAK2;TNFRSF10B;CYLD
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6511695022091104,-1.1716438439045125,0.22535211267605634,0.7793801198549614,1.0,7/16,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CD34;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6711905403946368,-1.1716310379262327,0.2948717948717949,0.778883744951297,1.0,1/12,2.31%,RTN4
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8002558094670618,-1.1715367259031748,0.24193548387096775,0.7786914440352606,1.0,1/5,2.05%,RFTN1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,-0.5206028443956109,-1.1714122943437661,0.11,0.7785254169465755,1.0,34/279,9.43%,SERPINE1;DDIT4;PSMC6;BTG2;NDRG1;LBR;PCK1;PRKAG2;NR4A1;RFC3;BNIP3L;ZNF43;PPARG;JUN;SLC2A3;GRIN2B;PSMB9;FOS;LGALS3;PPM1D;SMAD7;GRIA2;ESR2;RPS27A;CDKN1B;PSMA1;PBRM1;BCL2L14;BCL6;SIN3B;UBC;KLF4;CCNH;CNOT6L
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,-0.7669090485188698,-1.1713632419613764,0.27692307692307694,0.7780914122962883,1.0,4/5,13.55%,ACTN1;LIMS1;PARVB;RSU1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,-0.6288997224990148,-1.1712234279189253,0.30666666666666664,0.7780384994206527,1.0,11/22,25.90%,GAS7;IFNGR2;SLC8A1;TNS1;DYSF;CST3;PSAP;CCDC149;SPARC;NID1;KCTD12
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.7536028876562306,-1.1707367861678837,0.23809523809523808,0.7790915096235569,1.0,1/5,3.56%,GRIN2B
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.6314518766846953,-1.1702172720212212,0.2,0.7805141136426537,1.0,7/26,8.84%,NRG3;RPS27A;CDC37;ERBB4;PIK3R1;PRKCE;UBC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,-0.6034349977704087,-1.1695960289941245,0.26582278481012656,0.7825297417135736,1.0,4/24,9.11%,SERPINE1;S100A6;EMP1;ANXA1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.6279517729898678,-1.1691021556729453,0.2857142857142857,0.7838354804496671,1.0,4/17,19.07%,PRNP;FGFR1;CACNA1C;GRB2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.7317062238731389,-1.1690189397607198,0.2753623188405797,0.7835802773146606,1.0,2/6,14.16%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.7659761674304608,-1.1688259507190182,0.23809523809523808,0.7837643889805632,1.0,2/5,9.16%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.5959444755924735,-1.168801490310198,0.27906976744186046,0.7832344368091488,1.0,5/32,12.30%,ADM;PPARG;GGT5;KLF4;PLCG2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.6721606837098747,-1.1687002345110453,0.30985915492957744,0.7830318362699398,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.7609871416962005,-1.1686552262960461,0.32786885245901637,0.7826148780546865,1.0,1/7,5.42%,FES
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5937470123452562,-1.1686218321176316,0.23255813953488372,0.7815256592723479,1.0,2/37,2.23%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5937470123452562,-1.1686218321176316,0.23255813953488372,0.7815256592723479,1.0,2/37,2.23%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.6267323474914483,-1.1686133786911062,0.2077922077922078,0.780999427413388,1.0,6/20,14.61%,BCAP31;ATP2B1;SLC8A1;CD55;SMAD3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.5188917648733165,1.1684806948533135,0.24,1.0,1.0,6/22,15.43%,ATG10;HSPB1;NDUFS4;STAT2;FNIP2;PARG
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6115714716836971,1.1683859452710743,0.2558139534883721,1.0,1.0,2/9,3.19%,CPEB3;TNRC6C
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6115714716836971,1.1683859452710743,0.2558139534883721,1.0,1.0,2/9,3.19%,CPEB3;TNRC6C
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.750410122283109,-1.1673694573600641,0.18055555555555555,0.7845172235086507,1.0,2/8,3.67%,JUN;FOS
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.750410122283109,-1.1673694573600641,0.18055555555555555,0.7845172235086507,1.0,2/8,3.67%,JUN;FOS
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.7212070230273268,-1.16728801314923,0.30303030303030304,0.7842292502825213,1.0,2/7,13.04%,OGT;ARPP19
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,0.5236747131528946,1.166930533631024,0.25,1.0,1.0,2/15,2.82%,GBP2;IL1R1
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,0.5236747131528946,1.166930533631024,0.25,1.0,1.0,2/15,2.82%,GBP2;IL1R1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8019156941031296,-1.1664284867867374,0.2903225806451613,0.7866321497328291,1.0,2/5,8.98%,ENPP2;RREB1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,-0.8117969304146516,-1.1663665102548042,0.23880597014925373,0.786334475138734,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.6054923121085395,-1.1659406601335467,0.30952380952380953,0.7873249983931216,1.0,8/33,13.76%,PSMC6;ST18;PSMB9;RPS27A;PSMA1;UBC;NFKBIA;PELI1
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.6732950728339107,-1.1652856155852345,0.3076923076923077,0.7894303606125379,1.0,6/13,25.29%,VAV3;CTNNA1;MTOR;CDH5;HSP90AA1;MAPKAP1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7055669355017599,-1.1652479638449973,0.3,0.7888928186393245,1.0,5/15,19.42%,TSG101;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.7474851713285494,1.1650725041671506,0.3829787234042553,1.0,1.0,1/5,1.06%,CWC27
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.7474851713285494,1.1650725041671506,0.3829787234042553,1.0,1.0,1/5,1.06%,CWC27
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.616724305274903,-1.1645490026061418,0.3076923076923077,0.7909512691674635,1.0,7/24,10.44%,ITPR1;GLUD1;RAPGEF3;SLC2A1;RAP1A;PRKN;ENSA
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7968549662049444,-1.1644143406678926,0.3387096774193548,0.790744982506797,1.0,3/5,15.17%,CX3CL1;SCARF1;ANKS1A
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.5497306625505336,-1.1642118078993218,0.2222222222222222,0.7909128287175398,1.0,17/67,21.57%,LBR;PKN3;BCAP31;MYO9B;ARHGAP21;PIK3R1;VAV3;DLC1;ARHGAP23;STOM;RASGRF2;FAM13A;ARHGAP29;ERBIN;ECT2;PCDH7;VAPB
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,-0.7897489564238467,-1.164180703889034,0.23880597014925373,0.7903927693604179,1.0,3/6,19.18%,ALPL;PECAM1;CD34
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.7061013479645157,-1.1640629753688254,0.2857142857142857,0.790136471103926,1.0,6/11,24.41%,DUSP1;DUSP16;DUSP5;DUSP22;DUSP6;TNS2
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6559824768844505,-1.1640537126479948,0.3333333333333333,0.7895414888214682,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.7385565102436329,1.1639957978496418,0.36363636363636365,1.0,1.0,2/5,13.49%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.6968908611190946,-1.1639070404516934,0.3194444444444444,0.7893539797851805,1.0,4/12,15.59%,BCAP31;RPS7;NCK1;RACK1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.606013238736644,-1.1638985894970457,0.24390243902439024,0.7887774085591388,1.0,4/27,4.78%,MAP2;NRCAM;MAP1B;S100A6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6842195081379137,-1.1637931806010504,0.28125,0.7885146365455113,1.0,4/9,22.36%,CD55;PLCG2;MALT1;B2M
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.7242043129910771,1.1636834210873637,0.35,1.0,1.0,2/5,2.74%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5896260474106028,-1.163644751754873,0.2345679012345679,0.7885057979262338,1.0,9/24,21.70%,PGK1;PPARG;KLF4;ADAMTS1;CLDN5;ATF2;MECP2;SPRED1;SPARC
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.5492654245243066,-1.163629356794585,0.23529411764705882,0.78799027528801,1.0,16/63,15.03%,PIK3R3;JUN;GRIN2B;FOS;ATP2B1;GRIA2;PIK3R1;RAPGEF3;VAV3;RAP1A;AFDN;ATP1B3;NFKBIA;ACOX1;CACNA1C;CREB3L2
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.6624989495360992,-1.1633302399974208,0.3055555555555556,0.78847128319335,1.0,5/14,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,-0.7697490391493054,-1.162994271145125,0.31343283582089554,0.7891792426700098,1.0,1/6,3.85%,HSPA5
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.7192505676340915,-1.1629782460585882,0.2535211267605634,0.7886980775328867,1.0,7/9,24.99%,CX3CL1;LGALS3;PECAM1;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.7854961139640191,-1.1629253301025952,0.3384615384615385,0.7883102487462483,1.0,1/6,7.49%,HIF1A
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.5744745909637441,1.1629166186628834,0.3055555555555556,1.0,1.0,2/11,9.64%,ATR;ATM
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.6863865016546775,-1.162804337612904,0.2753623188405797,0.7881501613804588,1.0,3/11,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7412317225425852,1.1627243150685935,0.35294117647058826,1.0,1.0,2/5,14.56%,RFX3;CLOCK
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.6418625511603621,-1.1626302008241773,0.34782608695652173,0.787822302618745,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.6418625511603621,-1.1626302008241773,0.34782608695652173,0.787822302618745,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,-0.7622615078488092,-1.1626157131709605,0.23728813559322035,0.7872851813993794,1.0,3/5,23.27%,PECAM1;CD34;CDH5
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.5633732321230525,-1.1625828426278517,0.27710843373493976,0.7868746854490615,1.0,15/54,22.60%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;PLCG2;NFKBIA;PELI1;PIK3C3;TBK1;DUSP6;CUL1;DNM2;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.7030025907376649,-1.1625723159726251,0.30985915492957744,0.7863725980032682,1.0,6/17,19.42%,TSG101;SNX6;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.5107481545858436,-1.1623669095498372,0.19791666666666666,0.7866669622014534,1.0,23/157,10.20%,PSMC6;ANGPTL4;SLCO4A1;SLC6A6;CLIC2;SLC2A3;SLC4A10;PSMB9;ABCA5;ATP2B1;TSC22D3;SPG7;RPS27A;ANO2;SLC20A2;PSMA1;SLC8A1;SLC2A1;SLC30A7;UBC;LRRC8B;SLC4A7;SLC26A2
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.6294101993712757,-1.1620222431602627,0.2727272727272727,0.7869365695584216,1.0,5/28,11.95%,JUN;FOS;RPS27A;UBC;MEF2A
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.6294101993712757,-1.1620222431602627,0.2727272727272727,0.7869365695584216,1.0,5/28,11.95%,JUN;FOS;RPS27A;UBC;MEF2A
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.6601184975920189,-1.1616142275649848,0.3108108108108108,0.7881157207950543,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,KEGG_2021_Human__Hepatitis C,-0.5729641917845372,-1.1611739636951395,0.21686746987951808,0.7893348774622521,1.0,8/53,13.17%,PIK3R3;JAK1;PIK3R1;PPP2R2B;CD81;CLDN5;NFKBIA;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.693891587152967,-1.16107692906979,0.3548387096774194,0.789033474466021,1.0,3/8,12.22%,SMAD7;CDKN1B;ZFP36
prerank,KEGG_2021_Human__Vibrio cholerae infection,-0.6725417021983755,-1.1606411919684059,0.25609756097560976,0.7902251293252703,1.0,3/17,12.30%,ERO1A;ARF1;PLCG2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,-0.7338368910031962,-1.160621085166046,0.3230769230769231,0.7896985377210505,1.0,3/8,7.92%,CD9;ALPL;PECAM1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7414037390197883,-1.1606126452256194,0.30357142857142855,0.789131093720628,1.0,1/6,2.47%,PPARG
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.7586158825376064,-1.1606007911910066,0.3103448275862069,0.7886060891221828,1.0,3/6,18.01%,RTN4;TPR;NUP54
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5715420327767495,-1.1603851430470342,0.2777777777777778,0.7887054082699074,1.0,11/42,15.59%,UFL1;SMAD7;RNF19A;COMMD1;PRKN;ARIH2;HERPUD1;OGT;TRIB2;SDCBP;RACK1
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.5241148308736236,1.1603683814711796,0.375,1.0,1.0,6/23,9.16%,SLCO1A2;MIPOL1;WDPCP;PREX2;KPNA5;SEMA6A
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7509619029324457,-1.1603308459434423,0.3076923076923077,0.7877164619568786,1.0,2/5,13.76%,YBX3;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7509619029324457,-1.1603308459434423,0.3076923076923077,0.7877164619568786,1.0,2/5,13.76%,YBX3;PELI1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6760428244621416,-1.1599219301012729,0.27692307692307694,0.788571116407505,1.0,4/16,13.07%,RPS27A;UBC;ALPK1;NFKBIA
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5650057500798639,-1.1597599019103888,0.24719101123595505,0.7886618792750744,1.0,11/43,15.38%,GRIK1;DTNA;GRIN2B;GRM7;KCNMB4;GRIA2;MBP;PLP1;SYT1;SDCBP;PAFAH1B1
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,-0.6210461361013346,-1.1597115313801294,0.2702702702702703,0.7883052056063821,1.0,5/23,13.07%,PCK1;PRKAG2;SLC2A1;ACSL5;NFKBIA
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7444931075117188,-1.1594656564884522,0.32857142857142857,0.7886360721487586,1.0,4/8,15.56%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5145707715772619,-1.1590969149948882,0.22105263157894736,0.7887425831000519,1.0,49/118,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;STXBP3;RAP1B;FGR;CAP1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5145707715772619,-1.1590969149948882,0.22105263157894736,0.7887425831000519,1.0,49/118,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;STXBP3;RAP1B;FGR;CAP1
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.6961251826810235,-1.1590836157794597,0.3142857142857143,0.7882299744525825,1.0,6/10,25.07%,GRIN2B;LRRC7;RASGRF2;DLG1;RPS6KA2;CAMK2D
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6927947733396354,-1.1590453451308527,0.21739130434782608,0.7878171537172785,1.0,4/13,14.95%,CD9;HIF1A;ANXA1;BTG1
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.7321983583517381,-1.1589763201040977,0.3235294117647059,0.7874956546023365,1.0,6/8,25.55%,CD55;CD81;CFH;CLU;PSMA7;CD46
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7186262145765638,-1.158893541037491,0.2898550724637681,0.7873394450113537,1.0,7/9,24.99%,CX3CL1;LGALS3;ANXA1;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6546760808585024,1.1588516821017785,0.2647058823529412,1.0,1.0,2/5,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6546760808585024,1.1588516821017785,0.2647058823529412,1.0,1.0,2/5,8.98%,CLASP1;PHLDB2
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.6207252840966531,-1.1585044932238464,0.2948717948717949,0.7883610563665244,1.0,5/22,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.6305887449427647,-1.1584938236802318,0.2972972972972973,0.7878094557213184,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,0.5534064067027673,1.1583507953870118,0.26666666666666666,1.0,1.0,4/16,10.36%,MLLT3;TAF3;TAF1;RTF1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6938490914518975,-1.1583338241485481,0.32432432432432434,0.7876698049884828,1.0,1/9,1.46%,TSG101
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.6394812245863266,-1.158229293042983,0.3181818181818182,0.7876946957103652,1.0,5/18,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5773402594796536,-1.1582186828680185,0.2857142857142857,0.7871940534240512,1.0,8/47,13.17%,CEP57;NES;CEP70;CCNH;ENSA;CDK14;ARPP19;CDKN1A
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,-0.750194469286809,-1.1582034408415174,0.34375,0.7866285017266395,1.0,1/5,8.05%,JAG2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6449564398732542,-1.1581410221956765,0.2911392405063291,0.7862687469831731,1.0,10/21,22.60%,MAP2;NES;KDM1A;TMBIM6;CDKN1A;RACK1;ADAM15;LRPAP1;B2M;MAPK8
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.7410066329352043,-1.158057947569144,0.3064516129032258,0.7859750595658247,1.0,2/7,21.43%,KMT2A;SETD3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.7002740103426436,-1.1578196586398954,0.30985915492957744,0.7862139543100783,1.0,3/10,22.68%,SPG7;HSPA9;MFN1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.7461126133341878,-1.1576195025934137,0.2923076923076923,0.7862152513783431,1.0,3/5,20.16%,RAP1A;PRKN;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8398883275387159,-1.1574325805917374,0.23636363636363636,0.7863064727575649,1.0,3/5,14.05%,PKM;YBX3;CNBP
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6663405378637847,-1.157155552937143,0.28169014084507044,0.7867733438375752,1.0,4/11,22.36%,SOD2;CBR4;RYR3;B2M
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.641890449328236,-1.1571413513071904,0.36231884057971014,0.7862599475563472,1.0,5/16,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.688238776281179,-1.1570914006137225,0.27692307692307694,0.7858533407041309,1.0,3/10,12.40%,RAPGEF3;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.7022210719713031,-1.156839617764072,0.3333333333333333,0.7860342256571986,1.0,4/8,23.27%,FOXF1;NOTCH4;ACVRL1;CDH5
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.5734476601870095,-1.1567825810201642,0.275,0.7856528071619493,1.0,9/42,14.95%,PSMC6;BTG2;PSMB9;CDKN1B;PSMA1;SDCBP;CYLD;SMAD3;BTG1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.6062853872655374,-1.1564232752818775,0.32894736842105265,0.7863056747534694,1.0,5/27,9.11%,PCK1;PPARG;ALPL;GGT5;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.5987082418792342,-1.15642174363909,0.34210526315789475,0.7857375348150636,1.0,6/24,13.71%,NEDD9;PTPRD;RREB1;IL1RAPL1;LIMS1;CASS4
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.5160909816674789,-1.1563336565513254,0.17708333333333334,0.7854140519287327,1.0,33/117,25.21%,PKM;SLC2A3;LGALS3;NFASC;TINAGL1;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;CD55;DLC1;CST3;SDCBP;STOM;TMEM30A;EGFL7;RAB14;B4GALT1;KPNB1;PIKFYVE;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;HLA-B;DNAJC3;PDXK;HSP90AA1;STK10
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.6643537241738388,-1.155950169258008,0.3055555555555556,0.7864392917301403,1.0,4/13,13.39%,ANO2;SLC20A2;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5151848622495162,-1.1559024608374082,0.20212765957446807,0.7860264914959606,1.0,50/120,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;KMT2E;STXBP3;RAP1B;FGR;CAP1
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.5907614300661927,-1.1557931615071753,0.30120481927710846,0.7859062576055595,1.0,5/35,6.88%,PIK3R3;PRKAG2;PPARG;PIK3R1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7430320171204504,-1.155685570142497,0.29508196721311475,0.785713256506092,1.0,1/5,8.82%,CAMKMT
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,-0.7702750033150295,-1.1556528324499897,0.3382352941176471,0.7852937708843957,1.0,1/5,3.85%,HSPA5
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.6263242597671415,-1.1554425732670468,0.30666666666666664,0.7854656648926136,1.0,7/22,15.46%,JUN;FOS;RPS27A;CDKN1B;UBC;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.6293343548983258,-1.15538746305207,0.33766233766233766,0.785144004025052,1.0,5/22,15.72%,RFTN1;RPS27A;UBC;PLCG2;PIK3C3
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6358136186510515,-1.1550153664494385,0.28169014084507044,0.7860188239606631,1.0,5/20,11.24%,GRIN2B;GRIA2;MAGI2;LSAMP;PPFIA2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6114954959674482,-1.1548458941871331,0.3333333333333333,0.786004093434933,1.0,4/19,14.16%,MTHFD1L;BTD;MTHFD2L;PLPP1
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,-0.5102015830308542,-1.1542945754571858,0.11,0.7873692896212879,1.0,74/317,19.42%,PSMC6;ADM;ITPR1;TSG101;PGK1;RPS12;RPL23;SEC24D;RPL34;JUN;CD9;PSMB9;MYO9B;RPS9;KDM1A;GPC5;RPS27A;NFE2L2;RPL37;CANX;JAK1;GGT5;MGAT4A;PSMA1;PBRM1;IFNGR1;IFNGR2;RPS11;VAV3;PACS1;AP1G1;UBC;CCNH;S1PR1;RPS27;DUSP16;RPS6;WIPF1;ARPC2;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;ATP1B3;GJA1;PLCG2;RPL15;NPM1;SH3KBP1;CNBP;SYT1;RPL37A;NCK1;RPL7A;RPLP1;SH3GL1;PIK3C3;SGIP1;RCOR1;TBK1;TXNRD1;KPNB1;RPS28;MYO1E;NUP54;RPL31;KPNA4;ITGB1;GRB2;RPS19;CHMP4B;EGFR
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.6348709127387034,-1.1542161302332066,0.3333333333333333,0.7842222401925721,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.772415266840004,-1.1538872401117146,0.3333333333333333,0.7848672804536577,1.0,1/5,2.26%,RPL23
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.6558403952050996,-1.1538212688808844,0.32857142857142857,0.7845405444110477,1.0,4/18,8.34%,PSMC6;UFL1;COMMD1;PRKN
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.7072340928112016,-1.153820716363957,0.2857142857142857,0.7839817548495014,1.0,5/12,20.16%,KCNMB4;RIMS1;RIMS2;PREPL;SLC30A1
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.6435782256857934,-1.153758507452163,0.2602739726027397,0.7837041873087697,1.0,6/14,16.73%,RAB21;RAB2A;RAB1A;RAB8B;RAB30;RAB14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.682871737150493,-1.153404487490609,0.30303030303030304,0.7843957998595342,1.0,4/10,7.60%,CLIC2;DMD;SLC8A1;ANK2
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.6645189672940406,-1.1531584881724017,0.3026315789473684,0.7848464053297384,1.0,4/14,14.50%,ACTN1;PIK3R1;MAGI2;NCK1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.6462003730555884,-1.153064735886807,0.3157894736842105,0.7847047320858211,1.0,5/18,19.07%,RPS27A;PIK3R1;UBC;CDKN1A;GRB2
prerank,Reactome_2022__Disease R-HSA-1643685,-0.5032843488205991,-1.153000253168882,0.06,0.7843395555476466,1.0,114/514,19.42%,PIK3R3;PSMC6;ADM;ITPR1;ADAMTS9;TSG101;NR4A1;RFC3;PGK1;RPS12;RPL23;SEC24D;RPL34;JUN;CD9;NRG3;PSMB9;MYO9B;LRRFIP1;RPS9;KDM1A;GPC5;ESR2;RPS27A;POLA1;NFE2L2;CDKN1B;RPL37;WDR48;RRBP1;CDC37;CANX;SLC20A2;JAK1;PEBP1;ERBB4;GGT5;PIK3R1;MGAT4A;PSMA1;PBRM1;IFNGR1;IFNGR2;RPS11;VAV3;SLC2A1;JAG2;RAP1A;PACS1;AP1G1;UBC;CCNH;VWF;ADAMTS1;PRNP;SLC26A2;S1PR1;RPS27;DUSP16;RPS6;WIPF1;FGFR1;ARPC2;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;ATP1B3;GJA1;PLCG2;RPL15;NPM1;NFKBIA;CDKN1A;ZNF160;MSN;SH3KBP1;CNBP;SYT1;RPL37A;NCK1;SMAD3;ALG11;RPL7A;RPLP1;CDK6;SH3GL1;PIK3C3;SGIP1;RCOR1;TBK1;EGFL7;NOTCH4;TXNRD1;B4GALT1;KPNB1;RPS28;MYO1E;CHSY1;DAG1;NUP54;RPL31;ERBIN;MTOR;KPNA4;PMM2;ITGB1;MECP2;GRB2;RPS19;CHMP4B;EGFR
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6840038484806552,-1.1528060453435973,0.2537313432835821,0.7839617925071044,1.0,3/11,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6840038484806552,-1.1528060453435973,0.2537313432835821,0.7839617925071044,1.0,3/11,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5532571105152301,1.1527664942582845,0.3125,1.0,1.0,2/15,10.97%,BICD1;CIRBP
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.734852445620833,-1.1526730535047833,0.27941176470588236,0.7839088442462767,1.0,6/9,20.00%,CD55;CD81;CFH;PIKFYVE;CLU;PSMA7
prerank,KEGG_2021_Human__Insulin resistance,-0.591089802333594,-1.1525235660831548,0.2976190476190476,0.7838081699762998,1.0,6/36,7.81%,PIK3R3;PCK1;PRKAG2;PIK3R1;PRKCE;SLC2A1
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.6843244056630162,-1.152521965676834,0.3181818181818182,0.7832618113869071,1.0,2/12,6.27%,LRRFIP1;PIK3R1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.7497298550584799,-1.152414967914459,0.3548387096774194,0.78307422546398,1.0,5/7,21.62%,AKAP12;GRM7;PSAP;GNAI3;ADCY2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.7726207566751077,-1.1523659056039703,0.2753623188405797,0.7826404561441774,1.0,2/5,8.15%,KCNMB4;TPM1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5798360977440049,-1.152252875222634,0.2891566265060241,0.7824932951682957,1.0,11/37,16.95%,ERO1A;JUN;FOS;NFE2L2;HIF1A;TPM1;SOD2;MSRA;PINK1;VRK2;TXNRD1
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,-0.506784021423571,-1.1521294646966083,0.16161616161616163,0.7824177903582288,1.0,47/252,19.07%,PIK3R3;DOCK3;LBR;AKAP12;PKN3;BCAP31;PDE5A;MYO9B;KDM1A;CDKN1B;ARHGAP21;CDC37;ACTN1;PIK3R1;SPC25;GIT2;VAV3;DLC1;SLC4A7;RPS27;WIPF1;ARPC2;ARHGAP23;GNA13;GJA1;FGD4;NCK1;STK38;PAFAH1B1;TMEM59;STOM;PIK3C3;MYL6;PICALM;CTNNA1;SRRM1;VRK2;RASGRF2;FAM13A;ARHGAP29;MYH10;ARHGAP15;ARHGAP17;ERBIN;ITGB1;MYL12B;GRB2
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,-0.6552723872556604,-1.1519768441458258,0.32857142857142857,0.7824217233602617,1.0,4/11,19.04%,CDKN1B;MYL6;MYH10;MYL12B
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.6281098491914742,-1.151699113469257,0.25675675675675674,0.7828933764213892,1.0,7/22,10.92%,PSMC6;PSMB9;RPS27A;PSMA1;HIF1A;UBC;EPAS1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.7430442887836797,-1.151684614723534,0.29411764705882354,0.7824374947313664,1.0,1/7,1.78%,RFC3
prerank,CellMarker_Augmented_2021__Myotube:Muscle,0.8171338681232843,1.151683866209492,0.2631578947368421,1.0,1.0,2/5,9.11%,TTN;RCSD1
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.608600338429643,-1.1516255572091156,0.4230769230769231,0.7820297526410828,1.0,6/23,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;REL;UBC
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6861156797063634,-1.1516146591817746,0.3181818181818182,0.7814960101930918,1.0,3/13,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.6832208243529839,-1.151356669126219,0.3384615384615385,0.7819116514767603,1.0,3/6,22.44%,ZFP36;CDK6;HSPA9
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5876614022017784,-1.1512623725965279,0.3125,0.781789527319264,1.0,10/27,19.04%,DTNA;DMD;SLC8A1;TPM1;ITGB5;MYL12A;DYSF;MYL6;CALD1;MYL12B
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5769823978119198,-1.1511628857764533,0.27380952380952384,0.7816202092633563,1.0,8/48,13.17%,CEP57;NES;CEP70;CCNH;ENSA;CDK14;ARPP19;CDKN1A
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.605571954420962,-1.151155467459618,0.2898550724637681,0.781080361271283,1.0,6/26,16.18%,PCK1;SLC8A1;FGD4;NEBL;CPEB4;THRB
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.6390556625800896,-1.1511360907793715,0.22972972972972974,0.7806516333352552,1.0,3/15,4.91%,NR4A1;PPARG;ESR2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7616552958386431,-1.151082098973202,0.32786885245901637,0.7803259145492243,1.0,1/5,9.54%,ADAMTS1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.6169302657908231,-1.1509557222840945,0.3013698630136986,0.779660109446461,1.0,6/20,8.84%,PSMC6;PSMB9;RPS27A;CDKN1B;PSMA1;UBC
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.6169302657908231,-1.1509557222840945,0.3013698630136986,0.779660109446461,1.0,6/20,8.84%,PSMC6;PSMB9;RPS27A;CDKN1B;PSMA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7345813888446139,-1.1508624683146869,0.3684210526315789,0.7794536822448369,1.0,4/6,21.83%,PNP;CD55;HSPH1;GLI3
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.611158822466253,-1.1507591526903624,0.3026315789473684,0.779326099495517,1.0,4/27,8.26%,ITPR1;RAPGEF3;SLC2A1;RAP1A
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6276261305638144,-1.1506916411977186,0.3484848484848485,0.7790338413971216,1.0,5/18,14.66%,SSH1;SPOPL;KLF2;KLF4;CENATAC
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.6366815156747165,-1.1506432761096026,0.32,0.7787341459409716,1.0,5/20,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.7358972260329409,-1.1505380456792587,0.27692307692307694,0.7785838131295535,1.0,4/8,24.14%,KIF16B;SNX25;MTOR;NEDD4
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6362266142433483,-1.1505071693438662,0.2777777777777778,0.7781595076706072,1.0,2/20,3.19%,PCK1;GLUL
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6819108224728239,-1.150500521122361,0.2459016393442623,0.7776575091415416,1.0,4/10,18.57%,ITGB5;LCP2;ARHGAP15;KPNA4
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.7543301092653467,-1.1504179202619436,0.25757575757575757,0.7774221862431951,1.0,1/5,1.78%,RFC3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.6771916527979689,-1.1502616021979442,0.3026315789473684,0.7774998880870656,1.0,9/15,24.44%,KCNIP4;KCNMB4;DPP10;NOS1AP;DLG1;CD63;STK39;NEDD4;NEDD4L
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.6157245438995372,-1.1502112317894624,0.3157894736842105,0.7770931366850434,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,-0.7775192224297802,-1.1498536765822513,0.2727272727272727,0.7778579401991369,1.0,1/5,3.45%,JUNB
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.6055249541670017,-1.1496428570780524,0.34177215189873417,0.7781146060109457,1.0,10/23,19.76%,NFE2L2;YBX3;PRKN;HERPUD1;SOD2;TMBIM6;PTTG1IP;MCL1;PINK1;CLU
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.5758397962371902,-1.149636552702619,0.34615384615384615,0.7770532115729719,1.0,6/24,9.46%,MGLL;SRGN;LRRC32;EMP1;TNS1;VWF
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.5758397962371902,-1.149636552702619,0.34615384615384615,0.7770532115729719,1.0,6/24,9.46%,MGLL;SRGN;LRRC32;EMP1;TNS1;VWF
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.6333681161094338,-1.1494828417551897,0.2676056338028169,0.7771464161919163,1.0,5/15,20.85%,RPS27A;JAK1;UBC;GRB2;SOCS3
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7634375956141937,-1.1492291829810384,0.3076923076923077,0.7774339827356254,1.0,2/6,13.68%,NPM1;RIOK3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6438398633207045,-1.1491386243820942,0.32432432432432434,0.7771614055621522,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5268214466032464,-1.1490154174362512,0.2823529411764706,0.7770834269178157,1.0,14/57,19.07%,JUN;MYO9B;EPS8;RAPGEF3;RASSF1;RAP1A;RREB1;CFL1;SHC2;GNA13;CDKN1A;KPNB1;ARHGAP29;GRB2
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.6472718763727519,-1.1490116087695923,0.3194444444444444,0.7765785614498032,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.6975903545086832,1.1490031540510939,0.35294117647058826,1.0,1.0,2/6,9.08%,DISP1;ABCG2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.806516427418585,-1.1488822455402472,0.3220338983050847,0.7765476410748332,1.0,3/5,13.23%,ANXA1;RIMS2;RAB1A
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.5876228401965091,1.148756064741697,0.35294117647058826,1.0,1.0,1/10,0.05%,DSE
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.5235210681464568,-1.1487506776180383,0.25,0.776462493405597,1.0,15/60,21.38%,PPP2R3A;SSH1;PPM1D;DUSP1;PTPRD;PPP2R2B;DUSP16;DUSP5;NCK1;PPP3CC;MTMR2;PPM1A;DUSP22;MTMR6;DUSP6
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6120111660168858,1.1487469883849075,0.3,1.0,1.0,1/8,0.93%,HOMER1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7914251385666473,-1.148746137703297,0.3382352941176471,0.7759436026662605,1.0,2/5,13.68%,RFTN1;RIOK3
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.69144021135705,-1.1487130224899595,0.32894736842105265,0.7755260739633425,1.0,4/12,18.43%,NR4A1;CDKN1B;CDKN1A;MTOR
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.6293164164483608,-1.1486833724522096,0.31645569620253167,0.7751013823276622,1.0,3/13,19.04%,MYL6;MYH10;MYL12B
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.6013696175270488,-1.148668835254158,0.3055555555555556,0.7746386163515953,1.0,9/18,13.31%,MAP2;NFASC;GRIA2;ANK2;CTNND2;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,-0.5622529660858844,-1.1484931660471016,0.26506024096385544,0.7721910070058398,1.0,11/52,15.27%,PLS3;AKAP12;MAP1B;NES;SMARCA1;PLOD2;ARHGAP23;GJA1;BCAR1;NAV2;WWTR1
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.63471543715693,-1.1481106623886417,0.32894736842105265,0.7728404595369083,1.0,5/20,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7542803406098402,-1.1479894359757121,0.3064516129032258,0.772712406270759,1.0,3/5,10.15%,VSIR;RFTN1;PRNP
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,-0.7163598920719342,-1.147643376017268,0.36764705882352944,0.7732991439206494,1.0,1/6,3.88%,LGALS3
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6485909883572837,-1.1475734216552824,0.3026315789473684,0.7730480916292274,1.0,5/14,9.11%,MGLL;GRK5;SLC8A1;ANK2;ANXA1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.5411362038341273,-1.1475549393226196,0.25287356321839083,0.7725748481257475,1.0,12/73,14.48%,SERPINE1;JUN;SSH1;FOS;FES;RAPGEF3;TPM1;RAP1A;TGM2;ZFP36;CPEB4;LARS1
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.5396472111816444,-1.1475519475828453,0.2235294117647059,0.7720715760042208,1.0,10/44,15.51%,ITPR1;ATP2B1;ERBB4;FLT1;SLC8A1;FGFR1;PLCG2;VEGFC;CACNA1C;PPP3CC
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.7181418972275818,-1.147490484617532,0.3384615384615385,0.7718525245453995,1.0,5/9,23.27%,PECAM1;KLF4;ITGB1;CD34;CDH5
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.7569641722175916,-1.1473754779468264,0.3387096774193548,0.7716873764708926,1.0,3/6,17.24%,ATF3;HERPUD1;DCP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6022857572307784,-1.1473627465206804,0.2875,0.771216344856721,1.0,5/27,10.49%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,-0.7159593393880452,-1.146725490848452,0.38095238095238093,0.7726960665236814,1.0,3/6,18.73%,ITGA10;VWF;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.6017677010520974,-1.1466639869853918,0.30985915492957744,0.7723625512812162,1.0,6/24,13.55%,SMAD7;TPM1;TGM2;AFDN;LIMS1;RSU1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.7029024035821215,-1.1465415122074891,0.27941176470588236,0.7723807963921636,1.0,1/7,2.82%,HES1
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,0.6918118701099212,1.146463899990307,0.30952380952380953,1.0,1.0,1/6,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6910105970766905,-1.1461721267731617,0.2714285714285714,0.7733072186788333,1.0,5/9,13.17%,PPARG;CDKN1B;TPM1;SOD2;CDKN1A
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.760523422471198,-1.1461352923346955,0.2676056338028169,0.7729434601404823,1.0,3/8,13.07%,RPS27A;UBC;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6427141420918673,-1.145927461402604,0.3,0.7731594368660235,1.0,4/16,18.99%,PPARG;KLF4;ACVRL1;MECP2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.602544533593063,-1.1456599461745822,0.3333333333333333,0.7734741352871145,1.0,5/26,10.49%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.6437261434276826,-1.1456044716844545,0.3472222222222222,0.7731338356620371,1.0,5/15,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.684342929791464,-1.145313740686312,0.35526315789473684,0.7735774309224085,1.0,2/10,4.46%,NES;KDM1A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5773305993414812,-1.145260902792198,0.2564102564102564,0.7732907283099164,1.0,4/27,6.48%,PSMC6;HES1;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.7170042461602619,-1.145191661996748,0.36764705882352944,0.7729892208094861,1.0,1/8,6.03%,ZC3H7A
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.5302688219546925,-1.145175267795027,0.2765957446808511,0.7725438951351362,1.0,20/71,18.73%,SEC24D;JUN;FOS;GAPDH;ARF1;WIPF1;ARPC2;GNA13;MYO1B;TMBIM6;TMED10;PAK2;CLDN5;NFKBIA;RAB1A;TNFRSF10B;NCK1;MYH10;MYO1E;ITGB1
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.7244650324515776,-1.1449448793901882,0.3333333333333333,0.77241309860902,1.0,1/7,8.82%,CAMKMT
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.7244650324515776,-1.1449448793901882,0.3333333333333333,0.77241309860902,1.0,1/7,8.82%,CAMKMT
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.595405478146301,-1.1446880827702266,0.32926829268292684,0.7725902469012685,1.0,4/20,7.01%,CX3CL1;NES;FES;PRKCE
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7964855731215204,-1.144681357649206,0.23809523809523808,0.7721085356544448,1.0,2/5,10.92%,HIF1A;EPAS1
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.6746559743191592,-1.144466772784729,0.3181818181818182,0.7723007810673386,1.0,3/13,11.02%,LRRFIP1;PIK3R1;FGFR1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.651120475105614,-1.144207640571278,0.30985915492957744,0.7727044536107031,1.0,7/15,19.10%,RPL10;RPS27;RPS15;NPM1;RPL24;RPS28;RPS19
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.5682021202034993,1.1441005899886825,0.3333333333333333,1.0,1.0,3/12,8.90%,SMAD1;ZNF521;ABL1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.7779635323691572,-1.1440191968623397,0.38095238095238093,0.7728204898594819,1.0,2/5,14.10%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.7480667189295496,-1.1436843177180631,0.43283582089552236,0.7734799740605713,1.0,3/7,18.73%,GJA1;PAFAH1B1;ITGB1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5593615359774957,-1.1436342416306469,0.24096385542168675,0.773127545619946,1.0,14/46,14.13%,DOK5;HES1;GLUL;NES;NFASC;TIMP3;SPC25;PTPRD;ANK2;GJA1;DCLK1;PLP1;PLSCR4;NAV2
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.5989722785274262,-1.1435448613029806,0.2328767123287671,0.7729942474335427,1.0,6/26,8.84%,PSMC6;PSMB9;RPS27A;POLA1;PSMA1;UBC
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.7237408919982071,-1.1434679292348866,0.2916666666666667,0.7727405694634542,1.0,3/8,14.10%,RIMS1;PPFIA2;SYT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5816004629157081,-1.14345843371844,0.2962962962962963,0.7722387458378264,1.0,10/29,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.6527666129015108,-1.1434560375248395,0.29411764705882354,0.7717375930993985,1.0,3/9,18.67%,ANXA1;TGM2;SCARB1
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.5040002700312405,-1.1432657264690085,0.1717171717171717,0.7718988513616838,1.0,47/257,19.07%,PIK3R3;DOCK3;LBR;AKAP12;PKN3;BCAP31;PDE5A;MYO9B;KDM1A;CDKN1B;ARHGAP21;CDC37;ACTN1;PIK3R1;SPC25;GIT2;VAV3;DLC1;SLC4A7;RPS27;WIPF1;ARPC2;ARHGAP23;GNA13;GJA1;FGD4;NCK1;STK38;PAFAH1B1;TMEM59;STOM;PIK3C3;MYL6;PICALM;CTNNA1;SRRM1;VRK2;RASGRF2;FAM13A;ARHGAP29;MYH10;ARHGAP15;ARHGAP17;ERBIN;ITGB1;MYL12B;GRB2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6812981224621407,1.142977051870724,0.41379310344827586,1.0,1.0,3/7,20.50%,NKD1;SKI;SHROOM2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,-0.7948304345161319,-1.1429662075675018,0.3,0.7724882361822099,1.0,2/5,4.46%,NES;KDM1A
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.7770195786856485,-1.1429295705659235,0.2153846153846154,0.7720930565671439,1.0,2/5,11.85%,KCNMB4;ATP1B3
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.54417779434198,-1.1428488668990755,0.3058823529411765,0.7718409941028467,1.0,11/47,19.12%,SERPINE1;SMAD7;RPS27A;UBC;ITGB5;SMAD3;WWTR1;ITGB1;SMAD5;ACVRL1;PPM1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.5752554398268666,-1.142692603629663,0.24675324675324675,0.7717842609948958,1.0,5/31,10.49%,CD9;ALPL;PECAM1;CD55;ITGB5
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.5593624946293273,-1.1425005930070538,0.2682926829268293,0.7718475195376868,1.0,12/46,14.56%,VSIR;CX3CL1;SRGN;NPLOC4;ATP2B1;ANXA1;KLF4;TMSB4X;PRNP;ZFP36;TRIB2;CYLD
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6536689659943165,-1.1423627133525665,0.3026315789473684,0.7718133268918157,1.0,4/15,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.6399998927383623,-1.1422133679906497,0.22784810126582278,0.7718839667787505,1.0,9/25,28.18%,RAB11FIP3;PIK3C3;ECT2;CAV2;PRPF40A;RAB11A;CSNK2A1;RPRD1B;DYNC1H1
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.7139196423760367,1.1421423046982615,0.38235294117647056,1.0,1.0,1/5,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7975459022040056,1.1420814953970813,0.2857142857142857,1.0,1.0,2/5,3.59%,ZNRF3;RNF213
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.6619985898399143,-1.1419916671751593,0.3835616438356164,0.7721415082169136,1.0,5/10,20.13%,RPS27A;JAG2;UBC;EGFR;MIB1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.5724861636561523,1.141535046239275,0.2857142857142857,1.0,1.0,1/15,0.16%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.5906853541174365,-1.14153215658852,0.3048780487804878,0.7732284160195767,1.0,9/30,15.27%,PRKAG2;CDKN1B;SLC8A1;HYAL2;PAK2;NPM1;CDKN1A;TRIB2;WWTR1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,-0.6767877344685468,-1.1413763956636263,0.35,0.7732307472602193,1.0,2/9,8.76%,ANKRD37;TBC1D15
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.7015465602157318,-1.141234208577901,0.3225806451612903,0.773404768953608,1.0,3/6,16.41%,PRNP;TMED10;PICALM
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.7531039615661114,-1.1412165485335168,0.35384615384615387,0.7729370008810406,1.0,1/5,8.50%,PNP
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6959682952293902,-1.1410591393934482,0.2777777777777778,0.7730066159247232,1.0,3/10,9.77%,SSH1;HIP1R;TMSB4X
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7676320256270444,-1.1408647545733073,0.3076923076923077,0.7732102409037206,1.0,3/5,9.80%,BCAP31;NFE2L2;HERPUD1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.7380911630865498,-1.1407908162685996,0.3384615384615385,0.7729445496802206,1.0,2/5,21.97%,COL18A1;ADAM9
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.7377755597725435,-1.1406863794157351,0.3333333333333333,0.7728131344810397,1.0,1/5,6.27%,PIK3R1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.7485662197391607,-1.14066142284461,0.2711864406779661,0.7724216555237856,1.0,2/5,11.37%,SULF2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.7219671292067525,-1.1401300272689485,0.2878787878787879,0.7737174044453538,1.0,3/7,14.00%,CD81;PTTG1IP;MSN
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.6253904560637666,-1.139991915096403,0.32,0.7736822715748709,1.0,6/22,15.46%,CDKN1B;CCNH;CRLF3;CDKN1A;MAX;CDK6
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.7537605995231202,-1.1397962027216708,0.38333333333333336,0.7739811142295109,1.0,1/5,17.34%,KPNB1
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.5837912754274324,-1.139602327916013,0.27710843373493976,0.7741460794614515,1.0,9/33,9.19%,MGLL;LGALS3;S100A6;NFE2L2;EMP1;FOSL2;CD55;ANXA1;KLF4
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.5812846461081244,-1.1395583741494066,0.2682926829268293,0.7737846551112451,1.0,6/45,6.27%,PIK3R3;ITPR1;JUN;FOS;ESR2;PIK3R1
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.6924964198081328,-1.1394254304297693,0.3684210526315789,0.7737791944638646,1.0,2/7,12.96%,PECAM1;INPP5D
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.7392271289969656,-1.1393283696794332,0.36507936507936506,0.7736405205876522,1.0,1/6,9.40%,CCNH
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.7021119013892845,-1.1391244930143816,0.35384615384615387,0.7739679940149685,1.0,2/9,4.06%,HES1;NES
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.738448395337189,-1.1390995713298513,0.3148148148148148,0.7735115474476733,1.0,4/5,25.05%,CTNNA3;CACNA1C;DLG1;DSP
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.5700261120332203,-1.1390483618111498,0.3291139240506329,0.7731960446205733,1.0,6/37,8.84%,PSMC6;JUN;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.7508855105101242,-1.138752178225977,0.4,0.7732965909649824,1.0,3/5,22.50%,GJA1;CLTA;DNM2
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.7508855105101242,-1.138752178225977,0.4,0.7732965909649824,1.0,3/5,22.50%,GJA1;CLTA;DNM2
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.622466592201264,-1.1383391459607257,0.3466666666666667,0.7742793300436751,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.7089394717867721,-1.138335154374178,0.3333333333333333,0.7737726027334371,1.0,3/12,8.84%,RPS27A;CANX;UBC
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.4090751551000511,1.138188598019487,0.125,1.0,1.0,11/54,18.62%,FASTKD1;THOC1;NOVA1;BICD1;TENT2;RBMX;DDX17;PNPT1;PARN;HNRNPR;ADARB1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7510440279844552,-1.138138769767378,0.29508196721311475,0.7738628934383639,1.0,2/5,14.00%,LGALS3;MSN
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.7202104392223847,1.1380904168993278,0.30952380952380953,1.0,1.0,2/5,5.76%,HABP4;CHN1
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.624682329436468,-1.1380418703061486,0.32432432432432434,0.7736587622057707,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,-0.6048891778024839,-1.1378689977006082,0.2911392405063291,0.7738519484059073,1.0,7/26,12.03%,ADM;CLEC1A;BCL6;FOSL2;TNS1;KLF4;DYSF
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.5515198493054582,1.137652291430791,0.3783783783783784,1.0,1.0,2/9,7.84%,TAF3;TAF1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6722215815486,-1.137353505272767,0.323943661971831,0.7749119455247369,1.0,3/10,7.60%,BCAP31;HSPA5;ANK2
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.6219928012359287,-1.137178993966278,0.3287671232876712,0.7749278254329514,1.0,5/23,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,-0.6923594963636818,-1.1371338383844976,0.3582089552238806,0.7745474103692879,1.0,2/7,9.19%,NES;KLF4
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.736850143934846,-1.1371126913323577,0.3492063492063492,0.7741968254870101,1.0,4/5,26.37%,ABCA5;SCARB1;CLU;ABCG1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.614276792629269,-1.1369995549314842,0.3157894736842105,0.7741105359526885,1.0,5/23,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4898657376495213,1.1367635351075613,0.23333333333333334,1.0,1.0,5/20,12.88%,UIMC1;ATR;ERCC6;ATM;BABAM2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.75477480641136,-1.1366752402473164,0.31343283582089554,0.7747201471429497,1.0,2/6,10.15%,ARF1;PRNP
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.6391629004960308,-1.1363454888959408,0.4025974025974026,0.7752630916598983,1.0,7/20,17.48%,SMAD7;AFDN;PAK2;CADM2;TBCD;CTNNA1;PIP5K1C
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5798581960363317,-1.1362467310054716,0.3058823529411765,0.7751689629299011,1.0,12/45,26.22%,YTHDC1;RPL10;RPS27;RPS15;RPL24;STRAP;RPS28;RPS19;USP39;HSP90AA1;RPS14;EIF3A
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.638701894834822,1.136135721168124,0.34210526315789475,1.0,1.0,1/7,3.82%,H2AC6
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.7556100445238081,-1.1357512162233832,0.3484848484848485,0.776514991212056,1.0,2/7,18.49%,RAPGEF3;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.6955837267791591,-1.1355280158132735,0.296875,0.7768365616765279,1.0,3/9,9.93%,PTPRD;IL1RAPL1;TGM2
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6832403287600998,-1.135506443443842,0.3287671232876712,0.7764130803591787,1.0,6/11,28.95%,CD9;SYT1;TXNRD1;HSP90AA1;MAP2K1;SNAP25
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7151138789661893,-1.135465523356664,0.3787878787878788,0.7760047391661226,1.0,4/6,22.12%,SLC8A1;GJA1;CACNA1C;ATP1A1
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,-0.5858342485403281,-1.135403982081748,0.25,0.7757208719369002,1.0,13/39,23.27%,TINAGL1;TIMP3;EMP1;VWF;EPAS1;CFH;PLSCR4;NOTCH4;TIE1;ACVRL1;CD34;OMD;CDH5
prerank,KEGG_2021_Human__Thyroid cancer,-0.6052488803122922,-1.135311491138547,0.3194444444444444,0.7755393784801743,1.0,3/15,13.17%,PPARG;TPR;CDKN1A
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5515170634047085,-1.1351675245362023,0.24691358024691357,0.7754673415923596,1.0,16/51,19.60%,PLS3;NEDD9;PPP1R9A;EPS8;ACTN1;HIP1R;TPM1;MYO1B;NEBL;CASS4;BCAR1;SPIRE1;MYO1E;ARHGAP17;DLG1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6912325648913114,1.1350925496196287,0.4358974358974359,1.0,1.0,3/5,23.13%,STX3;PPM1F;PDGFB
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.7407355731040585,-1.1349694799175916,0.38095238095238093,0.7757519583425189,1.0,1/5,21.43%,SETD3
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.6300625377654253,-1.1348660071923522,0.391304347826087,0.7755562524470428,1.0,5/18,21.91%,ITPR1;PLCG2;PRKAR1A;ADCY2;AHCYL1
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.5660672909528819,-1.134853606249121,0.35,0.7750773726028065,1.0,14/34,25.10%,SCARB2;KIAA1217;LAMA5;COL18A1;SUN1;EPAS1;BCAR1;CTNNA1;DAG1;CADPS2;ATP1A1;TMEM50B;DSP;APLP2
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.7243280960232447,-1.1348506483682257,0.36065573770491804,0.7745845853460143,1.0,3/6,22.50%,GJA1;CLTA;DNM2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.6983367903042732,-1.13483073008432,0.36486486486486486,0.7741142074691306,1.0,1/9,5.71%,DUSP1
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.7264715466188152,-1.1347937214797654,0.3387096774193548,0.7737024621646393,1.0,2/7,8.84%,RPS27A;UBC
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,-0.7948358946630647,-1.1345749841622146,0.36538461538461536,0.7741030938356775,1.0,2/5,6.19%,NRG3;ERBB4
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6720442311018355,-1.1344698120475312,0.265625,0.7739309365075147,1.0,4/8,22.36%,SMAD7;CD55;MALT1;B2M
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.5056359220157682,-1.134029118180816,0.21505376344086022,0.7747942217059537,1.0,28/112,18.43%,PIK3R3;VSIR;RPL23;RIMS1;NFE2L2;KLF2;IFNGR1;MAGI2;HIF1A;ANK2;PRKN;KLF4;AFDN;LIMS1;RPS7;GJA1;PLCG2;RIMS2;CLDN5;MSN;SMAD3;PPHLN1;SLC38A2;NOS1AP;ATF2;ANK3;GATA2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7550366307845315,-1.1340066323128863,0.30303030303030304,0.7743686285337448,1.0,3/5,18.19%,DMD;ATP1B3;ANK3
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.6730547573471444,-1.1335694088377781,0.3283582089552239,0.7751726836364727,1.0,2/8,6.19%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7440199084841748,-1.133566853763077,0.25,0.7746751401938308,1.0,2/5,13.07%,TMSB4X;NFKBIA
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.5817094008264491,-1.1335181403952643,0.2777777777777778,0.7742576631124516,1.0,5/28,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,-0.6626461609208693,-1.1334010936144052,0.31343283582089554,0.7741149332669756,1.0,2/10,4.06%,SLC2A3;NES
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.5741851694780375,-1.1333436155451941,0.25,0.7738642140499862,1.0,5/23,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.7456846811709934,-1.1333067105940449,0.3235294117647059,0.7734624716718963,1.0,3/7,17.32%,KLF4;EPAS1;TSC22D1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.7290294538423648,-1.1332765541923484,0.28125,0.7730252320845178,1.0,2/7,9.16%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.652784778454737,-1.1330631451160758,0.2898550724637681,0.7732867236754892,1.0,7/14,19.76%,RTN4;IFNGR1;PRNP;TMED10;PICALM;SLC2A13;CLU
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7001967181727851,-1.1329762111476251,0.35294117647058826,0.7731091049902622,1.0,4/8,21.75%,RPS27A;UBC;USP45;RNF111
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.6508757455524875,1.1328438080914287,0.37142857142857144,1.0,1.0,1/6,11.00%,BCOR
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.5434757467486002,-1.1328244993833674,0.26744186046511625,0.7731833091642256,1.0,13/55,18.43%,MAP3K5;PRKAG2;HSPA5;LAMP2;SIK2;GABARAPL1;CDKN1A;CPEB4;LARS1;SREBF2;PIK3C3;ATF2;MTOR
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6845833300760082,-1.1324352562554005,0.36363636363636365,0.7743349991568783,1.0,4/10,17.48%,SYN3;RIMS1;SYT1;PIP5K1C
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6235305146223666,-1.1322504264333833,0.32894736842105265,0.774437044016929,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6803151787100679,-1.132220280718719,0.35384615384615387,0.774086951886579,1.0,5/8,25.07%,ANK2;CTNNA3;CACNA1C;DSP;CAMK2D
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.5820093996908176,-1.1321808885756057,0.358974358974359,0.7737229654473826,1.0,2/24,2.20%,PRKAG2;GLUD1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,-0.5595208141718316,-1.1319956933771549,0.2625,0.7739111919713594,1.0,14/39,13.31%,GRIN2B;NFASC;GRIA2;GPM6B;NPAS3;MAGI2;PTPRD;ANK2;LSAMP;PPFIA2;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,-0.6789296896920517,-1.1317731202006076,0.3076923076923077,0.774142145145719,1.0,3/7,20.35%,PIK3R1;GRB2;PIK3CB
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,0.5125054383111162,1.1316271218780944,0.3333333333333333,1.0,1.0,3/23,7.78%,MMRN1;RALGAPA2;CYYR1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.6328882752642024,-1.1314596406423345,0.36486486486486486,0.7745803422528967,1.0,1/18,0.90%,UFL1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,-0.5019085984953403,-1.131377341130463,0.12,0.7742813346425215,1.0,36/311,9.43%,SERPINE1;DDIT4;PSMC6;BTG2;NDRG1;LBR;PCK1;PRKAG2;NR4A1;RFC3;BNIP3L;ZNF43;PPARG;JUN;SLC2A3;GRIN2B;PSMB9;FOS;LGALS3;PPM1D;SMAD7;GRIA2;ESR2;RPS27A;CDKN1B;PSMA1;PBRM1;ELL2;BCL2L14;BCL6;SIN3B;UBC;KLF4;AFF4;CCNH;CNOT6L
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.502118352614299,-1.1311551491447307,0.19387755102040816,0.7746045288437249,1.0,14/128,10.49%,PSMC6;UFL1;SEC22B;SEC24D;PSMB9;HSPA5;RPS27A;CANX;RNF19A;PSMA1;PRKN;UBC;ARIH2;ITGB5
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.41687222885913033,1.1309601609380506,0.16666666666666666,1.0,1.0,7/60,8.42%,IVNS1ABP;THOC1;NOVA1;BICD1;TENT2;CDK12;WBP4
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.6123354650990486,-1.1308673630354933,0.3150684931506849,0.7751130268841067,1.0,5/22,16.49%,ATG12;RPS27A;UBC;CYLD;TBK1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6971954457509262,-1.130701588492908,0.2948717948717949,0.7751711661138994,1.0,3/8,13.68%,ARF1;HIF1A;RIOK3
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.6090449038443847,-1.130650442707681,0.2948717948717949,0.7749224785786855,1.0,4/19,8.84%,PRKAG2;RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.6978057687429138,-1.1306227174104262,0.32857142857142857,0.7745671669183588,1.0,4/10,8.15%,DTNA;DMD;SLC8A1;TPM1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7133001245452011,-1.130284872392307,0.2857142857142857,0.7752810193780038,1.0,6/8,24.99%,CX3CL1;LGALS3;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6996818110655478,-1.1301204555465496,0.3283582089552239,0.775353145767655,1.0,3/8,14.56%,RPS27A;UBC;CYLD
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.6466765139504682,-1.1299462218745127,0.29850746268656714,0.7753753706877718,1.0,8/14,22.66%,ADSS2;GMPS;UPP1;ENTPD4;TXNRD1;ADK;CMPK1;GUK1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7797502778626737,-1.1299354058112927,0.2833333333333333,0.7749140018486133,1.0,2/5,14.87%,DDX18;RPL7A
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.6604575740130959,-1.129907653745751,0.28125,0.7745171764809523,1.0,3/11,12.40%,RAPGEF3;PDE7A;RIMS2
prerank,KEGG_2021_Human__Ferroptosis,-0.6173731240583594,-1.1298157546724503,0.3924050632911392,0.7743481250168446,1.0,8/16,33.28%,PRNP;ACSL5;FTL;TF;SLC3A2;ACSL4;SLC7A11;TFRC
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.7220881367329759,-1.1295422784788063,0.3466666666666667,0.7747471114272134,1.0,2/8,4.86%,KCNMB4;DMD
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7445711092572113,-1.1292115106214882,0.34375,0.7742974748507052,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7445711092572113,-1.1292115106214882,0.34375,0.7742974748507052,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7445711092572113,-1.1292115106214882,0.34375,0.7742974748507052,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6402060411218559,1.1291986995157017,0.2571428571428571,1.0,1.0,2/7,5.10%,PRKD1;STXBP4
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7184087667761552,-1.1291800956358027,0.30434782608695654,0.773895454737528,1.0,4/7,9.11%,CX3CL1;LGALS3;FLT1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7236185815579854,-1.1291788866327492,0.3230769230769231,0.7734161094640127,1.0,6/7,25.07%,PRKCE;COMMD1;STK39;NEDD4;NEDD4L;CAMK2D
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.6160773772396568,-1.1284896079974218,0.3561643835616438,0.7751364654677209,1.0,5/18,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6805515285791427,-1.1282491063563265,0.373134328358209,0.7755261371449458,1.0,3/11,17.45%,PPARG;IL18R1;LCP2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,-0.6944387371009129,-1.127879339547214,0.35,0.7761413098529375,1.0,2/10,4.14%,B3GNT2;ATP2B1
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,-0.7556715849488512,-1.1277498999089663,0.375,0.776000531040597,1.0,4/6,19.42%,NRG3;ERBB4;GRB2;EGFR
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6580380889220642,-1.1276808094526984,0.32857142857142857,0.7757752886084106,1.0,4/12,16.65%,PRKN;ARIH2;SREBF2;PINK1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.6537895176333179,-1.127399545087769,0.35064935064935066,0.7761988288598528,1.0,4/21,8.84%,RPS27A;CANX;MGAT4A;UBC
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,0.6558153336989377,1.1272079345333472,0.47368421052631576,1.0,1.0,3/7,10.44%,OCLN;CDH2;TEK
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5561323618006353,-1.1271864368866733,0.25882352941176473,0.7765020823789569,1.0,6/38,7.60%,ADAMTS9;MAP1B;NES;TIMP3;SMARCA1;ANK2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5733017726777758,-1.1269770180025631,0.2926829268292683,0.7767204753590136,1.0,7/29,12.32%,SRGN;GAPDH;ATP2B1;POLA1;BCL6;ANXA1;BTNL9
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.6111780363216177,-1.1269194444575172,0.36,0.776389810524819,1.0,5/24,14.42%,SEC22B;GOLPH3;TMED10;RAB1A;COPA
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.5326479537197112,-1.126662865437055,0.3068181818181818,0.7768822218336171,1.0,6/53,8.84%,PSMC6;ITPR1;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.7173376919167909,-1.1266552111100796,0.4,0.7764113304649005,1.0,3/6,26.37%,ABCA5;SCARB1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.7357622347968988,-1.1266131659032341,0.3333333333333333,0.7760674322496997,1.0,2/6,8.15%,ADM;TPM1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.7384124183775208,-1.126092599487625,0.29577464788732394,0.77718373958812,1.0,1/5,5.05%,SPG7
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5918787685456826,-1.1259903285490775,0.2876712328767123,0.7769940919199316,1.0,7/29,15.46%,NEDD9;CX3CL1;RREB1;LIMS1;RSU1;CASS4;CDK6
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.7107621758386882,-1.1259765421536911,0.36486486486486486,0.7765383225590224,1.0,5/10,19.07%,RPS27A;UBC;SH3KBP1;SH3GL1;GRB2
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,-0.6692499042741562,-1.125952274758365,0.42857142857142855,0.7761461659298466,1.0,3/9,21.81%,NPM1;PRKAR1A;EML4
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,-0.7478502070877447,-1.125510844671524,0.296875,0.7771686383288968,1.0,4/6,24.67%,CDC37;ERBIN;GRB2;HSP90AA1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.39694600217234843,1.125256927534064,0.25,1.0,1.0,9/53,10.39%,IVNS1ABP;MLLT3;TAF3;ERCC6;BAZ2A;TAF1;FUBP3;RTF1;MTERF1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.7257992653848385,-1.1251346139247385,0.38461538461538464,0.777979949334507,1.0,3/8,14.50%,DUSP1;PPP2R2B;NCK1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7052033461124203,-1.1249516518318234,0.3582089552238806,0.7780630842048374,1.0,2/6,9.19%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.5511330390645229,-1.1249365987743114,0.32558139534883723,0.7776360164906191,1.0,6/36,8.29%,PSMC6;PPARG;PSMB9;LSS;PSMA1;SIN3B
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5624757377156925,1.124898856101182,0.3076923076923077,1.0,1.0,4/18,17.88%,TNRC6C;TCF7L2;PPP3CA;TNRC6A
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.7099073365279543,-1.1248790652894904,0.3787878787878788,0.7774189784740902,1.0,1/5,10.65%,SBNO1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.6241581618840306,-1.1246169118595974,0.3382352941176471,0.777851256428732,1.0,4/19,11.93%,RPL23;PRNP;SNX6;GJA1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.5149878081991089,-1.1245644029457713,0.30526315789473685,0.7775436832304319,1.0,24/90,23.16%,MAP3K5;BNIP3L;JUN;RPS27A;HIP1R;VAV3;BCL6;UBC;TGM2;RPS6;GNA13;FGD4;TNFRSF10B;RACK1;RASGRF2;ITGB1;CLU;GADD45B;ECT2;DUSP6;DNM2;MAPK8;BCLAF1;KALRN
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,-0.5761045771720162,-1.1244934174758352,0.3333333333333333,0.777285283418151,1.0,7/26,19.63%,SERPINE1;GJA1;PLSCR4;VEGFC;CALD1;EGFR;PLAT
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.70867870318422,-1.1242192854237336,0.34782608695652173,0.7777168416086788,1.0,4/5,26.43%,GATA2;PPP1R16B;JCAD;DLL4
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.6736212509894135,-1.1241632319928776,0.2972972972972973,0.7773820752354346,1.0,2/11,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6641128140817822,-1.1241418173138833,0.3181818181818182,0.7769711909156036,1.0,5/9,27.38%,HIP1R;SGIP1;PICALM;CLTA;FCHO2
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.6106744513956085,1.1240472312548622,0.2972972972972973,1.0,1.0,2/6,6.77%,IGFBP3;PPP1R13B
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.6369219170489286,-1.124033011647219,0.3333333333333333,0.7768319864148343,1.0,3/15,9.46%,PEBP1;RAP1A;VWF
prerank,Reactome_2022__Signal Transduction R-HSA-162582,-0.48675054124401734,-1.1240131191726561,0.08,0.7764358466052564,1.0,161/689,21.91%,PIK3R3;SERPINE1;LAMC1;PSMC6;ADM;ITPR1;DOCK3;LBR;PCK1;PRKAG2;MGLL;NR4A1;WNT2B;RTN4;AKAP12;PPARG;CX3CL1;PKN3;BCAP31;PDE5A;JUN;GRK5;NRG3;GRIN2B;PSMB9;FOS;GRM7;SPOPL;MYO9B;KHDRBS3;KDM1A;SMAD7;GPC5;RAD21;ESR2;RPS27A;CDKN1B;FES;JUND;ARHGAP21;CDC37;LRRC7;JAK1;PEBP1;ACTN1;ERBB4;PIK3R1;LAMA5;PSMA1;SPC25;CNTN1;PRKCE;GIT2;RAPGEF3;FLT1;PDE7A;HIF1A;VAV3;JAG2;RAP1A;UBC;CD55;ANXA1;CNOT6L;VWF;DLC1;SLC4A7;S1PR1;RPS27;DUSP16;ITGB5;RPS6;WIPF1;DGKG;SHC2;EPAS1;FGFR1;ARPC2;ARHGAP23;GNA13;GJA1;MEF2A;PLCG2;FGD4;DUSP5;NFKBIA;TEC;CDKN1A;BCAR1;SH3KBP1;TNFRSF10B;RGS7;VEGFC;NCK1;CYLD;SMAD3;STK38;WWTR1;PAFAH1B1;SMC3;TMEM59;PPP3CC;RACK1;SH3GL1;STOM;PIK3C3;USP34;CHD1;RCOR1;MYL6;PICALM;CTNNA1;SRRM1;VRK2;NOTCH4;RASGRF2;FAM13A;B4GALT1;ARHGAP29;MYH10;PIP5K1C;ZDHHC21;FKBP5;ARHGAP15;ARHGAP17;ERBIN;PDE10A;DLG1;MTOR;ITGB1;SMAD5;ACVRL1;MYL12B;GRB2;PPM1A;BOC;EGFR;PLAT;PSMA7;DYNC1I2;MIB1;ECT2;GNAI3;CAV2;PIK3CB;SPRED1;PCDH7;XIAP;KLC1;SOCS3;TRA2B;DUSP6;CBFB;PRKAR1A;VAPB;ADCY2;CUL1;SPARC;RNF111;GLI3;AHCYL1
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.6652566345163465,-1.1237990263392261,0.32786885245901637,0.7766721501121097,1.0,1/10,0.61%,ANGPTL4
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.6197044618361089,-1.1237593585907824,0.36619718309859156,0.7763390597705317,1.0,8/15,30.23%,PIK3R1;BCAR1;NCK1;GRB2;PIK3CB;STAT5B;CRK;STAT3
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.7395285461782111,-1.1234592902100864,0.359375,0.776790147653012,1.0,1/7,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7058907208776928,-1.1234405914496077,0.3142857142857143,0.7759380101596689,1.0,6/10,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7058907208776928,-1.1234405914496077,0.3142857142857143,0.7759380101596689,1.0,6/10,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.6964411702980084,-1.1232599236345522,0.2876712328767123,0.7760215827798453,1.0,2/8,4.70%,B3GNT2;GPC5
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5807175372131242,1.1232389174814401,0.2926829268292683,1.0,1.0,1/10,1.12%,HABP4
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.5326100373175489,-1.1231341201685772,0.30120481927710846,0.7759251600809143,1.0,10/46,10.20%,SLCO4A1;SLC6A6;SLC2A3;SLC4A10;SLC20A2;SLC8A1;SLC2A1;SLC30A7;SLC4A7;SLC26A2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.6123687636420081,-1.1230626951237062,0.36363636363636365,0.7756075855754732,1.0,2/16,5.42%,MAP2;FES
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,-0.6994488601095736,-1.1228543261201536,0.2786885245901639,0.7757326698311149,1.0,1/5,6.43%,LAMA5
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.5663640792968134,-1.1227743689449687,0.3068181818181818,0.7755537273077342,1.0,10/32,16.65%,UFL1;SPOPL;SMAD7;NDFIP1;COMMD1;PRKN;OGT;PTTG1IP;MALT1;PINK1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.5719909070865459,-1.1227277748313877,0.36,0.7752438666470902,1.0,6/21,25.02%,CD9;CD55;ITGB1;CD34;CD63;SLC3A2
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.5284946017112249,-1.12254467771363,0.29411764705882354,0.775444819062343,1.0,14/66,18.09%,LBR;MYO9B;ARHGAP21;PIK3R1;GIT2;VAV3;DLC1;WIPF1;GNA13;FGD4;STOM;RASGRF2;ARHGAP29;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.6948585688826456,-1.1225149414303133,0.36363636363636365,0.7750733628771387,1.0,6/10,24.67%,NOSTRIN;NOS1AP;ZDHHC21;EGFR;DNM2;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7406027566667659,-1.1221437642280174,0.359375,0.7756668640682228,1.0,3/5,19.60%,RAP1A;CD34;EMP2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5284069825546214,-1.1219494267775412,0.32941176470588235,0.7757914530431144,1.0,15/52,19.60%,EHD4;KCNIP4;ANK2;RAP1A;PACS1;CD81;AFDN;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.6192280330384771,-1.1219039749562687,0.35714285714285715,0.7755236793782022,1.0,6/25,20.53%,RAB11FIP3;PRKCE;PIK3C3;CSPP1;ECT2;PRPF40A
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.5258770075955763,-1.1218807206806447,0.32098765432098764,0.7750911925535665,1.0,8/38,15.27%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;CDKN1A;SMAD3;WWTR1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,-0.5682080994834885,-1.1218588141894672,0.3246753246753247,0.7747485760544025,1.0,12/33,19.18%,LRRC32;FLT1;PECAM1;TNS1;VWF;PLXDC2;DYSF;CLDN5;NOTCH4;TIE1;ACVRL1;CD34
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.7362576728062253,-1.1217741322981754,0.3225806451612903,0.7746467677267576,1.0,3/6,19.42%,FLT1;FGFR1;EGFR
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.7298340963123748,1.1210775022854436,0.3548387096774194,1.0,1.0,1/5,1.12%,HABP4
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,-0.7382886176038304,-1.1209830550422295,0.32,0.7762614014446018,1.0,1/5,6.43%,LAMA5
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,-0.7382886176038304,-1.1209830550422295,0.32,0.7762614014446018,1.0,1/5,6.43%,LAMA5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5849300840282693,-1.1209366756833405,0.33783783783783783,0.7759257626443908,1.0,4/24,6.48%,PSMC6;PSMB9;CDKN1B;PSMA1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5950713359353297,-1.1209173756201298,0.3150684931506849,0.7755357198764383,1.0,11/20,26.77%,TIMP3;FOXF1;TPM1;MSRB3;ADAMTS1;VEGFC;CALD1;PLAT;NID1;SERPINH1;LAMA4
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5257371365381436,-1.1207556838196262,0.2727272727272727,0.7756049273712927,1.0,5/49,6.24%,ADAMTS9;SRGN;TINAGL1;SPG7;GGT5
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.5757841618524712,-1.1201903355247373,0.3037974683544304,0.7768305577464918,1.0,9/41,15.72%,JUN;FOS;RPS27A;UBC;ALPK1;MEF2A;NFKBIA;PELI1;PIK3C3
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,-0.6749778893205749,-1.120006242722427,0.323943661971831,0.7769878025236144,1.0,6/13,14.98%,MAP2;MAP1B;GRIA2;DCLK1;SYT1;EFR3B
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5764771252011182,-1.119719214062699,0.30120481927710846,0.7774797677710563,1.0,9/36,11.93%,SLC6A6;CX3CL1;ALPL;TIMP3;EMP1;HIF1A;EFNB2;FGFR1;GJA1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5213360669645266,-1.1196782238473255,0.29411764705882354,0.777151442436288,1.0,14/49,19.60%,EHD4;KCNIP4;ANK2;RAP1A;PACS1;CD81;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;ANK3;DLG1;EMP2
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.6042385860165225,-1.1194744340507268,0.33783783783783783,0.7771989803533624,1.0,5/21,16.60%,PDE5A;CDC37;ACTN1;STK38;SRRM1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6926503107867433,1.1194196577932538,0.3783783783783784,1.0,1.0,1/5,10.04%,TMTC4
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5776905176622633,-1.1193852735711216,0.32432432432432434,0.7769530931597977,1.0,7/21,20.29%,SMIM3;TINAGL1;EMP1;WWTR1;EGFR;CD109;CAV2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.602120568464697,-1.119265369626297,0.37142857142857144,0.7769188732201451,1.0,3/21,8.34%,ITPR1;SCARB2;PRKN
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,-0.6084211691456789,-1.119257675747156,0.3372093023255814,0.776489468785659,1.0,3/16,15.41%,PBX3;SERPINB6;UPP1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.615359685301906,-1.119177325424934,0.35526315789473684,0.7762853177812037,1.0,5/21,13.17%,CDKN1B;CDC37;IPO7;CCNH;CDKN1A
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.5993458255367319,1.119121223533043,0.35294117647058826,1.0,1.0,4/8,21.27%,PPP2R5A;PPP2R5E;YES1;AKT3
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5984607781516529,-1.1190303913538437,0.38961038961038963,0.7762992056451918,1.0,9/26,17.48%,CD9;SMAD7;CTNND2;GJA1;PAK2;CLDN5;TBCD;CTNNA1;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7400504846298909,-1.1189699765694643,0.38095238095238093,0.7761022181994822,1.0,3/5,25.07%,SLC8A1;ANK3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.6858044722499972,-1.1188280469423397,0.3194444444444444,0.7761229976386085,1.0,4/10,14.50%,PRKN;HERPUD1;TMBIM6;NCK1
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,-0.5879770906211228,-1.1186517711056183,0.3466666666666667,0.773336704710976,1.0,6/30,7.60%,DOK5;SPOCK1;MAP1B;NES;NFASC;ANK2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6554115959361716,-1.1186463334657346,0.3380281690140845,0.7728787241940673,1.0,6/16,15.19%,PPARG;GGT5;ACSL5;PON2;ACOX1;LPIN2
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,-0.694317786772866,-1.1184792982469545,0.4,0.7724711858650631,1.0,5/9,25.05%,LAMA5;CTNNA1;DAG1;EGFR;DSP
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,-0.694317786772866,-1.1184792982469545,0.4,0.7724711858650631,1.0,5/9,25.05%,LAMA5;CTNNA1;DAG1;EGFR;DSP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.5339489686995903,-1.118297500078001,0.2891566265060241,0.7726493236267608,1.0,14/36,22.97%,LGALS3;PIK3R1;PRKCE;PRKN;CD81;PRNP;DPP10;PPP3CC;ANK3;DLG1;ITGB1;EGFR;MAPK8;PRKCH
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.6071104286330309,-1.1182892330899015,0.2692307692307692,0.7721996023590887,1.0,5/19,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.6249473088156818,-1.1182869956358599,0.38666666666666666,0.7717436751704821,1.0,4/16,16.73%,EHD4;RAB11FIP3;ACAP2;RAB14
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6950586756117553,-1.1181347136633701,0.3188405797101449,0.7718747430072609,1.0,3/9,14.56%,RPS27A;UBC;CYLD
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.5477533965588222,-1.11774760149748,0.3048780487804878,0.7726591196101025,1.0,12/35,21.81%,RRBP1;PIK3R1;RPS6;TPR;NPM1;MSN;MECP2;GRB2;KLC1;PRKAR1A;CUL1;EML4
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.5540816473412249,-1.117464836907398,0.29333333333333333,0.7730183959728579,1.0,10/33,18.75%,NEDD9;LAMA5;ITGA10;ADAMTS1;ITGB5;TEC;BCAR1;ERBIN;ITGB1;ADAM15
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.7086982977126729,-1.1173996365019878,0.373134328358209,0.7727111009753982,1.0,3/8,18.73%,ACTN1;ITGB5;ITGB1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7411619786047999,-1.1171581122509746,0.32786885245901637,0.7730631923568718,1.0,2/5,18.83%,TIE1;ACVRL1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6794007338667004,1.1171115283443571,0.3333333333333333,1.0,1.0,2/6,15.64%,MFF;PNPT1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.6006548666879344,-1.1170924512868636,0.3108108108108108,0.7728368855913581,1.0,5/27,16.12%,MAP3K5;RPS27A;UBC;ZFP36;SH2D3C
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.5721243197053809,-1.11676213775513,0.3333333333333333,0.7734437149003182,1.0,8/27,13.33%,PSMC6;PSMB9;SMAD7;RPS27A;PSMA1;UBC;OGT;FOXK1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.5393240899806006,-1.1166725170602263,0.31521739130434784,0.773251014404251,1.0,20/50,24.67%,NDRG1;BNIP3L;RTN4;ACTN1;BCL2L14;BCL6;PRKN;TGM2;BCAR1;TNFRSF10B;MALT1;PINK1;CLU;ACER2;ZNF420;PHLPP1;CALR;CHM;ACER3;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.52030800102189,-1.1165116979533787,0.26373626373626374,0.7732396772958563,1.0,18/73,20.35%,UFL1;ITPR1;PRKAG2;GAPDH;EEF1A1;RB1CC1;PRKN;SNX6;FOXK1;DHRSX;TMEM59;SREBF2;MCL1;PINK1;PSAP;MTOR;ACER2;PIK3CB
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.48643852247753794,1.1163613496501366,0.30434782608695654,1.0,1.0,5/20,10.44%,PODN;LDB2;PDZRN3;FBXL7;TEK
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.7095097351637216,-1.1163578953934672,0.41935483870967744,0.7732417630125759,1.0,1/6,2.42%,CLIC2
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.5345493347176672,1.116321732593018,0.3333333333333333,1.0,1.0,2/12,7.84%,TAF3;TAF1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.564504884599333,-1.1160221733187536,0.36470588235294116,0.7739206138546709,1.0,7/48,12.56%,DDIT4;PBX3;GRIN2B;NES;SMARCA1;SYNJ2;ADGRL3
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,-0.7629693070394943,-1.115588389645223,0.3076923076923077,0.7747593774202123,1.0,3/7,13.07%,RPS27A;UBC;NFKBIA
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.7158504380212394,-1.1155275261782935,0.3333333333333333,0.774499540535448,1.0,3/9,15.03%,WNT2B;SULF2;CREB3L2
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.7329733787556656,-1.1153301607539174,0.36363636363636365,0.7746614021188881,1.0,3/7,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.6774826462821261,1.1151381763674515,0.3783783783783784,1.0,1.0,4/5,32.30%,PDCD4;PDGFB;NFATC3;NFATC2
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.7068363011057219,-1.1151374081725391,0.40625,0.7739306529358562,1.0,1/6,1.78%,RFC3
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.7068363011057219,-1.1151374081725391,0.40625,0.7739306529358562,1.0,1/6,1.78%,RFC3
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.7068363011057219,-1.1151374081725391,0.40625,0.7739306529358562,1.0,1/6,1.78%,RFC3
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.7331253096510367,-1.1149052179189545,0.30985915492957744,0.7741925609389108,1.0,4/7,25.37%,NPM1;CENATAC;CHMP4B;ALMS1
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.5674515197243638,-1.1148714525540047,0.32432432432432434,0.7738739632227578,1.0,10/36,15.96%,FOS;JAK1;PIK3R1;LAMA5;HIF1A;BCL6;ANXA1;S1PR1;CDKN1A;MCL1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5270588592543564,-1.1148465469723818,0.3372093023255814,0.7734357734125162,1.0,11/58,12.88%,SERPINE1;CX3CL1;SMAD7;MAGI2;TPM1;DLC1;AFDN;HYAL2;TMEFF2;GJA1;CLDN5
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.5444599179089054,-1.114617666799706,0.3373493975903614,0.7738973399319973,1.0,4/49,3.67%,ITPR1;PRKAG2;JUN;FOS
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,-0.5707919310640492,-1.114571421775973,0.35714285714285715,0.7735794820231509,1.0,5/32,13.78%,SERPINE1;TIMP3;EMP1;ARHGAP23;PLSCR4
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5630196068393745,-1.1145680453811249,0.36585365853658536,0.7731355900415472,1.0,7/39,13.23%,SEC22B;CDKN1B;KLF2;PRKN;KLF4;NFKBIA;RAB1A
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.7632835220950708,-1.1145227569686018,0.34375,0.7723889294360511,1.0,1/5,12.01%,CSTF3
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.7632835220950708,-1.1145227569686018,0.34375,0.7723889294360511,1.0,1/5,12.01%,CSTF3
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.63000983461766,-1.1143310478413933,0.323943661971831,0.772623945380802,1.0,4/13,21.83%,WNT2B;CDKN1A;GADD45B;GLI3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.5602121233784924,-1.113945343390141,0.29069767441860467,0.773177282049436,1.0,5/34,12.70%,RAPGEF5;PPP1R9A;HIP1R;SHC2;NEBL
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.538644186251641,-1.1138624388822562,0.3333333333333333,0.7730201773492716,1.0,5/53,6.27%,PIK3R3;ITPR1;JUNB;FOS;PIK3R1
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.6135493063536747,-1.1137588408628587,0.3924050632911392,0.7728831466085447,1.0,3/17,5.66%,SEC24D;HSPA5;CANX
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.5831457645185216,-1.1137080794036829,0.4177215189873418,0.7726203882012836,1.0,6/29,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;REL;UBC
prerank,KEGG_2021_Human__Circadian entrainment,-0.587163221687568,-1.11368203038298,0.32926829268292684,0.7722387458378263,1.0,4/31,4.59%,ITPR1;GRIN2B;FOS;GRIA2
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7292664017973083,-1.1134122612472057,0.39655172413793105,0.7727906824571951,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7552829467566771,-1.1133159961141381,0.3770491803278688,0.7726276523742562,1.0,2/5,19.81%,PIK3R1;GIGYF2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.6469131734042906,-1.113144686104004,0.358974358974359,0.7727292206725047,1.0,1/10,1.46%,TSG101
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.6632255344915099,-1.1130605887391505,0.32432432432432434,0.7725399928334925,1.0,5/14,19.07%,RPS27A;UBC;SH3KBP1;SH3GL1;GRB2
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,-0.5595481692060308,-1.113011667026458,0.3902439024390244,0.770470804213542,1.0,16/47,12.75%,MAP2;MAP1B;NFASC;GPM6B;NPAS3;CNTN1;PTPRD;ANK2;LSAMP;STOX2;PPFIA2;GJA1;DCLK1;ATRNL1;ADGRL3;PLP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,-0.5595481692060308,-1.113011667026458,0.3902439024390244,0.770470804213542,1.0,16/47,12.75%,MAP2;MAP1B;NFASC;GPM6B;NPAS3;CNTN1;PTPRD;ANK2;LSAMP;STOX2;PPFIA2;GJA1;DCLK1;ATRNL1;ADGRL3;PLP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,-0.5595481692060308,-1.113011667026458,0.3902439024390244,0.770470804213542,1.0,16/47,12.75%,MAP2;MAP1B;NFASC;GPM6B;NPAS3;CNTN1;PTPRD;ANK2;LSAMP;STOX2;PPFIA2;GJA1;DCLK1;ATRNL1;ADGRL3;PLP1
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,-0.5595481692060308,-1.113011667026458,0.3902439024390244,0.770470804213542,1.0,16/47,12.75%,MAP2;MAP1B;NFASC;GPM6B;NPAS3;CNTN1;PTPRD;ANK2;LSAMP;STOX2;PPFIA2;GJA1;DCLK1;ATRNL1;ADGRL3;PLP1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,-0.5595481692060308,-1.113011667026458,0.3902439024390244,0.770470804213542,1.0,16/47,12.75%,MAP2;MAP1B;NFASC;GPM6B;NPAS3;CNTN1;PTPRD;ANK2;LSAMP;STOX2;PPFIA2;GJA1;DCLK1;ATRNL1;ADGRL3;PLP1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.584227895842754,1.112718060386633,0.3125,1.0,1.0,1/6,4.94%,GNB4
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5401552652500514,-1.1126639571056431,0.2948717948717949,0.7711130333803368,1.0,13/45,13.31%,UFL1;ZEB2;GRIN2B;NFASC;GRIA2;GPM6B;NPAS3;MAGI2;LSAMP;PPFIA2;GJA1;PLP1;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.7125417898240278,-1.1125112421322483,0.34782608695652173,0.7711229022797302,1.0,3/8,18.19%,ANK2;TMSB4X;ANK3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.5932140029728865,1.112464543507587,0.2894736842105263,1.0,1.0,3/10,8.87%,RSAD2;FBXO7;SLC25A37
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.49446376068047837,-1.1122160823795115,0.27472527472527475,0.7715404358904818,1.0,29/104,14.37%,SPNS2;MGLL;SRGN;CD9;APOLD1;LRRC32;CAVIN2;TIMP3;GGT5;FOXF1;EMP1;FLT1;SLC2A1;PECAM1;SCARF1;TNS1;CD55;VWF;ADAMTS1;HYAL2;GPM6A;EPAS1;CFH;BTNL9;PLEC;CLDN5;NOSTRIN;PLSCR4;VEGFC
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.6594097029753474,-1.1118958260021263,0.4090909090909091,0.7716515889317611,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6594097029753474,-1.1118958260021263,0.4090909090909091,0.7716515889317611,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.5035592634041186,-1.1116696158765413,0.29545454545454547,0.7720483921278134,1.0,13/71,15.51%,PSMC6;BCAP31;PSMB9;RPS27A;CDC37;PSMA1;UBC;OGT;PLEC;PELI1;TNFRSF10B;SDCBP;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5959281777824266,1.1109361175907835,0.3,1.0,1.0,3/12,8.13%,PRKD1;IL6R;HSPB1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,-0.733319478323077,-1.1108090197115594,0.36666666666666664,0.7746095644982968,1.0,1/6,5.42%,FES
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.6553221757322235,-1.1106582358540729,0.3333333333333333,0.7746173624923237,1.0,6/9,23.21%,GPC5;SLC26A2;B4GALT1;CHSY1;OMD;GPC3
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.5277978718917521,-1.1103581464512624,0.3076923076923077,0.7749003546866753,1.0,13/83,9.16%,PRKAG2;GRIK1;SYN3;GLUL;GRIN2B;KCNMB4;RIMS1;GRIA2;LRRC7;ERBB4;PTPRD;NCALD;IL1RAPL1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.6277597909804438,-1.1101436447485635,0.375,0.7750520446844669,1.0,5/16,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,-0.735120947949965,-1.109741996011446,0.40625,0.7760020287625733,1.0,2/6,18.43%,RPS6;MTOR
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.6004605735701618,-1.1097128313301818,0.345679012345679,0.7756688656095143,1.0,4/17,8.84%,RFC3;RPS27A;POLA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4932138809327727,-1.1096737037344717,0.2736842105263158,0.7753687755976753,1.0,21/106,16.65%,PIK3R3;PRKAG2;CX3CL1;ENPP2;ERBB4;RB1CC1;RAPGEF3;PECAM1;RAP1A;CD81;PRNP;PLCG2;PAK2;TEC;CDKN1A;SDCBP;VEGFC;RACK1;SH2D3C;TBK1;PINK1
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.7501050535745353,-1.10942967796461,0.423728813559322,0.7752463047584741,1.0,1/5,9.40%,CCNH
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.7501050535745353,-1.10942967796461,0.423728813559322,0.7752463047584741,1.0,1/5,9.40%,CCNH
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5846245735911154,1.1093330057414714,0.36,1.0,1.0,3/12,8.37%,HOMER1;CTNNA2;FBXO7
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,-0.6963832959242668,-1.1091347916732035,0.421875,0.7757627152699674,1.0,2/6,16.44%,PSMA1;STRAP
prerank,CellMarker_Augmented_2021__Stem cell:Liver,-0.702050244228968,-1.108954477232929,0.3770491803278688,0.7759002462644464,1.0,3/7,19.18%,NES;DCLK1;CD34
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.629487702030954,-1.1088744676076554,0.32432432432432434,0.7757312573301419,1.0,3/15,4.57%,UFL1;SPOPL;SMAD7
prerank,KEGG_2021_Human__African trypanosomiasis,0.6585492390529785,1.1086113813448253,0.375,1.0,1.0,1/6,4.97%,PLCB4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6108582957763511,-1.1084995515728238,0.3448275862068966,0.7765201013185099,1.0,8/25,19.76%,CX3CL1;LGALS3;PRKN;HERPUD1;TMBIM6;MCL1;PINK1;CLU
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,-0.7240600225734227,-1.1084826176349858,0.359375,0.7761230723394934,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5094148997668874,1.108146866371642,0.3225806451612903,1.0,1.0,7/16,15.09%,UIMC1;MGMT;ERCC6;SLF2;BABAM2;SPIDR;FAM168A
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.5360589268707754,-1.1079964799341353,0.325,0.7772101002743697,1.0,2/25,4.20%,YTHDC1;KHDRBS3
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.566501804928868,-1.1079243686545195,0.32,0.7768911704021708,1.0,13/30,30.20%,GRIA2;MAGI2;LSAMP;PPFIA2;RNPC3;SGIP1;CADM2;SCN2A;KIF1B;CNTNAP2;SLC1A2;SNAP25;GRIA4
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,-0.7457457742692029,-1.107875504418404,0.39655172413793105,0.7766116057766195,1.0,2/5,13.17%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5232705697788124,-1.1076962050103651,0.32978723404255317,0.7767415956677844,1.0,17/74,16.65%,UFL1;CX3CL1;GAPDH;NDFIP1;REL;SHISA5;PRKN;ALPK1;GJA1;PLCG2;SLC20A1;RIOK3;PELI1;TNFRSF10B;MALT1;TBK1;PINK1
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,-0.7423505031543435,-1.1076586697425854,0.38461538461538464,0.776455947754696,1.0,3/6,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.6650609762131474,-1.1073414180882815,0.3787878787878788,0.7770660084797412,1.0,2/9,8.34%,MTFR1;PRKN
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.5846344780196253,-1.1073099311687642,0.40540540540540543,0.7767221421114915,1.0,5/24,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.6247957635249437,-1.107307978261229,0.3582089552238806,0.7762814598906874,1.0,1/18,1.01%,ADM
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,-0.5313203956089312,-1.107251620881062,0.325,0.7760615047124542,1.0,10/45,9.85%,ADAMTS9;ENPP2;LRRC32;PTPRD;FLT1;TMEM132C;SLC8A1;TNS1;VWF;PLXDC2
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.6470893849916087,-1.1072209926348422,0.30303030303030304,0.7756670225341256,1.0,3/11,15.46%,CDKN1B;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.7290236431304572,-1.1071463298076056,0.36666666666666664,0.7755835351511717,1.0,2/5,26.37%,STARD4;ABCG1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.6311462055694013,1.1070493711047429,0.4411764705882353,1.0,1.0,1/6,1.65%,PLA2G4A
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.6413159738471463,1.1068633277371853,0.36666666666666664,1.0,1.0,1/6,4.94%,GNB4
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,-0.5824382282706616,-1.1067728027939563,0.3717948717948718,0.7762372557959627,1.0,6/29,7.92%,ITPR1;PDE5A;ATP2B1;KCNMB4;SLC8A1;PECAM1
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,0.563776618956443,1.1065861471370018,0.391304347826087,1.0,1.0,2/13,1.86%,COL8A1;GBP1
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6991006421181993,-1.1059569398874178,0.37142857142857144,0.7782731332821646,1.0,2/8,12.70%,CCDC60;NEBL
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.7514772359940756,-1.1059399212202774,0.41379310344827586,0.7778847460118787,1.0,1/5,11.02%,FGFR1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,-0.6976205992511233,-1.1059067222292756,0.35064935064935066,0.7775484423259622,1.0,4/8,22.87%,CLEC1A;PECAM1;NOTCH4;CPM
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.7029114874047304,-1.1058497361482018,0.3424657534246575,0.7772641326824358,1.0,5/11,19.07%,RPS27A;UBC;SH3KBP1;SH3GL1;GRB2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6807355290513293,1.1057307824968332,0.375,1.0,1.0,2/5,15.64%,MFF;PNPT1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.5693128293251543,-1.105433930327452,0.36363636363636365,0.7781148874973679,1.0,6/29,18.67%,SERPINE1;GGT5;ZFP36;PELI1;ERBIN;SCARB1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.43759376615065604,1.1053234906600427,0.2777777777777778,1.0,1.0,2/29,2.31%,EVI5;TBC1D5
prerank,KEGG_2021_Human__Cocaine addiction,0.5502737806538717,1.105313418718392,0.3333333333333333,1.0,1.0,1/13,0.03%,CREB5
prerank,KEGG_2021_Human__Legionellosis,-0.6889520427430993,-1.1052499728306586,0.3611111111111111,0.7783074120797476,1.0,5/12,13.23%,SEC22B;EEF1A1;ARF1;NFKBIA;RAB1A
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5617838651360293,1.1051581968383604,0.3548387096774194,1.0,1.0,3/9,12.88%,UIMC1;ATM;BABAM2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7102494281823922,-1.1049322337332417,0.41935483870967744,0.7786027564241602,1.0,5/7,25.66%,RPS27;RPS15;RPS28;RPS19;RPS14
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7461683304604378,-1.1046386852908197,0.4482758620689655,0.7792067064237508,1.0,3/5,24.89%,CFL1;RACK1;NR2C2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.6548239662868509,-1.1045386333422085,0.3898305084745763,0.7790509143662916,1.0,2/9,10.81%,MGLL;DGKG
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5839161628405822,-1.104374662002841,0.3448275862068966,0.7791203141673341,1.0,9/29,21.49%,CDC37;JAK1;IFNGR1;IFNGR2;CYLD;RACK1;VRK2;SOCS3;CBFB
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7353211226745769,-1.1039515334839118,0.42424242424242425,0.7798385899857637,1.0,4/5,25.07%,COMMD1;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6739135860040624,-1.1038955340887557,0.3582089552238806,0.779599222841674,1.0,5/10,22.79%,RIMS1;RIMS2;SYT1;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6996503648396023,-1.1037929457056126,0.3787878787878788,0.7795526678250274,1.0,2/6,12.40%,RIMS1;RIMS2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.46400620442625495,1.1037590508608388,0.30434782608695654,1.0,1.0,8/25,14.56%,UIMC1;INO80;ATM;XRRA1;COP1;BABAM2;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7337433293217099,-1.1034873713867084,0.35384615384615387,0.7800193111422983,1.0,3/5,13.92%,PRKN;RPS7;PTTG1IP
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.5133574874451492,-1.1031418840136644,0.29473684210526313,0.7807033855238695,1.0,26/113,19.81%,CCDC3;BTG2;SRGN;GAPDH;ATP2B1;PPM1D;NDFIP1;HIF1A;REL;PRKN;KLF4;RPL13A;ZFP36;TMBIM6;CLDN5;PPHLN1;RACK1;PICALM;PINK1;PTBP2;DCP2;GATA2;ACVRL1;MECP2;CD34;GIGYF2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6593580570400802,-1.1031132684165765,0.4090909090909091,0.7803487448628136,1.0,5/10,19.63%,TIMP3;PRNP;CST3;TMEM59;PLAT
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5909842771964787,-1.1030831070573919,0.35064935064935066,0.780026524511312,1.0,6/22,8.02%,GRIN2B;GRIA2;DMD;LRRC7;ANK2;AHNAK
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.5352215904202778,-1.1028390552709157,0.35294117647058826,0.7803894416073469,1.0,11/45,9.77%,SERPINE1;SYTL4;SRGN;CD9;HSPA5;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.553225025937585,1.102524517570969,0.43902439024390244,1.0,1.0,2/9,9.48%,PLA2G4A;GPD1L
prerank,KEGG_2021_Human__Cholinergic synapse,-0.5801086073358911,-1.1024228639047022,0.34523809523809523,0.7813084064328273,1.0,4/33,6.27%,PIK3R3;ITPR1;FOS;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.6913432914553039,-1.102149906795923,0.30357142857142855,0.7817213231202794,1.0,3/6,18.67%,PPARG;SREBF2;SCARB1
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.5974576695472407,-1.1020611206146875,0.2948717948717949,0.7816546086065441,1.0,5/21,16.49%,JUN;FOS;JUND;NFKBIA;TBK1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7056420317738515,1.1015355590176614,0.4411764705882353,1.0,1.0,3/5,21.86%,PIAS1;HDAC4;UBA2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.7183443764031334,-1.100832840264977,0.3880597014925373,0.7850998350713796,1.0,3/7,6.37%,LBR;PRKAG2;LSS
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.5589453420585726,-1.1008020098760196,0.36363636363636365,0.7847249646265114,1.0,8/29,19.42%,CDC37;ERBB4;PIK3R1;KIF16B;BCAR1;ERBIN;GRB2;EGFR
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.6197278810365167,-1.1007902137089638,0.41025641025641024,0.7842931171956463,1.0,5/20,17.24%,ATF3;HSPA5;HERPUD1;CREB3L2;DCP2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.5582233788879291,-1.1006062199716353,0.3493975903614458,0.7844800720176842,1.0,12/37,26.72%,RFC3;ERBB4;FLT1;KLF4;FGFR1;PINK1;TIE1;EGFR;HSP90AA1;ARRDC3;TNKS;CD74
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5918116519038827,-1.1004447931878378,0.3888888888888889,0.7846222199457389,1.0,4/21,7.68%,PSMC6;PSMB9;PSMA1;REL
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.7055756226973962,-1.100247331793507,0.3382352941176471,0.7848087771363323,1.0,2/6,18.73%,PECAM1;ITGB1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,-0.7444236118573545,-1.0998051989909194,0.36666666666666664,0.7857523861697924,1.0,3/5,23.27%,PECAM1;CD34;CDH5
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.564372017639698,-1.0996961276490358,0.42105263157894735,0.7856518959668967,1.0,7/25,16.65%,SMAD7;NDFIP1;WDR48;COMMD1;PTTG1IP;MALT1;PINK1
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.5585918560690598,-1.09960125495362,0.325,0.7854561737548436,1.0,6/31,15.64%,ARHGAP21;PIK3R1;GIT2;SLC4A7;GJA1;STOM
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.5887981410968298,-1.0995390186805785,0.36486486486486486,0.7851844390989561,1.0,8/29,13.07%,PSMC6;PSMB9;RPS27A;PIK3R1;PSMA1;UBC;INPP5D;NFKBIA
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.7322561635620917,-1.0993963297043918,0.3620689655172414,0.7851225344375883,1.0,1/5,13.86%,ACOX1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6509210417669226,1.099338194349062,0.3953488372093023,1.0,1.0,2/8,6.19%,PLPPR4;MBOAT2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.5299981802611701,-1.0991862090529534,0.2823529411764706,0.785384326034756,1.0,9/51,12.14%,MAP2;NRCAM;MAP1B;S100A6;GAS7;GPM6A;CTNND2;MEF2A;DCLK1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.7327745156068503,-1.0984897056257263,0.3898305084745763,0.7871869388648846,1.0,1/7,1.54%,PCK1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6489163131270863,-1.0979167683695206,0.3974358974358974,0.7883853669763897,1.0,4/11,18.14%,RIMS1;RAP1A;RIMS2;PREPL
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,-0.6716203451402804,-1.0978574012402122,0.3582089552238806,0.7881444230368401,1.0,3/10,7.46%,JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6908746160214765,-1.097715893316212,0.3188405797101449,0.7882076545008192,1.0,2/7,13.17%,CDKN1B;CDKN1A
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,-0.5800637101281285,-1.0977046537025796,0.41025641025641024,0.7877772478648714,1.0,10/29,17.29%,PPP1R9A;GPM6B;MAGI2;PTPRD;LSAMP;DCLK1;ADGRL3;PLP1;SULT1C4;ROBO2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.6758021918752795,-1.097489503453048,0.43478260869565216,0.7878912083787624,1.0,2/7,8.23%,SUN2;SUN1
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.5378434945835304,-1.0973727520770054,0.35714285714285715,0.7878343826576448,1.0,11/43,9.77%,SERPINE1;SYTL4;SRGN;CD9;HSPA5;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5689198463743813,1.09716125693491,0.3888888888888889,1.0,1.0,3/11,16.18%,SOBP;CHD7;APP
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.5466472714952451,-1.097115957681663,0.3488372093023256,0.7882893081946694,1.0,14/40,26.56%,RTN4;RPS27A;VAV3;UBC;GNA13;FGD4;NFKBIA;RASGRF2;ECT2;MAPK8;KALRN;ARHGEF2;PREX1;MCF2L
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6139500997283697,-1.096872966996898,0.3108108108108108,0.7885290615013963,1.0,3/18,9.64%,SERPINE1;MAGI2;RAB21
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.6042692514129933,-1.096798856070766,0.38666666666666666,0.7883079125656451,1.0,3/16,8.29%,MAFK;NFE2L2;SIN3B
prerank,Reactome_2022__Kinesins R-HSA-983189,0.6440032198805248,1.096613239634037,0.45454545454545453,1.0,1.0,1/7,0.48%,KIF26B
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.6446052230819275,-1.0965778535666104,0.37142857142857144,0.7885284672814985,1.0,5/13,12.72%,PIK3R1;PRKN;DLC1;TMEFF2;PAK2
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,-0.7442528511179993,-1.0964893982123172,0.38596491228070173,0.7883390812320664,1.0,2/5,19.07%,PIK3R1;GRB2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.4387010839150712,1.0963114301117822,0.23809523809523808,1.0,1.0,5/27,5.90%,BMP6;IL1R1;IL6R;IL15;LEPR
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.5409228142048038,1.0960249248516944,0.34375,1.0,1.0,2/13,5.31%,BMP6;MIA3
prerank,KEGG_2021_Human__Phagosome,-0.5580817603871582,-1.0959438039717628,0.35,0.7893908996109239,1.0,13/41,23.82%,SEC22B;CANX;LAMP2;ITGB5;PIK3C3;PIKFYVE;SCARB1;ITGB1;DYNC1I2;TUBB6;ATP6V1E1;CALR;HLA-B
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.6478425729340214,-1.095935957768948,0.3787878787878788,0.7889745895430763,1.0,6/13,14.53%,RPS27A;CANX;EDEM3;UBC;UGGT2;AMFR
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6034262627168324,-1.095861933998386,0.38961038961038963,0.7887412248261554,1.0,6/15,24.67%,CDC37;ACTN1;STK38;SRRM1;TRA2B;HSP90AA1
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.534534522495486,-1.095428831754576,0.3253012048192771,0.7895332109668555,1.0,8/48,10.33%,PSMC6;PSMB9;RAD21;RPS27A;PSMA1;SPC25;UBC;RPS27
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7150446935493618,1.0953941488948242,0.5,1.0,1.0,2/5,13.49%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6188492710177707,-1.0953923318671985,0.36363636363636365,0.7892243703220236,1.0,6/18,18.67%,SYTL4;TPM1;DYSF;PLEC;SMAD3;SCARB1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.6791178812919919,-1.09487856891403,0.4166666666666667,0.7903921155903558,1.0,2/8,10.15%,LGALS3;PRNP
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.71362534742141,-1.0948618336745213,0.4393939393939394,0.790014078295408,1.0,1/6,2.47%,PPARG
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.6621617640685709,-1.0946349792338794,0.4666666666666667,0.7903015991272878,1.0,1/6,1.41%,LDHA
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,0.7340191550989486,1.0942506089692594,0.34210526315789475,1.0,1.0,3/5,25.68%,RBPJ;CREB1;MAML2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.4802016253512437,-1.0937289802647518,0.22,0.7928276817594875,1.0,59/279,19.18%,PIK3R3;CCDC3;BHLHE40;YTHDC1;VSIR;NFKBIZ;RPL23;RIMS1;ESR2;NFE2L2;NDFIP1;ZC3H7A;YBX3;IFNGR1;PRX;HIF1A;SLC8A1;ANK2;REL;BCL6;AHNAK;PRKN;RREB1;KLF4;AFF4;AFDN;CREM;SBNO1;LIMS1;RPS7;GJA1;HNRNPH3;ZNF280D;PLCG2;BTNL9;RIMS2;CLDN5;MSN;CNBP;SMAD3;BTG1;WWTR1;CDK6;RACK1;PICALM;NSD2;SLC38A2;PINK1;ZBTB38;NOS1AP;PTBP2;ATF2;ANK3;GATA2;ZNF326;MTOR;ACVRL1;MECP2;CD34
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.7325923528541072,-1.0937046591924424,0.39705882352941174,0.7924927950312101,1.0,2/5,18.19%,SLC8A1;ANK3
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.525462569421811,-1.0931463829341028,0.3411764705882353,0.7936617367233173,1.0,9/42,18.73%,LBR;ARHGAP21;PIK3R1;GIT2;VRK2;ARHGAP15;ARHGAP17;ERBIN;ITGB1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4807606300553599,-1.0929826569492318,0.28,0.7937963272261911,1.0,65/334,16.92%,MAFF;TBX3;SERPINE1;ST18;MAP3K5;NR4A1;ATF3;KLF6;ZEB2;PPARG;CX3CL1;PHF10;HES1;JUN;JUNB;FOS;KDM1A;SMAD7;ESR2;RPS27A;NFE2L2;JUND;NPAS3;ERBB4;PIK3R1;FOXF1;HMGN1;KLF2;SMARCA1;HIF1A;REL;FOSL2;PRKN;NPAS2;UBC;RREB1;CD81;KLF4;CEBPZ;HYAL2;ZFPM2;CRLF3;EPAS1;OGT;MEF2A;NPM1;NFKBIA;FOXK1;CNBP;NCK1;SMAD3;MAX;NAA16;TMF1;CREB3L2;LPIN2;WWTR1;CRTC3;SREBF2;THRB;SMARCC1;PICALM;TBK1;NOTCH4;ZBTB38
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.620135561041125,-1.0928944824957352,0.37142857142857144,0.793655440985151,1.0,1/12,1.27%,ADAMTS9
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.5311967857260043,-1.0928457679901291,0.3373493975903614,0.7933708702481439,1.0,6/51,8.84%,MAP3K5;JUN;FOS;RPS27A;CDKN1B;UBC
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.6486968500984324,-1.0927911194363957,0.4,0.7930928660108864,1.0,3/15,12.56%,NRCAM;GPM6A;ADGRL3
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,-0.4786280604766276,-1.0927698125573746,0.23,0.792702724018982,1.0,29/280,10.65%,PIK3R3;TBX3;MAP2;ANGPTL4;NDRG1;PRKAG2;KLF6;BNIP3L;PPP1R9A;HES1;GLUL;ABCA5;EPS8;OXR1;RRBP1;ARHGAP21;GMPS;MGAT4A;YBX3;BAZ1A;DENND2C;SMARCA1;VAV3;CD55;CNOT6L;VWF;NGLY1;LPGAT1;SBNO1
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.49953529894867615,-1.0927458456759525,0.3225806451612903,0.7923255019012504,1.0,23/96,20.05%,MAP3K5;NR4A1;JUN;FOS;JUND;DUSP1;ERBB4;FLT1;RAP1A;DUSP16;FGFR1;PAK2;DUSP5;VEGFC;CACNA1C;MAX;PPP3CC;RASGRF2;ATF2;GRB2;PPM1A;EGFR;GADD45B
prerank,KEGG_2021_Human__Proteasome,-0.6343613350280077,-1.092358496556057,0.43283582089552236,0.7931530355968172,1.0,3/13,6.48%,PSMC6;PSMB9;PSMA1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,0.6105857490054855,1.0921059101088724,0.40540540540540543,1.0,1.0,3/7,12.72%,ABCG2;TEK;PROM1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6835566483522675,-1.0919705001938185,0.37142857142857144,0.7938486830411575,1.0,3/9,19.07%,RPS27A;UBC;GRB2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.6286033639986427,-1.0918998327296254,0.41025641025641024,0.7936210493492999,1.0,2/15,8.92%,CX3CL1;CD55
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.5337459138212635,-1.091896358745224,0.34146341463414637,0.7931818567375958,1.0,11/46,15.59%,DDIT4;PRKAG2;SMAD7;DMD;PRKN;PRNP;PAK2;TRIB2;NCK1;WWTR1;RACK1
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.6753521492634411,-1.0915677511733677,0.43661971830985913,0.7937518082444517,1.0,5/6,31.42%,RIMS1;SYT1;DNAJC5;SNAP25;STXBP1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.48271346843182167,1.0915511849134738,0.3333333333333333,1.0,1.0,3/17,9.91%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.6605320117257426,-1.0914264225046098,0.41935483870967744,0.7937610736734998,1.0,3/7,26.80%,GOLPH3;ALG11;GCNT1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.583477020912625,-1.0910763054342483,0.35064935064935066,0.7944358052896505,1.0,7/24,19.18%,WNT2B;FLT1;ARIH2;ZNF160;NOTCH4;KMT2A;CD34
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.5777737040444059,1.0909491026843192,0.34285714285714286,1.0,1.0,1/8,4.94%,GNB4
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.6687413368948291,-1.0908591171429212,0.4342105263157895,0.7946249459725743,1.0,3/9,24.67%,FES;PLXNA2;HSP90AA1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.683769390836888,-1.0908197814629523,0.38333333333333336,0.7942982369749889,1.0,2/5,27.73%,GJA1;SLC1A2
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.6532410400060285,-1.0905592622120064,0.46153846153846156,0.7946735183221132,1.0,3/9,19.07%,PIK3R1;CDKN1A;GRB2
prerank,KEGG_2021_Human__Hepatitis B,-0.5380209711847656,-1.0905198353306575,0.3855421686746988,0.7943037029152785,1.0,5/54,6.27%,PIK3R3;JUN;FOS;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.7219822401731106,-1.0902990633808674,0.38333333333333336,0.7945979381752909,1.0,2/6,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7266085731512483,1.090224277927445,0.5,1.0,1.0,2/6,12.72%,NKD1;PROM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5805554693369269,-1.0898950758223216,0.37333333333333335,0.7951707979591744,1.0,6/20,14.00%,JAK1;ARF1;SOD2;CFL1;PAK2;MSN
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.5286325058244059,-1.0897187036920488,0.4044943820224719,0.7952164143151912,1.0,7/55,9.19%,PIK3R3;JUN;FOS;ESR2;PIK3R1;BCL6;KLF4
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.5669595188822775,-1.08941106257161,0.36,0.7955468142233166,1.0,6/24,23.59%,JUN;PLCG2;NFKBIA;EGFR;MAPK8;ATP6V1E1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.46996202867991055,1.0893635305083185,0.27586206896551724,1.0,1.0,6/19,14.21%,PSMD14;INO80;RAD51B;SEM1;SPIDR;MCM9
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,0.3959748824877716,1.0892118242862103,0.25925925925925924,1.0,1.0,7/31,9.14%,RSAD2;STARD3;PLAAT3;UBQLN1;MBOAT2;SRBD1;SPOCK3
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.49871194152695897,-1.0891116086979422,0.3563218390804598,0.7960686984975802,1.0,6/86,8.34%,PIK3R3;ATF3;ERBB4;RB1CC1;PECAM1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6857438086753246,-1.0890705015387947,0.4492753623188406,0.7957488175461657,1.0,2/7,9.06%,PCK1;CD81
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6141176240245845,-1.0889413931367249,0.3380281690140845,0.7956951068960268,1.0,3/16,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5870909100046984,-1.0889249442578117,0.3333333333333333,0.7953016407956581,1.0,1/18,1.75%,NR4A1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6618382458635327,-1.0886066296593708,0.35714285714285715,0.7957422387379728,1.0,1/7,3.03%,SRGN
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.5272697209143701,1.0886015099949538,0.3,1.0,1.0,1/9,4.91%,CLASP1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.6152835808622656,-1.0885121854128323,0.4142857142857143,0.7956207316735987,1.0,3/13,9.19%,NR4A1;PPARG;KLF4
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7000904173710405,-1.088466970703911,0.3770491803278688,0.7952649628449959,1.0,3/6,19.12%,TMSB4X;CYLD;PPM1A
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.6463102612417121,-1.0884540640779017,0.4861111111111111,0.7948664293206829,1.0,4/12,10.36%,PGK1;RPS27A;UBC;DUSP16
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.5453940276899604,-1.0883466180987058,0.39473684210526316,0.7946839857948208,1.0,8/27,21.30%,GRIN2B;ATP2B1;SPG7;SLC8A1;CACNA1C;MICU2;TMEM165;RYR3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.4733641120292087,1.0883139534219912,0.3333333333333333,1.0,1.0,3/26,3.61%,PGM5;EPB41L5;TTN
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6752996878390449,-1.088250954423129,0.390625,0.7945694816876545,1.0,6/10,30.36%,ARIH2;SREBF2;PINK1;UBE2D3;NPEPPS;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.648394493477275,1.0878528452550724,0.4444444444444444,1.0,1.0,2/9,4.99%,IL1R1;HSPD1
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,-0.6882752439799085,-1.0876754753278304,0.4444444444444444,0.7958583966134517,1.0,3/7,21.27%,ITGA10;ITGB1;CHL1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6508350779142668,-1.0876291943650893,0.36764705882352944,0.7955834386037979,1.0,5/9,26.37%,IFNGR1;PICALM;SLC2A13;CLU;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5312024412886442,-1.0870847683173117,0.32954545454545453,0.796759726533901,1.0,5/39,6.48%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.4678209279059552,-1.0864686556625818,0.22,0.7980330458053458,1.0,90/482,16.23%,LAMC1;B3GNT2;PSMC6;SEC22B;DPH6;ADAMTS9;ERO1A;RPS12;RPL23;PPARG;SEC24D;PPA1;RPL34;MDGA2;CNTN5;PSMB9;NPLOC4;RPS9;SMAD7;RAD21;ALPL;RPS27A;NFE2L2;RPL37;WDR48;EEF1A1;CANX;MGAT4A;PSMA1;FEM1C;HIF1A;ANK2;RPS11;SHISA5;SLC30A7;COMMD1;PRKN;EDEM3;MSRB3;CAMKMT;UBC;CD55;LSAMP;KLF4;ARSG;ADAMTS1;TRAM1;NGLY1;RAB21;RPS27;RPS6;EPAS1;MSRA;RPL8;RPS15;RAB2A;TPR;OGT;RPS7;RPLP2;ERO1B;RPL13A;PIAS2;RPL15;CBX5;NPM1;NFKBIA;UGGT2;PPA2;RAB1A;FOXK1;PIGN;CST3;SMC6;RGS7;RPL37A;COPA;LARS1;AMFR;CYLD;SMAD3;ALG11;RPL7A;RPLP1;SMC3;RAB8B;USP34;RAB30;THRB;TBCD
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5810041768976042,-1.0861920902289515,0.4025974025974026,0.7984758912872908,1.0,6/19,14.00%,JAK1;ARF1;SOD2;CFL1;PAK2;MSN
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6528201187284073,-1.0861690769554724,0.36764705882352944,0.7981018974783822,1.0,5/8,26.37%,IFNGR1;PICALM;SLC2A13;CLU;ABCG1
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.7734582080560986,-1.085815358768576,0.3389830508474576,0.7988693604316252,1.0,3/5,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7044639176361183,-1.0852968767573998,0.40298507462686567,0.799807664649678,1.0,1/8,3.82%,NPLOC4
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.6590243503284257,-1.0852523037457131,0.4025974025974026,0.7994641966061145,1.0,4/10,6.37%,LBR;PRKAG2;SCP2;LSS
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6825530800760007,-1.0844349655877428,0.40298507462686567,0.8012524838879866,1.0,4/7,25.07%,ANK2;PRNP;NOS1AP;CAMK2D
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.645217637009611,-1.0842232688447053,0.44776119402985076,0.8005888449030327,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.645217637009611,-1.0842232688447053,0.44776119402985076,0.8005888449030327,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.645217637009611,-1.0842232688447053,0.44776119402985076,0.8005888449030327,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.5805892913085425,-1.084204976852975,0.32051282051282054,0.8002092169314102,1.0,3/21,7.57%,ITPR1;NDFIP1;SLC8A1
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.5850235270586597,-1.0840389554257677,0.43478260869565216,0.8003675087745102,1.0,5/20,20.13%,RPS27A;JAG2;UBC;EGFR;MIB1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6740421707483816,-1.0837970666580041,0.4262295081967213,0.8007270850684158,1.0,2/7,5.95%,CD9;ACTN1
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.6831558446718862,-1.083681371549577,0.3880597014925373,0.7998043782294545,1.0,3/10,19.07%,RPS27A;UBC;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6831558446718862,-1.083681371549577,0.3880597014925373,0.7998043782294545,1.0,3/10,19.07%,RPS27A;UBC;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.6831558446718862,-1.083681371549577,0.3880597014925373,0.7998043782294545,1.0,3/10,19.07%,RPS27A;UBC;GRB2
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6788935474090732,-1.083488918461887,0.39344262295081966,0.7995298148586085,1.0,2/5,30.65%,TERF2IP;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6788935474090732,-1.083488918461887,0.39344262295081966,0.7995298148586085,1.0,2/5,30.65%,TERF2IP;POLR2B
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,-0.5575185802758229,-1.0832446617920923,0.375,0.7998217435124214,1.0,9/27,25.05%,KIAA1217;TINAGL1;LAMA5;MYO1B;DAG1;EGFR;ADAM9;LIMA1;DSP
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.604957921212828,-1.0831360858132697,0.39436619718309857,0.7998396827209734,1.0,3/15,11.50%,PCK1;ANXA1;OGT
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.6094733126642091,-1.0828894257592176,0.3855421686746988,0.8001432855238035,1.0,3/16,13.76%,PRKN;ARIH2;PELI1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.710962500139782,-1.082807948234126,0.37681159420289856,0.7998876532124967,1.0,5/6,25.07%,PRKCE;STK39;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6754018742845945,-1.0823355969614987,0.45714285714285713,0.8008527292637444,1.0,4/9,25.05%,JAK1;PAK2;CDH5;DSP
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6685223030978971,1.081443050596866,0.39473684210526316,1.0,1.0,3/6,18.99%,SLC23A2;ABCG2;SLC12A2
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.5479691820068879,1.081382234128647,0.3235294117647059,1.0,1.0,3/10,3.82%,PSMD14;UIMC1;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.7248233257023121,-1.0812130294031823,0.37681159420289856,0.8034067198629815,1.0,2/5,8.15%,SERPINE1;TPM1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5670391961754468,1.080907993785449,0.40540540540540543,1.0,1.0,1/7,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5146954744327157,1.080857455199977,0.3125,1.0,1.0,1/12,0.16%,BMP6
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5679472566729563,1.0806084128901114,0.3225806451612903,1.0,1.0,1/7,4.91%,CLASP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.5453770557552216,-1.0801360089261522,0.36046511627906974,0.8034576179537474,1.0,11/47,9.51%,KLF6;NFKBIZ;SRGN;PSMB9;LGALS3;S100A6;JAK1;EMP1;FOSL2;ANXA1;CLEC2B
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.5548606128697655,-1.0800492874839334,0.36585365853658536,0.8032801308974897,1.0,9/29,19.42%,PRKAG2;ERBB4;FLT1;RAP1A;FGFR1;CDKN1A;TIE1;LCP2;EGFR
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6225168072217224,-1.0800437827155274,0.4647887323943662,0.8028854220007899,1.0,3/14,11.93%,PRNP;SNX6;GJA1
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.6269274074601316,-1.0800306028390607,0.4153846153846154,0.8024790644009501,1.0,4/11,22.26%,RPS27A;UBC;SCARB1;CLTA
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,-0.5432710653486558,-1.0798938964811313,0.3707865168539326,0.8020776628684864,1.0,8/42,13.78%,MGLL;ENPP2;SCARB2;EMP1;TNS1;CDK14;CST3;PLSCR4
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,-0.5432710653486558,-1.0798938964811313,0.3707865168539326,0.8020776628684864,1.0,8/42,13.78%,MGLL;ENPP2;SCARB2;EMP1;TNS1;CDK14;CST3;PLSCR4
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3986581883713617,1.0798923173213244,0.4,1.0,1.0,7/50,3.59%,ANKRD6;ZNRF3;PSMD14;MLLT3;TLE4;NKD1;RNF213
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.39203727556188706,1.0797292697544267,0.17647058823529413,1.0,1.0,1/36,0.03%,CREB5
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,-0.6728071273604648,-1.079596685688888,0.47692307692307695,0.8025642823933877,1.0,3/8,17.34%,RPS27A;UBC;KPNB1
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,-0.7153579898067004,-1.0793485553992288,0.36619718309859156,0.8027793428787384,1.0,3/6,23.64%,FES;PIP5K1C;PLXNA2
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.6921008502613748,-1.0793474062176902,0.45901639344262296,0.8023500491124931,1.0,2/8,5.50%,HES1;WDR48
prerank,Reactome_2022__Immune System R-HSA-168256,-0.4679635272784115,-1.0793052887200079,0.25,0.8020535802143292,1.0,86/508,17.45%,PIK3R3;PSMC6;PKM;UFL1;ITPR1;SEC22B;SEC24D;ATG12;JUN;SLC2A3;PSMB9;FOS;HSPA5;LGALS3;MYO9B;LRRFIP1;NFASC;SMAD7;TINAGL1;RPS27A;CDKN1B;EEF1A1;CANX;RNF19A;LRRC7;JAK1;PIK3R1;LAMA5;PSMA1;IFNGR1;PRKCE;LAMP2;RAPGEF3;IFNGR2;HIF1A;REL;VAV3;PECAM1;BCL6;SERPINB6;RAP1A;PRKN;AP1G1;UBC;CD55;ARIH2;CD81;ANXA1;IL1RAPL1;DLC1;S1PR1;ALPK1;ITGB5;WIPF1;CFH;ARPC2;TPR;MEF2A;PLCG2;BTNL9;INPP5D;NFKBIA;TEC;CDKN1A;CST3;PELI1;MSN;SH3KBP1;SDCBP;NCK1;CYLD;SMAD3;STOM;PIK3C3;SGIP1;MALT1;MCL1;TMEM30A;TBK1;EGFL7;RAB14;TRIM9;B4GALT1;IL18R1;KPNB1;LCP2
prerank,CellMarker_Augmented_2021__Basophil:Lung,0.5903391836733523,1.0792376529278287,0.42424242424242425,1.0,1.0,2/11,1.91%,GBP1;SMAD1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.6567804644312153,-1.0792177012747295,0.44285714285714284,0.8018536427963974,1.0,3/9,10.09%,HES1;SMAD7;ZFPM2
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.5674160712904303,-1.0791965218656558,0.3170731707317073,0.8015216942381496,1.0,9/34,15.51%,JUN;FOS;JAK1;IFNGR1;IFNGR2;HIF1A;NFKBIA;SMAD3;PPP3CC
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.6850351033101054,-1.0790529035550371,0.4,0.801520485140273,1.0,2/7,26.75%,SMC6;CSNK2A1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.5544845090992396,-1.079033595416585,0.3950617283950617,0.801153045545931,1.0,3/27,4.09%,SPNS2;SCP2;ABCA5
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,-0.5393771652338811,-1.0787083748971358,0.3918918918918919,0.8017820971875279,1.0,7/32,15.27%,PLS3;KIAA1217;LAMA5;PLOD2;MYO1B;BCAR1;WWTR1
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,-0.5285726856831524,-1.0785844233470574,0.4125,0.8018167357038196,1.0,19/40,27.57%,AKAP12;MAP1B;NES;TIMP3;SMARCA1;DLC1;GJA1;NAV1;NAV2;CALD1;PLAT;HMCN1;SPARC;TNS2;CNN3;EDIL3;LAMA4;FZD4;RHOJ
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5423693507525791,-1.0785586173590502,0.34615384615384615,0.8014437311167429,1.0,6/33,8.84%,PSMC6;ENPP2;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.7273535890046657,-1.0780037510247853,0.38095238095238093,0.8028504561773078,1.0,3/5,18.19%,SLC8A1;PRKN;ANK3
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8016245065240889,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8016245065240889,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8016245065240889,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6366375643713981,-1.0778304685738647,0.4142857142857143,0.8017248795756379,1.0,3/10,4.09%,LBR;PRKAG2;ABCA5
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6825884697096012,-1.077823508654789,0.45901639344262296,0.8013112858227579,1.0,2/7,13.92%,KDM1A;PTTG1IP
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.6710312567470895,-1.077691813914798,0.4142857142857143,0.8012564478587372,1.0,4/12,10.41%,TSG101;RPS27A;UBC;PLIN2
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.6756798637502948,-1.0775954350708685,0.42028985507246375,0.8011837616986418,1.0,5/7,23.27%,FLT1;PECAM1;S1PR1;CD34;CDH5
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.609269998753622,-1.0775792174483327,0.3424657534246575,0.8008069059672694,1.0,3/17,14.93%,ESR2;PLPP1;TMF1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5717832356494208,-1.0774230103327709,0.4166666666666667,0.8008120468906937,1.0,2/12,12.16%,KDM1A;PIAS2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6144928439526423,-1.0772654361343674,0.3972602739726027,0.8008291009783866,1.0,4/13,4.59%,GRIK1;GRIN2B;GRM7;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.7201620872076253,-1.077007890478882,0.3484848484848485,0.8010486461387625,1.0,2/5,20.35%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6621756756969489,-1.076895406897896,0.3880597014925373,0.8008155310357787,1.0,4/8,23.72%,TGM2;ERBIN;GRB2;SHOC2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4827490247493083,-1.076803956467691,0.35789473684210527,0.8005945620635327,1.0,27/128,13.17%,CX3CL1;JUNB;FOS;GAPDH;RPS27A;NFE2L2;CDKN1B;DUSP1;JAK1;PIK3R1;YBX3;LAMA5;IFNGR1;IFNGR2;HIF1A;BCL6;UBC;ANXA1;IL1RAPL1;HYAL2;S1PR1;TPR;RPL13A;ZFP36;INPP5D;TEC;CDKN1A
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.555267447920068,1.0764524093093946,0.41025641025641024,1.0,1.0,3/8,17.53%,PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5626811865436214,-1.0761678569184094,0.4027777777777778,0.8018307708296882,1.0,7/30,13.68%,SERPINE1;NFKBIZ;CX3CL1;SCARF1;HYAL2;NFKBIA;RIOK3
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.674189726940738,-1.0761471780562692,0.373134328358209,0.8014430791594769,1.0,3/8,20.37%,CCDC14;NUDCD3;CSNK1D
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.5148341293136156,1.076110058711627,0.4074074074074074,1.0,1.0,5/14,18.86%,TBL1X;HDAC9;TBL1XR1;RBPJ;HDAC4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6292329268142871,-1.0759329980705281,0.4166666666666667,0.8016082571297962,1.0,2/13,2.52%,PPARG;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6463489711727626,-1.0757472505081904,0.4117647058823529,0.8017435743517953,1.0,4/8,28.82%,TMBIM6;PTBP2;PTBP1;NCOR2
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.6819031743922006,-1.075597207990194,0.4027777777777778,0.8017838021549003,1.0,2/7,5.95%,GRIN2B;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.49181418216655753,-1.0755840438692716,0.3473684210526316,0.8014206764665938,1.0,27/95,23.16%,MAP3K5;BNIP3L;JUN;RPS27A;HIP1R;VAV3;BCL6;UBC;DLC1;TGM2;PRNP;RPS6;GNA13;FGD4;TNFRSF10B;BTG1;RACK1;RASGRF2;ITGB1;CLU;GADD45B;ECT2;DUSP6;DNM2;MAPK8;BCLAF1;KALRN
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,-0.475578512970159,-1.0750675334928554,0.25,0.8025695534207173,1.0,37/344,9.43%,SERPINE1;DDIT4;PSMC6;BTG2;NDRG1;LBR;PCK1;PRKAG2;NR4A1;RFC3;BNIP3L;ZNF43;PPARG;JUN;SLC2A3;GRIN2B;PSMB9;FOS;TAF1D;LGALS3;PPM1D;SMAD7;GRIA2;ESR2;RPS27A;CDKN1B;PSMA1;PBRM1;ELL2;BCL2L14;BCL6;SIN3B;UBC;KLF4;AFF4;CCNH;CNOT6L
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.6844766774528352,-1.075031946335563,0.38666666666666666,0.8022360204287187,1.0,1/7,1.38%,SLCO4A1
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.6574941649188046,-1.0748407854422546,0.4461538461538462,0.8023706515121545,1.0,2/9,8.37%,GRIK1;NCALD
prerank,KEGG_2021_Human__Lysosome,-0.5685603108228068,-1.0748072825732033,0.35443037974683544,0.8020257366688114,1.0,9/24,22.26%,SCARB2;LAMP2;AP1G1;ARSG;HYAL2;ENTPD4;PSAP;CD63;CLTA
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.57198760925674,-1.0747741489780143,0.32857142857142857,0.8016693533969538,1.0,5/24,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.6020641295760218,-1.0747397406689214,0.5,0.8013133444772725,1.0,3/11,19.18%,PECAM1;ITGB1;CD34
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5880384613490374,1.0742942460706804,0.38235294117647056,1.0,1.0,2/7,9.64%,LDB2;ATM
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5143237276798078,-1.0741484205725895,0.38823529411764707,0.8028486698787494,1.0,9/56,14.08%,DDIT4;RTN4;GAPDH;PRKCE;BCL2L14;DLC1;OGT;NFKBIA;TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6960190515405511,-1.0740427021780363,0.4305555555555556,0.8027286618427792,1.0,4/8,14.21%,PKM;YBX3;CNBP;CPEB4
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.5360702834482352,-1.074018295062489,0.3780487804878049,0.8023608513862146,1.0,6/41,4.59%,ITPR1;GRIK1;GLUL;GRIN2B;GRM7;GRIA2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5985523752737971,-1.073932465803128,0.36764705882352944,0.802270724617246,1.0,4/12,11.71%,RPL23;RPL37;RPS15;RPS7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.6236703436412854,-1.0736895258412953,0.410958904109589,0.8026111637715384,1.0,4/15,16.49%,NPLOC4;REL;CYLD;TBK1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.5168197232242745,-1.0734506680510554,0.31868131868131866,0.8028510521425419,1.0,6/48,7.84%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1;SULF2
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.3935959683203938,1.0733927968698667,0.2,1.0,1.0,13/80,10.17%,ARID5B;MSL2;DNMT3A;YEATS2;H2AC6;ATF7IP;SMYD3;KDM7A;TBL1X;UTY;NCOA2;TBL1XR1;KMT5B
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.6840482961265553,-1.0732495589726854,0.5076923076923077,0.8028491708200275,1.0,2/7,16.65%,BCL6;PINK1
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.48444593202003605,-1.0731114510527586,0.2857142857142857,0.8028649543177901,1.0,42/187,20.53%,PSMC6;RPS12;RPL23;RPL34;ENPP2;PSMB9;RPS9;RPS27A;RPL37;PSMA1;RPS11;UBC;CCNH;CNOT6L;RPS27;RPS6;RPL8;RPS15;TPR;RPS7;RPLP2;RPL13A;CSTF3;ZFP36;RPL15;RIOK3;RPL37A;RPL7A;RNPC3;RPLP1;TRMT9B;SRRM1;DCP2;RPS28;NUP54;RPL31;RBM17;RPS19;USP39;PSMA7;CSNK1D;PRPF40A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.6476604125117993,-1.0729985787648166,0.390625,0.8027630305189019,1.0,3/10,15.46%,CDKN1B;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5403749659225952,-1.072988186612249,0.4074074074074074,0.8023553770281135,1.0,9/37,20.35%,UFL1;BNIP3L;PRKN;DHRSX;TMEM59;TBK1;PINK1;GNAI3;PIK3CB
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5077575016498316,1.072762750932911,0.43902439024390244,1.0,1.0,3/12,9.27%,SLC23A2;SLC38A3;SLC38A6
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.7032574704744092,-1.0727033368824337,0.4857142857142857,0.8028063948140437,1.0,1/6,11.00%,EFNB2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.6345672869132459,-1.0726257916115276,0.46774193548387094,0.8026517832331753,1.0,2/10,7.22%,FES;RAPGEF3
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6125242699950142,-1.0722696340633224,0.423728813559322,0.8033722998655679,1.0,3/9,7.81%,GLUD1;SLC2A3;SLC2A1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6013469313811353,-1.0720808064786802,0.4307692307692308,0.8035051452306224,1.0,1/11,1.01%,ADM
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.6401390819214928,-1.0720361581337887,0.42424242424242425,0.8031861592861422,1.0,2/12,9.11%,CALCOCO2;ANXA1
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,-0.6693593842750033,-1.0716755198660504,0.4189189189189189,0.8038466409332748,1.0,3/8,7.36%,PDE5A;ATP2B1;MBP
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.5230407922512513,-1.0711750020907096,0.39759036144578314,0.8047173961469885,1.0,9/43,11.39%,PSMC6;PSMB9;RPS27A;SLC20A2;PSMA1;SLC2A1;UBC;SLC26A2;TPR
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.7270322940280272,-1.0711432782411128,0.41935483870967744,0.8043572784828894,1.0,3/6,10.92%,RPS27A;UBC;EPAS1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6098903966349459,1.070850833037651,0.391304347826087,1.0,1.0,2/7,3.27%,UGCG;ATP2A2
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.6893126504383712,-1.0703915151636918,0.4117647058823529,0.8058298182432683,1.0,3/6,29.75%,ACSL5;CBR4;ACSL4
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.5125608830520357,-1.0703160476387072,0.36904761904761907,0.8055982164595643,1.0,8/52,11.95%,DOCK3;GRIN2B;FOS;JUND;PIK3R1;RAP1A;SHC2;MEF2A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.643309746802339,-1.0701079735997407,0.40298507462686567,0.805863923139462,1.0,3/10,7.60%,SMAD7;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6947334694240086,1.0699811284255853,0.4864864864864865,1.0,1.0,2/5,12.54%,BICD1;PCM1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5386653895989534,1.0698940885869113,0.28,1.0,1.0,8/16,14.02%,HABP4;RBM20;HSPA1A;HNRNPLL;CIRBP;TRA2A;RBMX;NCL
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.6813222971724638,-1.0695882278010513,0.4794520547945205,0.8070002321808861,1.0,2/8,21.43%,CAMKMT;SETD3
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.6494289879248741,-1.069079309481494,0.4189189189189189,0.8080652604164038,1.0,3/11,7.30%,JUN;FOS;FLT1
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.6289884708466283,-1.0687899896817892,0.4,0.8084694042466132,1.0,3/12,17.66%,EPS8;MSN;MYO1E
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.5284972385931205,-1.0687474715701732,0.4457831325301205,0.8081845128318781,1.0,4/46,6.27%,PIK3R3;JUN;FOS;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.6178973820052173,-1.068500428402271,0.3888888888888889,0.8084598565166349,1.0,5/15,18.27%,ZFPM2;TRIB2;SMAD3;WWTR1;GATA2
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,-0.6749603681453291,-1.0684959404530612,0.4375,0.8080411823288998,1.0,6/18,12.99%,RFC3;POLA1;CANX;IPO7;NOC3L;NPM1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5618005773310233,-1.0683844373220552,0.3563218390804598,0.807914275003028,1.0,2/29,3.88%,PSMC6;LGALS3
prerank,KEGG_2021_Human__p53 signaling pathway,-0.5671939286925883,-1.0681843639218722,0.4444444444444444,0.8079913268984565,1.0,6/22,15.46%,SERPINE1;PPM1D;SHISA5;CDKN1A;TNFRSF10B;CDK6
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7487783584691017,-1.0681696856273757,0.46774193548387094,0.8076550334223189,1.0,1/5,2.82%,HES1
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.5131039544715637,-1.0680629464534013,0.39080459770114945,0.8070997813111364,1.0,17/66,20.08%,PSMC6;LBR;PSMB9;RAD21;RPS27A;PSMA1;SPC25;UBC;RPS27;PAFAH1B1;SMC3;VRK2;KPNB1;NUP54;CHMP4B;PSMA7;DYNC1I2
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.5131039544715637,-1.0680629464534013,0.39080459770114945,0.8070997813111364,1.0,17/66,20.08%,PSMC6;LBR;PSMB9;RAD21;RPS27A;PSMA1;SPC25;UBC;RPS27;PAFAH1B1;SMC3;VRK2;KPNB1;NUP54;CHMP4B;PSMA7;DYNC1I2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.6220835465112651,-1.0679172524375635,0.4142857142857143,0.8070550503826294,1.0,5/13,30.23%,ZFP36;EGFR;AGO2;MAP2K1;STAT3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.5920891282058871,-1.0675151624935788,0.4473684210526316,0.8078235737896965,1.0,4/13,13.86%,PPARG;SLC4A10;SLC4A7;ACOX1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.6644991433811361,1.0674990153263815,0.48717948717948717,1.0,1.0,1/5,11.26%,MSH3
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.5929160803561406,-1.067361464827041,0.3611111111111111,0.8077843213521403,1.0,5/16,14.85%,RFC3;RPS27A;UBC;CCNH;USP45
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,-0.5233381711012383,-1.0669149343231807,0.45977011494252873,0.8086097029694986,1.0,13/48,14.79%,MAP2;PPP1R9A;MAP1B;RIMS1;NPAS3;ERBB4;CNTN1;ANKS1B;STOX2;TMEFF2;DCLK1;LRRC4C;LRP1B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6189320083555305,-1.0667506944036205,0.42857142857142855,0.8086628803974208,1.0,3/10,10.09%,SMAD7;TPM1;ZFPM2
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.6041600315719736,-1.0664408530133518,0.42105263157894735,0.8090580063294952,1.0,9/14,22.87%,MDGA2;CNTN5;ALPL;LSAMP;PIGN;PIGC;CD109;NEGR1;CPM
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6985054758271299,-1.0664228668971356,0.47761194029850745,0.8082835491448706,1.0,1/6,8.26%,RAP1A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6985054758271299,-1.0664228668971356,0.47761194029850745,0.8082835491448706,1.0,1/6,8.26%,RAP1A
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6297019455541177,-1.0663799685119775,0.43478260869565216,0.8079779459663504,1.0,3/13,11.93%,PRNP;SNX6;GJA1
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.6589954916668004,-1.0663496254083489,0.463768115942029,0.8076090246151854,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.42814377706111684,1.066349601188538,0.375,1.0,1.0,3/24,4.91%,BMP6;TTN;CLASP1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.5710658971613848,-1.0663362330040784,0.34177215189873417,0.8072404822279147,1.0,9/25,18.73%,PRKAG2;DMD;SLC8A1;TPM1;ITGA10;ITGB5;CACNA1C;DAG1;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.5290381785464485,-1.0660813073107012,0.38372093023255816,0.8074906510389439,1.0,11/37,24.67%,SEC22B;CDKN1B;PRKN;PTTG1IP;MSN;ADAM9;GPC3;SNX9;NEDD4;NEDD4L;HSP90AA1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.7142284824938626,-1.0660588479554756,0.45454545454545453,0.8071283234197212,1.0,1/5,4.01%,GAPDH
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6879235085081098,1.0659527409601537,0.5333333333333333,1.0,1.0,1/7,7.92%,SLTM
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6769504281462428,-1.0657938766606496,0.4225352112676056,0.8070683238921055,1.0,1/6,11.29%,ACSL5
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.6769504281462428,-1.0657938766606496,0.4225352112676056,0.8070683238921055,1.0,1/6,11.29%,ACSL5
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.5196919546562098,1.065766999309878,0.3548387096774194,1.0,1.0,2/13,4.94%,RAB11FIP2;GNB4
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.5196919546562098,1.065766999309878,0.3548387096774194,1.0,1.0,2/13,4.94%,RAB11FIP2;GNB4
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5247281406043081,1.0650525278901688,0.42857142857142855,1.0,1.0,5/19,9.64%,PSMD14;UIMC1;HERC2;ERCC6;ATM
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.5213928350113514,-1.0648518619225895,0.4659090909090909,0.8095037497200288,1.0,10/42,24.67%,SEC24D;JAK1;TPR;CNBP;PIK3C3;TBK1;NUP54;B2M;HLA-B;HSP90AA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,-0.6745409792756264,-1.0647553288282254,0.5147058823529411,0.8093082899064733,1.0,2/6,19.18%,CD81;CD34
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7213982920253915,-1.0647101545606847,0.421875,0.8089920477508268,1.0,2/5,20.66%,PRKN;XIAP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.6676098956784658,-1.063950818330803,0.36065573770491804,0.8108296659917644,1.0,4/7,32.67%,STARD4;ABCG1;LDLR;LRP6
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5907928377516458,-1.0636042371239502,0.4084507042253521,0.8112553871175022,1.0,4/17,10.73%,PSMC6;PSMB9;PSMA1;CHFR
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.651676901828059,-1.0632587107476905,0.43333333333333335,0.8119165148172405,1.0,2/9,9.40%,TAF1D;CCNH
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.5773437708099686,-1.0631875858650268,0.4084507042253521,0.8116858260897529,1.0,4/17,7.94%,NDRG1;BNIP3L;BCL2L14;BCL6
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.67603556325358,-1.0631473625648844,0.42857142857142855,0.8113749238009619,1.0,3/6,28.82%,EGFR;MAP2K1;NCOR2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.652171770172974,1.0629931766093048,0.4722222222222222,1.0,1.0,3/5,9.08%,SLCO1A2;SLC26A3;ABCG2
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,-0.6278489396859755,-1.0629917627987708,0.4153846153846154,0.8109836905628642,1.0,2/8,15.43%,RAD21;SMC3
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,-0.6278489396859755,-1.0629917627987708,0.4153846153846154,0.8109836905628642,1.0,2/8,15.43%,RAD21;SMC3
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.6107388819534281,-1.0628987664152805,0.463768115942029,0.8108744366953344,1.0,3/12,13.04%,PRKAG2;PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.6765059596018423,-1.0623758750588386,0.515625,0.8119867753098158,1.0,2/7,9.06%,VAV3;CD81
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6545240027870844,-1.0621569452229762,0.4246575342465753,0.8122152942390818,1.0,3/8,3.93%,LBR;PRKAG2;SCP2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.7046110154668664,-1.062039129088442,0.40384615384615385,0.8121915126496944,1.0,3/5,22.60%,CD55;CFH;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.698409828844877,-1.0620051110576656,0.463768115942029,0.8118585565110366,1.0,2/7,15.96%,PRNP;MCL1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.5055526893199157,-1.0614117623951094,0.4125,0.8122567088517613,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5055526893199157,-1.0614117623951094,0.4125,0.8122567088517613,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5055526893199157,-1.0614117623951094,0.4125,0.8122567088517613,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.49346915911937117,-1.0613446983275756,0.40217391304347827,0.8120158240946015,1.0,12/87,9.32%,PLS3;RPS18;PGK1;RPS12;CD9;KCNMB4;S100A6;NDFIP1;IPO7;SLC2A1;SULF2;AAMDC
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.609401561641661,-1.0610797034068218,0.4827586206896552,0.8123805897557335,1.0,2/13,7.65%,SLC4A10;COL18A1
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.6233647065766906,-1.0608229609079374,0.3880597014925373,0.8127564024340195,1.0,1/9,2.52%,CX3CL1
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.5185018156479423,-1.0606159369672679,0.4418604651162791,0.812778087717982,1.0,4/39,8.84%,PRKAG2;RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.6220367017029509,1.060606266341184,0.34285714285714286,1.0,1.0,1/8,2.18%,GCH1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6070447999233093,-1.060560832239311,0.44285714285714284,0.8124861026766217,1.0,3/12,8.84%,RPS27A;WDR48;UBC
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5159874748828324,-1.0604406418473518,0.37037037037037035,0.8123711074235674,1.0,3/30,7.60%,ITPR1;SLC8A1;ANK2
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.5156756939598754,-1.0603670217882375,0.3974358974358974,0.8121992593085482,1.0,14/41,26.99%,CD99L2;PIK3R1;PECAM1;ATP1B3;INPP5D;TNFRSF10B;ITGB1;GRB2;PIK3CB;SELENOP;BSG;SLC3A2;CD74;TNFRSF10D
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5697223197085358,-1.060174443607266,0.44,0.8122553467925304,1.0,4/17,13.73%,RPS27A;PRKN;UBC;CST3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5349118395763081,-1.0597663010779992,0.32941176470588235,0.8131764346609495,1.0,4/35,8.34%,SEC22B;CDKN1B;EEF1A1;PRKN
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.5085998108364371,-1.0596236235452103,0.38461538461538464,0.8131523356394396,1.0,7/45,11.85%,CLIC2;ATP2B1;TSC22D3;RPS27A;ANO2;UBC;ATP1B3
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6279136941617931,-1.0595767341295645,0.44,0.8128553609706815,1.0,8/11,22.18%,GRIA2;CTNND2;ATRNL1;HS6ST3;SMAD3;CADPS2;SCN2A;NOL4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.7226413934827008,-1.059560686411705,0.48214285714285715,0.8124507177418092,1.0,3/5,21.43%,ATP2B1;ZDHHC21;SETD3
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,-0.5339229864942626,-1.05949672332376,0.3764705882352941,0.8122225528924927,1.0,11/42,16.10%,RFTN1;ZEB2;SRGN;SLC2A3;ANXA1;S1PR1;WIPF1;CHST11;SH3RF3;MSN;AGPAT4
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.4835330777317229,-1.0593198643284842,0.3626373626373626,0.8123238734466269,1.0,26/105,17.50%,DENND3;NR4A1;NFKBIZ;ZEB2;GLUL;LGALS3;TSC22D3;DUSP1;IFNGR2;PECAM1;PHTF2;SOD2;PLIN2;LIMS1;ATP1B3;FGD4;PELI1;MSN;SDCBP;STK38;UPP1;TBCD;MBD2;ARL4A;LCP2;PSAP
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.6662490104191313,-1.0591672550960023,0.48484848484848486,0.8124307658170246,1.0,4/8,24.67%,NOSTRIN;ZDHHC21;DNM2;HSP90AA1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.51602162780534,1.0590964450142775,0.34375,1.0,1.0,1/17,0.16%,BMP6
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5894048005220549,-1.0590605178774746,0.4,0.8122823511896331,1.0,8/19,15.70%,KCNMB4;RIMS1;ANXA1;RAB21;STXBP5L;RIMS2;SYT1;RAB8B
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8110905482187479,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8110905482187479,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8110905482187479,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.6494523251819788,1.0590406162239079,0.4634146341463415,1.0,1.0,1/5,2.68%,DCP1A
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.6495363972719868,-1.0590275093204289,0.4393939393939394,0.8107393570158976,1.0,5/10,25.29%,RPS6;PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8092759848054651,1.0,1/7,9.40%,CCNH
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8092759848054651,1.0,1/7,9.40%,CCNH
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8092759848054651,1.0,1/7,9.40%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8092759848054651,1.0,1/7,9.40%,CCNH
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,-0.5706616487108062,-1.0587991629188855,0.43209876543209874,0.8088653100561953,1.0,4/25,7.60%,DOK5;MAP1B;NFASC;ANK2
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,-0.5706616487108062,-1.0587991629188855,0.43209876543209874,0.8088653100561953,1.0,4/25,7.60%,DOK5;MAP1B;NFASC;ANK2
prerank,KEGG_2021_Human__Endocytosis,-0.48096241100856707,-1.0587129522429142,0.3684210526315789,0.8087251394875399,1.0,30/103,24.70%,TSG101;GRK5;EHD4;RAB11FIP3;ASAP2;ARF1;GIT2;WIPF1;SNX6;ARPC2;ACAP2;SH3KBP1;SMAD3;SH3GL1;RUFY2;PIP5K1C;ARFGEF2;CHMP4B;PSD3;EGFR;CAV2;CAPZA2;CLTA;VPS37A;DNM2;HLA-B;WASHC4;NEDD4;NEDD4L;RAB11A
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5907975643002954,-1.0586810587388689,0.4189189189189189,0.8083990877121574,1.0,7/15,15.86%,MAP2;GRIA2;ANK2;PPFIA2;CTNND2;HS6ST3;CADM2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.523478074634613,-1.058547165356874,0.3764705882352941,0.8083212669602214,1.0,6/42,11.95%,MTFR1;BNIP3L;BCAP31;SPG7;PRKN;MEF2A
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.5324765601608609,-1.0581872610889944,0.41025641025641024,0.8087841363537049,1.0,11/36,12.75%,MAP2;MAP1B;NFASC;GRIA2;MAGI2;PTPRD;ANK2;LSAMP;PPFIA2;DCLK1;PLP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.6568074715676692,-1.0581243059283512,0.4246575342465753,0.8085373440295767,1.0,1/8,4.46%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.4942828248085879,-1.0580353748277318,0.391304347826087,0.8083808103650418,1.0,7/62,6.69%,ADM;SRGN;RAB11FIP3;ATP2B1;SMAD7;PLCL1;IFNGR1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.5503487437591856,-1.057965924485516,0.352112676056338,0.8081794495630095,1.0,5/23,13.09%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6699582356096772,1.0579524549978114,0.55,1.0,1.0,2/5,15.43%,GMDS;PARG
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.5731336233327229,1.057727444812908,0.36,1.0,1.0,4/11,23.51%,CDC16;NSMCE2;PDGFB;PHIP
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5231525227719495,-1.0575427503501984,0.38823529411764707,0.8089730531999988,1.0,10/29,19.95%,BNIP3L;CDKN1B;PRKN;NPAS2;NCK1;TBK1;CHMP4B;LRPAP1;CLU;ACER2
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.478988767793756,-1.057296824769114,0.39285714285714285,0.8091367241225857,1.0,9/59,15.51%,PSMC6;BCAP31;PSMB9;RPS27A;PSMA1;UBC;PLEC;TNFRSF10B;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6164997361495732,1.0570814530802877,0.38235294117647056,1.0,1.0,1/6,2.60%,PRKD1
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,-0.7091069146070408,-1.056979831503156,0.4444444444444444,0.8093457301543957,1.0,1/6,1.38%,SLCO4A1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.7091069146070408,-1.056979831503156,0.4444444444444444,0.8093457301543957,1.0,1/6,1.38%,SLCO4A1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6393639365587618,-1.0568622861828725,0.4153846153846154,0.8092341331178936,1.0,3/8,10.04%,FOXF1;SULF2;HYAL2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5983984082728975,-1.0567651580776718,0.45454545454545453,0.8091114349583454,1.0,2/10,8.84%,RPS27A;UBC
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.5262613819142231,-1.0566471856415787,0.4642857142857143,0.8089552388639387,1.0,9/40,17.64%,ADM;ITPR1;KCNMB4;PRKCE;GNA13;CACNA1C;MYL6;MYH10;CALD1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5402496244228068,-1.0565140013170515,0.4146341463414634,0.8089000082593515,1.0,10/26,21.70%,NR4A1;HIF1A;VEGFC;EGFL7;TIE1;ACVRL1;CAV2;ATOH8;PPP1R16B;SPARC
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.6170286454892,-1.0564392688715785,0.4444444444444444,0.8086433127002703,1.0,7/13,27.36%,MAGI2;DLC1;MTOR;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.5226752973068857,-1.0562962724611513,0.4177215189873418,0.8086106719990988,1.0,6/40,13.17%,RAPGEF5;JUN;RASSF1;RREB1;SHC2;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.6250109257152294,-1.0559850867216833,0.40789473684210525,0.8090310329730235,1.0,9/14,35.06%,EEF1A1;ZFP36;EGFR;DUSP22;STAT5B;FOXC1;DAB2IP;ZFP36L1;IQGAP1
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,-0.6738257957812189,-1.055816955544686,0.4915254237288136,0.8091379680789532,1.0,3/7,20.35%,PIK3R1;GRB2;PIK3CB
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.6179294996871278,-1.0557611471667545,0.484375,0.808909597306617,1.0,2/12,8.82%,GPC5;CAMKMT
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.5858210139483772,-1.0551422415008933,0.4520547945205479,0.8099992514059179,1.0,2/19,4.46%,PCK1;KDM1A
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.640598371683035,1.0550874283124843,0.4594594594594595,1.0,1.0,2/6,21.27%,YWHAG;AKT3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.7512726451955014,-1.054656140499585,0.40625,0.8109203913527918,1.0,3/5,9.80%,BCAP31;NFE2L2;HERPUD1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6565930302092066,-1.0541869055390305,0.5,0.8117234728774819,1.0,1/7,3.35%,SLC4A10
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.613231130230985,1.053957171034077,0.4642857142857143,1.0,1.0,4/8,18.49%,ZDHHC2;ABL1;APP;EPHA4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6969695746260112,-1.0539142643460702,0.421875,0.8120685601583925,1.0,2/5,8.66%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.49579062116964634,-1.0537946191101741,0.43529411764705883,0.812056644396058,1.0,13/85,13.73%,LAMC1;PSMC6;PSMB9;MGAT4A;PSMA1;FEM1C;HIF1A;SHISA5;COMMD1;EPAS1;RAB2A;RAB1A;CST3
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.5530114473066184,-1.0531867043384586,0.4383561643835616,0.8132088864109019,1.0,8/26,22.50%,SEC24D;CANX;AP1G1;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.47594087530972357,-1.053115156023973,0.37755102040816324,0.8130405334661613,1.0,39/149,20.35%,RPL23;RTN4;CX3CL1;BCAP31;GAPDH;NDFIP1;RPL37;ERBB4;PIK3R1;FLT1;REL;SHISA5;PRKN;VWF;TGM2;ALPK1;FGFR1;LIMS1;RPS15;GOLPH3;GJA1;PLCG2;SLC20A1;CASS4;PELI1;TNFRSF10B;LARS1;RACK1;MALT1;TBK1;PINK1;NOS1AP;ITGB1;GRB2;PPM1A;EGFR;ECT2;CAV2;PIK3CB
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.5729548875013393,-1.0530900913511576,0.4520547945205479,0.8123316846770512,1.0,3/13,13.60%,B3GNT2;ACSL5;CDR2
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.5729548875013393,-1.0530900913511576,0.4520547945205479,0.8123316846770512,1.0,3/13,13.60%,B3GNT2;ACSL5;CDR2
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.5498727418675933,-1.0529713857495346,0.42105263157894735,0.8121918096994428,1.0,15/37,21.67%,PSMC6;PSMB9;RPS27A;PIK3R1;PSMA1;UBC;PLCG2;INPP5D;NFKBIA;NCK1;MALT1;LCP2;PSMA7;PIK3CB;CUL1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.6528091212310441,-1.0528731668615585,0.42028985507246375,0.8116514551042882,1.0,3/8,29.75%,ACSL5;CBR4;ACSL4
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.6528091212310441,-1.0528731668615585,0.42028985507246375,0.8116514551042882,1.0,3/8,29.75%,ACSL5;CBR4;ACSL4
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.4778252119301152,1.0526540297667322,0.4074074074074074,1.0,1.0,7/16,23.11%,COG3;COG6;COG5;RIC1;NAA35;GOLGA4;USP6NL
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.603375734130742,-1.0525551264120343,0.46153846153846156,0.8121837753574824,1.0,4/17,14.26%,RPL23;OGT;RPS7;SDCBP
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.7165817462597673,-1.0524533420592614,0.5161290322580645,0.8120997301753293,1.0,2/5,15.46%,FES;CDK6
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.5758434846519356,1.052363199605396,0.4230769230769231,1.0,1.0,2/11,4.94%,PLA2G4A;GNB4
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.619043931122409,-1.0522533752657754,0.37333333333333335,0.8123318545454589,1.0,2/8,2.20%,PCK1;GLUD1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.646039698851347,-1.0520721181564834,0.43283582089552236,0.8124251840543807,1.0,2/7,14.93%,PLPP1;TMF1
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.6840764124257901,-1.0514278061688027,0.45,0.8133757010231746,1.0,2/8,8.84%,RPS27A;UBC
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.6840764124257901,-1.0514278061688027,0.45,0.8133757010231746,1.0,2/8,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6595476688433727,-1.0512594241170534,0.5,0.8134130349171733,1.0,1/7,1.46%,TSG101
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.6350045771240078,-1.0512223787754018,0.4626865671641791,0.81307417267413,1.0,2/8,13.07%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5540107985832442,-1.0510074413830708,0.42168674698795183,0.8132498439821433,1.0,7/25,13.23%,PPARG;MAGI2;STARD4;KLF4;NFKBIA;CDKN1A;RAB1A
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.7255231159295644,-1.0508414698155593,0.47368421052631576,0.8132816583527176,1.0,1/5,5.02%,SEMA6B
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5985081062199553,-1.0507884784857613,0.46153846153846156,0.8130372608206982,1.0,2/15,10.15%,PRKN;PRNP
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,-0.687928458918231,-1.0507397854434875,0.46153846153846156,0.8127875821069666,1.0,1/5,8.26%,RAP1A
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5490169523760966,-1.0507288075199455,0.4605263157894737,0.8124001932182621,1.0,9/18,26.72%,LGALS3;ANXA1;RAB30;LCP2;ZBTB46;FTL;HLA-B;CAMK2D;CD74
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.41137017104516355,1.05031440779017,0.2631578947368421,1.0,1.0,2/31,3.32%,ZMAT1;EVL
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.607819807379896,-1.0498588258821437,0.4383561643835616,0.8142469592686119,1.0,5/12,27.99%,PIK3R1;CDKN1A;GRB2;SPTBN1;STAT5B
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4937165334850314,-1.0497832651651637,0.3522727272727273,0.8140797468655154,1.0,12/72,14.58%,LAMC1;PLS3;HES1;CD9;NES;SMARCA1;PECAM1;KLF4;GJA1;MYO1B;NAV2;SMAD3
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.46513173054371193,1.04939847264608,0.38095238095238093,1.0,1.0,2/16,4.67%,GXYLT1;C1GALT1
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.6572536134327502,-1.0493802004728285,0.4925373134328358,0.8147447225366311,1.0,2/6,29.93%,KLC1;RHOA
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6824746543035308,-1.049226628495736,0.4788732394366197,0.8146600412148269,1.0,3/5,29.91%,PIAS2;NCOR2;SMARCA4
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6918885529320682,-1.049226005419339,0.49230769230769234,0.8142616744465069,1.0,3/5,26.72%,PLCG2;GPRC5B;CD74
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.531990734581698,1.0491791142808902,0.35714285714285715,1.0,1.0,6/12,15.46%,ARID5B;KDM7A;UTY;KDM5A;KDM4C;KDM6A
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5870722943762205,-1.0490222263373343,0.48717948717948717,0.8143258664259031,1.0,4/15,9.72%,SLCO4A1;SLC4A10;SLC52A3;SLC4A7
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.655850655491971,1.048926309712525,0.41935483870967744,1.0,1.0,2/7,14.66%,ARHGAP12;SPRY3
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.5036302769147205,-1.048921056970057,0.38461538461538464,0.8142415138290996,1.0,15/46,17.00%,KLF6;NFKBIZ;JUNB;PSMB9;FOS;LRRFIP1;DUSP1;KLF2;CLEC2B;ARPC2;ZFP36;NFKBIA;BTG1;MCL1;PNRC1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5499032631067101,-1.048855627032531,0.4375,0.8139978409649726,1.0,4/27,16.49%,GAPDH;LRRFIP1;RIOK3;TBK1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.618394378719186,-1.0487086237325085,0.4868421052631579,0.8140071281184998,1.0,5/12,28.18%,HIF1A;RAB21;PAFAH1B1;KIF1B;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.6281439226375911,-1.047955965435446,0.4696969696969697,0.8156637902955205,1.0,3/7,16.65%,PRKN;SREBF2;PINK1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,-0.6835430432992857,-1.047911209822356,0.45454545454545453,0.8154142917939244,1.0,2/6,12.46%,LAMA5;PLEC
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.5994899792124815,-1.047855943617509,0.3918918918918919,0.8152144098216546,1.0,4/12,20.35%,WDR48;PIK3R1;GRB2;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6714585758614373,-1.0475582221217512,0.4827586206896552,0.8154753160755103,1.0,4/6,16.65%,HIF1A;PRKN;RACK1;PINK1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.5458158622217184,-1.0475019029619295,0.4266666666666667,0.8152262737422323,1.0,8/31,19.07%,DENND3;MYO9B;EPS8;DLC1;OGT;ARHGAP17;ERBIN;GRB2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.47463684847819315,-1.0474017182393647,0.4479166666666667,0.8150925100954454,1.0,32/165,14.00%,PSMC6;ST18;CX3CL1;JUNB;PSMB9;FOS;RPS27A;CDKN1B;CANX;JAK1;PIK3R1;LAMA5;PSMA1;IFNGR1;ARF1;IFNGR2;HIF1A;BCL6;UBC;ANXA1;TMSB4X;SOD2;CFL1;S1PR1;LIMS1;PAK2;INPP5D;NFKBIA;TEC;CDKN1A;PELI1;MSN
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5865337778093781,1.0473937921396181,0.4594594594594595,1.0,1.0,1/6,2.18%,GCH1
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.5481617686981558,-1.0472585782026205,0.3815789473684211,0.8150355301409453,1.0,5/32,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6610479936537811,1.0470002757435433,0.4864864864864865,1.0,1.0,1/5,2.18%,GCH1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.4827940079738623,-1.0468748781391695,0.43333333333333335,0.8155805908588554,1.0,8/82,6.43%,DOK5;NRCAM;MAP1B;S100A6;SEMA6B;FEZ2;PIK3R1;LAMA5
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.6324046741823887,1.04677759505373,0.5111111111111111,1.0,1.0,1/5,8.71%,CARMIL1
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.695103262051592,-1.0466610719137335,0.45714285714285713,0.8157695761546061,1.0,3/7,17.34%,LBR;VRK2;KPNB1
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.5048459793951003,-1.0466253503358223,0.4,0.8154772574517253,1.0,7/30,19.07%,MYO9B;VAV3;WIPF1;ARPC2;NCK1;MYO1E;GRB2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.6907784709440601,-1.0466187873160762,0.4782608695652174,0.8146968400496128,1.0,2/5,17.56%,PRNP;MTMR2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.6907784709440601,-1.0466187873160762,0.4782608695652174,0.8146968400496128,1.0,2/5,17.56%,PRNP;MTMR2
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.527885146210501,-1.0459890605182431,0.39759036144578314,0.8159449960423354,1.0,5/37,1.62%,PKM;ITPR1;LDHA;PCK1;PRKAG2
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.34728054483222476,1.0459561540037854,0.25,1.0,1.0,16/89,16.02%,NHLRC2;RBM26;MGA;CHD9;SLF2;PPIP5K2;BDP1;SCAF8;ZMYM4;CENPC;PCM1;ANKRD17;HELZ;PHF3;ANKRD26;MKLN1
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.5190871167990567,-1.0459401906148238,0.46987951807228917,0.8157022691843883,1.0,12/44,18.01%,PSMC6;PSMB9;RPS27A;PSMA1;PACS1;AP1G1;UBC;TPR;NPM1;SGIP1;KPNB1;NUP54
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.5986853137181634,-1.0455077650913698,0.4520547945205479,0.8164251414075807,1.0,1/13,3.80%,MAP1B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5983327387018552,-1.0454715431223196,0.4225352112676056,0.8161279031998037,1.0,9/12,36.33%,KLF4;PAK2;XIAP;CSNK2A1;MAP2K5;RPS6KA3;DDX3X;DNAJB6;YWHAE
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.5938427699959763,-1.045409587491613,0.4025974025974026,0.8158854402689697,1.0,4/11,27.04%,GOLPH3;PREPL;ANK3;SPTBN1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.593783795483777,-1.045257854476002,0.43243243243243246,0.8159917634526279,1.0,3/13,8.84%,RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.5669565727118975,-1.0450735414216246,0.42857142857142855,0.8161959665182883,1.0,6/20,17.56%,LGALS3;NDFIP1;PRKN;DYSF;RACK1;MTMR2
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,-0.564970110618074,-1.0449259064084007,0.417910447761194,0.8161116069891684,1.0,9/20,30.23%,PIK3R1;BCAR1;NCK1;GRB2;PLAT;PIK3CB;STAT5B;CRK;STAT3
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.7090402007870562,-1.0448083226825526,0.5,0.8159946996202458,1.0,2/7,14.61%,NES;CACNA1C
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.539882887088895,1.0446911308646671,0.40540540540540543,1.0,1.0,1/10,0.82%,PSMD14
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.6551685237006186,-1.0446047793441282,0.43661971830985913,0.8162257834572776,1.0,2/9,13.33%,PRKN;FOXK1
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.7143398963598336,-1.044408921790804,0.4603174603174603,0.8164566442404125,1.0,2/6,16.49%,NFKBIA;TBK1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.678893049472914,-1.044350899993926,0.45454545454545453,0.8161551075658025,1.0,3/7,12.43%,PRKN;HERPUD1;TMBIM6
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.6381875573718896,1.044254637583087,0.48484848484848486,1.0,1.0,1/5,3.11%,RNLS
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.6381875573718896,1.044254637583087,0.48484848484848486,1.0,1.0,1/5,3.11%,RNLS
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.6535874075361398,-1.0442242839830627,0.4411764705882353,0.815580031731243,1.0,3/9,8.84%,TSG101;RPS27A;UBC
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.6535874075361398,-1.0442242839830627,0.4411764705882353,0.815580031731243,1.0,3/9,8.84%,TSG101;RPS27A;UBC
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6821286734022386,-1.043808561275956,0.46551724137931033,0.816277094355435,1.0,1/6,3.98%,CCDC14
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.6019306876570352,1.0435039892176778,0.375,1.0,1.0,2/6,7.94%,HSPD1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4621311329968924,-1.0434401231748522,0.44086021505376344,0.8169789056552778,1.0,21/136,12.99%,PIK3R3;VSIR;RPL23;TAF1D;GAPDH;RIMS1;NFE2L2;PIK3R1;IFNGR1;HIF1A;ANK2;PRKN;KLF4;AFDN;LIMS1;RPS7;GJA1;PLCG2;RIMS2;CLDN5;NPM1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5677520498328258,-1.0433506840151272,0.4492753623188406,0.8167807716702157,1.0,4/18,13.71%,NEDD9;RREB1;LIMS1;CASS4
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,-0.45427194190371933,-1.043016505759433,0.3838383838383838,0.8172975663584852,1.0,43/245,18.19%,TBX3;B3GNT2;ITPR1;SLCO4A1;RFTN1;MDGA2;GLUL;MAP1B;LGALS3;EPS8;ADSS2;ESR2;CDKN1B;ERBB4;MGAT4A;BAZ1A;ELL2;SLC8A1;HIP1R;VAV3;PECAM1;KLHL7;CCNH;HERPUD1;ITGB5;DYSF;BRI3;NFKBIA;UGGT2;NOSTRIN;PON2;SH3KBP1;NAV2;MAX;THRB;TBCD;ENTPD4;RASGRF2;FAM13A;TSC22D1;MYO1E;ARHGAP15;ANK3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.5312113067109022,-1.0429356857040608,0.43902439024390244,0.8171211180010992,1.0,11/24,29.93%,SEPTIN11;SPIRE1;MYH10;ANK3;CHMP4B;ECT2;RASA1;SNX9;SPTBN1;RHOB;RHOA
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.5923375321897321,-1.042791128636921,0.5384615384615384,0.8170584382707137,1.0,4/11,22.42%,PECAM1;ITGB1;CD34;PODXL
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.6450032251107221,-1.042611147835623,0.47540983606557374,0.8170390737929986,1.0,1/8,1.78%,RFC3
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5456108484613472,-1.0423439341854033,0.4050632911392405,0.8172845378477488,1.0,7/27,15.59%,JUN;NES;KDM1A;TMBIM6;NFKBIA;CDKN1A;RACK1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.5255464976532819,-1.0423145583482574,0.4074074074074074,0.8169571870593855,1.0,4/39,5.47%,PRKAG2;RFC3;RPL23;RPL37
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.6500145852350546,-1.0421999265257984,0.39705882352941174,0.8168839080008049,1.0,2/8,15.22%,RAD21;PPHLN1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.6160835068577066,-1.04216639446102,0.44285714285714284,0.8165840456852594,1.0,7/14,25.07%,DMD;PRKCE;ANK3;STK39;NEDD4;NEDD4L;CAMK2D
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,-0.5635248356573602,-1.0421579377838497,0.4520547945205479,0.8162359253934118,1.0,5/18,25.05%,CD9;ITGB5;CTNNA1;CD63;DSP
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.5929649398756863,-1.0417363239913722,0.43661971830985913,0.8170634513649314,1.0,3/10,9.06%,CD9;PECAM1;CD81
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5584615327435948,-1.0414168124255039,0.45977011494252873,0.8176099694236518,1.0,7/29,15.59%,PSMC6;SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.6041134422767422,-1.041394416250034,0.4492753623188406,0.8172672441374079,1.0,4/15,15.33%,GGT5;PRNP;SLC26A2;SULT1C4
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6530858880814735,-1.0413384136169077,0.45454545454545453,0.8170056007828697,1.0,4/8,25.66%,RIOK3;RPS28;RPS19;RPS14
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.5472104192315882,-1.0413305701624838,0.45569620253164556,0.8166365868715487,1.0,4/19,11.93%,KDM1A;EPAS1;OGT;GJA1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.6404669698520735,-1.0412291235172304,0.45901639344262296,0.8164991995175824,1.0,4/9,19.18%,NES;PECAM1;ITGB1;CD34
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.6022128447063513,-1.041018301636939,0.5396825396825397,0.8158622518717626,1.0,3/10,19.18%,PECAM1;ITGB1;CD34
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.6022128447063513,-1.041018301636939,0.5396825396825397,0.8158622518717626,1.0,3/10,19.18%,PECAM1;ITGB1;CD34
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.6022128447063513,-1.041018301636939,0.5396825396825397,0.8158622518717626,1.0,3/10,19.18%,PECAM1;ITGB1;CD34
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5674062855904115,-1.041007841100537,0.48717948717948717,0.8155000312570764,1.0,5/22,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.6319545181562202,1.0408772267318815,0.5,1.0,1.0,1/6,3.64%,GMDS
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.39553737712234993,1.0404923285862444,0.35,1.0,1.0,10/42,14.21%,PSMD14;UIMC1;HERC2;INO80;ATM;RAD51B;SEM1;BABAM2;SPIDR;MCM9
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.625748254350069,-1.040436883381956,0.4647887323943662,0.8167693122210351,1.0,2/9,13.15%,NGLY1;UGGT2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6584277319585314,-1.040271613820038,0.5142857142857142,0.8167931470376363,1.0,4/7,19.76%,RTN4;PRNP;PICALM;CLU
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.46984060434724767,1.0401038028219562,0.3548387096774194,1.0,1.0,3/14,9.08%,SLCO1A2;NCOA2;ABCG2
prerank,KEGG_2021_Human__Olfactory transduction,-0.6506960534660216,-1.0400409443283327,0.48,0.816934890935673,1.0,3/8,8.37%,ANO2;SLC8A1;NCALD
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.6007802112755621,-1.0399900147400476,0.4927536231884058,0.8166907250492317,1.0,6/10,29.85%,ATP1B3;ITGB1;BSG;SLC3A2;ATP1B1;SLC7A11
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.614225611757821,-1.0399653630195531,0.45454545454545453,0.8163450382136226,1.0,3/9,18.83%,CDKN1A;DCP2;ACVRL1
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.54291925075712,-1.0398351486147484,0.49333333333333335,0.8162566187832757,1.0,6/30,8.84%,PSMC6;RFC3;PSMB9;RPS27A;PSMA1;UBC
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.6046509483871785,-1.039636959321586,0.5324675324675324,0.8163555454551066,1.0,5/19,19.31%,RPS27A;CANX;UBC;PIK3C3;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6432574389843303,-1.0393214431130449,0.39705882352941174,0.816753855083161,1.0,3/9,20.16%,ARF1;MTMR2;SLC30A1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.5129037322673904,-1.0392788440273844,0.4358974358974359,0.8164569022164422,1.0,3/42,6.48%,PSMC6;PSMB9;PSMA1
prerank,KEGG_2021_Human__Amphetamine addiction,0.4637370770136394,1.039236909583822,0.375,1.0,1.0,1/21,0.03%,CREB5
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.5767321971239423,1.0389583947302647,0.5625,1.0,1.0,4/10,14.98%,COL8A1;RTF1;ITGA5;LAMA3
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,-0.5461440511829388,-1.0388132104191912,0.45454545454545453,0.8174104292055652,1.0,10/32,21.83%,KIAA1217;NES;LAMA5;GJA1;MYO1B;BCAR1;DAG1;BOC;EGFR;GLI3
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.45676255256446746,-1.0387121558095427,0.4897959183673469,0.8172683121757927,1.0,30/211,14.00%,PIK3R3;PSMC6;JUN;PSMB9;FOS;SMAD7;RPS27A;CDKN1B;CANX;JAK1;PIK3R1;LAMA5;PSMA1;IFNGR1;IFNGR2;HIF1A;BCL6;UBC;ANXA1;IL1RAPL1;S1PR1;ALPK1;TPR;MEF2A;INPP5D;NFKBIA;TEC;CDKN1A;PELI1;MSN
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.4909869521176027,-1.0386117624835929,0.4431818181818182,0.8171476805572858,1.0,12/57,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;UBC;NFKBIA;CYLD;SMAD3;USP34
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.6956109295468462,-1.038556379349079,0.47619047619047616,0.8169524714597215,1.0,1/5,5.34%,NDFIP1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6606802350176928,-1.0384224150005454,0.5230769230769231,0.8168854297747542,1.0,3/7,8.15%,DMD;SLC8A1;TPM1
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,-0.6741583959649531,-1.038138136305943,0.47058823529411764,0.8173088187452131,1.0,4/5,23.27%,PECAM1;VWF;CD34;CDH5
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,-0.6049432117241735,-1.0379471041090333,0.44285714285714284,0.8172629820930825,1.0,4/14,6.27%,NRG3;CDC37;ERBB4;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7219449379824948,-1.037852966694925,0.4745762711864407,0.8170947129944437,1.0,3/5,26.37%,SREBF2;KPNB1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.594219881659189,-1.0376912999564485,0.391304347826087,0.817064988471287,1.0,4/17,14.61%,BCAP31;SLC8A1;CD55;CACNA1C
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.5408903960646044,1.037618585743511,0.4,1.0,1.0,3/10,5.60%,PLPPR4;PLA2G4A;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.5449305615799338,-1.0375520044728674,0.38235294117647056,0.8170565720517908,1.0,3/20,8.15%,CX3CL1;RAPGEF3;TPM1
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.507811927524584,-1.0375088283767215,0.42857142857142855,0.8168248290383852,1.0,22/54,28.21%,SCARB2;RPS27A;HIP1R;UBC;ARPC2;SYNJ2;SH3KBP1;SYT1;SH3GL1;SGIP1;PICALM;PIP5K1C;GRB2;EGFR;CLTA;DNM2;SNX9;TF;SYNJ1;FZD4;FCHO2;DNAJC6
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,0.6682372366786414,1.0373806321954206,0.5357142857142857,1.0,1.0,3/5,13.28%,HADHB;ACBD6;DECR1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.5318902967540415,-1.0369840593236967,0.4025974025974026,0.8174510556099382,1.0,3/29,7.86%,LAMC1;MGAT4A;SHISA5
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.5318902967540415,-1.0369840593236967,0.4025974025974026,0.8174510556099382,1.0,3/29,7.86%,LAMC1;MGAT4A;SHISA5
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7166458293951051,-1.0369312524347962,0.5,0.8172035245643425,1.0,2/5,18.19%,DMD;ANK3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.5367117320392041,-1.0365977608717734,0.4155844155844156,0.8176886565330925,1.0,5/25,8.98%,LAMC1;NR4A1;RTN4;HIF1A;RREB1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.5237992141951489,-1.0365425979451592,0.4470588235294118,0.817425331937753,1.0,6/33,13.89%,SLC4A10;SCARB2;KIAA1217;SMARCA1;SHC2;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.6322637920255403,-1.0365118049178057,0.5068493150684932,0.8171463480279838,1.0,2/11,11.02%,NRCAM;FGFR1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6686178103066862,-1.0364162714884617,0.515625,0.8170372256785801,1.0,3/6,18.73%,PECAM1;MSN;ITGB1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6678853187964084,-1.0362388462786232,0.47368421052631576,0.8171242124369269,1.0,2/8,17.66%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5469241220368873,-1.036208411758513,0.44871794871794873,0.8168192889450109,1.0,8/29,21.81%,SUN2;SPC25;RPS27;PAFAH1B1;KPNB1;MECP2;DYNC1I2;EML4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6058002143927507,-1.0358847737354677,0.4473684210526316,0.8172026757689013,1.0,3/9,17.56%,RIMS1;RIMS2;MTMR2
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.5159780161737697,-1.0356976154168707,0.4666666666666667,0.817300042150737,1.0,9/29,24.67%,MYO9B;VAV3;WIPF1;ARPC2;NCK1;MYO1E;GRB2;ABI1;HSP90AA1
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.5208239442762153,-1.0356725684623758,0.4166666666666667,0.8169901782249024,1.0,6/33,15.27%,PPP2R3A;MAP1B;UGGT2;NAV1;NAV2;WWTR1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.636193668688735,-1.0352884185950872,0.4647887323943662,0.8174522203628172,1.0,3/10,25.58%,DUSP1;CAV2;TOM1L2
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5988104901571414,-1.0351794110944537,0.4492753623188406,0.81733803037359,1.0,4/11,14.85%,RPS27A;UBC;CCNH;USP45
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.523008543661596,-1.035097171632858,0.5,0.8172081072728494,1.0,7/39,8.84%,PSMC6;PSMB9;LGALS3;PPM1D;RPS27A;PSMA1;UBC
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,-0.5926344100379519,-1.0350963840001592,0.5,0.8168249811091022,1.0,4/13,21.12%,PDE5A;STK38;SRRM1;TRA2B
prerank,KEGG_2021_Human__Prostate cancer,-0.5139566470191452,-1.034918871301262,0.47058823529411764,0.8169328009799346,1.0,3/44,6.27%,PIK3R3;CDKN1B;PIK3R1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.5905503649429553,-1.034882124060207,0.4520547945205479,0.8166187072181048,1.0,8/15,24.91%,CDC37;ERBB4;PIK3R1;ERBIN;GRB2;EGFR;HSP90AA1;NRG2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.5908018880542838,1.0343790727110844,0.375,1.0,1.0,3/6,17.50%,NNT;ATP6V1H;SLC25A27
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.6704087586259462,-1.0343515672558534,0.5081967213114754,0.8176329952823039,1.0,4/7,30.97%,CACNA1C;SCN2A;CAMK2D;SCN3A
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6205111066167868,-1.0342130333453827,0.45588235294117646,0.8175559153712425,1.0,4/14,9.11%,RPS27A;PURA;UBC;ANXA1
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,0.6380490637623142,1.0341826724411873,0.4772727272727273,1.0,1.0,1/5,8.55%,ENTPD1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5154424755230494,-1.033916173919161,0.4523809523809524,0.8179001283160341,1.0,3/25,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.565724570374948,-1.0339028088909665,0.5362318840579711,0.8175493301015102,1.0,4/20,11.18%,ENPP2;PIK3R1;RREB1;ARPC2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6783456014958082,-1.0336582086771868,0.5074626865671642,0.8177722366417024,1.0,2/6,7.81%,PRKAG2;SLC2A1
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,-0.6352051744786327,-1.0336579855331287,0.44594594594594594,0.8173902785676054,1.0,5/10,14.98%,GRIA2;STXBP5L;RIMS2;SYT1;EFR3B
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5733035233062431,-1.0335315702844319,0.4583333333333333,0.8173555353105445,1.0,4/13,11.02%,KIAA1217;FOXF1;SULF2;FGFR1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4265323674072719,1.033412185261391,0.36,1.0,1.0,3/29,4.49%,EVI5;TBC1D5;RALGAPA2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6694909850789504,-1.0333372935638658,0.5,0.8174574018180479,1.0,2/8,12.72%,JAK1;PAK2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.5206359196697704,-1.033331241092781,0.3855421686746988,0.8170813755693337,1.0,6/34,4.44%,GRIK1;SYN3;NRG3;GRM7;KCNMB4;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6381230554943911,-1.0333150499117345,0.5072463768115942,0.8167476845416435,1.0,4/8,29.93%,KLF4;DLL4;MAP2K5;RHOA
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.5953311268096587,-1.0330201948930418,0.5540540540540541,0.8170385346166877,1.0,2/10,3.29%,GRIK1;NRG3
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.4873527962181565,1.0327763646148191,0.38461538461538464,1.0,1.0,4/13,13.39%,UIMC1;ATM;BABAM2;STK33
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.7002659574468085,-1.032422666323602,0.5333333333333333,0.8182991035302071,1.0,5/5,30.09%,COMMD1;STK39;NEDD4L;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.4532408311943478,-1.0322749424225746,0.43434343434343436,0.818243071230446,1.0,43/324,13.73%,LAMC1;B3GNT2;PSMC6;PPP2R3A;MAP3K5;UFL1;PRKAG2;ERO1A;PKN3;GRK5;PSMB9;SSH1;PPM1D;MACROD2;DUSP1;JAK1;MGAT4A;PSMA1;PRKCE;PTPRD;FEM1C;HIF1A;SHISA5;COMMD1;PLOD2;ANXA1;NGLY1;TGM2;SIK2;ZDHHC6;DUSP16;CDK14;EPAS1;FGFR1;MSRA;RAB2A;DCLK1;PAK2;DUSP5;TEC;RAB1A;TRIB2;CST3
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,-0.5047728371226531,-1.0316331254378412,0.4074074074074074,0.8194128552243681,1.0,13/46,19.18%,TIMP3;GGT5;FLT1;VWF;DLC1;EPAS1;CFH;CLDN5;PLSCR4;NOTCH4;TIE1;ACVRL1;CD34
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.6338836329554343,-1.031224463354207,0.5138888888888888,0.820110322576556,1.0,2/10,8.34%,MTFR1;PRKN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,0.4492005152819883,1.0310802875021976,0.375,1.0,1.0,5/25,7.76%,SAMD9L;GBP2;GBP4;TRIM22;XAF1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.5361694754144135,-1.031078413832882,0.5131578947368421,0.8200378260760178,1.0,4/23,11.93%,KDM1A;EPAS1;OGT;GJA1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.5266886115068432,-1.0309502853308938,0.4268292682926829,0.8199340109163493,1.0,14/42,19.07%,KDM1A;NFE2L2;JAK1;IFNGR1;IFNGR2;S1PR1;ATP1B3;PLCG2;SH3KBP1;NCK1;RCOR1;TBK1;ITGB1;GRB2
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,-0.6377258676201542,-1.030892774048279,0.5,0.8196577491795084,1.0,3/7,19.18%,PECAM1;ITGB1;CD34
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6656319373805388,-1.0308492702428922,0.5076923076923077,0.8193869701019286,1.0,2/6,20.29%,CFL1;CAV2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.5141178473073053,-1.0308101491485566,0.46511627906976744,0.8191112186037366,1.0,14/44,23.35%,CX3CL1;DUSP1;PEBP1;FLT1;FGFR1;PLCG2;PAK2;VRK2;DAG1;EGFR;CAV2;SPRED1;PHLPP1;JCAD
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.47803891028077267,-1.030802024118457,0.4065934065934066,0.8187469607907129,1.0,13/91,13.23%,LAMC1;SEC22B;CX3CL1;SEC24D;HES1;RIMS1;DMD;SPG7;SLC2A1;AFDN;WIPF1;TMED10;RAB1A
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6194018216869157,-1.030674928211654,0.4461538461538462,0.8186178903311878,1.0,3/7,15.17%,SDCBP;VEGFC;ANKS1A
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.5216572151704285,-1.0306749187493058,0.4,0.8182385493254737,1.0,6/28,9.40%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;CCNH
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6639072997428307,-1.0303780386165295,0.423728813559322,0.8182366076424684,1.0,2/5,9.93%,PRKN;TGM2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6639072997428307,-1.0303780386165295,0.423728813559322,0.8182366076424684,1.0,2/5,9.93%,PRKN;TGM2
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,0.46491004336820935,1.0302445787898316,0.45454545454545453,1.0,1.0,2/19,1.86%,GBP2;GBP1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.6031383542183307,-1.0302145513596777,0.4794520547945205,0.8182694980791988,1.0,4/11,12.72%,PIK3R1;DLC1;TMEFF2;PAK2
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.6237266052068692,-1.029915771771646,0.43243243243243246,0.8186355939701011,1.0,3/11,8.84%,TSG101;RPS27A;UBC
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,-0.49922039177524535,-1.0298480177045768,0.4634146341463415,0.8184652978022905,1.0,19/49,27.57%,LRRC32;GGT5;TNS1;VWF;EPAS1;CFH;DYSF;CLDN5;PLSCR4;NOTCH4;TIE1;ACVRL1;CD34;SPARC;CDH5;TNS2;SPARCL1;LAMA4;RHOJ
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4304847928486356,1.0298235709174544,0.3793103448275862,1.0,1.0,3/25,7.22%,EVI5;TBC1D5;MYO10
prerank,CellMarker_Augmented_2021__B cell:Kidney,-0.4644653319925644,-1.0297805654418877,0.43,0.8182483410388983,1.0,31/178,13.94%,LAMC1;RAPGEF5;PCDH9;NR4A1;AKAP12;CHPT1;PKIG;TAF1D;ATP2B1;ALPL;MACROD2;KLF2;IFNGR2;ANK2;RPS11;HIP1R;CD55;STEAP1B;AFF4;NGLY1;CDK14;GPM6A;ERO1B;MEF2A;BTNL9;NOC3L;INPP5D;NPM1;LRRC4C;MTHFD2L;SMC6
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.5587436373552627,-1.0291575172125804,0.52,0.8194718726915676,1.0,3/21,12.99%,RFC3;POLA1;NPM1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6471222098783337,-1.0289992264689924,0.4492753623188406,0.8195456944668791,1.0,1/8,5.74%,ANO2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.527544028947654,-1.028621093388032,0.4457831325301205,0.8200817850209698,1.0,9/44,10.04%,PSMC6;ST18;CX3CL1;PSMB9;RPS27A;PSMA1;HIF1A;UBC;HYAL2
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.6224398346236948,-1.0284774764936382,0.4864864864864865,0.8200358321555511,1.0,6/9,37.37%,MEF2A;DUSP6;RPS6KA2;RPS6KA3;MEF2C;MAPK1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.5194521796927364,-1.0284528561405335,0.46987951807228917,0.8197044712929502,1.0,7/35,9.83%,ZEB2;CLIC2;SRGN;TM6SF1;PECAM1;CLEC2B;SOD2
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,0.4635451786735906,1.0282005513312849,0.2857142857142857,1.0,1.0,2/22,0.21%,MMRN1;ZMAT1
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,-0.5874415515806513,-1.028025978962775,0.4935064935064935,0.8203590626842456,1.0,3/19,7.17%,KLF6;TIMP3;EMP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6602479904522445,-1.027956654603784,0.45,0.8201834149623372,1.0,1/7,4.57%,SMAD7
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4872250999560107,-1.0279499297791486,0.4074074074074074,0.8198213468033879,1.0,9/52,10.15%,MAFF;LRRC32;FES;PECAM1;SCARF1;TNS1;VWF;PLXDC2;PRNP
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5003946843286791,-1.0276283828594084,0.4318181818181818,0.8202781234760776,1.0,10/42,9.77%,SERPINE1;SYTL4;SRGN;CD9;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.5357826520909496,1.0273950485582484,0.3793103448275862,1.0,1.0,1/13,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.49142695114202817,-1.0270272976091888,0.4166666666666667,0.8213454922124713,1.0,14/52,22.36%,PPARG;FES;REL;CALCOCO2;ALPK1;PLCG2;CYLD;MALT1;TBK1;SERINC3;ADAM15;IFITM3;CAPZA2;B2M
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5871121602570301,-1.0269792270682727,0.3950617283950617,0.8210920786481427,1.0,6/15,16.65%,BCAP31;HERPUD1;CYLD;RACK1;MCL1;PINK1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6009006165848308,-1.0269684438689335,0.5076923076923077,0.8207354317821737,1.0,8/15,27.20%,PPARG;LGALS3;DUSP5;LCP2;SELENOP;CPM;CD74;MARCHF1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.5800815015810712,-1.026657229855182,0.5147058823529411,0.8211444108835066,1.0,2/15,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6432956242389777,1.0266381437432803,0.5641025641025641,1.0,1.0,1/5,11.00%,BCOR
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.6364498592005677,-1.0265350417804664,0.49230769230769234,0.8203758629420351,1.0,2/7,18.91%,SPG7;MICU2
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.6364498592005677,-1.0265350417804664,0.49230769230769234,0.8203758629420351,1.0,2/7,18.91%,SPG7;MICU2
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.6364498592005677,-1.0265350417804664,0.49230769230769234,0.8203758629420351,1.0,2/7,18.91%,SPG7;MICU2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5680781261754217,-1.0262203023058973,0.3902439024390244,0.820681027811794,1.0,3/20,6.51%,RFC3;POLA1;BAZ1A
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,-0.6782097808724178,-1.026193805702663,0.5178571428571429,0.820325550025583,1.0,3/5,27.94%,ITGB1;CD34;VIM
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.6985266857238654,-1.0261459549076195,0.4,0.8200374353062736,1.0,3/5,15.46%,CD9;ANXA1;CDK6
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.5215831730498852,-1.0261118144210506,0.45,0.8197650475114896,1.0,8/39,13.76%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;ALPK1;NFKBIA;PELI1
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.5477313166780351,1.0260761450745628,0.34285714285714286,1.0,1.0,2/7,9.19%,TBL1X;TBL1XR1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.5101469889951853,-1.0260318757391806,0.4457831325301205,0.8195341250586685,1.0,17/41,24.70%,RTN4;ENPP2;PRKCE;HIF1A;RREB1;PLCG2;BCAR1;MTOR;SCARB1;PIK3CB;ATOH8;SASH1;SPARC;ADAM9;ANXA3;CALR;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5882800176984495,-1.0259940695530938,0.4864864864864865,0.819293114589267,1.0,3/15,4.57%,UFL1;SPOPL;SMAD7
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.6951161424026238,-1.0258326845739472,0.5238095238095238,0.8192633634378856,1.0,4/6,28.37%,KIF16B;INPP5F;ECE1;ANXA2
prerank,KEGG_2021_Human__Type I diabetes mellitus,0.5614304356567977,1.0256382428801576,0.5,1.0,1.0,1/8,4.99%,HSPD1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.4930008509166743,1.0252935853518095,0.5,1.0,1.0,1/13,1.81%,UBE3D
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5417183810931145,-1.0252812372522786,0.4861111111111111,0.8202934967310797,1.0,7/17,21.01%,MGAT4A;UGGT2;ALG11;B4GALT1;PMM2;TMEM165;UBE2J1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.41670569962991644,1.0243419019282143,0.42857142857142855,1.0,1.0,4/36,8.29%,CTBP2;ATP2A2;GOLM1;YWHAG
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.41670569962991644,1.0243419019282143,0.42857142857142855,1.0,1.0,4/36,8.29%,CTBP2;ATP2A2;GOLM1;YWHAG
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.41670569962991644,1.0243419019282143,0.42857142857142855,1.0,1.0,4/36,8.29%,CTBP2;ATP2A2;GOLM1;YWHAG
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.6177474750490497,-1.0236367448289245,0.5223880597014925,0.8241305417425497,1.0,2/11,15.38%,RAB1A;PAFAH1B1
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.45708641990936555,1.0232011994089014,0.3125,1.0,1.0,1/21,0.03%,CREB5
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.5504408376378518,-1.0230107818178746,0.48,0.8253477006815796,1.0,5/25,4.78%,NRCAM;RTN4;GRM7;MAP1B;S100A6
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,-0.45689663540475584,-1.022560642969632,0.46,0.8261321655164698,1.0,31/227,11.16%,LAMC1;DIXDC1;ANGPTL4;RAPGEF5;ADM;PLS3;NEDD9;ADAMTS9;LBR;DENND3;RFC3;KLF6;AKAP12;SSH1;LRRFIP1;LRRC32;CDC37;TIMP3;ASAP2;TMEM184B;GGT5;BAZ1A;REL;VAV3;PNP;KLF4;TMSB4X;HYAL2;WIPF1;EFNB2;LIMS1
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.5898969516332525,-1.02227943786712,0.5,0.8264485795913304,1.0,1/10,1.41%,LDHA
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5425039177502847,-1.022174117386918,0.5333333333333333,0.8263027164022192,1.0,7/25,18.99%,PPARG;HIF1A;TMSB4X;FGFR1;GATA2;ACVRL1;MECP2
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.5955363201999556,-1.0217127967541173,0.48484848484848486,0.8270394954889786,1.0,4/13,18.01%,PBRM1;TPR;KPNB1;NUP54
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,-0.663815965061451,-1.0214764153474083,0.5333333333333333,0.8273396781533966,1.0,2/5,26.43%,NOTCH4;DLL4
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6595152634253877,-1.0212503688321237,0.5606060606060606,0.827583199280632,1.0,1/5,8.34%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.5044999586785339,-1.0212345971614596,0.46153846153846156,0.8272270068814598,1.0,13/39,20.48%,PPARG;SMAD7;RPS27A;MAGI2;UBC;SNX6;SMAD3;STRAP;SNX25;SMAD5;PPM1A;CD109;SPRED1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.5077600760533071,-1.0211425886743655,0.44,0.8270503921642348,1.0,7/40,11.39%,LAMC1;HES1;RIMS1;SPG7;SLC2A1;WIPF1;TPR
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6218876098415566,-1.0211372002309045,0.5428571428571428,0.8266845276153424,1.0,4/13,10.36%,PGK1;RPS27A;UBC;DUSP16
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.5486544558617121,-1.0209050590870195,0.4864864864864865,0.8269023193985571,1.0,2/16,8.84%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,-0.5009070205335338,-1.0208233269227498,0.4827586206896552,0.8266800619782247,1.0,4/45,5.58%,PCDH9;SPOCK1;MAP1B;ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6059218807142368,-1.020609563181388,0.4782608695652174,0.8269078824313852,1.0,4/12,9.99%,CX3CL1;SMAD7;JAK1;AFDN
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.43646541312218967,1.0204287142879438,0.4166666666666667,1.0,1.0,4/29,8.42%,IVNS1ABP;NOVA1;CDK12;WBP4
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4822831604838037,-1.020002694576082,0.45348837209302323,0.8279224216969051,1.0,16/72,19.39%,SERPINE1;RTN4;GAPDH;KDM1A;RREB1;CFL1;EPAS1;OGT;GJA1;SDCBP;SMAD3;WWTR1;RIF1;MTOR;RPS19;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.45688273477078345,-1.0198537641493988,0.45918367346938777,0.8278940923182281,1.0,14/141,11.16%,TBX3;BHLHE40;PPARG;PHF10;HES1;JUN;KDM1A;CDKN1B;ARID5A;BCL6;KLF4;ZFPM2;SNX6;LIMS1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.5963161706665657,-1.0196538398191928,0.5074626865671642,0.8279576835296216,1.0,2/13,14.61%,PBX3;CACNA1C
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,-0.6795343263110551,-1.019470559585033,0.5074626865671642,0.8276715407880069,1.0,3/5,19.18%,PECAM1;ITGB1;CD34
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,-0.6795343263110551,-1.019470559585033,0.5074626865671642,0.8276715407880069,1.0,3/5,19.18%,PECAM1;ITGB1;CD34
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.4693493704809031,1.0194564382214786,0.47619047619047616,1.0,1.0,1/20,0.03%,CREB5
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,-0.5163602794730119,-1.0189365668319996,0.43209876543209874,0.8285712733980322,1.0,14/52,19.18%,ENPP2;CLEC1A;LRRC32;FLT1;PECAM1;VWF;S1PR1;CACNA1C;SGIP1;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5143354477232002,-1.0187430730629417,0.45121951219512196,0.8287006912610999,1.0,3/25,6.48%,PSMC6;PSMB9;PSMA1
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.5848290102312723,-1.0186476534082076,0.5131578947368421,0.8286415243074268,1.0,3/20,8.47%,MAFK;NFE2L2;NPAS2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.6255431729845239,-1.0185874431217297,0.5205479452054794,0.8284093026718725,1.0,1/8,5.26%,POLA1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.6335513961767383,-1.0185247505684951,0.5606060606060606,0.8282129148135766,1.0,3/6,16.12%,CHPT1;LPIN2;SH2D3C
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5745001355286335,-1.018471527514876,0.49295774647887325,0.8279607494611068,1.0,1/15,3.80%,MAP1B
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.6791436207966849,-1.0182542102006358,0.5538461538461539,0.8281359114776504,1.0,4/6,31.42%,SYT1;REST;STXBP3;STXBP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.5141908031839618,-1.0178465925750178,0.5,0.8286971643039723,1.0,4/29,14.53%,PRKN;ARIH2;PELI1;AMFR
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.4853808460274147,-1.0177216433047809,0.39325842696629215,0.8286076795620454,1.0,6/54,9.56%,B3GNT2;ERO1A;NFKBIZ;S100A6;ANXA1;TRAM1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.587988182756926,-1.0176241526304408,0.4852941176470588,0.8284674991610004,1.0,3/12,15.46%,SPOCK1;ANXA1;CDK6
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.561262936625687,-1.0175297288027716,0.5,0.8282919177179255,1.0,11/21,30.04%,LBR;VRK2;KPNB1;NUP54;CHMP4B;TUBB6;TUBB4B;TNPO1;PPP2R2A;TUBA1B;NUP98
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5303686078000224,-1.0174318699061011,0.5232558139534884,0.8281367867756103,1.0,9/29,15.59%,BCAP31;SMAD7;NFE2L2;RNF19A;PRKN;ARIH2;HERPUD1;TRIB2;RACK1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5561073740369368,-1.0174109460742748,0.4166666666666667,0.8278043184016569,1.0,3/11,13.07%,JUN;KDM1A;NFKBIA
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.5332809173376615,-1.0173224484369008,0.49382716049382713,0.8275937932634286,1.0,7/22,19.42%,RPS27A;PIK3R1;UBC;SH3KBP1;SH3GL1;GRB2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7124098577433986,-1.0172082277962566,0.5873015873015873,0.8275759736986129,1.0,3/6,9.19%,PKM;JAK1;KLF4
prerank,PanglaoDB_Augmented_2021__Basophils,0.4714378372948518,1.0171921559251946,0.4230769230769231,1.0,1.0,3/18,3.82%,JAZF1;SLC26A3;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5449999114037427,-1.0170746845568897,0.44,0.827517658696339,1.0,4/15,16.47%,GPM6B;COMMD1;PICALM;CTNNA1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.671245157317953,-1.0170381246714626,0.5223880597014925,0.8272265599258812,1.0,1/8,3.35%,SLC4A10
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,-0.6543427988331435,-1.0169657802961525,0.45901639344262296,0.8270318510720364,1.0,2/5,12.14%,NES;DCLK1
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.6333834831027533,1.0168512508565564,0.55,1.0,1.0,1/6,0.03%,CREB5
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.6375602630895199,-1.0166932869583931,0.5466666666666666,0.8273278567291856,1.0,4/10,18.14%,RIMS1;RIMS2;SYT1;PREPL
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,-0.5095943957596429,-1.0163129235100647,0.45569620253164556,0.8279268868421855,1.0,17/40,28.37%,SERPINE1;EMP1;MSRB3;ANXA1;MSN;VEGFC;ITGB1;PLAT;SPARC;ANXA5;TUBB6;NID1;ELK3;ANO6;VIM;TPM4;ANXA2
prerank,KEGG_2021_Human__Renin secretion,-0.5718085657722662,-1.0160883096775415,0.4936708860759494,0.8281110685371569,1.0,3/18,15.51%,ITPR1;CACNA1C;PPP3CC
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.605766795691552,-1.0159258912073996,0.4782608695652174,0.8281738777093883,1.0,4/13,6.27%,NRG3;CDC37;ERBB4;PIK3R1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6165404675242148,1.0158726886660157,0.5161290322580645,1.0,1.0,1/6,6.08%,SMYD3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.5458197527522805,-1.0156985685147735,0.4935064935064935,0.8282719668160052,1.0,8/19,23.32%,PRKN;SOD2;SNX6;CPEB4;PINK1;CD34;CHMP4B;RASA1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.6870463266441993,-1.0154334578349604,0.47619047619047616,0.8284910665956768,1.0,3/5,21.30%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6248026757907243,1.0150106463144521,0.5151515151515151,1.0,1.0,2/6,14.69%,MVB12B;RBPJ
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,-0.6556097296450376,-1.0147327048931445,0.5172413793103449,0.8298598913769237,1.0,3/6,22.02%,STK38;BLCAP;FTL
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6964486557367114,-1.0144992357731752,0.5245901639344263,0.8301083313372171,1.0,3/5,23.77%,GJA1;AGO2;CALR
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.5237785495635128,1.0144314901322529,0.4375,1.0,1.0,2/10,2.82%,RSAD2;IL1R1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.44915262575837467,-1.0143868524918147,0.45263157894736844,0.829983662927563,1.0,9/105,9.00%,PSMC6;UFL1;PSMB9;RPS27A;RNF19A;PSMA1;PRKN;UBC;ARIH2
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5566666559881573,-1.0141985841301413,0.4657534246575342,0.8300958330824901,1.0,4/12,23.82%,CD81;ITGB1;B2M;HLA-B
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.5970275772644691,-1.0140649308262397,0.48717948717948717,0.83000652321805,1.0,1/14,0.50%,B3GNT2
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,-0.6284888584074163,-1.0140555449294368,0.46774193548387094,0.8296656811189133,1.0,2/7,15.43%,RAD21;SMC3
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5754292451526584,-1.0137590841078346,0.45714285714285713,0.8298985628293103,1.0,4/11,14.50%,LGALS3;PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.5050249775344192,-1.0135882525166948,0.4772727272727273,0.8299200711607139,1.0,14/46,22.12%,SSH1;FES;RAPGEF3;RAP1A;TGM2;GOLPH3;RIOK3;MSN;CTNNA1;TFPI;EGFR;RYR3;ADCY2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.5750083225024799,-1.0135821434535293,0.4342105263157895,0.8295696731371153,1.0,3/14,8.34%,SSH1;HIP1R;PRKN
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5319901321477284,1.0133454318534105,0.4,1.0,1.0,2/9,8.79%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.5193495029299958,-1.0131496798330741,0.4567901234567901,0.8301087047635851,1.0,7/34,11.66%,TSG101;PRKAG2;ATG12;RB1CC1;LAMP2;PRKN;GABARAPL1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.6337073200156078,-1.0130970797020173,0.45454545454545453,0.8298991237116818,1.0,2/7,14.82%,RPL10;RPL24
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5346372953273912,-1.0129376846287668,0.48148148148148145,0.829910555875739,1.0,7/21,14.71%,TSG101;DUSP1;FLT1;HYAL2;FGFR1;TRIB2;STK38
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5547934679892126,-1.0126420748962863,0.5185185185185185,0.8303032351892454,1.0,6/23,19.42%,TSG101;HIP1R;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5800252977944469,-1.0125393631353434,0.5,0.8302242195946595,1.0,3/16,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6219983736162991,-1.0125132484632668,0.49206349206349204,0.8299297550572725,1.0,1/8,7.60%,ANK2
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.5756819231447606,-1.0125057459511522,0.53125,0.8295804443066016,1.0,3/10,9.40%,TAF1D;SIN3B;CCNH
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.4133085641444179,1.0122696911267646,0.35294117647058826,1.0,1.0,8/21,16.71%,PRKG1;ZNF521;PODN;LDB2;TEK;CNRIP1;FAT4;IGFBP7
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.6555886691601567,-1.0121216416322862,0.48214285714285715,0.8301678688392966,1.0,1/6,7.22%,RAPGEF3
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5108287337021035,1.0119327079154665,0.41935483870967744,1.0,1.0,1/11,0.77%,ZNRF3
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,-0.5069953178555755,-1.011603222938978,0.4482758620689655,0.831100142970303,1.0,7/44,13.78%,DOK5;ADAMTS9;PTPRD;FLT1;VWF;GJA1;PLSCR4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6282081666720832,-1.01123944235907,0.48484848484848486,0.8316463445944078,1.0,1/7,6.27%,PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6343100918117339,-1.010767976244897,0.5352112676056338,0.8324271052819385,1.0,6/8,30.09%,PRKCE;STK39;NEDD4;NEDD4L;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7066039157017118,-1.0105701606497663,0.5147058823529411,0.8325423423949415,1.0,2/5,18.94%,PRNP;MT1M
prerank,KEGG_2021_Human__Huntington disease,-0.4689436823950375,-1.0105552698165974,0.5,0.8322127883133633,1.0,11/60,10.46%,PSMC6;MAP3K5;ITPR1;PPARG;GRIN2B;GRIA2;PSMA1;RB1CC1;SOD2;TGM2;NDUFA12
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.4961402816649565,-1.0102696972129113,0.5,0.8324978240414014,1.0,2/36,8.29%,UFL1;SIN3B
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5694102613564034,1.0095987640019863,0.5151515151515151,1.0,1.0,1/5,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.4980943578608423,-1.009427987261642,0.4875,0.8340456014306336,1.0,15/47,20.35%,RTN4;CX3CL1;ERBB4;PIK3R1;MAGI2;HYAL2;FGFR1;CASS4;RACK1;PINK1;DAG1;ITGB1;GRB2;EGFR;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.48356296191231235,-1.0092983947678544,0.4945054945054945,0.8339952514179396,1.0,14/54,16.65%,CX3CL1;GAPDH;NDFIP1;REL;SHISA5;PRKN;ALPK1;GJA1;SLC20A1;PELI1;TNFRSF10B;MALT1;TBK1;PINK1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.6703468024378509,-1.0087678007103646,0.5147058823529411,0.8347529452161268,1.0,2/6,6.96%,SMAD7;MAGI2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.36910963103617583,1.0087246981647642,0.4166666666666667,1.0,1.0,3/32,6.69%,RSAD2;IL15;HERC5
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.5031403178039329,-1.0082970725159552,0.4827586206896552,0.8355797640614584,1.0,12/33,26.56%,RPS27A;VAV3;UBC;GNA13;FGD4;RASGRF2;ECT2;MAPK8;KALRN;ARHGEF2;PREX1;MCF2L
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.7229191852311312,-1.00799354891365,0.5087719298245614,0.8359673263329603,1.0,3/5,24.67%,CD9;TXNRD1;HSP90AA1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.5034968701172694,-1.0079660980068261,0.525,0.8357020308859426,1.0,12/50,17.26%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;IL1RAPL1;ALPK1;NFKBIA;PELI1;SMAD3;TBK1;IL18R1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.3882476605965648,1.0077261334828713,0.42857142857142855,1.0,1.0,4/28,7.89%,GBP2;TAF3;IPO8;TNPO3
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,-0.638716049609193,-1.0076783234237023,0.5079365079365079,0.8360891962572377,1.0,2/5,7.57%,ATP2B1;SLC8A1
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,-0.43435215768413243,-1.0073959588703725,0.53,0.8363366738217954,1.0,63/369,16.73%,LAMC1;B3GNT2;PSMC6;SEC22B;DPH6;ADAMTS9;PPARG;SEC24D;MDGA2;CNTN5;PSMB9;NPLOC4;SMAD7;RAD21;ALPL;RPS27A;NFE2L2;WDR48;EEF1A1;CANX;MGAT4A;PSMA1;FEM1C;HIF1A;ANK2;SHISA5;COMMD1;PRKN;EDEM3;CAMKMT;UBC;CD55;LSAMP;ARSG;ADAMTS1;NGLY1;RAB21;EPAS1;RAB2A;TPR;OGT;PIAS2;CBX5;NPM1;NFKBIA;UGGT2;RAB1A;FOXK1;PIGN;CST3;SMC6;COPA;AMFR;CYLD;SMAD3;ALG11;SMC3;RAB8B;USP34;RAB30;THRB;EGFL7;RAB14
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.6046759299490619,-1.0069377172131884,0.4583333333333333,0.8370565030785698,1.0,4/8,31.74%,MYO1B;EMP2;DSP;RND3
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6458493209600975,-1.006735956428948,0.5423728813559322,0.837154167922634,1.0,3/8,17.56%,RAB21;MSN;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6562355392428689,1.0065924325512523,0.5,1.0,1.0,2/7,10.20%,EIF2AK2;KLHDC10
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.4357330816180733,1.006334955386999,0.4444444444444444,1.0,1.0,8/26,18.14%,MSL2;YEATS2;H2AC6;NCOA2;KAT6B;CLOCK;ELP2;ZZZ3
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.5022299465221218,-1.00632003276691,0.4823529411764706,0.8377835400513896,1.0,2/33,3.05%,ITPR1;JUN
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.44529772204288137,1.0060887173833275,0.38461538461538464,1.0,1.0,5/24,13.92%,UIMC1;OTUD4;ERCC6;BABAM2;TOX
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.44683581602638267,-1.0059397185977306,0.5425531914893617,0.838337839094143,1.0,12/108,9.80%,PSMC6;PSMB9;NPLOC4;HSPA5;SPOPL;RPS27A;NFE2L2;PSMA1;FEM1C;PRKN;UBC;HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5911474068696221,-1.0058401350820794,0.44285714285714284,0.8381666644774255,1.0,7/12,35.86%,OGT;SDCBP;TLK2;USP7;EIF3H;RPL11;FHIT
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.464235104164952,-1.0057786271721307,0.4659090909090909,0.8379857138907275,1.0,7/69,8.34%,PSMC6;PSMB9;SPOPL;NFE2L2;PSMA1;FEM1C;PRKN
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.6082002383173115,-1.0052842798461417,0.4852941176470588,0.8387723707052097,1.0,3/9,19.97%,PTPRD;IL1RAPL1;HMCN1
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.4704713936505208,-1.0049846975984982,0.4942528735632184,0.8391268939727117,1.0,9/62,10.33%,PSMC6;RFC3;PSMB9;RPS27A;CDKN1B;PSMA1;SPC25;UBC;RPS27
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.5284386587552747,-1.0049180174084493,0.45,0.8389160181877816,1.0,9/24,19.76%,BNIP3L;PRKN;NPAS2;NCK1;PINK1;CD34;CHMP4B;LRPAP1;CLU
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.6275822977745512,-1.004868257839481,0.5223880597014925,0.8386508261093859,1.0,2/11,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.6175549507486018,-1.0048139446256719,0.5,0.8384254876960829,1.0,2/8,9.19%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5603953305447454,-1.004406279475145,0.5,0.8389181500480335,1.0,3/15,11.02%,MAP3K5;FLT1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3900124378966533,1.0043999623211262,0.45454545454545453,1.0,1.0,6/42,3.35%,ANKRD6;ZNRF3;PSMD14;MLLT3;TLE4;NKD1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.33748456695706264,1.0043142070362001,0.45454545454545453,1.0,1.0,3/46,2.31%,STX8;EVI5;TBC1D5
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.5162705837416408,-1.0042852283122428,0.48148148148148145,0.8389106124409651,1.0,1/27,0.40%,DOK5
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.48808298719569926,-1.0034948265747115,0.4418604651162791,0.8403473171234765,1.0,12/48,13.31%,MAP2;MAP1B;NFASC;GRIA2;CNTN1;ANK2;LSAMP;PPFIA2;DCLK1;ATRNL1;ADGRL3;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5208352093922921,-1.003422164243241,0.4605263157894737,0.8401463487082033,1.0,8/23,23.35%,NR4A1;HIF1A;FGFR1;VEGFC;EGFL7;GATA2;PPP1R16B;JCAD
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6175504229719624,-1.0032925410419855,0.5373134328358209,0.8401283985309029,1.0,3/9,8.15%,DMD;SLC8A1;TPM1
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.6263578666123168,-1.0029702046091444,0.5441176470588235,0.8405204427546865,1.0,3/9,17.26%,SMAD3;TBK1;IL18R1
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.6056984671923304,-1.0027582739407324,0.5555555555555556,0.8407097123310938,1.0,4/10,23.21%,GPC5;PIK3C3;CHMP4B;GPC3
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,-0.6332173254624294,-1.0027190677857585,0.48333333333333334,0.8404398450707549,1.0,4/6,25.52%,PIK3C3;MTMR2;PIKFYVE;MTM1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.44955501397621583,-1.0026189597164148,0.5204081632653061,0.8403724676623401,1.0,20/168,13.33%,TBX3;BHLHE40;BTG2;PPARG;PHF10;HES1;JUN;GAPDH;KDM1A;CDKN1B;ARID5A;BCL6;KLF4;ZFPM2;SNX6;LIMS1;RPL13A;CBX5;CDKN1A;FOXK1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.579155204816345,-1.0018950178535115,0.547945205479452,0.841912605526038,1.0,2/9,9.93%,PRKN;TGM2
prerank,KEGG_2021_Human__Basal transcription factors,0.5495542468457716,1.0018636953690312,0.4594594594594595,1.0,1.0,4/8,17.61%,TAF3;TAF1;GTF2I;TAF2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.6468991303734664,-1.001859331241491,0.4868421052631579,0.8416228513174882,1.0,2/7,21.12%,SRRM1;TRA2B
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.6261093938189618,-1.0017014458935007,0.543859649122807,0.841678207931109,1.0,2/5,9.40%,TAF1D;CCNH
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.6730498323078864,-1.0011675310450323,0.5423728813559322,0.8426445257578218,1.0,3/5,31.21%,ITGB1;CD34;ITGA1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.6223533966927467,-1.0007021496239896,0.46153846153846156,0.8433884984854864,1.0,1/7,7.22%,RAPGEF3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.637410574606411,-1.0005842721859453,0.5614035087719298,0.8432954086593101,1.0,4/6,29.51%,PLPP1;ACER2;ACER3;SPTLC2
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,-0.5160990863779427,-1.0004527406832633,0.5522388059701493,0.8432122360147861,1.0,7/29,16.12%,ZEB2;MYO9B;GAS7;PPP2R2B;S1PR1;TRIB2;SH2D3C
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.6556972473421075,-1.0003830140085015,0.576271186440678,0.8430062416370379,1.0,1/5,1.78%,RFC3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.5031784593174953,-1.0000524950849337,0.4657534246575342,0.8433458399334797,1.0,5/31,9.69%,EPS8;GPM6B;RAPGEF3;HIP1R;DLC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5491822525830105,-0.9997262491561112,0.52,0.8437588141775786,1.0,5/16,14.50%,VAV3;PNP;CD81;ANXA1;NCK1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.4981029535857752,-0.9996616741980804,0.4823529411764706,0.8435479415967757,1.0,12/40,15.86%,MAP2;MAP1B;GRIA2;GPM6B;ANK2;INSYN2A;PPFIA2;DCLK1;ATRNL1;ADGRL3;SYT1;CADM2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5893883738834337,-0.9994919091012257,0.5151515151515151,0.8435139121850477,1.0,5/9,21.91%,ATP2B1;ANK2;ANK3;DLG1;AHCYL1
prerank,KEGG_2021_Human__ABC transporters,-0.6306620065232917,-0.9988843378415903,0.4406779661016949,0.844681653396271,1.0,1/8,4.09%,ABCA5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.5086802796043182,-0.9988577231400423,0.4823529411764706,0.8443627899783063,1.0,8/37,21.70%,S100A6;ACTN1;ANXA1;DYSF;MSN;IFITM3;DUSP6;SPARC
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.6003392374816168,-0.9987030216562189,0.5342465753424658,0.8443823590037475,1.0,9/12,30.09%,ANK2;ATP1B3;DLG1;ITGB1;STK39;NEDD4;NEDD4L;ATP1B1;CAB39
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,-0.5975690966039581,-0.9986685818579578,0.47761194029850745,0.8441030926344455,1.0,4/12,18.09%,GIT2;CNOT6L;NSD2;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.6145364212769994,-0.9984115711708392,0.5909090909090909,0.8442549639316638,1.0,6/9,36.47%,RAB14;SPAAR;DUSP6;DHX36;TRIP12;MYSM1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6644663151136203,-0.9981650803567079,0.5294117647058824,0.8444409639808078,1.0,2/6,10.15%,RTN4;PRNP
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5148371082147448,-0.9978866620196305,0.5294117647058824,0.8447344324091564,1.0,12/42,22.60%,NES;KDM1A;HIP1R;PRKN;TMBIM6;CLDN5;CDKN1A;AMFR;RACK1;LRPAP1;B2M;MAPK8
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.66973645830619,0.9977886712214392,0.5806451612903226,1.0,1.0,2/5,3.61%,PGM5;TTN
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.6638848434921993,-0.9976840761745278,0.5357142857142857,0.8447782482353432,1.0,2/5,4.57%,NFKBIZ;SMAD7
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.6561608322111245,-0.9969163047443265,0.5409836065573771,0.8461711212699617,1.0,1/7,2.23%,BNIP3L
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6030571142046353,-0.9967380899838837,0.53125,0.8461605305463061,1.0,5/12,14.53%,RPS27A;EDEM3;UBC;UGGT2;AMFR
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.6841880198048623,-0.9967065845190636,0.5571428571428572,0.8458618056931618,1.0,2/6,16.49%,NFKBIA;TBK1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.4742669607897413,0.9966687922846061,0.46875,1.0,1.0,4/16,2.18%,GBP2;GBP4;GBP1;GCH1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5677755698348639,-0.9965312999113703,0.5135135135135135,0.8459441099668815,1.0,2/8,10.09%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5940124859001269,-0.9965103060449781,0.5,0.84562134014079,1.0,3/11,16.65%,PRKN;CYLD;PINK1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5757392426251753,0.9964710253111922,0.4857142857142857,1.0,1.0,2/7,3.13%,MMRN1;SLC26A3
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.48622039782299975,-0.9959800567081414,0.47126436781609193,0.8465328415699416,1.0,10/47,18.43%,SPOCK1;NRG3;CHPT1;HIP1R;RAP1A;BCAR1;PICALM;PINK1;RUFY2;MTOR
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6013552983202699,-0.995708405031322,0.5507246376811594,0.8466976288099128,1.0,1/12,0.90%,UFL1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.5971076460932137,0.9957076061099961,0.5365853658536586,1.0,1.0,1/7,2.63%,ATR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6216188491085477,-0.9955782826183409,0.48484848484848486,0.8466478519564749,1.0,2/5,22.76%,AP1G1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.5979400007160744,-0.9950088268479557,0.4838709677419355,0.8474992726798706,1.0,3/9,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5482189577860068,-0.9946914973937186,0.4936708860759494,0.8478289740386638,1.0,5/19,14.58%,PIK3R1;RAPGEF3;HYAL2;TPR;SMAD3
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.6327490014913649,-0.9945561882790542,0.5,0.8473880792791204,1.0,1/9,4.17%,EPS8
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.6327490014913649,-0.9945561882790542,0.5,0.8473880792791204,1.0,1/9,4.17%,EPS8
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.4787695153873891,-0.9941085618375763,0.5,0.8479605358509027,1.0,12/44,18.43%,ATF3;PRKN;NPAS2;TPR;NPM1;AMFR;MCL1;SLC38A2;PINK1;HSPH1;NUP54;MTOR
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,-0.4959932947154001,-0.9941080223898586,0.46987951807228917,0.8475944043587391,1.0,10/34,14.61%,DOK5;MAP1B;NFASC;MAGI2;PTPRD;ANK2;LSAMP;DCLK1;PLP1;CACNA1C
prerank,CellMarker_Augmented_2021__Neuron:Embryo,-0.6492732226372058,-0.9937846435832685,0.4915254237288136,0.8479767965815164,1.0,1/6,4.59%,GRIA2
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.5436872733637969,-0.9935130146715023,0.45454545454545453,0.8482083106134967,1.0,5/19,15.27%,PRKAG2;CDKN1B;PAK2;TRIB2;WWTR1
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.6143596713734203,-0.9932667211748355,0.5454545454545454,0.8483619561585164,1.0,2/10,5.44%,FOS;JUND
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5393262083337951,-0.9931572233187699,0.5063291139240507,0.8482971198513978,1.0,5/19,13.78%,SYTL4;CAVIN2;ANK2;DYSF;PLSCR4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5808367861963398,-0.9926683001903481,0.5,0.8490762599978106,1.0,4/14,18.41%,KLF4;CDKN1A;CDK6;DLG1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.477431590375779,-0.9924425627049364,0.4878048780487805,0.8492972056539537,1.0,6/44,14.02%,NEDD9;TPM1;CFL1;FGD4;BRWD3;SH3KBP1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.5194564986005761,-0.9923830659289177,0.5303030303030303,0.849038212771902,1.0,11/17,34.93%,GAS7;PRKN;SPIRE1;CHMP4B;PREX1;FAM107A;RAC1;MICALL2;UBE2K;GSN;HDGFL3
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.5667987549598099,-0.9922582503691882,0.5068493150684932,0.8490167917874121,1.0,5/11,19.18%,CD9;PECAM1;CD81;IL18R1;CD34
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.42677819004900824,-0.9915559418870539,0.54,0.8503414024045525,1.0,273/1465,20.08%,CEP57;MAFF;DDIT4;B3GNT2;PSMC6;PKM;BHLHE40;UFL1;SUN2;BTG2;PCDH9;NEDD9;RPS18;TAMALIN;LDHA;TSG101;LBR;NR4A1;PGK1;YTHDC1;KLF6;RFTN1;RPS12;NFKBIZ;TCP11L2;GLUD1;RPL23;PPP1R9A;SLC6A6;BCAP31;PPA1;RPL34;ATG12;SRGN;JUN;SLC2A3;SLC4A10;JUNB;PSMB9;FOS;TAF1D;HSPA5;SCP2;GAPDH;ABCA5;LRRFIP1;ATP2B1;KCNIP4;RPS9;PPM1D;KDM1A;SMAD7;RAD21;ADSS2;S100A6;TSC22D3;SPG7;RPS27A;NFE2L2;OXR1;NDFIP1;CDKN1B;JUND;RPL37;RRBP1;CDC37;CANX;DUSP1;ARID5A;RNF19A;JAK1;GMPS;ZC3H7A;TMEM184B;PIK3R1;MGAT4A;PSMA1;BAZ1A;PBRM1;HMGN1;IFNGR1;ARF1;RSRC2;ELL2;RB1CC1;MBP;PDE7A;RPS11;COL18A1;REL;HIP1R;SHISA5;FOSL2;SLC30A7;AHNAK;RASSF1;COMMD1;RAP1A;CALCOCO2;NCALD;PACS1;AP1G1;PDXDC1;CAMKMT;UBC;CD55;ARIH2;CD81;RPL10;TACC1;CCNH;CNOT6L;CLEC2B;TRAM1;NGLY1;RAB21;CEBPZ;HERPUD1;CFL1;CREM;S1PR1;ZDHHC6;RPS27;DUSP16;PLIN2;ENSA;NDUFA12;RPS6;WIPF1;SBNO1;CHFR;CRLF3;MYL12A;CFH;ARPC2;RPL8;RPS15;RAB2A;CHST11;TPR;OGT;GOLPH3;SYNJ2;GABARAPL1;RPS7;RPLP2;ERO1B;RPL13A;ATP1B3;HNRNPH3;ZNF586;DDX18;ZFP36;PLCG2;TTC7A;TMBIM6;ZFYVE28;TMED10;ACAP2;NOC3L;PAK2;RPL15;GGNBP2;DUSP5;INPP5D;NPM1;ARPP19;NFKBIA;PPA2;RAB1A;SLC20A1;TRIB2;RSU1;CCNL1;RIOK3;ACOX1;SMC6;MSN;SH3KBP1;CNBP;SDCBP;RPL37A;LARS1;NCK1;CYLD;SMAD3;MAX;STK38;NARF;RPL24;RPL7A;TMF1;BTG1;ACBD3;RPLP1;LPIN2;PPHLN1;SUGP2;CRTC3;PAFAH1B1;UPP1;SMC3;TMEM59;PPP3CC;STOM;RAB8B;PTMA;USP34;MALT1;CHD1;MCL1;EWSR1;KLF12;AGPAT4;TBCD;MYL6;MBD2;TMEM30A;SMARCC1;STRAP;TBK1;SLC38A2;SRRM1;RAB14;TXNRD1;TIE1;PNRC1;ARL4A;B4GALT1;DCP2;IL18R1;KPNB1;PSAP;RPS28;MTMR2;ATF2;ARHGAP15;MRPL33;TOR1AIP2;SERINC3;NUP54;KANK3;RIF1;PREPL;RPL31;ZNF326;DLG1;KMT2A;KPNA4;ITGB1;RBM17;MICU2;MECP2;MYL12B;RPS19;PPM1A;SERBP1;IFITM3;USO1;CHMP4B;FBXO34;LRPAP1;ZKSCAN1;RLF;UBXN4;PLAT;GIGYF2;SPCS3;CMPK1;HBP1;PSMA7;GADD45B;DYNC1I2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.5096848285945551,-0.9913560342670978,0.48717948717948717,0.8504162334165519,1.0,7/25,13.39%,SLC6A6;SLC4A10;SLC20A2;SLC8A1;SLC4A7;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.6079953396379583,-0.9912195511238092,0.5454545454545454,0.8503990854732669,1.0,3/11,10.09%,HES1;SMAD7;ZFPM2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4862026453116768,-0.9907598508580704,0.46153846153846156,0.8510879403151287,1.0,6/39,12.88%,NRCAM;GPM6A;LIMS1;CTNND2;ADGRL3;CLDN5
prerank,KEGG_2021_Human__Salmonella infection,-0.44762287376602533,-0.9905960320214563,0.4945054945054945,0.8511381871047919,1.0,32/89,29.93%,JUN;FOS;GAPDH;ARF1;AHNAK;MYL12A;ARPC2;NFKBIA;TNFRSF10B;ACBD3;PIK3C3;KPNA4;MYL12B;DYNC1I2;PIK3CB;KLC1;PODXL;DNM2;MAPK8;TUBB6;SNX9;ABI1;HSP90AA1;TUBB4B;RHOB;MAP2K1;RHOJ;DYNC1H1;ANXA2;TUBA1B;RAC1;RHOA
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.5842066700994726,-0.990286777781105,0.547945205479452,0.8515797328631193,1.0,5/14,23.59%,PPA1;NDUFA12;PPA2;COX6C;ATP6V1E1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.48531326775556555,0.9901708590224025,0.5357142857142857,1.0,1.0,4/17,7.84%,ATR;RHBDD1;INO80;TAF1
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.5301066982548325,0.9899821713537644,0.5,1.0,1.0,2/8,15.83%,PPP2R5A;PPP2R5E
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.5016344768930444,-0.9899406207194845,0.45121951219512196,0.8520257290860791,1.0,7/32,18.70%,B3GNT2;MGAT4A;PLOD2;OGT;ALG11;B4GALT1;PMM2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5787235853991353,-0.9898466856962704,0.5441176470588235,0.8518582832792543,1.0,4/16,16.47%,GLUL;TPR;WWTR1;CTNNA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.493644640532738,-0.9897746265692302,0.524390243902439,0.8516523796477464,1.0,15/34,27.57%,ADAMTS9;GLUL;BCAR1;SCARB1;ACVRL1;EMP2;PIK3CB;ATOH8;SASH1;SPARC;ANXA3;CALR;DLL4;RHOB;RHOJ
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6257582315868523,0.989253118292541,0.5428571428571428,1.0,1.0,1/5,2.18%,GCH1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.5328697204777102,-0.9889715880956095,0.5384615384615384,0.8531685005580127,1.0,3/19,11.53%,B3GNT2;CHST11;GOLPH3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5612273228060044,0.9885949580095604,0.4722222222222222,1.0,1.0,3/10,17.88%,TNRC6C;HELZ;TNRC6A
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4744721982190194,-0.9885634542126889,0.5104166666666666,0.853661262730935,1.0,11/68,14.85%,BTG2;RFC3;RAD21;RPS27A;POLA1;PURA;UBC;NOC3L;NPM1;CNBP;USP45
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.5342047444912033,-0.9885589713442381,0.525,0.8533054634956692,1.0,4/18,11.77%,ERO1A;SLC30A7;KLF4;ERO1B
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5441406715612598,-0.9879910732221908,0.4675324675324675,0.8542601689599506,1.0,1/16,3.75%,TAF1D
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.6787747537313864,-0.9879583104594191,0.6190476190476191,0.8539814555610574,1.0,2/5,10.04%,GPC5;HYAL2
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.38885404687452174,0.9879231853886041,0.5,1.0,1.0,3/29,4.75%,TPD52L1;HOMER2;AP1S2
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,-0.5670362716693245,-0.987772827848316,0.527027027027027,0.8540543144241419,1.0,4/16,13.78%,TIMP3;EMP1;EPAS1;PLSCR4
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.6536397249895166,-0.9866423814956218,0.5714285714285714,0.8562098744908181,1.0,1/5,5.87%,JAK1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.6536397249895166,-0.9866423814956218,0.5714285714285714,0.8562098744908181,1.0,1/5,5.87%,JAK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.578364904984698,-0.9866028005713363,0.45454545454545453,0.8559067714784282,1.0,4/11,16.65%,NFE2L2;PRKN;SOD2;PINK1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.6443938701203049,-0.9865875207489722,0.5633802816901409,0.8555606860011858,1.0,1/7,11.39%,TPR
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.5750094107076271,-0.9865192781144497,0.5806451612903226,0.8553637741727389,1.0,2/12,3.19%,GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5448817714383648,-0.9862357285179392,0.524390243902439,0.855623075844621,1.0,8/20,15.70%,SYTL4;ANXA1;IL1RAPL1;RAB21;STXBP5L;RIMS2;SYT1;RAB8B
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.4398107323290709,0.9860943256390967,0.48,1.0,1.0,5/24,13.33%,TNRC6C;H2AC6;IPO8;NUP58;NUP214
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.5810327367123503,-0.9859738798854384,0.5714285714285714,0.8558293736914105,1.0,3/9,18.67%,LPGAT1;MTOR;SCARB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.47898483643990086,-0.9858454296233828,0.5301204819277109,0.8557908799110107,1.0,13/38,29.93%,ENPP2;FES;ERBB4;TMSB4X;CDK6;EGFR;PLXNA2;NRG2;INPP5F;RHOB;CRK;RAC1;RHOA
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5190815404318819,-0.9856378125777284,0.4939759036144578,0.8558818662630991,1.0,4/27,6.19%,CD9;FES;ACTN1;ERBB4
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.6260360910183939,-0.9855335032972455,0.55,0.8557667060296515,1.0,1/7,1.41%,LDHA
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.5745372516115372,-0.9853934153046272,0.5,0.8557234977915613,1.0,4/11,23.27%,FLT1;PECAM1;CD34;CDH5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5479645122956481,0.98510680496398,0.4444444444444444,1.0,1.0,2/7,2.15%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.6167096019191234,-0.9847442913094033,0.5507246376811594,0.8567720423478364,1.0,1/8,7.73%,HIP1R
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.5940453572013569,-0.9847006907220079,0.5277777777777778,0.8564891337914697,1.0,3/9,25.07%,GRIA2;DLG1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.5419292441385484,-0.9846280051499027,0.5128205128205128,0.8563021488681717,1.0,4/17,14.10%,GRIN2B;RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.4800324042815676,-0.9842531961718527,0.5333333333333333,0.8567943847008131,1.0,15/51,24.67%,NEDD9;PRKAG2;RAP1A;PRNP;PAK2;CDKN1A;CASS4;LCP2;EMP2;CLU;ECT2;GPRC5B;CCDC88A;SNX9;HSP90AA1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.559981384982012,0.9841978321375401,0.5,1.0,1.0,1/5,11.74%,ST3GAL1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.45801843800411146,0.9838702886214307,0.4782608695652174,1.0,1.0,4/19,2.82%,GBP2;GBP1;RC3H1;IL1R1
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.5668745810525372,-0.983831044633514,0.5405405405405406,0.8572336214498074,1.0,3/12,17.45%,SRGN;IL18R1;LCP2
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.5243629730781849,0.9832972656263664,0.35714285714285715,1.0,1.0,4/10,27.30%,RBPJ;AKT3;MAML2;FOXO1
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.5770918900697968,-0.9832906081255475,0.6065573770491803,0.8581120674464217,1.0,3/9,9.40%,TAF1D;SIN3B;CCNH
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.6252580656155196,-0.9832224688400555,0.5573770491803278,0.8578960550554057,1.0,1/7,4.73%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.4775268898406271,0.9831509684127027,0.3793103448275862,1.0,1.0,4/18,8.10%,HABP4;RBM20;HSPA1A;HNRNPLL
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.5123352263146882,-0.983106799531806,0.5072463768115942,0.857813898267816,1.0,8/17,31.55%,S1PR1;GOLPH3;PARVB;ITGB1;CCDC88A;VCL;RAC1;SNX1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.5993257204312534,-0.9830122887585556,0.5483870967741935,0.8576793192433679,1.0,4/9,19.39%,SDCBP;PICALM;MTMR2;LRPAP1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.537869472967849,-0.9826657339216186,0.5068493150684932,0.8581554101780875,1.0,4/23,16.60%,RFTN1;TPR;ZFP36;SRRM1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.48423245413400734,-0.9824847704421393,0.49411764705882355,0.8581876786785271,1.0,10/48,19.60%,PRKAG2;CDKN1B;HIF1A;TPR;OGT;CDKN1A;SDCBP;NUP54;EGFR;EMP2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5592779501453904,-0.9824757499123266,0.5362318840579711,0.8578481773847915,1.0,4/13,20.03%,GLUL;ZDHHC6;ZDHHC21;ZDHHC14
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,-0.5166354787105361,-0.9822332562803313,0.5616438356164384,0.8580187020462403,1.0,4/30,14.13%,MAP2;LAMA5;BCAR1;NAV2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5624654757706876,0.9821029121639855,0.45161290322580644,1.0,1.0,4/7,14.02%,CIRBP;TRA2A;RBMX;NCL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5781671794590302,-0.9820359625227436,0.5606060606060606,0.8581700348516726,1.0,2/7,10.09%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6485434501186264,-0.981767963093487,0.5535714285714286,0.8584116774673851,1.0,1/5,7.49%,HIF1A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5137618851521654,0.9817308222479004,0.4594594594594595,1.0,1.0,4/12,10.49%,PARD3;CLASP1;OPHN1;CYTH3
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.5677247798472185,-0.9815195598774705,0.55,0.8585769898724342,1.0,10/14,37.37%,RAP1A;VWF;CAMK2D;MAP2K1;VCL;MARK3;RAP1B;IQGAP1;JAK2;MAPK1
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.4554618617694014,0.9815144445227912,0.52,1.0,1.0,3/21,3.53%,HOMER1;HOMER2;EPB41L5
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.47811653254794345,-0.9814066275810258,0.5543478260869565,0.8585043695129903,1.0,7/71,7.81%,PIK3R3;JUN;FOS;CANX;JAK1;PIK3R1;SLC2A1
prerank,KEGG_2021_Human__Drug metabolism,-0.5986720650463039,-0.9811901342496284,0.5625,0.858636226179492,1.0,3/9,19.89%,GMPS;UPP1;CMPK1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,-0.5624098081752884,-0.9809119215746559,0.515625,0.8588915195389504,1.0,2/14,6.61%,ZEB2;GAS7
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.6532452826626788,-0.9806648766797994,0.582089552238806,0.8590848495202684,1.0,3/6,31.10%,CCNH;PPP2R2A;PPME1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.5745348227345782,0.9806273703659353,0.4642857142857143,1.0,1.0,2/7,12.80%,HSD17B4;FAR2
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.667926876544536,-0.9802726782017754,0.5862068965517241,0.8591625410692216,1.0,1/5,16.49%,TBK1
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.667926876544536,-0.9802726782017754,0.5862068965517241,0.8591625410692216,1.0,1/5,16.49%,TBK1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4710602512916164,-0.9802144239965522,0.5909090909090909,0.8589712616522924,1.0,26/55,22.92%,SERPINE1;SYTL4;SRGN;CD9;RIMS1;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X;RIMS2;TMED10;SYT1;VEGFC;PIP5K1C;PSAP;ARHGAP17;CLU;CD109;PCDH7;SELENOP;SPARC;CD63;DNAJC5;ANXA5
prerank,KEGG_2021_Human__Salivary secretion,-0.5289732104693272,-0.9800382476003288,0.5,0.8589461077277623,1.0,4/21,13.73%,ITPR1;ATP2B1;ATP1B3;CST3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5015991872155421,-0.9799445220134207,0.4883720930232558,0.8587645602019173,1.0,11/33,21.83%,PBX3;TIMP3;EMP1;GJA1;CREB3L2;CALD1;BOC;HMCN1;GADD45B;SPARC;GLI3
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.5891390800689253,-0.9799256313668178,0.5483870967741935,0.858459981470729,1.0,4/10,21.06%,PPARG;PIAS2;THRB;NR2C1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.6014970758803834,-0.9797733840456461,0.47058823529411764,0.8584824329259649,1.0,1/9,1.54%,PCK1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5256252265338658,-0.9797339263992844,0.5844155844155844,0.8582018983106778,1.0,7/26,19.31%,RPS27A;PRKN;UBC;NGLY1;CHFR;MALT1;CHMP4B
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5532919693264001,-0.9795162369763426,0.5142857142857142,0.8583143449517786,1.0,8/17,27.30%,MYH10;ANK3;CHMP4B;ECT2;RASA1;SNX9;SPTBN1;RHOB
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.5078581330231897,-0.9789451259593003,0.45714285714285713,0.8592165877738567,1.0,7/25,18.57%,RPL23;IPO7;TPR;PTTG1IP;KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5377243519892214,-0.9785961025888719,0.5277777777777778,0.8597398409060413,1.0,3/16,15.38%,ARHGAP21;RAB1A;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.596709750115266,-0.9785292323729295,0.578125,0.859497056805901,1.0,4/11,19.18%,VSIR;PLCG2;TRIB2;CD34
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6339882963524532,-0.9785233179700704,0.532258064516129,0.859164721804073,1.0,3/7,25.98%,HYAL2;SOCS3;INPP5F
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6093495280633165,-0.9782673009428907,0.5428571428571428,0.859389855497648,1.0,2/7,26.43%,NOTCH4;DLL4
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,-0.4692709706076626,-0.9782528951655789,0.5641025641025641,0.8590625640999653,1.0,17/44,19.18%,CLEC1A;LRRC32;ANO2;GGT5;RAPGEF3;FLT1;PECAM1;SCARF1;TNS1;VWF;DYSF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6358287436164661,-0.9780956998885848,0.59375,0.859084678318937,1.0,1/6,1.04%,ITPR1
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.5505524337063539,-0.9780368842963623,0.5507246376811594,0.858861541299395,1.0,4/12,18.01%,TPR;NPM1;KPNB1;NUP54
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.6276171585682268,-0.9778617579698936,0.5806451612903226,0.8588648650225805,1.0,1/6,12.01%,CSTF3
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.4653220403281343,-0.977626650132035,0.4878048780487805,0.8590802289125409,1.0,10/53,15.51%,PPP2R3A;SSH1;PPM1D;ALPL;DUSP1;PTPRD;DUSP16;DUSP5;PLPP1;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.6234530929892844,-0.9776006668113939,0.5373134328358209,0.8587631719636962,1.0,4/7,32.03%,RIOK3;RPS19;UBE2K;HLA-E
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.47466518767545984,-0.9775239880534706,0.5060240963855421,0.8585734995725346,1.0,11/39,23.16%,GRIN2B;VAV3;MYL12A;EFNB2;ARPC2;SDCBP;MYL6;MYH10;MYL12B;CLTA;KALRN
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.44121677813992566,-0.9772765163719028,0.5520833333333334,0.8587793028540626,1.0,38/199,16.33%,TBX3;BHLHE40;MAFK;ATF3;ZEB2;RPL23;PPARG;HES1;JUN;LRRFIP1;KDM1A;SMAD7;ESR2;RPS27A;ARID5A;KLF2;BCL6;SIN3B;PRKN;PURA;UBC;RREB1;RPL10;KLF4;ZFPM2;CREM;TPR;MEF2A;ZFP36;CBX5;CNBP;SDCBP;SMAD3;MAX;SREBF2;KLF12;THRB;MBD2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6072139909799353,-0.9770827113288456,0.515625,0.8589708215638029,1.0,5/9,24.44%,ANK2;GJA1;CACNA1C;ATP1A1;NEDD4L
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,-0.4800550845444925,-0.9768333397234562,0.49382716049382713,0.8591433713780884,1.0,11/46,19.18%,ADAMTS9;LRRC32;FLT1;VWF;GJA1;CLDN5;PLSCR4;TIE1;CALD1;ACVRL1;CD34
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.35131166196364605,0.9767297120157173,0.3333333333333333,1.0,1.0,10/74,7.76%,RSAD2;GBP2;GBP4;GBP1;PIAS1;EIF2AK2;HERC5;KPNA5;TRIM22;XAF1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.48490733782173706,-0.9765921219591438,0.5176470588235295,0.8593439786653679,1.0,14/50,19.76%,ZEB2;KLF2;HIF1A;STARD4;KLF4;LPGAT1;NPM1;ARPP19;SMAD3;NOS1AP;MTOR;SCARB1;EGFR;CLU
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5147575181741665,-0.976464669559289,0.5308641975308642,0.8592202358649002,1.0,9/31,21.67%,PSMC6;PSMB9;PSMA1;KLF4;CDKN1A;CDK6;DLG1;PSMA7;CUL1
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,-0.5125217596610769,-0.9764176874018379,0.5974025974025974,0.8589697951595842,1.0,8/27,11.93%,DOK5;MAP1B;NES;PTPRD;SMARCA1;ANK2;FGFR1;GJA1
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.39350858753526274,0.9763645095842309,0.4444444444444444,1.0,1.0,3/31,4.97%,CREB5;PRKD1;PLCB4
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.5988049689703638,0.9758651572881427,0.46875,1.0,1.0,1/6,3.82%,H2AC6
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6277078350734165,-0.9758140005425833,0.5428571428571428,0.8598931584680859,1.0,3/9,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.44641549031922884,-0.9757195979639909,0.5617977528089888,0.8597083399815512,1.0,16/66,23.64%,DOK5;SEMA6B;FEZ2;PIK3R1;LAMA5;EFNB2;SH3KBP1;ROBO2;DAG1;GRB2;PIK3CB;UNC5C;NRXN3;BSG;NFIB;PLXNA2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.4972254778342124,-0.9757012088438054,0.47619047619047616,0.8593829614532356,1.0,8/49,10.70%,NFKBIZ;SCARB2;YBX3;ARF1;HIF1A;SLC8A1;AFF4;KIF16B
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.5930966620725886,-0.9756299591204177,0.5915492957746479,0.8591703783213608,1.0,6/8,37.37%,SOCS3;STAT5B;STAT3;PTPN1;JAK2;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.4938374898785058,0.9754752109374207,0.47058823529411764,1.0,1.0,1/10,1.25%,SLC4A4
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.6151803714252209,-0.9750213412023425,0.5714285714285714,0.8601296129704965,1.0,3/7,33.41%,AGO2;POLR2B;PRKRA
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6253387930480007,0.9749610179011896,0.5476190476190477,1.0,1.0,1/5,4.22%,MFF
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.5290999323442409,-0.9747640052745178,0.4868421052631579,0.8603431958190887,1.0,4/17,12.46%,LAMC1;ACTN1;DLC1;PLEC
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.4471616214969628,0.9743590276246105,0.45714285714285713,1.0,1.0,2/14,3.82%,TNRC6C;H2AC6
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.5421254532100057,-0.9741527056151534,0.5769230769230769,0.8613292405600103,1.0,3/12,11.77%,ERO1A;SLC30A7;ERO1B
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.4569205397385566,-0.9736745895472431,0.49411764705882355,0.8619774536756204,1.0,17/56,21.38%,NFKBIZ;PPARG;PBX3;CDKN1B;FLT1;REL;BCL6;CDK14;CDKN1A;MAX;EWSR1;NSD2;KMT2A;PLAT;GADD45B;KLF3;DUSP6
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.5855358220939876,-0.9736354666563175,0.5068493150684932,0.8617221250334643,1.0,7/12,24.44%,TSG101;RPS27A;UBC;SGIP1;CHMP4B;VPS37A;NEDD4L
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.6435310827683381,-0.9735826878696109,0.6065573770491803,0.8615137768246414,1.0,1/6,7.49%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6090761866534653,0.9732513999897827,0.5675675675675675,1.0,1.0,1/5,8.07%,WWC3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.484144475767152,-0.9727662849737752,0.49333333333333335,0.8631381568258587,1.0,13/38,21.75%,ZEB2;SMAD7;RPS27A;UBC;SNX6;SDCBP;SMAD3;STRAP;SNX25;PPM1A;CD109;SPRED1;RNF111
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3089582199953135,0.9726640008215441,0.625,1.0,1.0,11/109,5.63%,PGM5;PACS2;EXOC5;RC3H1;ATP2A2;INO80;OFD1;STARD9;WDPCP;RFX3;UBQLN1
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,-0.43889835834328156,-0.9724009036663275,0.5816326530612245,0.8635135119115508,1.0,21/150,10.49%,B3GNT2;BTG2;NEDD9;PPP1R9A;PPA1;MAP1B;MYO9B;TINAGL1;RAD21;DMD;PEBP1;ERBB4;GAS7;SLC52A3;SMARCA1;REL;AP1G1;CD55;SLC4A7;PRNP;ITGB5
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,-0.49037932360024383,-0.9722579755267303,0.55,0.8631707259066437,1.0,9/36,13.25%,DOK5;CX3CL1;NFASC;PTPRD;TMEM132C;GJA1;DCLK1;PLP1;NAV1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,-0.49037932360024383,-0.9722579755267303,0.55,0.8631707259066437,1.0,9/36,13.25%,DOK5;CX3CL1;NFASC;PTPRD;TMEM132C;GJA1;DCLK1;PLP1;NAV1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.46118768438154956,-0.9718521849070367,0.5212765957446809,0.8637136174145409,1.0,5/84,6.27%,PIK3R3;ITPR1;CX3CL1;JAK1;PIK3R1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5929165718928895,-0.9715943432295245,0.5921052631578947,0.8639714818266717,1.0,5/9,29.93%,DUSP1;STK39;LRCH1;FOXC1;RHOA
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.5189166019552504,0.9712428998283198,0.4857142857142857,1.0,1.0,4/10,20.24%,TENT2;CIRBP;PARN;LARP1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4653377618064754,-0.9711674686483435,0.5789473684210527,0.86462084695772,1.0,13/63,15.56%,DOK5;MGLL;CX3CL1;GRK5;GIT2;CD55;SIK2;PRNP;OGT;NCK1;AMFR;WWTR1;SREBF2
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.520342412833458,-0.9707601570570075,0.5555555555555556,0.8652090769543023,1.0,9/20,28.61%,ATP2B1;SLC8A1;ATP1B3;ATP1A1;CLTA;DNM2;RAB11A;ADCY9;ATP1B1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.507310529513028,-0.97061650126826,0.48,0.8651305249665288,1.0,4/23,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6058266748084572,-0.9705329886826864,0.6,0.8648936837228304,1.0,2/9,8.84%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.4257334778935456,-0.9704959873222697,0.59,0.8646104828582627,1.0,83/490,16.92%,MAFF;TBX3;ST18;MAP3K5;BHLHE40;MAFK;NR4A1;ATF3;KLF6;ZEB2;ZNF43;PPARG;PHF10;HES1;PBX3;JUN;JUNB;FOS;LRRFIP1;KDM1A;SMAD7;RAD21;ESR2;ELP3;POLA1;NFE2L2;CDKN1B;JUND;NPAS3;ARID5A;ERBB4;BAZ1A;FOXF1;KLF2;SMARCA1;HIF1A;REL;BCL6;FOSL2;NPAS2;PURA;RREB1;KLF4;CCNH;SOD2;ZFPM2;CREM;CDK14;SBNO1;CRLF3;EPAS1;SNX6;LIMS1;OGT;ELP4;MEF2A;ZNF586;PIAS2;ZNF280D;CBX5;NPM1;BRWD3;CDKN1A;FOXK1;ZNF160;CCNL1;CNBP;SMAD3;MAX;NAA16;BTG1;CREB3L2;WWTR1;SREBF2;CHD1;KLF12;RCOR1;MBD2;SMARCC1;PICALM;NSD2;NOTCH4;ZBTB38
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.6423035139569614,-0.9704949023830115,0.5588235294117647,0.8642530581030505,1.0,6/7,35.88%,TUBB6;TUBB4B;AGBL4;TUBA1B;TTLL7;TUBB
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.4772211563089047,-0.9702175737353271,0.525,0.864500650308271,1.0,19/44,30.31%,FOS;JUND;PIK3R1;RAP1A;SHC2;MEF2A;GRB2;PIK3CB;DUSP6;CLTA;DNM2;TF;RPS6KA2;MAP2K1;MAP2K5;CRK;RHOA;STAT3;REST
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,-0.5470844504658047,-0.9701738802076989,0.5616438356164384,0.8642226125005323,1.0,2/12,8.45%,ALPL;TNS1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.46873953195499607,-0.9701643620591185,0.5294117647058824,0.8638843820652718,1.0,11/37,13.71%,NEDD9;ENPP2;HES1;ERBB4;PECAM1;CD81;PRNP;PLCG2;PAK2;TEC;CASS4
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5206359514868338,-0.9700808044463408,0.5342465753424658,0.8637043929409551,1.0,3/27,6.48%,PSMC6;PSMB9;PSMA1
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,-0.566064058710113,-0.968897457850122,0.5555555555555556,0.8657026015905142,1.0,1/13,4.62%,TINAGL1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.4556260424244929,-0.9688416023790536,0.5434782608695652,0.865475589997321,1.0,13/61,22.18%,PPP1R9A;GRIA2;RB1CC1;NCALD;PPFIA2;RNPC3;SGIP1;CADM2;MECP2;CSPP1;SCN2A;SCAMP1;NOL4
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5699902167498618,-0.9688119849260937,0.547945205479452,0.8652534057527516,1.0,2/12,12.22%,YBX3;ZFP36
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.623188631506722,-0.9683944029612298,0.5,0.8658941261391753,1.0,2/6,18.88%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.49014849345997386,-0.9680850864698171,0.5066666666666667,0.8661680449266738,1.0,4/23,20.13%,HES1;JAG2;NOTCH4;MIB1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.5890972219518298,-0.9680798205541586,0.5866666666666667,0.8658160848935936,1.0,3/11,11.66%,TSG101;LAMP2;GABARAPL1
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.5819216348364398,-0.9679334262001709,0.6,0.8657747961636344,1.0,4/10,29.56%,TBC1D15;RAB8B;RAB11A;RABGAP1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5787709991660694,-0.96788093739704,0.5857142857142857,0.8655205312292387,1.0,2/6,10.09%,ERBB4;ZFPM2
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.5288804183413616,-0.9677814100873136,0.55,0.8653868229432048,1.0,7/19,24.86%,FOS;JUND;MEF2A;DUSP6;DNM2;TF;RPS6KA2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5175040531063155,-0.9677002665203883,0.5416666666666666,0.8651791949791495,1.0,7/20,20.35%,CX3CL1;SPOCK1;LIMS1;RSU1;TBCD;EMP2;PIK3CB
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6058528859967707,-0.9676651342047167,0.582089552238806,0.8648884885490219,1.0,3/8,33.41%,AGO2;TUT7;PRKRA
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5480777682423353,-0.9676476289269886,0.5131578947368421,0.8645702825975023,1.0,2/17,8.50%,LBR;PNP
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.525745457809017,0.9675143840643193,0.5806451612903226,1.0,1.0,1/9,4.99%,HSPD1
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.46287237391831554,-0.967468170765592,0.6111111111111112,0.8646081665491728,1.0,11/68,12.99%,PSMC6;TSG101;PSMB9;RPS27A;PSMA1;PACS1;AP1G1;UBC;CCNH;TPR;NPM1
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,-0.4270010329403024,-0.9673328920172891,0.6161616161616161,0.8645952076045659,1.0,25/319,10.76%,PIK3R3;UFL1;RTN4;ZNF43;BCAP31;PBX3;SPOPL;ABCA5;ADSS2;OXR1;ARHGAP21;RNF19A;LSS;MTMR12;BAZ1A;GIT2;REL;NUFIP2;TBC1D15;CD55;ARIH2;TACC1;NGLY1;LPGAT1;WDR37
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,-0.643367633908297,-0.9672334212036316,0.5964912280701754,0.8644899120834173,1.0,3/5,31.21%,ITGB1;CD34;ITGA1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.45140017530038956,-0.9664411193836231,0.5,0.8660278092394745,1.0,14/59,18.11%,RTN4;SLC6A6;ENPP2;RAPGEF3;PRKN;RREB1;CFL1;ZDHHC6;FGFR1;GJA1;SPIRE1;PINK1;DAG1;RIF1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.623353341160242,-0.966145960442772,0.5606060606060606,0.8663741433075666,1.0,2/6,13.23%,SEC24D;RAB1A
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.6688099764721706,-0.9659538780550058,0.5166666666666667,0.8664342691037292,1.0,2/5,18.41%,ANK2;DLG1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6463652833748543,-0.9659069669722496,0.6060606060606061,0.8661900990466833,1.0,2/7,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5573927843356649,-0.9658658177517249,0.5915492957746479,0.8659553447036217,1.0,3/10,15.46%,S100A6;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5789939173940756,0.9657400523133717,0.5121951219512195,1.0,1.0,3/5,21.67%,CDH2;TAPT1;FBXL17
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.6084166968444265,-0.9655194431945301,0.5555555555555556,0.8664024741354254,1.0,5/9,26.72%,PECAM1;ITGB1;CD34;CDH5;CD74
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.624153981965561,-0.9652323722650533,0.6119402985074627,0.8666788846027569,1.0,4/7,20.03%,GLUL;ZDHHC6;ZDHHC21;ZDHHC14
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.5488008789106052,-0.9651117973085335,0.5588235294117647,0.8665684793361447,1.0,4/13,18.01%,TPR;NPM1;KPNB1;NUP54
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.4231499566798699,-0.9649776537043004,0.67,0.8665179692186976,1.0,91/514,16.49%,MAFF;TBX3;SERPINE1;ST18;BHLHE40;MAFK;NR4A1;ATF3;KLF6;ZEB2;RPL23;ZNF43;PPARG;CX3CL1;PHF10;HES1;PBX3;JUN;JUNB;FOS;LRRFIP1;PPM1D;KDM1A;SMAD7;RAD21;ESR2;RPS27A;ELP3;NFE2L2;JUND;NPAS3;ARID5A;PIK3R1;BAZ1A;FOXF1;KLF2;SMARCA1;HIF1A;REL;BCL6;FOSL2;SIN3B;PRKN;NPAS2;PURA;UBC;RREB1;CD81;RPL10;KLF4;CCNH;CEBPZ;SOD2;HYAL2;ZFPM2;CREM;CRLF3;EPAS1;TPR;OGT;ELP4;MEF2A;ZNF586;PIAS2;ZFP36;CBX5;NPM1;NFKBIA;BRWD3;CDKN1A;FOXK1;ZNF160;CCNL1;CNBP;SDCBP;NCK1;SMAD3;MAX;TMF1;CREB3L2;LPIN2;WWTR1;CRTC3;SREBF2;CHD1;KLF12;RCOR1;THRB;MBD2;SMARCC1;TBK1
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,-0.4877511654718841,-0.964961833987995,0.5405405405405406,0.8662237799418409,1.0,9/31,14.61%,DOK5;GPM6B;TMEM132C;PPP2R2B;S1PR1;ARMCX4;PLP1;LRRC4C;CACNA1C
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3416834804376893,0.9648502317988235,0.5384615384615384,1.0,1.0,7/54,5.87%,BMP6;GCNT2;HIVEP1;SMAD1;PARD3;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4978280497505043,-0.9644121220558528,0.5487804878048781,0.8670376165535525,1.0,5/30,18.01%,YTHDC1;TPR;ZFP36;SRRM1;NUP54
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.43712794278299427,-0.9642018870879421,0.5684210526315789,0.867097250674037,1.0,33/146,21.59%,DDIT4;UFL1;PRKAG2;RFC3;AKAP12;MYO9B;ARHGAP21;VAV3;VWF;DLC1;TMSB4X;ARHGAP23;GNA13;PLCG2;FGD4;PAK2;NFKBIA;CYLD;VRK2;RASGRF2;FAM13A;ARHGAP29;PIP5K1C;ARHGAP15;ARHGAP17;DLG1;MTOR;EGFR;ECT2;SPRED1;XIAP;PRKAR1A;PPP1R16B
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.6263611832218369,-0.9641644675358466,0.5507246376811594,0.8668169637472822,1.0,3/8,11.29%,TMEM45B;RAP1A;ACSL5
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,0.470923473892366,0.964081895459057,0.631578947368421,1.0,1.0,2/17,1.86%,DSE;GBP1
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.5734475896914143,-0.964054792682641,0.6060606060606061,0.8663993383582581,1.0,4/13,8.84%,RPS27A;CDC37;PIK3R1;UBC
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.5734475896914143,-0.964054792682641,0.6060606060606061,0.8663993383582581,1.0,4/13,8.84%,RPS27A;CDC37;PIK3R1;UBC
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.5204541150072068,-0.9638348402575863,0.5263157894736842,0.8666380383304682,1.0,3/15,15.64%,SLC4A7;TMEM59;STOM
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.5659192465157616,-0.9636849495733661,0.5555555555555556,0.8666335183424281,1.0,4/10,15.94%,CANX;GOLPH3;RAB8B;MIA2
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,-0.6415077988535739,-0.9636404127487089,0.5735294117647058,0.8664273271649258,1.0,4/7,24.14%,RPS27A;UBC;XIAP;NEDD4
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,-0.471926812919952,-0.9633724268760017,0.5185185185185185,0.8667115408355589,1.0,6/28,17.77%,NDFIP1;ACTN1;CD55;NPM1;RACK1;FKBP5
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.5954395549499067,0.9631903436832643,0.5,1.0,1.0,2/5,8.79%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.5103717824458428,-0.9630345416926734,0.5507246376811594,0.8671100180078319,1.0,6/20,22.44%,LGALS3;FES;CDK6;KMT2A;CBFB;HSPA9
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.47960885525026875,-0.9629833546889521,0.5529411764705883,0.8668809949681875,1.0,8/46,13.78%,CX3CL1;ARID5A;TIMP3;TNS1;VWF;EPAS1;PARVB;PLSCR4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.48573198818011454,-0.9628756664020821,0.569620253164557,0.8666887666613392,1.0,11/32,23.27%,PTPRD;PECAM1;IL1RAPL1;ADGRL3;CLDN5;LRRC4C;ROBO2;ITGB1;HMCN1;BSG;CDH5
prerank,CellMarker_Augmented_2021__Muller cell:Retina,-0.5066003602858092,-0.9627828670505719,0.48,0.8665195656114952,1.0,6/21,13.73%,GLUL;TM6SF1;GAS7;VWF;PLXDC2;CST3
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5567556157770216,-0.9625338942618719,0.5942028985507246,0.8666385600329424,1.0,4/12,20.35%,DUSP1;HYAL2;STK38;PIK3CB
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.4471544353315358,0.9623974865739874,0.5185185185185185,1.0,1.0,2/13,3.82%,IL6R;H2AC6
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.38192778494243723,0.9622026339735095,0.68,1.0,1.0,6/34,6.61%,PLPPR4;NREP;ZNF385D;PRKG1;NOVA1;PDZRN3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6308280455475466,-0.9619390049349297,0.609375,0.8675801465918797,1.0,3/6,22.79%,RIMS1;PIP5K1C;DNAJC5
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.6346080373611016,-0.9618643008951759,0.5507246376811594,0.8670451986470876,1.0,2/6,17.45%,ALPL;LCP2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.6346080373611016,-0.9618643008951759,0.5507246376811594,0.8670451986470876,1.0,2/6,17.45%,ALPL;LCP2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.6306679226462883,-0.9618202399400073,0.6031746031746031,0.8667620728036068,1.0,2/5,25.37%,NPM1;ALMS1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6320737270257262,-0.9618171121005018,0.6440677966101694,0.8664152933353341,1.0,1/6,6.43%,LAMA5
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.5961187648432255,-0.9617629873192365,0.5967741935483871,0.8662010706626889,1.0,2/7,12.22%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.46069717515600106,0.9617439717910635,0.5925925925925926,1.0,1.0,5/15,15.43%,UIMC1;ERCC6;WRNIP1;BABAM2;PARG
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.5439016012259672,-0.9611983798879334,0.5138888888888888,0.8669855271019299,1.0,4/10,19.89%,PNP;UPP1;ENTPD4;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5886714030926716,-0.9610895518100074,0.5507246376811594,0.8668669553716537,1.0,3/7,25.87%,DCP2;TNKS2;TNKS
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3780510997410509,0.9607729530941163,0.5416666666666666,1.0,1.0,4/28,5.79%,ANKRD6;TPD52L1;EIF2AK2;MFHAS1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.646852761939146,-0.9607580527588335,0.6176470588235294,0.8673133859039219,1.0,1/6,15.72%,PIK3C3
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.3714856257295668,0.9606265089466399,0.5454545454545454,1.0,1.0,3/32,4.75%,TPD52L1;HOMER2;AP1S2
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.5685568920927485,-0.9598905669308864,0.5652173913043478,0.8688432722564818,1.0,3/12,18.01%,PBRM1;TPR;NUP54
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.4870615591434532,-0.9598752190681799,0.5443037974683544,0.8685238046461979,1.0,5/30,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.5642896797862749,-0.9598677256947622,0.6197183098591549,0.8681863946094471,1.0,2/16,9.19%,PPARG;KLF4
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.5645585941901018,0.9597152620989463,0.5116279069767442,1.0,1.0,1/6,2.71%,SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5826313297830652,-0.9596987200035646,0.6301369863013698,0.8681676405485816,1.0,3/8,19.07%,PLCG2;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4097116682759039,0.9593440287738804,0.45161290322580644,1.0,1.0,5/19,22.05%,YEATS2;KAT6B;ZZZ3;MORF4L2;EPC1
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.6398667990514405,-0.9593419824132787,0.6451612903225806,0.868671748698635,1.0,3/5,35.01%,ZDHHC21;HSP90AA1;LYPLA1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5531805931811551,0.9591398218021037,0.4523809523809524,1.0,1.0,2/6,16.18%,ENTPD1;APP
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.5011387506182681,-0.9591213004393915,0.5,0.8688027876393859,1.0,9/27,20.19%,CDKN1B;EEF1A1;ERBB4;FLT1;FGFR1;TIE1;EGFR;EMP2;ECT2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5869334578281965,-0.9591006878043151,0.6086956521739131,0.8684976094546036,1.0,5/10,13.17%,PPARG;CDKN1B;TPM1;SOD2;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.5324989872134201,-0.9582825960012473,0.569620253164557,0.8699227962635303,1.0,5/28,11.79%,BTG2;RTN4;GAPDH;PRNP;RPL13A
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.6096377014712195,-0.958027462367083,0.5555555555555556,0.8697750830856223,1.0,1/5,4.70%,GPC5
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.6096377014712195,-0.958027462367083,0.5555555555555556,0.8697750830856223,1.0,1/5,4.70%,GPC5
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.5017072084933639,-0.9578684431608501,0.525,0.8698101678985879,1.0,10/28,18.73%,DMD;SLC8A1;ITGA10;ITGB5;GJA1;CTNNA3;CACNA1C;CTNNA1;DAG1;ITGB1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4682472191715525,-0.9578683374934215,0.5476190476190477,0.8694598617496155,1.0,10/41,18.30%,YTHDC1;KHDRBS3;PIK3R1;PRX;AHNAK;HNRNPH3;TMBIM6;SLC38A2;PTBP2;ZNF326
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,0.5334547351384701,0.9577195893379674,0.5641025641025641,1.0,1.0,1/6,2.39%,CASP10
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.5682844694775813,-0.957492772104798,0.5362318840579711,0.8699618261450788,1.0,1/6,5.02%,SEMA6B
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5899154351626653,-0.9571602954134327,0.6,0.8703003054646921,1.0,2/13,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.536226759457986,-0.9569011889640597,0.5675675675675675,0.8705071944499082,1.0,6/15,15.94%,CANX;ANXA1;GOLPH3;RIMS2;RAB8B;MIA2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.49037016230010955,-0.9567902701069121,0.5454545454545454,0.8704785449325652,1.0,4/31,8.66%,SPNS2;ENPP2;ESYT2;PDXDC1
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,-0.5951188992603198,-0.9565293554979295,0.5901639344262295,0.8706218520200776,1.0,1/6,4.06%,NES
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.49131591079880366,-0.9562290204176634,0.5609756097560976,0.8709776132019431,1.0,11/24,21.94%,SPOCK1;NFASC;GRIA2;LSAMP;PPFIA2;PLP1;LRRC4C;CADM2;PDE10A;SCN2A;NEGR1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.6192683941585982,-0.9562268504920737,0.5901639344262295,0.8699336020803419,1.0,3/5,27.14%,CHST11;CHSY1;CSGALNACT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.6192683941585982,-0.9562268504920737,0.5901639344262295,0.8699336020803419,1.0,3/5,27.14%,CHST11;CHSY1;CSGALNACT1
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.6192683941585982,-0.9562268504920737,0.5901639344262295,0.8699336020803419,1.0,3/5,27.14%,CHST11;CHSY1;CSGALNACT1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.5173664965793869,-0.9562079362549056,0.5555555555555556,0.8696207755237909,1.0,6/20,19.42%,PIK3R1;KIF16B;BCAR1;ERBIN;GRB2;EGFR
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,-0.4853108663260881,-0.9554818616259566,0.5783132530120482,0.870987289783188,1.0,3/36,4.04%,PLS3;PPP1R9A;KIAA1217
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,-0.5554767778140353,-0.9553111763306935,0.5538461538461539,0.8709675634521997,1.0,2/10,9.06%,NES;CD81
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6199386827112602,-0.9552621228523698,0.6212121212121212,0.8703601174628499,1.0,2/6,15.33%,SLC26A2;SULT1C4
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.6199386827112602,-0.9552621228523698,0.6212121212121212,0.8703601174628499,1.0,2/6,15.33%,SLC26A2;SULT1C4
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5718783204044902,-0.9547788046188778,0.5277777777777778,0.8708228565765482,1.0,1/9,8.34%,PRKN
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.436749557113967,0.9545917187220294,0.4827586206896552,1.0,1.0,5/18,13.33%,RPP38;CDKAL1;NUP58;TRMT11;NUP214
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5079853775656179,0.9544212520418172,0.5454545454545454,1.0,1.0,4/10,8.45%,THOC1;ERCC6;CDK12;SCAF8
prerank,KEGG_2021_Human__Gastric acid secretion,-0.5318214809219677,-0.9542160915219051,0.5421686746987951,0.8714654114184452,1.0,8/20,28.61%,ITPR1;ATP1B3;GNAI3;ADCY2;ATP1A1;CAMK2D;ADCY9;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5514809344118543,-0.9538753489835393,0.5915492957746479,0.8717427213802419,1.0,10/14,40.05%,KLF4;XIAP;CSNK2A1;MAP2K5;RPS6KA3;DDX3X;DNAJB6;YWHAE;CAST;CARD8
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.39129485736095004,0.9536936526842873,0.5217391304347826,1.0,1.0,3/21,5.79%,ANKRD6;TPD52L1;MFHAS1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.49734862229133414,0.9536513370113261,0.4166666666666667,1.0,1.0,4/11,10.41%,GBP2;IL1R1;ENTPD1;TNFRSF1B
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.4340978192227531,-0.9534475215058453,0.532608695652174,0.8723258809426663,1.0,15/84,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;PRKN;UBC;OGT;NFKBIA;FOXK1;CYLD;SMAD3;USP34
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.626921805227523,-0.9532391571096291,0.6181818181818182,0.8724631485578326,1.0,3/6,27.97%,UGGT2;DNAJB14;ATXN3
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.47804736717893703,-0.9530398609630237,0.6219512195121951,0.8725328446972282,1.0,13/42,25.07%,ITPR1;CX3CL1;GRM7;ANXA1;RGS7;PPP3CC;GNAI3;PRKAR1A;ADCY2;AHCYL1;RGS3;PDE4B;CAMK2D
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.451126426028835,-0.9528150877716643,0.6067415730337079,0.8727328592153752,1.0,9/65,9.40%,PSMC6;PSMB9;LGALS3;RPS27A;PSMA1;PBRM1;SIN3B;UBC;CCNH
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.6236702127659575,-0.9525937588156487,0.660377358490566,0.8728203674886486,1.0,5/5,37.74%,DSP;MTM1;VIM;DNAJB6;KLHL24
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5625260364665998,-0.9525511476584859,0.5882352941176471,0.8725394562760126,1.0,3/10,18.33%,ANXA1;PRNP;ERBIN
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,-0.522311422714627,-0.9518430015197757,0.5846153846153846,0.8737809730862388,1.0,9/22,12.88%,ZEB2;TM6SF1;LRRC32;FES;PECAM1;SCARF1;VWF;DYSF;CLDN5
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.5540516646957518,-0.9516787446043347,0.5333333333333333,0.8738320508829213,1.0,1/14,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6422059088579417,-0.9514076078203292,0.6206896551724138,0.8740042288023333,1.0,1/5,23.43%,AGO2
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.4621824514159085,-0.951320331289655,0.5421686746987951,0.8738085068926696,1.0,10/36,25.39%,HSPA5;EEF1A1;TPR;HSPH1;NUP54;MTOR;HSPA9;HSP90AA1;CAMK2D;SERPINH1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6321808510638298,-0.9512512364878777,0.576271186440678,0.8735725927578547,1.0,5/5,36.89%,CD55;CD46;STAT3;BACH2;MSH2
prerank,KEGG_2021_Human__GABAergic synapse,-0.5390865030591738,-0.9508749290573912,0.5466666666666666,0.873986660665886,1.0,7/21,21.62%,GLUL;PLCL1;GABARAPL1;CACNA1C;SLC38A2;GNAI3;ADCY2
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.4910861955567536,-0.9508248115956157,0.5,0.8737284656124964,1.0,10/27,17.29%,NFASC;RIMS1;GRIA2;CNTN1;LSAMP;CTNND2;ERO1B;LRRC4C;CADM2;ROBO2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4478122537470043,-0.9508154986264127,0.574468085106383,0.8733943538018807,1.0,18/65,20.42%,SUN2;SRGN;NPLOC4;ARHGAP21;SUN1;RAB2A;GOLPH3;DYSF;TMED10;RAB1A;RAB30;TOR1AIP2;ANK3;ATP8B1;ARFGEF2;CAV2;CSNK1D;REEP3
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.6161974364532556,-0.950606755612043,0.6197183098591549,0.8735662949934854,1.0,1/7,3.85%,HSPA5
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.480476228551142,0.9502167117512458,0.46875,1.0,1.0,2/11,1.62%,BET1;STX8
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.48168458740910614,-0.9500883428432157,0.5432098765432098,0.874346592727142,1.0,10/35,19.42%,PCK1;PPARG;TIMP3;TNS1;EPAS1;CFH;PLSCR4;PIKFYVE;ACVRL1;EGFR
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5053363488671719,-0.9497449495475914,0.5733333333333334,0.874602995279738,1.0,2/28,4.09%,SPNS2;ABCA5
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5120473429588308,-0.9496610377583168,0.5972222222222222,0.8744076574085172,1.0,1/22,0.72%,SPNS2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.6158815227569097,-0.9494116475563396,0.5915492957746479,0.8742988748706183,1.0,4/6,28.61%,SLC8A1;ATP1A1;CAMK2D;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.6158815227569097,-0.9494116475563396,0.5915492957746479,0.8742988748706183,1.0,4/6,28.61%,SLC8A1;ATP1A1;CAMK2D;ATP1B1
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.4820294734077719,-0.949057821881435,0.6056338028169014,0.8745906122523477,1.0,2/27,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5522362918248934,-0.9486512468196714,0.5733333333333334,0.8750919060893729,1.0,7/15,31.47%,KLF4;CDKN1A;CDK6;DLG1;FAM107A;SLFN11;NACC2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.568338540574052,-0.9485884678443919,0.6307692307692307,0.8748699907433592,1.0,3/9,16.41%,GPM6B;COMMD1;PICALM
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5206614156962419,-0.9481269392635286,0.6216216216216216,0.8754778174740582,1.0,3/17,8.45%,TIMP3;TPM1;TNS1
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,-0.5440659888630265,-0.9478603076381219,0.5555555555555556,0.8756437943091627,1.0,5/10,32.96%,LAMA5;EGFR;DSP;TM4SF1;FLNB
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.6210840508277635,-0.947442374415579,0.6610169491525424,0.8761928989193151,1.0,3/5,19.18%,PECAM1;ITGB1;CD34
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5130533428512194,-0.9470980464840937,0.5671641791044776,0.8765767436092097,1.0,10/24,21.38%,DUSP1;PEBP1;TIMP3;HYAL2;STK38;DAG1;DLG1;PIK3CB;SPRED1;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.46644810428378525,0.9470317366382305,0.5142857142857142,1.0,1.0,2/10,10.81%,IL15;RAB27A
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.5106501868093917,-0.9465968019881269,0.5616438356164384,0.8773343346499394,1.0,5/19,15.72%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.5464262993641309,-0.9464925627178818,0.5588235294117647,0.8772144370693423,1.0,3/9,19.18%,PECAM1;ITGB1;CD34
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,-0.6058220519063517,-0.9463329447411255,0.6,0.87723701687276,1.0,3/6,27.99%,CDKN1A;GRB2;STAT5B
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.45003683563634533,-0.9463191864417425,0.5681818181818182,0.8769171060590804,1.0,14/52,18.83%,JUN;FOS;LRRC32;SMAD7;RPS27A;UBC;HYAL2;ITGB5;LIMS1;CLDN5;SMAD3;ITGB1;SMAD5;ACVRL1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6074631385028001,-0.9462893391605125,0.5507246376811594,0.8766463532990938,1.0,5/7,35.88%,CHMP4B;TUBB6;TUBB4B;TUBA1B;TUBB
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.5581618372465631,0.9451698477172016,0.5675675675675675,1.0,1.0,2/5,9.19%,TBL1X;TBL1XR1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6170406118762535,-0.9446146357658827,0.6451612903225806,0.8799489403195003,1.0,1/7,4.46%,KDM1A
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,-0.6076710929843718,-0.944553828511034,0.5901639344262295,0.8797260715538247,1.0,1/7,8.26%,RAP1A
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.5918554829093766,-0.9443997760730705,0.5873015873015873,0.8797120905958614,1.0,7/8,35.43%,ANXA1;ZFP36;ADAM9;FAM107A;REST;ZFP36L1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5005726887575465,-0.9442023201237422,0.5263157894736842,0.879742509956378,1.0,3/29,9.69%,MYO9B;EPS8;DLC1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4526974020670946,-0.9441249113854421,0.5632183908045977,0.8795510463577044,1.0,15/56,15.59%,NR4A1;SMAD7;EEF1A1;MAGI2;FLT1;RAP1A;ANXA1;KLF4;HYAL2;LIMS1;ZFP36;ACAP2;BCAR1;SMAD3;RACK1
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,-0.47387626967821606,-0.9440932215792154,0.5584415584415584,0.8792754604423542,1.0,10/33,13.25%,PPA1;EHD4;ACTN1;VAV3;BCL6;SCARF1;NCALD;TGM2;KIF16B;NAV1
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.5569374099891127,-0.9439318450531226,0.5588235294117647,0.8792173421426005,1.0,3/10,17.45%,LRRC32;PECAM1;LCP2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5027914414130251,-0.9434432862494957,0.5185185185185185,0.879855083998303,1.0,5/26,10.94%,LRRC32;TIMP3;PECAM1;TNS1;CFH
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,-0.5629774272185806,-0.9434431390041774,0.6486486486486487,0.8795088206830735,1.0,4/14,23.67%,CFH;PLSCR4;ATP8B1;VWA2
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.5596374319678565,-0.94326608372101,0.6212121212121212,0.8795702473708025,1.0,1/9,3.93%,SCP2
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,-0.5295080409873838,-0.9431260943193225,0.6027397260273972,0.8795298114086699,1.0,5/19,5.55%,BHLHE40;EHD4;JUNB;LGALS3;RRBP1
prerank,KEGG_2021_Human__Wnt signaling pathway,0.35275289282336164,0.9428717459639857,0.46153846153846156,1.0,1.0,10/53,12.24%,ZNRF3;CTBP2;TLE4;NKD1;PLCB4;TBL1X;TBL1XR1;INVS;ROR1;PPARD
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.4416179873882007,-0.9428491475034416,0.5402298850574713,0.8797062307830524,1.0,9/68,8.84%,PSMC6;JUN;PSMB9;RPS27A;PSMA1;CNTN1;HIF1A;JAG2;UBC
prerank,KEGG_2021_Human__Lysine degradation,0.3978347584991566,0.9424445487574127,0.625,1.0,1.0,5/22,11.45%,ACAT1;SMYD3;EZH1;KMT5B;AASS
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5542831857138484,-0.9422677933774238,0.5975609756097561,0.8805592659614468,1.0,9/15,24.75%,PRKN;SNX6;SYT1;ANK3;ATP1A1;B2M;NEDD4;NEDD4L;TF
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6468549673640495,-0.9418385832362391,0.6417910447761194,0.8810004320684264,1.0,2/5,28.50%,ZDHHC21;ADCY9
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.4824300906441998,-0.9417439082536159,0.5733333333333334,0.8808490041332975,1.0,6/32,13.89%,NEDD9;ANXA1;S1PR1;PARVB;CASS4;BCAR1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5156725658064001,-0.9416921484598166,0.6052631578947368,0.8806137526067039,1.0,1/20,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5534828476322968,-0.9415851168907228,0.6376811594202898,0.8804758440552772,1.0,4/13,17.18%,RPL10;TMED10;PICALM;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.46176583856282416,-0.9412888321453233,0.5568181818181818,0.8807132811532501,1.0,17/62,24.41%,DDIT4;CX3CL1;SULF2;TMBIM6;NCK1;RACK1;EGFL7;MTMR2;GATA2;LRPAP1;EGFR;PIK3CB;GLI3;GPC3;CALR;NEDD4;TNS2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.49390158096359715,-0.9410947117702566,0.5569620253164557,0.8807651933173376,1.0,8/29,16.95%,ERO1A;NFE2L2;SERPINB6;SOD2;MSRA;PINK1;VRK2;TXNRD1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.5900576610916949,-0.9410682238327411,0.6307692307692307,0.8804818212760881,1.0,4/12,24.44%,PTPRD;IL1RAPL1;NEDD4;NEDD4L
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.4168755616654636,-0.9407263875278593,0.5913978494623656,0.8808027550753567,1.0,14/131,10.73%,PSMC6;TSG101;PSMB9;NPLOC4;SPOPL;NFE2L2;NDFIP1;RNF19A;PSMA1;FEM1C;PRKN;ARIH2;HERPUD1;CHFR
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.4831731907744841,-0.9405128903346683,0.5975609756097561,0.8809074629655541,1.0,12/40,23.27%,CX3CL1;LRRC32;TNS1;VWF;CLDN5;PLSCR4;NOTCH4;TIE1;ACVRL1;CD34;SPARC;CDH5
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.5516296127764831,-0.9404540750516873,0.5254237288135594,0.880681644922719,1.0,5/12,22.90%,SLC6A6;SLC30A7;SLC2A13;SLC30A1;BSG
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6396711938292644,-0.9403853894505279,0.5942028985507246,0.8804868329472199,1.0,2/5,6.37%,SCP2;LSS
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.575714390664335,-0.940270052901191,0.5942028985507246,0.8804242475502102,1.0,3/7,28.47%,HIP1R;PIK3CB;SCYL2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5343977047192299,-0.9399580251420915,0.5675675675675675,0.8807093705238848,1.0,2/14,8.34%,HIF1A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.5966041314689303,-0.9397052581164073,0.576271186440678,0.8808886938743689,1.0,2/7,17.29%,SEMA6B;ROBO2
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.6185271213914425,-0.9391152400748382,0.5522388059701493,0.8816703091858136,1.0,1/5,13.07%,NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.5471963030519175,-0.9389863431760141,0.6133333333333333,0.8815458210638141,1.0,4/11,28.34%,GOLPH3;LARS1;WDR59;SIK3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5378595593662182,-0.9388662536512693,0.582089552238806,0.8814785505826097,1.0,7/14,32.14%,DMD;SPCS3;CPM;SPPL3;BACE2;NPEPPS;ERAP1
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.4947940110927794,-0.9388502059626851,0.6125,0.881178547732499,1.0,4/20,19.07%,PIK3R1;GIT2;NCK1;GRB2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.45628980064677216,-0.9386807527561161,0.6625,0.8811729393255312,1.0,8/48,11.02%,SLC6A6;LGALS3;SMAD7;FES;BCL6;KLF4;PLEKHB2;FGFR1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4274678853531712,-0.9386016030403929,0.6170212765957447,0.8809478981653739,1.0,16/88,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;PRKN;UBC;OGT;NFKBIA;FOXK1;CYLD;SMAD3;USP45;USP34
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4776542234668345,-0.938435271161597,0.5822784810126582,0.8808853525981987,1.0,6/35,16.49%,ATG12;RPS27A;UBC;NFKBIA;CYLD;TBK1
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.4660953836748763,0.9383318593132414,0.5555555555555556,1.0,1.0,3/12,10.01%,UGCG;SGMS1;SGPL1
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,0.35863151389295383,0.9382191340638211,0.625,1.0,1.0,5/46,4.14%,SAMD9L;GBP2;GBP4;GBP1;SP140L
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.4200026194912826,-0.9380534533882219,0.6363636363636364,0.8813096266332623,1.0,24/179,16.71%,MAP3K5;PCK1;PRKAG2;PKN3;GRK5;SMAD7;FES;JAK1;ERBB4;PRKCE;FLT1;CCNH;SIK2;CDK14;FGFR1;DCLK1;PAK2;TEC;TRIB2;STK38;CDK6;TBK1;PINK1;VRK2
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.43753518342846215,-0.9380463899414982,0.5053763440860215,0.8809752047572953,1.0,20/60,26.99%,RTN4;RPS27A;VAV3;UBC;GNA13;FGD4;NFKBIA;TNFRSF10B;CYLD;RACK1;RASGRF2;ECT2;XIAP;MAPK8;KALRN;NSMAF;ARHGEF2;PREX1;MCF2L;TNFRSF10D
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,-0.5904091329488931,-0.937982022685113,0.6440677966101694,0.8807549728707011,1.0,3/5,37.37%,GRB2;GRB10;MAPK1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5833343989495107,-0.9379018699076154,0.6056338028169014,0.8805480529831334,1.0,1/9,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5752447563148535,-0.9375460884809805,0.5645161290322581,0.8809499056181972,1.0,2/8,23.82%,AP1G1;HLA-B
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5561091882492066,-0.9373744673026996,0.5714285714285714,0.881001301926954,1.0,4/9,23.21%,GPC5;HYAL2;OMD;GPC3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.501723571587874,0.9373252452806062,0.5,1.0,1.0,1/8,3.48%,DISP1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5309096360976706,0.9372843886895085,0.5263157894736842,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5943209038018338,-0.9372838992662192,0.5806451612903226,0.8805004459161894,1.0,3/7,32.03%,B2M;HLA-B;HLA-E
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.5943209038018338,-0.9372838992662192,0.5806451612903226,0.8805004459161894,1.0,3/7,32.03%,B2M;HLA-B;HLA-E
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.6006484827242419,-0.937203599333613,0.6231884057971014,0.8803290002511426,1.0,4/8,25.05%,TMEM45B;EGFR;VWA2;DSP
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,-0.4199891070606754,-0.9367916729980349,0.6632653061224489,0.8808568879802393,1.0,29/156,15.86%,NRCAM;PCDH9;NEDD9;GRIK1;HES1;MDGA2;SYN3;JUNB;MYO9B;SMIM3;TSC22D3;JUND;DUSP1;PIK3R1;PDE7A;IFNGR2;BCL6;SIN3B;HERPUD1;RPS27;EFNB2;NFKBIA;TRIB2;CSMD1;CACNA1C;BTG1;EFR3B;SGIP1;CADM2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5650084718500483,-0.9367339202754364,0.6212121212121212,0.8806199124667808,1.0,1/13,5.60%,CDC37
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5337585888731264,-0.93670708068591,0.6027397260273972,0.8803263548476408,1.0,2/13,4.78%,PCK1;S100A6
prerank,KEGG_2021_Human__Morphine addiction,-0.5191404957352486,-0.9366267402083144,0.6142857142857143,0.8801508776778069,1.0,8/20,28.50%,GRK5;PDE7A;PDE10A;GNAI3;ADCY2;PDE4B;GABRB1;ADCY9
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.3895560387512081,0.9365049906853876,0.6,1.0,1.0,6/25,7.52%,GULP1;PTPN21;GOLM1;EFNA5;PLCB4;KIAA1549
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.42569583854733273,-0.9364688309720786,0.5760869565217391,0.8801413391468045,1.0,16/88,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;PRKN;UBC;OGT;NFKBIA;FOXK1;CYLD;SMAD3;USP45;USP34
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.626456437401175,-0.9362212724679971,0.6176470588235294,0.8803193540577947,1.0,2/6,18.49%,OGT;KMT2A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.4704536720675277,-0.9358461848270571,0.5647058823529412,0.8806062272509502,1.0,10/38,18.67%,FES;HIP1R;RAB21;STXBP5L;RIMS2;SYT1;RAB8B;PICALM;RUFY2;SCARB1
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,0.34933239678703276,0.9356826555090472,0.5416666666666666,1.0,1.0,8/30,13.78%,SAMD9L;GBP2;SP140L;HADHB;CPQ;RAB27A;DECR1;PPP2R5A
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.616973438721339,-0.9355783342350761,0.5692307692307692,0.8808144314589199,1.0,3/7,23.21%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4046037469985485,0.9354131796498765,0.5555555555555556,1.0,1.0,2/22,6.03%,BMP6;ELAPOR2
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5224412151124418,0.93524359844595,0.5294117647058824,1.0,1.0,1/8,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5224412151124418,0.93524359844595,0.5294117647058824,1.0,1.0,1/8,1.25%,SLC4A4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.46529590877003435,-0.9351698741495843,0.5853658536585366,0.8812359416636985,1.0,11/37,23.27%,LRRC32;GGT5;TNS1;VWF;CFH;TIE1;ITGB1;ACVRL1;CD34;SPARC;CDH5
prerank,Reactome_2022__PKA Activation R-HSA-163615,-0.5924085007283122,-0.9350050948601722,0.65,0.8812172922543672,1.0,3/8,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.5772701311494364,-0.9346678472036617,0.5522388059701493,0.8815817303397805,1.0,1/7,16.49%,TBK1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.48983272136936196,0.9344329278736555,0.5925925925925926,1.0,1.0,2/9,11.42%,CLASP1;CLIP1
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.4678908049845438,-0.934346233755527,0.5384615384615384,0.8818545068510756,1.0,7/30,18.09%,ARHGAP21;GIT2;DLC1;SLC4A7;GJA1;STOM;ARHGAP17
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.43769409152227057,0.9339749778367251,0.5,1.0,1.0,2/17,7.94%,RC3H1;HSPA1A
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,-0.6098819332766603,-0.9339261659291223,0.6119402985074627,0.8816110558002466,1.0,2/5,17.45%,PECAM1;LCP2
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,-0.6098819332766603,-0.9339261659291223,0.6119402985074627,0.8816110558002466,1.0,2/5,17.45%,PECAM1;LCP2
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,-0.6098819332766603,-0.9339261659291223,0.6119402985074627,0.8816110558002466,1.0,2/5,17.45%,PECAM1;LCP2
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.6141386795655466,-0.9338966387139913,0.6,0.8813359673451416,1.0,1/5,14.58%,SMAD3
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5023336940703231,-0.9338157393653181,0.5375,0.8811522947052308,1.0,4/18,12.88%,PTPRD;IL1RAPL1;LIMS1;CLDN5
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5081398632186296,-0.9334313788167651,0.631578947368421,0.8814463124041236,1.0,2/22,2.82%,NRCAM;HES1
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.5741106961426925,-0.9333805875501768,0.5967741935483871,0.8812106627038129,1.0,3/7,17.82%,CYLD;LCP2;ARHGAP15
prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.5030974346862755,-0.9328631365610417,0.6619718309859155,0.8819772739191866,1.0,8/20,31.42%,RIMS1;SYT1;CLTA;DNM2;ATP6V1E1;SLC1A2;SNAP25;STXBP1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.5144084036125065,-0.9328460150060623,0.625,0.8816722198832389,1.0,1/22,0.72%,SPNS2
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.5934229537713015,-0.9325895930685766,0.589041095890411,0.8819699191872922,1.0,1/7,5.87%,JAK1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5747322418398865,-0.9325149246445078,0.609375,0.8817950927110252,1.0,2/7,17.18%,DMD;SAMD8
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,-0.4798444796238662,-0.9318941558227853,0.5974025974025974,0.882742215029622,1.0,4/32,9.46%,KIAA1217;TINAGL1;NPAS2;VWF
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34359613439635506,0.931745669112081,0.6923076923076923,1.0,1.0,7/82,6.56%,BMP6;TPD52L1;HOMER1;CTBP2;LIMS2;WLS;NPTN
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,-0.4953752316190265,-0.9315732177533113,0.5675675675675675,0.8830434889611816,1.0,5/20,17.64%,ENPP2;LRRC32;TNS1;CACNA1C;CALD1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6242188946108936,-0.9314926960825205,0.6964285714285714,0.8828900913709314,1.0,3/6,34.29%,IFITM3;LY6E;GSN
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.41341983297959,0.9311228067097512,0.4583333333333333,1.0,1.0,4/13,9.61%,CTNNA2;HDAC9;ABL1;CDH2
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,-0.4785414714597228,-0.9311124230895002,0.620253164556962,0.8832819299419485,1.0,11/34,23.88%,EPS8;TIMP3;EMP1;EPAS1;ARHGAP23;MYO1B;WWTR1;EGFR;CAV2;ADAM9;CTTNBP2NL
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5349742857551538,0.9309478177414098,0.5384615384615384,1.0,1.0,3/6,14.00%,SPG11;RAB27A;NLGN1
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.4561745330957232,-0.9305699057078206,0.6309523809523809,0.8838897011105847,1.0,11/43,13.76%,SRGN;FES;IFNGR1;CLEC2B;SOD2;PLIN2;WIPF1;ATP1B3;PLCG2;INPP5D;PELI1
prerank,CellMarker_Augmented_2021__B cell:Undefined,-0.5306176202919867,-0.9301440197163858,0.6056338028169014,0.8843673151058017,1.0,6/13,21.78%,CD9;PECAM1;CD81;IL18R1;CD34;CD63
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.287453933773126,0.9297521979596052,0.8181818181818182,1.0,1.0,13/104,10.92%,SCFD2;STX8;EVI5;HERC2;TBC1D5;XPO4;WLS;VPS45;IPO8;TNPO3;RAB28;TBC1D4;SYNRG
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.49984407044015,-0.9296670927343192,0.6,0.8849439535298984,1.0,3/20,15.27%,RTN4;PRKN;WWTR1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.47450006757086216,-0.9296173900997645,0.5529411764705883,0.8847166861797132,1.0,4/29,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,KEGG_2021_Human__Bladder cancer,-0.5731933724422159,-0.9295263708092898,0.6268656716417911,0.8845327735592746,1.0,3/11,19.42%,RASSF1;CDKN1A;EGFR
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.5022376546342997,-0.9293614262620642,0.6375,0.8844828098219122,1.0,8/28,24.44%,LGALS3;RAPGEF3;RACK1;TMEM30A;CLU;GPC3;CDH5;NEDD4L
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.3937319682343324,0.9293510387705982,0.6666666666666666,1.0,1.0,5/33,6.96%,GBP2;GBP4;GBP1;PIAS1;TRIM22
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4387571052126379,0.929316668662263,0.5333333333333333,1.0,1.0,3/12,17.53%,SLC25A29;TRPM7;PKD2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.49741116125247975,-0.9291733932918179,0.6176470588235294,0.8845709556720817,1.0,3/15,9.08%,PBX3;NES;RPL10
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.620335322108525,-0.929136696423053,0.6271186440677966,0.884296735715358,1.0,3/5,13.81%,MGLL;GGT5;PON2
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5812271911615225,-0.9289644414905097,0.6666666666666666,0.8842210512509204,1.0,6/8,34.00%,TINAGL1;ATP8B1;DSP;TM4SF1;S100A10;EFNA1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6073178892173483,0.9289007193692146,0.631578947368421,1.0,1.0,1/5,2.68%,DCP1A
prerank,KEGG_2021_Human__Peroxisome,-0.5445759115907878,-0.9285868126056994,0.6363636363636364,0.8846410485227163,1.0,4/15,13.86%,SCP2;SOD2;ACSL5;ACOX1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.47605449581607906,-0.9285423283268459,0.6190476190476191,0.8840115711980333,1.0,4/28,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.47605449581607906,-0.9285423283268459,0.6190476190476191,0.8840115711980333,1.0,4/28,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5588496052342529,-0.9284591558330318,0.6176470588235294,0.8838758439643133,1.0,7/13,23.11%,DUSP1;CYLD;RELL1;DLG1;GADD45B;SASH1;PHLPP1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.45284347296991845,0.9284006273251567,0.5333333333333333,1.0,1.0,2/15,4.91%,OFD1;CLASP1
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.6064543050922259,-0.9281290459512271,0.5909090909090909,0.8842307832657634,1.0,4/6,29.06%,TBCD;TUBB6;TUBB4B;TUBA1B
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.46537021831924924,-0.9278105247445321,0.5694444444444444,0.8845381343941427,1.0,8/35,14.50%,PIK3R1;FLT1;VAV3;SHC2;PAK2;BCAR1;VEGFC;NCK1
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.4657529308778042,0.9277925452331778,0.6,1.0,1.0,2/17,7.57%,PLA2G4A;BICD1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.527570301909688,-0.9277568913910303,0.6231884057971014,0.8843034639798582,1.0,4/13,22.74%,GOLPH3;TMED10;CSNK1D;ARL5B
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.4875703788763166,-0.9277012488571768,0.68,0.8840775692776693,1.0,10/32,19.42%,SCARB2;RPS27A;UBC;SH3KBP1;SYT1;SH3GL1;SGIP1;PICALM;GRB2;EGFR
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.5219150719290004,-0.9272902947812164,0.6029411764705882,0.8845221185537584,1.0,4/17,16.97%,RAP1A;MSN;PINK1;TIE1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.6021697406967799,-0.9272618843510513,0.6129032258064516,0.8842662479884663,1.0,2/6,18.49%,KDM1A;KMT2A
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.5150895696352977,-0.9268717593054591,0.5774647887323944,0.8846674528621863,1.0,4/18,11.02%,RPS27A;PIK3R1;UBC;FGFR1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.37494685389135124,0.9263290696142539,0.6190476190476191,1.0,1.0,8/31,8.74%,PLPPR4;ARNT2;PRKG1;ZNF521;LDB2;PDZRN3;TLN2;FBXL7
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5728701423856749,-0.9260850426448065,0.5942028985507246,0.8858666077020454,1.0,3/10,17.29%,PTPRD;IL1RAPL1;ROBO2
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.5058820995507272,-0.9260454086344999,0.6323529411764706,0.8856362576664777,1.0,6/20,24.75%,RPS27A;UBC;CUL1;FTL;ATP6V1E1;TF
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.4858955163113207,-0.9260389137773172,0.5903614457831325,0.8853203145675093,1.0,5/24,15.72%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.5399440269046227,-0.9260056119942963,0.5882352941176471,0.8850474800488709,1.0,3/14,18.01%,PBRM1;TPR;NUP54
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.4813408221485734,-0.9255416047745401,0.5822784810126582,0.8855676084976454,1.0,5/23,18.80%,SCARB2;SCP2;TMEM30A;SCARB1;ATP8B1
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.5703119122060862,-0.9253141859386911,0.6212121212121212,0.8856332866184756,1.0,2/9,8.84%,RPS27A;UBC
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.5173368504750241,-0.9252609735166338,0.5915492957746479,0.8854291548479177,1.0,1/18,0.72%,SPNS2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3809756849635776,0.9252101025890898,0.5416666666666666,1.0,1.0,2/24,3.59%,UBE3D;RNF213
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.5982474944009428,-0.9247812070031931,0.5588235294117647,0.8860384306563605,1.0,3/8,6.27%,NRG3;ERBB4;PIK3R1
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4228801117585749,-0.9243507797483401,0.6288659793814433,0.8865702276377543,1.0,11/72,10.94%,ADAMTS9;ENPP2;LRRC32;DUSP1;SMARCA1;TNS1;CD55;LSAMP;VWF;GPM6A;CFH
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5313373512970287,-0.924208888942759,0.6666666666666666,0.8864814521809558,1.0,1/11,3.80%,MAP1B
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.6041568798101786,-0.9240314712566126,0.6333333333333333,0.8864654259336852,1.0,2/6,9.06%,RTN4;CD81
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.6286192495169555,-0.9239862888565703,0.6964285714285714,0.8862186279800554,1.0,2/5,5.98%,CHPT1;DHRS7B
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5979577957705892,0.9239701530109976,0.575,1.0,1.0,1/5,3.75%,MRPS31
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5650511135418276,-0.9233583069927889,0.582089552238806,0.8870272392734488,1.0,4/9,17.48%,CANX;SYNJ2;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5561931250199599,-0.9230675911100125,0.640625,0.8872330919220597,1.0,3/13,19.42%,ANXA1;ADAMTS1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.46160489355679307,-0.9228057466673133,0.6962025316455697,0.8874217127907703,1.0,11/38,20.35%,RTN4;CX3CL1;ERBB4;PIK3R1;FGFR1;CASS4;PINK1;ITGB1;GRB2;EGFR;PIK3CB
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.48562758235083325,-0.9223387072030634,0.5844155844155844,0.8878960994308156,1.0,9/22,26.56%,PPP1R9A;TMEM132C;SHC2;NEBL;ANK3;KALRN;VWA2;SPARCL1;MCF2L
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.59187286299748,-0.9219388885386046,0.6233766233766234,0.8879398133435886,1.0,2/8,13.97%,GPC5;HS6ST3
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,-0.59187286299748,-0.9219388885386046,0.6233766233766234,0.8879398133435886,1.0,2/8,13.97%,GPC5;HS6ST3
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5097750375310413,0.9217920621239072,0.5625,1.0,1.0,4/9,14.02%,CIRBP;TRA2A;RBMX;NCL
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4378742655011193,-0.9216405052879114,0.627906976744186,0.8881747678607005,1.0,11/59,15.27%,TAMALIN;PKN3;CLEC1A;TIMP3;TMEM184B;HYAL2;ITGB5;EPAS1;EFNB2;PLSCR4;WWTR1
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.5794940354499719,-0.921568966763268,0.6071428571428571,0.8879578960666947,1.0,3/6,34.95%,HSPA9;CHCHD3;ATP5F1E
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.48077133939089245,-0.9214697983400258,0.6547619047619048,0.8878434097185401,1.0,5/28,8.63%,SEC24D;TIMP3;TPM1;TNS1;MSRB3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.5144196995055748,-0.9212336398134524,0.5584415584415584,0.8879674362103595,1.0,7/21,34.24%,CDC37;RIOK3;XIAP;FGR;HLA-E;ERAP1;PTPN1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.4749465662693685,0.9211699173684609,0.5416666666666666,1.0,1.0,2/10,3.82%,DNMT3A;H2AC6
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6252082993233844,-0.9208806716713471,0.6229508196721312,0.8883084250085439,1.0,1/6,12.22%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5027578132392356,-0.920867498806126,0.6027397260273972,0.8879939795050918,1.0,2/11,6.19%,HES1;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.6080060497558843,-0.9208269907038787,0.6129032258064516,0.8873870568878763,1.0,2/5,27.36%,PTBP1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.6080060497558843,-0.9208269907038787,0.6129032258064516,0.8873870568878763,1.0,2/5,27.36%,PTBP1;SPPL3
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,0.5752140144002102,0.9203467485595921,0.6923076923076923,1.0,1.0,2/5,8.55%,IL6R;ENTPD1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5343778480698662,0.919608208868397,0.5555555555555556,1.0,1.0,1/5,11.50%,ACVR1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.8888457408119714,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.8888457408119714,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.8888457408119714,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.4252711904485249,-0.9191149956433892,0.6631578947368421,0.8892534146655893,1.0,20/104,20.66%,UFL1;BTG2;RFC3;MACROD2;POLA1;WDR48;VAV3;BCL6;CBX5;NPM1;CDKN1A;SMC6;USP45;MCL1;ZBTB38;ATF2;RIF1;GRB2;ACER2;XIAP
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,-0.4780230101711594,-0.9184174364303236,0.6710526315789473,0.8904033355802322,1.0,6/31,14.10%,MAP2;MAP1B;STXBP5L;BCAR1;HS6ST3;SYT1
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.4922885228834297,0.9183872957822327,0.5675675675675675,1.0,1.0,5/10,31.58%,RBPJ;MAML2;PLXND1;PBX1;STAT1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.454766974573254,-0.9179815702264198,0.5733333333333334,0.8908652557326437,1.0,8/31,19.60%,KIAA1217;TINAGL1;LAMA5;SMARCA1;EPAS1;WWTR1;EGFR;EMP2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.47015065783175397,-0.9178285699991583,0.6585365853658537,0.890784111558919,1.0,13/46,15.64%,SERPINE1;LGALS3;TIMP3;EMP1;AHNAK;ANXA1;TGM2;EPAS1;CFH;GJA1;PLSCR4;VEGFC;STOM
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5872352709939693,-0.9176989764192435,0.6190476190476191,0.8906691214860032,1.0,1/5,12.99%,NPM1
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.46685956144025703,0.9174366580949381,0.53125,1.0,1.0,2/10,6.56%,GNB4;NPTN
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,-0.5240178316069861,-0.9174156563121716,0.6756756756756757,0.8908423190123492,1.0,2/21,1.27%,B3GNT2;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.524398314870364,-0.9172773632456059,0.6081081081081081,0.8907570398667158,1.0,1/14,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.48502024355890105,-0.9168404358105949,0.6285714285714286,0.8912475935531535,1.0,5/24,13.09%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.5357300557138307,-0.916650730615133,0.6119402985074627,0.891191850180368,1.0,4/11,28.50%,PRKAR1A;ADCY2;CAMK2D;ADCY9
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5286049724425477,0.9166294233839176,0.6,1.0,1.0,2/6,7.20%,EZH1;BAZ2A
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.4069031074988797,-0.916519595021771,0.6565656565656566,0.8911319182928022,1.0,24/126,20.53%,NEDD9;MTFR1;NPLOC4;ARHGAP21;TPM1;PRKN;CFL1;RAB2A;GOLPH3;FGD4;TMED10;BRWD3;RAB1A;SH3KBP1;RAB30;PINK1;RAB14;TOR1AIP2;PIKFYVE;ATP8B1;CHMP4B;CAV2;CSNK1D;PRPF40A
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5568549096438871,0.9164281321498904,0.5365853658536586,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.49623583088247564,-0.9163287463446157,0.6,0.8911650655203467,1.0,4/22,18.01%,PPARG;TPR;ZFP36;NUP54
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.4801554826676039,-0.916215853465242,0.68,0.8910840525308511,1.0,8/32,26.43%,JAG2;SREBF2;EGFL7;NOTCH4;GATA2;EGFR;CD46;DLL4
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5179751108567747,0.9158438970292107,0.6,1.0,1.0,1/6,3.03%,IGFBP3
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.41181583668806937,0.9158023429780427,0.6129032258064516,1.0,1.0,3/18,10.20%,TGFBR3;EIF2AK2;KLHDC10
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,-0.44421043909934244,-0.9156449426241879,0.6103896103896104,0.8918566811292338,1.0,18/53,19.18%,ZEB2;CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;TNS1;VWF;S1PR1;CFH;DYSF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,-0.4672547641147505,-0.9154565381470064,0.6582278481012658,0.8918852950250357,1.0,6/32,10.41%,ZEB2;CLIC2;ENPP2;LRRC32;FLT1;PLIN2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.6345594502776749,-0.9154389478071001,0.7,0.8916056466096,1.0,2/5,21.97%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.4955176756252643,-0.9153166381915427,0.6111111111111112,0.8915414735035571,1.0,3/11,17.29%,SULF2;HYAL2;ROBO2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5986947710778586,-0.9148628676756095,0.6885245901639344,0.8921482191207604,1.0,2/7,11.93%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.6303310727765851,-0.9147170146877561,0.6842105263157895,0.8920628021596506,1.0,2/6,6.96%,LRRC7;MAGI2
prerank,KEGG_2021_Human__Spliceosome,0.33685418116779187,0.9144959230375006,0.5333333333333333,1.0,1.0,5/36,13.47%,THOC1;HSPA1A;DDX42;TRA2A;RBMX
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.48134964808097974,-0.9144370288448634,0.6710526315789473,0.892251499030485,1.0,4/34,9.46%,ADAMTS9;PTPRD;FLT1;VWF
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6223806537002478,-0.9144323742285624,0.6451612903225806,0.8919216621250354,1.0,2/5,18.11%,KDM1A;RIF1
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.3484438556489912,0.9142875937227344,0.6666666666666666,1.0,1.0,3/46,4.97%,CREB5;ATP2A2;PLCB4
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.5190360132512593,-0.9135682116830689,0.5945945945945946,0.8929136051696515,1.0,4/19,10.28%,MGLL;PECAM1;SOD2;ALPK1
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.5190360132512593,-0.9135682116830689,0.5945945945945946,0.8929136051696515,1.0,4/19,10.28%,MGLL;PECAM1;SOD2;ALPK1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4753279447053904,0.913231063210295,0.4772727272727273,1.0,1.0,1/10,4.91%,CLASP1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,-0.41780168472402157,-0.9131014428392206,0.65625,0.8935816238845563,1.0,21/134,13.76%,DDIT4;PKM;NEDD9;PGK1;SSH1;LGALS3;GAPDH;ZC3H7A;VAV3;RAP1A;PHTF2;HERPUD1;PRNP;CREM;DUSP16;GABARAPL1;PAK2;CBX5;ARPP19;CDKN1A;PELI1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.4496184403449631,-0.9129077012656259,0.5866666666666667,0.8936936513914925,1.0,16/46,19.18%,ZEB2;CLEC1A;LRRC32;GGT5;FLT1;PECAM1;VWF;S1PR1;CFH;CLDN5;NOTCH4;TIE1;LCP2;ACVRL1;ZNF366;CD34
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,-0.5654288358573382,-0.9128299308296923,0.6307692307692307,0.893527953084917,1.0,5/9,18.73%,ACTN1;LIMS1;PARVB;RSU1;ITGB1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.437859876115783,-0.912588916461126,0.5681818181818182,0.8936525323249539,1.0,12/45,18.83%,JUN;FOS;LRRC32;SMAD7;RPS27A;UBC;ITGB5;CLDN5;SMAD3;ITGB1;SMAD5;ACVRL1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.545854157182786,-0.9125715964221474,0.6515151515151515,0.8933398486395729,1.0,1/12,2.90%,PBX3
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,-0.5872010737595261,-0.9124874465503476,0.5967741935483871,0.8931744679506429,1.0,1/6,5.87%,JAK1
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,-0.4440595316866986,-0.9123969696203426,0.6282051282051282,0.8929630060643448,1.0,15/40,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;TNS1;VWF;DYSF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4327136292724484,0.9122385411549782,0.6896551724137931,1.0,1.0,2/16,2.68%,RC3H1;DCP1A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.6243277202661565,-0.9119013198783088,0.6379310344827587,0.8930778081369779,1.0,3/5,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6243277202661565,-0.9119013198783088,0.6379310344827587,0.8930778081369779,1.0,3/5,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.5301187589826232,-0.911689483370308,0.6111111111111112,0.8928527121847014,1.0,3/15,8.84%,RPS27A;PIK3R1;UBC
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.5301187589826232,-0.911689483370308,0.6111111111111112,0.8928527121847014,1.0,3/15,8.84%,RPS27A;PIK3R1;UBC
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.49085944468803183,-0.9113004830858712,0.618421052631579,0.8931909942032482,1.0,4/24,7.57%,SLC6A6;KCNMB4;NDFIP1;SLC8A1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,-0.5158132288417483,-0.9111615666885575,0.625,0.8931434489600948,1.0,2/15,7.81%,NES;SLC2A1
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.5484690285068066,-0.9111448648109021,0.65625,0.892823623104034,1.0,1/10,2.34%,SLC6A6
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.5362871606323171,-0.9109505911502237,0.6056338028169014,0.8928432566014995,1.0,4/10,27.44%,FGFR1;ITGB1;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4477332455326541,0.910879363297857,0.45454545454545453,1.0,1.0,2/21,2.31%,EVI5;TBC1D5
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.4981494100338003,-0.9106826966937339,0.625,0.8930428890166763,1.0,3/27,11.50%,B3GNT2;PLOD2;OGT
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.5069407745451606,0.9106369367801975,0.6285714285714286,1.0,1.0,3/10,3.29%,ZNF385D;TLE4;RBM20
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,0.5554580803233897,0.910368333915525,0.5365853658536586,1.0,1.0,2/5,14.98%,ABCG2;LAMA3
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.6082032418466662,-0.9102734203173212,0.6551724137931034,0.8935185701147945,1.0,1/5,13.17%,CDKN1A
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5644391991044928,0.9101350673018773,0.6444444444444445,1.0,1.0,2/5,8.13%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.5503003357414755,-0.9100590425802857,0.6984126984126984,0.8935128239783126,1.0,1/8,3.51%,SCARB2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.538333554419314,-0.9099682812011856,0.6216216216216216,0.893335632590977,1.0,2/16,5.50%,KDM1A;WDR48
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.3803602736867487,0.909829284733908,0.5454545454545454,1.0,1.0,2/22,1.20%,DSE;GCNT2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4598374787266949,-0.9094049644024058,0.6835443037974683,0.8940782042148749,1.0,9/42,21.81%,SUN2;SPC25;RPS27;PAFAH1B1;SMC3;KPNB1;MECP2;DYNC1I2;EML4
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.5290800596766603,-0.9093802405427135,0.5909090909090909,0.8937881125450657,1.0,8/12,26.06%,MTMR12;SYNJ2;MTMR2;MTMR6;SACM1L;MTM1;INPP5F;SYNJ1
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),-0.5750379775620784,-0.9093463228537279,0.639344262295082,0.8935316524819128,1.0,1/5,7.60%,ANK2
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,-0.5594605005720057,-0.9091347315042254,0.640625,0.8935593160801916,1.0,3/7,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5307230609855768,-0.9089624777230088,0.6153846153846154,0.8931889973582058,1.0,5/13,26.37%,ABCA5;CNBP;SCARB1;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5307230609855768,-0.9089624777230088,0.6153846153846154,0.8931889973582058,1.0,5/13,26.37%,ABCA5;CNBP;SCARB1;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5902081744793191,-0.9087667582304048,0.6376811594202898,0.8932417822650349,1.0,2/5,20.35%,PIK3C3;PIK3CB
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.5874801837946074,-0.9087129376394677,0.6166666666666667,0.8930068459994638,1.0,2/5,25.05%,ANXA3;DSP
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.45589246000038486,-0.9082088478421054,0.6506024096385542,0.8936264748617653,1.0,4/29,8.45%,WNT2B;TIMP3;TPM1;TNS1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.31739158197590256,0.9077524962100509,0.5833333333333334,1.0,1.0,11/52,13.89%,RC3H1;EFNA5;CLASP1;CHN1;PHLDB2;CDH2;ZMYM4;STAT2;MARK2;PDLIM5;SIPA1L1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5525115143929009,-0.9074097472503572,0.6290322580645161,0.8947372589580096,1.0,1/8,5.02%,SEMA6B
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,-0.5971349826211342,-0.9072986725673661,0.6229508196721312,0.8945978177709903,1.0,2/5,33.41%,AGO2;PRKRA
prerank,KEGG_2021_Human__Propanoate metabolism,-0.5468969633962857,-0.9072376011777797,0.6290322580645161,0.8943752169652124,1.0,1/9,1.41%,LDHA
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.46986079414148135,-0.9072117197841559,0.6282051282051282,0.8940820335656593,1.0,12/26,24.44%,ATP2B1;SLC8A1;ANK2;ATP1B3;ATP13A3;SLC30A1;TMEM165;VAPB;ATP1A1;CDH5;CALR;NEDD4L
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.5863782414377208,-0.9071799396249204,0.671875,0.8938181872831882,1.0,3/6,22.42%,MAGI2;MYO1E;PODXL
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.3899065296652667,0.9069728417750991,0.47058823529411764,1.0,1.0,6/27,13.33%,HSD17B4;H2AC6;TBL1X;TBL1XR1;NUP58;NUP214
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,-0.49225414676171936,-0.90697051725249,0.618421052631579,0.8939329616246106,1.0,8/22,21.83%,KIAA1217;TIMP3;ARHGAP23;GJA1;BOC;EGFR;PCDH7;GLI3
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.44622739216158863,-0.9066387918211908,0.6075949367088608,0.8941598898858408,1.0,14/39,18.70%,ADAMTS9;GPC5;RPS27A;UBC;ADAMTS1;PRNP;SLC26A2;ALG11;EGFL7;NOTCH4;B4GALT1;CHSY1;DAG1;PMM2
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,-0.4772378251181346,-0.906621844178752,0.6376811594202898,0.8938589079671025,1.0,4/24,8.29%,MYO9B;GAS7;TMEM132C;SIN3B
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5554130923849727,0.9064240082530161,0.6153846153846154,1.0,1.0,2/6,4.78%,PRKD1;LIMS2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.520329502104804,-0.9063647297853881,0.6351351351351351,0.89399846374902,1.0,2/12,5.05%,BCAP31;SPG7
prerank,KEGG_2021_Human__Long-term depression,-0.47920165867565645,-0.9062204757050201,0.6125,0.8939718210453013,1.0,2/22,4.59%,ITPR1;GRIA2
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.44582305704336994,-0.9057646581584538,0.6578947368421053,0.8945470722754936,1.0,14/42,19.18%,CLEC1A;LRRC32;FES;GGT5;FLT1;PECAM1;SCARF1;VWF;DYSF;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.4460090634707937,-0.9056571791586899,0.6385542168674698,0.8944206631460775,1.0,6/33,16.57%,SLC6A6;SCARB2;SLC52A3;LRP1B;TMEM30A;SLC38A2
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.4036391957906265,-0.9055895131838594,0.6666666666666666,0.8942445735904861,1.0,18/89,20.82%,PKN3;KDM1A;CDKN1B;SPC25;RPS27;WIPF1;ARPC2;NCK1;PAFAH1B1;PIK3C3;MYL6;CTNNA1;MYH10;ITGB1;MYL12B;GRB2;DYNC1I2;KLC1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.48553319816515206,-0.905506878020123,0.6153846153846154,0.894068613750958,1.0,1/19,2.05%,RFTN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4462421267286207,-0.9052989472747344,0.6179775280898876,0.8940751522181213,1.0,15/53,21.57%,SEC22B;BCAP31;SEC24D;ANK2;CD55;RAB2A;TMED10;RAB1A;COPA;MIA2;ANK3;USO1;DYNC1I2;CAPZA2;VAPB
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.5283565354030479,0.9048212823056977,0.631578947368421,1.0,1.0,2/7,3.82%,DNMT3A;H2AC6
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.4427575540208337,-0.9047752886904304,0.6265060240963856,0.8946907389869316,1.0,8/41,16.95%,ANGPTL4;PPARG;SIN3B;NPAS2;PLIN2;ACOX1;SREBF2;TXNRD1
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,-0.5463037252822647,-0.9047329046586795,0.6060606060606061,0.8944154085529681,1.0,1/9,8.26%,RAP1A
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.6036743623801823,-0.9041861318322398,0.7352941176470589,0.8948131055932227,1.0,3/5,28.61%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.6036743623801823,-0.9041861318322398,0.7352941176470589,0.8948131055932227,1.0,3/5,28.61%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5420456374073387,-0.9030876586079544,0.6521739130434783,0.8960745602558107,1.0,3/12,20.19%,PRKCE;CSPP1;ECT2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.5420456374073387,-0.9030876586079544,0.6521739130434783,0.8960745602558107,1.0,3/12,20.19%,PRKCE;CSPP1;ECT2
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.39427146284680753,0.902570498672101,0.6875,1.0,1.0,8/18,17.32%,HOMER2;LEMD3;PKP4;RBMX;ANKRD26;RRAS2;FAM135A;ARHGAP35
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,0.41757033607939115,0.9024695438658549,0.68,1.0,1.0,6/23,10.41%,SAMD9L;GBP4;TRIM22;XAF1;RCSD1;TNFRSF1B
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.5666095677819123,-0.9023584792703738,0.6507936507936508,0.8970683925377463,1.0,4/8,17.48%,CANX;SYNJ2;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.5980943414404258,-0.9021994450111905,0.6825396825396826,0.8970366174191174,1.0,1/5,4.57%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.4042595487154415,-0.902166421164122,0.6530612244897959,0.8967446091636148,1.0,32/152,19.52%,MAP3K5;KLF6;PPARG;HES1;JUN;FOS;ESR2;NPAS3;ERBB4;FOXF1;KLF2;SMARCA1;HIF1A;NPAS2;RREB1;KLF4;CRLF3;NPM1;FOXK1;CNBP;SMAD3;NAA16;CREB3L2;SMARCC1;PICALM;NOTCH4;KMT2A;SMAD5;ACVRL1;PPM1A;EGFR;RLF
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.4518887927173353,-0.9020907146764405,0.569620253164557,0.8965436650156536,1.0,4/23,14.71%,ERO1A;PLOD2;MSRA;STK38
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.48442045487185204,0.9019941202146025,0.5454545454545454,1.0,1.0,1/8,2.74%,CPEB3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.47137380735916223,-0.9019725291969528,0.6049382716049383,0.8963800204677915,1.0,7/25,21.57%,RTN4;TRAM1;PRNP;TOR1AIP2;CAV2;REEP3;VAPB
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5472669088469608,-0.9019385216536197,0.6417910447761194,0.8961092065834737,1.0,1/7,6.24%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4234099398421346,-0.9018252414032663,0.6162790697674418,0.896007716163919,1.0,14/52,20.19%,PIK3R1;RAPGEF3;ARIH2;CD81;HYAL2;PRNP;TPR;SMAD3;PPP3CC;SREBF2;TMEM30A;PINK1;ANK3;ECT2
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5213872175274583,-0.9015574187683311,0.6375,0.8958915198574319,1.0,3/12,8.13%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5213872175274583,-0.9015574187683311,0.6375,0.8958915198574319,1.0,3/12,8.13%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.5023228249122178,-0.9013998381856607,0.6285714285714286,0.8958643890280431,1.0,3/14,17.93%,TPM1;ATP1B3;TOR1AIP2
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.4856621086938809,-0.9013434982923763,0.6266666666666667,0.8956395678518062,1.0,4/20,16.49%,ATG12;NFKBIA;CYLD;TBK1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.45122148140010593,-0.9007188091546048,0.5853658536585366,0.8964607449507617,1.0,13/27,34.21%,RIMS1;RIMS2;SYT1;SDCBP;EGFR;NEDD4L;CSNK2A1;MAP3K13;CDKL5;RPS6KA3;DDX3X;MTPN;MFSD2A
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.38465310748871523,0.9006303405676517,0.5217391304347826,1.0,1.0,4/25,4.17%,BMP6;IL6R;IL15;EFNA5
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,-0.5809255237967157,-0.9005477411207138,0.6567164179104478,0.8964293198043053,1.0,1/6,3.24%,CD9
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.4037022891153112,-0.9005104902984024,0.8247422680412371,0.8961469364163372,1.0,46/272,16.92%,TBX3;BHLHE40;MAFK;ATF3;ZEB2;RPL23;PPARG;PHF10;HES1;JUN;LRRFIP1;KDM1A;SMAD7;ESR2;RPS27A;CDKN1B;ARID5A;KLF2;BCL6;SIN3B;PRKN;PURA;UBC;RREB1;RPL10;KLF4;ZFPM2;CREM;SNX6;LIMS1;TPR;MEF2A;ZFP36;CBX5;FOXK1;CNBP;SDCBP;SMAD3;MAX;SREBF2;KLF12;RCOR1;THRB;MBD2;NOTCH4;ZBTB38
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.4713738375086448,-0.9004217988354107,0.620253164556962,0.895992260601843,1.0,5/24,13.28%,ADM;DMD;TPM1;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.4835358664288728,-0.9002093786757304,0.5949367088607594,0.8960679384498116,1.0,6/24,15.59%,PPARG;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.4549620784274698,0.9000091645774918,0.6,1.0,1.0,1/10,1.65%,PLA2G4A
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5746008892204942,-0.8994193755432481,0.6349206349206349,0.8969778787778852,1.0,2/9,9.19%,CD9;KLF4
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5393679401691831,0.899334062793142,0.6216216216216216,1.0,1.0,2/5,23.51%,PDGFB;PHIP
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.38512694176812157,0.8989674652440591,0.5769230769230769,1.0,1.0,6/14,15.94%,CTNNA2;ABL1;CDH2;TCF7L1;TCF12;TCF7L2
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.41940765572847494,-0.8988446806138561,0.6813186813186813,0.8977474679686586,1.0,23/79,20.56%,SEC22B;SEC24D;RPS27A;CANX;MGAT4A;ANK2;EDEM3;UBC;CD55;NGLY1;UGGT2;RAB1A;COPA;AMFR;ALG11;EGFL7;B4GALT1;ANK3;PMM2;USO1;DYNC1I2;CSNK1D;CAPZA2
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,-0.5190118672855626,-0.8987614465906014,0.5882352941176471,0.897580113131173,1.0,4/11,25.05%,TINAGL1;EGFR;CAV2;DSP
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4833677184249312,-0.8987149329273245,0.7051282051282052,0.8973266660594068,1.0,6/34,15.59%,BTG2;GAPDH;TPR;RPL13A;CPEB4;RACK1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.5845495817432789,-0.8986953590114253,0.5660377358490566,0.897048780105648,1.0,1/6,10.81%,DGKG
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.533650386625163,-0.8986313373578756,0.6027397260273972,0.8968285310017273,1.0,4/11,26.35%,CNOT6L;ZFP36;CNOT8;TUT7
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5508218035364825,-0.8982937863714603,0.6666666666666666,0.8971374657114203,1.0,4/7,25.95%,TRAM1;PRNP;EGFR;SERP1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5422136107638033,0.8970637630546949,0.6176470588235294,1.0,1.0,1/5,8.05%,CDK12
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.42955989956325674,0.8960400404048209,0.5384615384615384,1.0,1.0,3/13,16.47%,C1GALT1;ST3GAL1;GALNT2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5141272073890903,0.896019554335294,0.5882352941176471,1.0,1.0,2/8,7.70%,PDZRN3;ZC4H2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.40787557428465965,-0.8959394491801432,0.7010309278350515,0.9011561891577705,1.0,20/152,16.71%,MAP3K5;PRKAG2;PGK1;PKN3;GRK5;JAK1;PRKCE;SIK2;CDK14;DGKG;FGFR1;DCLK1;PAK2;TEC;TRIB2;STK38;CDK6;TBK1;PINK1;VRK2
prerank,KEGG_2021_Human__Serotonergic synapse,-0.4672116657174411,-0.8958492248791635,0.65,0.900967469116412,1.0,3/28,7.22%,ITPR1;DUSP1;RAPGEF3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5453873014517269,-0.8957641596544055,0.65625,0.9008116582587079,1.0,2/11,9.11%,GGT5;ANXA1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5353448971225527,0.8956387020778177,0.6578947368421053,1.0,1.0,4/8,18.62%,DTWD1;CDKAL1;PARN;ADARB1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5613914719264905,0.8955414888034184,0.6341463414634146,1.0,1.0,2/5,14.69%,ACVR1;RBPJ
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.5017881334583383,-0.895065351186895,0.5945945945945946,0.901671518014423,1.0,3/17,16.65%,FES;PRKN;PINK1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.5515834617163187,-0.894579049183917,0.6417910447761194,0.9021214024330471,1.0,3/10,10.20%,ADSS2;GMPS;SLC26A2
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.47588347434151285,-0.894364789780149,0.618421052631579,0.9020758263491628,1.0,4/27,11.02%,RPS27A;PIK3R1;UBC;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5254677615045843,0.8943258701378313,0.6,1.0,1.0,2/5,23.13%,PDGFC;PDGFB
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,-0.5802648514454052,-0.8942165095742924,0.6785714285714286,0.9020507360120237,1.0,4/5,37.32%,SOCS3;STAT5B;STAT3;JAK2
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.5426250835141747,-0.8939193100584296,0.6721311475409836,0.9023078075987285,1.0,2/11,6.43%,DIXDC1;LAMA5
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.44744616900009254,-0.8938790748584792,0.5952380952380952,0.9020660108697793,1.0,16/50,20.29%,CX3CL1;RAPGEF3;RAP1A;TGM2;AFDN;LIMS1;RSU1;RGS7;LARS1;RACK1;PICALM;PINK1;PSAP;ITGB1;ECT2;CAV2
prerank,KEGG_2021_Human__Viral myocarditis,-0.48368024888295985,-0.8936355976366457,0.5945945945945946,0.902257513160212,1.0,2/17,8.92%,DMD;CD55
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.5825799731951169,-0.8935508687919779,0.65625,0.9020812635579301,1.0,2/6,16.65%,SMAD7;PINK1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,-0.4045234396046718,-0.892582489352812,0.6702127659574468,0.9033301459744522,1.0,21/91,17.66%,ITPR1;SCARB2;RRBP1;GPM6B;MGAT4A;SLC2A1;SULF2;RREB1;TACC1;TRAM1;NGLY1;HERPUD1;OGT;DUSP5;SLC20A1;SMC6;CREB3L2;SLC38A2;NOTCH4;B4GALT1;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.5108487022433225,-0.89243050619279,0.691358024691358,0.9032760840457152,1.0,5/15,15.59%,BCAP31;HYAL2;PAK2;CYLD;RACK1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5008936418895947,-0.8922864205873445,0.6753246753246753,0.903238381893041,1.0,3/10,14.50%,PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.48869650138172627,-0.8916844497791765,0.6388888888888888,0.903983811379021,1.0,3/23,14.90%,SRGN;OGT;NAA16
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,-0.5397504612035008,-0.8916565019171234,0.5915492957746479,0.9036849399775886,1.0,5/8,37.37%,GRB2;EGFR;RPS6KA2;RPS6KA3;MAPK1
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,-0.6069859086161815,-0.8915270457387109,0.6666666666666666,0.9035778435934708,1.0,1/5,17.29%,ROBO2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.48163256724314957,-0.8913698789190875,0.64,0.9034911959301792,1.0,8/17,29.93%,ANXA1;KLF4;GATA2;JCAD;DLL4;RHOJ;MAP2K5;RHOA
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.508257972105027,-0.8904384924210784,0.631578947368421,0.9047852785585722,1.0,7/18,19.60%,RFTN1;PTPRD;IL1RAPL1;PICALM;ANK3;CHMP4B;EMP2
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.49347990335472125,-0.8901827258873439,0.6323529411764706,0.9049995325513037,1.0,3/15,13.86%,RPS27A;UBC;ACOX1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5961064751867191,-0.8900999254145638,0.7,0.9048188589982108,1.0,2/6,27.14%,HS6ST3;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.49553235420000485,-0.8898401752695884,0.6714285714285714,0.9050085358908792,1.0,4/20,12.30%,CX3CL1;MBP;HYAL2;PLCG2
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,-0.5452259557785835,-0.8895918392321098,0.6153846153846154,0.9051004706073976,1.0,3/9,20.35%,PIK3R1;GRB2;PIK3CB
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,0.389003215781708,0.888690512523848,0.6774193548387096,1.0,1.0,2/35,0.98%,MMRN1;GBP4
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,0.389003215781708,0.888690512523848,0.6774193548387096,1.0,1.0,2/35,0.98%,MMRN1;GBP4
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,0.389003215781708,0.888690512523848,0.6774193548387096,1.0,1.0,2/35,0.98%,MMRN1;GBP4
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,0.389003215781708,0.888690512523848,0.6774193548387096,1.0,1.0,2/35,0.98%,MMRN1;GBP4
prerank,KEGG_2021_Human__Necroptosis,-0.46375207794519197,-0.8886637844238975,0.6216216216216216,0.9064200932084181,1.0,5/38,7.46%,GLUD1;GLUL;JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.5402104081124356,-0.8882990476768684,0.6567164179104478,0.9067674804236613,1.0,4/11,21.62%,GOLPH3;CTNNA1;ADAM15;ADCY2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5083797980098462,0.8879489502500455,0.6285714285714286,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5096647860034567,-0.8878933602086919,0.6619718309859155,0.907163366635826,1.0,4/12,18.43%,VAV3;MSN;LARS1;MTOR
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,-0.5824468085106383,-0.8877724193156705,0.6885245901639344,0.907120377946651,1.0,5/5,41.86%,PODXL;ATXN3;POU2F1;PCDH11X;NASP
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.4840758875681659,-0.8875957722405219,0.5972222222222222,0.9070895989044659,1.0,5/17,24.41%,SIK2;OGT;NCK1;VWA2;TNS2
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.6320383736040337,-0.8875032086862344,0.7076923076923077,0.9069046348674135,1.0,1/5,13.07%,NFKBIA
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.5459286692009027,0.8874953409350074,0.6190476190476191,1.0,1.0,1/5,4.83%,TEAD4
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.43754214217093973,-0.8872746488775235,0.6266666666666667,0.906878012375044,1.0,14/38,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;VWF;CLDN5;NOTCH4;TIE1;LCP2;ACVRL1;ZNF366;CD34
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,-0.6005616490159426,-0.8872321137233147,0.6617647058823529,0.906624320094775,1.0,2/6,10.92%,HIF1A;EPAS1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4760343740319204,-0.88711369571769,0.6351351351351351,0.9064762067210625,1.0,2/22,1.75%,LAMC1;NR4A1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.5941900720064432,-0.8867469231584593,0.6268656716417911,0.9067698942132287,1.0,3/5,38.65%,DNM2;ASAP1;WASL
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.44744486052717186,-0.8864731823220802,0.654320987654321,0.9070512179958921,1.0,3/30,6.67%,SUN2;TSC22D3;KLF2
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.4405488287747962,-0.8861458978267397,0.6410256410256411,0.9073201914111847,1.0,11/37,23.21%,ATP2B1;EPS8;GPC5;ANO2;CAMKMT;MSN;MYO1E;CAPZA2;SCN2A;DNAJC5;GPC3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5189945069835327,-0.8859561457341634,0.5942028985507246,0.9073177641456618,1.0,5/11,25.26%,YBX3;SERPINB6;SCN2A;STK39;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.465830283637511,0.885809713944861,0.5483870967741935,1.0,1.0,2/7,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6260360989809433,-0.8852511327297298,0.7407407407407407,0.9082136425991028,1.0,3/5,34.29%,IFITM3;LY6E;GSN
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5326999277210223,-0.8851001406034131,0.6428571428571429,0.9081825813168061,1.0,8/10,46.16%,TERF2IP;USP7;DHX36;SMG1;SMG6;XRCC5;PPP1R10;YLPM1
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.46859262691955017,0.8850916155343498,0.6216216216216216,1.0,1.0,3/9,13.07%,GMDS;ST3GAL1;ST3GAL6
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5756716175787787,-0.8850448540060336,0.746031746031746,0.9079534104865189,1.0,2/6,15.19%,CHPT1;LPIN2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.5043185241018601,-0.8849883421375343,0.6119402985074627,0.9076880257318104,1.0,4/11,18.91%,ATP2B1;SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5496419369159687,-0.8849853554543379,0.6666666666666666,0.9073703036296633,1.0,3/8,24.67%,PTTG1IP;MSN;HSP90AA1
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.46525193630014894,-0.8848201773892511,0.6578947368421053,0.9072830413570724,1.0,2/19,11.18%,GRIN2B;ARPC2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5688095606152532,-0.8848112048285781,0.7313432835820896,0.906961654729819,1.0,2/7,3.93%,MGLL;SCP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.5812706322580017,-0.8844269979799345,0.7333333333333333,0.9072580460994153,1.0,3/6,19.18%,PECAM1;VWF;CD34
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.46013617575786603,-0.8840372252324634,0.6216216216216216,0.9076389560472675,1.0,5/21,18.03%,SSH1;PRKCE;HIP1R;NCK1;KANK3
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.5592702345971751,-0.8839454213940149,0.6875,0.9074670218938453,1.0,4/7,15.38%,ENPP2;CHPT1;PLPP1;PAFAH1B1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.4892601402584268,-0.8833070741869833,0.6557377049180327,0.9081782016910711,1.0,7/15,29.61%,S1PR1;GOLPH3;PARVB;ITGB1;CCDC88A;VCL;RAC1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5592579032506337,-0.8833036573976915,0.6714285714285714,0.9078611003833226,1.0,4/7,26.43%,EGFL7;GATA2;EGFR;DLL4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4815824843299964,-0.882437049117554,0.6493506493506493,0.9089987077993226,1.0,5/15,10.25%,SRGN;ATP2B1;GPM6B;SLC8A1;S1PR1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5405942873795102,-0.8824345006700516,0.6507936507936508,0.9086734846480526,1.0,3/8,20.16%,PRKN;MT1M;SLC30A1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.541190542421814,-0.881675904134397,0.6666666666666666,0.9096529677945541,1.0,2/11,20.35%,PIK3R1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.5484723514484421,-0.8814178865042227,0.6363636363636364,0.9097422888039998,1.0,5/10,27.36%,DLC1;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.5082954015627462,-0.8813811864042773,0.6753246753246753,0.9095660097905856,1.0,5/16,20.66%,RPS27A;UBC;CYLD;RACK1;XIAP
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.45890975366214726,0.8812540580678888,0.5172413793103449,1.0,1.0,6/12,13.28%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.46516192567385556,-0.8811608296985666,0.7164179104477612,0.909550730255922,1.0,3/23,17.29%,JAG2;NOTCH4;ROBO2
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,-0.46049165980977613,-0.8806924184619024,0.6933333333333334,0.9100581138476175,1.0,1/27,1.04%,ITPR1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5208750748955,-0.8804766565399679,0.6891891891891891,0.9100627643657517,1.0,4/12,13.86%,MGLL;SCP2;ACSL5;ACOX1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,-0.5912758296786564,-0.8804762359122199,0.7313432835820896,0.9097379739430659,1.0,2/5,12.14%,NES;DCLK1
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.49446240802886976,-0.8804548660377377,0.6119402985074627,0.9094696406466353,1.0,3/17,11.02%,LRRFIP1;PIK3R1;FGFR1
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.5612398433351229,-0.8804311814677679,0.65,0.9091774107450492,1.0,2/9,16.81%,SMAD3;NOTCH4
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5897490684072862,-0.8799703229321021,0.6515151515151515,0.9097723141735362,1.0,5/6,40.77%,CLU;NACC2;CXCL12;TPT1;BCL2L1
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.46394332795480503,-0.8799550787750164,0.7183098591549296,0.9094601256701688,1.0,5/22,19.04%,PKN3;KDM1A;MYL6;MYH10;MYL12B
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,-0.4656986624870657,-0.8798662631684837,0.6951219512195121,0.909324616133065,1.0,11/36,14.98%,GRIN2B;MAP1B;MAGI2;ANK2;IL1RAPL1;KLHL7;STXBP5L;RIMS2;ATRNL1;CTNNA3;EFR3B
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5636960877539173,-0.8798146257341137,0.7101449275362319,0.9090969973202675,1.0,4/8,25.95%,HSPA5;VAPB;DNAJC3;SERP1
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.48492662221690325,-0.8797557746368196,0.64,0.9088975932136466,1.0,3/24,8.84%,RPS27A;PIK3R1;UBC
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.5418461684473316,-0.8795540179979044,0.6363636363636364,0.9089386966809426,1.0,2/9,7.57%,DMD;SLC8A1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.45846587261565397,0.8795442467149539,0.696969696969697,1.0,1.0,3/11,14.21%,ASCC3;MTERF1;MCM9
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5504093465431216,0.879246035447372,0.5714285714285714,1.0,1.0,1/6,3.75%,MRPS31
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,-0.52733645162956,-0.8788190412950092,0.6811594202898551,0.9098247560637023,1.0,3/9,15.62%,TMEM184B;HYAL2;SH3GL1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5221582399490294,0.8787624628730536,0.631578947368421,1.0,1.0,1/5,1.27%,CTBP2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.36559293359466416,0.8785819669049714,0.75,1.0,1.0,13/42,17.08%,GBP2;GBP1;DCP1A;COG3;UBAC2;BICD1;CEP68;TRAM2;CNTLN;GBF1;APP;MDM2;RIPOR1
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.4526051481858724,-0.8784967380361213,0.5975609756097561,0.9100416433544374,1.0,10/27,26.56%,VAV3;GNA13;FGD4;RASGRF2;ECT2;MAPK8;KALRN;ARHGEF2;PREX1;MCF2L
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.4067994319834895,0.8783102797947702,0.5789473684210527,1.0,1.0,4/18,9.51%,IL15;NOVA1;NOVA2;ID1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4743837201631145,-0.8782935810980373,0.6111111111111112,0.9101023053934831,1.0,1/15,1.12%,NDRG1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.4645295653283075,-0.8777575447102725,0.6891891891891891,0.9107269806667087,1.0,7/24,19.76%,LAMP2;IPO7;TPR;PTTG1IP;RAB8B;KPNB1;CLU
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.552613154677825,0.8776836628740124,0.71875,1.0,1.0,1/5,12.30%,ROCK1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5269657905373126,-0.8776218928504154,0.6891891891891891,0.9106513908773576,1.0,3/12,23.21%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5262145749151154,0.8776013236701491,0.65,1.0,1.0,3/5,26.43%,IGF1R;GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5384263868541422,-0.8770460876827251,0.6363636363636364,0.9112674323845391,1.0,2/7,29.22%,CBR4;ABHD2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.48300932305569977,-0.8770373161906524,0.6582278481012658,0.9109559321862217,1.0,9/15,24.67%,HIF1A;NOSTRIN;NOS1AP;ZDHHC21;SCARB1;EGFR;PIK3CB;DNM2;HSP90AA1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.5333617835523861,-0.8767877767847324,0.6527777777777778,0.911032141031255,1.0,4/12,18.73%,KLF6;PLCG2;MALT1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.48423884157412256,-0.8765692221013784,0.7105263157894737,0.9111003091998638,1.0,7/29,19.81%,BTG2;GAPDH;RPL13A;CST3;RACK1;PLAT;GIGYF2
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.39715987357171717,-0.8764155558896646,0.7419354838709677,0.9110686318185757,1.0,7/87,8.84%,PSMC6;ITPR1;WNT2B;PSMB9;RPS27A;PSMA1;UBC
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,-0.5597891626495977,-0.87636720651298,0.6567164179104478,0.9107895675642351,1.0,2/6,17.45%,PECAM1;LCP2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.4381998066364674,-0.8763156024210211,0.7160493827160493,0.9105545807368373,1.0,12/46,14.16%,PGK1;PPA1;ALPL;PTPRD;DUSP16;PLCG2;PAK2;DUSP5;INPP5D;PPA2;SLC20A1;PLPP1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.49352974717954273,-0.8763004145652143,0.6623376623376623,0.9102519704081578,1.0,12/22,25.74%,RFTN1;AFDN;ZDHHC6;SDCBP;ZDHHC21;PIKFYVE;EGFR;ZDHHC14;VPS37A;CHM;RAB11A;ZDHHC20
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5633609912353634,-0.8762760616671595,0.6935483870967742,0.909981464264059,1.0,2/5,25.66%,RPS19;RPS14
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.41933648135928714,-0.8761127524303555,0.6506024096385542,0.909958208645954,1.0,5/49,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.4648800353759497,-0.875293523922328,0.6233766233766234,0.9109507397503664,1.0,8/23,25.15%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.43489549424541474,0.8752615005906076,0.53125,1.0,1.0,1/10,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3978992927022984,-0.8752317405560003,0.6629213483146067,0.9107439855490653,1.0,25/63,30.68%,MYO9B;ARHGAP21;VAV3;DLC1;TGM2;ARHGAP23;GNA13;FGD4;RASGRF2;FAM13A;ARHGAP29;ARHGAP15;ARHGAP17;ECT2;KALRN;ARHGEF2;BCR;PREX1;MCF2L;RHOB;RHOJ;TRIO;RAC1;RHOA;STARD8
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5626631828279589,-0.8751481017055137,0.7536231884057971,0.9105970865022996,1.0,2/7,10.15%,TRAM1;PRNP
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.49661690659440805,-0.8745688716423013,0.6486486486486487,0.9113495879334481,1.0,3/15,12.30%,KLF6;JAG2;PLCG2
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.5411767313970284,-0.8744646055114464,0.6268656716417911,0.9112224676211641,1.0,1/7,16.49%,TBK1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5640088919193711,-0.8743003863750424,0.6451612903225806,0.9111829174188316,1.0,2/6,9.80%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.4381130508941328,0.8742697709707764,0.5882352941176471,1.0,1.0,4/8,15.91%,TGFBR3;TEK;RBPJ;ADGRG6
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4633234809379616,-0.8742318623897278,0.6753246753246753,0.911036070866528,1.0,4/19,11.95%,DMD;TPM1;WIPF1;MEF2A
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.5249371957686689,-0.8742031254161025,0.6567164179104478,0.9107939622963309,1.0,4/10,16.65%,HIF1A;PRKN;EPAS1;PINK1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,0.349872083356079,0.874080918673547,0.72,1.0,1.0,4/42,7.78%,MMRN1;PREX2;LDB2;CYYR1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.48621137524530766,-0.8740381516896282,0.6,0.9107546051624288,1.0,2/12,9.40%,TAF1D;CCNH
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.4050789068525941,0.8739515429771861,0.6956521739130435,1.0,1.0,3/20,10.17%,ATF7IP;SMYD3;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.35044749961872357,0.8736215976675578,0.6785714285714286,1.0,1.0,2/27,3.61%,BMP6;TTN
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.521242375737311,-0.8735709749608181,0.7272727272727273,0.9112950077823898,1.0,5/11,32.67%,NOTCH4;TIE1;DLL4;RASIP1;LRP6
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5215700518990676,-0.8734225232952599,0.6708860759493671,0.9112555017305688,1.0,2/10,11.95%,DMD;MEF2A
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.5794238294854819,-0.8733087792068996,0.6865671641791045,0.911104920431658,1.0,2/6,29.11%,LARS1;RARS2
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.4296489937916053,-0.873239254563453,0.6835443037974683,0.9109227126937052,1.0,7/37,15.17%,GRIN2B;VAV3;ANKS1B;EFNB2;ARPC2;SDCBP;ANKS1A
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.6013732051953016,-0.8732236225693355,0.7540983606557377,0.9106177129704243,1.0,2/6,23.77%,FTL;CALR
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4718576854666674,-0.8731070003901638,0.6623376623376623,0.9105190444011368,1.0,5/24,20.19%,RAD21;PRKCE;TPR;CSPP1;ECT2
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.4471179659143873,-0.8730735508099393,0.7307692307692307,0.9102777995743494,1.0,5/34,8.84%,RPS27A;CNTN1;HIF1A;JAG2;UBC
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.5094768320709215,-0.8729859558400379,0.6621621621621622,0.9100802953738735,1.0,4/17,19.60%,CX3CL1;LIMS1;CDK6;EMP2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.4253566104042896,-0.8728039017320528,0.7051282051282052,0.9099937987345997,1.0,2/42,4.20%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5246175329138698,-0.872637393782442,0.7105263157894737,0.9099073629227797,1.0,6/13,26.72%,VAV3;CD81;SH3KBP1;RIF1;CD320;CD74
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4671837817758054,-0.872095113527116,0.7692307692307693,0.9104461638612085,1.0,5/25,15.86%,PDE5A;GRIA2;CTNND2;PLP1;CADM2
prerank,KEGG_2021_Human__Cell cycle,-0.4426537971805456,-0.8720721549161844,0.6829268292682927,0.910146037177798,1.0,7/37,15.46%,RAD21;CDKN1B;CCNH;CDKN1A;SMAD3;SMC3;CDK6
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.4256712582627156,0.8717395889844637,0.5,1.0,1.0,1/10,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.4256712582627156,0.8717395889844637,0.5,1.0,1.0,1/10,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5209872503879003,0.8715909000144775,0.6470588235294118,1.0,1.0,1/6,4.91%,CLASP1
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,-0.5422668840022246,-0.8714705411976897,0.704225352112676,0.9108899853595573,1.0,2/9,8.26%,RAPGEF3;RAP1A
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,-0.443408765967498,-0.8714325616730053,0.7142857142857143,0.9106373453077362,1.0,7/37,13.25%,DOK5;MAP1B;NES;ANK2;GJA1;DCLK1;NAV1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5772194243177645,-0.8713206051109558,0.7692307692307693,0.9105824453432612,1.0,2/6,25.52%,MEF2A;MTM1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.565097111602175,-0.8708623267234029,0.6724137931034483,0.9109502198101693,1.0,2/6,22.60%,CACNA1C;MAPK8
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,-0.4826999512681952,-0.8705386920493248,0.68,0.9111361060696489,1.0,4/17,10.92%,LGALS3;S100A6;KLF4;EPAS1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.46015959495610964,0.8702362532155092,0.5641025641025641,1.0,1.0,3/6,19.58%,WWC3;LATS1;PTEN
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.5703237921182035,-0.8697485192480392,0.7454545454545455,0.9122454829946287,1.0,2/7,8.84%,RPS27A;UBC
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5309530168533426,-0.8696017927037135,0.6612903225806451,0.9121111820384511,1.0,2/8,17.45%,BCL6;LCP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.49652456005241447,-0.8689109765940771,0.625,0.9128447283171682,1.0,7/11,25.07%,ANK2;CTNNA3;CACNA1C;NOS1AP;DLG1;DSP;CAMK2D
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,-0.4221185654093686,-0.8689029896739325,0.6404494382022472,0.912536821713108,1.0,7/50,14.40%,CCDC60;DTNA;TMEM45B;ERBB4;CHST11;PLCG2;CSMD1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.43519587978267243,-0.8688615417055929,0.6153846153846154,0.9122882542833584,1.0,13/35,30.73%,PEBP1;RAP1A;VWF;DUSP16;SPRED1;DUSP6;SHOC2;MPRIP;CAMK2D;MAP2K1;VCL;MARK3;RAP1B
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.4570759213199427,-0.8686642291242695,0.6623376623376623,0.9123511359177586,1.0,8/24,25.15%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,-0.47400479188334743,-0.8686523399576609,0.6612903225806451,0.9120594804720296,1.0,5/18,19.60%,KIAA1217;LAMA5;BCAR1;EGFR;EMP2
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.5157557785391617,-0.8686315308698578,0.64,0.9118310280007986,1.0,4/12,23.27%,AFDN;CADM2;CTNNA1;CDH5
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.4904124079696348,0.8683128395275631,0.6041666666666666,1.0,1.0,3/6,24.30%,ATM;CREB1;ABL2
prerank,KEGG_2021_Human__Melanogenesis,-0.4486695541318726,-0.8682113253153712,0.625,0.9122561208387897,1.0,8/29,28.50%,WNT2B;CREB3L2;GNAI3;ADCY2;CAMK2D;FZD4;MAP2K1;ADCY9
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.46160989515617507,-0.8681038030381983,0.6410256410256411,0.9120789102005014,1.0,5/17,18.65%,SLC6A6;SLC16A6;SLC38A2;PSAP;SLC16A14
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.48073745667197365,-0.8680535709545196,0.6056338028169014,0.9118624903293436,1.0,2/13,6.19%,HES1;ERBB4
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.45290224955668523,-0.867621662969777,0.6533333333333333,0.9123028544762614,1.0,5/19,24.30%,WIPF1;ARPC2;NCK1;GRB2;ABI1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,-0.5724791821730773,-0.8672924001240186,0.6764705882352942,0.9126446470999019,1.0,1/6,4.33%,KCNMB4
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.4030024414506436,0.8672152282179644,0.625,1.0,1.0,2/12,6.14%,IL6R;CCM2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3736088046173785,0.8670020923344534,0.68,1.0,1.0,1/27,0.16%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.5579872768385776,0.8667957841562189,0.71875,1.0,1.0,1/6,0.42%,RSAD2
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.4744279009563451,-0.8667846030332997,0.6933333333333334,0.9131590854115174,1.0,4/17,13.73%,RPS27A;PRKN;UBC;CST3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.538815305039967,-0.8667379063633924,0.7014925373134329,0.9128836734383534,1.0,3/8,19.76%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4465347533548984,-0.8664731248815788,0.6075949367088608,0.9130128776685941,1.0,3/28,7.84%,PPARG;SMAD7;SULF2
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,-0.42125635796214667,-0.8660803621926199,0.6823529411764706,0.9133186203219202,1.0,7/40,16.95%,ANGPTL4;PPARG;NPAS2;PLIN2;ACOX1;SREBF2;TXNRD1
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.4591517383635438,0.8659306662461586,0.5581395348837209,1.0,1.0,3/6,10.81%,CASP10;TNFRSF1B;RAB27A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.44045686254105243,0.8655906965911955,0.6153846153846154,1.0,1.0,1/11,2.82%,IL1R1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.4331618898247346,0.8653631079949158,0.65625,1.0,1.0,4/13,19.52%,TEAD4;FAT4;STK4;LATS1
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.4331348975346205,-0.8649097872208563,0.7333333333333333,0.9148954319459539,1.0,15/42,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;TNS1;VWF;CFH;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.49894767237727855,0.8644625921238344,0.6086956521739131,1.0,1.0,3/6,23.16%,PARP9;PARP11;PARP4
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.48206840658635886,-0.8639738840837853,0.7205882352941176,0.9161455902727873,1.0,3/20,11.02%,LRRFIP1;PIK3R1;FGFR1
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.5174565990639369,-0.8639473860209378,0.7571428571428571,0.9158617757589947,1.0,2/15,5.26%,JUN;POLA1
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.5129249425520421,0.8638817074967262,0.574468085106383,1.0,1.0,2/5,17.45%,JARID2;SCAI
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.4707042442303132,-0.8635531423359983,0.6438356164383562,0.9161974575237052,1.0,4/15,16.65%,PRKN;GOLPH3;SREBF2;PINK1
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.4877462103997402,-0.8635008498364163,0.65625,0.9159961057240961,1.0,2/11,9.40%,TAF1D;CCNH
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.4418328000976391,-0.8634620727854304,0.675,0.9157557252041845,1.0,5/29,15.43%,RAD21;SPC25;RPS27;PAFAH1B1;SMC3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3533828136724749,0.86337291883489,0.75,1.0,1.0,6/35,9.08%,ZNRF3;ARNT2;PTPN21;SLC23A2;SLC38A3;ABCG2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5318209554863855,-0.8630851905002237,0.6470588235294118,0.9159971210612301,1.0,1/10,0.90%,UFL1
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.49366502013617153,-0.8627185440796047,0.7183098591549296,0.9163166322519973,1.0,4/16,14.42%,SEC22B;KIF16B;RAB1A;COPA
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.4901507230619351,-0.8626954636833302,0.65,0.9160255245842087,1.0,3/16,16.49%,REL;RIOK3;TBK1
prerank,KEGG_2021_Human__RNA degradation,-0.4671730295806228,-0.8626214088627753,0.6625,0.9158480509775764,1.0,4/22,17.24%,BTG2;CNOT6L;BTG1;DCP2
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5769475002418447,-0.8622859153623158,0.6956521739130435,0.9161360003551835,1.0,1/5,15.46%,CDK6
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.44352433610452124,-0.8622348312012882,0.7297297297297297,0.9159038895011185,1.0,14/35,25.68%,PLS3;NES;TPM1;EFNB2;GJA1;VEGFC;WWTR1;CALD1;PLAT;GLI3;CTTNBP2NL;SERPINH1;CNN3;MID1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5506347622189627,-0.8621597126989222,0.6557377049180327,0.915691476614628,1.0,3/8,24.83%,RAB1A;PINK1;ARRDC3
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.5458204973142211,0.8618780909434953,0.6451612903225806,1.0,1.0,3/5,32.30%,PPP3CA;NFATC3;NFATC2
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.5359521689586677,-0.8618479271041711,0.7205882352941176,0.9158190341180712,1.0,4/8,30.23%,JAK1;SOCS3;STAT5B;STAT3
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.482058706579759,-0.8618231244858059,0.7222222222222222,0.9155560374860666,1.0,1/21,1.04%,ITPR1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,0.41332270922022013,0.861297670277579,0.6956521739130435,1.0,1.0,5/25,9.61%,BMP6;SMAD9;CARMIL1;PHLDB2;CDH2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5632066723750487,-0.8611902402993451,0.7285714285714285,0.9164329875839974,1.0,1/6,5.50%,WDR48
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5440317523696743,-0.8609643051959583,0.6229508196721312,0.9165406456744928,1.0,2/7,18.54%,AP1G1;PIKFYVE
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,-0.4620022409539863,-0.8606493586909174,0.671875,0.9166404279627254,1.0,3/12,11.63%,SLC4A10;PPP2R2B;CTNND2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.500979466674318,-0.8605988756619164,0.6567164179104478,0.916397007435867,1.0,6/12,28.02%,KLF4;RACK1;ACVRL1;ACVR2A;STAT5B;MAP2K5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4541113727764696,-0.8605343793502297,0.7125,0.9161927344459905,1.0,7/30,19.42%,ANXA1;KLF4;ADAMTS1;CDKN1A;CDK6;DLG1;EGFR
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4202785302242064,-0.8603792882495065,0.6987951807228916,0.91611329237767,1.0,6/33,12.72%,PIK3R1;RAPGEF3;TPM1;DLC1;TMEFF2;PAK2
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.4061479663510027,-0.8602970657972937,0.6741573033707865,0.9159482109126331,1.0,5/50,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.47053494786039185,-0.8602909738062036,0.640625,0.9156352772957747,1.0,6/12,30.36%,GAS7;SPIRE1;PREX1;FAM107A;RAC1;MICALL2
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.35159373355339996,0.8600792830439105,0.6956521739130435,1.0,1.0,5/40,7.78%,MMRN1;PREX2;PODN;LDB2;CYYR1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4906622424659831,0.8596409737355181,0.6428571428571429,1.0,1.0,3/6,17.32%,TAPT1;SEPTIN9;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.49977370092480966,0.8595961389587083,0.6842105263157895,1.0,1.0,1/7,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.559916804358144,-0.8592160753068694,0.7049180327868853,0.9171676074810375,1.0,1/6,5.42%,FES
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.4695259753674483,0.8591790520078196,0.631578947368421,1.0,1.0,2/9,7.33%,STX8;EEA1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5653319872071868,-0.8589310017534117,0.746031746031746,0.9173175166899924,1.0,3/7,10.25%,SMAD7;TPM1;S1PR1
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,-0.4443182095066837,-0.8588474037264723,0.6867469879518072,0.9171172389500326,1.0,10/31,18.73%,ACTN1;AFDN;LIMS1;PLEC;CLDN5;PARVB;RSU1;CADM2;CTNNA1;ITGB1
prerank,KEGG_2021_Human__Dilated cardiomyopathy,-0.45975639619717523,-0.8586873622574331,0.7317073170731707,0.9170026459410324,1.0,8/26,18.73%,DMD;SLC8A1;TPM1;ITGA10;ITGB5;CACNA1C;DAG1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.4720471694170701,-0.8586471254879341,0.6944444444444444,0.9167637439540011,1.0,2/20,4.57%,PPARG;SMAD7
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5045948326908956,-0.8586224689886613,0.6567164179104478,0.916482263241961,1.0,3/11,18.01%,TPR;NPM1;NUP54
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.48955298642783096,-0.8583277077207851,0.6764705882352942,0.9166632258652683,1.0,3/17,15.46%,S100A6;CDKN1A;CDK6
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.4305875730274077,-0.8578489490647556,0.75,0.9170731669034332,1.0,7/41,16.73%,DENND3;DENND2C;TBC1D15;RAB21;RAB1A;RAB8B;RAB14
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.5640959145512816,-0.8578423300483754,0.7258064516129032,0.9167646983111043,1.0,2/6,13.86%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5387981387672535,-0.8574264314749707,0.7333333333333333,0.9172286477565518,1.0,4/8,24.70%,KPNB1;CHMP4B;EML4;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.32165906634997005,0.8572171071277583,0.5,1.0,1.0,3/33,4.28%,ATG10;CPEB3;LARP4B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.550627250406095,-0.8570317463713675,0.65,0.9162276733322148,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.550627250406095,-0.8570317463713675,0.65,0.9162276733322148,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,KEGG_2021_Human__Allograft rejection,-0.550627250406095,-0.8570317463713675,0.65,0.9162276733322148,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.550627250406095,-0.8570317463713675,0.65,0.9162276733322148,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.550627250406095,-0.8570317463713675,0.65,0.9162276733322148,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.44433832801954043,0.8568805087864501,0.6538461538461539,1.0,1.0,2/11,2.15%,HOMER1;HOMER2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.38537513670764945,0.8567321307524639,0.6896551724137931,1.0,1.0,4/20,7.84%,ATR;RHBDD1;INO80;TAF1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,0.4247620378516894,0.856695010009156,0.625,1.0,1.0,2/12,2.39%,GBP4;CASP10
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,0.4247620378516894,0.856695010009156,0.625,1.0,1.0,2/12,2.39%,GBP4;CASP10
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3569798335214687,0.8564715254402044,0.6818181818181818,1.0,1.0,4/30,5.68%,ALS2;DISP1;RNF213;CLYBL
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5572593058476178,-0.8563675605015659,0.676056338028169,0.9170664746565996,1.0,2/6,27.14%,CHST11;CSGALNACT1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5886438801054753,-0.8562616001922341,0.711864406779661,0.9169137005016784,1.0,1/6,27.84%,WTAP
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.43571477109519186,-0.8562409240230917,0.7625,0.9166217201121795,1.0,15/45,24.67%,RTN4;DMD;HIP1R;TPR;NCK1;SMAD3;SGIP1;TBCD;PICALM;CHMP4B;CLU;CLTA;DNAJB14;SNX9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.48416928298024137,-0.8560031103332416,0.6716417910447762,0.9166780988884947,1.0,7/11,25.07%,ANK2;CTNNA3;CACNA1C;DLG1;PDE4B;DSP;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4990036467688479,-0.8559746847929048,0.6623376623376623,0.9164328052242764,1.0,2/13,11.71%,RPL23;RPS7
prerank,KEGG_2021_Human__Mineral absorption,-0.49206133524541046,-0.8554577230455644,0.68,0.9169453711081372,1.0,8/18,24.75%,ATP2B1;SLC8A1;ATP1B3;MT1M;SLC30A1;FTL;ATP1A1;TF
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.4493315191136754,0.8554416462178396,0.6153846153846154,1.0,1.0,6/12,13.28%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.4113922519808592,-0.8554222376447561,0.7011494252873564,0.9166885607742943,1.0,5/56,8.74%,SERPINE1;WNT2B;SMAD7;RASSF1;PPP2R2B
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5405947027402331,-0.8551666540572767,0.6363636363636364,0.9168105122211676,1.0,2/5,15.72%,RB1CC1;PIK3C3
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.45163960850454926,-0.8551096725553274,0.7349397590361446,0.9165770951041355,1.0,3/25,8.84%,RPS27A;HMGN1;UBC
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.4730789524409301,0.854556060459697,0.6176470588235294,1.0,1.0,2/6,9.64%,TENT2;ATM
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4730789524409301,0.854556060459697,0.6176470588235294,1.0,1.0,2/6,9.64%,TENT2;ATM
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5445976425780018,-0.8542198382418252,0.6666666666666666,0.9175174203413567,1.0,5/7,36.63%,CACNA1C;ATP1A1;CAMK2D;GSN;CACNA2D1
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,-0.4694133812920632,-0.8540487135335527,0.6933333333333334,0.9174845964379031,1.0,8/20,21.78%,HYAL2;ITGB5;BCAR1;PTTG1IP;SH3GL1;DAG1;ADAM15;CD63
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3602787073553702,0.8538761397096725,0.5333333333333333,1.0,1.0,3/22,4.91%,INO80;OFD1;CLASP1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.4831335458364324,-0.8531885052405519,0.6666666666666666,0.9185512742999232,1.0,2/14,12.46%,BCAP31;PLEC
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.4492010225779166,-0.8528247180315915,0.7402597402597403,0.9187186567245762,1.0,3/19,14.00%,CANX;JAK1;MSN
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,0.4906678538172706,0.852585217044565,0.6511627906976745,1.0,1.0,2/7,25.68%,RBPJ;MAML2
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.4906678538172706,0.852585217044565,0.6511627906976745,1.0,1.0,2/7,25.68%,RBPJ;MAML2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.49397002468164913,-0.8521130910124518,0.7142857142857143,0.9195914223794884,1.0,3/8,17.56%,LGALS3;PICALM;MTMR2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4438960788543218,0.8517436525209756,0.6363636363636364,1.0,1.0,3/12,6.85%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.5745100426253735,-0.8515826245651816,0.7611940298507462,0.9201591355274759,1.0,3/8,21.43%,OGT;KMT2A;SETD3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.5405418287810656,-0.85128106338003,0.711864406779661,0.92026800772724,1.0,2/6,11.02%,FLT1;FGFR1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.4926500969622447,-0.851035234585145,0.6825396825396826,0.9203459956502343,1.0,6/14,31.42%,ACTN1;MYL12A;PIK3CB;VCL;STXBP3;STXBP1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,-0.553320237405096,-0.8508365883611981,0.7121212121212122,0.9203507820196138,1.0,1/6,14.50%,NCK1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.41876670198368204,-0.8505719344638829,0.686046511627907,0.920486417162603,1.0,8/35,18.57%,RPS27A;JAK1;UBC;TPR;SGIP1;KPNB1;NUP54;KPNA4
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,-0.5102894169144336,-0.8503943115159157,0.7,0.9204219013321879,1.0,3/11,24.99%,PPP3CC;PRKAR1A;PDE4B
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.4996232567762967,-0.8503088643081237,0.6268656716417911,0.9202382048286739,1.0,1/13,2.34%,SLC6A6
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.45633981883527264,-0.8495327355291991,0.7397260273972602,0.9211426687239652,1.0,3/19,17.34%,BCAP31;PLEC;KPNB1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5328119350028965,-0.8494236649725319,0.7230769230769231,0.9210587782513704,1.0,3/7,38.59%,SPCS3;SRP14;RAB3GAP2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.33257287207800174,0.8493732024747085,0.7142857142857143,1.0,1.0,4/36,5.79%,ANKRD6;TPD52L1;TGFBR3;MFHAS1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4285746166053426,-0.8492306103548889,0.6966292134831461,0.9211132578353086,1.0,17/36,25.07%,JUN;FOS;CDKN1B;PRKN;PRNP;MEF2A;PLCG2;SYT1;ANK3;MT1M;EGFR;ECT2;RYR3;B2M;MAPK8;TF;CAMK2D
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.44526293455703814,0.8489297277410084,0.6136363636363636,1.0,1.0,2/11,8.29%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.44526293455703814,0.8489297277410084,0.6136363636363636,1.0,1.0,2/11,8.29%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3691006433600067,0.8487449037760748,0.7857142857142857,1.0,1.0,7/32,16.47%,PRKD1;TAF1;ACVR1;ROCK1;MARK2;HIPK2;GALNT2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4860738014967911,-0.8479136512612968,0.7142857142857143,0.9229766752273695,1.0,7/13,23.37%,ARF1;MAGI2;SDCBP;MTMR2;LRPAP1;CD63;AHI1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.45747957802616546,-0.8477220710684374,0.7261904761904762,0.9229843907079506,1.0,2/23,2.63%,SEC22B;SEC24D
prerank,KEGG_2021_Human__Fatty acid degradation,0.472675578342237,0.8475400020966307,0.6333333333333333,1.0,1.0,3/8,12.32%,ACAT1;HADHB;CPT1A
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.47095693514454917,-0.8475206475766298,0.625,0.9229422057281039,1.0,1/15,2.82%,HES1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5506133499673835,-0.8470797553274796,0.703125,0.923467893552294,1.0,1/5,17.24%,DCP2
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.45359873423203345,-0.8466276128055402,0.7702702702702703,0.9239165136193644,1.0,6/25,17.18%,SPNS2;ESYT2;ARSG;PLPP1;EGFL7;SAMD8
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.5374357868864877,-0.8465973923471949,0.7301587301587301,0.9236746773977377,1.0,2/6,25.68%,BCAR1;MID1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.5267453873476754,0.8464416852831146,0.65625,1.0,1.0,1/6,4.94%,GNB4
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,-0.5823483783973333,-0.8463620556071749,0.7407407407407407,0.9238507881461846,1.0,3/5,34.29%,PLEC;VIM;GSN
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5126776417447554,-0.8462549737130003,0.7,0.923689601691062,1.0,2/13,3.77%,GRIK1;GRM7
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.42185590481918284,-0.8461634814234115,0.6746987951807228,0.9235017131266797,1.0,14/35,30.23%,IL1RAPL1;KLF4;SMAD3;RACK1;TBK1;IL18R1;ROBO2;ACVRL1;MAPK8;ACVR2A;STAT5B;MAP2K5;RHOA;STAT3
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.48129659259036145,-0.8459579095289982,0.7564102564102564,0.9235245448441846,1.0,6/20,23.48%,RPS27A;UBC;CYLD;RACK1;XIAP;NSMAF
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.4849502227954884,-0.8459129131153985,0.6447368421052632,0.9232641147861106,1.0,3/10,17.26%,CX3CL1;TNFRSF10B;IL18R1
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.46939262775135226,0.8458562038839047,0.6486486486486487,1.0,1.0,2/7,13.71%,H2AC6;CENPP
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.48046858871045495,0.8456951681076361,0.6774193548387096,1.0,1.0,2/6,8.98%,CLASP1;PHLDB2
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.555021870919123,-0.8442765709209696,0.6774193548387096,0.9255522115217131,1.0,2/5,8.55%,PACS1;AP1G1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3671029220445565,0.8441042414951424,0.8235294117647058,1.0,1.0,6/29,15.33%,PRKD1;TAF1;ACVR1;ROCK1;MARK2;HIPK2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,-0.49975184585937854,-0.8440863589920446,0.6956521739130435,0.9252637535271894,1.0,4/11,12.03%,ALPL;COL18A1;SULF2;DYSF
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,-0.49975184585937854,-0.8440863589920446,0.6956521739130435,0.9252637535271894,1.0,4/11,12.03%,ALPL;COL18A1;SULF2;DYSF
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.41666519654205736,-0.8440392751615842,0.7411764705882353,0.9250413111625952,1.0,14/69,17.61%,PPARG;CX3CL1;KDM1A;ESR2;RPS27A;UBC;PLCG2;NPM1;NFKBIA;SMAD3;CRTC3;MALT1;IL18R1;ATF2
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.4616072422112487,-0.8439321888631038,0.7297297297297297,0.9249069063913317,1.0,1/23,1.04%,ITPR1
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.41822375129240746,-0.8438931193774661,0.8181818181818182,0.9246465374865667,1.0,5/47,4.59%,PPP2R3A;ITPR1;GRIN2B;FOS;GRIA2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.4126048523096008,-0.8438130262911523,0.735632183908046,0.9244512607987563,1.0,11/60,19.87%,B3GNT2;BAZ1A;SLC30A7;TRAM1;LIMS1;TEC;NCK1;VRK2;ARFGEF2;ATP13A3;CD109
prerank,KEGG_2021_Human__Bile secretion,0.4111200635795328,0.8435134113981759,0.6451612903225806,1.0,1.0,2/15,2.71%,SLC4A4;SLCO1A2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.41335298364596595,0.8433409351988354,0.75,1.0,1.0,1/12,3.43%,ATP10D
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.513004314726554,-0.8432641607217587,0.703125,0.9249699457416279,1.0,5/10,19.73%,KLF2;CPEB4;LARS1;MTOR;SPAAR
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.45577341112006065,-0.842960352927447,0.6623376623376623,0.9252020809512782,1.0,9/28,19.28%,ENSA;RAB2A;TPR;ARPP19;RAB1A;LPIN2;VRK2;NUP54;USO1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.5342020732061101,-0.8427658830795195,0.7096774193548387,0.9251403283728276,1.0,1/7,21.51%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.4189875115921452,0.8422811011112644,0.6428571428571429,1.0,1.0,2/9,9.91%,ATM;NEK7
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.43115601708121354,-0.8421516190126513,0.6712328767123288,0.9258107883362252,1.0,3/28,9.46%,PEBP1;RAP1A;VWF
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.46801353544452423,0.8421261778137824,0.6923076923076923,1.0,1.0,1/6,1.73%,RARB
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9250956404461779,1.0,1/5,23.05%,STK39
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9250956404461779,1.0,1/5,23.05%,STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9250956404461779,1.0,1/5,23.05%,STK39
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,0.34776542458334136,0.8418454738354058,0.6666666666666666,1.0,1.0,5/27,10.44%,THSD1;IL1R1;ENTPD1;TNFRSF1B;TEK
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.49635380155198,-0.8417817255348088,0.7424242424242424,0.9251558916531785,1.0,7/13,13.81%,SLC2A1;COMMD1;PNP;TGM2;ATP1B3;ZNF586;PON2
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.47602900159254646,-0.8416049396262124,0.7575757575757576,0.925166611875435,1.0,4/11,25.39%,EEF1A1;HSPH1;HSP90AA1;SERPINH1
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.33422626038546677,0.8414987310669394,0.8947368421052632,1.0,1.0,13/42,22.74%,MIPOL1;WDPCP;KPNA5;OPHN1;STRN3;ATP9B;BRWD1;CEP112;ODF2L;TBC1D32;USP8;TULP4;FTO
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.48392432935761914,0.8412520622019257,0.6451612903225806,1.0,1.0,1/6,2.52%,MSL2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.44597565693668173,-0.8409564559036583,0.7567567567567568,0.9259042047661707,1.0,9/23,23.77%,ATP2B1;SLC8A1;ANK2;ATP13A3;SLC30A1;TMEM165;VAPB;CDH5;CALR
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.3458943058413913,0.8400275440393531,0.6666666666666666,1.0,1.0,7/42,10.44%,MMRN1;ZNF521;PREX2;LDB2;CYYR1;SEMA6A;TEK
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.3458943058413913,0.8400275440393531,0.6666666666666666,1.0,1.0,7/42,10.44%,MMRN1;ZNF521;PREX2;LDB2;CYYR1;SEMA6A;TEK
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.5172488292885685,-0.8397013144772102,0.7230769230769231,0.9276342391331706,1.0,1/7,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4076035526696801,0.8392708910945934,0.6428571428571429,1.0,1.0,1/15,1.20%,GCNT2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.507842058040523,-0.8389892229983535,0.6865671641791045,0.9284275462318737,1.0,3/9,9.11%,PRKCE;SCARF1;ANXA1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.5658824773260813,-0.8389250894656842,0.7777777777777778,0.9282280481538645,1.0,1/6,11.63%,CTNND2
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.46860778397307035,-0.8384659075494312,0.68,0.9286519691934918,1.0,7/12,35.46%,MYL6;MYH10;MYL12B;RHOB;RHOA;PPP1R12B;LIMK2
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.44656900393948895,-0.8382129738515312,0.7125,0.9287184762769531,1.0,5/20,10.89%,NFASC;GRIA2;CNTN1;PTPRD;SHC2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5463114698523721,-0.8379181124965772,0.7681159420289855,0.9289558462456046,1.0,2/6,9.83%,NFE2L2;SOD2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4462542445747763,0.8377114184866409,0.5897435897435898,1.0,1.0,1/9,1.22%,UGCG
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4140614643886794,-0.8374459322906949,0.7228915662650602,0.9293107528489557,1.0,3/42,4.86%,SPNS2;CHPT1;DMD
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.42066101701808917,0.8373998662353129,0.59375,1.0,1.0,3/11,12.88%,UIMC1;ATM;BABAM2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,-0.5509613975962894,-0.8373801214584213,0.7272727272727273,0.9290771347987952,1.0,2/8,17.45%,PECAM1;LCP2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5074066292207193,-0.8372956417221857,0.704225352112676,0.9289195564276366,1.0,3/10,18.73%,KLF6;PLCG2;ITGB1
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.4351354881552249,0.8371847546030929,0.6666666666666666,1.0,1.0,2/11,8.29%,PPP1R13B;YWHAG
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.47213641298986253,-0.8370571285001314,0.7428571428571429,0.9289820684817088,1.0,4/14,24.86%,MSN;CLTA;DNM2;RPS6KA2
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5397541559252175,-0.8368773450519779,0.7333333333333333,0.9289383749068809,1.0,1/6,4.54%,LRRC32
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.4499082740758598,-0.8367315049994011,0.6351351351351351,0.9288568079789893,1.0,6/17,19.26%,NFKBIZ;PECAM1;DYSF;LCP2;PSAP;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5425098315369434,-0.8367239243842753,0.7391304347826086,0.9285555338510005,1.0,6/8,43.24%,ADGRG1;RAC1;ARHGEF3;GPR174;LPAR6;PRAG1
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.5342183168701573,-0.8366963391739982,0.7384615384615385,0.9282771888265468,1.0,3/5,28.07%,ITGB5;ITGB1;MFAP3
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5168472927108297,-0.8365089857910235,0.6956521739130435,0.928218645320893,1.0,1/10,1.09%,BTG2
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,-0.40793303593107577,-0.8363097894810438,0.717948717948718,0.9282055633424451,1.0,17/55,19.18%,ZEB2;ENPP2;CLEC1A;LRRC32;GGT5;FLT1;PECAM1;TNS1;VWF;S1PR1;CLDN5;SGIP1;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.47943410607939,-0.8357235626262068,0.7948717948717948,0.9287903475309854,1.0,2/21,2.63%,SEC22B;SEC24D
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,-0.4535956994696889,-0.8352340536067772,0.7215189873417721,0.9292612596410232,1.0,7/21,25.68%,KIAA1217;LAMA5;NAV2;EGFR;CADPS2;VWA2;MID1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.43608891536791894,-0.8348946459089284,0.6962025316455697,0.9294180020621338,1.0,7/30,20.35%,CX3CL1;GPM6B;CDK6;ADAM15;EMP2;ACER2;PIK3CB
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.3106181919288532,0.8347877166930766,0.8181818181818182,1.0,1.0,8/58,10.49%,KIF26B;PLA2G4A;MAN1A2;VPS45;COG3;BICD1;COG6;CYTH3
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.4282133484726345,0.8347065690176545,0.7407407407407407,1.0,1.0,2/14,9.64%,ATR;ATM
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5112671992792942,0.8345851915099357,0.7777777777777778,1.0,1.0,2/7,20.00%,NCOA3;ZNF706
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,-0.4197926283842671,-0.8344626550588711,0.7469879518072289,0.9297371833253794,1.0,13/31,27.57%,LRRC32;GGT5;TNS1;VWF;TIE1;ACVRL1;CD34;SPARC;CDH5;TNS2;SPARCL1;LAMA4;RHOJ
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.3974273574636391,0.834338892959001,0.6578947368421053,1.0,1.0,1/10,7.36%,SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.4409697756760616,-0.8343036088195567,0.7341772151898734,0.9296669311566879,1.0,4/20,28.18%,CNOT6L;SDCBP;CCDC88A;DYNC1H1
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,-0.4053305490873864,-0.8339820745648652,0.7051282051282052,0.9298384898863622,1.0,17/58,19.18%,ZEB2;ENPP2;LRRC32;PLCL1;GAS7;FLT1;TMEM132C;PECAM1;VWF;S1PR1;CLDN5;CACNA1C;SGIP1;NOTCH4;TIE1;ACVRL1;CD34
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.49375444552610104,-0.8338767204583066,0.6363636363636364,0.9297682508668745,1.0,3/10,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.351447555978563,0.8337869684403135,0.76,1.0,1.0,4/26,8.71%,BMP6;PRKD1;HSPA1A;CARMIL1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.39142783039500817,0.8336797805536341,0.7777777777777778,1.0,1.0,3/17,8.98%,WDPCP;CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.45496206635121417,-0.8336188622187927,0.7297297297297297,0.9298566100064024,1.0,3/19,9.08%,YTHDC1;ZC3H7A;RPL10
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4516787190734672,0.8335827802351466,0.7333333333333333,1.0,1.0,2/10,9.48%,PLA2G4A;GPD1L
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4516787190734672,0.8335827802351466,0.7333333333333333,1.0,1.0,2/10,9.48%,PLA2G4A;GPD1L
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.5421796509270629,-0.8335491102434153,0.6984126984126984,0.9296845204989483,1.0,2/5,9.72%,SLC4A10;SLC4A7
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,-0.47659205770987,-0.8329870287073504,0.684931506849315,0.9300482405989507,1.0,2/14,5.63%,AKAP12;GPM6B
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.36888604452807827,0.8329689087440719,0.6086956521739131,1.0,1.0,1/14,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.41921803402498614,0.8327849217579618,0.75,1.0,1.0,4/12,11.42%,OCLN;CLASP1;HSPA1A;CLIP1
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.32390724999246473,0.8325586767883959,0.84,1.0,1.0,5/28,7.68%,DNMT3A;H2AC6;ERCC6;BAZ2A;JARID2
prerank,KEGG_2021_Human__Thermogenesis,-0.4125182500222143,-0.8325290209043211,0.7555555555555555,0.9303551485351932,1.0,9/51,11.29%,MAP3K5;PRKAG2;MGLL;PPARG;KDM1A;NDUFA12;RPS6;FGFR1;ACSL5
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4430577146850823,-0.83217203334106,0.7283950617283951,0.9306656208748861,1.0,10/31,21.30%,SSH1;RAPGEF3;RAP1A;GOLPH3;CPEB4;LARS1;CTNNA1;MTOR;SPAAR;RYR3
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3933482322780435,-0.8319900309537677,0.7528089887640449,0.9306367017996408,1.0,19/71,26.75%,PCK1;PKN3;PRKCE;PAK2;STK38;TBK1;PINK1;VRK2;MTOR;PIKFYVE;CSNK1D;MAPK8;PRKCH;STK39;RPS6KA2;CAMK2D;TNKS;TLK2;CSNK2A1
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.40932131505005653,-0.8318988118779146,0.7209302325581395,0.9304985461867378,1.0,8/36,18.57%,RPS27A;JAK1;UBC;TPR;SGIP1;KPNB1;NUP54;KPNA4
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.5179895993819787,-0.8318336252982683,0.7377049180327869,0.930307756437728,1.0,3/8,19.18%,PECAM1;ITGB1;CD34
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4537310484964451,-0.8317579784300669,0.7066666666666667,0.9300869749104236,1.0,2/20,9.19%,RFC3;KLF4
prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.47241937751543395,-0.831709225567169,0.7160493827160493,0.9298437590185605,1.0,5/17,21.83%,SPOPL;BOC;CSNK1D;CUL1;GLI3
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,-0.4420591020772048,-0.8314165773417952,0.75,0.9299468472352115,1.0,14/29,35.46%,FES;MYL6;MYH10;PIP5K1C;ITGB1;MYL12B;PLXNA2;HSP90AA1;RHOB;RHOA;ITGA1;FYN;ARHGEF12;LIMK2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5160638189320081,-0.8312141658274078,0.704225352112676,0.9299182262849549,1.0,1/6,3.88%,LGALS3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.44531657016097165,-0.8308795018764319,0.7948717948717948,0.9301678566574915,1.0,6/27,12.22%,CX3CL1;NFE2L2;GGT5;YBX3;HYAL2;ZFP36
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.45905268469221383,-0.830826015967854,0.7323943661971831,0.9299324558677888,1.0,3/14,11.85%,SLC6A6;SLC8A1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.34816910856938676,0.8306326487438268,0.8333333333333334,1.0,1.0,6/29,10.41%,RC3H1;RBM20;NOVA1;NOVA2;HNRNPLL;TNFRSF1B
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5648519143862902,-0.8301941963042409,0.7285714285714285,0.9306064993199766,1.0,1/5,4.57%,SMAD7
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.47076170624545516,-0.8295909930381398,0.6891891891891891,0.9312012142092758,1.0,3/12,11.85%,SLC6A6;SLC8A1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.43495253266607936,-0.8294679459165988,0.6904761904761905,0.9310896152727383,1.0,8/29,20.37%,SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1;CLU;CSNK1D
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.42533939985489494,-0.8288784617401841,0.75,0.9317062942172953,1.0,8/37,19.31%,TSG101;RPS27A;UBC;CCNH;TPR;SGIP1;NUP54;CHMP4B
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.42772479551330095,-0.8288276774048966,0.75,0.9314782776994387,1.0,6/35,16.73%,DENND3;DENND2C;RAB21;RAB1A;RAB8B;RAB14
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.3399800528810407,0.828606030505211,0.6666666666666666,1.0,1.0,4/31,5.47%,PACS2;MVB12B;BEND7;WLS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9313686791142918,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9313686791142918,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9313686791142918,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.5408558535988658,-0.8280908468176015,0.7678571428571429,0.931388405573505,1.0,2/7,8.92%,LGALS3;CD55
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.38075303554415496,0.8280506354750802,0.8387096774193549,1.0,1.0,3/23,3.82%,TNRC6C;ATP2A2;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.5109349781334045,-0.8272695257618539,0.7611940298507462,0.9324008436997495,1.0,4/9,38.83%,CD34;NFKB1;FYN;ATP2B4
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.43917356391626355,-0.8271676243551461,0.7407407407407407,0.931960384867756,1.0,12/38,21.70%,CD9;MT1L;SERPINB6;VWF;EPAS1;CFH;CST3;PLSCR4;MT1M;IFITM3;CLU;SPARC
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.43917356391626355,-0.8271676243551461,0.7407407407407407,0.931960384867756,1.0,12/38,21.70%,CD9;MT1L;SERPINB6;VWF;EPAS1;CFH;CST3;PLSCR4;MT1M;IFITM3;CLU;SPARC
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.45091774520658046,0.8266943816932207,0.6511627906976745,1.0,1.0,2/10,5.26%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.46892653637654746,0.8266437970004286,0.7073170731707317,1.0,1.0,2/8,11.08%,PPIP5K2;TPK1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.41336176570388233,-0.8264831562045035,0.6712328767123288,0.9323435648665385,1.0,3/29,7.81%,SLC6A6;SLC2A3;SLC2A1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.41336176570388233,-0.8264831562045035,0.6712328767123288,0.9323435648665385,1.0,3/29,7.81%,SLC6A6;SLC2A3;SLC2A1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.42259894023370537,-0.8264355562541793,0.6794871794871795,0.932093654709838,1.0,3/28,7.25%,MAP1B;NES;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4239973246207395,0.8261664776381465,0.6333333333333333,1.0,1.0,1/12,0.16%,BMP6
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.5442603921103656,-0.8261460934761725,0.7258064516129032,0.9322439478576301,1.0,2/5,19.18%,CD81;CD34
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.4682757199193251,-0.8258506045156289,0.72,0.9324203031852791,1.0,8/17,28.21%,CANX;SGIP1;PICALM;PIP5K1C;CLTA;INPP5F;FCHO2;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.48703763532499617,0.8256889119472672,0.7352941176470589,1.0,1.0,1/6,4.99%,HSPD1
prerank,CellMarker_Augmented_2021__Macrophage:Brain,0.42889084576288794,0.825069946964047,0.696969696969697,1.0,1.0,2/13,4.62%,DSE;SH3BGRL
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5176224136902989,-0.8250564773842384,0.6724137931034483,0.9333064165476361,1.0,2/6,12.40%,RIMS1;RIMS2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.531823222103286,-0.824995312670825,0.7258064516129032,0.9331573621150457,1.0,4/5,38.54%,AHCYL1;ZFP36L1;DHX36;PAPOLA
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.45771487117202814,-0.8248590044603967,0.7066666666666667,0.9330382762083144,1.0,5/18,19.44%,GRIA2;CDK14;DPP10;NARF;MTUS2
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.41481822267374435,0.8239846581424691,0.6857142857142857,1.0,1.0,1/12,1.17%,MLLT3
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.43645289287826344,-0.823850169189476,0.7236842105263158,0.9342965500959959,1.0,5/28,14.05%,PKM;RPS9;YBX3;NPM1;CNBP
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4221232990465853,-0.8232396752688746,0.7341772151898734,0.934897293167318,1.0,9/23,24.25%,TMSB4X;LIMS1;NFKBIA;CYLD;DLG1;PPM1A;EGFR;SASH1;TERF2IP
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.39260818563584504,-0.8231935693522026,0.7037037037037037,0.9346397393074376,1.0,4/47,4.91%,NR4A1;PPARG;TAF1D;ESR2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.49814380229155464,0.8230783739840987,0.7419354838709677,1.0,1.0,1/7,3.80%,RALA
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5018193510843496,-0.8230198558267856,0.6764705882352942,0.9346433692262794,1.0,4/8,21.17%,OGT;RIF1;KMT2A;MTF2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.5510247563795129,-0.8228865306045277,0.8103448275862069,0.9345538086238598,1.0,2/5,15.38%,DHRS7B;PAFAH1B1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4166952094195316,0.8228704809205502,0.6206896551724138,1.0,1.0,3/10,12.27%,COG3;COG6;COG5
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.47487482860329416,-0.8228679376592736,0.7222222222222222,0.9342817190631598,1.0,2/11,3.32%,ENPP2;CHPT1
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.40719346245439964,-0.82282596659849,0.7386363636363636,0.9340507852104165,1.0,8/41,19.31%,TSG101;RPS27A;UBC;CCNH;TPR;SGIP1;NUP54;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4873649845898558,-0.8227851879221615,0.7846153846153846,0.9338051088401098,1.0,5/11,30.07%,ROBO2;PLXNA2;MAP3K13;RHOA;CDKL5
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.5259271471523785,-0.822780221520738,0.75,0.9335037560425932,1.0,3/6,19.18%,DLG1;ACVRL1;CD34
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.5033555721452818,-0.822773092894023,0.7313432835820896,0.9332063238500914,1.0,2/9,15.83%,NPM1;MALT1
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,-0.5560033478439231,-0.8227277259394409,0.6956521739130435,0.9329537298463814,1.0,2/5,38.33%,MFN1;TRAK1
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.3959348067964616,0.8226000600296226,0.6470588235294118,1.0,1.0,5/14,12.88%,UIMC1;HERC2;YWHAG;ATM;BABAM2
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.5396277881267217,-0.8222757008517011,0.7936507936507936,0.9333446732524711,1.0,2/6,22.50%,CLTA;DNM2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4402697599226516,-0.8220172338722225,0.7402597402597403,0.9333747438149094,1.0,2/22,7.49%,NDRG1;HIF1A
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.49984287718429804,-0.8219072013303534,0.6923076923076923,0.9331966733679984,1.0,4/9,35.35%,LCP2;FGR;MAP3K8;MAP3K2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.4697121200260009,-0.8218367429348419,0.6944444444444444,0.9330298661272319,1.0,3/13,18.01%,PBRM1;TPR;NUP54
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.530119261861577,-0.8206280450566265,0.7903225806451613,0.9346013194986506,1.0,2/6,32.22%,CD320;LMBRD1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.4633678704084174,-0.8206170740224238,0.7236842105263158,0.9343042119967464,1.0,1/17,1.49%,LBR
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5417710166478832,-0.8204694310706097,0.7096774193548387,0.934278243403174,1.0,3/7,26.80%,GOLPH3;ITGB1;GCNT1
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.478752323533323,-0.8200013901872379,0.7285714285714285,0.93462332437937,1.0,3/13,8.84%,RFC3;RPS27A;UBC
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,-0.5258361195150612,-0.8198322075278441,0.7916666666666666,0.9345824313464254,1.0,4/6,23.27%,PECAM1;CD34;PODXL;CDH5
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.441587839660451,-0.8188717088340013,0.6714285714285714,0.935639097819487,1.0,2/14,13.17%,PPARG;CDKN1A
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.4822678866813829,-0.8186825851555714,0.7681159420289855,0.9356349638442882,1.0,2/11,11.85%,SLC8A1;ATP1B3
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.4433608869906592,0.8183245446565145,0.7575757575757576,1.0,1.0,3/11,13.33%,RPP38;NUP58;NUP214
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,-0.5227119888508881,-0.8183182854005746,0.782608695652174,0.9358790970232926,1.0,3/6,14.58%,LRRC32;REL;SMAD3
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,-0.5151223141684892,-0.8182221065385752,0.765625,0.9356970842357056,1.0,1/5,9.06%,CD81
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.43715457842347166,0.8168763341689044,0.59375,1.0,1.0,1/10,1.22%,UGCG
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5507860236223947,-0.8166997948453054,0.7647058823529411,0.9377110710857792,1.0,1/5,18.43%,MTOR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5230805214288381,-0.8166149435982096,0.7391304347826086,0.9375285755791896,1.0,2/7,9.54%,TPM1;ADAMTS1
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.4152405962128411,-0.8161039358395605,0.7662337662337663,0.9380567089054049,1.0,7/35,10.57%,RFTN1;ZEB2;SRGN;PECAM1;CLEC2B;S1PR1;WIPF1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5059661385848112,0.8160512383590701,0.7222222222222222,1.0,1.0,2/5,10.81%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.42387450808826427,-0.816022362528976,0.7682926829268293,0.937848324302913,1.0,3/28,8.26%,CX3CL1;ERBB4;RAP1A
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5119280616620479,-0.8159351029834013,0.6417910447761194,0.9373728149713005,1.0,3/7,16.25%,DMD;TPM1;MYL6
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5119280616620479,-0.8159351029834013,0.6417910447761194,0.9373728149713005,1.0,3/7,16.25%,DMD;TPM1;MYL6
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.4263770514837485,-0.8157514578726812,0.7763157894736842,0.937334862666309,1.0,9/20,28.37%,HIP1R;ANXA1;GATA2;KMT2A;GPC3;CALR;NEDD4L;DYNC1H1;ANXA2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5677506028111964,-0.8155787983907216,0.7647058823529411,0.9372489068447887,1.0,1/6,4.17%,EPS8
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.48715151922953526,0.8154114707194222,0.75,1.0,1.0,1/5,4.99%,HSPD1
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,-0.4420817880583935,-0.8153511592539913,0.72,0.9372885790243147,1.0,3/18,14.50%,PIK3R1;GIT2;NCK1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.5126807400052377,-0.8153098048094155,0.7878787878787878,0.9370513198534058,1.0,4/9,25.07%,COMMD1;DLG1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4613543138990961,-0.8152998300330729,0.7733333333333333,0.9367477807729866,1.0,7/15,30.23%,HIF1A;ZFP36;CDK6;HSPA9;ACVR2A;STAT5B;STAT3
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,0.5252118718107189,0.8150867949715073,0.6470588235294118,1.0,1.0,1/5,4.36%,USP25
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.5039000607602483,-0.8147268514072201,0.75,0.9372303362886388,1.0,4/10,18.73%,GJA1;PAFAH1B1;KPNB1;ITGB1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,-0.4687928373849383,-0.8146898410989432,0.746268656716418,0.9369638218830147,1.0,2/12,8.92%,ACTN1;CD55
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.46685250462615013,-0.8143704273174477,0.6956521739130435,0.9368183494459634,1.0,2/14,8.84%,RPS27A;UBC
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.46685250462615013,-0.8143704273174477,0.6956521739130435,0.9368183494459634,1.0,2/14,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.48296118326181503,-0.813866476391614,0.7384615384615385,0.9372265536417356,1.0,2/8,9.11%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.41157602542275584,0.8136408112631084,0.6764705882352942,1.0,1.0,1/8,5.79%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3804704579591422,-0.8133107655674451,0.8021978021978022,0.9377560499522262,1.0,19/71,19.18%,NRCAM;SLC6A6;PPARG;FES;RAP1A;AAMDC;FGFR1;GJA1;MEF2A;ZFP36;SDCBP;SMAD3;BTG1;WWTR1;CTNNA1;MTOR;ACVRL1;BOC;CD34
prerank,KEGG_2021_Human__Gap junction,-0.4200686795501344,-0.8132564704712593,0.6962025316455697,0.9375450356208539,1.0,13/34,29.06%,ITPR1;GJA1;GRB2;EGFR;GNAI3;CSNK1D;ADCY2;TUBB6;TUBB4B;MAP2K1;MAP2K5;ADCY9;TUBA1B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.4608030292589811,-0.8127913146308301,0.6923076923076923,0.9379857325643082,1.0,2/13,11.16%,PIK3R1;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5276596958922962,-0.812655920700389,0.7352941176470589,0.9379072611655109,1.0,4/5,26.19%,NPM1;MECP2;RAB11A;BRD4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.48656053065944793,-0.8124068736004728,0.7162162162162162,0.9379943870048405,1.0,5/10,19.76%,PRKN;HERPUD1;TMBIM6;RACK1;CLU
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.5291768960150726,-0.8121285669968541,0.7272727272727273,0.937952740020975,1.0,6/8,46.16%,TERF2IP;WAPL;SMG1;SMG6;XRCC5;YLPM1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.46277957809884684,-0.8120821085884606,0.7391304347826086,0.9377015656671548,1.0,1/8,10.25%,S1PR1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.518260934305198,-0.8118125600042836,0.75,0.93775559656584,1.0,1/9,1.09%,BTG2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4078433785609597,0.8117938070111471,0.7027027027027027,1.0,1.0,1/7,1.22%,UGCG
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,-0.4053714271319504,-0.811791113957719,0.8192771084337349,0.937475258535637,1.0,15/33,27.57%,LRRC32;TPM1;TNS1;MSRB3;DLC1;GJA1;PLSCR4;CALD1;ITGB1;CD34;SPARC;CDH5;NID1;LAMA4;RHOJ
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.46042453215745816,-0.8116116678335503,0.7536231884057971,0.9374926000377757,1.0,4/16,14.37%,NR4A1;FLT1;ANXA1;VEGFC
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4760080299348567,-0.8113938295792567,0.6756756756756757,0.9375686758224303,1.0,1/11,7.49%,HIF1A
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.41532497946023456,-0.8113266936924333,0.7272727272727273,0.9373584106001038,1.0,10/28,23.77%,ATP2B1;SLC8A1;ANK2;MT1M;ATP13A3;SLC30A1;TMEM165;VAPB;CDH5;CALR
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.5318056723103075,-0.8111832608182115,0.8307692307692308,0.9371923129218921,1.0,3/6,40.24%,GRB2;FYN;PKN2
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.4635330636587253,0.810780905685747,0.75,1.0,1.0,2/7,15.33%,TEAD4;HIPK2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.4218592444180881,0.8107698138254065,0.7307692307692307,1.0,1.0,4/14,9.19%,TBL1X;HDAC9;BAZ2A;TBL1XR1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5184423853405006,-0.810653309175343,0.7213114754098361,0.9375728570674065,1.0,1/5,15.41%,UPP1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.4085875931491881,-0.810598499129551,0.782051282051282,0.9373371282432552,1.0,11/33,25.29%,PAK2;TNFRSF10B;MALT1;PINK1;MTOR;EMP2;ECT2;PRKAR1A;ADCY2;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.507496840691363,-0.8105552995984255,0.7536231884057971,0.9370942216947465,1.0,1/7,13.07%,NFKBIA
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.38889245422890534,-0.8105499934307169,0.8,0.9367928424313612,1.0,10/53,13.78%,AKAP12;ACTN1;TIMP3;TPM1;TNS1;DLC1;OGT;GJA1;NOSTRIN;PLSCR4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.3962273126943218,-0.810539405794547,0.6666666666666666,0.9365099754951485,1.0,7/44,13.23%,SEC22B;NPLOC4;ARHGAP21;RAB2A;GOLPH3;TMED10;RAB1A
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.3475393687659837,0.8103790144786054,0.6774193548387096,1.0,1.0,2/18,3.82%,RARB;H2AC6
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.46437060820176235,-0.810362187269819,0.7424242424242424,0.9364763116184558,1.0,7/17,27.36%,DLC1;ENSA;ARPP19;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.4279474093601497,0.8097568318624515,0.6756756756756757,1.0,1.0,6/14,29.51%,ABL1;MSH3;BCAS3;ABL2;WRN;PSEN1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4111136806409356,-0.8097219329480446,0.7468354430379747,0.9370686755889374,1.0,2/25,4.41%,JUN;PPM1D
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.4854944750815416,-0.8088093455992379,0.7464788732394366,0.9380412593994216,1.0,3/10,12.93%,JAK1;DUSP16;DUSP5
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.3819415818968426,-0.808482046534786,0.7261904761904762,0.9381424942282854,1.0,11/60,18.01%,PPARG;RAD21;TPR;PIAS2;CBX5;NPM1;NFKBIA;SMC6;SMC3;THRB;NUP54
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,-0.525308381033296,-0.8078937221248655,0.8153846153846154,0.9386313355338487,1.0,2/6,18.73%,DCLK1;ITGB1
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.3807793259168591,-0.8075886045702297,0.8404255319148937,0.9387505934471825,1.0,20/98,16.49%,PKM;NEDD9;LDHA;SRGN;SSH1;GAPDH;RNF19A;CALCOCO2;PHTF2;STARD4;CREM;LIMS1;GABARAPL1;PELI1;PON2;PLPP1;MCL1;EWSR1;CTNNA1;TBK1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4906045396148011,-0.8073389621847114,0.676923076923077,0.938793020798211,1.0,2/8,11.39%,RAPGEF3;TPR
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.450896086240122,-0.8072793719473232,0.7027027027027027,0.9385613912852929,1.0,2/19,5.66%,HSPA5;CANX
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.48931032397189755,-0.8071521156305882,0.7183098591549296,0.9384869712518513,1.0,6/13,24.52%,NFASC;MBP;PLP1;CMTM8;SCN2A;ACER3
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.43479377350599985,-0.8068508535267009,0.7662337662337663,0.9386353320938997,1.0,4/17,10.94%,CX3CL1;TGM2;SLC26A2;CFH
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.42813944702586304,-0.8066257097323555,0.75,0.9386339397487709,1.0,2/23,10.46%,LDHA;NDUFA12
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5676388810913927,-0.8066106559706305,0.828125,0.9383406293545977,1.0,4/5,41.27%,NEDD4;DAB2IP;PTPN1;MMRN2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.46303823994797016,0.8062352502959393,0.6578947368421053,1.0,1.0,2/7,9.22%,ARNT2;CHD7
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.5118844540751353,-0.8060128513917023,0.7619047619047619,0.9389266299271576,1.0,2/5,23.21%,DCLK1;GPC3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.44523670437400115,-0.8058006960389928,0.7605633802816901,0.9389178513267816,1.0,4/19,17.29%,RTN4;PAK2;LRRC4C;ROBO2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.38645423208167534,-0.8056204351461723,0.7333333333333333,0.9388835603187557,1.0,9/50,14.13%,MAP1B;NES;NFASC;ANK2;GJA1;DCLK1;ADGRL3;PLP1;NAV2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5515910487909942,-0.8055417074244775,0.7377049180327869,0.9384143058246484,1.0,2/5,25.98%,SOCS3;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5515910487909942,-0.8055417074244775,0.7377049180327869,0.9384143058246484,1.0,2/5,25.98%,SOCS3;INPP5F
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,-0.46051498951855746,-0.8052891750429922,0.765625,0.9383911367164123,1.0,6/10,44.06%,NCK1;TRIO;FYN;WASL;DOCK1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.42129653710126214,0.805045535473876,0.6551724137931034,1.0,1.0,2/11,9.91%,ATM;NEK7
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3829064949877017,0.805025243737463,0.7241379310344828,1.0,1.0,2/16,4.91%,EFNA5;CLASP1
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.36551391237194886,0.8049441263042189,0.7307692307692307,1.0,1.0,3/17,9.19%,TNRC6C;TBL1X;TBL1XR1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.3768749931512122,-0.8047937705784005,0.7558139534883721,0.9387757438987987,1.0,11/62,18.01%,PPARG;RAD21;TPR;PIAS2;CBX5;NPM1;NFKBIA;SMC6;SMC3;THRB;NUP54
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4062252426900902,-0.8047340380806715,0.7466666666666667,0.9385522977289794,1.0,11/25,29.93%,GPM6B;HIP1R;DLC1;ARHGAP17;MTOR;CCDC88A;RHOB;FAM107A;CRK;RAC1;RHOA
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,-0.48260475022488486,-0.8046041822780022,0.7605633802816901,0.9384636157807537,1.0,6/10,32.72%,GRIA2;CADM2;RALYL;SNAP25;GRIA4;NRXN1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.4375919878098461,-0.8042956401147043,0.7714285714285715,0.9386441437137683,1.0,4/19,16.81%,HIF1A;FGFR1;LIMS1;NOTCH4
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.38092031709457724,-0.8028612503828325,0.797752808988764,0.9403553203516166,1.0,18/70,26.75%,PCK1;PKN3;PRKCE;PAK2;STK38;TBK1;PINK1;VRK2;MTOR;CSNK1D;MAPK8;PRKCH;STK39;RPS6KA2;CAMK2D;TNKS;TLK2;CSNK2A1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.49623141595660514,-0.8026069367750487,0.7571428571428571,0.9404478845293087,1.0,3/10,19.42%,TIMP3;CST3;EGFR
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.5159859801241111,-0.8025841531196656,0.6923076923076923,0.9401733877933725,1.0,2/6,20.16%,SLC30A7;SLC30A1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5009221042926144,-0.8024292164641357,0.684931506849315,0.9400952233325304,1.0,4/9,29.30%,CLDN5;ZDHHC21;CDH5;VCL
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.4657817799649422,-0.8023772970771579,0.7384615384615385,0.9399299573681797,1.0,6/12,26.37%,ABCA5;STARD4;SCARB1;CLU;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.45251768039308904,-0.8018736362538537,0.7808219178082192,0.9402693901615975,1.0,9/16,28.21%,CANX;SYNJ2;SYT1;PICALM;PIP5K1C;DNM2;SYNJ1;FCHO2;DNAJC6
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.4235810735786522,0.8012857340024534,0.84375,1.0,1.0,4/13,11.58%,GULP1;TEAD4;PRTG;ROR1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5386283089538044,-0.8011729690627774,0.8620689655172413,0.9409279551590785,1.0,1/5,5.50%,WDR48
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.5088462546538484,-0.8010172263142756,0.7164179104477612,0.9405320329023212,1.0,3/7,22.31%,LARS1;MTOR;UBR1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.5088462546538484,-0.8010172263142756,0.7164179104477612,0.9405320329023212,1.0,3/7,22.31%,LARS1;MTOR;UBR1
prerank,KEGG_2021_Human__Tuberculosis,-0.4095778115209221,-0.8006279310636487,0.8024691358024691,0.940729440682815,1.0,7/34,15.83%,JAK1;IFNGR1;LAMP2;IFNGR2;PPP3CC;PIK3C3;MALT1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.40683080339858513,-0.800244950887519,0.825,0.940966588822215,1.0,8/33,24.67%,HSPA5;LGALS3;RIOK3;RACK1;PINK1;CLU;CDH5;HSP90AA1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.45995303208949423,-0.7998129553062412,0.7049180327868853,0.9412543083963658,1.0,2/15,10.86%,ACTN1;MYL12A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5456481778801503,-0.7994573272621072,0.7818181818181819,0.9414621591867981,1.0,1/5,11.82%,TMEFF2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.5335677148710289,-0.7994440847777281,0.7230769230769231,0.9411810657767828,1.0,3/5,30.86%,LCP2;CD74;FGR
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,-0.4421523453556697,-0.7994129299607913,0.6891891891891891,0.9403207828147466,1.0,5/13,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.4421523453556697,-0.7994129299607913,0.6891891891891891,0.9403207828147466,1.0,5/13,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.4421523453556697,-0.7994129299607913,0.6891891891891891,0.9403207828147466,1.0,5/13,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.36169490096204593,0.7992301636968331,0.8064516129032258,1.0,1.0,4/17,10.23%,PODN;PDZRN3;HSPG2;PARVA
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.5186493258626201,-0.7991244835818925,0.7619047619047619,0.9404454278250335,1.0,1/5,14.90%,NAA16
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.3800375934725887,0.7989904047989435,0.7857142857142857,1.0,1.0,5/19,15.33%,PIAS1;NCOA2;PHC3;DDX17;HIPK2
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.45722668251876597,-0.7983336335542693,0.765625,0.9411483935295922,1.0,1/15,6.80%,ELL2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5683779191711731,-0.7983117343064204,0.8153846153846154,0.9408787838113399,1.0,1/5,15.96%,MCL1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.4357497042437189,-0.7978451335049274,0.75,0.941284919123557,1.0,6/20,18.43%,TIMP3;FOXK1;CST3;MCL1;MTMR2;MTOR
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4230852645987082,-0.7977104468543434,0.8313253012048193,0.9412104609679892,1.0,5/32,7.46%,CX3CL1;GAPDH;JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.42249982722261803,0.7972772256628057,0.7428571428571429,1.0,1.0,2/12,5.26%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.46986951950743805,0.7972383196107794,0.8,1.0,1.0,1/5,1.73%,RARB
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5222407191749409,-0.7969724926475695,0.7424242424242424,0.9420350319770973,1.0,2/6,21.97%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.4978748349359374,-0.7969698444824883,0.78125,0.9417366100766797,1.0,2/8,18.83%,FOXF1;ACVRL1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.39674209899884727,0.7967868281748031,0.7419354838709677,1.0,1.0,2/15,5.74%,PLPPR4;MTMR3
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.5077341685642096,-0.7966686013126615,0.7647058823529411,0.941842481380169,1.0,3/7,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.4871427367540315,0.7966467026578542,0.725,1.0,1.0,1/5,2.47%,NIPAL2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,-0.5210646696447927,-0.7957252907957438,0.8028169014084507,0.942785084871665,1.0,1/7,4.89%,ALPL
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.3968118276011775,-0.7955300667947636,0.8169014084507042,0.9427823802768043,1.0,5/30,14.56%,TSG101;TBC1D15;NPM1;MSN;CYLD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.4856388382871275,-0.7950952069362107,0.7966101694915254,0.9430428122503574,1.0,1/8,14.90%,NAA16
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,-0.45226307849227776,-0.7948212151729348,0.7605633802816901,0.9431841642063311,1.0,5/12,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3591824672614058,-0.7947858277683006,0.8111111111111111,0.9429111635126969,1.0,12/88,15.70%,EHD4;RAB11FIP3;EMP1;RAP1A;S1PR1;NUDCD3;GOLPH3;FGD4;RAB1A;PARVB;SDCBP;RAB8B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5040775629377184,-0.7947206548125472,0.6825396825396826,0.9426995566511677,1.0,2/6,32.03%,HLA-B;HLA-E
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.37189242061497557,-0.7947010313983532,0.7411764705882353,0.9424304855173407,1.0,6/30,16.12%,MGLL;CHPT1;LPGAT1;LPIN2;AGPAT4;SH2D3C
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5421501960996367,-0.7943952664720756,0.7627118644067796,0.9426078407228853,1.0,3/6,26.80%,GOLPH3;ITGB1;GCNT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,-0.3921450917838471,-0.7943112463357205,0.7948717948717948,0.9424361081067055,1.0,14/41,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;TNS1;VWF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,-0.36252658456215875,-0.7942325240210449,0.7865168539325843,0.9422285199695939,1.0,25/71,32.46%,SPOPL;IFNGR1;EDEM3;TRAM1;TMBIM6;ACAP2;STK38;TMF1;TMEM59;PICALM;UBXN4;HBP1;KLF3;SACM1L;CD46;ZDHHC20;CLINT1;FCHO2;SCYL2;SEL1L;STXBP3;COPB1;ERAP1;LMBRD1;ARFGEF1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.3975946631088245,0.7937261816071322,0.7857142857142857,1.0,1.0,7/15,15.11%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1;AIG1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.4636036194542007,-0.7935096466440159,0.7611940298507462,0.9429594577635975,1.0,2/11,11.39%,RAPGEF3;TPR
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.47265697028337444,-0.7933668512585268,0.75,0.9428776330960703,1.0,9/14,29.77%,SLC8A1;TPM1;ATP1B3;CACNA1C;COX6C;ATP1A1;TPM4;ATP1B1;TPM3
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,-0.43379624917884685,-0.7933573203943037,0.7083333333333334,0.9425910550128285,1.0,6/19,22.79%,ATP2B1;EPS8;MSN;MYO1E;CAPZA2;DNAJC5
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.40721178969,-0.7932677285765977,0.8493150684931506,0.9424196017357651,1.0,6/23,17.34%,LAMP2;IPO7;TPR;PTTG1IP;PINK1;KPNB1
prerank,CellMarker_Augmented_2021__Basal cell:Lung,-0.4762669203053318,-0.7932507450353742,0.7894736842105263,0.9421513065266547,1.0,4/9,23.13%,ATP1B3;PLAT;CD109;TUBB6
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,-0.38639166993813984,-0.7931217445155637,0.7792207792207793,0.9420806128615611,1.0,14/48,19.18%,ZEB2;CLEC1A;LRRC32;FLT1;PECAM1;VWF;S1PR1;CLDN5;NOTCH4;TIE1;LCP2;ACVRL1;ZNF366;CD34
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.39313985432309845,-0.7928407684482983,0.8539325842696629,0.9420924997678901,1.0,4/52,5.87%,ITPR1;ATG12;JUN;JAK1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.4253174916635537,-0.7920548766845981,0.7702702702702703,0.9429509952229327,1.0,3/22,18.43%,LAMP2;SREBF2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.45622906985449435,-0.7917266291918303,0.7323943661971831,0.9430809423251195,1.0,2/12,10.78%,PIK3R1;GPM6A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.5211331163330362,-0.791614713944499,0.8461538461538461,0.9428989054361533,1.0,2/5,11.21%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4595360228287292,-0.7914728523728798,0.75,0.942474271856681,1.0,1/14,6.80%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4595360228287292,-0.7914728523728798,0.75,0.942474271856681,1.0,1/14,6.80%,ELL2
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.3633008531465414,0.791431158141712,0.7058823529411765,1.0,1.0,5/28,10.89%,EXOC5;RALA;RALGAPA2;YWHAG;TBC1D4
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.4167592782858688,-0.7913788945730112,0.7439024390243902,0.942346326488478,1.0,8/24,24.44%,LGALS3;HIP1R;PICALM;RUFY2;MTMR2;LRPAP1;GPC3;NEDD4L
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.40273342455396177,-0.7908515124950533,0.8352941176470589,0.9427662805956872,1.0,9/30,19.42%,LGALS3;PIK3R1;PRKCE;DPP10;TMEM59;PICALM;DLG1;ITGB1;EGFR
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3782563124164,-0.7906783704081269,0.8,0.9426991730652492,1.0,8/76,8.84%,BTG2;RFC3;RAD21;RPS27A;POLA1;WDR48;COMMD1;UBC
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.4014971844469097,-0.7902871856206575,0.7951807228915663,0.9429362580980429,1.0,8/27,17.85%,B3GNT2;GPC5;HYAL2;SLC26A2;CHST11;HS6ST3;B4GALT1;CHSY1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.39891132453133027,-0.7901776655672397,0.8333333333333334,0.9427761346790161,1.0,4/31,11.18%,EPS8;PIK3R1;GPM6A;ARPC2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.40016448148110945,-0.7901745074349128,0.7790697674418605,0.942476650519334,1.0,6/32,9.48%,ST18;ENPP2;GRIA2;GPM6B;MBP;ARSG
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.417767721435438,-0.7901150507793409,0.8055555555555556,0.9422595775484556,1.0,12/33,21.97%,ADAMTS9;ACTN1;ITGA10;DLC1;ITGB5;PPFIA2;ITGB1;ADAM15;CD34;EMP2;CD63;ADAM9
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.46393286401485584,-0.7899841096592527,0.7536231884057971,0.9421033951374863,1.0,3/10,26.43%,TIE1;ROBO2;DLL4
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4959237240317803,0.7899335639514788,0.7307692307692307,1.0,1.0,2/6,18.86%,HDAC9;HDAC4
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3158343281179057,0.7898281302195966,0.8333333333333334,1.0,1.0,2/23,3.88%,TTN;INO80
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.40265805389908066,0.7896436727510123,0.6818181818181818,1.0,1.0,1/14,2.84%,RHBDD1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.41684857226130667,0.7894713837100173,0.6756756756756757,1.0,1.0,3/8,22.12%,ATP6V1H;DMXL1;CLCN3
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.5455201284013298,0.788936406939093,0.8285714285714286,1.0,1.0,1/5,1.14%,COL8A1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.450307813512796,0.7889143605056865,0.75,1.0,1.0,1/8,4.99%,HSPD1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.450307813512796,0.7889143605056865,0.75,1.0,1.0,1/8,4.99%,HSPD1
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.5170037717094458,-0.7887279009355486,0.8225806451612904,0.9436621388327604,1.0,1/5,27.81%,SLC5A6
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.48510349094127,0.7881807131592299,0.6216216216216216,1.0,1.0,1/5,4.33%,PARD3
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.45674665274088444,-0.7880042350265218,0.7466666666666667,0.9442484664836935,1.0,2/14,10.15%,VSIR;PRNP
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5132760569488327,-0.7878645771705178,0.7428571428571429,0.9438745609400192,1.0,1/5,14.56%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5132760569488327,-0.7878645771705178,0.7428571428571429,0.9438745609400192,1.0,1/5,14.56%,CYLD
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,-0.431918855479696,-0.7875169537887545,0.7183098591549296,0.944017828415882,1.0,5/15,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,-0.39766345892972677,-0.787077373963679,0.7974683544303798,0.9443750188763905,1.0,10/33,27.57%,LRRC32;TNS1;VWF;ACVRL1;CD34;SPARC;CDH5;SPARCL1;LAMA4;RHOJ
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,-0.4366005453352059,-0.7869339328098353,0.7866666666666666,0.9442933937830081,1.0,8/18,24.62%,NFASC;EMP1;NAV1;BOC;CHL1;PLXNA2;VWA2;ADGRG1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.4881771650982494,0.786661198218767,0.6976744186046512,1.0,1.0,1/5,5.60%,PLAAT3
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.41927176592517845,0.7866324910395908,0.71875,1.0,1.0,2/9,8.90%,ZNF521;ABL1
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,-0.48780617940775917,-0.7865307996803609,0.7714285714285715,0.9445433316521503,1.0,5/10,19.42%,CDC37;PIK3R1;ERBIN;GRB2;EGFR
prerank,CellMarker_Augmented_2021__T cell:Skin,0.4266874685438137,0.7865252108237103,0.7647058823529411,1.0,1.0,1/7,0.72%,GBP2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.44263454202127933,-0.7859358665275074,0.7285714285714285,0.9450425569048012,1.0,3/13,12.43%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4561197353090267,-0.7858352478932191,0.8064516129032258,0.9448539266215471,1.0,4/16,19.42%,ANXA1;ADAMTS1;PLCG2;EGFR
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.3978772356313506,-0.7853693058530589,0.7692307692307693,0.9451639912769364,1.0,4/23,11.37%,B3GNT2;GGT5;SLC26A2;CHST11
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.47838922925243743,-0.7853428137915319,0.7808219178082192,0.9448899988293549,1.0,1/8,11.29%,ACSL5
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.44376458060454,-0.785296949207944,0.7808219178082192,0.9446410926470026,1.0,7/11,35.46%,MYL6;MYH10;MYL12B;RHOB;RHOA;ARHGEF12;LIMK2
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,-0.45284659748674944,-0.7849874106184201,0.7702702702702703,0.9447801524542292,1.0,5/11,20.35%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.41546276558351636,-0.7846924659334146,0.8354430379746836,0.9448479893195563,1.0,5/25,13.86%,PRKAG2;GGT5;ACSL5;PON2;ACOX1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.45054110891550986,-0.7843996294663108,0.7464788732394366,0.9449513396315093,1.0,6/18,25.07%,MEF2A;PLCG2;SYT1;ECT2;RYR3;CAMK2D
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.50673216911276,-0.7838370201063283,0.7936507936507936,0.9450974369663862,1.0,3/9,21.41%,ITGB5;ITGB1;FAM171A1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.50673216911276,-0.7838370201063283,0.7936507936507936,0.9450974369663862,1.0,3/9,21.41%,ITGB5;ITGB1;FAM171A1
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,-0.4064951851959155,-0.7835302423567955,0.8289473684210527,0.9452894173243443,1.0,5/29,11.93%,MAP1B;NES;ANK2;FGFR1;GJA1
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,0.34068839342280516,0.7833858700154233,0.9230769230769231,1.0,1.0,2/41,0.98%,MMRN1;GBP4
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.36906425979057267,-0.7833744279277386,0.8170731707317073,0.9451545713663382,1.0,7/57,12.99%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;ZFP36;NPM1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4918374036092322,0.7833245145462182,0.75,1.0,1.0,2/6,5.66%,IL6R;EIF2AK2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.40989321896907716,-0.7826955686529076,0.8333333333333334,0.9457191650908205,1.0,3/27,8.84%,RPS27A;JAG2;UBC
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3582367882430339,0.7826186180664618,0.8571428571428571,1.0,1.0,7/20,12.24%,SLCO1A2;SLC23A2;SLC25A29;NCOA2;SLC38A3;ABCG2;PPARD
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.3739324367371307,0.782311067279375,0.8125,1.0,1.0,4/17,13.33%,H2AC6;IPO8;NUP58;NUP214
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.4179793190137713,-0.7817782710032914,0.75,0.946815738480746,1.0,5/16,16.65%,HIP1R;PRKN;ZDHHC6;SPIRE1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.36245518941861254,0.7815673763000384,0.8064516129032258,1.0,1.0,3/11,9.61%,CTNNA2;ABL1;CDH2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3921936358020252,0.781161928003005,0.6666666666666666,1.0,1.0,3/12,12.83%,HOMER1;GPD1L;WWP2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5631800204182654,-0.7810661094508696,0.8253968253968254,0.9474504085169,1.0,4/5,43.69%,LRP6;CTNNB1;APC;GSK3B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.40047424968520345,-0.780894633648598,0.7692307692307693,0.9473682516771242,1.0,9/29,24.94%,PIK3R1;FLT1;FGFR1;PIP5K1C;EGFR;PIK3CB;PPP1R16B;NEDD4;DIPK2A
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4423511510986685,-0.7808463619111123,0.7432432432432432,0.9471230512415166,1.0,2/11,8.66%,ENPP2;PDXDC1
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.4712631041017825,-0.7807507799924606,0.8208955223880597,0.9460835935981554,1.0,3/11,17.45%,PECAM1;SCARF1;LCP2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.4712631041017825,-0.7807507799924606,0.8208955223880597,0.9460835935981554,1.0,3/11,17.45%,PECAM1;SCARF1;LCP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.4712631041017825,-0.7807507799924606,0.8208955223880597,0.9460835935981554,1.0,3/11,17.45%,PECAM1;SCARF1;LCP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.4712631041017825,-0.7807507799924606,0.8208955223880597,0.9460835935981554,1.0,3/11,17.45%,PECAM1;SCARF1;LCP2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.40608739880485584,-0.780746763146227,0.7532467532467533,0.9458002429392564,1.0,13/29,26.88%,BCAP31;CDC37;LAMP2;ZDHHC6;SDCBP;ZDHHC21;PIKFYVE;SPCS3;ZDHHC14;VPS37A;CHM;ZDHHC20;AP4S1
prerank,KEGG_2021_Human__Notch signaling pathway,0.3633293629392148,0.7807461780954187,0.7631578947368421,1.0,1.0,2/19,2.23%,CTBP2;TLE4
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.31652415665993006,0.7802535437086838,0.8571428571428571,1.0,1.0,3/30,3.53%,HOMER1;HOMER2;EPB41L5
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4494337826891923,-0.7801809827982038,0.7837837837837838,0.9462036099379645,1.0,3/12,19.76%,KDM1A;PTTG1IP;CLU
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.46027156267275193,0.7800741505863064,0.7647058823529411,1.0,1.0,1/6,9.11%,RCSD1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.4546661029204527,-0.7797364215321412,0.7763157894736842,0.9464899776139293,1.0,3/12,24.67%,RIOK3;TBK1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3917734372511758,0.7794131747027205,0.8148148148148148,1.0,1.0,1/10,4.99%,HSPD1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.40395678841600474,-0.7789672475020488,0.8,0.9472288552522673,1.0,3/25,7.01%,CX3CL1;FES;PRKCE
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.4774645680110636,0.7788049005255286,0.7435897435897436,1.0,1.0,1/5,4.46%,GAB1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4598278448215205,-0.7781717542134687,0.726027397260274,0.9480096951203864,1.0,9/13,39.36%,NEDD4;NEDD4L;CDKL5;DAB2IP;MFSD2A;CSMD3;ADGRB3;LRP8;CAMSAP2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,0.37731186280720697,0.7776777658079275,0.75,1.0,1.0,7/12,15.94%,CTBP2;CYYR1;SEMA6A;TEK;PROM1;TCF7L1;TCF7L2
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,0.40813333315458733,0.777569032443034,0.8484848484848485,1.0,1.0,8/15,19.39%,GBP4;XAF1;RCSD1;TNFRSF1B;CFLAR;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,-0.3813727987113127,-0.7774872555495377,0.782051282051282,0.9485850483621066,1.0,14/43,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;SCARF1;VWF;DYSF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.4401061804073235,-0.777402035938136,0.8260869565217391,0.9484109787801099,1.0,4/16,21.70%,TIMP3;GJA1;CALD1;SPARC
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.44168919523127825,-0.7772740451762364,0.75,0.9483288556612799,1.0,6/18,22.79%,ATP2B1;EPS8;MSN;MYO1E;CAPZA2;DNAJC5
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,-0.5154786571957869,-0.7771382047833308,0.8064516129032258,0.9481479134578013,1.0,2/5,27.22%,SMAD3;ACVR2A
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3482769261784201,-0.7771121332249742,0.9010989010989011,0.9478717751178801,1.0,10/79,10.73%,NPLOC4;RPS27A;NDFIP1;RNF19A;FEM1C;PRKN;UBC;ARIH2;HERPUD1;CHFR
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.42481194719908444,-0.7769020217979616,0.7951807228915663,0.9478357736894868,1.0,13/26,28.05%,LDHA;SERPINB6;CEBPZ;TMSB4X;SDCBP;MYL6;IFITM3;CYSTM1;ANXA3;RPS14;CARHSP1;LAMA4;TPM4
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.446049855403898,0.7766340631063298,0.7575757575757576,1.0,1.0,1/6,4.94%,GNB4
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.4095196958945787,-0.7764524369863224,0.8441558441558441,0.9481772665676962,1.0,13/28,26.06%,SYNJ2;PLCG2;INPP5D;PIK3C3;PIP5K1C;MTMR2;PIKFYVE;PIK3CB;MTMR6;SACM1L;MTM1;INPP5F;SYNJ1
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,-0.4240595869706493,-0.7763536635250807,0.7792207792207793,0.9480036519353509,1.0,6/18,20.05%,ACTN1;TACC1;PTMA;AMD1;ADAM15;GADD45B
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4801182900950388,-0.7758888831741786,0.8142857142857143,0.9482391114276384,1.0,2/11,19.42%,SDCBP;EGFR
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.38894255911020525,-0.7757051250470501,0.8148148148148148,0.9482065645371216,1.0,7/32,12.75%,NFASC;GRIA2;GPM6B;TMEM132C;S1PR1;GJA1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.32522048498508127,0.7750245967936854,0.875,1.0,1.0,5/21,11.42%,OCLN;EVL;CLASP1;CARMIL1;CLIP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5289651501998243,-0.774443809326339,0.7846153846153846,0.9496362310401455,1.0,3/6,39.73%,RPS19;ETS1;ACTN4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.42975198886364996,-0.7743391847468286,0.8194444444444444,0.9491689129364907,1.0,4/17,19.76%,IFNGR1;PLCG2;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.42975198886364996,-0.7743391847468286,0.8194444444444444,0.9491689129364907,1.0,4/17,19.76%,IFNGR1;PLCG2;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3810730245277003,-0.7740793091807694,0.7469879518072289,0.9493085985319726,1.0,10/36,14.61%,ITPR1;SYTL4;RAPGEF3;SLC2A1;RAP1A;ENSA;GOLPH3;STXBP5L;TMED10;CACNA1C
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.4563969708029711,-0.7738949236948214,0.759493670886076,0.9492757681926743,1.0,3/16,21.49%,PBRM1;SMARCC1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.2990812803768057,0.7738255479817513,0.8823529411764706,1.0,1.0,5/36,11.47%,CPEB3;LARP4B;SLC25A37;CIRBP;SAMD4A
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.43738893325535655,-0.7734359735260258,0.7945205479452054,0.9495771542581555,1.0,4/16,14.50%,PNP;CD81;ANXA1;NCK1
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.3802043779499266,-0.7720219601191909,0.8426966292134831,0.9510810813522163,1.0,13/53,20.56%,SEC22B;SEC24D;MGAT4A;ANK2;CD55;RAB1A;COPA;B4GALT1;ANK3;USO1;DYNC1I2;CSNK1D;CAPZA2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.4397773517313648,0.7719015813604718,0.7631578947368421,1.0,1.0,1/7,4.04%,RAB11FIP2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.49198354356948043,0.7715045991564824,0.6785714285714286,1.0,1.0,2/7,5.79%,RSAD2;MFHAS1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5130641872100409,-0.7713050551110748,0.7903225806451613,0.9515926546098282,1.0,1/6,11.02%,FGFR1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.36721912849462096,-0.7713039568761535,0.8271604938271605,0.9512955604310552,1.0,8/47,14.61%,CDKN1B;ERBB4;FOXF1;DLC1;ZFPM2;MEF2A;CDKN1A;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4190448888846744,0.7711357694271751,0.723404255319149,1.0,1.0,2/9,4.22%,RALA;MFF
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.3695977532862497,-0.7711301660785698,0.8409090909090909,0.9512691880939255,1.0,13/56,19.42%,GRK5;FES;ERBB4;FLT1;SIK2;FGFR1;PAK2;TEC;PINK1;VRK2;MTOR;PIKFYVE;EGFR
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.48573133870861407,0.7707126678001873,0.7083333333333334,1.0,1.0,3/6,20.77%,MBOAT2;SOX5;TRPS1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.4501607228302418,0.7703944753551919,0.7297297297297297,1.0,1.0,1/6,1.97%,ACAT1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.48031562957843343,-0.7695187977360537,0.76,0.9529463284443146,1.0,4/9,26.93%,TMBIM6;PTBP2;PTBP1;SRSF7
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.36392206717220804,-0.7691692837845592,0.8539325842696629,0.9530563971037792,1.0,17/68,20.29%,CX3CL1;RAPGEF3;RAP1A;TBC1D15;TGM2;AFDN;LIMS1;RSU1;RGS7;LARS1;RACK1;PICALM;ARHGAP29;ITGB1;TBC1D9;ECT2;CAV2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.5027116877414892,-0.7691641494352849,0.8656716417910447,0.952762727233954,1.0,1/5,8.34%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.44883469880183036,-0.7691133255994652,0.7297297297297297,0.9525324038672737,1.0,5/12,29.91%,PIAS2;ZNF366;CALR;NCOR2;SMARCA4
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.42872719252671543,0.7688369627440941,0.8,1.0,1.0,1/10,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4960628912268783,-0.7687823581605676,0.8064516129032258,0.9527722940686112,1.0,1/8,1.27%,ADAMTS9
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.44723844960597986,-0.7686401763935526,0.7948717948717948,0.9526367973198188,1.0,4/18,16.39%,PBRM1;SMARCA1;MBD2;SMARCC1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.48930157414912223,-0.7682465532061666,0.8253968253968254,0.9528835171926898,1.0,1/8,6.75%,ARF1
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.33170618290572695,0.7682418563800896,0.76,1.0,1.0,4/24,8.47%,ARNT2;MIA3;NCOA2;SLC38A3
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,-0.45163488757692344,-0.7679860769830511,0.8333333333333334,0.9529513432943699,1.0,2/12,8.45%,LRRC32;TNS1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.42776417761644175,-0.767892805566615,0.7777777777777778,0.9527808811535052,1.0,5/13,23.82%,CD55;MALT1;B2M;ZBTB1;HLA-B
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.49409769222784483,-0.7676488011562326,0.819672131147541,0.9528206767596148,1.0,2/6,27.17%,CLTA;FZD4
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.4611656860421851,-0.7675949332522276,0.803030303030303,0.9525943382883049,1.0,3/9,19.04%,MYL6;MYH10;MYL12B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.37545632261617234,-0.7675460840345314,0.7804878048780488,0.952343638126982,1.0,12/36,23.77%,HIF1A;TMSB4X;FGFR1;BCAR1;GATA2;SCARB1;PIK3CB;ATOH8;SASH1;SPARC;ANXA3;CALR
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4645926543848018,-0.7669612838861474,0.821917808219178,0.9526809697744575,1.0,5/11,32.14%,DAG1;ADAM9;SPPL3;BACE2;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.4632339361941922,0.766350897389106,0.75,1.0,1.0,2/7,15.80%,SEMA6A;ZNF609
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.49337003717565564,-0.7662148298540391,0.8461538461538461,0.95336091284053,1.0,3/8,23.59%,RAB14;PIKFYVE;ATP6V1E1
prerank,KEGG_2021_Human__Oocyte meiosis,-0.37960156809271756,-0.7658794719639883,0.8333333333333334,0.9534983848922376,1.0,8/40,25.07%,ITPR1;CPEB4;SMC3;PPP3CC;ADCY2;CUL1;RPS6KA2;CAMK2D
prerank,KEGG_2021_Human__Protein export,-0.49413405345307637,-0.7652529647479368,0.8,0.9539958597039174,1.0,1/7,3.85%,HSPA5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4616457953370958,-0.7651633683162227,0.8305084745762712,0.9538289915727678,1.0,2/11,9.99%,SMAD7;AFDN
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,-0.38206055859935695,-0.7650816204512748,0.8395061728395061,0.9536237948773533,1.0,9/44,15.80%,CX3CL1;ENPP2;NFASC;PTPRD;TMEM132C;VWF;PLP1;CACNA1C;SGIP1
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.4517825817440599,0.7644272020348171,0.7714285714285715,1.0,1.0,1/7,0.13%,THSD1
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.4517825817440599,0.7644272020348171,0.7714285714285715,1.0,1.0,1/7,0.13%,THSD1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.4574901805330499,0.7643699923435098,0.8378378378378378,1.0,1.0,2/5,29.14%,NRP2;NF1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.4197733464375888,0.7640735294147739,0.84375,1.0,1.0,7/10,25.58%,ZSWIM5;ZSWIM6;STX3;PPM1F;PDGFB;USP14;PTPN2
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.3822857532525142,0.7639270055405293,0.7647058823529411,1.0,1.0,5/15,12.88%,UIMC1;HERC2;ABL1;ATM;BABAM2
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.3822857532525142,0.7639270055405293,0.7647058823529411,1.0,1.0,5/15,12.88%,UIMC1;HERC2;ABL1;ATM;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.41158244345151773,0.7634952367462498,0.7941176470588235,1.0,1.0,3/10,11.42%,OCLN;CLASP1;CLIP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.38100672488673604,0.7634129548935993,0.7727272727272727,1.0,1.0,2/12,4.22%,RALA;MFF
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.46577448469497446,-0.7631464279973096,0.7692307692307693,0.9558357066520655,1.0,5/10,19.73%,TMBIM6;CPEB4;LARS1;MTOR;SPAAR
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3368488321982002,-0.7625896273417736,0.782608695652174,0.9562829559783065,1.0,13/87,13.89%,PPP1R9A;RPS27A;ACTN1;COL18A1;HIP1R;TPM1;PRKN;UBC;PLOD2;MYO1B;PLEC;CST3;BCAR1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.413038840663572,-0.7619853542409543,0.8082191780821918,0.9568660606099019,1.0,5/17,22.42%,PECAM1;MCL1;GATA2;CD34;PODXL
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.2887288546319062,0.7619043730688758,0.9166666666666666,1.0,1.0,7/58,10.23%,EXOC5;RTTN;OFD1;WDPCP;RFX3;TTC17;PARVA
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3911959793134486,-0.761666010012187,0.7875,0.9569253788510765,1.0,4/24,13.71%,NEDD9;RREB1;LIMS1;CASS4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.39638609359582033,-0.7615608453600823,0.7901234567901234,0.9567614015827142,1.0,7/23,21.70%,MSRB3;ADAMTS1;DLC1;GJA1;CALD1;HMCN1;SPARC
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.38241991297245664,-0.7615076561451799,0.7931034482758621,0.9565103424804501,1.0,11/43,20.56%,SEC22B;SEC24D;ANK2;CD55;RAB1A;COPA;ANK3;USO1;DYNC1I2;CSNK1D;CAPZA2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3993184576546995,-0.761438107394401,0.8372093023255814,0.9563187052536822,1.0,4/28,14.53%,HIP1R;PRKN;CLDN5;AMFR
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.45100587311696766,-0.7614270602125527,0.8055555555555556,0.9560400572405617,1.0,3/10,10.25%,CX3CL1;ANXA1;S1PR1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3339027518960285,0.7614106959048118,0.75,1.0,1.0,4/23,10.94%,THOC1;TENT2;SCAF8;RPRD1A
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.4719817466976113,-0.7613505291719054,0.8260869565217391,0.955813843199787,1.0,4/11,26.59%,CNOT6L;CNOT8;TUT7;PABPC1
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.43182236640289834,-0.7603441715387507,0.7808219178082192,0.9566431245718451,1.0,1/12,3.48%,RAB11FIP3
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.38559881327136214,-0.76018927260454,0.8888888888888888,0.9566397083453431,1.0,7/46,16.39%,BAZ1A;PBRM1;HMGN1;SMARCA1;NPM1;CHD1;SMARCC1
prerank,KEGG_2021_Human__Pancreatic secretion,-0.40271871115017166,-0.7599721781385224,0.8571428571428571,0.9565597151527946,1.0,4/26,11.85%,ITPR1;ATP2B1;RAP1A;ATP1B3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.4990255092859893,-0.7599055103798605,0.7796610169491526,0.9560763565098762,1.0,4/5,25.74%,ZDHHC6;ZDHHC21;ZDHHC14;ZDHHC20
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.4990255092859893,-0.7599055103798605,0.7796610169491526,0.9560763565098762,1.0,4/5,25.74%,ZDHHC6;ZDHHC21;ZDHHC14;ZDHHC20
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.45848910910903506,-0.7598784547782385,0.7910447761194029,0.9558122965051388,1.0,4/9,25.29%,PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.41145716112631076,-0.759508545683327,0.8412698412698413,0.9559968767691382,1.0,8/21,30.36%,ARIH2;PPP3CC;SREBF2;PINK1;MAPK8;UBE2D3;NPEPPS;MICALL2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.3706760350361644,-0.7593612732141252,0.8674698795180723,0.9559067790455043,1.0,10/42,13.89%,MAP1B;NES;NFASC;SMARCA1;ANK2;SHC2;EPAS1;GJA1;DCLK1;BCAR1
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.49438181722825836,-0.7590288115014111,0.859375,0.9560321510499847,1.0,2/6,15.33%,GGT5;SULT1C4
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4175722577227336,-0.7579020638736073,0.8289473684210527,0.9571473501941864,1.0,3/19,11.02%,PIK3R1;FLT1;FGFR1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.43004085587563,0.7573271913497529,0.7027027027027027,1.0,1.0,1/6,1.20%,GCNT2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.38766380492939534,0.7571476468228994,0.8055555555555556,1.0,1.0,1/8,1.22%,UGCG
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.5119345868550229,-0.757144793025215,0.8548387096774194,0.9579736623124766,1.0,3/6,35.17%,AGO2;DDX3X;DHX36
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,-0.4111037138576194,-0.7571040688085549,0.8484848484848485,0.9577095058088878,1.0,7/25,19.60%,KIAA1217;LAMA5;MYO1B;BCAR1;DAG1;EGFR;EMP2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3358074933719496,0.7567023157872373,0.6666666666666666,1.0,1.0,7/17,16.84%,MGMT;ERCC6;SLF2;KMT5B;SPIDR;SHLD2;PARP9
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.5058757950102827,-0.7563087916986813,0.8088235294117647,0.9584240908105788,1.0,2/5,22.39%,PNP;NAMPT
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.48961202911544843,-0.756259621488982,0.8208955223880597,0.9578925205506135,1.0,2/6,20.64%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.48961202911544843,-0.756259621488982,0.8208955223880597,0.9578925205506135,1.0,2/6,20.64%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4699573247869214,-0.756236344270582,0.7540983606557377,0.9576217805911043,1.0,2/5,12.99%,PLCG2;NPM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3882772562400076,-0.7561309364907361,0.8780487804878049,0.9574759784285825,1.0,10/28,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,-0.3947236542442031,-0.7560172928675865,0.8356164383561644,0.9573025476442466,1.0,5/28,6.64%,LDHA;ZEB2;HES1;APOLD1;SPC25
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.4356369105507896,0.7549039039680981,0.696969696969697,1.0,1.0,2/7,13.07%,ATP2A2;ST3GAL6
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.37323489214714234,0.7546169282270586,0.8148148148148148,1.0,1.0,3/17,10.36%,MLLT3;CDK12;RTF1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.37323489214714234,0.7546169282270586,0.8148148148148148,1.0,1.0,3/17,10.36%,MLLT3;CDK12;RTF1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.34904121519291037,0.7541380874448084,0.8214285714285714,1.0,1.0,3/20,5.47%,BMP6;TTN;WLS
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4833385317628774,-0.7541180612242433,0.8787878787878788,0.9592559541985429,1.0,3/7,24.04%,TIMP3;ADAM9;SNX9
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.41617694720783494,0.7541064640383904,0.8125,1.0,1.0,3/12,8.34%,THSD1;C1GALT1;ADAMTS6
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.3695788420833911,0.7540883843603876,0.8181818181818182,1.0,1.0,2/10,5.47%,HOMER1;WLS
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.4113323047297741,0.7540506187810158,0.7941176470588235,1.0,1.0,1/10,1.83%,PIGU
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,-0.46414137335858696,-0.7538066184043888,0.8194444444444444,0.9591056291409213,1.0,2/10,7.12%,TINAGL1;SLC52A3
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,-0.46414137335858696,-0.7538066184043888,0.8194444444444444,0.9591056291409213,1.0,2/10,7.12%,TINAGL1;SLC52A3
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.5171418673698778,-0.753805201209369,0.8823529411764706,0.9588107918740474,1.0,2/6,6.37%,SCP2;LSS
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4196131822885299,-0.7537875884870119,0.8382352941176471,0.9585368926594116,1.0,5/16,15.72%,ATG12;RB1CC1;GABARAPL1;RAB1A;PIK3C3
prerank,KEGG_2021_Human__Arginine and proline metabolism,-0.4539971275522421,-0.7535761444029843,0.8305084745762712,0.9584291654195912,1.0,3/8,28.10%,AMD1;LAP3;P4HA1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.32567760182362415,0.7531240858707082,0.8620689655172413,1.0,1.0,4/26,9.80%,OCLN;LIMS2;OPHN1;SDK1
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,-0.44131292041160713,-0.7530151187019063,0.8387096774193549,0.9588228197884441,1.0,3/11,14.16%,SCP2;PEBP1;PLPP1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3999988604995966,0.7527848226621733,0.6451612903225806,1.0,1.0,2/6,13.47%,SFSWAP;RBMX
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3999988604995966,0.7527848226621733,0.6451612903225806,1.0,1.0,2/6,13.47%,SFSWAP;RBMX
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.3880859057479693,-0.7527008926805565,0.7647058823529411,0.9588844289414763,1.0,6/23,16.10%,CHPT1;LPGAT1;DGKG;PLPP1;LPIN2;AGPAT4
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5211859593760579,-0.7524057892169876,0.8709677419354839,0.9589701868525559,1.0,1/5,2.79%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.3619658696448027,0.7523776389396605,0.7333333333333333,1.0,1.0,3/10,12.30%,ABL1;TEK;ROCK1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.38109429857249477,-0.7522128676444625,0.8375,0.9589246338554831,1.0,6/30,13.78%,PPARG;TIMP3;FOXF1;SLC8A1;GJA1;PLSCR4
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,-0.4626718243429806,-0.7512753432934438,0.7538461538461538,0.9597216665953026,1.0,1/6,5.87%,JAK1
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,-0.36233160722164925,-0.7511858313285944,0.9259259259259259,0.9594895005651745,1.0,17/55,20.11%,APOLD1;LRRC32;FLT1;PECAM1;JAG2;VWF;HYAL2;CLDN5;INPP5D;EGFL7;TIE1;ARHGAP29;TFPI;ACVRL1;CD34;HMCN1;DIPK2B
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,-0.403644761030596,-0.7511020460477167,0.8591549295774648,0.959333398628458,1.0,11/25,18.70%,ADAMTS9;GPC5;ADAMTS1;SLC26A2;ALG11;EGFL7;NOTCH4;B4GALT1;CHSY1;DAG1;PMM2
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.4474464966068554,-0.7503193049795535,0.7611940298507462,0.9600640246168476,1.0,1/10,3.48%,RAB11FIP3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.3607752495623213,-0.7501881966599487,0.8295454545454546,0.9599043934384788,1.0,9/45,18.83%,CDKN1B;ERBB4;FOXF1;ZFPM2;MEF2A;CDKN1A;CACNA1C;NOTCH4;ACVRL1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,-0.3812705710893406,-0.7500675894735834,0.8311688311688312,0.959737964408106,1.0,7/33,10.62%,GPM6B;MGAT4A;GAS7;TMEM132C;NCALD;PPP2R2B;DPP10
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.34555697128538776,0.7492623637347703,0.7777777777777778,1.0,1.0,1/15,2.52%,MSL2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.39896550556889515,-0.7488010744127802,0.8194444444444444,0.961046851414511,1.0,2/28,4.41%,TAF1D;PPM1D
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.4752936555021362,-0.748717754892238,0.8208955223880597,0.9608767288657755,1.0,2/9,30.65%,PTBP1;POLR2B
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.44760532071481546,-0.7486521348712836,0.8,0.9606515959902039,1.0,4/8,30.04%,KPNB1;NUP54;TNPO1;NUP98
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,-0.4280282944734047,-0.7480776347851116,0.8309859154929577,0.9610464486420818,1.0,4/16,19.15%,TIMP3;GJA1;CALD1;BOC
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.36134635310041757,-0.747947795751688,0.7887323943661971,0.9609005801124423,1.0,6/24,16.81%,RAPGEF3;PRKN;CST3;CDK6;PINK1;NOTCH4
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.4631178522043408,-0.7477709044032617,0.7878787878787878,0.9608167476511019,1.0,2/8,18.83%,TMEFF2;ACVRL1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5086963198575145,-0.7477327886526323,0.8472222222222222,0.9605747061232818,1.0,1/5,3.93%,SCP2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3036755064347275,0.7475021590418315,0.9310344827586207,1.0,1.0,4/21,15.64%,THOC1;TENT2;RPRD1A;PNPT1
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.38202744786354137,-0.7471526191232254,0.7682926829268293,0.9609381451968174,1.0,4/29,13.86%,RPS27A;UBC;PRNP;ACOX1
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,-0.3494480320503702,-0.7469916950312422,0.9111111111111111,0.9608406247189836,1.0,16/60,28.34%,CD99L2;SIK2;SUGP2;PAFAH1B1;TRIM9;PIKFYVE;MECP2;SPEN;CDS2;TF;NR2C2;MAPK8IP3;FAM219A;SYNJ1;DYNC1H1;SIK3
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,-0.3646129900068814,-0.7469266541281558,0.8255813953488372,0.9603227557452534,1.0,11/37,17.29%,ENPP2;GPM6B;PTPRD;FLT1;TMEM132C;ARMCX4;ADGRL3;PLP1;CACNA1C;SGIP1;ROBO2
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,-0.3646129900068814,-0.7469266541281558,0.8255813953488372,0.9603227557452534,1.0,11/37,17.29%,ENPP2;GPM6B;PTPRD;FLT1;TMEM132C;ARMCX4;ADGRL3;PLP1;CACNA1C;SGIP1;ROBO2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.4391883276214509,-0.7463964497139081,0.855072463768116,0.9608094949954079,1.0,1/12,4.46%,KDM1A
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.3649401777738734,-0.7463159357519747,0.8850574712643678,0.9606159767274629,1.0,15/49,20.35%,ACTN1;PIK3R1;MAGI2;AFDN;LIMS1;PLEC;CLDN5;PARVB;RSU1;NCK1;CADM2;CTNNA1;ITGB1;GRB2;PIK3CB
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.3716527173304577,-0.7463075470380535,0.8076923076923077,0.9603333159763184,1.0,8/30,31.98%,CSTF3;ZFP36;DCP2;USP39;PTBP1;SRSF7;SFPQ;HIPK3
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.4516061621131655,-0.7462215763338061,0.7727272727272727,0.9601572211347239,1.0,3/7,16.63%,ESYT2;ARSG;EGFL7
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.395413724470247,-0.7455636673531933,0.8260869565217391,0.9607223305289907,1.0,4/24,11.02%,HIF1A;ANXA1;TMSB4X;FGFR1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.4145444460554317,-0.7452658207481131,0.8888888888888888,0.9607383021564164,1.0,4/18,13.39%,SLC20A2;SLC8A1;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5061470895542761,-0.7451128322868183,0.8,0.9606205364089792,1.0,1/6,23.43%,AGO2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.47891897151923185,-0.745055136497074,0.873015873015873,0.9604000062870742,1.0,2/10,8.26%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.4441289174531691,-0.7450516592581778,0.7910447761194029,0.9601076470766368,1.0,2/9,9.11%,JAG2;ANXA1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4260314835950379,0.744457680086569,0.7948717948717948,1.0,1.0,1/9,1.22%,UGCG
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.47844245529777035,-0.7442496014892955,0.7868852459016393,0.9601081035699284,1.0,1/6,14.08%,TNFRSF10B
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,-0.47844245529777035,-0.7442496014892955,0.7868852459016393,0.9601081035699284,1.0,1/6,14.08%,TNFRSF10B
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,-0.47844245529777035,-0.7442496014892955,0.7868852459016393,0.9601081035699284,1.0,1/6,14.08%,TNFRSF10B
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4656356731337207,-0.7440133915562864,0.8285714285714286,0.9600900013693877,1.0,3/9,9.93%,BCAP31;HERPUD1;TGM2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.49388465370845985,-0.7439680182313453,0.8870967741935484,0.9598597698316913,1.0,1/6,4.46%,KDM1A
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.436577179530731,-0.7439210914316604,0.8571428571428571,0.9596023135800709,1.0,1/12,4.46%,KDM1A
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.4766321509414885,-0.7439124138463113,0.8,0.9593142378847472,1.0,2/8,8.55%,PACS1;AP1G1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.42027954589127176,0.7434252766770735,0.8571428571428571,1.0,1.0,3/9,8.45%,THOC1;ERCC6;SCAF8
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.3555127217128017,-0.7432373957460596,0.875,0.9598570329525852,1.0,8/40,12.93%,HES1;PECAM1;VWF;CLEC2B;DLC1;EFNB2;BTNL9;DUSP5
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.3132219351261421,0.7428643500926884,0.8947368421052632,1.0,1.0,4/42,3.03%,GBP2;PKHD1L1;PTPN21;IGFBP3
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.3152018027680427,0.7421726534094097,0.8571428571428571,1.0,1.0,3/26,9.06%,BET1;COG3;COG6
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.4243247867932649,0.7419869900564791,0.7567567567567568,1.0,1.0,1/8,1.83%,PIGU
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.4243247867932649,0.7419869900564791,0.7567567567567568,1.0,1.0,1/8,1.83%,PIGU
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.4243247867932649,0.7419869900564791,0.7567567567567568,1.0,1.0,1/8,1.83%,PIGU
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.46215780948187496,-0.7413626670525638,0.819672131147541,0.9617596489040515,1.0,1/6,5.05%,SPG7
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4078303025324951,-0.7411952376178016,0.8311688311688312,0.9617069141760816,1.0,8/19,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3834542883085789,0.7410045335133334,0.775,1.0,1.0,2/6,10.60%,MFF;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.3834542883085789,0.7410045335133334,0.775,1.0,1.0,2/6,10.60%,MFF;CEMIP
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.44957186420136885,-0.7407151758566077,0.7916666666666666,0.9620947967234806,1.0,1/10,13.07%,NFKBIA
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4605486443366975,-0.7407092613932794,0.8571428571428571,0.9618064019184615,1.0,3/14,10.49%,FOS;PECAM1;ITGB5
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.48662809055405537,-0.7393326777417498,0.8153846153846154,0.9632589744642022,1.0,2/7,20.27%,CACNA1C;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4226588727056221,-0.7392610176049654,0.8115942028985508,0.9631034806807925,1.0,7/15,40.05%,RIOK3;PPM1A;DAB2IP;OTUD7B;TANK;TNIP1;CARD8
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2874241949883376,0.7391974568297537,0.95,1.0,1.0,1/28,0.80%,TPD52L1
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.3489793742412815,-0.739114744753832,0.8953488372093024,0.962937847386426,1.0,7/65,9.40%,RFC3;NPLOC4;RPS27A;WDR48;HMGN1;UBC;CCNH
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.430272398904837,0.7390540594801187,0.7941176470588235,1.0,1.0,1/8,1.83%,PIGU
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.42251840596438195,-0.7388827519969864,0.8611111111111112,0.9628712107231593,1.0,1/16,2.20%,GLUD1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.424161788185205,0.7385855780305816,0.7142857142857143,1.0,1.0,7/7,57.66%,CDC73;HUWE1;UBE2E1;WAC;USP22;UBR2;UBE2B
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.4446493790398688,-0.7385070359932053,0.7096774193548387,0.96306371238243,1.0,1/5,4.46%,KDM1A
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.39734370433624855,-0.7376026277240737,0.8285714285714286,0.9637639120611804,1.0,5/17,18.67%,TGM2;DYSF;RACK1;GATA2;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.4607787968207427,-0.7375999606657825,0.8208955223880597,0.9634756230819169,1.0,2/8,18.73%,MCL1;ITGB1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.43997535667245957,0.7375280977766648,0.75,1.0,1.0,2/5,20.90%,ARHGAP35;PIK3CA
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4134981516135933,-0.7375166835041386,0.8055555555555556,0.9632726607871712,1.0,9/21,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;CTNNA1;DLG1;ECT2;CDH5
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.4402659781951732,-0.7373537082221666,0.7857142857142857,0.9631821882188505,1.0,2/8,17.45%,PECAM1;LCP2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.42081375466455023,-0.7373265862372552,0.8472222222222222,0.9629113568185573,1.0,8/17,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.4063934545065634,-0.7373219341002014,0.8133333333333334,0.9623293614381896,1.0,3/18,8.84%,RFC3;RPS27A;UBC
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.4063934545065634,-0.7373219341002014,0.8133333333333334,0.9623293614381896,1.0,3/18,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3841192485617525,-0.7372203313338674,0.8395061728395061,0.9621134482597029,1.0,6/28,15.27%,DMD;PRKN;PRNP;ENSA;ARPP19;WWTR1
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.3582050284127969,0.7365645360932094,0.8666666666666667,1.0,1.0,1/27,0.08%,MMRN1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3593132148000942,0.735763945900862,0.8947368421052632,1.0,1.0,1/19,2.05%,ALS2
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.42777289353427683,0.7355290011662278,0.8235294117647058,1.0,1.0,2/7,12.46%,CDKAL1;TRMT11
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.4295697989571743,0.733725501017086,0.8214285714285714,1.0,1.0,4/8,8.37%,RALA;MFF;HSPD1;FBXO7
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4180729821370961,0.7336005267411237,0.7631578947368421,1.0,1.0,1/6,10.73%,ATP6V1H
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.38621676705284447,-0.7333242466528235,0.8356164383561644,0.966579350957383,1.0,4/19,17.34%,IPO7;TPR;PTTG1IP;KPNB1
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.42892263342405323,0.7332021955616111,0.8,1.0,1.0,1/7,1.83%,PIGU
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.42892263342405323,0.7332021955616111,0.8,1.0,1.0,1/7,1.83%,PIGU
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,-0.3250096111941938,-0.7331412762419207,0.9489795918367347,0.9664812461113118,1.0,52/226,22.50%,SEC22B;TSG101;PRKAG2;DENND3;SEC24D;SCARB2;RPS27A;DENND2C;ANK2;HIP1R;SCARF1;AP1G1;TBC1D15;UBC;CD55;RAB21;DLC1;KIF16B;ARPC2;SYNJ2;GJA1;RAB1A;SH3KBP1;SYT1;COPA;TMF1;ACBD3;PAFAH1B1;SH3GL1;RAB8B;SGIP1;RAB30;PICALM;RAB14;HSPH1;PIP5K1C;MYO1E;ANK3;SCARB1;GRB2;USO1;CHMP4B;EGFR;DYNC1I2;CSNK1D;CAPZA2;KLC1;SPARC;FTL;CLTA;VPS37A;DNM2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.43997203496178305,-0.7330494718134697,0.8484848484848485,0.9663050496094812,1.0,3/10,17.88%,EEF1A1;RACK1;MRPL33
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",-0.46708212137890265,-0.7329275835235365,0.8571428571428571,0.9661833088669148,1.0,3/7,29.93%,BCAR1;CRK;RHOA
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,-0.46378916612708276,-0.7326272205178878,0.8461538461538461,0.966194078332465,1.0,4/10,19.42%,CDC37;PIK3R1;GRB2;EGFR
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.45953838756576093,-0.7326022292125148,0.8507462686567164,0.9659128893383131,1.0,1/6,4.09%,ABCA5
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.3880779475464816,-0.7322290087800302,0.7894736842105263,0.9660662720425558,1.0,7/16,19.18%,PNP;ANXA1;PRNP;ZFP36;PLCG2;MALT1;CD34
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.42173247105050793,-0.7321461754216355,0.835820895522388,0.9658463604524503,1.0,5/14,22.36%,GRIN2B;SOD2;CBR4;RYR3;B2M
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.46130766193070194,-0.7319117045175139,0.8169014084507042,0.9658233012421352,1.0,5/8,36.41%,ACER2;PDE4B;REST;TFRC;MEF2C
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.46150805351556995,0.7316166515551003,0.6666666666666666,1.0,1.0,2/5,17.58%,BDP1;SNAPC3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.3783050624121783,0.7312628012608126,0.95,1.0,1.0,3/15,10.28%,USP25;OPHN1;PSMF1
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.2700313459451865,0.7311196660951166,1.0,1.0,1.0,3/56,8.61%,CWC27;WBP4;DDX42
prerank,KEGG_2021_Human__Adherens junction,-0.37665432916539765,-0.7308249248521376,0.8536585365853658,0.9668683264774565,1.0,7/42,19.42%,ACTN1;AFDN;FGFR1;CTNNA3;SMAD3;CTNNA1;EGFR
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3778425416839646,0.7307667803893363,0.7941176470588235,1.0,1.0,1/10,2.15%,HOMER2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.4726024136623231,-0.7306951170580763,0.7878787878787878,0.9666992172206722,1.0,2/7,33.41%,AGO2;PRKRA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4299161523412934,0.7306742176896891,0.7631578947368421,1.0,1.0,2/7,10.44%,PRKD1;TEK
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,-0.39318411015593935,-0.730627500682601,0.8055555555555556,0.9664997118462897,1.0,5/17,19.18%,ZEB2;PECAM1;SH2D3C;LCP2;CD34
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.43203442030778644,-0.7300120527481533,0.863013698630137,0.9668186353225565,1.0,5/16,23.93%,ZC3H7A;ZFP36;NOTCH4;AGO2;CNOT8
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.46665618646898127,-0.7296546969584136,0.8666666666666667,0.9670459281699202,1.0,2/8,12.14%,KLF6;DCLK1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.37564593385136924,0.7293357204713635,0.84,1.0,1.0,4/17,9.19%,TBL1X;HDAC9;BAZ2A;TBL1XR1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.39672569158879756,0.7293078698629826,0.7317073170731707,1.0,1.0,1/7,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.39672569158879756,0.7293078698629826,0.7317073170731707,1.0,1.0,1/7,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.4314476135751908,0.7290818383794851,0.7906976744186046,1.0,1.0,1/5,6.06%,ATF7IP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4314476135751908,0.7290818383794851,0.7906976744186046,1.0,1.0,1/5,6.06%,ATF7IP
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4473228634077645,-0.7286778941317282,0.7866666666666666,0.9679028061557003,1.0,4/11,14.56%,CX3CL1;BCL2L14;TMBIM6;CYLD
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.3517521937590956,0.7286168322270031,0.8235294117647058,1.0,1.0,3/11,13.07%,GMDS;ST3GAL1;ST3GAL6
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.42803965250822273,0.727120144160206,0.8611111111111112,1.0,1.0,1/6,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.4600731377932143,-0.7268034898271415,0.890625,0.9697880822517624,1.0,2/5,19.31%,TPR;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.357289158187477,0.726310670314939,0.8928571428571429,1.0,1.0,2/13,5.47%,HOMER1;WLS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.4431634112516516,-0.7259569562963016,0.8507462686567164,0.9703187985696006,1.0,1/10,2.60%,BCAP31
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.4497672584358116,-0.7259429463549764,0.7857142857142857,0.9700441491778653,1.0,2/7,17.45%,PECAM1;LCP2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4027995643527256,-0.725897691534274,0.8148148148148148,0.9697967170571972,1.0,12/20,25.74%,TRAM1;ZDHHC6;SDCBP;RAB8B;ZDHHC21;PIKFYVE;CHMP4B;ZDHHC14;VPS37A;SEC62;CHM;ZDHHC20
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.4001715744024341,-0.7255152922370773,0.8571428571428571,0.9698976268871163,1.0,5/19,15.72%,ATG12;RB1CC1;GABARAPL1;RAB1A;PIK3C3
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,-0.4022645251236432,-0.725393905748961,0.8450704225352113,0.9697416338988571,1.0,6/17,26.77%,TIMP3;TPM1;CALD1;SPARC;TNS2;LAMA4
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.4464958376199049,0.7250986027144829,0.8235294117647058,1.0,1.0,1/5,2.05%,ALS2
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.4171455716133952,-0.7249599678241245,0.8,0.9699269619094097,1.0,2/14,8.84%,RPS27A;UBC
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.32817975495713353,0.7248544786387952,0.9090909090909091,1.0,1.0,2/18,3.43%,ATP2A2;ATP10D
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3498778722256174,-0.7248057810116078,0.9431818181818182,0.9698082059512371,1.0,13/54,22.60%,TIMP3;GGT5;REL;CALCOCO2;ANXA1;IL1RAPL1;SMAD3;MCL1;TBK1;IL18R1;IFITM3;ADAM9;MAPK8
prerank,KEGG_2021_Human__Cushing syndrome,-0.3541701124166205,-0.7246313773435177,0.8777777777777778,0.9696928976944714,1.0,14/45,20.27%,ITPR1;NR4A1;WNT2B;CDKN1B;RAP1A;CDKN1A;CACNA1C;CREB3L2;CDK6;ATF2;KMT2A;SCARB1;EGFR;GNAI3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.44058828460990707,-0.7246197845507002,0.8529411764705882,0.9694156370049977,1.0,2/9,18.73%,MCL1;ITGB1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.3585914827112216,-0.7242865283238571,0.8214285714285714,0.9692293176466676,1.0,5/45,9.46%,ADAMTS9;CX3CL1;PTPRD;TMEM132C;VWF
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.3585914827112216,-0.7242865283238571,0.8214285714285714,0.9692293176466676,1.0,5/45,9.46%,ADAMTS9;CX3CL1;PTPRD;TMEM132C;VWF
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.44359078198034174,-0.7240851347899702,0.8333333333333334,0.9691514175659521,1.0,2/12,8.55%,PACS1;AP1G1
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.3637902664561774,0.7238629600960497,0.7857142857142857,1.0,1.0,1/9,4.94%,GNB4
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.37689107996932203,-0.7237712242215883,0.8987341772151899,0.9691207638297141,1.0,1/33,1.04%,ITPR1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.46464222229925795,-0.7234908969050696,0.8095238095238095,0.9691339436045378,1.0,1/7,14.08%,TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3735975976288632,-0.723379284342157,0.85,0.9689617991617112,1.0,5/26,15.27%,CDKN1B;PRKN;PRNP;CDKN1A;WWTR1
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.396864100540267,-0.7233386601246959,0.8518518518518519,0.968719021766405,1.0,3/20,17.34%,SEC24D;SREBF2;KPNB1
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.40335394633710175,-0.7229878073401312,0.8658536585365854,0.968819861559681,1.0,2/17,7.68%,NFKBIZ;REL
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.33180646650514106,0.7229007449805125,0.7857142857142857,1.0,1.0,2/13,13.09%,RALA;PDCD4
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.49118409855118567,-0.7228998530734088,0.819672131147541,0.968388672847626,1.0,2/6,22.68%,GNAI3;MFN1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.49118409855118567,-0.7228998530734088,0.819672131147541,0.968388672847626,1.0,2/6,22.68%,GNAI3;MFN1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.4255722410858338,0.7226690321728209,0.8064516129032258,1.0,1.0,1/10,1.14%,COL8A1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.4473395768562789,-0.7223545633507398,0.819672131147541,0.9686880177752288,1.0,5/6,39.42%,MAP2K1;USP7;DNAJC13;MAPK1;ATP9A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4750361236682756,-0.7221061273845546,0.863013698630137,0.9686407590216038,1.0,2/5,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.44219946510446523,-0.7215431895394557,0.8082191780821918,0.9686908637625601,1.0,4/9,27.89%,DLC1;ACVRL1;DUSP22;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.44219946510446523,-0.7215431895394557,0.8082191780821918,0.9686908637625601,1.0,4/9,27.89%,DLC1;ACVRL1;DUSP22;FAM107A
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,0.35107777971920223,0.7214454406123758,0.8461538461538461,1.0,1.0,3/15,10.41%,GBP4;RCSD1;TNFRSF1B
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.35485883492581577,0.7207390183115907,0.8666666666666667,1.0,1.0,3/26,6.96%,GBP2;GBP1;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.4460746534955452,-0.7202783243107805,0.8421052631578947,0.9697794399452302,1.0,2/6,15.22%,TPR;PPHLN1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.41477661939216953,0.7202072728178704,0.8666666666666667,1.0,1.0,1/9,8.05%,CDK12
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,0.455757551887011,0.7199291886638551,0.8,1.0,1.0,4/6,19.39%,RCSD1;TNFRSF1B;GIMAP7;GIMAP4
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3780660501242658,-0.7189687310848432,0.8309859154929577,0.9707766644370952,1.0,2/28,4.57%,PPARG;SMAD7
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.37967291624149724,-0.7189226237834345,0.8888888888888888,0.9705407865518807,1.0,8/28,13.78%,MGLL;CD9;EMP1;TNS1;VWF;EPAS1;GJA1;PLSCR4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.4729941938915185,-0.7188795455942764,0.8253968253968254,0.970298334705026,1.0,3/6,22.97%,CD81;CBFB;PRKCH
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.4261829891196299,-0.7181931333117607,0.927536231884058,0.9707239367323808,1.0,5/10,34.29%,PARVB;ITGB1;RHOJ;RAC1;GSN
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.30345690856272334,0.7176814413999016,0.9375,1.0,1.0,2/16,10.76%,DCP1A;EIF4A2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4113644492733296,-0.7176060954414505,0.8888888888888888,0.9710821784928048,1.0,6/23,26.19%,ANXA1;ADAMTS1;MECP2;EGFR;RAB11A;BRD4
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.41654334564566586,0.7167479848744541,0.8857142857142857,1.0,1.0,1/8,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.4520242492823066,-0.7164505568241957,0.8695652173913043,0.9721177810043038,1.0,4/9,32.11%,ATP1B3;ATP1A1;ATP1B1;KCNQ5
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.4720887293011843,-0.7161217749545387,0.8805970149253731,0.9721501212420713,1.0,3/8,28.02%,KLF4;CBFB;MAP2K5
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.46718032329617926,0.7159136106547033,0.8048780487804879,1.0,1.0,2/5,19.39%,GIMAP8;GIMAP4
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.37792597879647905,0.7150400173913097,0.7142857142857143,1.0,1.0,1/12,4.91%,CLASP1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4194512920579607,-0.7149483841296671,0.821917808219178,0.9730909236833295,1.0,2/12,8.26%,RAPGEF3;RAP1A
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.37149965431770915,-0.7148788983729597,0.8904109589041096,0.9728749563766801,1.0,6/26,25.39%,HSPA5;TPR;HSPH1;NUP54;HSPA9;SERPINH1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3743696630606528,0.7144192847365497,0.8333333333333334,1.0,1.0,2/9,10.81%,SPG11;RAB27A
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,-0.35355023960068527,-0.713236396131834,0.9358974358974359,0.9743007816225043,1.0,14/49,19.18%,CLEC1A;LRRC32;GGT5;FLT1;PECAM1;TNS1;VWF;CFH;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4483333205857566,-0.7130877875518573,0.8,0.9741582682930408,1.0,1/7,3.85%,HSPA5
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.48804538585307683,-0.7120084908994825,0.8571428571428571,0.9749500270584774,1.0,1/5,7.25%,SMARCA1
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,-0.41794516239597745,-0.7112816157549916,0.8783783783783784,0.9754233170900022,1.0,4/11,13.47%,YBX3;SOD2;NFKBIA;TRIB2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.48510783816725794,-0.7109426873528819,0.9047619047619048,0.9755081490267733,1.0,2/6,9.72%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.42433284014441974,0.710866096156588,0.8275862068965517,1.0,1.0,4/6,26.59%,RNF216;PARP9;TRIM44;DHX9
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.4505505734270321,-0.710452831813643,0.8032786885245902,0.9757401262287516,1.0,2/5,15.19%,LPGAT1;LPIN2
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.41816908719619217,0.7095282294333835,0.75,1.0,1.0,1/5,10.73%,ATP6V1H
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,-0.3859706766610393,-0.7091478900138434,0.8441558441558441,0.976824778062992,1.0,1/16,6.27%,PIK3R1
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.4010819781806084,-0.7090949589187752,0.8947368421052632,0.9766015282006324,1.0,1/15,0.50%,B3GNT2
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.36333819084879654,0.7089714783652096,0.8666666666666667,1.0,1.0,1/11,4.94%,GNB4
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.34061138361586824,-0.7089351068869969,0.9302325581395349,0.9764619703258313,1.0,18/71,20.29%,CX3CL1;RAPGEF3;VAV3;RAP1A;TBC1D15;TGM2;AFDN;LIMS1;FGD4;RSU1;RGS7;LARS1;RACK1;PICALM;ARHGAP15;ITGB1;ECT2;CAV2
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.4263352406110342,0.7088160142255311,0.7878787878787878,1.0,1.0,1/6,1.83%,PIGU
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.4263352406110342,0.7088160142255311,0.7878787878787878,1.0,1.0,1/6,1.83%,PIGU
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.4263352406110342,0.7088160142255311,0.7878787878787878,1.0,1.0,1/6,1.83%,PIGU
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.43795655442501286,-0.7072805256830588,0.8769230769230769,0.9779898461935715,1.0,1/8,9.11%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4092944695088402,-0.7072092496104933,0.8125,0.9777497473871709,1.0,2/9,19.42%,CST3;EGFR
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.4401503680579303,-0.7071861767925546,0.8225806451612904,0.9774763970090894,1.0,2/8,9.06%,FLT1;CD81
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35698802754938086,-0.7071420284895168,0.9529411764705882,0.97724326970208,1.0,7/45,17.26%,CX3CL1;RPS27A;UBC;NPM1;NFKBIA;MALT1;IL18R1
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.39631979760503305,0.7068784820501287,0.8611111111111112,1.0,1.0,1/9,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.4920003183184379,-0.7064682770258067,0.9032258064516129,0.9773846604456404,1.0,2/5,37.40%,DNM2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.4920003183184379,-0.7064682770258067,0.9032258064516129,0.9773846604456404,1.0,2/5,37.40%,DNM2;MX1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.4067859158001645,-0.7062305487099795,0.8507462686567164,0.9773852486464021,1.0,2/12,8.92%,CD9;CD55
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.40098364277037374,0.7061707335669487,0.8292682926829268,1.0,1.0,1/9,0.61%,ARID5B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.39521877635462155,-0.706065591668909,0.8181818181818182,0.9773024750904178,1.0,2/10,15.83%,TMED10;MALT1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5027089922461072,-0.7046585187682927,0.96,0.9784964691563752,1.0,1/5,23.43%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4229991936750949,-0.7041015895858377,0.8450704225352113,0.9788699656990774,1.0,4/13,21.04%,DLC1;ROBO2;ACVRL1;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.34564642444637245,0.7040778808809712,0.8055555555555556,1.0,1.0,2/10,14.69%,ELAPOR2;RBPJ
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,-0.4537989891479388,-0.7039498861565466,0.8484848484848485,0.9787768317494532,1.0,3/7,19.26%,SLC2A3;SMAD5;IFITM3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.4150616980715511,0.7038813580917799,0.875,1.0,1.0,2/8,12.30%,OCLN;ROCK1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,0.3571600378054827,0.7034880835988389,0.868421052631579,1.0,1.0,3/13,10.41%,GBP4;RCSD1;TNFRSF1B
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,0.3571600378054827,0.7034880835988389,0.868421052631579,1.0,1.0,3/13,10.41%,GBP4;RCSD1;TNFRSF1B
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.3901650789450977,-0.7030474122906947,0.8142857142857143,0.9795163804659895,1.0,5/14,25.39%,HSPH1;MTOR;HSP90AA1;CAMK2D;SERPINH1
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,-0.36276217698472796,-0.7029596669621224,0.9240506329113924,0.9793465313397637,1.0,9/32,19.60%,LRRFIP1;S100A6;ACTN1;ARHGAP23;ADK;GATA2;ADAM15;ATP8B1;EMP2
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4545790622563971,-0.702921005457508,0.8596491228070176,0.9791002262209386,1.0,3/5,27.94%,ERBIN;ARHGEF2;VIM
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.4163542958973518,-0.7028587056960975,0.8805970149253731,0.9788740320562038,1.0,3/12,12.43%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4137424300364542,0.7026783985350988,0.8181818181818182,1.0,1.0,1/6,0.42%,RSAD2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.39689839396449167,0.7026217918570832,0.7567567567567568,1.0,1.0,1/7,1.97%,ACAT1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.31838776540141794,-0.7024145195833991,0.9680851063829787,0.9791669170350898,1.0,13/132,12.16%,UFL1;RPS27A;NFE2L2;HIF1A;COMMD1;PRKN;UBC;ARIH2;KLHL7;CHFR;EPAS1;TPR;PIAS2
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.4288830937138238,0.7022188755238251,0.7037037037037037,1.0,1.0,1/6,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.32547685739866256,0.7021883185350873,0.8666666666666667,1.0,1.0,2/16,10.33%,EFNA5;ZMYM4
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.3779726304541363,-0.7020096580004531,0.9090909090909091,0.9793199541551567,1.0,3/26,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.45574227173594806,-0.7020083162169736,0.9206349206349206,0.9790307279430613,1.0,1/6,4.17%,EPS8
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.38013755651780723,-0.7016780360874323,0.8405797101449275,0.9790607407069369,1.0,2/17,11.18%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.3453236156902873,0.7015741018889105,0.8205128205128205,1.0,1.0,2/10,15.64%,XAF1;PNPT1
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.40990412882959,0.7011280598445991,0.84,1.0,1.0,1/8,4.94%,GNB4
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.376878698581706,-0.7008408001810257,0.881578947368421,0.9796622308620033,1.0,9/35,20.48%,PRKAG2;RAP1A;PAK2;CDKN1A;TRIB2;WWTR1;LCP2;ECT2;SPRED1
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,-0.31333472285206093,-0.7007372249946106,0.9795918367346939,0.9794927396415355,1.0,43/216,20.82%,SEC22B;TSG101;PRKAG2;DENND3;SEC24D;SCARB2;RPS27A;DENND2C;ANK2;HIP1R;AP1G1;TBC1D15;UBC;CD55;RAB21;KIF16B;ARPC2;SYNJ2;GJA1;RAB1A;SH3KBP1;SYT1;COPA;TMF1;ACBD3;PAFAH1B1;SH3GL1;RAB8B;SGIP1;RAB30;PICALM;RAB14;PIP5K1C;MYO1E;ANK3;GRB2;USO1;CHMP4B;EGFR;DYNC1I2;CSNK1D;CAPZA2;KLC1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3818144439144875,-0.7005121249572551,0.8260869565217391,0.979432931044493,1.0,2/15,11.18%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4548174313554316,-0.7004207001655016,0.921875,0.9792304103449657,1.0,3/8,10.15%,LGALS3;CD81;PRNP
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.4186170212765956,0.7002394300784166,0.7777777777777778,1.0,1.0,5/5,58.19%,UBN1;ATRX;RBBP4;CABIN1;NASP
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.4417507797274779,-0.7001779096394026,0.8787878787878788,0.9792702761829875,1.0,3/9,19.76%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.42348311223654134,-0.7001118625722337,0.8378378378378378,0.9790446985498427,1.0,2/7,23.24%,EGFR;CCNY
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.40603303547816505,0.6992884348824742,0.7575757575757576,1.0,1.0,1/6,10.73%,ATP6V1H
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.4541759650511905,-0.6990747658224397,0.9041095890410958,0.9799071550993238,1.0,1/7,3.93%,SCP2
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.3923778227147588,-0.6981136798327773,0.8285714285714286,0.9806298401774517,1.0,3/12,13.17%,CDKN1B;PLCG2;CDKN1A
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.4143472210518185,-0.6977801288785397,0.8285714285714286,0.9806029506018449,1.0,3/10,12.93%,DUSP1;ITGB5;DUSP5
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.37936415330013007,0.6976564775716755,0.8387096774193549,1.0,1.0,1/7,4.94%,GNB4
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.39813454975280627,-0.697338599785477,0.9076923076923077,0.980715258262416,1.0,1/12,4.46%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.39288338944727,-0.6971754660212087,0.8904109589041096,0.980559157533968,1.0,2/17,3.13%,CX3CL1;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3798495617914843,-0.6968995108555445,0.8947368421052632,0.9805157530211726,1.0,1/24,1.09%,BTG2
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),0.4343620028458374,0.6968850499081067,0.7608695652173914,1.0,1.0,1/5,6.14%,CCM2
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.36774798332269787,-0.6966426852679365,0.8837209302325582,0.9805021723113769,1.0,2/30,2.63%,LBR;SEC24D
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.3956580297831686,-0.6960856600689047,0.8923076923076924,0.9807533952262245,1.0,1/12,3.75%,TAF1D
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.34770755114323654,-0.6960463953373318,0.9178082191780822,0.9805114335415749,1.0,7/42,16.81%,NR4A1;PPARG;ESR2;CCNH;WWTR1;THRB;NOTCH4
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3858396607248491,0.6959779984637375,0.8529411764705882,1.0,1.0,1/8,2.84%,RHBDD1
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.3792335728926777,-0.6959081435106286,0.92,0.9803456980657388,1.0,2/16,11.00%,VAV3;EFNB2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.34133059434080754,-0.6955495392386026,0.9186046511627907,0.9804644644067042,1.0,6/59,15.59%,BTG2;GAPDH;RPL10;RPL13A;NPM1;RACK1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47085316386443005,-0.6953843819365619,0.896551724137931,0.9803649612162088,1.0,2/6,15.96%,FGFR1;MCL1
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.39758755690406244,-0.6953108994155446,0.84,0.9801663638592815,1.0,4/12,22.97%,PRKCE;GNAI3;ADCY2;PRKCH
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.39203888888334193,-0.6950536103245065,0.8260869565217391,0.9801562177191089,1.0,5/14,22.90%,PECAM1;ROBO2;ITGB1;HMCN1;BSG
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.4570292380683624,0.6949488162407211,0.8611111111111112,1.0,1.0,1/6,2.68%,DCP1A
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.4007450771687069,0.6943728597128562,0.8181818181818182,1.0,1.0,7/7,60.00%,MAPKBP1;ITCH;IFI16;ILRUN;PCBP2;IRAK3;CARD8
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4567005254342148,-0.6936297098864496,0.8615384615384616,0.9814409111111074,1.0,3/8,21.59%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4282037456281902,-0.6933793397877891,0.8285714285714286,0.9814270948683984,1.0,4/6,41.04%,ZBTB1;PPP2R3C;PRKDC;ZMIZ1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3916606570922733,-0.6932928774101564,0.8548387096774194,0.9812086117367868,1.0,3/12,33.28%,SLC30A1;TF;TFRC
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.34406873246646574,-0.6931975247885372,0.926829268292683,0.9810859637206649,1.0,12/49,15.51%,ITPR1;PDE5A;ATP2B1;KCNMB4;PRKCE;SLC8A1;ATP1B3;GNA13;MEF2A;CACNA1C;CREB3L2;PPP3CC
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.4669455432057169,-0.6929956099300332,0.8571428571428571,0.9810095774396193,1.0,1/5,22.26%,CLTA
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.4257177948223172,0.6925263377359889,0.8461538461538461,1.0,1.0,1/6,3.80%,RALA
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3106435277131244,-0.6920816540345949,1.0,0.9815764059445881,1.0,24/118,24.89%,BHLHE40;ESR2;HIF1A;RREB1;RPL10;CREM;SBNO1;ZNF280D;CNBP;BTG1;WWTR1;SMC3;NSD2;ZBTB38;ATF2;ACVRL1;MTF2;ZNF141;DNM2;CALR;CCDC88A;FOXN3;TERF2IP;NR2C2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.3947502156201065,-0.6917397101207721,0.8289473684210527,0.981635111766035,1.0,3/14,18.33%,GGT5;PELI1;ERBIN
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.3617320881521433,-0.6908365092590483,0.9166666666666666,0.9823069091714606,1.0,6/28,18.01%,RAD21;TPR;PIAS2;SMC6;SMC3;NUP54
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,-0.4410496880037024,-0.6903554603805453,0.8225806451612904,0.9825169556883334,1.0,1/6,5.87%,JAK1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.34177356984426616,0.6892858892262733,0.875,1.0,1.0,1/15,1.91%,SMAD1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.4627929955501267,-0.6887875091984422,0.855072463768116,0.9837778077792062,1.0,4/5,41.49%,NEDD4L;YWHAE;CACNA2D1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4244538246113472,0.6882454280411672,0.8048780487804879,1.0,1.0,2/5,8.13%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.4554778110701193,-0.6881954703207175,0.875,0.984036703294611,1.0,3/6,21.59%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.38456984774369596,-0.6881478655939985,0.8529411764705882,0.9838048619417238,1.0,3/11,14.63%,PRKCE;NCK1;SPIRE1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.43495878942355537,-0.6880319899518628,0.8620689655172413,0.983599488623721,1.0,4/8,30.60%,TPM1;LIMA1;RAC1;AIF1L
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.37643452702955943,-0.6879011465161287,0.855072463768116,0.9834567566718565,1.0,4/24,14.50%,ATF3;TPR;NPM1;NCK1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.40101666246759515,-0.6878519696896519,0.8421052631578947,0.9831989709805947,1.0,3/9,16.18%,MEF2A;PTMA;THRB
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,-0.3328308862060547,-0.687562268748152,0.9418604651162791,0.9832175843649025,1.0,7/72,11.16%,LDHA;AKAP12;TIMP3;KLHL7;TMSB4X;FGFR1;LIMS1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,-0.3707744531199373,-0.6874296419768287,0.8648648648648649,0.9831013907006295,1.0,6/20,23.59%,PIK3R1;FGFR1;PIK3C3;GRB2;PIK3CB;ATP6V1E1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.43042206728726506,-0.6871551308199134,0.8676470588235294,0.983100301196196,1.0,1/8,6.29%,MGAT4A
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.4748953843723446,-0.6870115876631333,0.8888888888888888,0.9829152079564486,1.0,1/5,15.30%,MYEF2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.4258700846809617,-0.6869991740630262,0.8484848484848485,0.9826316777307756,1.0,1/6,13.68%,RIOK3
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.43290944223258354,-0.6868938087772467,0.8888888888888888,0.9824895195637874,1.0,3/9,19.42%,NPM1;CDKN1A;EGFR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.41241409293004977,0.6868476480976223,0.8611111111111112,1.0,1.0,1/5,13.09%,PDCD4
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.41852476737849653,-0.6868001999123761,0.8857142857142857,0.9823047663827603,1.0,2/8,23.24%,EGFR;CCNY
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.3552149001784927,-0.6867520983462637,0.8831168831168831,0.9820577636797037,1.0,6/25,17.64%,TIMP3;TPM1;TNS1;GJA1;PLSCR4;CALD1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4075044676803254,-0.6863348828057259,0.8732394366197183,0.9821586913789628,1.0,5/15,23.90%,SRGN;CD34;ARFGEF2;CAV2;WASHC4
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.3606366436701819,0.6854376224404248,0.8620689655172413,1.0,1.0,2/7,8.98%,CLASP1;PHLDB2
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.3751382589646011,-0.6851836855099672,0.8840579710144928,0.9831320530180597,1.0,3/15,19.07%,RAP1A;SHC2;GRB2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3550460924840921,-0.6843512551127221,0.9264705882352942,0.983590030071798,1.0,10/20,31.85%,GAS7;CFL1;SPIRE1;DSTN;ABI1;PREX1;FAM107A;RAC1;MICALL2;ABI2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.30237422249454876,0.6826579947017852,0.92,1.0,1.0,5/16,16.18%,EIF2AK2;NFAT5;NOD1;PDCD4;APP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4309186165984913,-0.6822027194134872,0.828125,0.9854376707439544,1.0,4/6,48.92%,DIP2A;BRD7;GLYR1;DIP2B
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.3429746828894679,0.6816566457553543,0.8518518518518519,1.0,1.0,2/14,5.87%,SMAD1;SMAD9
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.3426592834142945,-0.6813149414405553,0.935064935064935,0.9860749550116041,1.0,11/37,19.18%,CLEC1A;GGT5;PECAM1;SCARF1;VWF;CLDN5;NOTCH4;TIE1;ACVRL1;ZNF366;CD34
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.35438508749409126,-0.6811481728949905,0.9402985074626866,0.9859812691544758,1.0,2/19,8.15%,RAPGEF3;TPM1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.43268434777551074,-0.6807896633437837,0.8823529411764706,0.9860317499697391,1.0,3/8,25.52%,MEF2A;MFN1;MTM1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.39846679731502477,-0.680770288330647,0.8235294117647058,0.9857580433811206,1.0,8/11,31.31%,PLPP1;SAMD8;ACER2;NSMAF;ACER3;SPTLC2;ST6GALNAC3;CERK
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.3564848180992851,-0.6805579867356472,0.9295774647887324,0.9856645314027949,1.0,8/33,20.82%,SEC22B;KIF16B;RAB1A;COPA;PAFAH1B1;DYNC1I2;CAPZA2;KLC1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4223194461169343,0.6802934031542839,0.84375,1.0,1.0,2/6,3.13%,SLC4A4;SLC26A3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.4443698341300054,-0.6800723823224215,0.8701298701298701,0.9858557743262053,1.0,1/6,15.30%,MYEF2
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.41342475477785473,-0.6797412138189086,0.859375,0.985830989145056,1.0,3/9,17.82%,PECAM1;LCP2;ARHGAP15
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.4018561520686183,-0.6797175165314321,0.890625,0.9855576589617774,1.0,2/10,13.17%,CDKN1B;CDKN1A
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.415605525558127,0.6790567481896542,0.9523809523809523,1.0,1.0,1/8,6.29%,EZH1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3363870320533924,0.6790468080556408,0.8787878787878788,1.0,1.0,2/14,7.14%,PLCB4;PPIP5K2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3363870320533924,0.6790468080556408,0.8787878787878788,1.0,1.0,2/14,7.14%,PLCB4;PPIP5K2
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.3983126624124888,-0.6789140256387779,0.9090909090909091,0.9860070622061543,1.0,2/12,18.01%,TPR;NUP54
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,-0.37163712700112095,-0.678755655063523,0.918918918918919,0.9859168823026372,1.0,2/22,6.06%,LRRC32;TIMP3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.41346354376334593,-0.6777512089308666,0.864406779661017,0.986532571562541,1.0,2/7,17.18%,AGPAT4;SAMD8
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,-0.38400071572043293,-0.677735722949922,0.9333333333333333,0.9862528216140753,1.0,7/14,35.46%,MYL6;MYH10;MYL12B;RHOB;RHOA;ARHGEF12;LIMK2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.42116852854581327,-0.6771981733572767,0.8970588235294118,0.9864728974735169,1.0,2/6,24.14%,TPR;NEDD4
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.24758780366069155,0.6765595419159545,1.0,1.0,1.0,3/57,8.61%,CWC27;WBP4;DDX42
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4043169664653167,-0.6759810513877686,0.8571428571428571,0.9874666097519058,1.0,3/10,9.16%,GRM7;ANXA1;IL1RAPL1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.34158492035855303,-0.6758280634052157,0.9024390243902439,0.9873075959069273,1.0,12/35,27.17%,KIAA1217;TIMP3;EPAS1;GJA1;PLSCR4;CALD1;EGFR;SASH1;CDH5;TNS2;SPARCL1;FZD4
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.4018858774978568,-0.6756198294398078,0.9014084507042254,0.9871845665251411,1.0,2/15,12.35%,NDFIP1;STXBP5L
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.985477218970164,1.0,2/10,18.01%,TPR;NUP54
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4470695948889035,-0.6755617561281755,0.8852459016393442,0.9852377403832615,1.0,3/5,34.00%,SMAD5;DSP;EFNA1
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.3649289899276131,0.6755088004572994,0.8125,1.0,1.0,1/8,2.82%,IL1R1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.4161639048504249,0.6750940038517453,0.7647058823529411,1.0,1.0,3/6,29.14%,SKI;CDC73;NF1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.4260824972020416,-0.674880345792396,0.8823529411764706,0.985548560526935,1.0,2/10,18.73%,HIF1A;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.394474859668375,-0.6747729514650981,0.8888888888888888,0.985371034233337,1.0,3/13,25.87%,KLF4;HSP90AA1;TNKS
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.4567988484180813,-0.67442500035773,0.9333333333333333,0.985375806791988,1.0,3/5,25.23%,PIK3C3;PIKFYVE;SACM1L
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,-0.3643499173129347,-0.6741617277430059,0.9324324324324325,0.985289504796113,1.0,6/23,19.18%,LRRC32;GGT5;TNS1;CACNA1C;ACVRL1;CD34
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.41098806107549773,-0.6740496725270559,0.9230769230769231,0.9850764392952036,1.0,4/9,27.57%,ANXA1;GATA2;JCAD;RHOJ
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.37436565170330593,-0.6739686222562846,0.9090909090909091,0.9848667475325491,1.0,8/17,20.03%,ATG12;GLUL;ZDHHC6;PIGN;PIK3C3;ZDHHC21;PIGC;ZDHHC14
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.3699634958230388,-0.6736524333586528,0.9154929577464789,0.9849301556104882,1.0,1/16,3.75%,TAF1D
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3961053994392154,0.6736477395106529,0.9318181818181818,1.0,1.0,2/6,15.46%,SMYD3;KDM6A
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.3464813678942523,-0.6736111539519388,0.9230769230769231,0.9847141294807514,1.0,13/34,25.07%,ATP2B1;SLC8A1;ANK2;HERPUD1;MICU2;ATP13A3;SLC30A1;CAV2;TMEM165;VAPB;CDH5;CALR;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.4633855955419036,-0.6735564508651767,0.8615384615384616,0.9844819886451247,1.0,3/5,29.22%,TFPI;ATP1A1;ABHD2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.4013144906129522,-0.6728543275774356,0.890625,0.9848279362017687,1.0,1/10,4.46%,KDM1A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3908564399034356,-0.6727077944169461,0.8961038961038961,0.9846932763961872,1.0,5/19,20.53%,RAB11FIP3;RACK1;PIK3C3;CSPP1;PRPF40A
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.3669537155231182,-0.6725908930528058,0.8695652173913043,0.9844678324544034,1.0,1/18,3.05%,JUN
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3602403333344154,-0.672348480226531,0.863013698630137,0.9844079689855889,1.0,4/24,10.89%,NFASC;PTPRD;SMARCA1;SHC2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.3763767650001273,-0.6720338811956418,0.8961038961038961,0.9844000311059808,1.0,2/15,11.24%,CFL1;PPFIA2
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,-0.3239068016881981,-0.671849209184133,0.9361702127659575,0.984333737130005,1.0,11/52,21.86%,SCARB2;EPS8;CANX;MYO1B;TMEM30A;SMAD5;PSD3;MIB1;CADPS2;PRKAR1A;SCAMP1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.410299308886855,-0.6716103086060647,0.873015873015873,0.9842739639824489,1.0,3/9,19.07%,PIK3R1;FGFR1;GRB2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3093031251205568,0.670765276690677,0.9166666666666666,1.0,1.0,3/12,12.56%,HSPB1;DLG2;DTNBP1
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.37712770388635897,-0.6707064301401897,0.9315068493150684,0.9848007363427659,1.0,3/16,15.46%,RPS27A;UBC;CDK6
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.33097168778899433,-0.6703696609153462,0.9,0.9848056524149451,1.0,15/44,26.88%,ARF1;COMMD1;AP1G1;KIF16B;MYO1B;ACBD3;RAB14;ARFGEF2;SCAMP1;FTL;CLTA;DNM2;KLHL20;CLINT1;AP4S1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.3890785302130119,0.6701419756334626,0.9210526315789473,1.0,1.0,1/5,4.22%,MFF
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.30329986122477803,0.6700267346637068,1.0,1.0,1.0,6/24,16.49%,ATR;INO80;ATM;SPIDR;CLOCK;MDM2
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.4007477965909796,-0.6699821718410292,0.9253731343283582,0.9849012444525884,1.0,2/11,18.01%,TPR;NUP54
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.39233886666103923,-0.6694134181492054,0.9117647058823529,0.9848398036661533,1.0,3/13,18.01%,TPR;SGIP1;NUP54
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.39233886666103923,-0.6694134181492054,0.9117647058823529,0.9848398036661533,1.0,3/13,18.01%,TPR;SGIP1;NUP54
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.39904093436709365,-0.6689010573921035,0.7692307692307693,0.9849611893425533,1.0,4/8,36.39%,TNFRSF10B;DAB2IP;DDX3X;TNFRSF10A
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3245022347929186,-0.6688900869914924,0.9310344827586207,0.984681389323942,1.0,12/49,24.67%,UFL1;HIF1A;PTTG1IP;MSN;DHRSX;TMEM59;PIK3CB;ZC3H18;ADAM9;CNOT8;SNX9;HSP90AA1
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.3074936991107646,0.6688397901564193,0.90625,1.0,1.0,3/15,9.19%,H2AC6;TBL1X;TBL1XR1
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.35883354266224415,-0.668656165814793,0.9487179487179487,0.9846281214283641,1.0,4/22,20.08%,SPC25;RPS27;PAFAH1B1;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.3835732901141688,0.6684340538250194,0.8918918918918919,1.0,1.0,2/7,25.84%,APP;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3929684079832706,-0.6682834086592115,0.8732394366197183,0.9846621737221354,1.0,3/12,19.76%,PRNP;EGFR;CLU
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.40968494383173826,-0.6682460668581436,0.8507462686567164,0.9844085567102064,1.0,1/7,3.85%,HSPA5
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.42059125082708804,0.6682089162057873,0.8181818181818182,1.0,1.0,3/5,16.04%,EYS;CFLAR;PPP3CA
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.37647681197801125,-0.6680028553979518,0.8767123287671232,0.9843877239128059,1.0,4/13,16.57%,SLC8A1;COL18A1;ATP1B3;SLC38A2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4132144867097192,0.6679059514977252,0.84375,1.0,1.0,2/5,11.50%,TTN;ACVR1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.28592759788688477,0.6673055119801631,0.9259259259259259,1.0,1.0,5/26,14.37%,THOC1;XPO4;XPO7;NUP214;RANBP17
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.41726855739365026,-0.6667593377276755,0.8620689655172413,0.985213206267261,1.0,2/9,7.49%,NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3443114293368805,0.6666822940029989,0.9354838709677419,1.0,1.0,4/11,16.18%,TENT2;SCAF8;PNPT1;APP
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3443114293368805,0.6666822940029989,0.9354838709677419,1.0,1.0,4/11,16.18%,TENT2;SCAF8;PNPT1;APP
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3927185964943596,-0.6666041119207194,0.873015873015873,0.9850791312598537,1.0,4/12,24.25%,CDKN1A;KMT2A;ACVRL1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3037278778198211,-0.6661386880910657,0.9789473684210527,0.9853163890531712,1.0,21/105,24.89%,BHLHE40;ESR2;HIF1A;RREB1;CREM;SBNO1;ZNF280D;CNBP;BTG1;WWTR1;NSD2;ZBTB38;ATF2;ACVRL1;MTF2;ZNF141;DNM2;CALR;FOXN3;TERF2IP;NR2C2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.4125196261574792,0.6660536206397396,0.7380952380952381,1.0,1.0,1/5,5.31%,MIA3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.42947037800493604,-0.6654909281421262,0.8333333333333334,0.9856212859234632,1.0,3/7,29.22%,TFPI;ATP1A1;ABHD2
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.37969331828988656,0.665340366636307,0.9411764705882353,1.0,1.0,1/8,4.94%,GNB4
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.40205651910549817,-0.6652566872834805,0.863013698630137,0.98552592677741,1.0,3/8,17.45%,PLCG2;NCK1;LCP2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,-0.3857540531505036,-0.6652371831168588,0.9166666666666666,0.9852596688106756,1.0,1/13,4.06%,NES
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.39861887094954773,-0.6651230152800136,0.8805970149253731,0.9851032002313602,1.0,3/11,17.85%,IL18R1;LCP2;CHSY1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.2928807037146318,0.6650456148655887,0.8888888888888888,1.0,1.0,1/16,3.43%,ATP10D
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,-0.3626643926882342,-0.663814355906239,0.9166666666666666,0.9859332703281838,1.0,5/20,25.05%,KIAA1217;EGFR;EMP2;VWA2;DSP
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.44410280358004117,-0.6635300760684599,0.864406779661017,0.985960396205327,1.0,2/5,16.65%,PRKN;PINK1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.40772051585720803,-0.6629097674425467,0.9,0.9862420322684069,1.0,3/8,18.57%,KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.28468380969721396,0.6625956159092442,0.9444444444444444,1.0,1.0,5/32,13.33%,ATR;HSPA1A;ATM;NUP58;NUP214
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.33369873158040014,-0.662555729141786,0.9540229885057471,0.9862819379694716,1.0,6/38,16.39%,BAZ1A;PBRM1;SMARCA1;NPM1;MBD2;SMARCC1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.30446119840222763,0.6623799494013091,0.8888888888888888,1.0,1.0,1/16,3.88%,INO80
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.3058046879955065,-0.6622756663685772,0.967391304347826,0.9861543807731403,1.0,11/60,25.68%,RPS27A;PRKN;UBC;PIAS2;XIAP;SOCS3;UBE2J1;CUL1;NEDD4;NEDD4L;MID1
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.29170707396776346,0.661905053207316,1.0,1.0,1.0,3/44,3.27%,PACS2;HERC2;ATP2A2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.38617203330101957,-0.6618634212071061,0.8243243243243243,0.9861846314745963,1.0,3/12,23.08%,PPA2;PINK1;SLC25A36
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.345844509483502,-0.661592375085733,0.972972972972973,0.9861923377582631,1.0,4/25,9.83%,MGLL;GAS7;SLC8A1;SOD2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3304877335225647,0.6614287552910624,0.9655172413793104,1.0,1.0,4/11,16.84%,ERCC6;KMT5B;SHLD2;PARP9
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.38089659844111207,-0.6612697423368664,0.918918918918919,0.9861292603456694,1.0,4/16,18.01%,TPR;LPIN2;VRK2;NUP54
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.24689536532714546,0.6612462954543564,1.0,1.0,1.0,7/71,13.47%,CWC27;THOC1;WBP4;DDX42;NUP58;NUP214;RBMX
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.3479400320766102,-0.6607728300880765,0.8947368421052632,0.9862881451475022,1.0,4/25,11.39%,SLC20A2;SLC2A1;SLC26A2;TPR
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2976000014531686,0.6605258509986697,1.0,1.0,1.0,5/26,11.79%,TNRC6C;ATF7IP;MED27;MED23;MED15
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.3962510484102125,-0.6600798494260699,0.8873239436619719,0.9866945251857427,1.0,1/6,14.56%,CYLD
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.3419392493449811,0.6600316196133528,0.8666666666666667,1.0,1.0,2/11,13.84%,EZH1;KAT6B
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3636812130839461,-0.6598455750562704,0.9090909090909091,0.9866120715016929,1.0,5/16,24.04%,WDR48;OGT;PINK1;ADAM9;SNX9
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.40554101493470973,-0.659713483644794,0.8767123287671232,0.9864107629212964,1.0,2/10,7.49%,MBP;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.39251589747290005,-0.659478741348746,0.84375,0.9863541384798926,1.0,2/7,30.07%,MAP3K13;CDKL5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.33775443586866344,-0.6593424787788705,0.9047619047619048,0.9861819239569445,1.0,6/34,12.22%,RFTN1;SRGN;PECAM1;CLEC2B;WIPF1;ZFP36
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3010257021235537,-0.6589235813432133,0.9896907216494846,0.9862763054889768,1.0,22/78,23.24%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1;PRKN;CDK14;CTNND2;AMFR;CYLD;WWTR1;USP34;PPM1A;EGFR;PSMA7;CSNK1D;XIAP;GLI3;GPRC5B;TNKS2;GPC3;CCNY
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3626391674893512,-0.658168100223578,0.9178082191780822,0.9866177956121708,1.0,3/25,8.84%,RPS27A;HIF1A;UBC
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.40937693496041705,-0.6581444248004548,0.8769230769230769,0.9863461746253157,1.0,2/7,16.68%,UPP1;ENTPD4
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.37461695155645736,-0.6575806020527124,0.9014084507042254,0.986607248400902,1.0,4/15,13.89%,ANK2;FGFR1;CTNND2;BCAR1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.3554539969709314,0.6569531455512637,0.8611111111111112,1.0,1.0,1/6,11.98%,ACBD6
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.42462827282936183,-0.6567584004883893,0.8688524590163934,0.9867153442537505,1.0,4/5,20.35%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.42462827282936183,-0.6567584004883893,0.8688524590163934,0.9867153442537505,1.0,4/5,20.35%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4275659494389967,-0.6565874140274761,0.859375,0.9866042714343358,1.0,1/6,12.01%,CSTF3
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.44084021893117686,-0.6558160960195418,0.9315068493150684,0.9870508307873295,1.0,2/7,22.36%,CDK6;B2M
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.32660208073642605,-0.6557979377900253,0.9642857142857143,0.9867827538571964,1.0,12/33,29.93%,VAV3;GNA13;FGD4;RASGRF2;ECT2;KALRN;ARHGEF2;PREX1;MCF2L;RHOB;TRIO;RHOA
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3951253656661854,-0.6555461512546108,0.9324324324324325,0.9866781618508698,1.0,3/10,25.18%,KIF16B;RAB14;KLHL20
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3818692261915926,0.6552283564779724,0.8666666666666667,1.0,1.0,1/6,2.31%,TBC1D5
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.367269890469632,-0.6545151175583339,0.918918918918919,0.9871819494956363,1.0,3/13,12.46%,COL18A1;PLOD2;PLEC
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.29820537104095163,-0.6544983274264882,0.956989247311828,0.9869172647283285,1.0,9/119,10.73%,PSMC6;PSMB9;RPS27A;RNF19A;PSMA1;PRKN;UBC;ARIH2;CHFR
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.3964153084658748,-0.6542993082247353,0.9090909090909091,0.9865259015777212,1.0,2/11,18.01%,TPR;NUP54
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.3964153084658748,-0.6542993082247353,0.9090909090909091,0.9865259015777212,1.0,2/11,18.01%,TPR;NUP54
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.37089606636929157,-0.6542701093281037,0.9444444444444444,0.9862680248647798,1.0,5/18,19.18%,OXR1;GAS7;STXBP5L;GRB2;CD34
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.415092120379162,-0.6538719784566059,0.8450704225352113,0.9863523884480441,1.0,2/8,9.83%,ERBB4;SOD2
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.36854709952102177,0.6537756680247743,0.868421052631579,1.0,1.0,7/7,63.21%,FOXO3;FOXO1;EP300;SIRT1;CREBBP;TXNIP;KAT2B
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4114901438466807,-0.6536519946336808,0.8714285714285714,0.9863376209725382,1.0,3/9,18.73%,GJA1;PAFAH1B1;ITGB1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.432136317306903,-0.6534793761470076,0.8923076923076924,0.9862238068530156,1.0,1/5,17.29%,ROBO2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3351455635909197,0.6530264976554937,0.9310344827586207,1.0,1.0,3/12,14.56%,INO80;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.42648991010993675,-0.6526848632517313,0.8088235294117647,0.9866179695881035,1.0,2/5,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.3982360735214005,-0.6526824203350166,0.9295774647887324,0.9863380779655253,1.0,3/11,13.68%,PCK1;CD81;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3554514872872775,0.652121041247117,0.8888888888888888,1.0,1.0,3/7,16.84%,KMT5B;SHLD2;PARP9
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.39730580262535387,-0.6520985073102062,0.9264705882352942,0.9865915101056395,1.0,5/11,24.14%,ANK3;DLG1;AHCYL1;ATP1A1;NEDD4
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.38342903966619946,0.6520932874733392,0.8,1.0,1.0,1/9,1.14%,COL8A1
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,-0.31917919518029725,-0.65187730877322,0.9425287356321839,0.9864905198777089,1.0,6/44,13.73%,LBR;JAK1;CALCOCO2;AAMDC;SLC20A1;CST3
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.3799691580589354,-0.6512736026038278,0.88,0.9866735676508046,1.0,1/11,7.49%,HIF1A
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3227931927315733,-0.6511468602999683,0.9873417721518988,0.9865375226063783,1.0,4/47,8.26%,CX3CL1;TIMP3;ERBB4;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.4010284318641706,-0.6507702678409232,0.8933333333333333,0.9866120277919893,1.0,6/10,37.10%,PLCG2;MTOR;VIM;MTPN;SORBS1;ZBTB20
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,-0.3942012477988609,-0.6505422747727193,0.9142857142857143,0.9865717197532822,1.0,1/9,5.87%,JAK1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.41297474999724687,-0.6500681824309631,0.8857142857142857,0.98669079360722,1.0,1/7,19.60%,EMP2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.36325470526046444,-0.6495046464876784,0.9710144927536232,0.9869245061073477,1.0,3/14,12.46%,COL18A1;PLOD2;PLEC
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.38402006782144726,-0.6494462216558433,0.9130434782608695,0.9866930212070976,1.0,4/12,20.35%,PIK3R1;PLCG2;GRB2;PIK3CB
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,0.3634847642726347,0.6490753478900559,0.9375,1.0,1.0,1/7,3.08%,OCLN
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.3490081898531848,-0.6489672644566501,0.961038961038961,0.9868246976000126,1.0,5/21,16.79%,HSPA5;PRKN;HERPUD1;TMBIM6;HSPH1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.4058188118093272,-0.6489084286798961,0.9130434782608695,0.9866188404641593,1.0,2/9,13.04%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.4045212575732132,-0.6486673087501598,0.9,0.9865276760619694,1.0,1/6,12.54%,FGD4
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.360269094258715,0.647607534531463,0.8857142857142857,1.0,1.0,2/8,12.54%,ELAPOR2;PCM1
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.3835768707633232,0.64720082822006,0.8484848484848485,1.0,1.0,1/6,1.83%,PIGU
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.29210716560736866,-0.6470565602986045,0.9777777777777777,0.9875851844411085,1.0,13/93,17.32%,NR4A1;PPARG;ESR2;ELL2;RREB1;AFF4;CCNH;ELP4;CSTF3;WWTR1;THRB;NOTCH4;TSC22D1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.36931083560262024,-0.6467943091612496,0.927536231884058,0.9874747132396472,1.0,4/15,18.41%,LRRC7;MSN;ERBIN;DLG1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.32692121809651414,-0.6467889560122441,0.9493670886075949,0.9871957655805399,1.0,6/28,17.82%,SCARB2;VAV3;TBC1D15;FGD4;PAFAH1B1;ARHGAP15
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.36104919220043286,-0.6467259610790966,0.9324324324324325,0.986964661684195,1.0,5/14,27.99%,MCL1;GATA2;CD34;PODXL;STAT5B
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.3227753739050279,0.6456725418601278,0.9259259259259259,1.0,1.0,2/15,7.14%,PLCB4;PPIP5K2
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.4058085835842126,-0.6455536003309204,0.873015873015873,0.9876426486506996,1.0,2/8,8.84%,RPS27A;UBC
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.34469626388879554,0.6452539438401642,0.8611111111111112,1.0,1.0,5/8,19.39%,IL6R;TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.39692136193432404,-0.6448862882782016,0.9402985074626866,0.9878849647053517,1.0,4/9,27.41%,AHCYL1;NEDD4;NEDD4L;ANO6
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.36717407605249713,-0.6446304346395022,0.9230769230769231,0.9878444453426012,1.0,3/11,16.65%,HIF1A;TMSB4X;PINK1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.45630445426844807,-0.644193471225608,0.8955223880597015,0.9879976539453778,1.0,1/5,15.70%,RAB8B
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.38590425531914896,0.6433046665298641,0.7777777777777778,1.0,1.0,5/5,61.46%,PIP4K2A;RALB;RAB3GAP1;SH3GLB1;RAB3GAP2
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.340757068227977,0.6421045747947884,0.8529411764705882,1.0,1.0,2/10,12.35%,ZNF521;CNRIP1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,-0.3429485987582269,-0.6413937867590733,0.9230769230769231,0.9898650590662701,1.0,2/17,6.27%,ARHGAP21;PIK3R1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.4077457285725681,-0.6411711478159582,0.8591549295774648,0.9897637153721983,1.0,1/6,6.85%,PRX
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.2638067362763335,0.6410394020263863,1.0,1.0,1.0,6/33,12.30%,EFNA5;CLASP1;ABL1;PHLDB2;TEK;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.37752028116330194,-0.6402346804387311,0.9193548387096774,0.9902367071447119,1.0,3/13,22.60%,HIP1R;PPP3CC;MAPK8
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.3998095511453359,-0.6397517795058885,0.9,0.9902273013632865,1.0,3/7,18.91%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.363416167182211,0.6392522692050748,0.9487179487179487,1.0,1.0,1/6,5.74%,MTMR3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.3088469534206789,-0.6389583941635293,0.967391304347826,0.9905793972756924,1.0,6/52,12.30%,CX3CL1;ERBB4;FLT1;RAP1A;FGFR1;PLCG2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,0.31524427363159424,0.6389223850306256,0.9411764705882353,1.0,1.0,1/15,0.98%,GBP4
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,-0.4126176480495442,-0.6387674903677723,0.9230769230769231,0.9904589458060976,1.0,3/7,19.07%,PIK3R1;FGFR1;GRB2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.3492296831068684,0.6387053922871947,0.8,1.0,1.0,3/11,12.30%,KANK1;TEK;ROCK1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.431138172884587,-0.6383448114982972,0.8596491228070176,0.990557239409309,1.0,1/5,18.43%,MTOR
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.42970697914774814,-0.6377939024842436,0.9491525423728814,0.9907378546144737,1.0,2/5,22.97%,CD81;PRKCH
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3387152057290298,-0.6376473045570439,0.975609756097561,0.9905762833580464,1.0,7/26,20.48%,SMAD7;SDCBP;SMAD3;WWTR1;DAG1;MTOR;SPRED1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.39339332996266285,-0.6366881941431125,0.873015873015873,0.9910702811394574,1.0,3/7,28.18%,TPR;CHMP4B;DYNC1H1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.4253631841162777,-0.6364427472832798,0.9516129032258065,0.9909308669662729,1.0,1/5,19.31%,CHMP4B
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.3968353719167078,-0.6363414150647277,0.8484848484848485,0.9907408946922023,1.0,1/8,10.92%,EPAS1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3984967280560249,0.6363258299394491,0.8837209302325582,1.0,1.0,2/5,9.22%,DISP1;CHD7
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,-0.41831341861404425,-0.6361694891198769,0.8771929824561403,0.9905984875707936,1.0,2/6,33.49%,GRB2;FYN
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.4009402958854338,-0.6358009079251227,0.9166666666666666,0.9906237995886692,1.0,2/10,17.29%,ZFPM2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3624257236908916,-0.6356409399682591,0.9090909090909091,0.9904340736584749,1.0,5/20,22.12%,ARID5A;THRB;ROBO2;TFPI;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.37995767150989024,-0.6353183376643964,0.9166666666666666,0.9903993543432849,1.0,1/8,9.69%,DLC1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.37989799599499163,-0.635273136077018,0.8933333333333333,0.9901465911883877,1.0,2/11,13.04%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32775713460843453,-0.6350634963627114,0.9367088607594937,0.9900582613773592,1.0,3/21,12.14%,GAS7;GPM6A;DCLK1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4228078187478552,-0.6343004551948361,0.9078947368421053,0.9902732033448974,1.0,2/6,20.29%,MYL6;CAV2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.283124567051317,-0.633607858334478,0.9891304347826086,0.9905353899084213,1.0,30/109,25.26%,PPARG;CANX;ARF1;LAMP2;TBC1D15;RAB21;SNX6;GOLPH3;TMED10;NPM1;RAB1A;COPA;LRP1B;RAB8B;MIA2;RAB14;ARL4A;PREPL;ANK3;TBC1D9;USO1;CLU;SCAMP1;DNM2;ARL5B;ATP6V1E1;SNX9;TF;ARRDC3;ARHGEF2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.3865834620031109,-0.63316706726741,0.9285714285714286,0.9906017082451445,1.0,1/7,5.05%,SPG7
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.41103534499900607,-0.6326974402129429,0.9,0.9903524755285734,1.0,1/5,17.45%,LCP2
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.41103534499900607,-0.6326974402129429,0.9,0.9903524755285734,1.0,1/5,17.45%,LCP2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.3882816966085172,0.6323195134824399,0.8787878787878788,1.0,1.0,1/5,6.91%,CTNNA2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.41123562067299146,-0.6311656854104464,0.9076923076923077,0.9912640988093823,1.0,3/7,32.14%,B2M;HLA-E;ERAP1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.34673026959694686,-0.630411561407599,0.9295774647887324,0.9915508666525467,1.0,2/18,10.78%,PIK3R1;GPM6A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2798934896586849,-0.6295688544697118,0.9896907216494846,0.991783883542628,1.0,14/174,10.92%,PSMC6;PSMB9;RPS27A;NFE2L2;RNF19A;PSMA1;HIF1A;COMMD1;PRKN;UBC;ARIH2;KLHL7;CHFR;EPAS1
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,-0.40587284055450296,-0.6283748427493988,0.8688524590163934,0.9922877981593782,1.0,3/6,37.80%,CLTA;LDLR;LSR
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.31517032369510656,-0.6283693376460464,0.9629629629629629,0.9920100797719841,1.0,9/34,22.12%,SLC6A6;SLC8A1;ATP1B3;CACNA1C;SLC30A1;TMEM165;SCN2A;RYR3;ATP1A1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3952764728878824,-0.6281169311834985,0.9264705882352942,0.9918868534217876,1.0,2/9,10.04%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3160865917800846,-0.6273364919215623,0.9726027397260274,0.9921793436860209,1.0,10/44,24.62%,FES;DUSP1;TPM1;TGM2;RSU1;ACVRL1;PODXL;RASA1;PLXNA2;ADGRG1
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.41547466348707407,-0.626294268294285,0.9838709677419355,0.9920521938463671,1.0,1/6,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.41547466348707407,-0.626294268294285,0.9838709677419355,0.9920521938463671,1.0,1/6,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.41547466348707407,-0.626294268294285,0.9838709677419355,0.9920521938463671,1.0,1/6,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.3518482728994544,0.6256026775857091,0.9166666666666666,1.0,1.0,2/8,20.24%,CIRBP;LARP1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.330877122866731,-0.6254989901351302,0.922077922077922,0.9923852002653901,1.0,7/24,16.47%,AFDN;LIMS1;CTNND2;CLDN5;SMAD3;CADM2;CTNNA1
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.33645023904575394,-0.6251790853229521,0.9302325581395349,0.9922840867949791,1.0,6/23,20.66%,PLCG2;NFKBIA;CYLD;MALT1;GADD45B;XIAP
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.34534556968964947,-0.6242645909938387,0.9342105263157895,0.9926042681919172,1.0,1/21,1.46%,TSG101
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,-0.31499113685099034,-0.624161884349728,0.927710843373494,0.9924088692446128,1.0,14/39,27.94%,LRRC32;TNS1;MSRB3;ADAMTS1;SH3RF3;TIE1;ACVRL1;CD34;SPARC;CDH5;NID1;LAMA4;RHOJ;VIM
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.31294805285029936,0.6238432459511691,0.9,1.0,1.0,2/14,7.36%,SLC23A2;SLC25A29
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.3798160800918995,-0.6209495058379739,0.9090909090909091,0.9942180575919434,1.0,2/12,17.24%,ZFP36;DCP2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3539829371878551,-0.6204595361583803,0.8955223880597015,0.9942641696939586,1.0,3/9,25.18%,TPR;IFITM3;KLHL20
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,0.3882113485274693,0.6202732038002641,0.8709677419354839,1.0,1.0,4/6,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,0.3882113485274693,0.6202732038002641,0.8709677419354839,1.0,1.0,4/6,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,0.3882113485274693,0.6202732038002641,0.8709677419354839,1.0,1.0,4/6,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,0.3882113485274693,0.6202732038002641,0.8709677419354839,1.0,1.0,4/6,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.33860573977681224,-0.6200516592140244,0.9428571428571428,0.9943228163215233,1.0,6/17,31.08%,FKBP5;DYNC1I2;CAPZA2;HSP90AA1;DYNC1H1;DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.28102100428769344,0.6199562723607993,0.9743589743589743,1.0,1.0,2/15,9.16%,GBP1;SEMA6A
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,-0.3294470121938967,-0.6196166355964751,0.9466666666666667,0.9943217856874657,1.0,8/28,25.68%,ASAP2;SMARCA1;MYO1B;MYH10;DAG1;SERPINH1;CNN3;MID1
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.33288006119034097,-0.6196117073170969,0.9466666666666667,0.9940445841860195,1.0,2/15,14.00%,JAK1;MSN
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3500932751724407,-0.6192629598335608,0.9102564102564102,0.994071868606192,1.0,6/19,23.56%,CDK6;CAV2;ATOH8;SPARC;B2M;NFIB
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.3975493049725596,-0.6187649234193093,0.9538461538461539,0.9941430497037699,1.0,4/10,21.78%,KCNIP4;DPP10;DLG1;CD63
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.3360880493393973,0.6186628780087841,1.0,1.0,1.0,2/7,21.20%,TMCC1;SLC25A46
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3646626010705359,0.6175976451857776,0.9393939393939394,1.0,1.0,3/8,21.33%,TMEM106B;GNPTAB;LRRK2
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.37234138087470087,-0.6171744575509491,0.9705882352941176,0.9949134498592884,1.0,3/10,17.21%,MGAT4A;ALG11;B4GALT1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.29963538856830885,-0.616122429922587,0.9487179487179487,0.9953385911722702,1.0,7/42,18.43%,GPM6B;HIP1R;DLC1;PAK2;CYLD;ARHGAP17;MTOR
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,0.3589340727891196,0.6159601698052852,0.9210526315789473,1.0,1.0,5/8,19.39%,RCSD1;TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,0.3589340727891196,0.6159601698052852,0.9210526315789473,1.0,1.0,5/8,19.39%,RCSD1;TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.327346571322725,-0.6158570383892026,0.9746835443037974,0.9952244575104445,1.0,5/24,21.81%,SPC25;RPS27;PAFAH1B1;DYNC1I2;EML4
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3587332326438938,-0.6157541518868214,0.9041095890410958,0.9950101291035387,1.0,2/13,7.49%,FES;HIF1A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.3776878391223524,-0.6156271680878905,0.890625,0.9948147131630389,1.0,2/9,9.06%,VAV3;CD81
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,-0.3866265380989412,-0.6150958933415579,0.9032258064516129,0.9948949628121001,1.0,3/7,19.18%,CD81;IL18R1;CD34
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.36606475957068035,-0.614859873489972,0.9538461538461539,0.9947748185590224,1.0,4/8,34.29%,PARVB;RHOJ;RAC1;GSN
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.35187184503170316,-0.6147987472614012,0.8923076923076924,0.9945452055620984,1.0,4/18,18.01%,TPR;PIAS2;CBX5;NUP54
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3325070805817578,0.6146360694041121,0.9487179487179487,1.0,1.0,1/7,7.62%,SGMS1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.3631919206536429,0.6134350008567434,0.8378378378378378,1.0,1.0,2/8,14.69%,CCM2;RBPJ
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.2497347814215869,0.6112074188627924,1.0,1.0,1.0,8/37,17.45%,EVL;CLASP1;CLIP1;CENPP;PPP2R5A;SRGAP2;PPP2R5E;SCAI
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3221781788300625,-0.6097874472539159,0.9166666666666666,0.9973975066653039,1.0,4/25,18.01%,PLOD2;TPR;PIAS2;NUP54
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.40948161017690365,-0.6091516724042447,0.8846153846153846,0.9975895520055564,1.0,1/5,12.99%,NPM1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.33045657297903397,0.6086640837208278,0.875,1.0,1.0,3/9,17.16%,NFAT5;PPP3CA;PLCE1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3124610345254359,-0.6084975724775864,0.9342105263157895,0.9977814906539534,1.0,8/36,23.24%,SULF2;PRKN;CDK14;CTNND2;RACK1;CBFB;GPC3;CCNY
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3148771534808048,0.6083695857869019,0.96875,1.0,1.0,1/10,6.96%,TRIM22
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4020086835045253,-0.6081315297845282,0.961038961038961,0.9977669993942025,1.0,2/7,27.49%,GLI3;KIAA0586
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.36887609055056725,-0.6080695408117704,0.9692307692307692,0.997539999670106,1.0,3/13,12.30%,MBP;HYAL2;PLCG2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3749071293985168,-0.6076720270864463,0.95,0.9975349566055337,1.0,3/7,28.18%,TPR;CHMP4B;DYNC1H1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.37300994926669023,-0.6073553067026627,0.8852459016393442,0.9975330398480378,1.0,3/8,25.05%,CTNNA3;ITGB1;DSP
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.4096929870961348,-0.6073531026976902,0.896551724137931,0.9972563316539051,1.0,2/5,17.82%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4070681205786576,-0.6071165363491122,0.921875,0.9971389875112723,1.0,2/5,23.27%,AFDN;CDH5
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.39527361749355183,-0.6068996109945184,0.96875,0.9967172916291002,1.0,1/6,5.87%,JAK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.39527361749355183,-0.6068996109945184,0.96875,0.9967172916291002,1.0,1/6,5.87%,JAK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.41513398629642084,-0.6067850998292802,0.8888888888888888,0.9964879038698855,1.0,2/5,19.42%,TEC;EGFR
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.36104649226666463,-0.6046224507192622,0.9428571428571428,0.9975309165544594,1.0,2/13,17.85%,S1PR1;CHSY1
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.3650269699699018,-0.6045198789719309,0.922077922077922,0.9973450748751785,1.0,1/9,14.56%,CYLD
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.27532681604104714,0.6039661703395346,1.0,1.0,1.0,2/19,10.41%,IL6R;TNFRSF1B
prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.358707505040913,-0.6027012664267919,0.9852941176470589,0.9981628782115333,1.0,3/12,17.21%,MGAT4A;ALG11;B4GALT1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.37401445419954205,-0.602385119827196,0.8888888888888888,0.9980268161378159,1.0,2/6,18.54%,PINK1;PIKFYVE
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.3567806066538326,-0.6022992855504585,0.9428571428571428,0.9978067279879016,1.0,2/10,12.96%,PLCG2;INPP5D
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.3246773354770731,0.6022653147697754,0.9285714285714286,1.0,1.0,1/11,4.36%,USP25
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.3649397432804853,0.6018175362324625,0.9032258064516129,1.0,1.0,2/5,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.3649397432804853,0.6018175362324625,0.9032258064516129,1.0,1.0,2/5,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3629737507746412,-0.601391498718213,0.9253731343283582,0.9980569762106317,1.0,3/10,22.63%,NPAS2;MCL1;BCLAF1
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.4097444826780082,-0.6013411550484751,0.8947368421052632,0.9975642395267782,1.0,2/5,17.82%,LCP2;ARHGAP15
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.4097444826780082,-0.6013411550484751,0.8947368421052632,0.9975642395267782,1.0,2/5,17.82%,LCP2;ARHGAP15
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,-0.3339630755748917,-0.601088521038539,0.961038961038961,0.9974160852614504,1.0,1/24,4.36%,DPY19L1P1
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,-0.3626286123635386,-0.5989746705458202,0.921875,0.9983131617686276,1.0,1/8,5.87%,JAK1
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.3559533027957501,-0.5986739771916454,0.9411764705882353,0.9982208571244702,1.0,3/11,21.59%,GAS7;SH2D3C;PPP1R16B
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.3075555859298381,0.598089204649748,0.9666666666666667,1.0,1.0,3/10,14.82%,ERCC6;RNF169;SHLD2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.3542989626447326,0.5976584298647639,0.7419354838709677,1.0,1.0,1/5,10.76%,EIF4A2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.37451920449052206,-0.5976567460704587,0.9117647058823529,0.9985949300819484,1.0,2/9,21.89%,GIGYF2;ZC3H18
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.3926991104316744,-0.5972107197968743,0.90625,0.9980478430017868,1.0,3/5,40.05%,XIAP;MAPK1;CARD8
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.3926991104316744,-0.5972107197968743,0.90625,0.9980478430017868,1.0,3/5,40.05%,XIAP;MAPK1;CARD8
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.3926991104316744,-0.5972107197968743,0.90625,0.9980478430017868,1.0,3/5,40.05%,XIAP;MAPK1;CARD8
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.32113845445204003,0.5971794749739452,1.0,1.0,1.0,3/10,13.01%,CTNNA2;ABL1;PDLIM5
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.3207697049512494,-0.5970084697671717,0.9487179487179487,0.9978936305922472,1.0,9/19,33.97%,FOXK1;MCL1;PINK1;MTOR;TLK2;RASIP1;STAT3;MTMR9;FOXK2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.3200786646328604,0.596139948599431,0.9230769230769231,1.0,1.0,1/8,8.13%,HSPB1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,-0.3709161816217438,-0.5959952923348496,0.921875,0.9981834549281653,1.0,1/7,21.51%,PRKAR1A
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.3597613467360433,-0.5959908679784002,0.84375,0.9979113495158815,1.0,5/9,28.21%,AP1G1;CLTA;DNM2;AP4S1;DNAJC6
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.2979059116908341,0.5957029874581623,0.9285714285714286,1.0,1.0,4/17,13.33%,EIF2AK2;KPNA5;NUP58;NUP214
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,-0.3894799733905814,-0.5956188188703635,0.927536231884058,0.9975444020512596,1.0,2/6,10.89%,NES;SHC2
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,-0.3894799733905814,-0.5956188188703635,0.927536231884058,0.9975444020512596,1.0,2/6,10.89%,NES;SHC2
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,-0.3888564977245531,-0.5945079294774165,0.9482758620689655,0.9978215986827418,1.0,3/5,37.32%,CUL1;STAT5B;JAK2
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.35272497791727697,-0.5943575585641281,0.9516129032258065,0.997642901151246,1.0,1/9,9.06%,CD81
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.3204575849857601,0.5941712540607571,0.9629629629629629,1.0,1.0,2/12,6.99%,ATR;SLF2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.40352976478202895,-0.5931295907424308,0.9565217391304348,0.9980376963073656,1.0,2/5,28.66%,RIF1;SMCHD1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,-0.3284056228481472,-0.5925488276502883,0.9078947368421053,0.9981317123073945,1.0,4/18,16.47%,AFDN;CLDN5;CADM2;CTNNA1
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.3326231691078563,0.5921992895725459,1.0,1.0,1.0,10/10,66.83%,PRKACB;PRKCA;RPS6KA5;ICAM2;EP300;CREBBP;ARHGEF7;PKN2;FYN;NFKB1
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.39911611048462226,-0.5915445104579202,0.9259259259259259,0.9983681718127744,1.0,2/5,17.82%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.38123912929568,-0.5913611537860054,0.9193548387096774,0.9981864236877218,1.0,3/5,25.87%,TNKS2;TERF2IP;TNKS
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,0.33635911596010615,0.5907875151378496,0.9210526315789473,1.0,1.0,1/7,9.61%,CDH2
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.30263410603574226,-0.590592206680251,0.9746835443037974,0.9983050893635536,1.0,4/27,20.08%,SPC25;RPS27;PAFAH1B1;DYNC1I2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.35690078716532603,0.5901001330108303,0.9024390243902439,1.0,1.0,3/6,31.18%,PARN;XRN1;DIS3L2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.3453012938016371,-0.5897340681817967,0.927536231884058,0.9984205946170793,1.0,2/12,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3652589036949846,-0.5897034649571044,0.974025974025974,0.9981647183534269,1.0,1/11,5.50%,WDR48
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.3445520739343444,-0.5894674690982031,0.9859154929577465,0.9980296279130633,1.0,3/12,11.24%,IL1RAPL1;CFL1;PPFIA2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3644062859739546,-0.5885369073567928,0.9193548387096774,0.9981945955124374,1.0,2/6,22.71%,CHMP4B;TMEM50B
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.339630788963016,-0.5875009120296776,1.0,0.9984800514181073,1.0,2/14,13.92%,KDM1A;PTTG1IP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3134601790052943,-0.5867306416470984,0.9859154929577465,0.9985984409759309,1.0,7/25,24.67%,RAPGEF3;SH2D3C;TBK1;PINK1;EGFR;TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.362611264852555,0.5865071028985439,0.9444444444444444,1.0,1.0,2/7,15.64%,ENTPD1;PNPT1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.36067743392832924,0.5861550188347185,0.9473684210526315,1.0,1.0,1/5,4.91%,CLASP1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3256076018883629,0.5848342702730414,0.9487179487179487,1.0,1.0,1/7,9.16%,SEMA6A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.36360610717769437,0.5847033434251107,1.0,1.0,1.0,1/5,6.93%,HDAC9
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.352045039835327,-0.5844739202823565,0.9104477611940298,0.9994707425889724,1.0,2/11,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3569229568787756,-0.5842357224024819,0.9545454545454546,0.9993231222171233,1.0,5/9,33.73%,ZFP36;CBFB;PRKCH;FOXC1;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3639553148942386,-0.5839575493675568,0.9193548387096774,0.9991817595928443,1.0,2/7,32.03%,HLA-B;HLA-E
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.32027475222739216,-0.5830472623123728,0.9625,0.9993615773528324,1.0,8/24,27.57%,TNS1;ACVRL1;CD34;OMD;CDH5;SPARCL1;LAMA4;RHOJ
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.35048210112855704,-0.5825346166003736,0.9264705882352942,0.9993159688091499,1.0,1/12,12.99%,NPM1
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,0.33754987030872013,0.5819235233940391,0.8648648648648649,1.0,1.0,1/7,8.47%,SLC38A3
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.40785604974765444,-0.5817033410991636,0.9523809523809523,0.9994894795258579,1.0,1/5,30.65%,POLR2B
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.3739237203104522,-0.5813802858294612,0.9523809523809523,0.9993543962499861,1.0,3/5,48.92%,DIP2A;SIRT1;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.36204052803262,-0.5813534353447933,1.0,0.9991021895310203,1.0,2/9,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3089356845314253,0.5810999423068979,0.9444444444444444,1.0,1.0,2/8,16.18%,HSPB1;APP
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.27576355027070854,0.5805817374924135,0.9411764705882353,1.0,1.0,1/17,2.63%,ATR
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.30379508983221065,-0.5803051785964954,0.987012987012987,0.9992694496309049,1.0,7/25,21.59%,ZEB2;PECAM1;NOTCH4;LCP2;ARHGAP15;CD34;PPP1R16B
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.33716941185414784,-0.5796484922801554,1.0,0.9993256497623076,1.0,1/11,14.90%,NAA16
prerank,KEGG_2021_Human__Taste transduction,0.3340354462975751,0.5788658323523896,0.896551724137931,1.0,1.0,1/7,4.97%,PLCB4
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.3079301143533784,0.5781740558534322,0.9642857142857143,1.0,1.0,3/13,14.29%,ATP6V1H;SESN1;FNIP2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.2545159276150577,0.5775438196653018,0.9583333333333334,1.0,1.0,3/18,12.54%,CLASP1;CLIP1;PCM1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3888246882690386,-0.5770095449945072,1.0,1.0,1.0,3/5,23.35%,PIK3CB;CD63;JCAD
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.3136315228966986,0.5769482069657282,0.9230769230769231,1.0,1.0,9/9,68.71%,AKT3;PIP4K2A;EP300;RBBP4;PDZD2;KAT6A;GATAD2B;BRD7;GATAD2A
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.3326483176555601,-0.5750205757309231,0.9117647058823529,1.0,1.0,2/12,18.01%,TPR;NUP54
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.3339788750513123,-0.5746260320255678,0.921875,1.0,1.0,3/13,18.01%,TPR;PIAS2;NUP54
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3365920167176034,-0.5740051869172329,0.9594594594594594,1.0,1.0,3/11,18.41%,LRRC7;ERBIN;DLG1
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.3323576370409793,0.5736896530582387,0.9714285714285714,1.0,1.0,7/7,66.83%,APP;NLRP1;SUGT1;HSP90AB1;BCL2L1;TXNIP;NFKB1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.31681169896209643,-0.5734498953258774,0.9577464788732394,1.0,1.0,3/13,24.75%,DNM2;ATP6V1E1;TF
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,-0.37553951919018674,-0.5733847041737941,0.9827586206896551,1.0,1.0,2/8,19.18%,PECAM1;CD34
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,-0.3159495891541274,-0.571897255810796,1.0,1.0,1.0,6/23,22.44%,CANX;IPO7;NPM1;ATP13A3;ECT2;HSPA9
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,-0.3159495891541274,-0.571897255810796,1.0,1.0,1.0,6/23,22.44%,CANX;IPO7;NPM1;ATP13A3;ECT2;HSPA9
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,-0.3159495891541274,-0.571897255810796,1.0,1.0,1.0,6/23,22.44%,CANX;IPO7;NPM1;ATP13A3;ECT2;HSPA9
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,-0.3159495891541274,-0.571897255810796,1.0,1.0,1.0,6/23,22.44%,CANX;IPO7;NPM1;ATP13A3;ECT2;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.30638630839160225,0.5718308732683172,0.96,1.0,1.0,6/13,29.93%,STAT2;OAS3;ISG15;PTPN2;A2M;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3469794794909016,-0.5706805426935238,0.9552238805970149,1.0,1.0,2/10,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.32443678453632896,0.5674189122716963,0.9722222222222222,1.0,1.0,1/6,13.09%,PDCD4
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.29148036672461847,0.5674053066358667,1.0,1.0,1.0,2/19,8.29%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.3627659574468085,0.5672053705107877,0.9375,1.0,1.0,5/5,63.77%,PKD2;STAT1;COL4A1;MEF2C;MTSS1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.3343465306409799,-0.5666505996113189,0.9852941176470589,1.0,1.0,3/6,28.92%,ARHGAP15;SCLT1;DENND4A
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.3343465306409799,-0.5666505996113189,0.9852941176470589,1.0,1.0,3/6,28.92%,ARHGAP15;SCLT1;DENND4A
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3284647913800082,0.5663669252228863,0.9705882352941176,1.0,1.0,3/6,22.10%,KMT5B;SHLD2;NECTIN2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.32099037747953013,0.5656634872067464,0.8936170212765957,1.0,1.0,3/5,21.62%,ST3GAL1;PARN;ST6GAL1
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,-0.3784371687430315,-0.5653656265901801,0.95,1.0,1.0,1/5,15.80%,SGIP1
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.3784371687430315,-0.5653656265901801,0.95,1.0,1.0,1/5,15.80%,SGIP1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.3794989092795803,-0.5650072570696002,0.9841269841269841,1.0,1.0,1/5,20.69%,UNC5C
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3183891342555423,-0.5644245247029366,0.9565217391304348,1.0,1.0,3/16,18.01%,TPR;PIAS2;NUP54
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,-0.3439493441598033,-0.5641985371917949,0.9701492537313433,1.0,1.0,2/10,18.75%,ITGB5;ADAM15
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.29587459024305707,-0.5638265093322976,0.9746835443037974,1.0,1.0,11/27,27.94%,IFNGR1;NPM1;RACK1;PICALM;SLC2A13;MTOR;CLU;NSMAF;ABCG1;LARP4;VIM
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.375707293238244,-0.563430948551183,0.9852941176470589,1.0,1.0,2/5,29.91%,MTOR;SMARCA4
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.35000000000000003,0.5617026401050793,0.8571428571428571,1.0,1.0,5/5,65.05%,HDAC4;LYPLAL1;SIRT1;HDAC7;LYPLA1
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.3415323114557666,-0.5613334037439908,0.971830985915493,1.0,1.0,2/11,20.64%,NDUFA12;COX6C
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.3175058533842593,-0.5605778947589622,0.9878048780487805,1.0,1.0,1/16,4.54%,LRRC32
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.3175058533842593,-0.5605778947589622,0.9878048780487805,1.0,1.0,1/16,4.54%,LRRC32
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.3175058533842593,-0.5605778947589622,0.9878048780487805,1.0,1.0,1/16,4.54%,LRRC32
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.3175058533842593,-0.5605778947589622,0.9878048780487805,1.0,1.0,1/16,4.54%,LRRC32
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.3175058533842593,-0.5605778947589622,0.9878048780487805,1.0,1.0,1/16,4.54%,LRRC32
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.31391327480712944,0.5598123127024982,0.9736842105263158,1.0,1.0,6/6,68.66%,PNPT1;IRF1;STAT1;IFI16;UBE2G2;UBE2K
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.3332080532934205,0.5592695933027646,0.8863636363636364,1.0,1.0,1/5,11.29%,NCOA3
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.31600117786691045,-0.5584425343145458,0.9733333333333334,1.0,1.0,4/15,28.87%,CSTF3;SRRM1;SRSF7;THOC2
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.31600117786691045,-0.5584425343145458,0.9733333333333334,1.0,1.0,4/15,28.87%,CSTF3;SRRM1;SRSF7;THOC2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.373936170212766,0.5564018943244895,0.9428571428571428,1.0,1.0,5/5,62.66%,ISG15;SP100;SETD2;TRIM56;MX1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.2924447203048478,-0.555972188608577,1.0,1.0,1.0,7/35,20.08%,TSG101;TPR;NUP54;ITGB1;CHMP4B;EGFR;DYNC1I2
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.37434501301104484,-0.5558885079920717,0.967741935483871,1.0,1.0,2/8,17.45%,PECAM1;LCP2
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.2905951883110536,-0.5552919991754182,0.9746835443037974,1.0,1.0,10/25,35.88%,RGS7;TBCD;ARFGEF2;TUBB6;TUBB4B;TUBA1B;STAT3;GNG4;GNG11;TUBB
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.3820959318828875,-0.5538641635104606,0.95,1.0,1.0,2/5,20.88%,TGM2;SPEN
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.3505011237809777,-0.5537909370740549,0.9571428571428572,1.0,1.0,2/6,28.18%,PAFAH1B1;DYNC1H1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.30848550172331324,-0.5531136510733746,0.987012987012987,1.0,1.0,7/14,34.69%,DLG1;RHOB;RAC1;RHOA;RND3;PPP2R3C;FMNL3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.33264730726426095,-0.5525188307512674,0.9705882352941176,1.0,1.0,3/10,24.75%,DNM2;ATP6V1E1;TF
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.32850709004784595,-0.5522926845154753,0.9859154929577465,1.0,1.0,5/15,23.29%,ADSS2;SULT1C4;GNAI3;MFN1;ACOT9
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.29594992828878963,0.5514134508435067,0.9696969696969697,1.0,1.0,1/10,2.79%,ARHGAP12
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.326416600159617,0.5513468718578031,0.9411764705882353,1.0,1.0,6/6,67.41%,URI1;PPP6R3;PPP6R2;HTT;HSP90B1;MTMR9
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.33846221880218536,-0.5504661326564749,0.9830508474576272,1.0,1.0,1/10,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.36717677693966216,-0.5492687261484094,0.9206349206349206,1.0,1.0,2/6,31.24%,B4GALT1;ST6GALNAC3
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.34289772369222177,-0.5464312857898703,0.9701492537313433,1.0,1.0,2/8,17.45%,SH2D3C;LCP2
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.34289772369222177,-0.5464312857898703,0.9701492537313433,1.0,1.0,2/8,17.45%,SH2D3C;LCP2
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.34289772369222177,-0.5464312857898703,0.9701492537313433,1.0,1.0,2/8,17.45%,SH2D3C;LCP2
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.3397132874440429,-0.5455924806435939,0.972972972972973,1.0,1.0,2/10,14.69%,CBX5;MAX
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,-0.2943304662872541,-0.5449087717560263,0.9726027397260274,1.0,1.0,8/30,25.63%,ABCA5;ZC3H7A;SPIRE1;SNX25;PPM1A;LRCH1;DNAJC3;CNN3
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.31343384212879166,-0.5443924059820786,0.9420289855072463,1.0,1.0,3/12,14.50%,JAG2;MSN;NCK1
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.34690449980130117,-0.5432640459607069,0.9818181818181818,1.0,1.0,2/7,32.51%,TNPO1;DYNC2I1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.35944447774203925,-0.5428741368047657,0.9565217391304348,1.0,1.0,2/6,17.34%,CFL1;KPNB1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.3172896884318228,0.5426711871746994,0.9428571428571428,1.0,1.0,2/7,13.07%,ST3GAL1;ST3GAL6
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.3631335771399017,-0.5421201465647313,0.9482758620689655,1.0,1.0,2/6,17.82%,LCP2;ARHGAP15
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.3486012734608471,-0.5415752360795886,0.9701492537313433,1.0,1.0,3/6,24.44%,CENATAC;ITGB1;NEDD4L
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.3029578024181544,0.5406126093869392,0.9375,1.0,1.0,2/6,16.76%,CTDSP2;SEC31A
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.33316455335267325,-0.5396906897580721,0.9848484848484849,1.0,1.0,4/9,32.32%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.33316455335267325,-0.5396906897580721,0.9848484848484849,1.0,1.0,4/9,32.32%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.31849342829998717,-0.5392987502282112,0.9523809523809523,1.0,1.0,5/14,22.31%,CPEB4;LARS1;MTOR;SPAAR;UBR1
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,0.3143992860475861,0.5390869626229959,0.967741935483871,1.0,1.0,4/7,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,0.3143992860475861,0.5390869626229959,0.967741935483871,1.0,1.0,4/7,19.39%,TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,0.34276714208037573,0.5385297268987258,0.975,1.0,1.0,1/5,16.18%,APP
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3133414928353391,-0.5377012782617938,0.9692307692307692,1.0,1.0,3/12,28.18%,TPR;NEDD4;DYNC1H1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.34194061687377747,-0.53706854939597,0.9701492537313433,1.0,1.0,6/10,31.16%,DYNC1I2;KIF1B;CCDC88A;TUBA1B;CCDC88C;HOOK3
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.3194356621253527,0.5361960914281168,0.925,1.0,1.0,1/7,8.29%,YWHAG
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.32349893199703283,-0.5350683572100019,0.984375,1.0,1.0,3/13,25.87%,CDKN1A;ACVRL1;TNKS
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.3160066020152738,0.5349700172671173,0.9318181818181818,1.0,1.0,3/8,26.37%,PCM1;DYNC2H1;TRIP11
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.25364515207379684,-0.5337486669730526,1.0,1.0,1.0,11/77,21.12%,YTHDC1;HNRNPH3;CSTF3;RNPC3;STRAP;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.33243458884378574,0.5335601630234401,0.926829268292683,1.0,1.0,1/5,13.07%,ST3GAL6
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.31249882219387737,-0.5323616017842094,1.0,1.0,1.0,4/16,19.76%,KLF4;CDK6;CD34;CLU
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.3156999140939014,0.5323603852000602,0.9655172413793104,1.0,1.0,2/6,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.32475415977131383,-0.5306428795158186,0.9714285714285714,1.0,1.0,2/11,11.39%,DUSP16;TPR
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.3301375285041248,0.5299589712002328,0.9523809523809523,1.0,1.0,1/5,7.94%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3301375285041248,0.5299589712002328,0.9523809523809523,1.0,1.0,1/5,7.94%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.3420708455150143,-0.5296282484545395,0.9846153846153847,1.0,1.0,3/7,21.33%,RELL1;GADD45B;SASH1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.378596414528059,-0.5293599595810693,0.9482758620689655,1.0,1.0,2/5,32.14%,B2M;ERAP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.278012408821648,-0.5289899889135242,1.0,1.0,1.0,5/23,19.23%,COMMD1;GOLPH3;PREPL;ANK3;ARFGEF2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.3362682742036217,-0.5288137378925003,0.9830508474576272,1.0,1.0,2/7,20.16%,MT1M;SLC30A1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.30472535962823283,-0.5279920861599503,0.9722222222222222,1.0,1.0,2/15,14.63%,KDM1A;SPIRE1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.31860341402004805,-0.5272209052846375,0.987012987012987,1.0,1.0,2/11,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.31860341402004805,-0.5272209052846375,0.987012987012987,1.0,1.0,2/11,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.3213086383230379,-0.5269520281483837,0.9433962264150944,1.0,1.0,3/7,34.21%,FZD4;MAP3K13;MFSD2A
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.30047008126351005,-0.5268779220776353,0.9545454545454546,1.0,1.0,3/9,27.97%,TPR;HSP90AA1;ATXN3
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.29774037505132117,0.5266504769494152,0.9714285714285714,1.0,1.0,1/6,12.43%,NOD1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.34229295923420744,-0.5265076348118819,0.9692307692307692,1.0,1.0,2/6,38.59%,ANXA2;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.3133000451290441,-0.526024290731674,0.9838709677419355,1.0,1.0,1/11,16.81%,NOTCH4
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.3142071922962254,-0.5250036010439806,0.958904109589041,1.0,1.0,3/8,31.16%,B2M;REST;HOOK3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.3195770283394803,-0.5241979269481,0.9714285714285714,1.0,1.0,3/13,21.17%,PPM1D;PPHLN1;MTF2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.29981558260314917,0.5234109210706925,0.9705882352941176,1.0,1.0,1/6,9.91%,NEK7
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.30359503330471466,-0.5231034935786246,0.984375,1.0,1.0,1/14,11.39%,TPR
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.3271536012597589,0.5229690837220619,0.9393939393939394,1.0,1.0,1/7,3.08%,OCLN
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,-0.3433146629217323,-0.5226182221723377,0.9661016949152542,1.0,1.0,1/7,16.47%,CTNNA1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3255163346691933,0.521430587887721,0.9743589743589743,1.0,1.0,2/6,19.58%,ARHGAP35;PTEN
prerank,KEGG_2021_Human__RNA transport,-0.26672256738689615,-0.5213713724832857,0.9871794871794872,1.0,1.0,6/39,18.01%,EEF1A1;TPR;STRAP;SRRM1;KPNB1;NUP54
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.30746429453815016,-0.5210437977457527,0.9857142857142858,1.0,1.0,2/11,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.3103941131340813,0.5196608444543209,0.96,1.0,1.0,3/6,24.46%,CD99;MCU;CAMK1D
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.3349560916544173,-0.5194652767529983,0.95,1.0,1.0,1/7,14.00%,MSN
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.318435754189944,0.5169202141484835,0.975609756097561,1.0,1.0,6/6,68.21%,FCHSD2;WASF2;CYFIP1;NCKAP1;GSN;ABI2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2844854082331202,0.5166264402356463,0.9,1.0,1.0,1/7,9.64%,ATM
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3397933839108107,-0.5161518509885673,0.9482758620689655,1.0,1.0,1/6,14.00%,MSN
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.30798783849192346,-0.5157703985030188,0.9242424242424242,1.0,1.0,2/8,31.50%,RBM17;SFPQ
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24536319604418125,-0.5157546192566255,1.0,1.0,1.0,10/71,21.12%,YTHDC1;HNRNPH3;CSTF3;RNPC3;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.3354478281801476,-0.5152977235086539,0.9701492537313433,1.0,1.0,2/6,29.30%,ZDHHC21;VCL
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.30136444666416407,-0.5146221037115779,0.9696969696969697,1.0,1.0,3/12,26.43%,TIE1;ROBO2;DLL4
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.2641740825679574,-0.5103406514943954,0.9873417721518988,1.0,1.0,10/34,25.07%,KCNMB4;MEF2A;PLCG2;SYT1;ECT2;RYR3;AHCYL1;ADAM9;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.3127908135895852,-0.5070770943802044,1.0,1.0,1.0,3/10,34.82%,ACVRL1;DLL4;CXCL12
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,0.3104366214542785,0.5068402838894238,0.9473684210526315,1.0,1.0,5/8,22.58%,RCSD1;TNFRSF1B;GIMAP7;GIMAP4;FLI1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.3137624150075604,-0.5058459859566656,0.9402985074626866,1.0,1.0,1/9,12.99%,NPM1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2348282586692344,-0.5049928048792677,1.0,1.0,1.0,22/85,31.50%,YTHDC1;CCNH;HNRNPH3;CSTF3;RNPC3;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B;PTBP1;CWF19L2;PABPC1;SRSF7;RPRD1B;CWC22;THOC2;GCFC2;POLR2B;HNRNPA3;SFPQ
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3135450329657647,0.5046960475221277,0.9459459459459459,1.0,1.0,2/5,22.05%,MORF4L2;EPC1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.29477136718576036,-0.5043700284128498,0.9859154929577465,1.0,1.0,3/11,27.73%,SLC38A2;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.2871986382903842,-0.5038971953980088,1.0,1.0,1.0,4/13,30.65%,RIF1;TERF2IP;SMCHD1;POLR2B
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.29398936142331733,0.5025996988010774,0.9722222222222222,1.0,1.0,3/8,19.52%,ARHGAP35;FCHSD2;LATS1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.3221508959231179,0.5024156497452404,1.0,1.0,1.0,2/5,16.12%,TAPT1;SOX5
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3022138980630865,-0.5002455947233581,0.9838709677419355,1.0,1.0,2/9,19.63%,BCAR1;PLAT
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.3015114498684755,0.4995185254166263,1.0,1.0,1.0,4/5,27.36%,GAS6;TRIM44;DHX9;IFIH1
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,-0.27921477408189654,-0.4986897862081906,0.9866666666666667,1.0,1.0,5/18,25.10%,GPM6A;RAPH1;ROBO2;TERF2IP;APLP2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.3176273898146232,0.498131712523261,0.9666666666666667,1.0,1.0,1/5,8.90%,ABL1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.27442108064945425,0.4981237512977022,1.0,1.0,1.0,8/8,72.62%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;CAMSAP2;MAPK1;MAP2K1
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.2697578403882363,-0.4971876340429726,0.9868421052631579,1.0,1.0,6/21,30.04%,TPR;SRRM1;NUP54;SRSF7;THOC2;NUP98
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3169050881159842,-0.49688827756843,0.9705882352941176,1.0,1.0,4/8,30.23%,PLCG2;CD34;CD46;STAT3
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.2732304889914628,-0.496451467622804,0.9864864864864865,1.0,1.0,6/20,30.04%,TPR;SRRM1;NUP54;SRSF7;THOC2;NUP98
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.3183510638297873,0.4964198108001019,0.9523809523809523,1.0,1.0,5/5,68.21%,FCHSD2;WASF2;CYFIP1;NCKAP1;ABI2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.3279772604359342,-0.4949685346070577,0.9821428571428571,1.0,1.0,1/6,17.29%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.31433560256378296,-0.4948284762220777,0.9863013698630136,1.0,1.0,3/8,34.82%,STK39;RHOA;CXCL12
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3158524063671862,-0.49438551584148405,1.0,1.0,1.0,4/8,31.00%,LARS1;SPAAR;SIK3;SESN3
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.290894582252475,-0.4938437364265573,1.0,1.0,1.0,4/15,22.97%,RAP1A;CLDN5;CBFB;PRKCH
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,0.30384089316741064,0.4912740790258023,0.9736842105263158,1.0,1.0,2/7,10.41%,RCSD1;TNFRSF1B
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,0.30384089316741064,0.4912740790258023,0.9736842105263158,1.0,1.0,2/7,10.41%,RCSD1;TNFRSF1B
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.29615562202236717,-0.489978931539378,1.0,1.0,1.0,2/11,30.23%,ARFGEF2;STAT3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.23747334754797444,0.4890435032752363,1.0,1.0,1.0,13/13,76.33%,PPP2R5A;PPP2R5E;BRAF;YWHAB;PPP2CB;CALM1;PPP2R5C;PPP1CB;JAK2;MARK3;MAP2K1;CAMK2D;SHOC2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.2678614368877227,-0.48883240307241327,1.0,1.0,1.0,4/16,33.68%,VAPB;PABPC1;POLR2B;DDX3X
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.2928053000481925,0.48881801776503414,1.0,1.0,1.0,1/7,10.07%,INVS
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3109259508974521,0.4859912939110458,0.9714285714285714,1.0,1.0,2/5,12.24%,TNFRSF1B;PPARD
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.2685393892399738,-0.4852914102387371,1.0,1.0,1.0,7/21,34.98%,KPNB1;PTBP1;EIF3A;NUP98;POLR2B;TFRC;ILF3
prerank,PanglaoDB_Augmented_2021__B Cells,-0.27765469349241834,-0.48509213752988706,1.0,1.0,1.0,3/15,19.84%,CD55;LCP2;SPCS3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.26501952148556107,0.48478713008831015,1.0,1.0,1.0,1/8,9.64%,ATM
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.2615087350777247,-0.48272061367901575,1.0,1.0,1.0,6/24,31.26%,DDX24;PTBP1;WTAP;MMS19;POLR2B;HNRNPA3
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,0.29734042553191486,0.481696741078729,0.9642857142857143,1.0,1.0,5/5,70.31%,GNAQ;GNA14;ACSL3;PLCB1;ACSL4
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.2708880545848523,-0.47820224298325686,1.0,1.0,1.0,3/11,25.39%,HSPH1;HSP90AA1;SERPINH1
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.29027153762599955,-0.47746977032717347,1.0,1.0,1.0,3/9,30.65%,RNPC3;SRSF7;POLR2B
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.27828089857034455,-0.47536119464585136,0.9852941176470589,1.0,1.0,2/15,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.28991353700399325,-0.4727201480352869,0.9848484848484849,1.0,1.0,1/11,12.99%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3025860262346266,-0.47156839309522053,0.9850746268656716,1.0,1.0,2/5,24.04%,ADAM9;SNX9
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.3028710837931463,-0.4700849071170132,0.971830985915493,1.0,1.0,1/7,18.41%,DLG1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2466702184336709,0.469647348340135,1.0,1.0,1.0,11/11,75.41%,KAT6B;MORF4L2;TRRAP;EP300;NAA50;MORF4L1;CREBBP;KAT6A;PHF20;KAT2B;PHF20L1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.30518079032915213,-0.4693404353882845,1.0,1.0,1.0,1/6,15.51%,PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.30518079032915213,-0.4693404353882845,1.0,1.0,1.0,1/6,15.51%,PPP3CC
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.2832906782520156,-0.467300338087573,1.0,1.0,1.0,2/13,20.64%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.27247240374892867,-0.46648722034534396,0.9841269841269841,1.0,1.0,1/11,9.69%,DLC1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.25024009096888034,0.4657073222464718,0.9767441860465116,1.0,1.0,1/5,13.49%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.2667499490049115,0.4640425690664485,1.0,1.0,1.0,4/11,21.25%,TOP2B;ADARB1;LARP1;STAU1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.2960415113750178,-0.46233312884902633,0.9838709677419355,1.0,1.0,1/8,14.00%,MSN
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.24845390315063448,-0.4608994982830982,1.0,1.0,1.0,9/23,35.88%,RGS7;ARFGEF2;TUBB6;TUBB4B;TUBA1B;STAT3;GNG4;GNG11;TUBB
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.30057513693494486,0.4604529947933841,1.0,1.0,1.0,3/5,27.07%,MAP4;ODF2L;YAP1
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.2411503617631809,-0.45973950819246245,1.0,1.0,1.0,3/19,22.60%,NCK1;UNC5C;MAPK8
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.27155172995214366,-0.4578019364059943,1.0,1.0,1.0,3/16,25.87%,KLF4;HSP90AA1;TNKS
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2624888113650985,-0.45758880645659455,1.0,1.0,1.0,2/14,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.274807129555733,0.4564433999735082,0.9696969696969697,1.0,1.0,6/6,72.56%,SPIDR;GAPVD1;SCFD1;CEP290;DNAJA1;KIAA0586
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.26713416108250726,-0.4524887323808208,1.0,1.0,1.0,2/10,24.41%,NCK1;TNS2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.23656200106439607,0.44674218428722734,1.0,1.0,1.0,7/7,76.39%,PROM1;SHROOM2;ARFGEF3;MYO5C;MAP7;ATP1B1;VWA2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.27450900449897053,-0.4450297577695446,1.0,1.0,1.0,2/9,24.41%,NCK1;TNS2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.28810365951686673,-0.4421019387306861,1.0,1.0,1.0,4/6,34.29%,EMP2;CAMK2D;CCDC88C;GSN
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.302337547211321,-0.44114087365890126,1.0,1.0,1.0,3/5,31.21%,ITGB1;PLXNA2;ITGA1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.2470149379180574,0.4409128254101806,1.0,1.0,1.0,2/7,16.68%,DDX17;PARN
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.2535923363491219,0.4401787798379014,1.0,1.0,1.0,7/7,74.69%,ROCK1;ACTG1;ROCK2;CDC42;AKAP13;RAC1;ALMS1
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,-0.2616315649386785,-0.4398552994292382,0.9710144927536232,1.0,1.0,1/10,15.27%,WWTR1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.30306105392841487,-0.43537622328835157,0.9824561403508771,1.0,1.0,2/5,35.88%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.30306105392841487,-0.43537622328835157,0.9824561403508771,1.0,1.0,2/5,35.88%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.26015749768339513,0.43501314166767757,0.9411764705882353,0.9997163443371534,1.0,2/8,20.66%,PCM1;TBC1D32
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.24251368603493945,-0.433887689140982,1.0,1.0,1.0,5/17,30.65%,TPR;NUP54;AGO2;NUP98;POLR2B
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.24251368603493945,-0.433887689140982,1.0,1.0,1.0,5/17,30.65%,TPR;NUP54;AGO2;NUP98;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.2835106382978723,0.4309406345619854,1.0,0.9989965454319957,1.0,5/5,71.69%,RIC1;EPHA4;EFNA1;DAB2IP;ANXA2
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.242166532268359,-0.4286831906256757,1.0,1.0,1.0,4/15,21.62%,ITGB1;GNAI3;PRKAR1A;ADCY2
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.259533172823202,0.4280465151927183,1.0,0.9981100370067261,1.0,4/6,31.05%,PPP6C;PPP6R3;ANKRD28;SHQ1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.2512693055437565,0.4276485444926986,1.0,0.997026812192363,1.0,3/9,21.33%,TMEM106B;GNPTAB;LRRK2
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.2649626489599156,-0.42421323448595166,1.0,1.0,1.0,4/7,38.30%,ATP6V1E1;TF;TFRC;ATP6V1C1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.26993731826123335,-0.4226031393857683,1.0,1.0,1.0,4/9,38.86%,LRCH1;ARFGEF1;DAB2IP;RDX
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.2729784844340528,-0.41356611279076344,0.9850746268656716,1.0,1.0,1/5,23.64%,PLXNA2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.27342087446643837,-0.4111665004503977,0.9852941176470589,1.0,1.0,1/5,26.37%,ABCG1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.26106720267919575,-0.4091233065233924,1.0,1.0,1.0,1/6,17.45%,LCP2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.2407745320080543,-0.40801598513673937,1.0,1.0,1.0,4/10,32.38%,LCP2;CD74;FGR;BACH2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.22626604618754093,-0.4071518316366377,0.9873417721518988,0.9998427319449423,1.0,1/16,14.56%,CYLD
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.2636375540179141,-0.4058321770151133,1.0,0.9996741905100152,1.0,2/7,30.12%,CDH5;CDH18
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.2658018895086967,-0.40366018814948584,1.0,0.99924250223121,1.0,2/5,30.86%,LCP2;FGR
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.2658018895086967,-0.40366018814948584,1.0,0.99924250223121,1.0,2/5,30.86%,LCP2;FGR
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.23834333664311638,-0.39310083137728213,1.0,0.9994477110728642,1.0,2/11,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.22818575475476305,-0.38853106954022054,1.0,0.9993653833255611,1.0,5/11,34.29%,RACK1;CDH5;RAP1B;ARFGEF1;GSN
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.23834027621056544,-0.37600549433428804,1.0,0.9994193693640318,1.0,4/9,35.59%,AGO2;TUT7;PRKRA;SND1
